PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Welscher, PT; Zuniga, A; Kuijper, S; Drenth, T; Goedemans, HJ; Meijlink, F; Zeller, R				Welscher, PT; Zuniga, A; Kuijper, S; Drenth, T; Goedemans, HJ; Meijlink, F; Zeller, R			Progression of vertebrate limb development through SHH-mediated counteraction of GLI3	SCIENCE			English	Article							CUBITUS INTERRUPTUS; POLARIZING ACTIVITY; MECHANISMS; ACTIVATION; MUTATIONS; MODEL; GENE	Distal limb development and specification of digit identities in tetrapods are under the control of a mesenchymal organizer called the polarizing region. Sonic Hedgehog (SHH) is the morphogenetic signal produced by the polarizing region in the posterior limb bud. Ectopic anterior SHH signaling induces digit duplications and has been suspected as a major cause underlying congenital malformations that result in digit polydactyly. Here, we report that the polydactyly of Gli3-deficient mice arises independently of SHH signaling. Disruption of one or both Gli3 alleles in mouse embryos lacking Shh progressively restores limb distal development and digit formation. Our genetic analysis indicates that SHH signaling counteracts GLI3-mediated repression of key regulator genes, cell survival, and distal progression of limb bud development.	Univ Utrecht, Fac Biol, Dept Dev Biol, NL-3584 CH Utrecht, Netherlands; Hubrecht Lab, NL-3584 CT Utrecht, Netherlands	Utrecht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Zeller, R (corresponding author), Univ Utrecht, Fac Biol, Dept Dev Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	R.Zeller@bio.uu.nl	Zuniga, Aimée/Q-2692-2018; Zeller, Rolf/C-2610-2013; Zuniga, Aimée/AAG-7335-2020	Zuniga, Aimée/0000-0002-9953-3637; Zeller, Rolf/0000-0002-3186-7403; Zuniga, Aimée/0000-0002-9953-3637				Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; Brewster R, 2000, DEVELOPMENT, V127, P4395; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Caruccio NC, 1999, DEV BIOL, V212, P137, DOI 10.1006/dbio.1999.9321; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Cohn MJ, 2000, NATURE, V406, P953, DOI 10.1038/35023216; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DESCHAMPS J, 810680123 NETH RES O; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; JOHNSON RL, 1994, CURR OPIN GENET DEV, V4, P535, DOI 10.1016/0959-437X(94)90069-F; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; Methot N, 2001, DEVELOPMENT, V128, P733; Qu SM, 1998, DEVELOPMENT, V125, P2711; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zuniga A, 1999, DEVELOPMENT, V126, P13; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	26	288	296	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2002	298	5594					827	830		10.1126/science.1075620	http://dx.doi.org/10.1126/science.1075620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12215652				2022-12-28	WOS:000178791200059
J	Xu, X; Cheng, YN; Wang, XL; Chang, CH; Chang, H				Xu, X; Cheng, YN; Wang, XL; Chang, CH; Chang, H			An unusual oviraptorosaurian dinosaur from China	NATURE			English	Article							EVOLUTION; SKELETON	Oviraptorosaurians are an unusual group of theropod dinosaurs, with highly specialized skulls(1-6). Here we report a new oviraptorosaurian, Incisivosaurus gauthieri, gen. et sp. nov., from the lowest part of the Lower Cretaceous Yixian Formation of China. This oviraptorosaurian displays a number of characters closer to more typical theropods, such as a low skull and toothed jaws, thus greatly reducing the morphological gap between oviraptorosaurs and other theropods(4-11). Incisivosaurus has a pair of premaxillary teeth resembling rodent incisors and small, lanceolate cheek teeth with large wear facets. These dental features were previously unknown among theropods and suggest a herbivorous diet. The new discovery provides a case of convergent evolution and demonstrates that non-avian theropods were much more diverse ecologically than previously suspected.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Natl Museum Nat Sci, Div Geol, Taichung, Taiwan	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	xing_xu@sina.com						[Anonymous], 1981, T JOINT SOVIET MONGO; Barrett Paul M., 2000, P42, DOI 10.1017/CBO9780511549717.004; Barsbold, 1983, SOVMESTNAIA SOVETSKO, V19, P1; Barsbold R., 1990, P249; BARSBOLD R, 1976, DOKL AKAD NAUK SSSR+, V226, P685; Barsbold R., 1997, ENCY DINOSAURS, P505; Benton MJ, 1997, VERTEBRATE PALEONTOL; Clark JM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)364<0001:CAOCOT>2.0.CO;2; Clark JM, 2001, J VERTEBR PALEONTOL, V21, P209, DOI 10.1671/0272-4634(2001)021[0209:TNOTOU]2.0.CO;2; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2255, DOI 10.1139/e93-196; Elzanowski A, 1999, SM C PALEOB, P311; Holtz Jr T. R., 2000, GAIA, V15, P5; HOLTZ TR, 2000, GAIA, V15, P159; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Kobayashi Y, 1999, NATURE, V402, P480, DOI 10.1038/44999; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Maryanska T, 2002, ACTA PALAEONTOL POL, V47, P97; OSMOLSKA H, 1976, NATURE, V262, P683, DOI 10.1038/262683a0; Paul G.S., 1988, HUNTERIA, V2, P1; Russell DA., 1997, ENCY DINOSAURS, P729; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; SUES HD, 1997, J VERT PALEONTOL, V17, P498; Swisher C.C., 2001, CHINESE SCI BULL, V46, P2009; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	29	107	119	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					291	293		10.1038/nature00966	http://dx.doi.org/10.1038/nature00966			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239565				2022-12-28	WOS:000178056300043
J	Yanovsky, MJ; Kay, SA				Yanovsky, MJ; Kay, SA			Molecular basis of seasonal time measurement in Arabidopsis	NATURE			English	Article							CIRCADIAN CLOCK; FLOWERING-TIME; THALIANA; GENES; INDUCTION; GIGANTEA; MUTANTS; RHYTHMS; SYSTEM; PLANTS	Several organisms have evolved the ability to measure daylength, or photoperiod, allowing them to adjust their development in anticipation of annual seasonal changes. Daylength measurement requires the integration of temporal information, provided by the circadian system, with light/dark discrimination, initiated by specific photoreceptors. Here we demonstrate that in Arabidopsis this integration takes place at the level of CONSTANS (CO)(1) function. CO is a transcriptional activator that accelerates flowering time in long days, at least in part by inducing the expression of FLOWERING LOCUS T (FT)(2-5). First, we show that precise clock control of the timing of CO expression, such that it is high during daytime only in long days, is critical for daylength discrimination. We then provide evidence that CO activation of FT expression requires the presence of light perceived through cryptochrome 2 (cry2) or phytochrome A (phyA). We conclude that an external coincidence mechanism, based on the endogenous circadian control of CO messenger RNA levels, and the modulation of CO function by light, constitutes the molecular basis for the regulation of flowering time by daylength in Arabidopsis.	Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Kay, SA (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevek@scripps.edu	Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878				Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; ARAKI T, 1993, PLANT J, V3, P231, DOI 10.1046/j.1365-313X.1993.t01-15-00999.x; Blazquez MA, 1999, PLANT PHYSIOL, V120, P1025, DOI 10.1104/pp.120.4.1025; Bunning E., 1936, BER DEUT BOT GES, V54, P590, DOI DOI 10.1038/424033A; Corbesier L, 1996, PLANT J, V9, P947, DOI 10.1046/j.1365-313X.1996.9060947.x; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; PITTENDRIGH CS, 1964, AM NAT, V98, P261, DOI 10.1086/282327; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Samach A, 2000, BIOESSAYS, V22, P38, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;38::AID-BIES8&gt;3.0.CO;2-L; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Somers DE, 1998, DEVELOPMENT, V125, P485; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Yanovsky MJ, 2001, CURR OPIN PLANT BIOL, V4, P429, DOI 10.1016/S1369-5266(00)00196-5; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x	25	495	534	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					308	312		10.1038/nature00996	http://dx.doi.org/10.1038/nature00996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239570				2022-12-28	WOS:000178056300048
J	Sachs, MS; Geballe, AP				Sachs, MS; Geballe, AP			Sense and sensitivity - Controlling the ribosome	SCIENCE			English	Editorial Material									Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, OGI Sch Sci & Engn, Beaverton, OR 97006 USA; Fred Hutchinson Canc Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98109 USA	Oregon Health & Science University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Sachs, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, OGI Sch Sci & Engn, Beaverton, OR 97006 USA.	msachs@bmb.ogi.edu; ageballe@fhcrc.org		Sachs, Matthew/0000-0001-9891-9223				Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Geballe AP, 2000, COLD SPRING HARBOR M, V39, P595; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; MILLIGAN RA, 1986, NATURE, V319, P693, DOI 10.1038/319693a0; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4	10	7	7	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1820	1821		10.1126/science.1076865	http://dx.doi.org/10.1126/science.1076865			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228706				2022-12-28	WOS:000177955000029
J	Kump, LR				Kump, LR			Reducing uncertainty about carbon dioxide as a climate driver	NATURE			English	Editorial Material							ATMOSPHERIC CO2; TEMPERATURES; HYPOTHESIS; ALBEDO; CORE; ICE	The lack of an adequate ancient analogue for future climates means that we ultimately must use and trust climate models, evaluated against modern observation and our best geologic records of warm and cold climates of the past. Armed with an elevated confidence in the models, we will then be able to make reliable predictions of the Earth's response to our risky experiment with the climate system.	Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Penn State Univ, NASA, Astrobiol Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kump, LR (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	lkump@psu.edu	Kump, Lee/H-8287-2012					Barron EJ, 1987, PALEOCEANOGRAPHY, V2, P729, DOI 10.1029/PA002i006p00729; Beerling DJ, 2002, P NATL ACAD SCI USA, V99, P7836, DOI 10.1073/pnas.122573099; BROCCOLI AJ, 1987, CLIM DYNAM, V1, P87; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Crowley TJ, 2001, SCIENCE, V292, P870, DOI 10.1126/science.1061664; Crowley TJ, 2000, WARM CLIMATES EARTH, P50, DOI DOI 10.1017/CBO9780511564512.004; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Kump LR, 1999, PALAEOGEOGR PALAEOCL, V152, P173, DOI 10.1016/S0031-0182(99)00046-2; Montgomery DR, 2001, GEOLOGY, V29, P579, DOI 10.1130/0091-7613(2001)029<0579:CTATMO>2.0.CO;2; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; Wilson PA, 2002, GEOLOGY, V30, P607, DOI 10.1130/0091-7613(2002)030<0607:TTCGHU>2.0.CO;2	14	52	59	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					188	190		10.1038/nature01087	http://dx.doi.org/10.1038/nature01087			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226672				2022-12-28	WOS:000177931200047
J	Seayad, A; Ahmed, M; Klein, H; Jackstell, R; Gross, T; Beller, M				Seayad, A; Ahmed, M; Klein, H; Jackstell, R; Gross, T; Beller, M			Internal olefins to linear amines	SCIENCE			English	Article							HYDROFORMYLATION; ALDEHYDES; CATALYST; LIGAND	The selective synthesis of linear amines from internal olefins or olefin mixtures was achieved through a catalytic one-pot reaction consisting of an initial olefin isomerization followed by hydroformylation and reductive amination. Key to the success is the use of specially designed phosphine ligands in the presence of rhodium catalysts. This reaction constitutes an economically attractive and environmentally favorable synthesis of linear aliphatic amines.	Univ Rostock EV IfOK, Inst Organ Katalyseforsch, D-18055 Rostock, Germany	University of Rostock	Beller, M (corresponding author), Univ Rostock EV IfOK, Inst Organ Katalyseforsch, Buchbinderstr 5-6, D-18055 Rostock, Germany.	matthias.better@ifok.uni-rostock.de	Seayad, Abdul Majeed/P-6458-2014; , 000/AAG-9847-2019; Jackstell, Ralf/A-1619-2015	Seayad, Abdul Majeed/0000-0002-4696-0846				BELLER M, IN PRESS SYNLETT; BROUSSARD ME, 1993, SCIENCE, V260, P1784, DOI 10.1126/science.260.5115.1784; Eilbracht P, 1999, CHEM REV, V99, P3329, DOI 10.1021/cr970413r; HERRMANN WA, 1995, ORGANOMETALLICS, V14, P1961, DOI 10.1021/om00004a057; Klein H, 2001, ANGEW CHEM INT EDIT, V40, P3408, DOI 10.1002/1521-3773(20010917)40:18<3408::AID-ANIE3408>3.0.CO;2-A; Muller TE, 1998, CHEM REV, V98, P675, DOI 10.1021/cr960433d; Ricci A., 2000, MODERN AMINATION MET; Selent D, 2000, ANGEW CHEM INT EDIT, V39, P1639, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1639::AID-ANIE1639>3.0.CO;2-C; TAMAO K, 1977, TETRAHEDRON LETT, P1389; van der Veen LA, 1999, ANGEW CHEM INT EDIT, V38, P336, DOI 10.1002/(SICI)1521-3773(19990201)38:3<336::AID-ANIE336>3.0.CO;2-P; van Leeuwen P.W.N.M., 2000, RHODIUM CATALYZED HY; van Leeuwen PWNM, 2000, CHEM REV, V100, P2741, DOI 10.1021/cr9902704; WEISSERMEL K, 2000, IND ORG CHEM	13	280	289	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587					1676	1678		10.1126/science.1074801	http://dx.doi.org/10.1126/science.1074801			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215640				2022-12-28	WOS:000177819100042
J	Jost, S; Bernard, MC; Kaiser, L; Yerly, S; Hirschel, B; Samri, A; Autran, B; Goh, LE; Perrin, L				Jost, S; Bernard, MC; Kaiser, L; Yerly, S; Hirschel, B; Samri, A; Autran, B; Goh, LE; Perrin, L			A patient with HIV-1 superinfection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SEROCONVERSION; PROGRESSION; COINFECTION; INFECTIONS; RESISTANCE; AIDS		Univ Geneva, Div Infect Dis, CH-1211 Geneva 4, Switzerland; Hop La Pitie Salpetriere, Lab Immunol Cellulaire, Paris, France; GlaxoSmithKline, Clin Dev Med Affairs, Greenford, Middx, England	University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; GlaxoSmithKline	Perrin, L (corresponding author), Univ Hosp Geneva, Virol Lab, CH-1211 Geneva 14, Switzerland.			Kaiser, Laurent/0000-0002-0857-2252				ANGEL JB, 2000, 7 C RETR OPP INF SAN, P235; [Anonymous], PHYLIP PHYLOGENY INF; Farzadegan H, 1996, J ACQ IMMUN DEF SYND, V13, P448, DOI 10.1097/00042560-199612150-00008; Goh L E, 2001, HIV Clin Trials, V2, P438; Kampinga GA, 1997, VIROLOGY, V227, P63, DOI 10.1006/viro.1996.8318; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Liu SL, 1997, J VIROL, V71, P4284, DOI 10.1128/JVI.71.6.4284-4295.1997; *LOS AL NAT LAB, 2002, HIV SEQ DAT BAS CIRC; Malim MH, 2001, CELL, V104, P469, DOI 10.1016/S0092-8674(01)00234-3; Samri A, 2000, J VIROL, V74, P9306, DOI 10.1128/JVI.74.19.9306-9312.2000; Shibata R, 1996, J VIROL, V70, P4361, DOI 10.1128/JVI.70.7.4361-4369.1996; StahlHennig C, 1996, J GEN VIROL, V77, P2969, DOI 10.1099/0022-1317-77-12-2969; Stephens EB, 1997, VIROLOGY, V234, P328, DOI 10.1006/viro.1997.8662; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; Yerly S, 2001, J INFECT DIS, V184, P369, DOI 10.1086/322036; ZHU TF, 1995, J VIROL, V69, P1324, DOI 10.1128/JVI.69.2.1324-1327.1995; 1999, CLIN INVESTIGATORS B	17	186	190	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2002	347	10					731	736		10.1056/NEJMoa020263	http://dx.doi.org/10.1056/NEJMoa020263			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NH	12213944				2022-12-28	WOS:000177765800005
J	Cortright, RD; Davda, RR; Dumesic, JA				Cortright, RD; Davda, RR; Dumesic, JA			Hydrogen from catalytic reforming of biomass-derived hydrocarbons in liquid water	NATURE			English	Article							GAS-SHIFT REACTION; METAL-CATALYSTS; KINETICS; GLUCOSE; CONVERSION; RUTHENIUM; FRUCTOSE; MODEL	Concerns about the depletion of fossil fuel reserves and the pollution caused by continuously increasing energy demands make hydrogen an attractive alternative energy source. Hydrogen is currently derived from nonrenewable natural gas and petroleum(1), but could in principle be generated from renewable resources such as biomass or water. However, efficient hydrogen production from water remains difficult and technologies for generating hydrogen from biomass, such as enzymatic decomposition of sugars(2-5), steam-reforming of bio-oils(6-8) and gasification(9), suffer from low hydrogen production rates and/or complex processing requirements. Here we demonstrate that hydrogen can be produced from sugars and alcohols at temperatures near 500 K in a single-reactor aqueous-phase reforming process using a platinum-based catalyst. We are able to convert glucose-which makes up the major energy reserves in plants and animals-to hydrogen and gaseous alkanes, with hydrogen constituting 50% of the products. We find that the selectivity for hydrogen production increases when we use molecules that are more reduced than sugars, with ethylene glycol and methanol being almost completely converted into hydrogen and carbon dioxide. These findings suggest that catalytic aqueous-phase reforming might prove useful for the generation of hydrogen-rich fuel gas from carbohydrates extracted from renewable biomass and biomass waste streams.	Univ Wisconsin, Dept Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dumesic, JA (corresponding author), Univ Wisconsin, Dept Chem Engn, 1415 Johnson Dr, Madison, WI 53706 USA.							AMPHLETT JC, 1998, HYDROGEN ENERGY PROG, V3, P1681; AMPHLETT JC, 1998, P 33 INT EN CONV ENG, V269, P1; Bates SP, 1998, ADV CATAL, V42, P1, DOI 10.1016/S0360-0564(08)60627-6; Blanc B, 2000, GREEN CHEM, V2, P89, DOI 10.1039/a909131i; Collins P. C., 1995, MONOSACCHARIDES THEI; Eggleston G, 2000, J CARBOHYD CHEM, V19, P1305, DOI 10.1080/07328300008544153; Garcia L, 2000, APPL CATAL A-GEN, V201, P225, DOI 10.1016/S0926-860X(00)00440-3; Gates B.C., 1992, CATALYTIC CHEM; Greeley J, 2002, J AM CHEM SOC, V124, P7193, DOI 10.1021/ja017818k; GRENOBLE DC, 1981, J CATAL, V67, P90, DOI 10.1016/0021-9517(81)90263-3; Hilaire S, 2001, APPL CATAL A-GEN, V215, P271, DOI 10.1016/S0926-860X(01)00535-X; IGLESIA E, 1992, J CATAL, V137, P212, DOI 10.1016/0021-9517(92)90150-G; Kabyemela BM, 1999, IND ENG CHEM RES, V38, P2888, DOI 10.1021/ie9806390; KELLNER CS, 1981, J CATAL, V70, P418, DOI 10.1016/0021-9517(81)90354-7; Kumar N, 2000, PROCESS BIOCHEM, V35, P589, DOI 10.1016/S0032-9592(99)00109-0; LARMINIE J, 2000, FUEL CELL SYSTEMS EX, P189; Li HX, 2000, J CATAL, V191, P257, DOI 10.1006/jcat.1999.2792; Marquevich M, 1999, ENERG FUEL, V13, P1160, DOI 10.1021/ef990034w; MILNE TA, 2002, HYDROGEN BIOMASS STA, P1; NARAYAN R, 1984, BIOTECHNOL BIOENG S, V14, P563; Rostrup-Nielsen JR, 2001, PHYS CHEM CHEM PHYS, V3, P283, DOI 10.1039/b004660o; TRONCONI E, 1992, CHEM ENG SCI, V47, P2451, DOI 10.1016/0009-2509(92)87075-2; VANNICE MA, 1977, J CATAL, V50, P228, DOI 10.1016/0021-9517(77)90031-8; Woodward J, 2000, NATURE, V405, P1014, DOI 10.1038/35016633; Woodward J, 2000, ENERG FUEL, V14, P197, DOI 10.1021/ef990126l; Yokoi H, 2001, J BIOSCI BIOENG, V91, P58, DOI 10.1263/jbb.91.58	26	1682	1777	48	1466	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					964	967		10.1038/nature01009	http://dx.doi.org/10.1038/nature01009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198544				2022-12-28	WOS:000177677500041
J	Courtney, SE; Durand, DJ; Asselin, JM; Hudak, ML; Aschner, JL; Shoemaker, CT				Courtney, SE; Durand, DJ; Asselin, JM; Hudak, ML; Aschner, JL; Shoemaker, CT		Neonatal Ventilation Study Grp	High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERMITTENT MANDATORY VENTILATION; RESPIRATORY-DISTRESS-SYNDROME; EXOGENOUS SURFACTANT THERAPY; HYALINE-MEMBRANE DISEASE; PRETERM INFANTS; INTRAVENTRICULAR HEMORRHAGE; LUNG INJURY; TRIGGERED VENTILATION; VOLUME OPTIMIZATION; CONTROLLED-TRIAL	Background The efficacy and safety of early high-frequency oscillatory ventilation as compared with conventional synchronized intermittent mandatory ventilation for the treatment of infants with very low birth weight have not been established. Methods We conducted a randomized, multicenter clinical trial to determine whether infants treated with early high-frequency oscillatory ventilation were more likely than infants treated with synchronized intermittent mandatory ventilation to be alive without requiring supplemental oxygen at 36 weeks of postmenstrual age. Eligible infants weighed 601 to 1200 g at birth, were less than four hours of age, had received one dose of surfactant, and required ventilation with a mean airway pressure of at least 6 cm of water and a fraction of inspired oxygen of at least 0.25. Infants were stratified according to birth weight and exposure to prenatal corticosteroids and then randomly assigned to high-frequency oscillatory ventilation or synchronized intermittent mandatory ventilation. Ventilation was managed according to protocols designed to optimize lung inflation and blood gas values. Results Five hundred infants were enrolled in the study. Infants randomly assigned to high-frequency oscillatory ventilation were successfully extubated earlier than infants assigned to synchronized intermittent mandatory ventilation (P < 0.001). Of infants assigned to high-frequency oscillatory ventilation, 56 percent were alive without a need for supplemental oxygen at 36 weeks of postmenstrual age, as compared with 47 percent of those receiving synchronized intermittent mandatory ventilation (P = 0.046). There was no difference between the groups in the risk of intracranial hemorrhage, cystic periventricular leukomalacia, or other complications. Conclusions There was a small but significant benefit of high-frequency oscillatory ventilation in terms of the pulmonary outcome for very-low-birth-weight infants without an increase in the occurrence of other complications of premature birth.	Cooper Univ Hosp, Div Neonatol, Camden, NJ 08103 USA; Childrens Hosp & Res Ctr, Div Neonatol, Oakland, CA USA; Childrens Hosp & Res Ctr, Neonatal Pediat Res Grp, Oakland, CA USA; Univ Florida, Div Neonatol, Jacksonville, FL USA; Wolfson Childrens Hosp, Div Neonatol, Jacksonville, FL USA; Wake Forest Univ, Div Neonatol, Sch Med, Winston Salem, NC 27109 USA; Meritcare Childrens Hosp, Fargo, ND USA	Cooper University Hospital; State University System of Florida; University of Florida; Wake Forest University	Courtney, SE (corresponding author), Long Isl Jewish Med Ctr, Schneider Childrens Hosp, Div Neonatol, 270-05 76th Ave, New Hyde Pk, NY 11040 USA.	scourtney@lij.edu		Durand, David/0000-0003-1181-0941				*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; AMITAY M, 1993, CRIT CARE MED, V21, P118, DOI 10.1097/00003246-199301000-00022; BERNSTEIN G, 1994, AM J RESP CRIT CARE, V150, P1444, DOI 10.1164/ajrccm.150.5.7952573; Bernstein G, 1996, J PEDIATR-US, V128, P453, DOI 10.1016/S0022-3476(96)70354-2; Bhuta T, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.5.e6; BOYNTON BR, 1991, J APPL PHYSIOL, V70, P701, DOI 10.1152/jappl.1991.70.2.701; BRYAN AC, 1986, AM REV RESPIR DIS, V133, P928; BRYAN AC, 1991, PEDIATRICS, V87, P565; Cannon ML, 2000, AM J RESP CRIT CARE, V162, P2109, DOI 10.1164/ajrccm.162.6.9906112; CHAN V, 1993, EUR J PEDIATR, V152, P51, DOI 10.1007/BF02072516; Claris O, 1996, BIOL NEONATE, V70, P29; Clark RH, 2000, PEDIATRICS, V105, P112, DOI 10.1542/peds.105.1.112; CLARK RH, 1992, PEDIATRICS, V89, P5; Clark RH, 1996, PEDIATRICS, V98, P1058; CLEARY JP, 1995, J PEDIATR-US, V126, P407, DOI 10.1016/S0022-3476(95)70460-4; DELEMOS RA, 1987, PEDIATR RES, V21, P594, DOI 10.1203/00006450-198706000-00018; DELEMOS RA, 1989, ACTA ANAESTH SCAND, V33, P102, DOI 10.1111/j.1399-6576.1989.tb03013.x; Durand D J, 2001, J Perinatol, V21, P221, DOI 10.1038/sj.jp.7210527; DURAND DJ, 1993, J PEDIATR-US, V122, P609; Froese AB, 1997, CRIT CARE MED, V25, P906, DOI 10.1097/00003246-199706000-00004; FROESE AB, 1989, ACTA ANAESTH SCAND, V33, P126, DOI 10.1111/j.1399-6576.1989.tb03018.x; FROESE AB, 1993, AM REV RESPIR DIS, V148, P569, DOI 10.1164/ajrccm/148.3.569; Gerstmann DR, 1996, PEDIATRICS, V98, P1044; GERSTMANN DR, 1990, PEDIATR RES, V28, P367, DOI 10.1203/00006450-199010000-00013; GOETZ MC, 1995, AM J PERINAT, V12, P325, DOI 10.1055/s-2007-994486; GREENOUGH A, 1991, J PERINAT MED, V19, P471, DOI 10.1515/jpme.1991.19.6.471; HAMILTON PP, 1983, J APPL PHYSIOL, V55, P131, DOI 10.1152/jappl.1983.55.1.131; HERSHENSON MB, 1995, CRIT CARE MED, V23, P1443, DOI 10.1097/00003246-199508000-00022; HIFI Study Group, 1989, N Engl J Med, V320, P88; HORBAR JD, 2000, VERMONT OXFORD NETWO; Ito Y, 1998, AM J RESP CRIT CARE, V157, P149, DOI 10.1164/ajrccm.157.1.9701073; JACKSON JC, 1994, AM J RESP CRIT CARE, V150, P534, DOI 10.1164/ajrccm.150.2.8049842; Kalenga M, 1998, J APPL PHYSIOL, V84, P1174, DOI 10.1152/jappl.1998.84.4.1174; Keszler M, 1997, PEDIATRICS, V100, P593, DOI 10.1542/peds.100.4.593; KESZLER M, 1991, J PEDIATR-US, V119, P85, DOI 10.1016/S0022-3476(05)81046-7; KINSELLA JP, 1991, PEDIATR RES, V29, P160, DOI 10.1203/00006450-199102000-00012; MCCULLOCH PR, 1988, AM REV RESPIR DIS, V137, P1185, DOI 10.1164/ajrccm/137.5.1185; MENT LR, 1994, PEDIATRICS, V93, P543; MEREDITH KS, 1989, J APPL PHYSIOL, V66, P2150, DOI 10.1152/jappl.1989.66.5.2150; Moriette G, 2001, PEDIATRICS, V107, P363, DOI 10.1542/peds.107.2.363; OGAWA Y, 1993, EARLY HUM DEV, V32, P1, DOI 10.1016/0378-3782(93)90088-C; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; PARDOU A, 1993, INTENS CARE MED, V19, P406, DOI 10.1007/BF01724881; PATEL CA, 1995, ARCH PEDIAT ADOL MED, V149, P317, DOI 10.1001/archpedi.1995.02170150097019; Perlman JM, 1996, PEDIATRICS, V97, P822; Pierrat V, 2001, ARCH DIS CHILD-FETAL, V84, pF151, DOI 10.1136/fn.84.3.F151; Pillow JJ, 1999, J APPL PHYSIOL, V87, P407, DOI 10.1152/jappl.1999.87.1.407; Plavka R, 1999, INTENS CARE MED, V25, P68, DOI 10.1007/s001340050789; Rimensberger PC, 2000, PEDIATRICS, V105, P1202, DOI 10.1542/peds.105.6.1202; ROJAS MA, 1995, J PEDIATR-US, V126, P605, DOI 10.1016/S0022-3476(95)70362-4; Simma B, 1996, PEDIATR PULM, V22, P263, DOI 10.1002/(SICI)1099-0496(199610)22:4<263::AID-PPUL6>3.0.CO;2-N; Stevenson DK, 1998, AM J OBSTET GYNECOL, V179, P1632, DOI 10.1016/S0002-9378(98)70037-7; Suzuki H, 1992, Acta Paediatr Jpn, V34, P494; Synnes AR, 2001, J PEDIATR-US, V138, P525, DOI 10.1067/mpd.2001.111822; Thome U, 1999, J PEDIATR-US, V135, P39, DOI 10.1016/S0022-3476(99)70325-2; TRUOG WE, 1984, AM REV RESPIR DIS, V130, P76; Wada K, 1997, J APPL PHYSIOL, V83, P1054, DOI 10.1152/jappl.1997.83.4.1054; Yoder BA, 2000, AM J RESP CRIT CARE, V162, P1867, DOI 10.1164/ajrccm.162.5.9912145; Zubrow A B, 1995, J Perinatol, V15, P470	59	214	248	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2002	347	9					643	652		10.1056/NEJMoa012750	http://dx.doi.org/10.1056/NEJMoa012750			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZT	12200551	Bronze			2022-12-28	WOS:000177675500003
J	Kleine, T; Munker, C; Mezger, K; Palme, H				Kleine, T; Munker, C; Mezger, K; Palme, H			Rapid accretion and early core formation on asteroids and the terrestrial planets from Hf-W chronometry	NATURE			English	Article							EARLY SOLAR-SYSTEM; ORDINARY CHONDRITES; METEORITES; EARTH; TUNGSTEN; CONSTRAINTS; CHRONOLOGY; EUCRITES; MOON; MARS	The timescales and mechanisms for the formation and chemical differentiation of the planets can be quantified using the radioactive decay of short-lived isotopes(1-10). Of these, the Hf-182-to-W-182 decay is ideally suited for dating core formation in planetary bodies(1-5). In an earlier study, the W isotope composition(1) of the Earth's mantle was used to infer that core formation was late(1) (greater than or equal to60 million years after the beginning of the Solar System) and that accretion was a protracted process(11,12). The correct interpretation of Hf-W data depends, however, on accurate knowledge of the initial abundance of Hf-182 in the Solar System and the Wisotope composition of chondritic meteorites. Here we report Hf-W data for carbonaceous and H chondrite meteorites that lead to timescales of accretion and core formation significantly different from those calculated previously(1,3,5,11,12). The revised ages for Vesta, Mars and Earth indicate rapid accretion, and show that the timescale for core formation decreases with decreasing size of the planet. We conclude that core formation in the terrestrial planets and the formation of the Moon must have occurred during the first similar to30 million years of the life of the Solar System.	Univ Munster, Inst Mineral, D-48149 Munster, Germany; Univ Cologne, Inst Mineral & Geochem, D-50674 Cologne, Germany	University of Munster; University of Cologne	Kleine, T (corresponding author), Univ Munster, Inst Mineral, Corrensstr 24, D-48149 Munster, Germany.		Mezger, Klaus/D-9502-2011; Munker, Carsten/O-7606-2015; Kleine, Thorsten/S-2792-2017	Mezger, Klaus/0000-0002-2443-8539; Kleine, Thorsten/0000-0003-4657-5961; Munker, Carsten/0000-0001-6406-559X				ALLEN KW, 1995, INT J ADHES ADHES, V15, P59, DOI 10.1016/0143-7496(95)98738-8; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; CANUP RM, 2001, ORIGIN EARTH MOON, P1839; Carlson RW, 2001, GEOCHIM COSMOCHIM AC, V65, P1839, DOI 10.1016/S0016-7037(01)00559-2; Chambers JE, 2001, ICARUS, V152, P205, DOI 10.1006/icar.2001.6639; CHEN JH, 1990, GEOCHIM COSMOCHIM AC, V54, P1729, DOI 10.1016/0016-7037(90)90404-9; GOPEL C, 1994, EARTH PLANET SC LETT, V121, P153, DOI 10.1016/0012-821X(94)90038-8; Halliday AN, 1999, GEOCHIM COSMOCHIM AC, V63, P4157, DOI 10.1016/S0016-7037(99)00315-4; Harper CL, 1996, GEOCHIM COSMOCHIM AC, V60, P1131, DOI 10.1016/0016-7037(96)00027-0; Horan MF, 1998, GEOCHIM COSMOCHIM AC, V62, P545, DOI 10.1016/S0016-7037(97)00368-2; Ireland T.R., 2000, LUNAR PLANET SCI, V31, P1540; Kong P, 1999, GEOCHIM COSMOCHIM AC, V63, P1865, DOI 10.1016/S0016-7037(99)00030-7; Lee DC, 2000, SCIENCE, V288, P1629, DOI 10.1126/science.288.5471.1629; Lee DC, 1997, NATURE, V388, P854, DOI 10.1038/42206; LEE DC, 1995, NATURE, V378, P771, DOI 10.1038/378771a0; Lee DC, 2002, EARTH PLANET SC LETT, V198, P267, DOI 10.1016/S0012-821X(02)00533-2; Lee DC, 2000, CHEM GEOL, V169, P35, DOI 10.1016/S0009-2541(99)00193-X; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Munker C, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2001GC000183; Newsom HE, 1996, GEOCHIM COSMOCHIM AC, V60, P1155, DOI 10.1016/0016-7037(96)00029-4; PALME H, 1981, LUNAR PLANET SCI, V22, P949; PALME H, 1993, LANDOLDTBORNSTEIN GR, V3, P196; Quitte G, 2000, EARTH PLANET SC LETT, V184, P83, DOI 10.1016/S0012-821X(00)00303-4; SCHOENBERG R, IN PRESS GEOCHIM COS; Shearer CK, 2000, GEOCHIM COSMOCHIM AC, V64, P3599, DOI 10.1016/S0016-7037(00)00442-7; SHUKOLYUKOV A, 1993, EARTH PLANET SC LETT, V119, P159, DOI 10.1016/0012-821X(93)90013-Y; Srinivasan G, 1999, SCIENCE, V284, P1348, DOI 10.1126/science.284.5418.1348; WETHERILL GW, 1990, ANNU REV EARTH PL SC, V18, P205, DOI 10.1146/annurev.ea.18.050190.001225; YIN Q, 2002, LUNAR PLANET SCI, V33, P1700	30	533	549	2	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					952	955		10.1038/nature00982	http://dx.doi.org/10.1038/nature00982			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198541				2022-12-28	WOS:000177677500038
J	Mayou, R; Farmer, A				Mayou, R; Farmer, A			ABC of psychological medicine - Trauma	BRITISH MEDICAL JOURNAL			English	Review									Univ Oxford, Dept Publ Hlth & Primary Care, Oxford OX1 2JD, England	University of Oxford	Mayou, R (corresponding author), Univ Oxford, Dept Publ Hlth & Primary Care, Oxford OX1 2JD, England.							Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; McDonald AS, 1996, CLIN PSYCHOL REV, V16, P105, DOI 10.1016/0272-7358(96)00007-4; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974	3	14	16	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2002	325	7361					426	429		10.1136/bmj.325.7361.426	http://dx.doi.org/10.1136/bmj.325.7361.426			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193360	Green Published			2022-12-28	WOS:000177715500022
J	Brooks, JI; Rud, EW; Pilon, RG; Smith, JM; Switzer, WM; Sandstrom, PA				Brooks, JI; Rud, EW; Pilon, RG; Smith, JM; Switzer, WM; Sandstrom, PA			Cross-species retroviral transmission from macaques to human beings	LANCET			English	Article							FOAMY; INFECTION	Cross-species transmission of simian foamy virus (SFV) to human beings from chimpanzees, baboons, and African green monkeys has been described. Although macaques are the non-human primate most often handled in research, human infection with SFV from macaques has not been reported. Two of 46 primate-facility workers tested positive for antibodies that reacted with an immunoblot that contained macaque foamy virus antigens. Phylogenetic assessment of a 96-bp fragment of amplified proviral DNA isolated from peripheral-blood mononuclear cells from one infected individual was consistent with SFV infection of macaque origin. Frequent use of macaques in biomedical research, and identification of persistent retroviral infection from macaques to human beings, could have implications for public-health policy and occupational health and safety.	Hlth Canada, Bur HIV AIDS STD & TB, Ctr Infect Dis Prevent & Control, Ottawa, ON K1A 0L2, Canada; Hlth Canada, Anim Resource Div, Ottawa, ON K1A 0L2, Canada; CDC, HIV & Retrovirol Branch, Div AIDS STD & TB Lab Res, Atlanta, GA 30333 USA	Health Canada; Health Canada; Centers for Disease Control & Prevention - USA	Sandstrom, PA (corresponding author), Hlth Canada, Bur HIV AIDS STD & TB, Ctr Infect Dis Prevent & Control, Ottawa, ON K1A 0L2, Canada.		Rud, Erling/P-5359-2016	Rud, Erling/0000-0001-8615-0277; Pilon, Richard/0000-0003-0100-6917				HAHN H, 1994, J GEN VIROL, V75, P2635, DOI 10.1099/0022-1317-75-10-2635; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; MACK D, 1982, ILAR NEWS, V25, P10; Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001; Sandstrom PA, 2000, LANCET, V355, P551, DOI 10.1016/S0140-6736(99)05292-7	5	62	63	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					387	388		10.1016/S0140-6736(02)09597-1	http://dx.doi.org/10.1016/S0140-6736(02)09597-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241782				2022-12-28	WOS:000177255600015
J	Wilson, JH; Elledge, SJ				Wilson, JH; Elledge, SJ			BRCA2 enters the fray	SCIENCE			English	Editorial Material							RADIATION HYPERSENSITIVITY; MEIOTIC CELLS; CANCER CELLS; HUMAN BREAST; RAD51; LOCATION; REPAIR		Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Wilson, JH (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.							Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Elledge SJ, 2002, CANCER CELL, V1, P129, DOI 10.1016/S1535-6108(02)00041-7; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1996, SCIENCE, V272, P123, DOI 10.1126/science.272.5258.123; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	14	12	15	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1822	1823		10.1126/science.1077171	http://dx.doi.org/10.1126/science.1077171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228708				2022-12-28	WOS:000177955000031
J	Yang, L; Huang, HW				Yang, L; Huang, HW			Observation of a membrane fusion intermediate structure	SCIENCE			English	Article							STALK MECHANISM; SYSTEMS; LIPIDS; PHASES; VIRUS	We report the observation of a phase of phospholipid that contains a structure similar to the commonly postulated interbilayer state that is crucial to membrane fusion. The widely accepted model for membrane fusion suggests that there is an intermediate state in which the two contacting monolayers become continuous via an hourglass-shaped structure called a stalk. Many efforts have been made to estimate the free energy for such a state in order to understand the functionality of membrane fusion proteins and to de ne key parameters in energy estimates. The observation of the stalk structure supports the stalk hypothesis for membrane fusion and enables the measurement of these parameters experimentally.	Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA	State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; Rice University	Huang, HW (corresponding author), Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA.		Yang, Lin/D-5872-2013	Yang, Lin/0000-0003-1057-9194	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055203] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55203] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENTZ J, 1988, BIOPHYS J, V53, P593, DOI 10.1016/S0006-3495(88)83138-2; BLAUROCK AE, 1971, J MOL BIOL, V56, P35, DOI 10.1016/0022-2836(71)90082-9; Brunger AT, 2001, CURR OPIN STRUC BIOL, V11, P163, DOI 10.1016/S0959-440X(00)00186-X; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Chernomordik LV, 1997, J CELL BIOL, V136, P81, DOI 10.1083/jcb.136.1.81; Chizmadzhev YA, 1995, BIOPHYS J, V69, P2489, DOI 10.1016/S0006-3495(95)80119-0; DOMS RW, 1993, METHOD ENZYMOL, V221, P61, DOI 10.1016/0076-6879(93)21007-U; ELLENS H, 1989, BIOCHEMISTRY-US, V28, P3692, DOI 10.1021/bi00435a011; Gingell D., 1978, MEMBRANE FUSION, P791; Hui SW, 1999, COLLOID SURFACE B, V14, P213, DOI 10.1016/S0927-7765(99)00037-5; Hung WC, 2000, BBA-BIOMEMBRANES, V1467, P198, DOI 10.1016/S0005-2736(00)00221-2; Kanaseki T, 1997, J CELL BIOL, V137, P1041, DOI 10.1083/jcb.137.5.1041; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Lentz BR, 2000, CURR OPIN STRUC BIOL, V10, P607, DOI 10.1016/S0959-440X(00)00138-X; Lentz BR, 2002, BIOPHYS J, V82, P555, DOI 10.1016/S0006-3495(02)75420-9; Ludtke S, 1995, BIOCHEMISTRY-US, V34, P16764, DOI 10.1021/bi00051a026; Luzzati V., 1968, BIOL MEMBR, P71; MARIANI P, 1988, J MOL BIOL, V204, P165, DOI 10.1016/0022-2836(88)90607-9; MARKIN VS, 1984, GEN PHYSIOL BIOPHYS, V3, P361; Markin VS, 2002, BIOPHYS J, V82, P693, DOI 10.1016/S0006-3495(02)75432-5; PERUTZ MF, 1954, PROC R SOC LON SER-A, V225, P264, DOI 10.1098/rspa.1954.0202; SIEGEL DP, 1993, BIOPHYS J, V65, P2124, DOI 10.1016/S0006-3495(93)81256-6; Siegel DP, 1999, BIOPHYS J, V76, P291, DOI 10.1016/S0006-3495(99)77197-3; SOWERS AE, 1987, CELL FUSION; STEGMANN T, 1994, CURR BIOL, V4, P551, DOI 10.1016/S0960-9822(00)00123-8; TURNER DC, 1992, BIOCHEMISTRY-US, V31, P1340, DOI 10.1021/bi00120a009; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; YANG L, IN PRESS	30	243	247	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1877	1879		10.1126/science.1074354	http://dx.doi.org/10.1126/science.1074354			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228719				2022-12-28	WOS:000177955000046
J	Calka, A; Wexler, D				Calka, A; Wexler, D			Mechanical milling assisted by electrical discharge	NATURE			English	Article								Mechanical milling is an effective technique for the preparation of fine metallic and ceramic powders and can also be used to drive a wide range of chemical reactions. Milling devices include planetary machines, attritors and vibrational mills; products include amorphous, nanocrystalline and quasicrystalline materials, supersaturated solid solutions, reduced minerals, high-surface-area catalysts and reactive chemicals(1-3). During milling, solid-solid, solid-liquid and solid-gas reactions are initiated through repeated deformation and fracture of powder particles. A separate materials synthesis and processing technique involves reacting a material in a gas atmosphere under an electrical discharge(4-7). Here we show that the application of low-current, high-voltage electrical impulses during milling can result in both faster reactions and new synthesis and processing routes. We demonstrate the effects of glow (cold) and spark (hot) discharge milling on particle fracture for brittle, low-conductivity materials and ductile metals. Glow discharge milling was found to promote solid-gas reactions whereas spark discharge milling promotes fast fracturing, recrystallization, mineral reduction and solid-solid reactions.	Univ Wollongong, Fac Engn, Wollongong, NSW 2522, Australia	University of Wollongong	Calka, A (corresponding author), Univ Wollongong, Fac Engn, Wollongong, NSW 2522, Australia.		Wexler, David/AAD-4778-2020	Wexler, David/0000-0003-4121-8973				BASSET D, 1993, MAT SCI ENG A-STRUCT, V168, P149, DOI 10.1016/0921-5093(93)90718-T; CALKA A, 1991, MAT SCI ENG A-STRUCT, V134, P1350, DOI 10.1016/0921-5093(91)90989-Z; El-Eskandarany MS, 1998, METALL MATER TRANS A, V29, P1973, DOI 10.1007/s11661-998-0023-3; KOCH CC, 1989, ANNU REV MATER SCI, V19, P121, DOI 10.1146/annurev.ms.19.080189.001005; LI ZL, 1997, J APPL PHYS, V81, P8028; Mishra RS, 2000, MAT SCI ENG A-STRUCT, V287, P178, DOI 10.1016/S0921-5093(00)00772-3; Pelletier J, 2001, SURF COAT TECH, V139, P222, DOI 10.1016/S0257-8972(01)01020-9; Takaki K, 2001, APPL PHYS LETT, V78, P2646, DOI 10.1063/1.1369612; Wexler D, 1998, MATER SCI FORUM, V269-2, P219, DOI 10.4028/www.scientific.net/MSF.269-272.219; ZOZ H, 1995, MATER SCI FORUM, V179-, P419, DOI 10.4028/www.scientific.net/MSF.179-181.419	10	113	119	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					147	151		10.1038/nature00985	http://dx.doi.org/10.1038/nature00985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226660				2022-12-28	WOS:000177931200036
J	Li, WKW				Li, WKW			Macroecological patterns of phytoplankton in the northwestern North Atlantic Ocean	NATURE			English	Article							SIZE; DIVERSITY; CHLOROPHYLL; ECOLOGY	Many issues in biological oceanography are regional or global in scope 1; however, there are not many data sets of extensive areal coverage for marine plankton. In microbial ecology, a fruitful approach to large-scale questions is comparative analysis(2,3) wherein statistical data patterns are sought from different ecosystems, frequently assembled from unrelated studies(4). A more recent approach termed macroecology characterizes phenomena emerging from large numbers of biological units by emphasizing the shapes and boundaries of statistical distributions, because these reflect the constraints on variation(5). Here, I use a set of flow cytometric measurements to provide macroecological perspectives on North Atlantic phytoplankton communities. Distinct trends of abundance in picophytoplankton and both small and large nanophytoplankton underlaid two patterns. First, total abundance of the three groups was related to assemblage mean-cell size according to the 3/4 power law of allometric scaling in biology(6,7). Second, cytometric diversity(8) (an ataxonomic measure of assemblage entropy) was maximal at intermediate levels of water column stratification(9). Here, intermediate disturbance shapes diversity through an equitable distribution of cells in size classes, from which arises a high overall biomass. By subsuming local fluctuations, macroecology reveals meaningful patterns of phytoplankton at large scales.	Fisheries & Oceans Canada, Bedford Inst Oceanog, Biol Oceanog Sect, Dartmouth, NS B2Y 4A2, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada	Li, WKW (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, Biol Oceanog Sect, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	Lib@mar.dfo-mpo.gc.ca						AGUSTI S, 1989, LIMNOL OCEANOGR, V34, P1104, DOI 10.4319/lo.1989.34.6.1104; BELGRANO A, IN PRESS ECOL LETT; Brown J., 2000, SCALING BIOL; Brown J.H., 1995, MACROECOLOGY; Cavender-Bares KK, 2001, LIMNOL OCEANOGR, V46, P778, DOI 10.4319/lo.2001.46.4.0778; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; Ciotti AM, 2002, LIMNOL OCEANOGR, V47, P404, DOI 10.4319/lo.2002.47.2.0404; Cole J. J., 1991, COMP ANAL ECOSYSTEMS; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cullen John J., 2002, P297; Cyr H, 2000, SFI S SCI C, P267; Damuth JD, 1998, NATURE, V395, P115, DOI 10.1038/25843; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Gasol JM, 2000, FEMS MICROBIOL ECOL, V31, P99, DOI 10.1111/j.1574-6941.2000.tb00675.x; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; LAWS EA, 1981, MAR BIOL, V65, P13, DOI 10.1007/BF00397062; Legendre P., 2012, NUMERICAL ECOLOGY; Li WKW, 1998, LIMNOL OCEANOGR, V43, P1746, DOI 10.4319/lo.1998.43.7.1746; LI WKW, 1995, MAR ECOL PROG SER, V122, P1, DOI 10.3354/meps122001; Li WKW, 2001, CYTOMETRY, V44, P236, DOI 10.1002/1097-0320(20010701)44:3<236::AID-CYTO1116>3.0.CO;2-5; Li WKW, 2001, DEEP-SEA RES PT II, V48, P2271, DOI 10.1016/S0967-0645(00)00180-6; Li WKW, 1997, LIMNOL OCEANOGR, V42, P874, DOI 10.4319/lo.1997.42.5.0874; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; MONTAGNES DJS, 1994, LIMNOL OCEANOGR, V39, P1044, DOI 10.4319/lo.1994.39.5.1044; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Reynolds C.S, 1997, VEGETATION PROCESSES, V9, DOI 10.1017/S0025315400036432; Rodriguez J, 2001, NATURE, V410, P360, DOI 10.1038/35066560; Rodriguez Jaime, 1994, Scientia Marina, V58, P1; SOMMER U, 1993, HYDROBIOLOGIA, V249, P1, DOI 10.1007/BF00008837; YENTSCH CS, 1989, LIMNOL OCEANOGR, V34, P1694, DOI 10.4319/lo.1989.34.8.1694	30	267	303	2	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					154	157		10.1038/nature00994	http://dx.doi.org/10.1038/nature00994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226662				2022-12-28	WOS:000177931200038
J	Zhou, ZL; Licklider, LJ; Gygi, SP; Reed, R				Zhou, ZL; Licklider, LJ; Gygi, SP; Reed, R			Comprehensive proteomic analysis of the human spliceosome	NATURE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; RNA-POLYMERASE-II; SPLICING FACTORS; PROTEIN; DATABASE; COMPLEX; GENE	The precise excision of introns from pre-messenger RNA is performed by the spliceosome, a macromolecular machine containing five small nuclear RNAs and numerous proteins. Much has been learned about the protein components of the spliceosome from analysis of individual purified small nuclear ribonucleoproteins and salt-stable spliceosome 'core' particles. However, the complete set of proteins that constitutes intact functional spliceosomes has yet to be identified. Here we use maltose-binding protein affinity chromatography to isolate spliceosomes in highly purified and functional form. Using nanoscale microcapillary liquid chromatography tandem mass spectrometry, we identify similar to145 distinct spliceosomal proteins, making the spliceosome the most complex cellular machine so far characterized. Our spliceosomes comprise all previously known splicing factors and 58 newly identified components. The spliceosome contains at least 30 proteins with known or putative roles in gene expression steps other than splicing. This complexity may be required not only for splicing multi-intronic metazoan pre-messenger RNAs, but also for mediating the extensive coupling between splicing and other steps in gene expression.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Reed, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.							Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; BENNETT M, 1992, MOL CELL BIOL, V12, P3165, DOI 10.1128/MCB.12.7.3165; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Burge CB, 1999, RNA WORLD, P525; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; FU XD, 1995, RNA, V1, P663; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hirose Y, 2000, GENE DEV, V14, P1415; Horowitz DS, 2002, EMBO J, V21, P470, DOI 10.1093/emboj/21.3.470; Licklider LJ, 2002, ANAL CHEM, V74, P3076, DOI 10.1021/ac025529o; Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; Zhou ZL, 1998, EMBO J, V17, P2095, DOI 10.1093/emboj/17.7.2095	30	697	713	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					182	185		10.1038/nature01031	http://dx.doi.org/10.1038/nature01031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226669				2022-12-28	WOS:000177931200045
J	Slivan, SM				Slivan, SM			Spin vector alignment of Koronis family asteroids	NATURE			English	Article							COLLISIONAL EVOLUTION; LIGHTCURVE INVERSION; OPTIMIZATION METHODS	Studies of asteroid families-groups of asteroids that formed from the fragmentation of larger bodies-are of broad interest to solar system researchers because they can provide insights into collisional processes, as well as the interior structures, strengths, and compositions of asteroids. It is generally accepted that members of the Koronis family were created by collisional disruption of a homogeneous parent body 1 and therefore share the same formation age and subsequent collisional history. The temporal variations in observed brightnesses of the Koronis family members (a consequence of their rotation) are, however, larger than expected(2). Preferential alignment of spin vectors had been proposed 2 as a possible explanation, but recent modelling 3 predicted that family formation yields random spin vectors among the resulting fragments. Both hypotheses have been untested by observations. Here I show that the actual distribution of spin vectors among the largest members of the Koronis family falls within markedly nonrandom 'spin clusters'. Reconciling models of family formation and evolution with the unexpected alignments of spin obliquities and correlations with spin rates presents a new challenge in understanding asteroid collisional processes.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Slivan, SM (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave,Rm 54-410, Cambridge, MA 02139 USA.							BELTON MJS, 1994, SCIENCE, V265, P1543, DOI 10.1126/science.265.5178.1543; BINZEL RP, 1987, ICARUS, V72, P135, DOI 10.1016/0019-1035(87)90125-4; BINZEL RP, 1988, ICARUS, V73, P303, DOI 10.1016/0019-1035(88)90100-5; BINZEL RP, 1993, ICARUS, V105, P310, DOI 10.1006/icar.1993.1129; Bowell E., 1989, ASTEROIDS, VII, P524; CHAPMAN CR, 1989, ASTEROIDS, V2, P386; DAVIES ME, 1994, B AM ASTRON SOC, V26, P1154; DRUMMOND JD, 1988, ICARUS, V76, P19, DOI 10.1016/0019-1035(88)90139-X; Kaasalainen M, 2001, ICARUS, V153, P24, DOI 10.1006/icar.2001.6673; Kaasalainen M, 2001, ICARUS, V153, P37, DOI 10.1006/icar.2001.6674; LANDOLT AU, 1983, ASTRON J, V88, P439, DOI 10.1086/113329; MARZARI F, 1995, ICARUS, V113, P168, DOI 10.1006/icar.1995.1014; Michel P, 2001, SCIENCE, V294, P1696, DOI 10.1126/science.1065189; MILLER I, 1977, PROBABILITY STAT ENG; Rubincam DP, 2000, ICARUS, V148, P2, DOI 10.1006/icar.2000.6485; Slivan SM, 1996, ICARUS, V124, P452, DOI 10.1006/icar.1996.0222; SLIVAN SM, 1995, THESIS MIT; SLIVAN SM, UNPUB ICARUS; ZAPPALA V, 1995, ICARUS, V116, P291, DOI 10.1006/icar.1995.1127	19	80	81	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					49	51		10.1038/nature00993	http://dx.doi.org/10.1038/nature00993			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214227				2022-12-28	WOS:000177788600032
J	Brothers, K				Brothers, K			Covenant and the vulnerable other	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Louisville, Sch Med, Louisville, KY 40292 USA	University of Louisville	Brothers, K (corresponding author), Univ Louisville, Sch Med, Louisville, KY 40292 USA.							BODDY J, 1982, AM ETHNOL, V9, P682, DOI 10.1525/ae.1982.9.4.02a00040; Davis D S, 2001, Health Matrix Clevel, V11, P487; Mandara M. U., 2000, FEMALE CIRCUMCISION; Mount Jr Eric, 1999, COVENANT COMMUNITY C; Shell-Duncan B., 2000, FEMALE CIRCUMCISION	5	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1133	1133		10.1001/jama.288.9.1133	http://dx.doi.org/10.1001/jama.288.9.1133			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NA	12204086	hybrid			2022-12-28	WOS:000177764600019
J	Deveugele, M; Derese, A; van den Brink-Muinen, A; Bensing, J; De Maeseneer, J				Deveugele, M; Derese, A; van den Brink-Muinen, A; Bensing, J; De Maeseneer, J			Consultation length in general practice: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article								Objectives To compare determinants of consultation length discussed in the literature with those found in consultations with general practitioners from different European countries; to explore the determinants of consultation length, particularly the effect of doctors' and patients' perceptions of psychosocial aspects. Design Analysis of videotaped consultations of general practitioners from the Eurocommunication study and of questionnaires completed by doctors and by patients. Setting General practices in six European countries. Participants 190 general practitioners and 3674 patients. Results In a multilevel analysis with three levels (country, general practitioner, and patient), country and doctor variables contributed a similar amount to the total variance in consultation length (23% and 22%, respectively) and patient variables accounted for 55% of the variance. The variables used in the multilevel analysis explained 25% of the total variation. The country in which the doctor practised, combined with the doctors' variables, was as important for the variance in consultation length as the variation between patients. Consultations in which psychosocial problems were considered important by the doctor and the patient lasted longer than consultations about biomedical problems only. The doctor's perception had more influence in this situation than the patient's. Consultation length is influenced by the patients' sex (women got longer consultations), whether the practice was urban or rural, the number of new problems discussed in the consultation (die more problems the longer the consultation), and the patient's age (the older the patient the longer the consultation). As a doctor's workload increased, the length of consultations decreased. The general practitioner's sex or age and patient's level of education were not related to the length of consultation. Conclusion Consultation length is determined by variables related to the doctor and the doctor's country as well as by those related to patients. Women consulting in an urban practice with problems perceived as psychosocial have longer consultations than other patients.	State Univ Ghent, Dept Gen Practice & Primary Hlth Care, B-9000 Ghent, Belgium; Netherlands Inst Primary Hlth Care, NL-1568 BN Utrecht, Netherlands	Ghent University	Deveugele, M (corresponding author), State Univ Ghent, Dept Gen Practice & Primary Hlth Care, B-9000 Ghent, Belgium.		Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				Lamberts H., 1987, ICPC INT CLASSIFICAT; MURRAY TS, 1978, UPDATE, V16, P969; Rice N, 1996, J Health Serv Res Policy, V1, P154; ROTER D, 1991, MED CARE, V29, P1083; STROBBE J, 1995, TELEMATICS PRIMARY C, P17; Valori R, 1996, J PSYCHOSOM RES, V40, P87, DOI 10.1016/0022-3999(95)00548-X; van den Brink-Muinen A, 2000, PATIENT EDUC COUNS, V39, P115, DOI 10.1016/S0738-3991(99)00098-1; VANDENBRINKMUIN.A, 1999, EUROCOMMUNICATION ST; WHITEHOUSE CR, 1987, J ROY COLL GEN PRACT, V37, P112; WILSON A, 1991, BRIT J GEN PRACT, V41, P119	10	308	313	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2002	325	7362					472	474		10.1136/bmj.325.7362.472	http://dx.doi.org/10.1136/bmj.325.7362.472			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592EZ	12202329	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000177924900021
J	Walt, G; Brugha, R; Haines, A				Walt, G; Brugha, R; Haines, A			Working with the private sector: the need for institutional guidelines	BRITISH MEDICAL JOURNAL			English	Article							CONFLICTS-OF-INTEREST; PARTNERSHIPS; UNIVERSITIES; HEALTH	Cooperation between academic institutions and the private sector does not always run smoothly. Gill Walt, Ruairi Brugha, and Andy Haines from the London School of Hygiene and Tropical Medicine point up the need for guidance on entering into partnership with a commercial partner and describe the school's experience in formulating guidelines for its staff.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Walt, G (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.		Brugha, Ruairi/C-8420-2012	Brugha, Ruairi/0000-0003-0729-0197; Haines, Andy/0000-0002-8053-4605				Birmingham K, 2001, NAT MED, V7, P643, DOI 10.1038/88975; Buse K, 2000, B WORLD HEALTH ORGAN, V78, P699; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; Cohen JE, 2001, BMJ-BRIT MED J, V323, P1, DOI 10.1136/bmj.323.7303.1; *COMM PUBL PRIV PA, 2001, BUILD BETT PARTN; *CONF BRIT IND, 2001, PARTN RES INN; HUNTER M, 2001, BRIT MED J, V322, P1270; Korn D, 2000, JAMA-J AM MED ASSOC, V284, P2234, DOI 10.1001/jama.284.17.2234; PHILLIPS S, 2001, TIMES HIGHER ED 0427; RUTHERFORD J, 2001, TIMES HIGHER ED 0427; TESNER S, 2000, UN BUSINESS; *UN GEN ASS, 2000, COOP UN ALL REL PART; WIDDUS R, 2001, WHO B, V79, P713; ZIMAN J, 2001, CORR SCI INT BRIT AC; 2001, NHS STARTS REV CONFL	15	10	11	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2002	325	7361					432	435		10.1136/bmj.325.7361.432	http://dx.doi.org/10.1136/bmj.325.7361.432			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193362	Green Published, Green Accepted			2022-12-28	WOS:000177715500024
J	Byerly, GR; Lowe, DR; Wooden, JL; Xie, XG				Byerly, GR; Lowe, DR; Wooden, JL; Xie, XG			An Archean impact layer from the Pilbara and Kaapvaal cratons	SCIENCE			English	Article							BARBERTON GREENSTONE-BELT; SOUTH-AFRICA; WESTERN-AUSTRALIA; MOUNTAIN LAND; SHOCKED ZIRCONS; SPHERULES; RECORD; STROMATOLITES; STRATIGRAPHY; MICROFOSSILS	The Barberton greenstone belt of South Africa and the eastern Pilbara block of Western Australia provide information about Earth's surface environments between 3.2 and 3.5 billion years ago, including evidence for four large bolide impacts that likely created large craters, deformed the target rocks, and altered the environment. We have obtained identical single-zircon uranium-lead ages of 3470 +/- 2 million years ago for the oldest impact events from each craton. These deposits represent a single global fallout layer that is associated with sedimentation by an impact-generated tsunami and in Western Australia is represented by a major erosional unconformity.	Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA; Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; Stanford Univ, US Geol Survey SUMAC, Stanford, CA 94305 USA	Louisiana State University System; Louisiana State University; Stanford University; Stanford University	Byerly, GR (corresponding author), Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA.	gary@geol.lsu.edu	Byerly, Gary Ray/D-7316-2012	Byerly, Gary Ray/0000-0003-4400-6909				ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; BOHOR BF, 1993, EARTH PLANET SC LETT, V119, P419, DOI 10.1016/0012-821X(93)90149-4; BUICK R, 1995, NATURE, V375, P574, DOI 10.1038/375574a0; Byerly G.R., 1999, GEOL S AM S, P1; BYERLY GR, 1986, NATURE, V319, P489, DOI 10.1038/319489a0; BYERLY GR, 1994, GEOCHIM COSMOCHIM AC, V58, P3469, DOI 10.1016/0016-7037(94)90099-X; Byerly GR, 1996, PRECAMBRIAN RES, V78, P125, DOI 10.1016/0301-9268(95)00073-9; Culler TS, 2000, SCIENCE, V287, P1785, DOI 10.1126/science.287.5459.1785; Dann JC, 2000, S AFR J GEOL, V103, P47, DOI 10.2113/103.1.47; DIMARCO MJ, 1989, PRECAMBRIAN RES, V44, P147, DOI 10.1016/0301-9268(89)90080-6; Glass BP, 2001, GEOLOGY, V29, P371, DOI 10.1130/0091-7613(2001)029<0371:DOHPZP>2.0.CO;2; Glikson AY, 2001, J GEODYN, V32, P205, DOI 10.1016/S0264-3707(01)00029-1; Hassler SW, 2001, J GEOL, V109, P1, DOI 10.1086/317958; KAMO SL, 1994, TECTONICS, V13, P167, DOI 10.1029/93TC02254; KROGH TE, 1993, NATURE, V366, P731, DOI 10.1038/366731a0; Kroner A., 1991, EARTH PLANET SC LETT, V103, P41, DOI DOI 10.1016/0012-821X(91)90148-B; LOWE DR, 1980, NATURE, V284, P441, DOI 10.1038/284441a0; LOWE DR, 1986, GEOLOGY, V14, P83, DOI 10.1130/0091-7613(1986)14<83:EASSOP>2.0.CO;2; LOWE DR, 1989, SCIENCE, V245, P959, DOI 10.1126/science.245.4921.959; LOWE DR, 1987, GEOLOGY, V15, P179; LOWE DR, IN PRESS ASTROBIOLOG; Ryder G., 1990, EOS T AM GEOPHYS UN, VAGU71, P313, DOI [10.1029/90EO00086, DOI 10.1029/90EO00086, 10.1029/ 90EO00086]; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Shukolyukov A, 2000, LECT NOTES EARTH SCI, V91, P99; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; THORPE RI, 1992, PRECAMBRIAN RES, V56, P169, DOI 10.1016/0301-9268(92)90100-3; VANKRANENDONK MJ, 1998, GEOL SURV W AUST ANN, P55; WALSH MM, 1985, NATURE, V314, P530, DOI 10.1038/314530a0	28	97	98	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1325	1327		10.1126/science.1073934	http://dx.doi.org/10.1126/science.1073934			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193781				2022-12-28	WOS:000177573900040
J	Lohmann, I; McGinnis, N; Bodmer, M; McGinnis, W				Lohmann, I; McGinnis, N; Bodmer, M; McGinnis, W			The Drosophila Hox gene Deformed sculpts head morphology via direct regulation of the apoptosis activator reaper	CELL			English	Article							PROGRAMMED CELL-DEATH; FUSHI-TARAZU; BITHORAX COMPLEX; HOMEOTIC GENES; EMBRYONIC HEAD; EXPRESSION; ADHESION; ELEMENT; PROTEIN; TARGET	Hox proteins control morphological diversity along the anterior-posterior body axis of animals, but the cellular processes they directly regulate are poorly understood. We show that during early Drosophila development, the Hox protein Deformed (Dfd) maintains the boundary between the maxillary and mandibular head lobes by activating localized apoptosis. Dfd accomplishes this by directly activating the cell death promoting gene reaper (rpr). One other Hox gene,Abdominal-B (Abd-B), also regulates segment boundaries through the regional activation of apoptosis. Thus, one mechanism used by Drosophila Hox genes to modulate segmental morphology is to regulate programmed cell death, which literally sculpts segments into distinct shapes. This and other emerging evidence suggests that Hox proteins may often regulate the maintenance of segment boundaries.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	McGinnis, W (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.							ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Asano M, 1996, GENE DEV, V10, P1422, DOI 10.1101/gad.10.11.1422; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BERGSON C, 1990, EMBO J, V9, P4287, DOI 10.1002/j.1460-2075.1990.tb07877.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; BROWN SJ, 1994, P NATL ACAD SCI USA, V91, P12922, DOI 10.1073/pnas.91.26.12922; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Christich A, 2002, CURR BIOL, V12, P137, DOI 10.1016/S0960-9822(01)00658-3; DAWES R, 1994, DEVELOPMENT, V120, P1561; DELORENZI M, 1990, DEVELOPMENT, V108, P323; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; GARCIABELLIDO A, 1977, AM ZOOL, V17, P613; Gavalas A, 1997, DEVELOPMENT, V124, P3693; GOULD AP, 1992, DEVELOPMENT, V116, P1163; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Handel K, 2000, DEV GENES EVOL, V210, P167, DOI 10.1007/s004270050301; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; HEUER JG, 1995, DEVELOPMENT, V121, P3861; HINZ U, 1992, DEVELOPMENT, V116, P543; Hu N, 1999, DEV BIOL, V214, P197, DOI 10.1006/dbio.1999.9391; Hughes CL, 2002, DEVELOPMENT, V129, P1225; Hurle JM, 1996, MICROSC RES TECHNIQ, V34, P236; Jiang CA, 2000, MOL CELL, V5, P445, DOI 10.1016/S1097-2765(00)80439-6; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Li XL, 1999, EMBO J, V18, P198, DOI 10.1093/emboj/18.1.198; Lohr U, 2001, CURR BIOL, V11, P1403, DOI 10.1016/S0960-9822(01)00443-2; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; McGinnis W, 1990, Adv Genet, V27, P363; MEADOWS LA, 1994, J CELL SCI, V107, P321; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Nassif C, 1998, DEV BIOL, V197, P170, DOI 10.1006/dbio.1998.8875; PATEL NH, 1994, DEVELOPMENT, P201; Peterson C, 2002, DEVELOPMENT, V129, P1467; Pradel J, 1998, INT J DEV BIOL, V42, P417; Raghavan S, 1997, NEURON, V18, P873, DOI 10.1016/S0896-6273(00)80327-X; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Saunders J., 1966, MAJOR PROBLEMS DEV B, P289; SCHMIDTOTT U, 1992, DEVELOPMENT, V116, P111; Srinivasula SM, 2002, CURR BIOL, V12, P125, DOI 10.1016/S0960-9822(01)00657-1; Stadler HS, 2001, DEVELOPMENT, V128, P4177; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Telford MJ, 2000, CURR BIOL, V10, P349, DOI 10.1016/S0960-9822(00)00387-0; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WHITE K, 1995, TRENDS CELL BIOL, V5, P74, DOI 10.1016/S0962-8924(00)88950-3; Wing JP, 2002, CURR BIOL, V12, P131, DOI 10.1016/S0960-9822(01)00664-9; YOFFE KB, 1995, DEV BIOL, V170, P636, DOI 10.1006/dbio.1995.1243	59	161	164	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 23	2002	110	4					457	466		10.1016/S0092-8674(02)00871-1	http://dx.doi.org/10.1016/S0092-8674(02)00871-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202035	Bronze			2022-12-28	WOS:000177653200007
J	Richardson, DR				Richardson, DR			Deferiprone: greater efficacy at depleting myocardial than hepatic iron?	LANCET			English	Editorial Material							CHELATION-THERAPY; THALASSEMIA MAJOR; DEFEROXAMINE; STORES		Childrens Canc Res Inst Australia, Iron Metab & Chelat Program, Sydney, NSW 2031, Australia	Children's Cancer Institute	Richardson, DR (corresponding author), Childrens Canc Res Inst Australia, Iron Metab & Chelat Program, Sydney, NSW 2031, Australia.	d.richardson@ccia.org.au		Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274				Aydinok Y, 1999, ACTA HAEMATOL-BASEL, V102, P17, DOI 10.1159/000040962; Giardina PJ, 2001, SEMIN HEMATOL, V38, P360, DOI 10.1053/shem.2001.27576; Hershko C, 2002, J LAB CLIN MED, V139, P50, DOI 10.1067/mlc.2002.120364; Hoffbrand AV, 1998, BLOOD, V91, P295, DOI 10.1182/blood.V91.1.295.295_295_300; Link G, 2001, J LAB CLIN MED, V138, P130, DOI 10.1067/mlc.2001.116487; Maggio A, 2002, BLOOD CELL MOL DIS, V28, P196, DOI 10.1006/bcmd.2002.0510; Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739; Olivieri NF, 1998, NEW ENGL J MED, V339, P417, DOI 10.1056/NEJM199808133390701; OLIVIERI NF, 1995, NEW ENGL J MED, V332, P918, DOI 10.1056/NEJM199504063321404; OLIVIERI NF, 1992, BLOOD, V79, P2741; RICHARDSON DR, 2000, EXPERT OPIN INVESTAT, V8, P2141; Tondury P, 1998, BRIT J HAEMATOL, V101, P413, DOI 10.1046/j.1365-2141.1998.00725.x; WANLESS IR, IN PRESS BLOOD	13	7	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2002	360	9332					501	502		10.1016/S0140-6736(02)09758-1	http://dx.doi.org/10.1016/S0140-6736(02)09758-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241649				2022-12-28	WOS:000177512800003
J	White, RE; Abnet, CC; Mungatana, CK; Dawsey, SM				White, RE; Abnet, CC; Mungatana, CK; Dawsey, SM			Oesophageal cancer: a common malignancy in young people of Bomet District, Kenya	LANCET			English	Article								Oesophageal cancer is a common cancer with uneven geographical distribution. We reviewed all malignancies diagnosed at Tenwek Hospital (Bomet District, Kenya) between 1989 and 1998. Oesophageal cancer was the most common malignancy; 274 cases accounted for 19% of 1459 malignancies diagnosed, and for a steady rise in total cancer cases during this period. A striking feature of our study was the presence of a subset of very young patients. 26 (11%) patients were aged 30 years or less at diagnosis, and the youngest patient was 14 years old. This area of West Kenya seems to be a high-risk region for oesophageal cancer.	Tenwek Hosp, Bomet, Kenya; NCI, Canc Prevent Studies Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	White, RE (corresponding author), Tenwek Hosp, POB 39, Bomet, Kenya.	rwhite@maf.or.ke	Abnet, Christian C/C-4111-2015	Abnet, Christian C/0000-0002-3008-7843				AHMED N, 1969, BRIT J CANCER, V23, P302, DOI 10.1038/bjc.1969.40; GATEI DG, 1978, CANCER RES, V38, P303; PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413; *SURV EP END RES S, 2002, PROGR PUBL US DAT 19; ZHANG ZX, 1990, SHI GUAN AI FANG ZHI, V1, P1	5	27	27	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					462	463		10.1016/S0140-6736(02)09639-3	http://dx.doi.org/10.1016/S0140-6736(02)09639-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241722				2022-12-28	WOS:000177342900016
J	Dayan, CM; Saravanan, P; Bayly, G				Dayan, CM; Saravanan, P; Bayly, G			Whose normal thyroid function is better - yours or mine?	LANCET			English	Editorial Material							SUBCLINICAL HYPOTHYROIDISM; SERUM-CHOLESTEROL; BLOOD-PRESSURE; SENSITIVITY; THYROXINE		Univ Bristol, Bristol Royal Infirm, Res Ctr Neuroendocrinol, Bristol BS2 8HW, Avon, England; Bristol Royal Infirm & Gen Hosp, Dept Chem Pathol, Bristol, Avon, England	Bristol Royal Infirmary; University of Bristol; Bristol Royal Infirmary	Dayan, CM (corresponding author), Univ Bristol, Bristol Royal Infirm, Res Ctr Neuroendocrinol, Bristol BS2 8HW, Avon, England.		Saravanan, P/M-6142-2016; Dayan, Colin/AAH-6242-2019	Saravanan, P/0000-0002-9566-2626; Dayan, Colin/0000-0002-6557-3462				Andersen S, 2002, J CLIN ENDOCR METAB, V87, P1068, DOI 10.1210/jc.87.3.1068; Bjoro T, 2000, EUR J ENDOCRINOL, V143, P639, DOI 10.1530/eje.0.1430639; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; DAYAN CM, 1996, P R COLL PHYSICIANS, V26, P419; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hearing SD, 1999, J CLIN ENDOCR METAB, V84, P4149, DOI 10.1210/jc.84.11.4149; Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P47, DOI 10.1210/jc.83.1.47; MARTIN MJ, 1986, LANCET, V2, P933; Michalopoulou G, 1998, EUR J ENDOCRINOL, V138, P141, DOI 10.1530/eje.0.1380141; Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x; SARAVANAN P, IN PRESS CLIN ENDOCR; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x	13	38	39	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					353	354		10.1016/S0140-6736(02)09602-2	http://dx.doi.org/10.1016/S0140-6736(02)09602-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241772				2022-12-28	WOS:000177255600005
J	Sharp, D				Sharp, D			Lightning strikes	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Carte AE, 2002, ANN EMERG MED, V39, P665, DOI 10.1067/mem.2002.124438; Cherington M, 1998, LANCET, V351, P1788, DOI 10.1016/S0140-6736(05)78750-X; Cooper MA, 2002, ACAD EMERG MED, V9, P172, DOI 10.1197/aemj.9.2.172; CURRAN EB, LIGHTNING FATALITIES; Makdissi M, 2002, MED J AUSTRALIA, V177, P35, DOI 10.5694/j.1326-5377.2002.tb04633.x; Muehlberger T, 2001, BURNS, V27, P829, DOI 10.1016/S0305-4179(01)00029-8; Zimmermann C, 2002, ANN EMERG MED, V39, P660, DOI 10.1067/mem.2002.124439; 1998, MMWR MORB MORTAL WKL, V47, P391	8	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					354	354		10.1016/S0140-6736(02)09604-6	http://dx.doi.org/10.1016/S0140-6736(02)09604-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241773				2022-12-28	WOS:000177255600006
J	Ivanova, NB; Dimos, JT; Schaniel, C; Hackney, JA; Moore, KA; Lemischka, IR				Ivanova, NB; Dimos, JT; Schaniel, C; Hackney, JA; Moore, KA; Lemischka, IR			A stem cell molecular signature	SCIENCE			English	Article							IN-VIVO; DIFFERENTIATION	Mechanisms regulating self-renewal and cell fate decisions in mammalian stem cells are poorly understood. We determined global gene expression profiles for mouse and human hematopoietic stem cells and other stages of the hematopoietic hierarchy. Murine and human hematopoietic stem cells share a number of expressed gene products, which de ne key conserved regulatory pathways in this developmental system. Moreover, in the mouse, a portion of the genetic program of hematopoietic stem cells is shared with embryonic and neural stem cells. This overlapping set of gene products represents a molecular signature of stem cells.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Lemischka, IR (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.		Schaniel, Chrisoph/C-9655-2012; Schaniel, Christoph/P-3836-2019	Schaniel, Christoph/0000-0002-1343-4858; Hackney, Jason/0000-0002-5922-563X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042989, R37DK042989, R01DK054493] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42989, DK54493] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Crooks GM, 1999, BLOOD, V94, P519, DOI 10.1182/blood.V94.2.519.414k20_519_528; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; HARRISON DE, 1993, EXP HEMATOL, V21, P206; IVANOVA NB, UNPUB; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kelly DL, 2000, MOL REPROD DEV, V56, P113, DOI 10.1002/(SICI)1098-2795(200006)56:2&lt;113::AID-MRD1&gt;3.0.CO;2-Q; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Ohta H, 2002, J EXP MED, V195, P759, DOI 10.1084/jem.20011911; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442	22	1125	1180	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 18	2002	298	5593					601	604		10.1126/science.1073823	http://dx.doi.org/10.1126/science.1073823			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604RL	12228721				2022-12-28	WOS:000178634800041
J	Krull, W				Krull, W			A fresh start for European science - The scientific community must take up the challenges set by EU objectives.	NATURE			English	Editorial Material									Volkswagen Fdn, D-30519 Hannover, Germany	Volkswagen; Volkswagen Germany	Krull, W (corresponding author), Volkswagen Fdn, Kastanienallee 35, D-30519 Hannover, Germany.							2002, NATURE, V419, P108	1	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2002	419	6904					249	250		10.1038/419249a	http://dx.doi.org/10.1038/419249a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239542				2022-12-28	WOS:000178056300022
J	Horn, PJ; Peterson, CL				Horn, PJ; Peterson, CL			Molecular biology: Chromatin higher order folding: Wrapping up transcription	SCIENCE			English	Review							RNA-POLYMERASE-II; HISTONE H3; NUCLEOSOMAL ARRAYS; LINKER HISTONES; LYSINE 9; PROTEIN; CHROMOSOMES; VARIANT; H2A.Z; METHYLATION		Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Peterson, CL (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	Craig.Peterson@umassmed.edu						Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; ANDERSSON K, 1984, J CELL BIOL, V98, P1296, DOI 10.1083/jcb.98.4.1296; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Belmont AS, 1999, CURR OPIN CELL BIOL, V11, P307, DOI 10.1016/S0955-0674(99)80041-6; BELMONT AS, 1987, J CELL BIOL, V105, P77, DOI 10.1083/jcb.105.1.77; BELMONT AS, 1989, CHROMOSOMA, V98, P129, DOI 10.1007/BF00291049; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P431, DOI 10.1016/S0968-0004(01)01855-2; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Carruthers LM, 2000, J BIOL CHEM, V275, P37285, DOI 10.1074/jbc.M006801200; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Falciola L, 1997, J CELL BIOL, V137, P19, DOI 10.1083/jcb.137.1.19; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Georges SA, 2002, MOL CELL BIOL, V22, P127, DOI 10.1128/MCB.22.1.127-137.2002; GERCHMAN SE, 1987, P NATL ACAD SCI USA, V84, P7802, DOI 10.1073/pnas.84.22.7802; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Hock R, 1998, EMBO J, V17, P6992, DOI 10.1093/emboj/17.23.6992; Horn PJ, 2002, NAT STRUCT BIOL, V9, P167, DOI 10.1038/nsb762; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Leach TJ, 2000, J BIOL CHEM, V275, P23267, DOI 10.1074/jbc.M910206199; LORCH Y, 1992, GENE DEV, V6, P2282, DOI 10.1101/gad.6.12a.2282; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; NER SS, 1994, EMBO J, V13, P1817, DOI 10.1002/j.1460-2075.1994.tb06450.x; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Parseghian MH, 2000, CHROMOSOME RES, V8, P405, DOI 10.1023/A:1009262819961; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Ramakrishnan V, 1997, CRIT REV EUKAR GENE, V7, P215, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.20; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Sawa H, 2000, MOL CELL, V6, P617, DOI 10.1016/S1097-2765(00)00060-5; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strick R, 2001, J CELL BIOL, V155, P899, DOI 10.1083/jcb.200105026; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; VANHOLDE K, 1995, J BIOL CHEM, V270, P8373, DOI 10.1074/jbc.270.15.8373; Wechser MA, 1997, EMBO J, V16, P2086, DOI 10.1093/emboj/16.8.2086; WEINTRAUB H, 1984, CELL, V38, P17, DOI 10.1016/0092-8674(84)90522-1; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; WOODCOCK CL, 1995, TRENDS CELL BIOL, V5, P272, DOI 10.1016/S0962-8924(00)89038-8; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9	56	295	307	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1824	1827		10.1126/science.1074200	http://dx.doi.org/10.1126/science.1074200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228709				2022-12-28	WOS:000177955000032
J	Hoege, C; Pfander, B; Moldovan, GL; Pyrowolakis, G; Jentsch, S				Hoege, C; Pfander, B; Moldovan, GL; Pyrowolakis, G; Jentsch, S			RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO	NATURE			English	Article							CELL NUCLEAR ANTIGEN; CONJUGATING ENZYME COMPLEX; RING FINGER PROTEINS; SACCHAROMYCES-CEREVISIAE; POSTREPLICATION REPAIR; POLYUBIQUITIN CHAIN; CRYSTAL-STRUCTURE; SRS2 SUPPRESSOR; UV SENSITIVITY; YEAST SEPTINS	The RAD6 pathway is central to post-replicative DNA repair in eukaryotic cells; however, the machinery and its regulation remain poorly understood. Two principal elements of this pathway are the ubiquitin-conjugating enzymes RAD6 and the MMS2-UBC13 heterodimer, which are recruited to chromatin by the RING-finger proteins RAD18 and RAD5, respectively. Here we show that UBC9, a small ubiquitin-related modifier (SUMO)-conjugating enzyme, is also affiliated with this pathway and that proliferating cell nuclear antigen (PCNA)-a DNA-polymerase sliding clamp involved in DNA synthesis and repair-is a substrate. PCNA is monoubiquitinated through RAD6 and RAD18, modified by lysine-63-linked multi-ubiquitination-which additionally requires MMS2, UBC13 and RAD5-and is conjugated to SUMO by UBC9. All three modifications affect the same lysine residue of PCNA, suggesting that they label PCNA for alternative functions. We demonstrate that these modifications differentially affect resistance to DNA damage, and that damage-induced PCNA ubiquitination is elementary for DNA repair and occurs at the same conserved residue in yeast and humans.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Pfander, Boris/A-8703-2013	George-Lucian, Moldovan/0000-0003-3825-149X; Pfander, Boris/0000-0003-2180-5054				Amin NS, 1996, GENETICS, V144, P479; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; BAUER GA, 1990, NUCLEIC ACIDS RES, V18, P261, DOI 10.1093/nar/18.2.261; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; BROODBAKKER JTW, 1983, OPHTHALMIC PAED GEN, V2, P95, DOI 10.3109/13816818309007797; Broomfield S, 2002, NUCLEIC ACIDS RES, V30, P732, DOI 10.1093/nar/30.3.732; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Cejka P, 2001, GENETICS, V159, P953; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Hochstrasser M, 2002, MOL CELL, V9, P453, DOI 10.1016/S1097-2765(02)00486-0; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; KRISHNA TSR, 1994, J MOL BIOL, V241, P265, DOI 10.1006/jmbi.1994.1495; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li ZQ, 2002, P NATL ACAD SCI USA, V99, P4459, DOI 10.1073/pnas.062047799; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; PRAKASH L, 1994, ANN NY ACAD SCI, V726, P267, DOI 10.1111/j.1749-6632.1994.tb52825.x; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; SCHIESTL RH, 1990, GENETICS, V124, P817; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; TorresRamos CA, 1996, P NATL ACAD SCI USA, V93, P9676, DOI 10.1073/pnas.93.18.9676; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tsurimoto T., 1999, FRONT BIOSCI, V4, P849; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2002, EUKARYOT CELL, V1, P1, DOI 10.1128/EC.1.1.1-10.2002; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Xiao W, 2000, GENETICS, V155, P1633; Xiao W, 1999, MUTAT RES-DNA REPAIR, V435, P1, DOI 10.1016/S0921-8777(99)00034-8; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	52	1683	1752	75	556	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					135	141		10.1038/nature00991	http://dx.doi.org/10.1038/nature00991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226657				2022-12-28	WOS:000177931200033
J	Nestle, FO; Speidel, H; Speidel, MO				Nestle, FO; Speidel, H; Speidel, MO			Metallurgy - High nickel release from 1-and 2-euro coins	NATURE			English	Article							CONTACT-DERMATITIS		Univ Zurich Hosp, Dept Dermatol, CH-8901 Zurich, Switzerland; Swiss Fed Inst Technol, Dept Mat, Inst Met, CH-8092 Zurich, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	Nestle, FO (corresponding author), Univ Zurich Hosp, Dept Dermatol, CH-8901 Zurich, Switzerland.							ANDERSEN KE, 1995, TXB CONTACT DERMATIT, P418; *EUR STAND, 1999, 1811 EN EUR STAND; GOLLHAUSEN R, 1991, J AM ACAD DERMATOL, V25, P365, DOI 10.1016/0190-9622(91)70206-H; Liden C, 2001, CONTACT DERMATITIS, V44, P160, DOI 10.1034/j.1600-0536.2001.044003160.x; Nielsen NH, 1999, BRIT J DERMATOL, V141, P676; Speidel M.O., 1998, MAT MED, P191	6	85	88	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					132	132		10.1038/419132a	http://dx.doi.org/10.1038/419132a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226655	Bronze			2022-12-28	WOS:000177931200030
J	Bonnici, F; Keavney, B; Collins, R; Danesh, J				Bonnici, F; Keavney, B; Collins, R; Danesh, J			Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MAJOR RISK FACTOR; MYOCARDIAL-INFARCTION; STENT RESTENOSIS; ARTERY DISEASE; ANGIOPLASTY; GENE; GENOTYPES; VARIANT	Objective To assess the association between genotype at the insertion or deletion polymorphism of the angiotensin converting enzyme gene and risk of coronary restenosis after percutaneous coronary intervention. Design Meta-analysis of studies before July 2001 that reported on these genotypes and risk of coronary restenosis after a percutaneous coronary intervention, with or without coronary stenting. Results 16 studies, involving 4631 patients undergoing a percutaneous coronary intervention, yielded 1683 patients with restenosis after a mean weighted follow up of 5.5 months. The combined odds ratio for restenosis in people with the DD genotype was 1.23 (99% confidence interval 1.03 to 1.46). When studies were grouped by size, however, the combined odds ratios for restenosis in people with the DD genotype were 1.94 (1.39 to 2.71) for studies with less than 100 cases, 1.33 (0.92 to 1.93) for studies with 100-200 cases, and 0.92 (0.72 to 1.18) for studies with more than 200 cases (trend P=0.02). Similarly, when studies were grouped by genotyping procedures, significantly larger odds ratios were found in the studies that did not conceal disease status from laboratory staff and in the studies that did not use a second polymerase chain reaction amplification to reduce genetic mistyping. Conclusion Compared with other studies, larger and more rigorous studies show a weaker association between the angiotensin converting enzyme gene DD genotype and restenosis. Publication bias or detection biases can produce artefactual associations at least as large as those that might be expected for common polymorphisms in complex diseases, suggesting the need for larger and more rigorous genetic epidemiological investigations, than are now customary.	Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England; Univ Oxford, Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Univ Oxford, Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England; Newcastle Univ, Freeman Hosp, Dept Cardiol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	University of Cambridge; Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; Newcastle Freeman Hospital; Newcastle University - UK	Danesh, J (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England.			Keavney, Bernard/0000-0001-9573-0812				Amant C, 1997, CIRCULATION, V96, P56; BEOHAR N, 1995, J INVEST MED, V43, P275; Gensini F, 1999, Minerva Cardioangiol, V47, P516; Guarda E, 1999, REV ESP CARDIOL, V52, P475, DOI 10.1016/S0300-8932(99)74954-7; Gurlek A, 2000, J CARDIOVASC RISK, V7, P403; Hamon M, 1998, AM J CARDIOL, V81, P79, DOI 10.1016/S0002-9149(97)00852-7; KAMITANI A, 1995, HYPERTENSION, V25, P950, DOI 10.1161/01.HYP.25.5.950; Kaski JC, 1996, AM J CARDIOL, V77, P875, DOI 10.1016/S0002-9149(97)89187-4; Keavney B, 2000, LANCET, V355, P434; Koch W, 2000, CIRCULATION, V102, P197, DOI 10.1161/01.CIR.102.2.197; OHISHI M, 1993, NAT GENET, V5, P324, DOI 10.1038/ng1293-324; Okamura A, 1999, ANGIOLOGY, V50, P811, DOI 10.1177/000331979905001005; Ribichini F, 1998, CIRCULATION, V97, P147, DOI 10.1161/01.CIR.97.2.147; SAMANI NJ, 1995, LANCET, V345, P1013, DOI 10.1016/S0140-6736(95)90756-4; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; TIRET L, 1992, AM J HUM GENET, V51, P197; VANBOCKXMEER FM, 1995, CIRCULATION, V92, P2066, DOI 10.1161/01.CIR.92.8.2066; Volzke H, 2000, CLIN SCI, V99, P19; Zee RYL, 2001, HYPERTENSION, V37, P851, DOI 10.1161/01.HYP.37.3.851	19	29	31	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2002	325	7363					517	519		10.1136/bmj.325.7363.517	http://dx.doi.org/10.1136/bmj.325.7363.517			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593NJ	12217990	Bronze, Green Published			2022-12-28	WOS:000177997800016
J	Cohn, RD; Henry, MD; Michele, DE; Barresi, R; Saito, F; Moore, SA; Flanagan, JD; Skwarchuk, MW; Robbins, ME; Mendell, JR; Williamson, RA; Campbell, KP				Cohn, RD; Henry, MD; Michele, DE; Barresi, R; Saito, F; Moore, SA; Flanagan, JD; Skwarchuk, MW; Robbins, ME; Mendell, JR; Williamson, RA; Campbell, KP			Disruption of Dag1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration	CELL			English	Article							MYOGENIC STEM-CELL; MUSCULAR-DYSTROPHY; MICE; GENE; EXPRESSION; MEMBRANE; DEFICIENCY; MYOTUBES; COMPLEX	Striated muscle-specific disruption of the dystroglycan (DAG1) gene results in loss of the dystrophin-glycoprotein complex in differentiated muscle and a remarkably mild muscular dystrophy with hypertrophy and without tissue fibrosis. We find that satellite cells, expressing dystroglycan, support continued efficient regeneration of skeletal muscle along with transient expression of dystroglycan in regenerating muscle fibers. We demonstrate a similar phenomenon of reexpression of functional dystroglycan in regenerating muscle fibers in a mild form of human muscular dystrophy caused by disruption of posttranslational dystroglycan processing. Thus, maintenance of regenerative capacity by satellite cells expressing dystroglycan is likely responsible for mild disease progression in mice and possibly humans. Therefore, inadequate repair of skeletal muscle by satellite cells represents an important mechanism affecting the pathogenesis of muscular dystrophy.	Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Neurol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; Ohio State Univ Hosp, Dept Neurol, Columbus, OH 43210 USA; Holden Comprehens Canc Ctr, Dept Radiat Oncol, Free Rad & Radiat Biol Program, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University System of Ohio; Ohio State University	Campbell, KP (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Cohn, Ronald/AAC-5835-2021; Barresi, Rita/AAB-9569-2022	Barresi, Rita/0000-0001-7351-959X; Moore, Steven/0000-0002-6353-7900; Campbell, Kevin/0000-0003-2066-5889; Henry, Michael/0000-0002-7871-245X	NHLBI NIH HHS [HL07121] Funding Source: Medline; NIDDK NIH HHS [DK25295] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alderton JM, 2000, TRENDS CARDIOVAS MED, V10, P268, DOI 10.1016/S1050-1738(00)00075-X; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bushby K, 2000, DEV MED CHILD NEUROL, V42, P780, DOI 10.1017/S0012162200001444; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Cossu G, 2000, J CLIN INVEST, V105, P1669, DOI 10.1172/JCI10376; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Heslop L, 2000, J CELL SCI, V113, P2299; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kong JM, 2001, MUSCLE NERVE, V24, P77, DOI 10.1002/1097-4598(200101)24:1<77::AID-MUS9>3.0.CO;2-Q; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Mussini I, 1995, ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY, VOL 100 - SUPPLEMENT N.1 - 1995, P155; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Winder SJ, 1997, J MUSCLE RES CELL M, V18, P617, DOI 10.1023/A:1018627705273	28	206	217	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2002	110	5					639	648		10.1016/S0092-8674(02)00907-8	http://dx.doi.org/10.1016/S0092-8674(02)00907-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230980	Bronze			2022-12-28	WOS:000177943700010
J	Weller, GR; Kysela, B; Roy, R; Tonkin, LM; Scanlan, E; Della, M; Devine, SK; Day, JP; Wilkinson, A; di Fagagna, FD; Devine, KM; Bowater, RP; Jeggo, PA; Jackson, SP; Doherty, AJ				Weller, GR; Kysela, B; Roy, R; Tonkin, LM; Scanlan, E; Della, M; Devine, SK; Day, JP; Wilkinson, A; di Fagagna, FD; Devine, KM; Bowater, RP; Jeggo, PA; Jackson, SP; Doherty, AJ			Identification of a DNA nonhomologous end-joining complex in bacteria	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; KU PROTEIN; BACILLUS-SUBTILIS; REPAIR; BINDING; LIGASE; DOMAINS; CONSERVATION; HOMOLOGS	in eukaryotic cells, double-strand breaks (DSBs) in DNA are generally repaired by the pathway of homologous recombination or by DNA nonhomologous end joining (NHEJ). Both pathways have been highly conserved throughout eukaryotic evolution, but no equivalent NHEJ system has been identified in prokaryotes. The NHEJ pathway requires a DNA end-binding component called Ku. We have identified bacterial Ku homologs and show that these proteins retain the biochemical characteristics of the eukaryotic Ku heterodimer. Furthermore, we show that bacterial Ku specifically recruits DNA ligase to DNA ends and stimulates DNA ligation. Loss of these proteins leads to hypersensitivity to ionizing radiation in Bacillus subtilis. These data provide evidence that many bacteria possess a DNA DSB repair apparatus that shares many features with the NHEJ system of eukarya and suggest that this DNA repair pathway arose before the prokaryotic and eukaryotic lineages diverged.	Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England; Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QR, England; Univ Cambridge, Wellcome Trust Canc Res UK, Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Dublin Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Cambridge; University of Cambridge; University of Sussex; University of Cambridge; Cancer Research UK; University of Cambridge; Trinity College Dublin; University of East Anglia	Doherty, AJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 2XY, England.		Dry, Kate/I-2328-2014; d'Adda di Fagagna, Fabrizio/AAC-4683-2022; Bowater, Richard P/A-4227-2010; Jackson, Stephen Philip/R-4548-2019	d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; Bowater, Richard P/0000-0002-2745-7807; Jackson, Stephen Philip/0000-0001-9317-7937; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185; Doherty, Aidan/0000-0002-6370-1109				Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Bliss TM, 1997, J BIOL CHEM, V272, P5765, DOI 10.1074/jbc.272.9.5765; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; DIFAGAGNA FD, UNPUB; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Doherty AJ, 2001, CURR BIOL, V11, pR920, DOI 10.1016/S0960-9822(01)00555-3; Doherty AJ, 2001, FEBS LETT, V500, P186, DOI 10.1016/S0014-5793(01)02589-3; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; KODAMA K, 1991, NUCLEIC ACIDS RES, V19, P6093, DOI 10.1093/nar/19.22.6093; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Osipovich O, 1997, J BIOL CHEM, V272, P27259, DOI 10.1074/jbc.272.43.27259; Osipovich O, 1999, BIOCHEM BIOPH RES CO, V261, P802, DOI 10.1006/bbrc.1999.1118; Pang DL, 1997, CANCER RES, V57, P1412; Petit JC, 2000, ACCREDIT QUAL ASSUR, V5, P28, DOI 10.1007/s007690050005; PFEIFFER P, 1994, MOL CELL BIOL, V14, P888, DOI 10.1128/MCB.14.2.888; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Sciochetti SA, 1999, J BACTERIOL, V181, P6053, DOI 10.1128/JB.181.19.6053-6062.1999; SHINOHARA A, 1995, TRENDS BIOCHEM SCI, V20, P387, DOI 10.1016/S0968-0004(00)89085-4; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Teo SH, 2000, CURR BIOL, V10, P165, DOI 10.1016/S0960-9822(00)00317-1; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang JS, 1998, J BIOL CHEM, V273, P842, DOI 10.1074/jbc.273.2.842; Weller GR, 2001, FEBS LETT, V505, P340, DOI 10.1016/S0014-5793(01)02831-9; WELLER GR, UNPUB; Wu XT, 1996, MOL CELL BIOL, V16, P5186	34	250	267	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1686	1689		10.1126/science.1074584	http://dx.doi.org/10.1126/science.1074584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215643				2022-12-28	WOS:000177819100045
J	Hahnloser, RHR; Kozhevnikov, AA; Fee, MS				Hahnloser, RHR; Kozhevnikov, AA; Fee, MS			An ultra-sparse code underlies the generation of neural sequences in a songbird	NATURE			English	Article							ZEBRA FINCH SONG; NUCLEUS ROBUSTUS-ARCHISTRIATALIS; IDENTIFICATION; BIRDSONG; VOCALIZATIONS; CONNECTIONS; PLASTICITY; BEHAVIOR; SYSTEM; SLEEP	Sequences of motor activity are encoded in many vertebrate brains by complex spatio-temporal patterns of neural activity; however, the neural circuit mechanisms underlying the generation of these pre-motor patterns are poorly understood. In songbirds, one prominent site of pre-motor activity is the forebrain robust nucleus of the archistriatum (RA), which generates stereotyped sequences of spike bursts during song(1) and recapitulates these sequences during sleep(2). We show that the stereotyped sequences in RA are driven from nucleus HVC (high vocal centre), the principal pre-motor input to RA(3,4). Recordings of identified HVC neurons in sleeping and singing birds show that individual HVC neurons projecting onto RA neurons produce bursts sparsely, at a single, precise time during the RA sequence. These HVC neurons burst sequentially with respect to one another. We suggest that at each time in the RA sequence, the ensemble of active RA neurons is driven by a subpopulation of RA-projecting HVC neurons that is active only at that time. As a population, these HVC neurons may form an explicit representation of time in the sequence. Such a sparse representation, a temporal analogue of the 'grandmother cell'(5) concept for object recognition, eliminates the problem of temporal interference during sequence generation and learning attributed to more distributed representations(6,7).	Bell Labs, Lucent Technol, Biol Computat Res Dept, Murray Hill, NJ 07974 USA; MIT, Howard Hughes Med Inst, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Fee, MS (corresponding author), Bell Labs, Lucent Technol, Biol Computat Res Dept, 600 Mt Ave, Murray Hill, NJ 07974 USA.		Kozhevnikov, Alexay/A-1092-2013	Kozhevnikov, Alexay/0000-0002-0033-9747; Hahnloser, Richard/0000-0002-4039-7773; Fee, Michale/0000-0001-7539-1745				AMARI SI, 1972, IEEE T COMPUT, P1197; Barlow Horace, 1995, P415; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; BRILLINGER DR, 1976, BIOL CYBERN, V22, P213, DOI 10.1007/BF00365087; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Doupe A J, 1993, Curr Opin Neurobiol, V3, P104, DOI 10.1016/0959-4388(93)90043-X; Doya K, 1998, CENTRAL AUDITORY PROCESSING AND NEURAL MODELING, P77; Dutar P, 1998, J NEUROPHYSIOL, V80, P1828, DOI 10.1152/jn.1998.80.4.1828; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; Hermann M., 1995, NETWORK COMPUTATION, V6, P403; Immelmann K., 1969, P61; KLEIN MK, 1989, J AM VET MED ASSOC, V195, P246; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; MOONEY R, 1992, J NEUROSCI, V12, P2464; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Pearlmutter BA, 1989, NEURAL COMPUT, V1, P263, DOI 10.1162/neco.1989.1.2.263; PHILLIPS NH, 1992, NEUROSCI LETT, V145, P217, DOI 10.1016/0304-3940(92)90026-4; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Swadlow HA, 1998, J NEUROSCI METH, V79, P131, DOI 10.1016/S0165-0270(97)00176-3; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1224, DOI 10.1152/jn.2000.84.3.1224; VICARIO DS, 1991, J COMP NEUROL, V309, P486, DOI 10.1002/cne.903090405; VU ET, 1994, J NEUROSCI, V14, P6924; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	30	691	702	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					65	70		10.1038/nature00974	http://dx.doi.org/10.1038/nature00974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214232				2022-12-28	WOS:000177788600037
J	Kimm, SYS; Glynn, NW; Kriska, AM; Barton, BA; Kronsberg, SS; Daniels, SR; Crawford, PB; Sabry, ZI; Liu, K				Kimm, SYS; Glynn, NW; Kriska, AM; Barton, BA; Kronsberg, SS; Daniels, SR; Crawford, PB; Sabry, ZI; Liu, K			Decline in physical activity in black girls and white girls during adolescence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; NHLBI GROWTH; LEISURE-TIME; SOCIAL-CLASS; CHILDREN; INACTIVITY; OBESITY; DETERMINANTS; PREVALENCE	Background: Physical activity declines during adolescence, but the underlying reasons remain unknown. Methods: We prospectively followed 1213 black girls and 1166 white girls enrolled in the National Heart, Lung, and Blood Institute Growth and Health Study from the ages of 9 or 10 to the ages of 18 or 19 years. We used a validated questionnaire to measure leisure-time physical activity on the basis of metabolic equivalents (MET) for reported activities and their frequency in MET-times per week; a higher score indicated greater activity. Results: The respective median activity scores for black girls and white girls were 27.3 and 30.8 MET-times per week at base line and declined to 0 and 11.0 by year 10 of the study (a 100 percent decline for black girls and a 64 percent decline for white girls, P<0.001). By the age of 16 or 17 years, 56 percent of the black girls and 31 percent of the white girls reported no habitual leisure-time activity. Lower levels of parental education were associated with greater decline in activity for white girls at both younger ages (P<0.001) and older ages (P=0.005); for black girls, this association was seen only at the older ages (P=0.04). Pregnancy was associated with decline in activity among black girls (P<0.001) but not among white girls, whereas cigarette smoking was associated with decline in activity among white girls (P<0.001). A higher body-mass index was associated with greater decline in activity among girls of both races (P lessthan/equal 0.05). Conclusions: Substantial declines in physical activity occur during adolescence in girls and are greater in black girls than in white girls. Some determinants of this decline, such as higher body-mass index, pregnancy, and smoking, may be modifiable.	Univ Pittsburgh, Sch Med, Dept Family Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; Maryland Med Res Inst, Baltimore, MD USA; Childrens Hosp, Med Ctr, Div Cardiol, Cincinnati, OH 45229 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cincinnati Children's Hospital Medical Center; University of California System; University of California Berkeley; Northwestern University	Kimm, SYS (corresponding author), Univ Pittsburgh, Sch Med, Dept Family Med, 3518 5th Ave, Pittsburgh, PA 15261 USA.			Glynn, Nancy/0000-0003-2265-0162; Barton, Bruce/0000-0001-7878-8895; Kriska, Andrea/0000-0002-3522-0869	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055023] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL048941] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-55023-26, U01-HL48941-44] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AARON DJ, 1993, MED SCI SPORT EXER, V25, P847, DOI 10.1249/00005768-199307000-00014; Ball K, 2000, AUST NZ J PUBL HEAL, V24, P331, DOI 10.1111/j.1467-842X.2000.tb01579.x; BarnekowBergkvist M, 1996, SCAND J MED SCI SPOR, V6, P359, DOI 10.1111/j.1600-0838.1996.tb00108.x; CARROLL MD, 1976, VITAL HLTH STAT, V231; Crawford Patricia B., 1995, Annals of Epidemiology, V5, P360, DOI 10.1016/1047-2797(95)00033-4; Crespo CJ, 2000, AM J PREV MED, V18, P46, DOI 10.1016/S0749-3797(99)00105-1; Crespo CJ, 1999, MED SCI SPORT EXER, V31, P1821, DOI 10.1097/00005768-199912000-00019; *DHHS, 1996, PHYS ACT HLTH REP SU; Draper NR., 1998, APPL REGRESSION ANAL, DOI [10.1002/9781118625590, DOI 10.1002/9781118625590]; HEATH GW, 1994, ARCH PEDIAT ADOL MED, V148, P1131, DOI 10.1001/archpedi.1994.02170110017003; Kann Laura., 1997, MMWR SURVEILL SUMM, V47, P1; Kimm SYS, 1996, ANN EPIDEMIOL, V6, P266, DOI 10.1016/S1047-2797(96)00056-7; Kimm SYS, 2000, MED SCI SPORT EXER, V32, P1445, DOI 10.1097/00005768-200008000-00013; Kimm SYS, 1997, ANN EPIDEMIOL, V7, P550, DOI 10.1016/S1047-2797(97)00124-5; KIMM SYS, 2002, RACIAL DIVERGENCE AD; KIMM SYS, 1999, ANN BEHAV MED, V21, pS206; Kriska A.M., 1997, MED SCI SPORTS EXERC, V29, P5, DOI [DOI 10.1097/00005768-199706001-00003, https://doi.org/10.1097/00005768-199706001-00003]; LAZARUS NB, 1989, AM J PREV MED, V5, P127, DOI 10.1016/S0749-3797(18)31093-6; MCDOWELL MA, 1988, VITAL HLTH STAT, V255; McNutt SW, 1997, J ADOLESCENT HEALTH, V20, P27, DOI 10.1016/S1054-139X(96)00176-0; MORRISON JA, 1992, AM J PUBLIC HEALTH, V82, P1613; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; SALLIS JF, 1992, MED SCI SPORT EXER, V24, pS248; Sallis JF, 1996, J CLIN EPIDEMIOL, V49, P125, DOI 10.1016/0895-4356(95)00514-5; Sallis JF, 1999, AM J PREV MED, V16, P222, DOI 10.1016/S0749-3797(98)00154-8; SAS Institute, 1999, SAS STAT US GUID VER; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; Trost SG, 2001, INT J OBESITY, V25, P822, DOI 10.1038/sj.ijo.0801621; Trost SG, 1997, PREV MED, V26, P257, DOI 10.1006/pmed.1996.0137; WASHBURN RA, 1992, PREV MED, V21, P127, DOI 10.1016/0091-7435(92)90012-7; WOLF AM, 1993, AM J PUBLIC HEALTH, V83, P1625, DOI 10.2105/AJPH.83.11.1625	31	661	667	0	52	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2002	347	10					709	715		10.1056/NEJMoa003277	http://dx.doi.org/10.1056/NEJMoa003277			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589NH	12213941				2022-12-28	WOS:000177765800002
J	Veasey, S; Rosen, R; Barzansky, B; Rosen, I; Owens, J				Veasey, S; Rosen, R; Barzansky, B; Rosen, I; Owens, J			Sleep loss and fatigue in residency training - A reappraisal	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							YOUNG HOSPITAL DOCTORS; HOUSE OFFICERS; COGNITIVE PERFORMANCE; DRIVER SLEEPINESS; CALL DUTY; PSYCHOMOTOR VIGILANCE; PHYSICIAN PERFORMANCE; DAYTIME SLEEPINESS; SURGICAL RESIDENTS; WORKING-CONDITIONS	Reduced sleep time is commonplace for many interns and residents. Recent studies, however, suggest that sleep loss and fatigue result in significant neurobehavioral impairments in healthy young adults. We reviewed studies addressing the effects of sleep loss on cognition, performance, and health in surgical and nonsurgical residents. We describe the effectiveness of countermeasures for sleepiness, including recent work-hour restrictions. A more complete understanding of the issues of sleep loss during residency training can inform innovative strategies to minimize the effects of sleepiness and fatigue on patient care and resident safety.	Univ Penn, Ctr Sleep & Resp Neurobiol, Sch Med, Philadelphia, PA 19106 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; Amer Med Assoc, Chicago, IL 60610 USA; Brown Univ, Sch Med, Providence, RI 02912 USA	University of Pennsylvania; Pennsylvania Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; American Medical Association; Brown University	Veasey, S (corresponding author), Univ Penn, Ctr Sleep & Resp Neurobiol, Sch Med, 972 Maloney Bldg,3600 Spruce St, Philadelphia, PA 19106 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K07HL003651] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 03651] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Achermann P, 1995, ARCH ITAL BIOL, V134, P109; AKERSTEDT T, 1990, ELECTROEN CLIN NEURO, V76, P193, DOI 10.1016/0013-4694(90)90217-8; ALTSHULER LL, 1987, ACTA PSYCHIAT SCAND, V75, P614, DOI 10.1111/j.1600-0447.1987.tb02845.x; ANDERSON CM, 2000, SLEEP, V23, pA74; [Anonymous], 2000, FED REG, V65, P25540; ASCH DA, 1988, NEW ENGL J MED, V318, P771, DOI 10.1056/NEJM198803243181209; ASKEN MJ, 1983, J MED EDUC, V58, P382; BARTLE EJ, 1988, SURGERY, V104, P311; BENSIMON J, 1989, PSYCHIAT PSYCHOBIOL, V9, P193; BERKOFF K, 1991, J DEV BEHAV PEDIATR, V12, P6; BERTRAM DA, 1988, NEW YORK STATE J MED, V88, P10; BLAGROVE M, 1995, APPL COGNITIVE PSYCH, V9, P21, DOI 10.1002/acp.2350090103; Blagrove M, 2000, J EXP PSYCHOL-APPL, V6, P59, DOI 10.1037//0278-7393.6.1.59; BONNET MH, 1994, PHYSIOL BEHAV, V56, P103, DOI 10.1016/0031-9384(94)90266-6; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; BROWNE BJ, 1994, SURGERY, V115, P604; Bruck D, 1999, J SLEEP RES, V8, P95, DOI 10.1046/j.1365-2869.1999.00150.x; BUNCH WH, 1992, J SURG RES, V53, P268, DOI 10.1016/0022-4804(92)90046-3; Cajochen C, 2001, NEUROREPORT, V12, P2277, DOI 10.1097/00001756-200107200-00046; Carrier J, 2000, CHRONOBIOL INT, V17, P719, DOI 10.1081/CBI-100102108; CARSKADON MA, 1981, PSYCHOPHYSIOLOGY, V18, P107, DOI 10.1111/j.1469-8986.1981.tb02921.x; CHRISTENSEN EE, 1977, RADIOLOGY, V125, P103, DOI 10.1148/125.1.103; Cook RI, 1994, HUMAN ERROR MED; Daugherty SR, 1998, JAMA-J AM MED ASSOC, V279, P1194, DOI 10.1001/jama.279.15.1194; De Valck E, 2001, J SLEEP RES, V10, P203, DOI 10.1046/j.1365-2869.2001.00260.x; DEACONSON TF, 1988, JAMA-J AM MED ASSOC, V260, P1721, DOI 10.1001/jama.260.12.1721; DEARY IJ, 1987, BRIT MED J, V295, P1513, DOI 10.1136/bmj.295.6612.1513; Defoe DM, 2001, OBSTET GYNECOL, V97, P1015, DOI 10.1016/S0029-7844(01)01363-1; DEMENT WC, 1993, JAMA-J AM MED ASSOC, V269, P1548, DOI 10.1001/jama.269.12.1548; Denisco R A, 1987, J Clin Monit, V3, P22, DOI 10.1007/BF00770879; Dinges DF, 2001, SLEEP, V24, pA28; Dinges DF, 1997, SLEEP, V20, P267; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; EDWARDS SJ, 1992, INT J PSYCHOPHYSIOL, V13, P97, DOI 10.1016/0167-8760(92)90048-G; ENGEL W, 1987, SOUTHERN MED J, V80, P761, DOI 10.1097/00007611-198706000-00022; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; FORD CV, 1984, SOUTHERN MED J, V77, P1435, DOI 10.1097/00007611-198411000-00019; Franco P, 2000, SLEEP, V23, P401; FREIDMAN RC, 1973, J MED EDUC, V48, P436; FRIEDMAN RC, 1971, NEW ENGL J MED, V285, P201, DOI 10.1056/NEJM197107222850405; Geer RT, 1997, ANESTHESIOLOGY, V87, pA938, DOI 10.1097/00000542-199709001-00938; Gillberg Mats, 1994, Journal of Sleep Research, V3, P90; Godellas CV, 2001, AM J SURG, V181, P294, DOI 10.1016/S0002-9610(01)00576-1; GOLDMAN LI, 1972, J SURG RES, V12, P83, DOI 10.1016/0022-4804(72)90125-4; GOTTLIEB DJ, 1991, ARCH INTERN MED, V151, P2065, DOI 10.1001/archinte.151.10.2065; Grantcharov TP, 2001, BRIT MED J, V323, P1222, DOI 10.1136/bmj.323.7323.1222; Harrison Y, 2000, Q J EXP PSYCHOL-A, V53, P271, DOI 10.1080/027249800390772; HART RP, 1987, J MED EDUC, V62, P940; HAWKINS MR, 1985, J MED EDUC, V60, P530; HAYNES DF, 1995, SOUTHERN MED J, V88, P283, DOI 10.1097/00007611-199503000-00007; Holzman IR, 2000, MT SINAI J MED, V67, P136; HORNE JA, 1988, SLEEP, V11, P528, DOI 10.1093/sleep/11.6.528; Horne JA, 1996, PSYCHOPHYSIOLOGY, V33, P306, DOI 10.1111/j.1469-8986.1996.tb00428.x; JACQUES CHM, 1990, J FAM PRACTICE, V30, P223; Jewett ME, 1999, SLEEP, V22, P171, DOI 10.1093/sleep/22.2.171; Kingshott RN, 2001, AM J RESP CRIT CARE, V163, P918, DOI 10.1164/ajrccm.163.4.2005036; Kleitman N, 1923, AM J PHYSIOL, V66, P67, DOI 10.1152/ajplegacy.1923.66.1.67; KLOSE JK, 1985, ANESTHESIOLOGY, V63, pA485; Lee MAM, 1923, AM J PHYSIOL, V67, P141, DOI 10.1152/ajplegacy.1923.67.1.141; Leonard C, 1998, IRISH J MED SCI, V167, P22, DOI 10.1007/BF02937548; LEUNG L, 1992, J OCCUP ENVIRON MED, V34, P1153; LEWITTES LR, 1989, CAN MED ASSOC J, V140, P21; LIGHT A I, 1989, Current Surgery, V46, P29; LIN TD, 1994, TIME DAY MODELS MOTO, P1; LINDE L, 1992, PSYCHOL RES-PSYCH FO, V54, P127, DOI 10.1007/BF00937141; LINGENFELSER T, 1994, MED EDUC, V28, P566, DOI 10.1111/j.1365-2923.1994.tb02737.x; Marcus CL, 1996, SLEEP, V19, P763, DOI 10.1093/sleep/19.10.763; MCDONALD CJ, 2001, JAMA-J AM MED ASSOC, V284, P95; MCKEE M, 1992, SOC SCI MED, V34, P549, DOI 10.1016/0277-9536(92)90210-H; Nelson C S, 1995, J Am Osteopath Assoc, V95, P600; NEWHOUSE PA, 1989, NEUROPSYCHOPHARMACOL, V2, P153, DOI 10.1016/0893-133X(89)90018-3; ORTON DI, 1989, BRIT MED J, V298, P21, DOI 10.1136/bmj.298.6665.21; OSBORN LM, 1990, J FAM PRACTICE, V31, P618; PARKER JBR, 1987, CAN J ANAESTH, V34, P489, DOI 10.1007/BF03014356; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; PITTS FN, 1979, AM J PSYCHIAT, V136, P694; POLZELLA DJ, 1975, J EXP PSYCHOL-HUM L, V104, P194; POULTON EC, 1978, ERGONOMICS, V21, P279, DOI 10.1080/00140137808931725; REUBEN DB, 1983, SOUTHERN MED J, V76, P380, DOI 10.1097/00007611-198303000-00024; Reyner LA, 2000, PSYCHOPHYSIOLOGY, V37, P251, DOI 10.1017/S0048577200000949; REZNICK RK, 1987, AM J SURG, V154, P520, DOI 10.1016/0002-9610(87)90269-8; Richardson GS, 1996, SLEEP, V19, P718; ROBBINS J, 1990, WESTERN J MED, V152, P82; ROSENTHAL L, 1991, NEUROPSYCHOPHARMACOL, V4, P103; RUBIN R, 1991, J OCCUP ENVIRON MED, V33, P13, DOI 10.1097/00043764-199101000-00007; RUBY ST, 1960, ARCH SURG-CHICAGO, V125, P764; SAMKOFF JS, 1991, ACAD MED, V66, P687, DOI 10.1097/00001888-199111000-00013; Sawyer RG, 1999, SURGERY, V126, P337, DOI 10.1016/S0039-6060(99)70174-1; SCHER KS, 1990, SURGERY, V108, P393; SMITH C, 1988, PHYSIOL BEHAV, V43, P213, DOI 10.1016/0031-9384(88)90240-5; SMITH HL, 1992, CONTEMP SOCIOL, V21, P139, DOI 10.2307/2074815; SMITHCOGGINS R, 1994, ANN EMERG MED, V24, P928, DOI 10.1016/S0196-0644(94)70209-8; SmithCoggins R, 1997, ACAD EMERG MED, V4, P951, DOI 10.1111/j.1553-2712.1997.tb03658.x; Steele MT, 1999, ACAD EMERG MED, V6, P1050, DOI 10.1111/j.1553-2712.1999.tb01191.x; STORER JS, 1989, ACAD MED, V64, P29, DOI 10.1097/00001888-198901000-00013; STRUNK CL, 1991, JAMA-J AM MED ASSOC, V266, P1371, DOI 10.1001/jama.266.10.1371; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; Thomas EJ, 1999, INQUIRY-J HEALTH CAR, V36, P255; TOV N, 1995, ISRAEL J MED SCI, V31, P417; Tyssen R, 2000, MED EDUC, V34, P374, DOI 10.1046/j.1365-2923.2000.00540.x; VALKO RJ, 1975, DIS NERV SYST, V36, P26; WENDT JR, 1988, JAMA-J AM MED ASSOC, V259, P43, DOI 10.1001/jama.1988.03720010023020; Wiegmann DA, 1996, INT J AVIAT PSYCHOL, V6, P379; WILKINSON RT, 1975, J OCCUP PSYCHOL, V48, P219, DOI 10.1111/j.2044-8325.1975.tb00318.x; WILLIAMS HL, 1959, PSYCHOL MONOGR, V73, P1; Wright KP, 1997, J SLEEP RES, V6, P26, DOI 10.1046/j.1365-2869.1997.00022.x; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089	108	275	280	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1116	1124		10.1001/jama.288.9.1116	http://dx.doi.org/10.1001/jama.288.9.1116			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589NA	12204082	Bronze			2022-12-28	WOS:000177764600016
J	Hofer, TP; Hayward, RA				Hofer, TP; Hayward, RA			Are bad outcomes from questionable clinical decisions preventable medical errors? A case of cascade latrogenesis	ANNALS OF INTERNAL MEDICINE			English	Article							PULMONARY-EMBOLISM; UPPER-EXTREMITY; ADVERSE EVENTS; COMPUTED-TOMOGRAPHY; DIAGNOSTIC-TEST; USERS GUIDES; RISK-FACTORS; HEALTH-CARE; MANAGEMENT; APPROPRIATENESS	When a patient with multiple, complicated conditions is admitted to a hospital and risky procedures are performed that result in adverse outcomes, the difficulties inherent in determining whether and when a preventable medical error has occurred must be addressed. This article analyzes the case of a 40-year-old woman with a history of chronic aortic dissection and pericardial effusion who was admitted to a teaching hospital with unilateral swelling of her left breast and arm accompanied by dyspnea. During her hospitalization, the patient developed multiple complications from the diagnostic and therapeutic procedures that were performed. The authors argue that this case illustrates some limitations of routinely undertaking time-consuming and costly reviews, or "root-cause analyses," as a patient safety strategy when they are unlikely to reveal remediable "errors" or to suggest better systems of care that will prevent errors. The ability to establish causality through post hoc reviews is the linchpin in the recommendation for widespread adoption of error reporting and reviews. When causality is not established, it is impossible to know whether any changes adopted as a result of the reviews will be effective. This case, in which the causal pathways to the adverse events are very uncertain, may be much more typical than the egregious errors featured in a classic root-cause analysis. The authors recommend that the relative merits of this approach to patient safety be compared with other proven, cost-effective interventions to improve quality, such as appropriate treatment of myocardial infarction or depression, before scarce resources and enormous human capital are allocated for widespread implementation.	VA Ann Arbor Healthcare Syst, VA Ctr Practice Management & Outcomes Res, Ann Arbor, MI USA; VA Ann Arbor Healthcare Syst, QUERI, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hofer, TP (corresponding author), POB 130170, Ann Arbor, MI 48113 USA.	thofer@umich.edu	Hofer, Timothy Philip/AAC-9238-2022	Hofer, Timothy/0000-0003-0434-8787				Ault M, 1998, ARCH INTERN MED, V158, P1950, DOI 10.1001/archinte.158.17.1950; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 2002, ANN INTERN MED, V137, P110, DOI 10.7326/0003-4819-137-2-200207160-00009; BIER V, 1997, ORG ANAL HIGH HAZARD; Braunwald E., 2001, HARRISONS PRINCIPLES; Bree RL, 1996, JAMA-J AM MED ASSOC, V276, P1595, DOI 10.1001/jama.276.19.1595; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 2000, NEW ENGL J MED, V342, P1123, DOI 10.1056/NEJM200004133421510; BROOK RH, 1994, BRIT MED J, V308, P218, DOI 10.1136/bmj.308.6923.218; CAPLAN RA, 1991, JAMA-J AM MED ASSOC, V265, P1957, DOI 10.1001/jama.265.15.1957; Chassin MR, 2002, ANN INTERN MED, V136, P826, DOI 10.7326/0003-4819-136-11-200206040-00012; CLARK LT, 1991, AM HEART J, V121, P664, DOI 10.1016/0002-8703(91)90443-L; de Monye W, 2000, RADIOLOGY, V215, P184, DOI 10.1148/radiology.215.1.r00ap22184; DIAMOND GA, 1993, ANN INTERN MED, V118, P455, DOI 10.7326/0003-4819-118-6-199303150-00010; Donohoe MT, 1998, ARCH INTERN MED, V158, P1596, DOI 10.1001/archinte.158.15.1596; Dowell AM, 1997, PROCESS SAF PROG, V16, P132, DOI 10.1002/prs.680160305; DUBOIS RW, 1987, NEW ENGL J MED, V317, P1674, DOI 10.1056/NEJM198712243172626; Ellis MH, 2000, CHEST, V117, P43, DOI 10.1378/chest.117.1.43; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; Enkin MW, 1998, ANN ONCOL, V9, P963, DOI 10.1023/A:1008495101125; FISCHHOFF B, 1975, J EXP PSYCHOL HUMAN, V1, P288, DOI 10.1037/0096-1523.1.3.288; Glasgow RE, 2001, DIABETES CARE, V24, P124, DOI 10.2337/diacare.24.1.124; Goldman L., 2000, CECIL TXB MED; GUYATT GH, 1990, ANN INTERN MED, V112, P293, DOI 10.7326/0003-4819-112-4-293; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; HILLMAN BJ, 1986, HEALTH SERV RES, V21, P681; Hofer T P, 1997, Jt Comm J Qual Improv, V23, P455; Hofer TP, 2000, MED CARE, V38, P152, DOI 10.1097/00005650-200002000-00005; Hofer TP, 2000, EFFECTIVE CLIN PRACT, V3, P1; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jarvik JG, 1996, ACAD RADIOL, V3, P537, DOI 10.1016/S1076-6332(96)80214-5; Kaufman Marc, 2000, WASH POST       0822, pA2; Kohn LT, ERR IS HUMAN BUILDIN; Kooij JDB, 1997, NETH J MED, V50, P238, DOI 10.1016/S0300-2977(97)00020-X; Lal NR, 2000, AM J NEURORADIOL, V21, P124; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; LEWIS BN, 1981, INSTR SCI, V10, P237, DOI 10.1007/BF00139801; LOURENS PF, 1989, ACCIDENT ANAL PREV, V21, P419, DOI 10.1016/0001-4575(89)90002-X; MAURINO DE, 1999, AVIATION HUMAN FACTO; McDonald CJ, 2000, JAMA-J AM MED ASSOC, V284, P93, DOI 10.1001/jama.284.1.93; *MED RISK MAN ASS, 2002, SOFTW FAC SENT EV RO; Merboth MK, 2000, NURS CLIN N AM, V35, P375; MOLD JW, 1986, NEW ENGL J MED, V314, P512, DOI 10.1056/NEJM198602203140809; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; PARK RE, 1994, NEW ENGL J MED, V330, P432; PEAR R, 2000, NY TIMES        0701, pA1; Potts S, 1993, QRB Qual Rev Bull, V19, P199; Prandoni P, 1997, ARCH INTERN MED, V157, P57, DOI 10.1001/archinte.157.1.57; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; Rex J H, 2000, Jt Comm J Qual Improv, V26, P563; Robert G, 1999, Health Technol Assess, V3, P1; Robinson PJA, 1997, BRIT J RADIOL, V70, P1085, DOI 10.1259/bjr.70.839.9536897; Siegle RL, 1998, ACAD RADIOL, V5, P148, DOI 10.1016/S1076-6332(98)80277-8; SPATH PL, 2000, ERROR REDUCTION HLTH, P155; STEIN PD, 1993, CHEST, V103, P1553, DOI 10.1378/chest.103.5.1553; Sturm R, 2000, PSYCHIATR SERV, V51, P177, DOI 10.1176/appi.ps.51.2.177; Tapson VF, 1999, AM J RESP CRIT CARE, V160, P1043; Thomas EJ, 2000, J GEN INTERN MED, V15, P211, DOI 10.1046/j.1525-1497.2000.015004211.x; Thomas EJ, 2000, BRIT MED J, V320, P741, DOI 10.1136/bmj.320.7237.741; Ukoumunne OC, 1999, HLTH TECHNOLOGY ASSE, V3, piii, DOI [DOI 10.3310/HTA3050, DOI 10.3310/hta3050]; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; WACHTER RM, 2000, HOSP MED; WAKELEY CJ, 1995, BRIT J RADIOL, V68, P358, DOI 10.1259/0007-1285-68-808-358; Warner K E, 1993, J Ambul Care Manage, V16, P38; Weeks W B, 2000, Eff Clin Pract, V3, P270; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Willison DJ, 1998, ARCH INTERN MED, V158, P1778, DOI 10.1001/archinte.158.16.1778; Wilson RM, 1999, MED J AUSTRALIA, V170, P411, DOI 10.5694/j.1326-5377.1999.tb127814.x	70	56	55	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2002	137	5	1				327	333		10.7326/0003-4819-137-5_Part_1-200209030-00008	http://dx.doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	591DZ	12204016				2022-12-28	WOS:000177865600004
J	Gibbs, S; Harvey, I; Sterling, J; Stark, R				Gibbs, S; Harvey, I; Sterling, J; Stark, R			Local treatments for cutaneous warts: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COMMON VIRAL WARTS; 5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY; ALPHA-2 INTERFERON; SALICYLIC-ACID; CRYOTHERAPY; BLEOMYCIN; TRIAL; REGRESSION; VULGARIS	Objective To assess the evidence for the efficacy of local treatments for cutaneous warts. Methods Systematic review of randomised controlled trials. Main outcomes measures Total clearance of warts and adverse effects such as irritation, pain, and blistering. Study selection Randomised controlled trials of any local treatment for uncomplicated cutaneous warts. All published and unpublished material was considered, with no restriction on date or language. Results 50 included trials provided generally weak evidence because of poor methods and reporting. The best evidence was for topical treatments containing salicylic acid. Data pooled from six placebo controlled trials showed a cure rate of 75% (144 of 19 1) in cases compared with 48% (89 of 185) in controls (odds ratio 3.91,95% confidence interval 2.40 to 6.36). Some evidence for the efficacy of contact immunotherapy was provided by two small trials comparing dinitrochlorobenzene with placebo. Evidence for the efficacy of cryotherapy was limited. No consistent evidence was found for the efficacy of intralesional bleomycin, and only limited evidence was found for the efficacy of topical fluorouracil, intralesional interferons, photodynamic therapy, and pulsed dye laser. Conclusions Reviewed trials of local treatments for cutaneous warts were highly variable in methods and quality, and there was a paucity of evidence from randomised, placebo controlled trials on which to base the rational use of the treatments. There is good evidence that topical treatments containing salicylic acid have a therapeutic effect and some evidence for the efficacy of dinitrochlorobenzene. Less evidence was found for the efficacy of all the other treatments reviewed, including cryotherapy.	Ipswich Hosp NHS Trust, Dept Dermatol, Ipswich IP4 5PD, Suffolk, England; Univ E Anglia, Sch Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Addenbrookes NHS Trust, Dept Dermatol, Cambridge CB2 2QQ, England; Norfolk Hlth Author, Dept Serv Dev Finance & Informat, Norwich, Norfolk, England	Ipswich Hospital NHS Trust; Ipswich Hospital; University of East Anglia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Gibbs, S (corresponding author), Ipswich Hosp NHS Trust, Dept Dermatol, Ipswich IP4 5PD, Suffolk, England.	sgibbs@fish.co.uk						ABOUAUDA H, 1987, CURR THER RES CLIN E, V41, P552; Artese O, 1994, DERMATOL CLIN, V14, P55; Auken G, 1975, Ugeskr Laeger, V137, P3036; BART BJ, 1989, J AM ACAD DERMATOL, V20, P74, DOI 10.1016/S0190-9622(89)70010-4; BERMAN B, 1986, J INFECT DIS, V154, P328, DOI 10.1093/infdis/154.2.328; BERTHJONES J, 1992, BRIT J DERMATOL, V127, P262, DOI 10.1111/j.1365-2133.1992.tb00125.x; BERTHJONES J, 1994, BRIT J DERMATOL, V131, P883, DOI 10.1111/j.1365-2133.1994.tb08594.x; BOURKE JF, 1995, BRIT J DERMATOL, V132, P433, DOI 10.1111/j.1365-2133.1995.tb08678.x; BUNNEY MH, 1976, BRIT J DERMATOL, V94, P667, DOI 10.1111/j.1365-2133.1976.tb05167.x; BUNNEY MH, 1973, BRIT J DERMATOL, V89, P96, DOI 10.1111/j.1365-2133.1973.tb01926.x; BUNNEY MH, 1971, PRACTITIONER, V207, P197; BUNNEY MH, 1984, BRIT J DERMATOL, V111, P197, DOI 10.1111/j.1365-2133.1984.tb04044.x; Caballero Martinez F, 1996, Aten Primaria, V18, P211; Clarke M, 2000, COCHRANE REV HDB 4 1; Connolly M, 2001, BRIT J DERMATOL, V145, P554, DOI 10.1046/j.1365-2133.2001.04449.x; ERKENS AMJ, 1992, J DERMATOLOGICAL TRE, V3, P193; Felt BT, 1998, AM J CLIN HYPN, V41, P130, DOI 10.1080/00029157.1998.10404199; FLINDTHANSEN H, 1984, ACTA DERM-VENEREOL, V64, P177; GIBBS S, 2001, COCHRANE LIB; GIBSON JR, 1984, DERMATOLOGICA, V168, P178, DOI 10.1159/000249695; Hansen J G, 1986, Ugeskr Laeger, V148, P173; HAYES ME, 1986, J AM ACAD DERMATOL, V15, P1002, DOI 10.1016/S0190-9622(86)70264-8; HURSTHOUSE MW, 1975, BRIT J DERMATOL, V92, P93; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Larsen PO, 1996, J DERMATOL TREAT, V7, P29, DOI 10.3109/09546639609086866; LEE S W, 1990, Annals of Dermatology, V2, P77; Marroquin E. A., 1997, Fitoterapia, V68, P160; MUNKVAD M, 1983, DERMATOLOGICA, V167, P86, DOI 10.1159/000249753; NIIMURA M, 1990, J INVEST DERMATOL, V95, pS149, DOI 10.1111/1523-1747.ep12875129; Parton AM, 1994, BR J POD MED, V131, P883; PAZIN GJ, 1982, J INTERFERON RES, V2, P235, DOI 10.1089/jir.1982.2.235; Perez AR, 1992, DERMATOL VENEZ, V30, P176; Robson KJ, 2000, J AM ACAD DERMATOL, V43, P275, DOI 10.1067/mjd.2000.106365; Rosado-Cancino MA, 1989, DERMATOL REV MEX, V33, P245; Rossi E, 1981, DERMATOL REV MEX, V25, P158; SCHMIDT H, 1981, Zeitschrift fuer Hautkrankheiten, V56, P41; SONNEX TS, 1988, BRIT J DERMATOL, V119, P38; SPANOS NP, 1990, PSYCHOSOM MED, V52, P109, DOI 10.1097/00006842-199001000-00009; STAHL D, 1979, CLIN EXP DERMATOL, V4, P81, DOI 10.1111/j.1365-2230.1979.tb01594.x; STEELE K, 1988, BRIT J DERMATOL, V118, P537, DOI 10.1111/j.1365-2133.1988.tb02464.x; STEELE K, 1988, J ROY COLL GEN PRACT, V38, P256; Stender IM, 1999, CLIN EXP DERMATOL, V24, P154, DOI 10.1046/j.1365-2230.1999.00441.x; Stender IM, 2000, LANCET, V355, P963, DOI 10.1016/S0140-6736(00)90013-8; Sterling JC, 1998, ROOK TXB DERMATOLOGY; VANCE JC, 1986, ARCH DERMATOL, V122, P272, DOI 10.1001/archderm.122.3.272; Varnavides CK, 1997, J DERMATOL TREAT, V8, P169, DOI 10.3109/09546639709160513; VEIEN NK, 1977, ACTA DERM-VENEREOL, V57, P445; Veien NK, 1991, J DERMATOL TREAT, V2, P59, DOI DOI 10.3109/09546639109086776; Wilson J. T., 1983, Nutrition and Health, V2, P191; WILSON P, 1983, SCOT MED J, V28, P191	50	120	128	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2002	325	7362					461	464		10.1136/bmj.325.7362.461	http://dx.doi.org/10.1136/bmj.325.7362.461			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592EZ	12202325	Bronze, Green Published			2022-12-28	WOS:000177924900016
J	Gursky, H				Gursky, H			X-ray astronomy - 40 years on	SCIENCE			English	Editorial Material							CRAB-NEBULA		USN, Res Lab, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Gursky, H (corresponding author), USN, Res Lab, Washington, DC 20375 USA.							GIACCONI R, 1960, J GEOPHYS RES, V65, P773, DOI 10.1029/JZ065i002p00773; GIACCONI R, 1962, PHYS REV LETT, V9, P439, DOI 10.1103/PhysRevLett.9.439; HESTER JJ, 1995, ASTROPHYS J, V448, P240, DOI 10.1086/175956; Weisskopf MC, 2000, ASTROPHYS J, V536, pL81, DOI 10.1086/312733	4	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1485	1486		10.1126/science.1075482	http://dx.doi.org/10.1126/science.1075482			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202808				2022-12-28	WOS:000177697300034
J	Jain, T; Harlow, BL; Hornstein, MD				Jain, T; Harlow, BL; Hornstein, MD			Insurance coverage and outcomes of in vitro fertilization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-GESTATION; UNITED-STATES; 2 EMBRYOS; PREGNANCIES; TRIPLET; BIRTHS; RATES; COST; RISK; IVF	Background Although most insurance companies in the United States do not cover in vitro fertilization, a few states mandate such coverage. Methods We used 19913 data reported to the Centers for Disease Control and Prevention by 360 fertility clinics in the United States and 2000 U.S. Census data to determine utilization and outcomes of in vitro fertilization services according to the status of insurance coverage. Results Of the states in which in vitro fertilization services were available, 13 states (31 clinics) required complete insurance coverage, 5 states (27 clinics) required partial coverage, and 37 states plus Puerto Rico and the District of Columbia (302 clinics) required no coverage. Clinics in states that required complete coverage performed more in vitro fertilization cycles than clinics in states that required partial or no coverage (3.35 vs. 1.46 and 1.21 transfers per 1000 women of reproductive age, respectively; P < 0.001) and more transfers of frozen embryos (0.43 vs. 0.30 and 0.20 per 1000 women of reproductive age, respectively; P < 0.001). The percentage of cycles that resulted in live births was higher in states that did not require any coverage than in states that required partial or complete coverage (25.7 percent vs. 22.2 percent and 22.7 percent, respectively; P < 0.001), but the percentage of pregnancies with three or more fetuses was also higher (11.2 percent vs. 8.9 percent and 9.7 percent, respectively; P = 0.007). The number of fresh embryos transferred per cycle was lower in states that required complete coverage than in states that required partial or no coverage (P = 0.001 and P < 0.001, respectively). Conclusions State-mandated insurance coverage for in vitro fertilization services is associated with increased utilization of these services but with decreases in the number of embryos transferred per cycle, the percentage of cycles resulting in pregnancy, and the percentage of pregnancies with three or more fetuses.	Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hornstein, MD (corresponding author), Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA.		Jain, Tarun/ABF-7304-2020	Jain, Tarun/0000-0002-8889-084X; Harlow, Bernard/0000-0002-6735-8862				Albrecht JL, 1996, AM J OBSTET GYNECOL, V174, P1551, DOI 10.1016/S0002-9378(96)70605-1; *AM SOC REPR MED, 2000, MULT PREGN ASS INF T; [Anonymous], 2002, CENSUS 2000 SUMMARY; BALEN AH, 1993, HUM REPROD, V8, P1324, DOI 10.1093/oxfordjournals.humrep.a138250; CALLAHAN TL, 1994, NEW ENGL J MED, V331, P244, DOI 10.1056/NEJM199407283310407; *CDCP AM SOC REPR, 2000, RESOLVE 1998 ASS REP; COLLINS JA, 1994, NEW ENGL J MED, V331, P270, DOI 10.1056/NEJM199407283310412; COLLINS JA, 1995, FERTIL STERIL, V64, P538, DOI 10.1016/S0015-0282(16)57789-9; Elster N, 2000, FERTIL STERIL, V74, P617, DOI 10.1016/S0015-0282(00)00713-5; Faber K, 1997, HUM REPROD, V12, P1614; GABBE SG, 1996, OBSTET NORMAL PROBLE, P821; MOSHER WD, 1991, FERTIL STERIL, V56, P192; NEUMANN PJ, 1994, NEW ENGL J MED, V331, P239, DOI 10.1056/NEJM199407283310406; Neumann PJ, 1997, J HEALTH POLIT POLIC, V22, P1215, DOI 10.1215/03616878-22-5-1215; Roest J, 1997, FERTIL STERIL, V67, P290, DOI 10.1016/S0015-0282(97)81913-9; Schieve LA, 1999, JAMA-J AM MED ASSOC, V282, P1832, DOI 10.1001/jama.282.19.1832; SEOUD MAF, 1992, FERTIL STERIL, V57, P825; STAESSEN C, 1993, HUM REPROD, V8, P1650, DOI 10.1093/oxfordjournals.humrep.a137907; STEPTOE PC, 1978, LANCET, V2, P336; TALLO CP, 1995, J PEDIATR-US, V127, P794, DOI 10.1016/S0022-3476(95)70175-3; TASDEMIR M, 1995, HUM REPROD, V10, P2155; Templeton A, 1998, NEW ENGL J MED, V339, P573, DOI 10.1056/NEJM199808273390901; 2002, 1998 ASSISTED REPROD	23	206	208	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2002	347	9					661	666		10.1056/NEJMsa013491	http://dx.doi.org/10.1056/NEJMsa013491			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZT	12200554				2022-12-28	WOS:000177675500006
J	Batta, K; Goodyear, HM; Moss, C; Williams, HC; Hiller, L; Waters, R				Batta, K; Goodyear, HM; Moss, C; Williams, HC; Hiller, L; Waters, R			Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis	LANCET			English	Article							CUTANEOUS HEMANGIOMAS; CAPILLARY HEMANGIOMAS; MANAGEMENT; INFANCY; THERAPY; CARE	Introduction The role of pulsed dye lasers (PDL) in the treatment of childhood haemangiomas is controversial. Our aim was to compare treatment with PDL with a wait-and-see policy. Methods We did a prospective, randomised controlled trial in which we enrolled 121 infants aged 1-14 weeks with early haemangiomas. We assigned infants to PDL treatment (n=60) or observation (n=61), and followed them up to age I year. The main outcome measures assessed were proportion of lesions completely clear or with minimum residual signs, adverse reactions, including pigmentary disturbance and skin atrophy, complications such as ulceration and infection, proportion of children whose parents considered the haemangioma a problem, characteristics of the haemangioma, and an independent assessment of the haemangioma problem by a panel of five parents. Analysis was by intention to treat. Findings All infants completed the study. The number of children whose lesions showed complete clearance or minimum residual signs at 1 year was not significantly different in the PDL treated and observation groups (25, 42%, vs 27, 44%; p=0.92). However, PDL treated infants were more likely to have skin atrophy (17, 28%, vs 5, 8%; p=0.008) and hypopigmentation (27, 45%, vs 9, 15%; p=0.001). The frequency of complications was similar between groups. The only objective measure of resolution that improved with PDL treatment was haemangioma redness. The number of children whose parents considered the haemangioma to be a problem at 1 year did not differ much between groups (11 of 60, 18%, vs 9 of 61, 15%; p=0.78). The independent parent panel validated this result. Interpretation PDL treatment in uncomplicated haemangiomas is no better than a wait-and-see policy.	Birmingham Childrens Hosp NHS Trust, Dept Dermatol, Birmingham B4 6NL, W Midlands, England; Birmingham Childrens Hosp NHS Trust, Dept Plast Surg, Birmingham B4 6NL, W Midlands, England; Birmingham Heartlands Hosp, Dept Paediat, Birmingham B9 5ST, W Midlands, England; Queens Med Ctr, Ctr Evidence Based Dermatol, Nottingham NG7 2UH, England; Univ Birmingham, Inst Canc Studies, Canc Res UK Trials Unit, Birmingham, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham; University of Nottingham; University of Birmingham	Batta, K (corresponding author), Birmingham Childrens Hosp NHS Trust, Dept Dermatol, Birmingham B4 6NL, W Midlands, England.	kapilabatta@yahoo.co.uk		williams, hywel/0000-0002-5646-3093				Achauer BM, 1997, PLAST RECONSTR SURG, V99, P1301, DOI 10.1097/00006534-199704001-00014; ASHINOFF R, 1991, ARCH DERMATOL, V127, P202, DOI 10.1001/archderm.127.2.202; Barlow RJ, 1996, BRIT J DERMATOL, V134, P700, DOI 10.1111/j.1365-2133.1996.tb06974.x; Bennett ML, 2001, ARCH DERMATOL, V137, P1208; BOWERS RE, 1960, ARCH DERMATOL, V82, P667, DOI 10.1001/archderm.1960.01580050009002; Drolet BA, 1999, NEW ENGL J MED, V341, P173, DOI 10.1056/NEJM199907153410307; ENJOLRAS O, 1990, PEDIATRICS, V85, P491; FINN MC, 1983, J PEDIATR SURG, V18, P894; Frieden IJ, 1997, J AM ACAD DERMATOL, V37, P631, DOI 10.1016/S0190-9622(97)70183-X; Frieden IJ, 1997, PEDIATR DERMATOL, V14, P57; GARDEN JM, 1992, J PEDIATR-US, V120, P555, DOI 10.1016/S0022-3476(05)82481-3; GOLDMAN MP, 1993, J PEDIATR-US, V122, P71, DOI 10.1016/S0022-3476(05)83489-4; HIDANO A, 1972, BRIT J DERMATOL, V87, P138, DOI 10.1111/j.1365-2133.1972.tb16188.x; Hohenleutner S, 2001, LASER SURG MED, V28, P273, DOI 10.1002/lsm.1050; HOLMDAHL K, 1955, Acta Paediatr, V44, P370, DOI 10.1111/j.1651-2227.1955.tb04151.x; JACOBS ALVIN H., 1957, CALIFORNIA MED, V86, P8; Kim HJ, 2001, J AM ACAD DERMATOL, V44, P962, DOI 10.1067/mjd.2001.112382; Lacour M, 1996, ARCH DIS CHILD, V74, P161, DOI 10.1136/adc.74.2.161; LANDTHALER M, 1995, BRIT J DERMATOL, V133, P275, DOI 10.1111/j.1365-2133.1995.tb02629.x; Maier H, 1996, LANCET, V347, P131, DOI 10.1016/S0140-6736(96)90263-9; MICHEL S, 1998, HAUZART, V29, P192; Poetke M, 2000, ARCH DERMATOL, V136, P628, DOI 10.1001/archderm.136.5.628; Ricci RM, 1998, LASER SURG MED, V22, P10, DOI 10.1002/(SICI)1096-9101(1998)22:1<10::AID-LSM5>3.0.CO;2-#; SCHEEPERS JH, 1995, PLAST RECONSTR SURG, V95, P305, DOI 10.1097/00006534-199502000-00010; Scherer K, 2001, BRIT J DERMATOL, V145, P79, DOI 10.1046/j.1365-2133.2001.04285.x; Tanner JL, 1998, PEDIATRICS, V101, P446, DOI 10.1542/peds.101.3.446; WANER M, 1992, LARYNGOSCOPE, V102, P1123, DOI 10.1288/00005537-199210000-00007; WANER M, 1994, J DERMATOL SURG ONC, V20, P43, DOI 10.1111/j.1524-4725.1994.tb03748.x	28	133	138	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2002	360	9332					521	527		10.1016/S0140-6736(02)09741-6	http://dx.doi.org/10.1016/S0140-6736(02)09741-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241656				2022-12-28	WOS:000177512800010
J	Ebbeling, CB; Pawlak, DB; Ludwig, DS				Ebbeling, CB; Pawlak, DB; Ludwig, DS			Childhood obesity: public-health crisis, common sense cure	LANCET			English	Review							BODY-MASS INDEX; NUTRITION-EXAMINATION-SURVEY; DISEASE RISK-FACTORS; 3RD NATIONAL-HEALTH; CONGENITAL LEPTIN DEFICIENCY; RANDOMIZED CONTROLLED TRIAL; SCHOOL BASED INTERVENTION; CORONARY HEART-DISEASE; FAMILY-BASED TREATMENT; FOOD RESTAURANT USE	During the past two decades, the prevalence of obesity in children has risen greatly worldwide. Obesity in childhood causes a wide range of serious complications, and increases the risk of premature illness and death later in life, raising public-health concerns. Results of research have provided new insights into the physiological basis of bodyweight regulation. However, treatment for childhood obesity remains largely ineffective. In view of its rapid development in genetically stable populations, the childhood obesity epidemic can be primarily attributed to adverse environmental factors for which straightforward, if politically difficult, solutions exist.	Childrens Hosp Boston, Div Endocrinol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Ludwig, DS (corresponding author), Childrens Hosp Boston, Div Endocrinol, 300 Longwood Ave, Boston, MA 02115 USA.		Fahimifar, Sepideh/M-5303-2019; Samaan, M. Constantine/R-1456-2017	Samaan, M. Constantine/0000-0002-6403-4715; Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059240, T32DK007699] Funding Source: NIH RePORTER; NIDDK NIH HHS [1R01DK059240, 5T32DK07699-18] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adelman RD, 2001, J PEDIATR-US, V138, P481, DOI 10.1067/mpd.2001.113006; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; [Anonymous], 1974, Lancet, V1, P17; Atkin LM, 2000, AM J CLIN NUTR, V72, P15; Balcer LJ, 1999, NEUROLOGY, V52, P870, DOI 10.1212/WNL.52.4.870; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Battle EK, 1996, ADDICT BEHAV, V21, P755, DOI 10.1016/0306-4603(96)00034-2; Bell EA, 2001, AM J CLIN NUTR, V73, P1010; Berkey CS, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e56; Binkley JK, 2000, INT J OBESITY, V24, P1032, DOI 10.1038/sj.ijo.0801356; Borzekowski DLG, 2001, J AM DIET ASSOC, V101, P42, DOI 10.1016/S0002-8223(01)00012-8; Braet C, 2000, BEHAV THER, V31, P55, DOI 10.1016/S0005-7894(00)80004-0; Bundred P, 2001, BRIT MED J, V322, P1; CASTROMAGANA M, 1984, PEDIATR ANN, V13, P494; Cavadini C, 2000, ARCH DIS CHILD, V83, P18, DOI 10.1136/adc.83.1.18; Chinn S, 2001, BRIT MED J, V322, P24, DOI 10.1136/bmj.322.7277.24; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Coon KA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.1.e7; Davison KK, 2001, PEDIATRICS, V107, P46, DOI 10.1542/peds.107.1.46; de Onis M, 2000, AM J CLIN NUTR, V72, P1032; Dean H, 2002, DIABETES, V51, pA24; DIETZ WH, 1982, J PEDIATR-US, V101, P735, DOI 10.1016/S0022-3476(82)80305-3; Dietz WH, 2000, LANCET, V356, P2027, DOI 10.1016/S0140-6736(00)03396-1; Doak C, 2002, PUBLIC HEALTH NUTR, V5, P215, DOI 10.1079/PHN2001296; Dowling AM, 2001, INT J OBESITY, V25, P845, DOI 10.1038/sj.ijo.0801598; Ebbeling C B, 2001, Adv Pediatr, V48, P179; EPSTEIN LH, 1994, HEALTH PSYCHOL, V13, P373, DOI 10.1037/0278-6133.13.5.373; Epstein LH, 2002, J PEDIATR-US, V140, P334, DOI 10.1067/mpd.2002.122395; EPSTEIN LH, 1990, JAMA-J AM MED ASSOC, V264, P2519, DOI 10.1001/jama.264.19.2519; Epstein LH, 2001, PEDIATR CLIN N AM, V48, P981, DOI 10.1016/S0031-3955(05)70352-7; Epstein LH, 1998, PEDIATRICS, V101, P554; Erickson SJ, 2000, ARCH PEDIAT ADOL MED, V154, P931, DOI 10.1001/archpedi.154.9.931; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Farooqi IS, 2000, ARCH DIS CHILD, V83, P31, DOI 10.1136/adc.83.1.31; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Ferguson MA, 1998, AM J CLIN NUTR, V67, P1136, DOI 10.1093/ajcn/67.6.1136; Field AE, 1999, J AM ACAD CHILD PSY, V38, P754, DOI 10.1097/00004583-199906000-00024; Figueroa-Munoz JI, 2001, THORAX, V56, P133, DOI 10.1136/thorax.56.2.133; Filozof C, 2001, Obes Rev, V2, P99, DOI 10.1046/j.1467-789x.2001.00029.x; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; FLODMARK CE, 1993, PEDIATRICS, V91, P880; Ford ES, 2001, J PEDIATR-US, V138, P486, DOI 10.1067/mpd.2001.112898; FOSTERPOWELL K, 1995, AM J CLIN NUTR, V62, p871S, DOI 10.1093/ajcn/62.4.871S; Freedman DS, 2001, INT J OBESITY, V25, P543, DOI 10.1038/sj.ijo.0801581; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Freemark M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e55; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; French SA, 2001, INT J OBESITY, V25, P1823, DOI 10.1038/sj.ijo.0801820; French SA, 2000, INT J OBESITY, V24, P1353, DOI 10.1038/sj.ijo.0801429; FRIESEN CA, 1989, CLIN PEDIATR, V28, P294, DOI 10.1177/000992288902800701; Gibson SA, 2000, INT J OBESITY, V24, P633, DOI 10.1038/sj.ijo.0801208; Gillman MW, 2001, JAMA-J AM MED ASSOC, V285, P2461, DOI 10.1001/jama.285.19.2461; Gillman MW, 2000, ARCH FAM MED, V9, P235, DOI 10.1001/archfami.9.3.235; Gittelsohn J, 1999, AM J CLIN NUTR, V69, p767S, DOI 10.1093/ajcn/69.4.767S; Glazer G, 2001, ARCH INTERN MED, V161, P1814, DOI 10.1001/archinte.161.15.1814; Going SB, 2001, FASEB J, V15, pA1092; GORANMI, 1999, INT J OBESITY S, V23, pS18; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Goulding A, 2001, J PEDIATR-US, V139, P509, DOI 10.1067/mpd.2001.116297; Gower BA, 1998, AM J CLIN NUTR, V67, P821, DOI 10.1093/ajcn/67.5.821; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6; Hernandez B, 1999, INT J OBESITY, V23, P845, DOI 10.1038/sj.ijo.0800962; HILL AJ, 1995, INT J OBESITY, V19, P423; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Himes JH, 2001, FASEB J, V15, pA1092; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; ISRAEL AC, 1994, J PEDIATR PSYCHOL, V19, P737, DOI 10.1093/jpepsy/19.6.737; James WPT, 1997, BMJ-BRIT MED J, V314, P1545, DOI 10.1136/bmj.314.7093.1545; Jequier E, 2001, J CLIN ENDOCR METAB, V86, P980, DOI 10.1210/jc.86.3.980; Johnson JG, 2002, AM J PSYCHIAT, V159, P394, DOI 10.1176/appi.ajp.159.3.394; Johnson MS, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e50; Kaplowitz PB, 2001, PEDIATRICS, V108, P347, DOI 10.1542/peds.108.2.347; Kimm SYS, 1997, ANN EPIDEMIOL, V7, P550, DOI 10.1016/S1047-2797(97)00124-5; KOTZ K, 1994, J AM DIET ASSOC, V94, P1296, DOI 10.1016/0002-8223(94)92463-5; Kris-Etherton P, 2001, J NUTR, V131, P1322; Le Stunff C, 2001, NAT GENET, V29, P96, DOI 10.1038/ng707; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Lewis MK, 1998, INT J OBESITY, V22, P206, DOI 10.1038/sj.ijo.0800568; Lewy VD, 2001, J PEDIATR-US, V138, P38, DOI 10.1067/mpd.2001.109603; Lin B. H., 2001, FoodReview, V24, P8; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; LITIN L, 1993, NEW ENGL J MED, V329, P1969, DOI 10.1056/NEJM199312233292620; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; LODER RT, 1993, J BONE JOINT SURG AM, V75A, P1141, DOI 10.2106/00004623-199308000-00003; LOEWENBERG S, 2000, LEGAL TIMES     0403; Lohman TG, 2001, FASEB J, V15, pA1093; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Ludwig DS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e26; Ludwig DS, 1999, JAMA-J AM MED ASSOC, V282, P1539, DOI 10.1001/jama.282.16.1539; Ludwig DS, 2001, LANCET, V357, P1978, DOI 10.1016/S0140-6736(00)05047-9; Ludwig DS, 2001, JAMA-J AM MED ASSOC, V286, P1427, DOI 10.1001/jama.286.12.1427; Luepker RV, 1996, JAMA-J AM MED ASSOC, V275, P768, DOI 10.1001/jama.275.10.768; Lustig RH, 2001, PEDIATR CLIN N AM, V48, P909, DOI 10.1016/S0031-3955(05)70348-5; Lustig RH, 1999, J PEDIATR-US, V135, P162, DOI 10.1016/S0022-3476(99)70017-X; Magarey AM, 2001, MED J AUSTRALIA, V174, P561, DOI 10.5694/j.1326-5377.2001.tb143435.x; Martorell R, 1998, J NUTR, V128, P1464, DOI 10.1093/jn/128.9.1464; McGill HC, 2000, CIRCULATION, V102, P374; McNutt SW, 1997, J ADOLESCENT HEALTH, V20, P27, DOI 10.1016/S1054-139X(96)00176-0; MELLBIN T, 1989, ACTA PAEDIATR SCAND, V78, P576, DOI 10.1111/j.1651-2227.1989.tb17939.x; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Morton J. F., 1998, FAM EC NUTR REV, V11, P44; Murata M, 2000, AM J CLIN NUTR, V72, p1379S, DOI 10.1093/ajcn/72.5.1379s; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Myers SE, 2000, J PEDIATR-US, V137, P42, DOI 10.1067/mpd.2000.105369; *NAT CTR HLTH STAT, 1999, PREV OV CHILDR AD; Nestle M, 2001, PUBLIC HEALTH NUTR, V4, P1015, DOI 10.1079/PHN2001253; Nestle M, 2000, PUBLIC HEALTH REP, V115, P308, DOI 10.1093/phr/115.4.308; NESTLE M, 2013, FOOD POLITICS FOOD I; *NIH, 2001, NCI 5 DAY BETT HLTH; NIH Technology Assessment Conference Panel, 1993, ANN INTERN MED, V119, P764; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Pine DS, 2001, PEDIATRICS, V107, P1049, DOI 10.1542/peds.107.5.1049; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; Popkin BM, 2002, PUBLIC HEALTH NUTR, V5, P93, DOI 10.1079/PHN200180; Rankinen T, 2002, OBES RES, V10, P196, DOI 10.1038/oby.2002.30; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Reaven P, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.4.e12; Redline S, 1999, AM J RESP CRIT CARE, V159, P1527, DOI 10.1164/ajrccm.159.5.9809079; Reybrouck T, 1997, EUR J APPL PHYSIOL O, V75, P478, DOI 10.1007/s004210050192; Robinson TN, 1998, JAMA-J AM MED ASSOC, V279, P959, DOI 10.1001/jama.279.12.959; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; Rolls BJ, 2000, J AM DIET ASSOC, V100, P232, DOI 10.1016/S0002-8223(00)00070-5; Rolls BJ, 2000, J NUTR, V130, p268S, DOI 10.1093/jn/130.2.268S; Sahota P, 2001, BRIT MED J, V323, P1027, DOI 10.1136/bmj.323.7320.1027; Sahota P, 2001, BMJ-BRIT MED J, V323, P1029, DOI 10.1136/bmj.323.7320.1029; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Slavin JL, 1999, AM J CLIN NUTR, V70, p459S, DOI 10.1093/ajcn/70.3.459s; Srinivasan SR, 2002, DIABETES, V51, P204, DOI 10.2337/diabetes.51.1.204; Story M, 1999, AM J CLIN NUTR, V69, p747S, DOI 10.1093/ajcn/69.4.747S; Strauss RS, 2001, J PEDIATR-US, V138, P499, DOI 10.1067/mpd.2001.113043; Strauss RS, 2000, J PEDIATR-US, V136, P727, DOI 10.1016/S0022-3476(00)24645-3; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; Strauss RS, 2001, ARCH PEDIAT ADOL MED, V155, P897, DOI 10.1001/archpedi.155.8.897; Strauss RS, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e15; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; Subar AF, 1998, PEDIATRICS, V102, P913, DOI 10.1542/peds.102.4.913; TARAS HL, 1995, ARCH PEDIAT ADOL MED, V149, P649, DOI 10.1001/archpedi.1995.02170190059010; Teachman BA, 2001, INT J OBESITY, V25, P1525, DOI 10.1038/sj.ijo.0801745; Tershakovec AM, 1999, J PEDIATR-US, V134, P573, DOI 10.1016/S0022-3476(99)70243-X; Toeller M, 2001, INT J OBESITY, V25, P1815, DOI 10.1038/sj.ijo.0801816; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Troiano RP, 2000, AM J CLIN NUTR, V72, p1343S, DOI 10.1093/ajcn/72.5.1343s; Trost SG, 2001, INT J OBESITY, V25, P822, DOI 10.1038/sj.ijo.0801621; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; Wang GJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e81; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; Wiecha JL, 2001, AMBUL PEDIATR, V1, P244, DOI 10.1367/1539-4409(2001)001<0244:HTAAWS>2.0.CO;2; Winkleby MA, 1999, JAMA-J AM MED ASSOC, V281, P1006, DOI 10.1001/jama.281.11.1006; Wisemandle W, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.1.e14; Yanovski JA, 2001, PEDIATR CLIN N AM, V48, P1041, DOI 10.1016/S0031-3955(05)70356-4; Young-Hyman D, 2001, DIABETES CARE, V24, P1359, DOI 10.2337/diacare.24.8.1359; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zoumas-Morse C, 2001, J AM DIET ASSOC, V101, P923, DOI 10.1016/S0002-8223(01)00228-0; 2000, REPORT PRESIDENT SEC	164	1902	1979	6	407	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					473	482		10.1016/S0140-6736(02)09678-2	http://dx.doi.org/10.1016/S0140-6736(02)09678-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582GZ	12241736				2022-12-28	WOS:000177342900029
J	Allen, MR; Ingram, WJ				Allen, MR; Ingram, WJ			Constraints on future changes in climate and the hydrologic cycle	NATURE			English	Review							NORTH-ATLANTIC; THERMOHALINE CIRCULATION; GLOBAL PRECIPITATION; GENERAL-CIRCULATION; WATER-VAPOR; GREENHOUSE GASES; TRENDS; MODEL; VARIABILITY; ATMOSPHERE	What can we say about changes in the hydrologic cycle on 50-year timescales when we cannot predict rainfall next week? Eventually, perhaps, a great deal: the overall climate response to increasing atmospheric concentrations of greenhouse gases may prove much simpler and more predictable than the chaos of short-term weather. Quantifying the diversity of possible responses is essential for any objective, probability-based climate forecast, and this task will require a new generation of climate modelling experiments, systematically exploring the range of model behaviour that is consistent with observations. It will be substantially harder to quantify the range of possible changes in the hydrologic cycle than in global-mean temperature, both because the observations are less complete and because the physical constraints are weaker.	Univ Oxford, Dept Phys, Oxford OX1 3PU, England; Hadley Ctr, Met Off, Bracknell RG12 2SZ, Berks, England	University of Oxford; Met Office - UK; Hadley Centre	Allen, MR (corresponding author), Univ Oxford, Dept Phys, Parks Rd, Oxford OX1 3PU, England.	myles.allen@physics.ox.ac.uk; williams.ingram@netoffice.com	Allen, Myles R/A-5172-2012	Stainforth, David/0000-0001-6476-733X				Allen M, 1999, NATURE, V401, P642, DOI 10.1038/44266; Allen MR, 2000, NATURE, V407, P617, DOI 10.1038/35036559; Andronova NG, 2000, GEOPHYS RES LETT, V27, P2137, DOI 10.1029/2000GL006109; Arrhenius S., 1896, LOND EDINB DUBLIN PH, V41, P237, DOI [10.1080/14786449608620846, DOI 10.1080/14786449608620846]; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Bates JJ, 2001, J GEOPHYS RES-ATMOS, V106, P32271, DOI 10.1029/2001JD000347; BOER GJ, 1993, CLIM DYNAM, V8, P225, DOI 10.1007/BF00198617; Carnell RE, 2002, CLIM DYNAM, V18, P533, DOI 10.1007/s00382-001-0197-5; Carnell RE, 1998, CLIM DYNAM, V14, P369, DOI 10.1007/s003820050229; Chen JY, 2002, SCIENCE, V295, P838, DOI 10.1126/science.1065835; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Collins M, 2000, GEOPHYS RES LETT, V27, P3509, DOI 10.1029/2000GL011747; Corti S, 1997, Q J ROY METEOR SOC, V123, P2425, DOI 10.1002/qj.49712354413; COVEY C, 2000, 66 PROGR CLIM MOD DI; CUBASCH U, 1994, CLIM DYNAM, V10, P1; CUBASCH U, 2001, CLIMATE CHANGE 2001, P527; Dai A, 1998, GEOPHYS RES LETT, V25, P3367, DOI 10.1029/98GL52511; Elliott WP, 1995, CLIMATIC CHANGE, V31, P349, DOI 10.1007/BF01095152; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; FOLLAND CK, 2001, CLIMATE CHANGE 2001, P101; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; Forest CE, 2000, GEOPHYS RES LETT, V27, P569, DOI 10.1029/1999GL010859; GAFFEN DJ, 1999, J CLIMATOL, V10, P1648; Gillett NP, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000589; Giorgi F., 2001, CLIMATE CHANGE 2001, P585; Gregory JM, 1997, J CLIMATE, V10, P662, DOI 10.1175/1520-0442(1997)010<0662:SDINMI>2.0.CO;2; GREGORY JM, IN PRESS J CLIM; Groisman PY, 1999, CLIMATIC CHANGE, V42, P243, DOI 10.1023/A:1005432803188; Hansen JA, 2001, GLOB WARM INT CTR M, P187; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; Huffman GJ, 2001, J HYDROMETEOROL, V2, P36, DOI 10.1175/1525-7541(2001)002<0036:GPAODD>2.0.CO;2; Huffman GJ, 1997, B AM METEOROL SOC, V78, P5, DOI 10.1175/1520-0477(1997)078<0005:TGPCPG>2.0.CO;2; Hulme M, 1998, GEOPHYS RES LETT, V25, P3379, DOI 10.1029/98GL02562; HULME M, 1992, CLIM DYNAM, V7, P57, DOI 10.1007/BF00209609; Hulme M., 2002, CLIMATE CHANGE SCENA; HUNTINGFORD C, IN PRESS Q J R METEO; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Ingram WJ, 2002, J CLIMATE, V15, P917, DOI 10.1175/1520-0442(2002)015<0917:OTROTW>2.0.CO;2; Karl TR, 1998, B AM METEOROL SOC, V79, P231, DOI 10.1175/1520-0477(1998)079<0231:STOPAF>2.0.CO;2; KARL TR, 1995, NATURE, V377, P217, DOI 10.1038/377217a0; Kharin VV, 2000, J CLIMATE, V13, P3760, DOI 10.1175/1520-0442(2000)013<3760:CITEIA>2.0.CO;2; Knutti R, 2002, NATURE, V416, P719, DOI 10.1038/416719a; Knutti R, 2002, J CLIMATE, V15, P179, DOI 10.1175/1520-0442(2002)015<0179:LPOTFT>2.0.CO;2; LETREUT H, 2000, 18 I PS LAPL; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; MANABE S, 1980, J ATMOS SCI, V37, P99, DOI 10.1175/1520-0469(1980)037<0099:OTDOCC>2.0.CO;2; Meehl GA, 2000, B AM METEOROL SOC, V81, P427, DOI 10.1175/1520-0477(2000)081<0427:TIEWAC>2.3.CO;2; Meehl GA, 2000, B AM METEOROL SOC, V81, P413, DOI 10.1175/1520-0477(2000)081<0413:AITTIE>2.3.CO;2; Milly PCD, 2002, NATURE, V415, P514, DOI 10.1038/415514a; Mitchell J. F. B., 1998, TRANSIENT RESPONSE I; MITCHELL JFB, 1983, Q J ROY METEOR SOC, V109, P113; MITCHELL JFB, 1987, Q J ROY METEOR SOC, V113, P293, DOI 10.1256/smsqj.47516; MITCHELL JFB, 2001, CLIMATE CHANGE 2001, P697; New M, 2001, INT J CLIMATOL, V21, P1899, DOI 10.1002/joc.680; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; NOZAWA T, 2001, PRESENT FUTURE MODEL; Osborn TJ, 2000, INT J CLIMATOL, V20, P347, DOI [10.1002/(SICI)1097-0088(20000330)20:4<347::AID-JOC475>3.0.CO;2-C, 10.1002/(SICI)1097-0088(20000330)20:4&lt;347::AID-JOC475&gt;3.0.CO;2-C]; Palmer TN, 2000, REP PROG PHYS, V63, P71, DOI 10.1088/0034-4885/63/2/201; Palmer TN, 2002, NATURE, V415, P512, DOI 10.1038/415512a; Pierrehumbert RT, 1999, GEOPH MONOG SERIES, V112, P339; Rahmstorf S, 1996, CLIM DYNAM, V12, P799, DOI 10.1007/s003820050144; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Ramaswamy V., 2001, CLIMATE CHANGE 2001; Ross RJ, 2002, J HYDROMETEOROL, V3, P26, DOI 10.1175/1525-7541(2002)003<0026:LTHTRI>2.0.CO;2; Santer BD, 1996, NATURE, V382, P39, DOI 10.1038/382039a0; SCHLESINGER M. J., 1985, POTENTIAL CLIMATIC E, P81; SCHONEWEISE CD, 1997, CLIMATIC TRENDS ATLA; SEAGER R, IN PRESS Q J R METEO; Smith LA, 2002, P NATL ACAD SCI USA, V99, P2487, DOI 10.1073/pnas.012580599; Smith LA, 2001, NONLINEAR DYNAMICS AND STATISTICS, P31; Soden BJ, 2002, SCIENCE, V296, P727, DOI 10.1126/science.296.5568.727; SOKOLOV A, 2001, 81 MIT JOINT PROGR S; Sokolov AP, 1998, CLIM DYNAM, V14, P291, DOI 10.1007/s003820050224; SPENCER RW, 1993, J CLIMATE, V6, P1301, DOI 10.1175/1520-0442(1993)006<1301:GOPFTM>2.0.CO;2; Stainforth D, 2002, COMPUT SCI ENG, V4, P82, DOI 10.1109/5992.998644; Stocker TF, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P417; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Stott PA, 2002, NATURE, V416, P723, DOI 10.1038/416723a; Tett SFB, 1996, SCIENCE, V274, P1170, DOI 10.1126/science.274.5290.1170; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Trenberth KE, 1999, CLIMATIC CHANGE, V42, P327, DOI 10.1023/A:1005488920935; Trenberth KE, 1999, B AM METEOROL SOC, V80, P2721; Trenberth KE, 1996, GEOPHYS RES LETT, V23, P57, DOI 10.1029/95GL03602; Trenberth KE, 2001, J CLIMATE, V14, P3433, DOI 10.1175/1520-0442(2001)014<3433:EOMAAO>2.0.CO;2; TRENBERTH KE, 2002, SCIENCE, V296, pA2095, DOI DOI 10.1126/SCIENCE.296.5576.2095A; Venzke S, 1999, J CLIMATE, V12, P2562, DOI 10.1175/1520-0442(1999)012<2562:TAROTN>2.0.CO;2; WEBSTER MD, 2001, 73 MIT; Wetherald RT, 1999, CLIMATIC CHANGE, V43, P495, DOI 10.1023/A:1005499220385; Wielicki BA, 2002, SCIENCE, V295, P841, DOI 10.1126/science.1065837; WIGLEY TML, 1993, CLIMATE SEA LEVEL CH, pCH7; Wunsch C, 1999, B AM METEOROL SOC, V80, P245, DOI 10.1175/1520-0477(1999)080<0245:TIOSCR>2.0.CO;2; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Zhai PM, 1997, J CLIMATE, V10, P2643, DOI 10.1175/1520-0442(1997)010<2643:AWVOC>2.0.CO;2	95	1957	2029	29	642	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					224	+		10.1038/nature01092	http://dx.doi.org/10.1038/nature01092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226677				2022-12-28	WOS:000177931200052
J	Lambeck, K; Esat, TM; Potter, EK				Lambeck, K; Esat, TM; Potter, EK			Links between climate and sea levels for the past three million years	NATURE			English	Review							LAST GLACIAL MAXIMUM; NORTH-ATLANTIC OCEAN; LAURENTIDE ICE-SHEET; PAPUA-NEW-GUINEA; HUON-PENINSULA; ICEBERG DISCHARGES; PENULTIMATE DEGLACIATION; LATE PLEISTOCENE; HEINRICH EVENTS; CORAL TERRACES	The oscillations between glacial and interglacial climate conditions over the past three million years have been characterized by a transfer of immense amounts of water between two of its largest reservoirs on Earth - the ice sheets and the oceans. Since the latest of these oscillations, the Last Glacial Maximum (between about 30,000 and 19,000 years ago), similar to50 million cubic kilometres of ice has melted from the land-based ice sheets, raising global sea level by similar to130 metres. Such rapid changes in sea level are part of a complex pattern of interactions between the atmosphere, oceans, ice sheets and solid earth, all of which have different response timescales. The trigger for the sea-level fluctuations most probably lies with changes in insolation, caused by astronomical forcing, but internal feedback cycles complicate the simple model of causes and effects.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Lund Univ, S-22363 Lund, Sweden; Swedish Res Council, S-22363 Lund, Sweden	Australian National University; Lund University; Swedish Research Council	Lambeck, K (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.			Esat, Sevilay/0000-0002-7257-4009; Esat, Tezer/0000-0001-5331-6568				Alley RB, 1999, ANNU REV EARTH PL SC, V27, P149, DOI 10.1146/annurev.earth.27.1.149; Alley RB, 1998, NATURE, V392, P335, DOI 10.1038/32781; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; Bard E, 2002, EARTH PLANET SC LETT, V196, P135, DOI 10.1016/S0012-821X(01)00600-8; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; Bennike O, 2002, EARTH PLANET SC LETT, V197, P171, DOI 10.1016/S0012-821X(02)00478-8; BERGER A, 1992, SCIENCE, V255, P560, DOI 10.1126/science.255.5044.560; BERGER A, 1988, REV GEOPHYS, V26, P624, DOI 10.1029/RG026i004p00624; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; BOND GC, 1995, SCIENCE, V267, P1005, DOI 10.1126/science.267.5200.1005; Broecker WS, 2001, SCIENCE, V294, P2308, DOI 10.1126/science.1068389; BROECKER WS, 1970, REV GEOPHYS SPACE GE, V8, P169, DOI 10.1029/RG008i001p00169; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; Chapman MR, 2000, PALAEOGEOGR PALAEOCL, V157, P1, DOI 10.1016/S0031-0182(99)00168-6; CHAPPELL J, 1974, GEOL SOC AM BULL, V85, P553, DOI 10.1130/0016-7606(1974)85<553:GOCTHP>2.0.CO;2; Chappell J, 2002, QUATERNARY SCI REV, V21, P1229, DOI 10.1016/S0277-3791(01)00141-X; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Chappell J, 1996, EARTH PLANET SC LETT, V141, P227, DOI 10.1016/0012-821X(96)00062-3; CLARK PU, 1993, QUATERNARY SCI REV, V12, P79, DOI 10.1016/0277-3791(93)90011-A; Clark PU, 1998, PALEOCEANOGRAPHY, V13, P1, DOI 10.1029/97PA02660; Clark PU, 2002, SCIENCE, V295, P2438; Clark PU, 1996, PALEOCEANOGRAPHY, V11, P563, DOI 10.1029/96PA01419; CLIMAP PM, 1976, SCIENCE, V191, P1131, DOI DOI 10.1126/SCIENCE.191.4232.1131; DENTON GH, 1980, LAST GREAT ICE SHEET; Dowdeswell JA, 1999, NATURE, V400, P348, DOI 10.1038/22510; DUPLESSY JC, 1975, SCIENCE, V188, P1208, DOI 10.1126/science.188.4194.1208; Elliot M, 1998, PALEOCEANOGRAPHY, V13, P433, DOI 10.1029/98PA01792; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fawcett PJ, 1997, PALEOCEANOGRAPHY, V12, P23, DOI 10.1029/96PA02711; FERLAND MA, 1995, QUATERNARY RES, V44, P294, DOI 10.1006/qres.1995.1074; Galewsky J, 1996, GEOLOGY, V24, P819, DOI 10.1130/0091-7613(1996)024<0819:FTACPD>2.3.CO;2; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; Gallup CD, 2002, SCIENCE, V295, P310, DOI 10.1126/science.1065494; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; HAY WW, 1992, TERRA NOVA, V4, P305, DOI 10.1111/j.1365-3121.1992.tb00819.x; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Heinrich H., 1988, QUATERNARY RES, V29, P143, DOI DOI 10.1016/0033-5894(88)90057-9); Helmens KF, 2000, QUATERNARY SCI REV, V19, P1605, DOI 10.1016/S0277-3791(00)00004-4; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Hughen KA, 2000, SCIENCE, V290, P1951, DOI 10.1126/science.290.5498.1951; IMBRIE J, 1980, SCIENCE, V207, P943, DOI 10.1126/science.207.4434.943; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Imbrie J., 1993, GLOBAL CHANGES PERSP, P263; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; JOHNSON RG, 1991, GEOLOGY, V19, P686, DOI 10.1130/0091-7613(1991)019<0686:MNHDCB>2.3.CO;2; Kanfoush SL, 2000, SCIENCE, V288, P1815, DOI 10.1126/science.288.5472.1815; Kitagawa H, 1998, SCIENCE, V279, P1187, DOI 10.1126/science.279.5354.1187; Lambeck K, 2000, EARTH PLANET SC LETT, V181, P513, DOI 10.1016/S0012-821X(00)00223-5; Lambeck K, 2002, QUATERNARY SCI REV, V21, P343, DOI 10.1016/S0277-3791(01)00071-3; Lambeck K, 1996, GLOBAL PLANET CHANGE, V12, P41, DOI 10.1016/0921-8181(95)00011-9; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; LAMBECK K, 1992, NATURE, V357, P125, DOI 10.1038/357125a0; Lambeck K, 1998, GEOPHYS J INT, V134, P647, DOI 10.1046/j.1365-246x.1998.00597.x; Licciardi JM, 1998, QUATERNARY SCI REV, V17, P427, DOI 10.1016/S0277-3791(97)00044-9; Ludwig KR, 1996, GEOLOGY, V24, P211, DOI 10.1130/0091-7613(1996)024<0211:SLRAKF>2.3.CO;2; Lund DC, 1998, PALEOCEANOGRAPHY, V13, P10, DOI 10.1029/97PA02984; Lundqvist J., 1992, GEOLOGICAL SURVEY FI, V15, P43; MACAYEAL DR, 1993, PALEOCEANOGRAPHY, V8, P775, DOI 10.1029/93PA02200; MANGERUD J, UNPUB QUAT SCI REV; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; MESOLELL.KJ, 1969, J GEOL, V77, P250, DOI 10.1086/627434; Miller GH, 2002, QUATERNARY SCI REV, V21, P33, DOI 10.1016/S0277-3791(01)00085-3; Milne GA, 2002, QUATERNARY SCI REV, V21, P361, DOI 10.1016/S0277-3791(01)00108-1; MIX AC, 1984, QUATERNARY RES, V21, P1, DOI 10.1016/0033-5894(84)90085-1; Mix AC, 2001, QUATERNARY SCI REV, V20, P627, DOI 10.1016/S0277-3791(00)00145-1; Muller RA, 1997, SCIENCE, V277, P215, DOI 10.1126/science.277.5323.215; Olsen L, 2001, NORSK GEOL TIDSSKR, V81, P93; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; PIRAZZOLI PA, 1991, SCIENCE, V252, P1834, DOI 10.1126/science.252.5014.1834; POTTER EK, 2001, EOS T AGU S, V82; Raymo M.E., 1992, START GLACIAL, VI, P207, DOI DOI 10.1007/978-3-642-76954-2_; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Sejrup HP, 2000, QUATERNARY SCI REV, V19, P667, DOI 10.1016/S0277-3791(99)00016-5; SHACKLETON N, 1967, NATURE, V215, P15, DOI 10.1038/215015a0; Shackleton N. J., 1973, Quaternary Research, V3, P39, DOI 10.1016/0033-5894(73)90052-5; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Shaffer JA, 1996, GEOLOGY, V24, P1017, DOI 10.1130/0091-7613(1996)024<1017:RWAIOA>2.3.CO;2; SHEMESH A, 1994, SCIENCE, V266, P1542, DOI 10.1126/science.266.5190.1542; STEIN M, 1993, GEOCHIM COSMOCHIM AC, V57, P2541, DOI 10.1016/0016-7037(93)90416-T; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; Stirling CH, 2001, SCIENCE, V291, P290, DOI 10.1126/science.291.5502.290; STOFFERS P, 1979, SEDIMENT GEOL, V23, P181, DOI 10.1016/0037-0738(79)90014-9; Svendsen JI, 1999, BOREAS, V28, P234, DOI 10.1111/j.1502-3885.1999.tb00217.x; Toscano MA, 1999, QUATERNARY SCI REV, V18, P753, DOI 10.1016/S0277-3791(98)00077-8; TUSHINGHAM AM, 1991, J GEOPHYS RES-SOLID, V96, P4497, DOI 10.1029/90JB01583; Ukkonen P, 1999, J QUATERNARY SCI, V14, P711, DOI 10.1002/(SICI)1099-1417(199912)14:7<711::AID-JQS506>3.0.CO;2-E; VORREN TO, 1988, BOREAS, V17, P41; WINOGRAD IJ, 1992, SCIENCE, V258, P255, DOI 10.1126/science.258.5080.255; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035; Yokoyama Y, 2000, RADIOCARBON, V42, P383, DOI 10.1017/S0033822200030320; Yokoyama Y, 2001, EARTH PLANET SC LETT, V193, P579, DOI 10.1016/S0012-821X(01)00515-5; Yokoyama Y, 2001, NATURE, V412, P99, DOI 10.1038/35083629; Zwartz D, 1998, EARTH PLANET SC LETT, V155, P131, DOI 10.1016/S0012-821X(97)00204-5	100	593	639	12	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					199	206		10.1038/nature01089	http://dx.doi.org/10.1038/nature01089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226674				2022-12-28	WOS:000177931200049
J	Vasan, RS; Benjamin, EJ; Larson, MG; Leip, EP; Wang, TJ; Wilson, PWF; Levy, D				Vasan, RS; Benjamin, EJ; Larson, MG; Leip, EP; Wang, TJ; Wilson, PWF; Levy, D			Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction - The Framingham Heart study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; DIAGNOSTIC-TEST; PRIMARY-CARE; ECHOCARDIOGRAPHY; POPULATION; ACCURACY; FAILURE; MARKER; MORTALITY; SURVIVAL	Context Several reports have suggested the usefulness of plasma brain natriuretic peptide (BNP) as a screening test for left ventricular hypertrophy (LVH) and systolic dysfunction (LVSD). Prior studies were limited by small sample sizes and selection bias and none compared the diagnostic performance of these peptides in men and women. Objectives To examine the usefulness of natriuretic peptides for screening for elevated LV mass and LVSD in the community. Design, Setting, and Participants Community-based prospective cohort study of 3177 participants (1707 women) from the Framingham Study who attended a routine examination in 1995-1998. Main Outcome Measures Receiver operating characteristic (ROC) curves, test sensitivity, specificity, positive and negative predictive values, and likelihood ratios for identifying elevated LV mass (sex-specific 90th percentile or higher of LV mass/[height](2)), LVSD (ejection fraction less than or equal to 50% and/or fractional shortening <29%), and moderate to severe LVSD (ejection fraction less than or equal to40% and/or fractional shortening <22%) at different discrimination limits of plasma BNP and N-terminal proatrial natriuretic peptide (NT-ANP), with echocardiography as the criterion standard. Results The areas under the ROC curves for elevated LV mass or LVSD were at or below 0.75 for both peptides, were higher for men compared with women, and were similar for BNP and NT-ANP. The diagnostic performance of natriuretic peptides for LVSD improved in women but not in men when select high-risk subgroups were targeted. Discrimination limits based on high specificity (0.95) yielded better positive predictive values and likelihood ratios compared with age- and sex-specific reference limits yet only identified less than one third of participants who had elevated LV mass or LVSD. Conclusion In our large community-based sample, the performance of BNP and NT-ANP for detection of elevated LV mass and LVSD was suboptimal, suggesting limited usefulness of natriuretic peptides as mass screening tools.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Prevent Med & Epidemiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Div Endocrinol, Boston, MA 02118 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Cardiol Div, Boston, MA USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Clin Epidemiol, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336	NHLBI NIH HHS [N01-HC-25195, K24 HL 04334-01A1, 1R01HL67288-01] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334, R01HL067288] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Black HR, 1997, ARCH INTERN MED, V157, P2413; BOYKO EJ, 1994, MED DECIS MAKING, V14, P175, DOI 10.1177/0272989X9401400210; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; Davidson NC, 1996, AM J CARDIOL, V77, P828, DOI 10.1016/S0002-9149(97)89176-X; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485; FOUAD FM, 1984, J AM COLL CARDIOL, V3, P1500, DOI 10.1016/S0735-1097(84)80289-2; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jacobsen SJ, 1996, ARCH INTERN MED, V156, P2462, DOI 10.1001/archinte.156.21.2462; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kannel WB, 1987, FRAMINGHAM HEART STU; LERMAN A, 1993, LANCET, V341, P1105, DOI 10.1016/0140-6736(93)93125-K; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Luchner A, 2002, CARDIOVASC RES, V53, P720, DOI 10.1016/S0008-6363(01)00510-7; Luchner A, 2000, J HYPERTENS, V18, P1121, DOI 10.1097/00004872-200018080-00018; Maisel AS, 2001, AM HEART J, V141, P367, DOI 10.1067/mhj.2001.113215; McClure SJ, 1998, BRIT MED J, V317, P516; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; McMurray JV, 1998, EUR HEART J, V19, P842, DOI 10.1093/eurheartj/19.6.842; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; QUINONES MA, 1978, CHEST, V74, P59, DOI 10.1378/chest.74.1.59; Remaley AT, 1999, CLIN CHEM, V45, P934; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schirmer H, 1999, EUR HEART J, V20, P755, DOI 10.1053/euhj.1998.1396; Sheps SG, 1997, HYPERTENSION, V29, P560, DOI 10.1161/01.HYP.29.2.560; Smith H, 2000, BMJ-BRIT MED J, V320, P906, DOI 10.1136/bmj.320.7239.906; Suzuki T, 2000, JPN HEART J, V41, P205, DOI 10.1536/jhj.41.205; SWETS JA, 1991, MED DECIS MAKING, V11, P9, DOI 10.1177/0272989X9101100102; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5; Watanabe J, 2001, CIRCULATION, V104, P1911, DOI 10.1161/circ.104.16.1911; Willenheimer RB, 1997, SCAND CARDIOVASC J, V31, P9, DOI 10.3109/14017439709058063; Yamamoto K, 1996, HYPERTENSION, V28, P988, DOI 10.1161/01.HYP.28.6.988; Yamamoto K, 2000, J CARD FAIL, V6, P194, DOI 10.1054/jcaf.2000.9676; YOUDEN WJ, 2001, CANCER, V3, P32	42	366	382	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1252	1259		10.1001/jama.288.10.1252	http://dx.doi.org/10.1001/jama.288.10.1252			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215132				2022-12-28	WOS:000177917700024
J	Dickstein, K; Kjekshus, J				Dickstein, K; Kjekshus, J		OPTIMAAL Steering Comm; OPTIMAL Study Grp	Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial	LANCET			English	Article							ANGIOTENSIN-II; HEART-FAILURE; SURVIVAL; MANAGEMENT; ANTAGONIST; INHIBITORS; ENALAPRIL; THERAPY	Background ACE inhibitors attenuate the detrimental effects of angiotensin II, and improve survival and reduce morbidity in patients with acute myocardial infarction and evidence of heart failure or left-ventricular dysfunction. Selective antagonism of the angiotensin type 1 receptor represents an alternative approach to inhibition of the renin-angiotensin system. We did a multicentre, randomised trial to test the hypothesis that the angiotensin II antagonist losartan would be superior or non-inferior to the ACE inhibitor captopril in decreasing all-cause mortality in high-risk patients after acute myocardial infarction. Methods 5477 patients 50 years of age or older (mean age 67.4 years [SD 9.8]), with confirmed acute myocardial infarction and heart failure during the acute phase or a new Q-wave anterior infarction or reinfarction, were recruited from 329 centres in seven European countries, Patients were randomly assigned and titrated to a target dose of losartan (50 mg once daily) or captopril (50 mg three times daily) as tolerated. The primary endpoint was all-cause mortality. Analysis was by intention to treat. Findings There were 946 deaths during a mean follow-up of 2.7 (0.9) years: 499 (18%) in the losartan group and 447 (16%) in the captopril group (relative risk 1.13 [95% CI 0.99-1.28], p=0.07). The results for the secondary and tertiary endpoints were as follows: sudden cardiac death or resuscitated cardiac arrest 239 (9%) versus 203 (7%), 1.19 (0.98-1.43), p=0.07, and fatal or non-fatal reinfarction 384 (14%) versus 379 (14%), 1.03 (0.89-1.18), p=0.72. The all-cause hospital admission rates were 1806 (66%) versus 1774 (65%), 1.03 (0.97-1.10), p=0.37. Losartan was significantly better tolerated than captopril, with fewer patients discontinuing study medication (458 [17%] vs 624 [23%], 0.70 [0.62-0.79], p<0.0001). Interpretation Since we saw a non-significant difference in total mortality in favour of captopril, ACE inhibitors should remain first-choice treatment in patients after complicated acute myocardial infarction. Losartan cannot be generally recommended in this population. However, it was better tolerated than captopril, and was associated with significantly fewer discontinuations. Although the role of losartan in patients intolerant of ACE inhibition is not clearly defined, it can be considered in such patients.	Univ Bergen, Div Cardiol, Cent Hosp Rogaland, N-4011 Stavanger, Norway; Univ Oslo, Rikshosp, Dept Cariol, N-0027 Oslo, Norway	University of Bergen; University of Oslo; National Hospital Norway	Dickstein, K (corresponding author), Univ Bergen, Div Cardiol, Cent Hosp Rogaland, N-4011 Stavanger, Norway.	trout@online.no						AMBROSIONI E, 1995, NEW ENGL J MED, V332, P80, DOI 10.1056/NEJM199501123320203; BALL SG, 1995, J AM COLL CARDIOL, V25, pS42; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; CATTANEO M, 1993, LANCET, V342, P812, DOI 10.1016/0140-6736(93)91581-6; COLLINS R, 1995, LANCET, V345, P669; CROZIER I, 1995, CIRCULATION, V91, P691, DOI 10.1161/01.CIR.91.3.691; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; DEVITA C, 1994, LANCET, V343, P1115; DICKSTEIN K, 1995, J AM COLL CARDIOL, V26, P438, DOI 10.1016/0735-1097(95)80020-H; Dickstein K, 1999, AM J CARDIOL, V83, P477, DOI 10.1016/S0002-9149(98)00898-4; Dickstein K, 2001, AM J CARDIOL, V87, P766, DOI 10.1016/S0002-9149(00)01500-9; Franzosi MG, 1998, CIRCULATION, V97, P2202, DOI 10.1161/01.CIR.97.22.2202; Gaudron P, 2000, AM J CARDIOL, V86, P139, DOI 10.1016/S0002-9149(00)00849-3; GOLDBERG AI, 1995, AM J CARDIOL, V75, P793, DOI 10.1016/S0002-9149(99)80413-5; GOTTLIEB SS, 1993, CIRCULATION, V88, P1602, DOI 10.1161/01.CIR.88.4.1602; KLINGER G, 1996, J AM COLL CARDIOL, V27, pA205; KOBER I, 1995, NEW ENGL J MED, V353, P1670; MAGGIONI A, 1999, EUR HEART J, V1, P7; Michaels AD, 1999, AM J CARDIOL, V84, P1176, DOI 10.1016/S0002-9149(99)00530-5; Pfeffer MA, 2000, AM HEART J, V140, P727, DOI 10.1067/mhj.2000.108832; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; Roig E, 2000, EUR HEART J, V21, P53, DOI 10.1053/euhj.1999.1740; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; SWEDBERG K, 1992, NEW ENGL J MED, V327, P678, DOI 10.1056/NEJM199209033271002; Tang WHW, 2002, J AM COLL CARDIOL, V39, P70; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; van Kats JP, 1998, CIRCULATION, V98, P73, DOI 10.1161/01.CIR.98.1.73; Wolny A, 1997, CIRC RES, V80, P219, DOI 10.1161/01.RES.80.2.219	30	825	884	1	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2002	360	9335					752	760		10.1016/S0140-6736(02)09895-1	http://dx.doi.org/10.1016/S0140-6736(02)09895-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592HX	12241832				2022-12-28	WOS:000177933000015
J	Maureille, B				Maureille, B			A lost Neanderthal neonate found	NATURE			English	Article							DIVERSITY; ONTOGENY		Univ Bordeaux, Lab Anthropol Populat Passe, CNRS, UMR 5809, F-33405 Talence, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Maureille, B (corresponding author), Univ Bordeaux, Lab Anthropol Populat Passe, CNRS, UMR 5809, 1 Ave Fac, F-33405 Talence, France.			Maureille, Bruno/0000-0002-7616-0073				de Leon MSP, 2001, NATURE, V412, P534, DOI 10.1038/35087573; Dodo Y, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P323; Heim J. L., 1982, ENFANTS NEANDERTALIE; Heim J. L., 1976, HOMMES FOSSILES FERR, VI; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Maureille B, 1999, J HUM EVOL, V37, P137, DOI 10.1006/jhev.1999.0312; Maureille B., 1994, THESIS U BORDEAUX 1; PATTE E, 1962, DENTITION NEANDERTAL; Peyrony D, 1921, MOUSTERIENS INHUMAIE; Peyrony D, 1930, REV ANTHR, V40, P155; Peyrony D., 1930, REV ANTHR, V40, p[48, 155]; SELLIER P, 1997, AM J PHYS ANTHR S, V22, P208; Trinkaus E., 1983, SHANIDAR NEANDERTHAL; VALLADAS H, 1986, NATURE, V322, P452, DOI 10.1038/322452a0	14	37	39	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					33	34		10.1038/419033a	http://dx.doi.org/10.1038/419033a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214223				2022-12-28	WOS:000177788600028
J	Zansky, S; Wallace, B; Schoonmaker-Bopp, D; Smith, P; Ramsey, F; Painter, J; Gupta, A; Kalluri, P; Noviello, S				Zansky, S; Wallace, B; Schoonmaker-Bopp, D; Smith, P; Ramsey, F; Painter, J; Gupta, A; Kalluri, P; Noviello, S		CDC	Outbreak of multidrug-resistant Salmonella Newport - United States, January-April 2002 (Reprinted from MMWR, vol 51, pg 545-548, 2002)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint									Wadsworth Ctr, Albany, CA USA; New York State Dept Hlth, Albany, NY 12237 USA; US Food Safety & Inspect Serv, USDA, Washington, DC 20250 USA; CDC, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	State University of New York (SUNY) System; United States Department of Agriculture (USDA); Centers for Disease Control & Prevention - USA								Altekruse SF, 1996, J FOOD PROTECT, V59, P287, DOI 10.4315/0362-028X-59.3.287; [Anonymous], PUBL HLTH ACT PLAN C; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P545; GUPTA A, 2001, INF DIS SOC AM; Helms M, 2002, EMERG INFECT DIS, V8, P490, DOI 10.3201/eid0805.010267; MCCARTHY T, 2002, INT C EM INF DIS; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; RANKIN SC, 2002, 3 INT C EM INF DIS; SPIKA JS, 1987, NEW ENGL J MED, V316, P565, DOI 10.1056/NEJM198703053161001; *USDA, PROGR REP SALM TEST; VARMA JK, 2002, NARMS 1996 2000 INT	11	41	43	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					951	953						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12201274				2022-12-28	WOS:000177656400007
J	Splawski, I; Timothy, KW; Tateyama, M; Clancy, CE; Malhotra, A; Beggs, AH; Cappuccio, FP; Sagnella, GA; Kass, RS; Keating, MT				Splawski, I; Timothy, KW; Tateyama, M; Clancy, CE; Malhotra, A; Beggs, AH; Cappuccio, FP; Sagnella, GA; Kass, RS; Keating, MT			Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia	SCIENCE			English	Article							LONG-QT SYNDROME; TORSADES-DE-POINTES; MOLECULAR MECHANISM; MUTATIONS; REPOLARIZATION; POPULATION; DURATION; THERAPY; DEATH	Every year, similar to450,000 individuals in the United States die suddenly of cardiac arrhythmia. We identified a variant of the cardiac sodium channel gene SCN5A that is associated with arrhythmia in African Americans ( P = 0.000028) and linked with arrhythmia risk in an African-American family (P = 0.005). In transfected cells, the variant allele (Y1102) accelerated channel activation, increasing the likelihood of abnormal cardiac repolarization and arrhythmia. About 13.2% of African Americans carry the Y1102 allele. Because Y1102 has a subtle effect on risk, most carriers will never have an arrhythmia. However, Y1102 may be a useful molecular marker for the prediction of arrhythmia susceptibility in the context of additional acquired risk factors such as the use of certain medications.	Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Univ London St Georges Hosp, Sch Med, Dept Gen Practice & Primary Care, London SW17 0RE, England; Univ London St Georges Hosp, Sch Med, Dept Med Physiol, London SW17 0RE, England	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Columbia University; Harvard University; Boston Children's Hospital; St Georges University London; St Georges University London	Keating, MT (corresponding author), Childrens Hosp, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA.		Cappuccio, Francesco/D-3028-2009; Clancy, Colleen/B-2528-2010; Cappuccio, Francesco Paolo/ABF-1094-2020	Cappuccio, Francesco Paolo/0000-0002-7842-5493; Beggs, Alan/0000-0001-8818-0568	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL053773, R01HL056810, P01HL067849] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL 67849, HL53773, R01 HL 56810, R01 HL48074] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Cappuccio FP, 1997, HEART, V78, P555, DOI 10.1136/hrt.78.6.555; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; Clancy CE, 2001, CARDIOVASC RES, V50, P301, DOI 10.1016/S0008-6363(00)00293-5; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Compton SJ, 1996, CIRCULATION, V94, P1018, DOI 10.1161/01.CIR.94.5.1018; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HASSTEDT SJ, 1993, PEDIGREE ANAL PACKAG; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kilborn MJ, 2001, BRIT MED J, V322, P672; MARTIN AB, 1995, AM J CARDIOL, V75, P950, DOI 10.1016/S0002-9149(99)80697-3; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Roden DM, 2001, CARDIOVASC RES, V50, P224, DOI 10.1016/S0008-6363(00)00302-3; RODEN DM, 1993, EUR HEART J, V14, P56, DOI 10.1093/eurheartj/14.suppl_H.56; Sagnella GA, 1999, J HYPERTENS, V17, P657, DOI 10.1097/00004872-199917050-00009; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Yap YG, 2000, BRIT MED J, V320, P1158, DOI 10.1136/bmj.320.7243.1158; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	27	377	401	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1333	1336		10.1126/science.1073569	http://dx.doi.org/10.1126/science.1073569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193783				2022-12-28	WOS:000177573900043
J	Talley, NJ; Spiller, R				Talley, NJ; Spiller, R			Irritable bowel syndrome: a little understood organic bowel disease?	LANCET			English	Review							FUNCTIONAL GASTROINTESTINAL DISORDERS; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED TRIAL; HUMAN ANTERIOR CINGULATE; BILE-ACID MALABSORPTION; HEALTH-CARE SEEKING; ABDOMINAL-PAIN; INTESTINAL GAS; PSYCHOSOCIAL FACTORS; RECEPTOR ANTAGONIST	Irritable bowel syndrome affects 10% of adults with an unexplained female predominance. Although only a few people see their family doctor, the disease causes reduced quality of life and represents a multi-billion pound health-care problem. The disorder clusters in families, which is possibly because of intra-familial learning and a genetic predisposition. Visceral hypersensitivity is a key feature in most patients. Results of imaging studies of regional cerebral blood flow during rectal distension suggest underlying disturbances of central processing of afferent signals, though this is not unique to the disorder, since it is seen in other chronic pain syndromes. Environmental factors that are strongly implicated in at least some patients include gastrointestinal infection and inflammation and chronic stress. Diagnosis is based on positive symptoms and absence of any alarm indicators. Treatment remains unsatisfactory and hinges on an excellent doctor-patient relationship, with drugs for symptom exacerbations. Cognitive behavioural treatment, psychotherapy, and hypnosis could provide long-lasting benefit in some patients. Tricyclic antidepressants in low doses seem to be the most effective class of drugs for the disorder on the basis of limited data.	Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Univ Nottingham, Sch Med & Surg Sci, Div Gastroenterol, Nottingham NG7 2RD, England	University of Sydney; University of Nottingham	Talley, NJ (corresponding author), Univ Sydney, Nepean Hosp, Level 5,South Block,POB 63, Penrith, NSW 2751, Australia.	ntalley@med.usyd.edu.au	Talley, Nicholas J/D-5399-2013; spiller, robin/ABE-6690-2021	Talley, Nicholas J/0000-0003-2537-3092; spiller, robin/0000-0001-6371-4500				Ali A, 2000, PSYCHOSOM MED, V62, P76, DOI 10.1097/00006842-200001000-00011; ANDERSON IH, 1981, NEW ENGL J MED, V304, P891, DOI 10.1056/NEJM198104093041507; Awad RA, 1997, INT J COLORECTAL DIS, V12, P91, DOI 10.1007/s003840050088; Aziz Q, 2000, J NEUROSCI, V20, P2657; BARROW L, 1994, EUR J GASTROEN HEPAT, V6, P381; Bassotti G, 1998, Z GASTROENTEROL, V36, P811; Bengtsson U, 1996, GUT, V39, P130, DOI 10.1136/gut.39.1.130; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Bensoussan A, 1998, JAMA-J AM MED ASSOC, V280, P1585, DOI 10.1001/jama.280.18.1585; Bertram S, 2001, J FAM PRACTICE, V50, P521; Boyce PM, 2000, AM J GASTROENTEROL, V95, P3176; Bradley L A, 2000, Curr Rheumatol Rep, V2, P141, DOI 10.1007/s11926-000-0054-2; Broekaert D, 2001, GASTROENTEROLOGY, V120, pA641, DOI 10.1016/S0016-5085(01)83187-5; Bueno L, 1999, Can J Gastroenterol, V13 Suppl A, p42A; Camilleri M, 2000, LANCET, V355, P1035, DOI 10.1016/S0140-6736(00)02033-X; Camilleri M, 2001, ARCH INTERN MED, V161, P1733, DOI 10.1001/archinte.161.14.1733; Camilleri M, 2001, NEUROGASTROENT MOTIL, V13, P277, DOI 10.1046/j.1365-2982.2001.00277.x; Camilleri M, 2001, ALIMENT PHARM THER, V15, P277, DOI 10.1046/j.1365-2036.2001.00925.x; CANN PA, 1983, GUT, V24, P405, DOI 10.1136/gut.24.5.405; CASH BD, IN PRESS AM J GASTRO; Chan J, 2000, GASTROENTEROLOGY, V118, pA184, DOI 10.1016/S0016-5085(00)82812-7; Chey WY, 2001, AM J GASTROENTEROL, V96, P1499; Colwell LJ, 1998, AM J GASTROENTEROL, V93, P901; Coulie B, 2000, GASTROENTEROLOGY, V119, P41, DOI 10.1053/gast.2000.8553; Coutinho SV, 2002, AM J PHYSIOL-GASTR L, V282, pG307, DOI 10.1152/ajpgi.00240.2001; Creed F, 2001, ANN INTERN MED, V134, P860, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00010; CREED F, 1988, GUT, V29, P235, DOI 10.1136/gut.29.2.235; Delvaux M, 1997, EUR J GASTROEN HEPAT, V9, P345, DOI 10.1097/00042737-199704000-00006; Dixon-Woods M, 2000, FAM PRACT, V17, P108, DOI 10.1093/fampra/17.2.108; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; DROSSMAN DA, 1988, GASTROENTEROLOGY, V95, P701, DOI 10.1016/S0016-5085(88)80017-9; DROSSMAN DA, 1982, GASTROENTEROLOGY, V83, P529; Drossman DA, 1997, EUR J GASTROEN HEPAT, V9, P327, DOI 10.1097/00042737-199704000-00002; DROSSMAN DA, 2000, ROME, V2; Dunlop SP, 2001, GUT, V48, pA44; El-Salhy M, 1999, SCAND J GASTROENTERO, V34, P1007; Emmanuel AV, 2001, GUT, V49, P214, DOI 10.1136/gut.49.2.214; Fass R, 2001, ARCH INTERN MED, V161, P2081, DOI 10.1001/archinte.161.17.2081; Fireman Z, 2001, DIGESTION, V64, P100, DOI 10.1159/000048847; Fitze G, 2002, LANCET, V359, P1200, DOI 10.1016/S0140-6736(02)08218-1; FRANCIS CY, 1994, LANCET, V344, P39, DOI 10.1016/S0140-6736(94)91055-3; Francis CY, 1996, EUR J GASTROEN HEPAT, V8, P525, DOI 10.1097/00042737-199606000-00004; Fukudo S, 1998, GUT, V42, P845, DOI 10.1136/gut.42.6.845; Gralnek IM, 2000, GASTROENTEROLOGY, V119, P654, DOI 10.1053/gast.2000.16484; GUTHRIE E, 1993, BRIT J PSYCHIAT, V163, P315, DOI 10.1192/bjp.163.3.315; Gwee KA, 1999, GUT, V44, P400, DOI 10.1136/gut.44.3.400; Hahn B, 1998, DIGEST DIS SCI, V43, P2715, DOI 10.1023/A:1026663613695; HEBDEN JM, IN PRESS AM J GASTRO; Herschbach P, 1999, PSYCHOSOM MED, V61, P148, DOI 10.1097/00006842-199903000-00005; Heymann-Monnikes I, 2000, AM J GASTROENTEROL, V95, P981; Houghton LA, 2002, GUT, V50, P471, DOI 10.1136/gut.50.4.471; Houghton LA, 2001, GASTROENTEROLOGY, V120, pA636; Hsieh JC, 1999, NEUROSCI LETT, V262, P61, DOI 10.1016/S0304-3940(99)00060-9; Jackson JL, 2000, AM J MED, V108, P65, DOI 10.1016/S0002-9343(99)00299-5; Jailwala J, 2000, ANN INTERN MED, V133, P136, DOI 10.7326/0003-4819-133-2-200007180-00013; Janssen HAM, 1998, SCAND J GASTROENTERO, V33, P561; Jones J, 2000, GUT, V47, pII1, DOI 10.1136/gut.47.suppl_2.ii1; Kadowaki M, 1996, AM J PHYSIOL-GASTR L, V271, pG849, DOI 10.1152/ajpgi.1996.271.5.G849; Kay L, 1998, J INTERN MED, V244, P489, DOI 10.1111/j.1365-2796.1998.00393.x; Kay L, 1996, EUR J EPIDEMIOL, V12, P199, DOI 10.1007/BF00145507; Keefer L, 2001, BEHAV RES THER, V39, P801, DOI 10.1016/S0005-7967(00)00078-4; KELLOW JE, 1988, GUT, V29, P1236, DOI 10.1136/gut.29.9.1236; Kennedy TM, 2000, BRIT J SURG, V87, P1658, DOI 10.1046/j.1365-2168.2000.01596.x; King TS, 1998, LANCET, V352, P1187, DOI 10.1016/S0140-6736(98)02146-1; Koloski NA, 2001, AM J GASTROENTEROL, V96, P1340, DOI 10.1016/S0002-9270(01)02352-8; KOLOSKI NA, IN PRESS AM J GASTRO; Kroenke K, 2000, PSYCHOTHER PSYCHOSOM, V69, P205, DOI 10.1159/000012395; Ladabaum U, 2001, GASTROENTEROLOGY, V120, P369, DOI 10.1053/gast.2001.21201; Ladabaum U, 2000, AM J PHYSIOL-GASTR L, V279, pG1, DOI 10.1152/ajpgi.2000.279.1.G1; Lee OY, 2001, AM J GASTROENTEROL, V96, P2184, DOI 10.1016/S0002-9270(01)02524-2; Levy RL, 2000, AM J GASTROENTEROL, V95, P451, DOI 10.1111/j.1572-0241.2000.01766.x; Levy RL, 2001, GASTROENTEROLOGY, V121, P799, DOI 10.1053/gast.2001.27995; Lewis MJV, 2001, GUT, V48, P216, DOI 10.1136/gut.48.2.216; Locke GR, 2000, MAYO CLIN PROC, V75, P907, DOI 10.4065/75.9.907; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; Maxwell PR, 2002, AM J GASTROENTEROL, V97, P104; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; McManis PG, 2001, AM J GASTROENTEROL, V96, P1139; Mertz H, 2000, GASTROENTEROLOGY, V118, P842, DOI 10.1016/S0016-5085(00)70170-3; MERTZ H, 1995, GASTROENTEROLOGY, V109, P40, DOI 10.1016/0016-5085(95)90267-8; Morris-Yates A, 1998, AM J GASTROENTEROL, V93, P1311; Muller-Lissner SA, 2001, ALIMENT PHARM THER, V15, P1655, DOI 10.1046/j.1365-2036.2001.01094.x; Munakata J, 1997, GASTROENTEROLOGY, V112, P55, DOI 10.1016/S0016-5085(97)70219-1; Naliboff BD, 2001, PSYCHOSOM MED, V63, P365, DOI 10.1097/00006842-200105000-00006; Naliboff BD, 1997, GUT, V41, P505, DOI 10.1136/gut.41.4.505; Niaz SK, 1997, J ROY COLL PHYS LOND, V31, P53; Nobaek S, 2000, AM J GASTROENTEROL, V95, P1231; Osterberg E, 2000, SCAND J GASTROENTERO, V35, P264; OWENS DM, 1995, ANN INTERN MED, V122, P107, DOI 10.7326/0003-4819-122-2-199501150-00005; PARKER TJ, 1995, J HUM NUTR DIET, V8, P159, DOI 10.1111/j.1365-277X.1995.tb00308.x; Parker TJ, 2001, EUR J GASTROEN HEPAT, V13, P219, DOI 10.1097/00042737-200103000-00001; PETERS GA, 1944, GASTROENTEROLOGY, V3, pK399; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Poynard T, 2001, ALIMENT PHARM THER, V15, P355, DOI 10.1046/j.1365-2036.2001.00937.x; Ragnarsson G, 1998, EUR J GASTROEN HEPAT, V10, P415, DOI 10.1097/00042737-199805000-00011; Ragnarsson G, 1999, SCAND J GASTROENTERO, V34, P993; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; RITCHIE J, 1973, GUT, V14, P125, DOI 10.1136/gut.14.2.125; ROSEN SD, 1994, LANCET, V344, P147, DOI 10.1016/S0140-6736(94)92755-3; Saito YA, 2000, AM J GASTROENTEROL, V95, P2816, DOI 10.1016/S0002-9270(00)01985-7; Sanders DS, 2001, LANCET, V358, P1504, DOI 10.1016/S0140-6736(01)06581-3; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; SCARINCI IC, 1994, AM J MED, V97, P108, DOI 10.1016/0002-9343(94)90020-5; Serra J, 2001, AM J PHYSIOL-GASTR L, V281, pG138, DOI 10.1152/ajpgi.2001.281.1.G138; Serra J, 1998, GASTROENTEROLOGY, V115, P542, DOI 10.1016/S0016-5085(98)70133-7; Serra J, 2001, GUT, V48, P14, DOI 10.1136/gut.48.1.14; Silverman DHS, 1997, GASTROENTEROLOGY, V112, P64, DOI 10.1016/S0016-5085(97)70220-8; SIMOONS FJ, 1978, AM J DIG DIS, V23, P963, DOI 10.1007/BF01263095; Spiller RC, 2000, GUT, V47, P804, DOI 10.1136/gut.47.6.804; STEED KP, 1993, DIGEST DIS SCI, V38, P1793, DOI 10.1007/BF01296101; STROCCHI A, 1991, CAN J PHYSIOL PHARM, V69, P108, DOI 10.1139/y91-015; SUAREZ FL, 1995, NEW ENGL J MED, V333, P1, DOI 10.1056/NEJM199507063330101; Suleiman S, 2001, ARCH INTERN MED, V161, P369, DOI 10.1001/archinte.161.3.369; SURRENTI E, 1995, AM J GASTROENTEROL, V90, P1471; SWARBRICK ET, 1980, LANCET, V2, P443; Tache Y, 2001, AM J PHYSIOL-GASTR L, V280, pG173, DOI 10.1152/ajpgi.2001.280.2.G173; Talley N J, 2000, Aust Fam Physician, V29, P823; Talley NJ, 1998, GUT, V42, P690, DOI 10.1136/gut.42.5.690; Talley NJ, 2001, LANCET, V358, P2061, DOI 10.1016/S0140-6736(01)07103-3; Talley NJ, 1996, AM J GASTROENTEROL, V91, P277; Talley NJ, 1997, GUT, V41, P394, DOI 10.1136/gut.41.3.394; Talley NJ, 1998, GUT, V42, P47, DOI 10.1136/gut.42.1.47; Talley NJ, 2001, AM J GASTROENTEROL, V96, P1072; TALLEY NJ, 1992, AM J EPIDEMIOL, V136, P165, DOI 10.1093/oxfordjournals.aje.a116483; Thompson WG, 2001, EUR J GASTROEN HEPAT, V13, P933, DOI 10.1097/00042737-200108000-00010; Thompson WG, 2000, GUT, V46, P78, DOI 10.1136/gut.46.1.78; Thompson WG, 2001, EUR J GASTROEN HEPAT, V13, P1135, DOI 10.1097/00042737-200110000-00001; Thompson WG, 1997, EUR J GASTROEN HEPAT, V9, P299; TOMBLON H, 2000, GASTROENTEROLOGY, V118, pA140; Tovey P, 2002, BRIT J GEN PRACT, V52, P19; Vanner SJ, 1999, AM J GASTROENTEROL, V94, P2912; Vidakovic-Vukic M, 1999, SCAND J GASTROENTERO, V34, P49, DOI 10.1080/003655299750025543; Wahnschaffe U, 2001, GASTROENTEROLOGY, V121, P1329, DOI 10.1053/gast.2001.29572; Watson ME, 2001, AM J GASTROENTEROL, V96, P455; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Whitehead WE, 1997, DIGEST DIS SCI, V42, P796, DOI 10.1023/A:1018820315549; WHITEHEAD WE, 1992, GUT, V33, P825, DOI 10.1136/gut.33.6.825; WILLIAMS AJK, 1991, GUT, V32, P1004, DOI 10.1136/gut.32.9.1004; Woodman CL, 1998, PSYCHOSOMATICS, V39, P45, DOI 10.1016/S0033-3182(98)71380-5; Zhao RH, 2000, DIS COLON RECTUM, V43, P858, DOI 10.1007/BF02238027	140	195	206	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2002	360	9332					555	564		10.1016/S0140-6736(02)09712-X	http://dx.doi.org/10.1016/S0140-6736(02)09712-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241674				2022-12-28	WOS:000177512800028
J	Ng, J; Frith, R				Ng, J; Frith, R			Nanging	LANCET			English	Editorial Material							NITROUS-OXIDE		Auckland Hosp, Dept Neurol, Auckland 1, New Zealand	Auckland City Hospital	Ng, J (corresponding author), Auckland Hosp, Dept Neurol, Auckland 1, New Zealand.							DEACON R, 1978, LANCET, V2, P1023, DOI 10.1016/S0140-6736(78)92341-3; FLIPPO TS, 1993, ARCH SURG-CHICAGO, V128, P1391; LAYZER RB, 1978, LANCET, V2, P1227; SCHILLING RF, 1986, JAMA-J AM MED ASSOC, V255, P1605, DOI 10.1001/jama.255.12.1605; *SUBST AB MENT HLT, 2000, SUMM FIND 1999 NAT H	5	17	19	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					384	384		10.1016/S0140-6736(02)09611-3	http://dx.doi.org/10.1016/S0140-6736(02)09611-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241780				2022-12-28	WOS:000177255600013
J	Galvin, R; Milstein, A				Galvin, R; Milstein, A			Large employers' new strategies in health care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PERFORMANCE-MEASUREMENT; QUALITY; INFORMATION; CONSUMERS; MORTALITY; OUTCOMES		GE Co, Fairfield, CT 06431 USA; Pacific Business Grp Hlth, San Francisco, CA 94111 USA	General Electric	Galvin, R (corresponding author), GE Co, Fairfield, CT 06431 USA.							Bentley J M, 1998, Jt Comm J Qual Improv, V24, P40; BIRKMEYER JD, 2001, LEAPFROG PATIENT SAF; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; CHRISTIANSON J, 1999, HLTH AFF MILLWOOD, V48, P100; DZIUBAN SW, 1994, ANN THORAC SURG, V58, P1871, DOI 10.1016/0003-4975(94)91730-2; EPSTEIN A, 1995, NEW ENGL J MED, V333, P57, DOI 10.1056/NEJM199507063330114; FRONSTIN P, 2001, DEFINED CONTRIBUTION; Galvin RS, 1998, HEALTH AFFAIR, V17, P29, DOI 10.1377/hlthaff.17.4.29; Galvin RS, 2001, HEALTH AFFAIR, V20, P57, DOI 10.1377/hlthaff.20.6.57; GALVIN RS, IN PRESS MED CARE; HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209; Hibbard JH, 1997, HEALTH AFFAIR, V16, P218, DOI 10.1377/hlthaff.16.3.218; Hibbard JH, 1998, HEALTH AFFAIR, V17, P181, DOI 10.1377/hlthaff.17.6.181; Hibbard JH, 2002, HEALTH SERV RES, V37, P291, DOI 10.1111/1475-6773.024; *HJ KAIS FAM FDN, 2000, NAT SURV AM HLTH CA; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Jencks SF, 2000, JAMA-J AM MED ASSOC, V283, P2015, DOI 10.1001/jama.283.15.2015; Khuri SF, 2001, SURGERY, V130, P429, DOI 10.1067/msy.2001.117138; Kohn LT., 2001, ERR IS HUMAN BUILDIN; Krumholz HM, 2002, JAMA-J AM MED ASSOC, V287, P1277, DOI 10.1001/jama.287.10.1277; MALENKA DJ, 1995, JOINT COMM J QUAL IM, V21, P627, DOI 10.1016/S1070-3241(16)30191-2; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; MAYS GP, 2001, ISSUE BRIEF CENT STU, V45, P1; *MERCK MEDC, 2001, MERCK MEDC DRUG TREN; Milstein A, 1997, HEALTH AFFAIR, V16, P87, DOI 10.1377/hlthaff.16.3.87; Milstein A, 2000, Eff Clin Pract, V3, P313; MILSTEIN A, 2001, EFF CLIN PRACT, V4, P94; Mukamel D B, 2001, Jt Comm J Qual Improv, V27, P20; *NAT COMM QUAL ASS, 2002, DIAB PROV REC PROGR; Newhouse JP., 1993, INSURANCE EXPT GROUP; Peterson ED, 1998, J AM COLL CARDIOL, V32, P993, DOI 10.1016/S0735-1097(98)00332-5; Robinson JC, 2001, JAMA-J AM MED ASSOC, V285, P2622, DOI 10.1001/jama.285.20.2622; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Romano PS, 1999, MED CARE, V37, P295, DOI 10.1097/00005650-199903000-00009; Rosenthal G E, 1998, Jt Comm J Qual Improv, V24, P347; RUNDLE RL, 2001, WALL STREET J   1109, pB8; Schneider EC, 1999, JAMA-J AM MED ASSOC, V282, P1184, DOI 10.1001/jama.282.12.1184; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Skolnick AA, 1998, JAMA-J AM MED ASSOC, V279, P1769, DOI 10.1001/jama.279.22.1769; VLADECK BC, 1988, HEALTH AFFAIR, V7, P122, DOI 10.1377/hlthaff.7.1.122; Wildavsky A.B., 1979, SPEAKING TRUTH POWER, DOI Transaction Books	41	93	93	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					939	942		10.1056/NEJMsb012850	http://dx.doi.org/10.1056/NEJMsb012850			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	594GJ	12239267				2022-12-28	WOS:000178040700014
J	Garibaldi, RA; Subhiyah, R; Moore, ME; Waxman, H				Garibaldi, RA; Subhiyah, R; Moore, ME; Waxman, H			The in-training examination in internal medicine: An analysis of resident performance over time	ANNALS OF INTERNAL MEDICINE			English	Article							CERTIFYING EXAMINATION; AMERICAN-BOARD; SCORES	Background: The In-Training Examination in Internal Medicine (IM-ITE) has been offered annually to all trainees in U.S. medical residency programs since 1988. Its purpose is to provide residents and program directors with an objective assessment of each resident's personal performance on a written, multiple-choice examination and the performance of the residency program compared with that of its peers. Objective: To analyze trends in the demographic characteristics and scores of examinees during the first 12 years of administration of this examination. Design: Descriptive analysis over time. Setting: U.S. residency programs in internal medicine, 1988-2000. Participants: Residents at all levels of training in categorical, primary care, and medicine-pediatrics programs in the United States and Canada. The number of examinees increased from 7500 in 1988 to almost 18 000 in 2000. Measurements: After calibration of the scores for each examination, test results were compared and analyzed for selected cohorts of residents over 12 years. Results: More than 80% of residents in medicine training programs participate in the IM-ITE, most on an annual basis throughout their period of training. Test performance improves at a predictable rate with each year of training. Since 1995, international medical school graduates have persistently outperformed graduates of U.S. medical schools. Test results were affected by the timing of the examination, the time that was available to complete the examination, and the actual time that residents spent in internal medicine training before each examination. Conclusions: The IM-ITE scores generally improve with year of training time spent in internal medicine training before the examination and time permitted to complete the examination. These observations provide evidence that the IM-ITE is a valid measure of knowledge acquired during internal medicine training.	Univ Connecticut, Ctr Hlth, Dept Med, Sch Med, Farmington, CT 06030 USA; Natl Board Med Examiners, Philadelphia, PA USA; Amer Coll Phys Amer Soc Internal Med, Philadelphia, PA USA	University of Connecticut	Garibaldi, RA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Sch Med, 263 Farmington Ave, Farmington, CT 06030 USA.							GARIBALDI RA, 1994, ANN INTERN MED, V121, P117, DOI 10.7326/0003-4819-121-2-199407150-00008; GROSSMAN RS, 1992, J GEN INTERN MED, V7, P63, DOI 10.1007/BF02599105; Hawkins RE, 1999, AM J MED, V106, P206, DOI 10.1016/S0002-9343(98)00392-1; Holmboe ES, 1998, ANN INTERN MED, V129, P42, DOI 10.7326/0003-4819-129-1-199807010-00011; LINN RL, 1989, ED MEASUREMENT, P113; MAJIDIAN AM, 1993, SOUTHERN MED J, V86, P441, DOI 10.1097/00007611-199304000-00014; Rollins LK, 1998, J GEN INTERN MED, V13, P414, DOI 10.1046/j.1525-1497.1998.00122.x; SCHWARTZ RW, 1995, AM J SURG, V169, P414, DOI 10.1016/S0002-9610(99)80187-1; WAXMAN H, 1994, J GEN INTERN MED, V9, P692, DOI 10.1007/BF02599012; Wise S, 1999, ACAD RADIOL, V6, P66, DOI 10.1016/S1076-6332(99)80064-6; WOLFSTHAL SD, 1995, ANN INTERN MED, V122, P73, DOI 10.7326/0003-4819-122-1-199501010-00031; WRIGHT BD, 1979, BEST TEST DESIGN, P15	12	83	83	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					505	510		10.7326/0003-4819-137-6-200209170-00011	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230352				2022-12-28	WOS:000178069100005
J	Halm, EA; Lee, C; Chassin, MR				Halm, EA; Lee, C; Chassin, MR			Is volume related to outcome in health care? A systematic review and methodologic critique of the literature	ANNALS OF INTERNAL MEDICINE			English	Review							IN-HOSPITAL MORTALITY; NEW-YORK-STATE; ABDOMINAL AORTIC-ANEURYSMS; PERCUTANEOUS CORONARY INTERVENTIONS; BYPASS GRAFT-SURGERY; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ACUTE MYOCARDIAL-INFARCTION; SHORT-TERM MORTALITY; CAROTID-ENDARTERECTOMY; SURGICAL VOLUME	Purpose: To systematically review the methodologic rigor of the research on volume and outcomes and to summarize the magnitude and significance of the association between them. Data Sources: The authors searched MEDLINE from January 1980 to December 2000 for English-language, population-based studies examining the independent relationship between hospital or physician volume and clinical outcomes. Bibliographies were reviewed to identify other articles of interest, and experts were contacted about missing or unpublished studies. Study Selection: Of 272 studies reviewed, 135 met inclusion criteria and covered 27 procedures and clinical conditions. Data Extraction: Two investigators independently reviewed each article, using a standard form to abstract information on key study characteristics and results. Data Synthesis: The methodologic rigor of the primary studies varied. Few studies used clinical data for risk adjustment or examined effects of hospital and physician volume simultaneously. Overall, 71% of all studies of hospital volume and 69% of studies of physician volume reported statistically significant associations between higher volume and better outcomes. The strongest associations were found for AIDS treatment and for surgery on pancreatic cancer, esophageal cancer, abdominal aortic aneurysms, and pediatric cardiac problems (a median of 3.3 to 13 excess deaths per 100 cases were attributed to low volume). Although statistically significant, the volume-outcome relationship for coronary artery bypass surgery, coronary angioplasty, carotid enclarterectomy, other cancer surgery, and orthopedic procedures was of much smaller magnitude. Hospital volume-outcome studies that performed risk adjustment by using clinical data were less likely to report significant associations than were studies that adjusted for risk by using administrative data. Conclusions: High volume is associated with better outcomes across a wide range of procedures and conditions, but the magnitude of the association varies greatly. The clinical and policy significance of these findings is complicated by the methodologic shortcomings of many studies. Differences in case mix and processes of care between high- and low-volume providers may explain part of the observed relationship between volume and outcome.	CUNY Mt Sinai Sch Med, Dept Hlth Policy, New York, NY 10029 USA; Cornell Med Ctr, New York, NY USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Cornell University	Halm, EA (corresponding author), CUNY Mt Sinai Sch Med, Dept Hlth Policy, Box 1077,1 Gustave L Levy Pl, New York, NY 10029 USA.	ethan.halm@mountsinai.org						AMUNDSEN S, 1990, ACTA CHIR SCAND, V156, P323; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; BENNETT CL, 1989, JAMA-J AM MED ASSOC, V261, P2975, DOI 10.1001/jama.261.20.2975; BENNETT CL, 1992, J ACQ IMMUN DEF SYND, V5, P856; Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1016/S0039-6060(99)70152-2; Birkmeyer JD, 1999, SURGERY, V125, P250, DOI 10.1067/msy.1999.95211; BROOK RH, 1990, ANN INTERN MED, V113, P747, DOI 10.7326/0003-4819-113-10-747; BROTT T, 1984, STROKE, V15, P950, DOI 10.1161/01.STR.15.6.950; BUNKER JP, 1982, SURG CLIN N AM, V62, P657; Casale PN, 1998, J AM COLL CARDIOL, V32, P885, DOI 10.1016/S0735-1097(98)00325-8; Cebul RD, 1998, JAMA-J AM MED ASSOC, V279, P1282, DOI 10.1001/jama.279.16.1282; Cunningham WE, 1999, AM J MED, V107, P137, DOI 10.1016/S0002-9343(99)00195-3; Dardik A, 1998, J VASC SURG, V28, P413, DOI 10.1016/S0741-5214(98)70126-0; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; EDWARDS WH, 1991, ANN SURG, V213, P433, DOI 10.1097/00000658-199105000-00008; Ellison LM, 2000, J UROLOGY, V163, P867, DOI 10.1016/S0022-5347(05)67821-4; Espehaug B, 1999, ACTA ORTHOP SCAND, V70, P12, DOI 10.3109/17453679909000949; Every NR, 2000, J INVASIVE CARDIOL, V12, P303; FARLEY DE, 1992, MED CARE, V30, P77, DOI 10.1097/00005650-199201000-00009; FISHER ES, 1989, AM J PUBLIC HEALTH, V79, P1617, DOI 10.2105/AJPH.79.12.1617; FLOOD AB, 1984, MED CARE, V22, P115, DOI 10.1097/00005650-198402000-00003; FLOOD AB, 1979, MED CARE, V17, P1088, DOI 10.1097/00005650-197911000-00002; FLOOD AB, 1984, MED CARE, V22, P98, DOI 10.1097/00005650-198402000-00002; Glasgow RE, 1996, WESTERN J MED, V165, P294; Gordon TA, 1999, J AM COLL SURGEONS, V189, P46, DOI 10.1016/S1072-7515(99)00072-1; GORDON TA, 1995, ANN SURG, V221, P43, DOI 10.1097/00000658-199501000-00005; GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282; Halm E, 2000, INTERPRETING VOLUME; Hamilton BH, 1997, HEALTH ECON, V6, P383, DOI 10.1002/(SICI)1099-1050(199707)6:4<383::AID-HEC278>3.0.CO;2-L; Hamilton BH, 1998, MED CARE, V36, P892, DOI 10.1097/00005650-199806000-00012; Hannan EL, 1998, STROKE, V29, P2292, DOI 10.1161/01.STR.29.11.2292; HANNAN EL, 1992, HEALTH SERV RES, V27, P517; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Hannan EL, 2002, SURGERY, V131, P6, DOI 10.1067/msy.2002.120238; HANNAN EL, 1991, MED CARE, V29, P1094, DOI 10.1097/00005650-199111000-00003; HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209; Hannan EL, 1999, NEW ENGL J MED, V340, P1677, DOI 10.1056/NEJM199905273402112; Hannan EL, 1998, PEDIATRICS, V101, P963, DOI 10.1542/peds.101.6.963; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; Harmon JW, 1999, ANN SURG, V230, P404, DOI 10.1097/00000658-199909000-00013; *HEALTHSC, CHOOS HOSP; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Ho V, 2000, CIRCULATION, V101, P1806, DOI 10.1161/01.CIR.101.15.1806; Hogg RS, 1998, CLIN INVEST MED, V21, P27; Hsia DC, 1998, STROKE, V29, P346, DOI 10.1161/01.STR.29.2.346; Hunt DL, 1997, ANN INTERN MED, V126, P532, DOI 10.7326/0003-4819-126-7-199704010-00006; Iezzoni LI, 1997, RISK ADJUSTMENT MEAS; Imperato P J, 1996, Am J Med Qual, V11, P193, DOI 10.1177/0885713X9601100407; JENKINS KJ, 1995, PEDIATRICS, V95, P323; Jollis JG, 1997, CIRCULATION, V95, P2485, DOI 10.1161/01.CIR.95.11.2485; JOLLIS JG, 1994, NEW ENGL J MED, V331, P1625, DOI 10.1056/NEJM199412153312406; Kantonen I, 1998, EUR J VASC ENDOVASC, V15, P155, DOI 10.1016/S1078-5884(98)80137-8; Karp HR, 1998, STROKE, V29, P46, DOI 10.1161/01.STR.29.1.46; KATZ DJ, 1994, J VASC SURG, V19, P804, DOI 10.1016/S0741-5214(94)70005-2; Kazmers A, 1996, J VASC SURG, V23, P191, DOI 10.1016/S0741-5214(96)70263-X; KEMPCZINSKI RF, 1986, J VASC SURG, V3, P911, DOI 10.1067/mva.1986.avs0030911; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; KIRSHNER DL, 1989, J VASC SURG, V10, P178, DOI 10.1067/mva.1989.vs0100178; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; Kreder HJ, 1997, J BONE JOINT SURG AM, V79A, P485, DOI 10.2106/00004623-199704000-00003; Kreder HJ, 1998, CAN J SURG, V41, P431; LAVERNIA CJ, 1995, J ARTHROPLASTY, V10, P133, DOI 10.1016/S0883-5403(05)80119-6; *LEAPFR GROUP, 2002, PURCH PRINC; LIEBERMAN MD, 1995, ANN SURG, V222, P638, DOI 10.1097/00000658-199511000-00006; LUFT HS, 1980, MED CARE, V18, P940, DOI 10.1097/00005650-198009000-00006; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; LUFT HS, 1987, HEALTH SERV RES, V22, P157; Malenka DJ, 1999, J AM COLL CARDIOL, V34, P1471, DOI 10.1016/S0735-1097(99)00393-9; Manheim LM, 1998, J VASC SURG, V28, P45, DOI 10.1016/S0741-5214(98)70199-5; Maynard C, 1999, Eff Clin Pract, V2, P108; McGrath P, 1998, J AM COLL CARDIOL, V31, P570, DOI 10.1016/S0735-1097(97)00541-X; McGrath PD, 2000, JAMA-J AM MED ASSOC, V284, P3139, DOI 10.1001/jama.284.24.3139; Meade MO, 1997, ANN INTERN MED, V127, P531, DOI 10.7326/0003-4819-127-7-199710010-00005; *NY STAT DEP HLTH, 2000, COR ART BYP SURG NEW; O'Neill L, 2000, NEUROLOGY, V55, P773, DOI 10.1212/WNL.55.6.773; Parry JM, 1999, BRIT J SURG, V86, P475, DOI 10.1046/j.1365-2168.1999.01064.x; Patti M G, 1998, J Gastrointest Surg, V2, P186, DOI 10.1016/S1091-255X(98)80011-5; Perler BA, 1998, J VASC SURG, V27, P25, DOI 10.1016/S0741-5214(98)70288-5; PHILLIPS KA, 1995, MED CARE, V33, P502, DOI 10.1097/00005650-199505000-00005; Porter GA, 1998, ANN SURG, V227, P157, DOI 10.1097/00000658-199802000-00001; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; RICHARDSON JD, 1989, J VASC SURG, V9, P65, DOI 10.1067/mva.1989.vs0090065; Riley G, 1985, Health Care Financ Rev, V7, P37; RITCHIE JL, 1993, CIRCULATION, V88, P2735, DOI 10.1161/01.CIR.88.6.2735; Ritchie JL, 1999, AM J CARDIOL, V83, P493, DOI 10.1016/S0002-9149(98)00901-1; ROMANO PS, 1992, CHEST, V101, P1332, DOI 10.1378/chest.101.5.1332; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Ruby ST, 1996, ANN VASC SURG, V10, P22, DOI 10.1007/BF02002337; Rutledge R, 1996, ANN SURG, V223, P492, DOI 10.1097/00000658-199605000-00005; SAINSBURY R, 1995, LANCET, V345, P1265, DOI 10.1016/S0140-6736(95)90924-9; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Segal H E, 1993, QRB Qual Rev Bull, V19, P152; Shacley P, 2000, EUR J VASC ENDOVASC, V20, P326, DOI 10.1053/ejvs.2000.1188; SHOWSTACK JA, 1987, JAMA-J AM MED ASSOC, V257, P785, DOI 10.1001/jama.257.6.785; Shroyer ALW, 1996, ANN THORAC SURG, V61, P17, DOI 10.1016/0003-4975(95)00830-6; Simons AJ, 1997, DIS COLON RECTUM, V40, P641, DOI 10.1007/BF02140891; Simunovic M, 1999, CAN MED ASSOC J, V160, P643; Simunovic M, 2000, J GASTROINTEST SURG, V4, P324, DOI 10.1016/S1091-255X(00)80083-9; Sollano JA, 1999, J THORAC CARDIOV SUR, V117, P419, DOI 10.1016/S0022-5223(99)70320-X; Solomon RA, 1996, STROKE, V27, P13, DOI 10.1161/01.STR.27.1.13; Sosa JA, 1998, ANN SURG, V228, P429, DOI 10.1097/00000658-199809000-00016; SOWDEN AJ, 1995, BMJ-BRIT MED J, V311, P151, DOI 10.1136/bmj.311.6998.151; STONE VE, 1992, JAMA-J AM MED ASSOC, V268, P2655, DOI 10.1001/jama.268.19.2655; Taylor CL, 1997, J NEUROSURG, V86, P583, DOI 10.3171/jns.1997.86.4.0583; Taylor HD, 1997, J ARTHROPLASTY, V12, P235, DOI 10.1016/S0883-5403(97)90018-8; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; THORPE AC, 1994, BRIT J UROL, V74, P559, DOI 10.1111/j.1464-410X.1994.tb09184.x; Tu JV, 1998, NEW ENGL J MED, V339, P1441, DOI 10.1056/NEJM199811123392006; TURNER BJ, 1992, J ACQ IMMUN DEF SYND, V5, P978; *U LEEDS NUFF I HL, 1996, B EFF HLTH SERV INT; Wade TP, 1996, SURGERY, V120, P680, DOI 10.1016/S0039-6060(96)80017-1; Wen SW, 1996, J EPIDEMIOL COMMUN H, V50, P207, DOI 10.1136/jech.50.2.207; Wennberg DE, 1998, JAMA-J AM MED ASSOC, V279, P1278, DOI 10.1001/jama.279.16.1278; Yao SL, 1999, J NATL CANCER I, V91, P1950, DOI 10.1093/jnci/91.22.1950	114	1279	1288	1	67	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					511	520		10.7326/0003-4819-137-6-200209170-00012	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00012			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230353				2022-12-28	WOS:000178069100006
J	Pukkala, E; Aspholm, R; Auvinen, A; Eliasch, H; Gundestrup, M; Haldorsen, T; Hammar, N; Hrafnkelsson, J; Kyyronen, P; Linnersjo, A; Raffnsson, V; Storm, H; Tveten, U				Pukkala, E; Aspholm, R; Auvinen, A; Eliasch, H; Gundestrup, M; Haldorsen, T; Hammar, N; Hrafnkelsson, J; Kyyronen, P; Linnersjo, A; Raffnsson, V; Storm, H; Tveten, U			Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study	BRITISH MEDICAL JOURNAL			English	Article							CABIN ATTENDANTS; BREAST-CANCER; MORTALITY; RADIATION; FLIGHT; LEUKEMIA; EXPOSURE; RISK	Objective To assess the incidence of cancer among male airline pilots in the Nordic countries, with special reference to risk related to cosmic radiation. Design Retrospective cohort study, with follow up of cancer incidence through the national cancer registries. Setting Denmark, Finland, Iceland, Norway, and Sweden. Participants 10 032 male airline pilots, with an average follow up of 17 years. Main outcome measures Standardised incidence ratios, with expected numbers based on national cancer incidence rates; dose-response analysis using Poisson regression. Results 466 cases of cancer were diagnosed compared with 456 expected. The only significantly increased standardised incidence ratios were for skin cancer: melanoma 2.3 (95% confidence interval 1.7 to 3.0), non-melanoma 2.1 (1.7 to 2.8), basal cell carcinoma 2.5 (1.9 to 3.2). The relative risk of skin cancers increased with the estimated radiation dose. The relative risk of prostate cancer increased with increasing number of flight hours in long distance aircraft. Conclusions This study does not indicate a marked increase in cancer risk attributable to cosmic radiation, although some influence of cosmic radiation on skin cancer cannot be entirely excluded. The suggestion of an association between number of long distance flights (possibly related to circadian hormonal disturbances) and prostate cancer needs to be confirmed.	Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FIN-00170 Helsinki, Finland; Pilots Assoc, Finnish Airline, FIN-01530 Vantaa, Finland; STUK, Radiat & Nucl Safety Author, FIN-00881 Helsinki, Finland; Swedish SAS, S-19587 Stockholm, Sweden; Univ Hosp, Natl Clin Aviat Med, Ctr Heart, DK-2220 Copenhagen N, Denmark; Kreftregisteret, Inst Populat Based Canc Res, N-0310 Oslo, Norway; Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; Stockholm Ctr Publ Hlth, Dept Epidemiol, S-17176 Stockholm, Sweden; Landspitalinn, Dept Oncol, IS-105 Reykjavik, Iceland; Univ Iceland, Dept Prevent Med, IS-105 Reykjavik, Iceland; Danish Canc Soc, Canc Prevent & Documentat, DK-2100 Copenhagen O, Denmark; Inst Energy Technol, N-2007 Kjeller, Norway	Finnish Cancer Registry; Radiation & Nuclear Safety Authority (STUK); Karolinska Institutet; University of Iceland; Danish Cancer Society; Institute for Energy Technology (IFE)	Pukkala, E (corresponding author), Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, Liisankatu 21 B, FIN-00170 Helsinki, Finland.		Auvinen, Anssi/AAD-9311-2020; Auvinen, Anssi/AAL-2111-2020	Auvinen, Anssi/0000-0003-1125-4818; Storm, Hans/0000-0001-7223-8198				ANDERSEN A, 1999, SCAND J WORK ENV S2, V25; Armstrong BK, 1996, CANC EPIDEMIOLOGY PR, P1282; Ballard T, 2000, AVIAT SPACE ENVIR MD, V71, P216; BAND PR, 1990, AVIAT SPACE ENVIR MD, V61, P299; Band PR, 1996, AM J EPIDEMIOL, V143, P137; CARDIS E, 1995, RADIAT RES, V142, P117, DOI 10.2307/3579020; DIFFEY BL, 1990, AVIAT SPACE ENVIR MD, V61, P1032; Gundestrup M, 1999, LANCET, V354, P2029, DOI 10.1016/S0140-6736(99)05093-X; Haldorsen T, 2001, INT J EPIDEMIOL, V30, P825, DOI 10.1093/ije/30.4.825; Haldorsen T, 2000, SCAND J WORK ENV HEA, V26, P106, DOI 10.5271/sjweh.519; Hammar N, 2002, AVIAT SPACE ENVIR MD, V73, P2; ICRP, 1991, ANN ICRP, V21, P1; Irvine D, 1999, AVIAT SPACE ENVIR MD, V70, P548; KAJI M, 1993, AVIAT SPACE ENVIR MD, V64, P748; PUKKALA E, 1995, BRIT MED J, V311, P649, DOI 10.1136/bmj.311.7006.649; Pukkala E, 1995, CONTRIBUTIONS EPIDEM, V7; Rafnsson V, 2000, OCCUP ENVIRON MED, V57, P175, DOI 10.1136/oem.57.3.175; Rafnsson V, 2001, CANCER CAUSE CONTROL, V12, P95, DOI 10.1023/A:1008983416836; Stevens RG, 1996, ENVIRON HEALTH PERSP, V104, P135, DOI 10.2307/3432703; Tveten U, 2000, RADIAT PROT DOSIM, V87, P157, DOI 10.1093/oxfordjournals.rpd.a032992	20	109	116	0	17	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2002	325	7364					567	569		10.1136/bmj.325.7364.567	http://dx.doi.org/10.1136/bmj.325.7364.567			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595JJ	12228131	Bronze, Green Published			2022-12-28	WOS:000178105200015
J	Garces-Chavez, V; McGloin, D; Melville, H; Sibbett, W; Dholakia, K				Garces-Chavez, V; McGloin, D; Melville, H; Sibbett, W; Dholakia, K			Simultaneous micromanipulation in multiple planes using a self-reconstructing light beam	NATURE			English	Article							TRAPPED MICROSCOPIC PARTICLES; HOLOGRAPHIC OPTICAL TWEEZERS; ORBITAL ANGULAR-MOMENTUM	Optical tweezers(1) are commonly used for manipulating microscopic particles, with applications in cell manipulation (2), colloid research(3-5), manipulation of micromachines(6) and studies of the properties of light beams(7). Such tweezers work by the transfer of momentum from a tightly focused laser to the particle, which refracts and scatters the light and distorts the profile of the beam. The forces produced by this process cause the particle to be trapped near the beam focus. Conventional tweezers use gaussian light beams, which cannot trap particles in multiple locations more than a few micrometres apart in the axial direction, because of beam distortion by the particle and subsequent strong divergence from the focal plane. Bessel beams(8,9), however, do not diverge and, furthermore, if part of the beam is obstructed or distorted the beam reconstructs itself after a characteristic propagation distance(10). Here we show how this reconstructive property may be utilized within optical tweezers to trap particles in multiple, spatially separated sample cells with a single beam. Owing to the diffractionless nature of the Bessel beam, secondary trapped particles can reside in a second sample cell far removed (similar to3 mm) from the first cell. Such tweezers could be used for the simultaneous study of identically prepared ensembles of colloids and biological matter, and potentially offer enhanced control of 'lab-on-a-chip' and optically driven microstructures.	Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland	University of St Andrews	Dholakia, K (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.	kd1@st-and.ac.uk	Dholakia, Kishan/C-9873-2009; McGloin, David/J-6167-2018	McGloin, David/0000-0002-0075-4481; Dholakia, Kishan/0000-0001-6534-9009				Arlt J, 2001, OPT COMMUN, V197, P239, DOI 10.1016/S0030-4018(01)01479-1; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Bouchal Z, 1998, OPT COMMUN, V151, P207, DOI 10.1016/S0030-4018(98)00085-6; Chavez-Cerda S, 2002, J OPT B-QUANTUM S O, V4, pS52, DOI 10.1088/1464-4266/4/2/368; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Crocker JC, 1999, PHYS REV LETT, V82, P4352, DOI 10.1103/PhysRevLett.82.4352; Curtis JE, 2002, OPT COMMUN, V207, P169, DOI 10.1016/S0030-4018(02)01524-9; DURNIN J, 1987, PHYS REV LETT, V58, P1499, DOI 10.1103/PhysRevLett.58.1499; DURNIN J, 1987, J OPT SOC AM A, V4, P651, DOI 10.1364/JOSAA.4.000651; Friese MEJ, 1998, NATURE, V394, P348, DOI 10.1038/28566; Friese MEJ, 2001, APPL PHYS LETT, V78, P547, DOI 10.1063/1.1339995; HERMAN RM, 1991, J OPT SOC AM A, V8, P932, DOI 10.1364/JOSAA.8.000932; Korda P, 2002, REV SCI INSTRUM, V73, P1956, DOI 10.1063/1.1455136; Larsen AE, 1997, NATURE, V385, P230, DOI 10.1038/385230a0; MacDonald MP, 2002, SCIENCE, V296, P1101, DOI 10.1126/science.1069571; MacDonald RP, 1996, OPT COMMUN, V122, P169, DOI 10.1016/0030-4018(95)00432-7; McQueen CA, 1999, AM J PHYS, V67, P912, DOI 10.1119/1.19148; Paterson L, 2001, SCIENCE, V292, P912, DOI 10.1126/science.1058591; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Volke-Sepulveda K, 2002, J OPT B-QUANTUM S O, V4, pS82, DOI 10.1088/1464-4266/4/2/373	20	810	870	7	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					145	147		10.1038/nature01007	http://dx.doi.org/10.1038/nature01007			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226659				2022-12-28	WOS:000177931200035
J	Amelin, Y; Krot, AN; Hutcheon, ID; Ulyanov, AA				Amelin, Y; Krot, AN; Hutcheon, ID; Ulyanov, AA			Lead isotopic ages of chondrules and calcium-aluminum-rich inclusions	SCIENCE			English	Article							EARLY SOLAR-SYSTEM; CARBONACEOUS CHONDRITE; CR; ANORTHITE; AL-26; METEORITES; DIFFUSION; RENAZZO; NEBULA; ORIGIN	The lead-lead isochron age of chondrules in the CR chondrite Acfer 059 is 4564.7+/-0.6 million years ago (Ma), whereas the lead isotopic age of calcium-aluminum-rich inclusions (CAIs) in the CV chondrite Efremovka is 4567.2+/-0.6 Ma. This gives an interval of 2.5+/-1.2 million years (My) between formation of the CV CAIs and the CR chondrules and indicates that CAI- and chondrule-forming events lasted for at least 1.3 My. This time interval is consistent with a 2- to 3-My age difference between CR CAIs and chondrules inferred from the differences in their initial Al-26/Al-27 ratios and supports the chronological significance of the Al-26-Mg-26 systematics.	Royal Ontario Museum, Dept Earth Sci, Toronto, ON M5S 2C6, Canada; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Lawrence Livermore Natl Lab, Livermore, CA 94451 USA; Moscow MV Lomonosov State Univ, Moscow 117999, Russia	Royal Ontario Museum; University of Hawaii System; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Lomonosov Moscow State University	Amelin, Y (corresponding author), Geol Survey Canada, 601 Booth St, Ottawa, ON K1A 0E8, Canada.	yamelin@NRCan.gc.ca						ALLEGRE CJ, 1995, GEOCHIM COSMOCHIM AC, V59, P1445, DOI 10.1016/0016-7037(95)00054-4; Amelin Y, 2001, LUNAR PLANET SCI, V32, P1389; AMELIN Y, UNPUB; Amelin YV, 1997, EARTH PLANET SC LETT, V148, P299, DOI 10.1016/S0012-821X(97)00046-0; ARDEN JW, 1984, GEOCHIM COSMOCHIM AC, V48, P1899, DOI 10.1016/0016-7037(84)90373-9; Bogdanovski O., 2002, LUNAR PLANET SCI, V33, P1802; BOSS AP, 2000, LUNAR PLANET SCI, V31, P1084; BREARLEY AJ, 1989, GEOCHIM COSMOCHIM AC, V53, P2081, DOI 10.1016/0016-7037(89)90326-8; CATANZAR.EJ, 1966, J RES NBS A PHYS CH, VA 70, P453, DOI 10.6028/jres.070A.037; CHAUSSIDON M, 2002, LUNAR PLANET SCI, V33; CHEN JH, 1981, EARTH PLANET SC LETT, V52, P1, DOI 10.1016/0012-821X(81)90202-8; Cherniak DJ, 2001, CHEM GEOL, V177, P381, DOI 10.1016/S0009-2541(00)00421-6; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; Desch SJ, 2002, METEORIT PLANET SCI, V37, P183, DOI 10.1111/j.1945-5100.2002.tb01104.x; FAURE G, 1986, PRINCIPELS ISOTOPE G; GOPEL C, 1991, METEORITICS, V26, P338; GOPEL C, 1985, GEOCHIM COSMOCHIM AC, V49, P1681, DOI 10.1016/0016-7037(85)90139-5; Goswami J. N., 2000, Protostars and planets 4, P963; Gounelle M, 2001, ASTROPHYS J, V548, P1051, DOI 10.1086/319019; HUTCHEON ID, 1987, GEOCHIM COSMOCHIM AC, V51, P3175, DOI 10.1016/0016-7037(87)90126-8; Kita NT, 2000, GEOCHIM COSMOCHIM AC, V64, P3913, DOI 10.1016/S0016-7037(00)00488-9; Krot AN, 2000, METEORIT PLANET SCI, V35, pA93; Krot AN, 2002, METEORIT PLANET SCI, V37, P91, DOI 10.1111/j.1945-5100.2002.tb00797.x; Krot AN, 1998, METEORIT PLANET SCI, V33, P1065, DOI 10.1111/j.1945-5100.1998.tb01713.x; KROT AN, 2000, LUNAR PLANET SCI, V31, P1470; KROT AN, IN PRESS METEORIT PL; KROT AN, 2002, LUNAR PLANET SCI, V33, P1412; LaTourrette T, 1998, EARTH PLANET SC LETT, V158, P91, DOI 10.1016/S0012-821X(98)00048-X; LATOURRETTE TZ, 1999, LUNAR PLANET SCI, V30, P2003; Liffman K, 1997, MON NOT R ASTRON SOC, V290, P629, DOI 10.1093/mnras/290.4.629; LIFFMAN K, 1992, ICARUS, V100, P608, DOI 10.1016/0019-1035(92)90121-M; Lugmair GW, 2001, METEORIT PLANET SCI, V36, P1017, DOI 10.1111/j.1945-5100.2001.tb01941.x; MacPherson G.J., 1988, METEORITES EARLY SOL, P746; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; Marhas KK, 2000, METEORIT PLANET SCI, V35, pA102; Marhas KK, 2002, METEORIT PLANET SCI, V37, pA94; MARHAS KK, 2001, METEORIT PLANET SC S, V36, pA121; McKeegan KD, 2000, SCIENCE, V289, P1334, DOI 10.1126/science.289.5483.1334; Mostefaoui S, 2002, METEORIT PLANET SCI, V37, P421, DOI 10.1111/j.1945-5100.2002.tb00825.x; NYQUIST LE, 1999, LUNAR PLANET SCI, V30, P1604; ROTENBERG E, 2001, 11 ANN VM GOLDSCHM C; Rubin AE, 2000, EARTH-SCI REV, V50, P3, DOI 10.1016/S0012-8252(99)00067-7; Russell SS, 1996, SCIENCE, V273, P757, DOI 10.1126/science.273.5276.757; Sahijpal S, 1998, NATURE, V391, P559, DOI 10.1038/35325; SCOTT ERD, 1992, GEOCHIM COSMOCHIM AC, V56, P4281, DOI 10.1016/0016-7037(92)90268-N; TATSUMOTO M, 1973, SCIENCE, V180, P1279, DOI 10.1126/science.180.4092.1279; Tera F, 1999, GEOCHIM COSMOCHIM AC, V63, P1877, DOI 10.1016/S0016-7037(99)00114-3; WEBER D, 1995, GEOCHIM COSMOCHIM AC, V59, P803, DOI 10.1016/0016-7037(94)00366-T; Weidenschilling SJ, 1998, SCIENCE, V279, P681, DOI 10.1126/science.279.5351.681; WEISBERG MK, 1993, GEOCHIM COSMOCHIM AC, V57, P1567, DOI 10.1016/0016-7037(93)90013-M; ZOLENSKY ME, 1991, METEORITICS, V26, P414; [No title captured]	53	633	649	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587					1678	1683		10.1126/science.1073950	http://dx.doi.org/10.1126/science.1073950			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215641				2022-12-28	WOS:000177819100043
J	Anandan, J				Anandan, J			Putting a spin on the Aharonov-Bohm oscillations	SCIENCE			English	Editorial Material							PHASE; RINGS		Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford	Anandan, J (corresponding author), Univ Oxford, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.							AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; ALTSHULER BL, 1981, JETP LETT+, V33, P94; ANANDAN J, 1989, PHYS LETT A, V138, P347, DOI 10.1016/0375-9601(89)90828-1; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; BUTTIKER M, 1983, PHYS LETT A, V96, P365, DOI 10.1016/0375-9601(83)90011-7; PESHKIN M, 1989, AHARONOVOBHM EFFECT; SAKURAI JJ, 1994, MODERN QUANTUM MECH, P304; WASHBURN S, 1986, ADV PHYS, V35, P375, DOI 10.1080/00018738600101921; Yau JB, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.146801; Zhu SL, 2000, PHYS REV LETT, V85, P1076, DOI 10.1103/PhysRevLett.85.1076	11	7	7	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1656	1657		10.1126/science.1076385	http://dx.doi.org/10.1126/science.1076385			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215633				2022-12-28	WOS:000177819100034
J	Mark, S; Gupta, J				Mark, S; Gupta, J			Reentry into clinical practice - Challenges and strategies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WOMEN PHYSICIANS; DEPRESSION; CARE	Women and men who reenter clinical practice after a period of clinical inactivity often face personal, professional, and institutional obstacles. Although many associations and academic medical institutions realize the critical importance of retaining and promoting highly qualified individuals, it is equally important for health care professionals to have the opportunity to return to a successful professional career following extended clinical inactivity. Here we provide a review of factors that may contribute to clinical inactivity, discuss challenges associated with the reentry process, describe current reentry efforts, and propose recommendations for future directions.	US Dept HHS, Off Womens Hlth, Washington, DC 20201 USA		Mark, S (corresponding author), US Dept HHS, Off Womens Hlth, 200 Independence Ave SW,Room 730B, Washington, DC 20201 USA.							Adlersberg M, 1997, Nurs BC, V29, P9; *AM COLL EM PHYS, 1995, ANN EMERG MED, V25, P307; *AM MED ASS, 2001, AMA WOM MED DAT SOUR; *ASS AM MED COLL, 1999, MED SCH FAC 1999; Bellack J P, 1995, J Contin Educ Nurs, V26, P60; CLARK DC, 1984, AM J PSYCHIAT, V141, P1095; *CONT MED ED FAC D, 2002, U FLOR CONT MED ED H; Davidson H, 1997, MED CARE, V35, P634, DOI 10.1097/00005650-199706000-00008; Frank E, 1999, AM J PSYCHIAT, V156, P1887; HALL C, 1999, CONTEMP NURSE, V8, P238; *HLTH RES SERV ADM, 1995, PUBL HLTH RES SERV A; *HLTH RES SERV ADM, 2001, HRSA RESP EM NURS SH; Jacoby I, 1997, JAMA-J AM MED ASSOC, V277, P1569; KENNEDY SR, 1998, NURS STAND, V13, P46; KINDIG DA, 1993, JAMA-J AM MED ASSOC, V270, P1069; KOMAROMY M, 1993, NEW ENGL J MED, V328, P322, DOI 10.1056/NEJM199302043280507; LAURICE F, 1992, J CONTIN ED NURS, V23, P220; Lenhart S A, 1991, J Am Med Womens Assoc (1972), V46, P121; LOWES R, 2000, MED ECON, V77, P89; Mark S, 2000, J Am Med Womens Assoc (1972), V55, P107; MARTIN AR, 1986, J GEN INTERN MED, V1, P252, DOI 10.1007/BF02596195; McMurray JE, 2000, J GEN INTERN MED, V15, P372, DOI 10.1111/j.1525-1497.2000.im9908009.x; Nahrwold D L, 2000, Bull Am Coll Surg, V85, P14; *NAT CTR HLTH STAT, 2002, PHYS ACC ACT PLAC ME; *NAT I DRUG AB, 2001, PUBL NAT I DRUG AB; *NAT PARTN WOM FAM, 1998, FAM MATT NAT SURV WO; Nonnemaker L, 2000, NEW ENGL J MED, V342, P399, DOI 10.1056/NEJM200002103420606; *PEW HLTH PROF COM, 1994, PHYS RETR STRAT ENH; Pfifferling J H, 1997, Fam Pract Manag, V4, P76; PFIFFERLING JH, 1990, RESID STAFF PHYS, V36, P85; Porta B A, 1997, J Contin Educ Nurs, V28, P252; QUADRIO C, 1991, AUST NZ J PSYCHIAT, V25, P95, DOI 10.3109/00048679109077723; REDFERN L, 1999, NT LEARN CURVE, V15, P134; TESCH BJ, 1992, ACAD MED, V67, P542, DOI 10.1097/00001888-199208000-00014; [U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Institute for Occupational Safety and Health (NIOSH)], 1999, PUBL US DEP HHS; *US DEP HHS, 2001, PHYS RETR COMP; *US DEP HHS, 1994, ORWH REENTR PROGR AS; VILLANUEVA AM, 1995, ACAD MED, V70, pS10; Warde C, 1996, J GEN INTERN MED, V11, P729, DOI 10.1007/BF02598986; WARDE C, 1996, J GEN INTEN MED, V11, P792; WHITE J, 1995, NURS CONNECT, V8, P15	41	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1091	1096		10.1001/jama.288.9.1091	http://dx.doi.org/10.1001/jama.288.9.1091			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NA	12204077				2022-12-28	WOS:000177764600011
J	Jetz, W; Rahbek, C				Jetz, W; Rahbek, C			Geographic range size and determinants of avian species richness	SCIENCE			English	Article							HABITAT HETEROGENEITY; GEOMETRIC CONSTRAINTS; LATITUDINAL GRADIENTS; PATTERNS; ENERGY; DIVERSITY; MODEL	Geographic patterns in species richness are mainly based on wide-ranging species because their larger number of distribution records has a disproportionate contribution to the species richness counts. Here we demonstrate how this effect strongly influences our understanding of what determines species richness. Using both conventional and spatial regression models, we show that for sub-Saharan African birds, the apparent role of productivity diminishes with decreasing range size, whereas the significance of topographic heterogeneity increases. The relative importance of geometric constraints from the continental edge is moderate. Our findings highlight the failure of traditional species richness models to account for narrow-ranging species that frequently are also threatened.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ Copenhagen, Zool Museum, DK-2100 Copenhagen O, Denmark	University of Oxford; University of New Mexico; University of Copenhagen	Jetz, W (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	walter.jetz@zoo.ox.ac.uk	Jetz, Walter/ABF-1517-2020; Rahbek, Carsten/L-1129-2013; Rahbek, Carsten/D-9372-2013	Rahbek, Carsten/0000-0003-4585-0300; Jetz, Walter/0000-0002-1971-7277				Ahn C-H, 1994, J JAPANESE SOC PHOTO, V33, P12, DOI DOI 10.4287/JSPRS.33.2_12; Anderson S., 1985, AM MUS NOVIT, V2833, P1; Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; Brown J.H., 1995, MACROECOLOGY; Burgess N. D., 1998, SPECIES, V30, P16; Cliff A. D., 1981, SPATIAL PROCESSES MO; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cressie N., 2011, STAT SPATIO TEMPORAL; CROWE TM, 1982, J ZOOL, V198, P417, DOI 10.1111/jzo.1982.198.4.417; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Elenga H, 2000, J BIOGEOGR, V27, P621, DOI 10.1046/j.1365-2699.2000.00430.x; Gaston K.J., 1994, RARITY, P1; GRAVES GR, 1985, AUK, V102, P556, DOI 10.1093/auk/102.3.556; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Hansson L., 1995, MOSAIC LANDSCAPES EC; Jetz W, 2001, P NATL ACAD SCI USA, V98, P5661, DOI 10.1073/pnas.091100998; JETZ W, GEOMETRIC EFFECTS SP; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Koleff P, 2001, ECOGRAPHY, V24, P341, DOI 10.1034/j.1600-0587.2001.240312.x; Lees DC, 1999, BIOL J LINN SOC, V67, P529, DOI 10.1111/j.1095-8312.1999.tb01945.x; Lennon JJ, 2000, ECOGRAPHY, V23, P101, DOI 10.1034/j.1600-0587.2000.230111.x; Lennon JJ, 2000, J ANIM ECOL, V69, P581, DOI 10.1046/j.1365-2656.2000.00418.x; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PAGEL MD, 1991, AM NAT, V137, P791, DOI 10.1086/285194; POMEROY D, 1993, CONSERV BIOL, V7, P901, DOI 10.1046/j.1523-1739.1993.740901.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Ricklefs Robert E., 1993, P350; Rosenzweig Michael L., 1993, P52; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Stattersfield A J, 2000, THREATENED BIRDS WOR, P205; TURNER JRG, 1988, NATURE, V335, P539, DOI 10.1038/335539a0; *USGS USAID AFR DA, AVHRR NDVI; Willig MR, 1998, OIKOS, V81, P93, DOI 10.2307/3546471; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432	38	503	547	9	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1548	1551		10.1126/science.1072779	http://dx.doi.org/10.1126/science.1072779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202829				2022-12-28	WOS:000177697300056
J	Wettey, FR; Hawkins, SFC; Stewart, A; Luzio, JP; Howard, JC; Jackson, AP				Wettey, FR; Hawkins, SFC; Stewart, A; Luzio, JP; Howard, JC; Jackson, AP			Controlled elimination of clathrin heavy-chain expression in DT40 lymphocytes	SCIENCE			English	Article							PROTEIN-KINASE-B; SIGNAL-TRANSDUCTION; LYSOSOMAL-ENZYMES; PLASMA-MEMBRANE; RECEPTOR; TRAFFICKING; CELLS; TRANSFECTION; TRANSFERRIN; ENDOCYTOSIS	We exploited the high rate of homologous recombination shown by the chicken B cell line DT40 to inactivate the endogenous alleles for clathrin heavy chain and replace them with human clathrin complementary DNA under the control of a tetracycline-regulatable promoter. Clathrin repression perturbed the activities of Akt-mediated and mitogen-activated protein kinase mediated signaling pathways and induced apoptosis; this finding suggests that in DT40 cells clathrin helps to maintain the integrity of antiapoptotic survival pathways. We also describe a variant cell line in which these signaling pathways were unaffected by clathrin down-regulation. This variant cell line did not undergo apoptosis in the absence of clathrin and was used to examine the effects of clathrin depletion on membrane-trafficking pathways. Receptor-mediated and fluid-phase endocytosis were both substantially inhibited, and transferrin-receptor recycling was modestly inhibited. Surprisingly, clathrin removal did not affect the morphology or biochemical composition of lysosomes.	Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2XY, England; Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England	University of Cambridge; University of Cologne; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Jackson, AP (corresponding author), Univ Cambridge, Dept Biochem, Bldg O,Downing Site,Tennis Court Rd, Cambridge CB2 1QW, England.	a.p.jackson@bioc.cam.ac.uk		Jackson, Antony Philip/0000-0002-2895-7387				ACTON SL, 1993, MOL BIOL CELL, V4, P647, DOI 10.1091/mbc.4.6.647; BAASS PC, 1995, TRENDS CELL BIOL, V5, P465, DOI 10.1016/S0962-8924(00)89116-3; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Balbis A, 2000, ENDOCRINOLOGY, V141, P4041, DOI 10.1210/en.141.11.4041; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Bennett EM, 2001, MOL BIOL CELL, V12, P2790, DOI 10.1091/mbc.12.9.2790; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bright NA, 1997, J CELL SCI, V110, P2027; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; CHANG MP, 1993, EMBO J, V12, P2169, DOI 10.1002/j.1460-2075.1993.tb05865.x; Copier J, 1998, IMMUNOLOGY, V93, P505; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dittmer F, 1999, J CELL SCI, V112, P1591; DOXSEY SJ, 1987, CELL, V50, P453, DOI 10.1016/0092-8674(87)90499-5; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; GABEL CA, 1984, J CELL BIOL, V99, P296, DOI 10.1083/jcb.99.1.296; Gold MR, 1999, J IMMUNOL, V163, P1894; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GRAHAM J, 1993, METHODS MOLEC BIOL, V19; Hueber AO, 1998, TRENDS GENET, V14, P364, DOI 10.1016/S0168-9525(98)01520-0; Jin J, 2001, DEV CELL, V1, P817, DOI 10.1016/S1534-5807(01)00090-9; KARIN M, 1981, J BIOL CHEM, V256, P3245; Lahti JM, 1999, METHODS, V17, P305, DOI 10.1006/meth.1999.0744; LEMMON SK, 1987, SCIENCE, V238, P504, DOI 10.1126/science.3116672; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; Luzio JP, 2000, J CELL SCI, V113, P1515; Moore DD, 1995, GLOB MOB SURV; PAYNE GS, 1987, MOL CELL BIOL, V7, P3888, DOI 10.1128/MCB.7.11.3888; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; RUSCETTI T, 1994, J CELL BIOL, V126, P343, DOI 10.1083/jcb.126.2.343; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; WETTEY FR, UNPUB; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780	43	57	58	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1521	1525		10.1126/science.1074222	http://dx.doi.org/10.1126/science.1074222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202821				2022-12-28	WOS:000177697300048
J	Brent, DA; Birmaher, B				Brent, DA; Birmaher, B			Adolescent depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAST 10 YEARS; MAJOR DEPRESSION; CONTROLLED TRIAL; BIPOLAR DISORDER; CLINICAL-TRIAL; DOUBLE-BLIND; EFFICACY; PSYCHOTHERAPY; CHILDREN; THERAPY		Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, Div Child & Adolescent Psychiat, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Brent, DA (corresponding author), Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, Div Child & Adolescent Psychiat, Pittsburgh, PA 15213 USA.				NIMH NIH HHS [MH 70008, MH 55123, MH 56612] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH070008, R01MH056612, R10MH056612, P30MH055123] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Angold A, 1995, INT J METHOD PSYCH, V5, P237; AXELSON D, IN PRESS J AM ACAD C; Beardslee WR, 1998, J AM ACAD CHILD PSY, V37, P1134, DOI 10.1097/00004583-199811000-00012; Birmaher B, 2000, ARCH GEN PSYCHIAT, V57, P29, DOI 10.1001/archpsyc.57.1.29; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011; BIRMAHER B, 2001, 48 ANN M AM AC CHILD; Brent DA, 1998, J AM ACAD CHILD PSY, V37, P906, DOI 10.1097/00004583-199809000-00010; Brent DA, 2000, J AM ACAD CHILD PSY, V39, P1220, DOI 10.1097/00004583-200010000-00007; Brent DA, 1997, ARCH GEN PSYCHIAT, V54, P877; BRENT DA, 1999, AMBULATORY PEDIAT, P447; Cornelius JR, 2001, ANN NY ACAD SCI, V932, P78; Daviss WB, 2001, J AM ACAD CHILD PSY, V40, P307, DOI 10.1097/00004583-200103000-00010; Dierker LC, 2001, J AM ACAD CHILD PSY, V40, P929, DOI 10.1097/00004583-200108000-00015; EMSLIE G, 2001, 48 ANN M AM AC CHILD; Emslie G J, 1998, Depress Anxiety, V7, P32, DOI 10.1002/(SICI)1520-6394(1998)7:1<32::AID-DA4>3.0.CO;2-7; Emslie GJ, 1997, ARCH GEN PSYCHIAT, V54, P1031; Geller B, 2000, J CHILD ADOL PSYCHOP, V10, P157, DOI 10.1089/10445460050167269; Geller B, 2001, AM J PSYCHIAT, V158, P125, DOI 10.1176/appi.ajp.158.1.125; HAZELL P, 1995, BRIT MED J, V310, P897, DOI 10.1136/bmj.310.6984.897; HOOG SL, 2001, 48 ANN M AM AC CHILD; Hughes CW, 1999, J AM ACAD CHILD PSY, V38, P1442, DOI 10.1097/00004583-199911000-00020; Joffe RT, 1996, J CLIN PSYCHIAT, V57, P114; KAPUR S, 1992, JAMA-J AM MED ASSOC, V268, P3441, DOI 10.1001/jama.268.24.3441; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Keller MB, 2001, NEW ENGL J MED, V345, P232; Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001; Kroll L, 1996, J AM ACAD CHILD PSY, V35, P1156, DOI 10.1097/00004583-199609000-00013; LEWINSOHN PM, 1990, BEHAV THER, V21, P385, DOI 10.1016/S0005-7894(05)80353-3; Mufson L, 1999, ARCH GEN PSYCHIAT, V56, P573, DOI 10.1001/archpsyc.56.6.573; Poirier MF, 1999, BRIT J PSYCHIAT, V175, P12, DOI 10.1192/bjp.175.1.12; POITIER MF, 1999, BRIT J PSYCHIAT, V175, P394; Rossello J, 1999, J CONSULT CLIN PSYCH, V67, P734, DOI 10.1037/0022-006X.67.5.734; ROTHERAM MJ, 1987, AM J ORTHOPSYCHIAT, V57, P102, DOI 10.1111/j.1939-0025.1987.tb03514.x; Sachs GS, 1996, J CLIN PSYCHOPHARM, V16, pS32, DOI 10.1097/00004714-199604001-00005; Stein MB, 2001, ARCH GEN PSYCHIAT, V58, P251, DOI 10.1001/archpsyc.58.3.251; Thase Michael E., 1995, P1081; Wood A, 1996, J CHILD PSYCHOL PSYC, V37, P737, DOI 10.1111/j.1469-7610.1996.tb01466.x; Wood A, 2001, J AM ACAD CHILD PSY, V40, P1246, DOI 10.1097/00004583-200111000-00003; 1998, J AM ACAD CHILD AD S, V37, pS63; 2001, J AM ACAD CHILD AD S, V40, pS24	41	82	86	2	16	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2002	347	9					667	671		10.1056/NEJMcp012249	http://dx.doi.org/10.1056/NEJMcp012249			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	587ZT	12200555				2022-12-28	WOS:000177675500007
J	Chow, A; Toomre, D; Garrett, W; Mellman, I				Chow, A; Toomre, D; Garrett, W; Mellman, I			Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane	NATURE			English	Article							EVANESCENT-WAVE MICROSCOPY; DEVELOPMENTAL REGULATION; ENDOCYTIC COMPARTMENTS; INFLAMMATORY STIMULI; DOWN-REGULATION; SURFACE; MACROPINOCYTOSIS; EXOCYTOSIS; COMPLEXES; IMMUNITY	Central to the initiation of immune responses is recognition of peptide antigen by T lymphocytes. The cell biology of dendritic cells makes them ideally suited for the essential process of antigen presentation(1). Their life cycle includes several stages characterized by distinct functions and mechanisms of regulation(2). Immature dendritic cells synthesize large amounts of major histocompatibility complex class II molecules (MHC II), but the alphabeta-dimers are targeted to late endosomes and lysosomes (often referred to as MHC class II compartments) where they reside unproductively with internalized antigens. After exposure to microbial products or inflammatory mediators, endocytosis is downregulated, the expression of co-stimulatory molecules is enhanced, and newly formed immunogenic MHC II-peptide complexes are transported to the cell surface(3-10). That these MHC II molecules reach the surface is surprising, as the lysosomes comprise the terminal degradative compartment of the endocytic pathway from which exogenous components generally cannot be recovered intact(11). Here we have visualized this pathway in live dendritic cells by video microscopy, using cells expressing MHC II tagged with green fluorescent protein (GFP). We show that on stimulation, dendritic cells generate tubules from lysosomal compartments that go on to fuse directly with the plasma membrane.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, Ludwig Inst Canc Res, New Haven, CT 06520 USA	Yale University; Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.		Mellman, Ira/ABG-5896-2020	Garrett, Wendy/0000-0002-5092-0150				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X; De Veerman M, 1999, J IMMUNOL, V162, P144; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Lankar D, 2002, J EXP MED, V195, P461, DOI 10.1084/jem.20011543; MATHIS DJ, 1983, P NATL ACAD SCI-BIOL, V80, P273, DOI 10.1073/pnas.80.1.273; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; OZATO K, 1980, J IMMUNOL, V124, P533; Pierre P, 1996, IMMUNITY, V4, P229, DOI 10.1016/S1074-7613(00)80431-8; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; Toomre D, 2000, J CELL BIOL, V149, P33, DOI 10.1083/jcb.149.1.33; Toomre D, 2001, TRENDS CELL BIOL, V11, P298, DOI 10.1016/S0962-8924(01)02027-X; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	30	334	347	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					988	994		10.1038/nature01006	http://dx.doi.org/10.1038/nature01006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198549				2022-12-28	WOS:000177677500047
J	Genoux, D; Haditsch, U; Knobloch, M; Michalon, A; Storm, D; Mansuy, IM				Genoux, D; Haditsch, U; Knobloch, M; Michalon, A; Storm, D; Mansuy, IM			Protein phosphatase 1 is a molecular constraint on learning and memory	NATURE			English	Article							GENE-EXPRESSION; CREB; TERM; PHOSPHORYLATION; CALCINEURIN; INDUCTION; CAMKII; RATS; LTP	Repetition in learning is a prerequisite for the formation of accurate and long-lasting memory. Practice is most effective when widely distributed over time, rather than when closely spaced or massed. But even after efficient learning, most memories dissipate with time unless frequently used(1,2). The molecular mechanisms of these time-dependent constraints on learning and memory are unknown. Here we show that protein phosphatase 1 (PP1) determines the efficacy of learning and memory by limiting acquisition and favouring memory decline. When PP1 is genetically inhibited during learning, short intervals between training episodes are sufficient for optimal performance. The enhanced learning correlates with increased phosphorylation of cyclic AMP-dependent response element binding (CREB) protein, of Ca2+/calmodulin-dependent protein kinase II (CaMKII) and of the GluR1 subunit of the AMPA receptor; it also correlates with CREB-dependent gene expression that, in control mice, occurs only with widely distributed training. Inhibition of PP1 prolongs memory when induced after learning, suggesting that PP1 also promotes forgetting. This property may account for ageing-related cognitive decay, as old mutant animals had preserved memory. Our findings emphasize the physiological importance of PP1 as a suppressor of learning and memory, and as a potential mediator of cognitive decline during ageing.	ETH Honggerberg, Dept Biol, Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Washington; University of Washington Seattle	Mansuy, IM (corresponding author), ETH Honggerberg, Dept Biol, Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland.	isabelle.mansuy@cell.biol.ethz.ch	Knobloch, Marlen/A-9565-2015; Mansuy, Isabelle M/N-3042-2015	Knobloch, Marlen/0000-0002-7490-0285; Mansuy, Isabelle M/0000-0001-7785-5371; Michalon, Aubin/0000-0002-5246-4881				Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Connor JH, 1998, METH MOL B, V93, P41; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Foster TC, 2001, J NEUROSCI, V21, P4066, DOI 10.1523/JNEUROSCI.21-11-04066.2001; Gallagher M, 1997, ANNU REV PSYCHOL, V48, P339, DOI 10.1146/annurev.psych.48.1.339; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Norris CM, 1998, J NEUROPHYSIOL, V80, P1567, DOI 10.1152/jn.1998.80.3.1567; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SAVE E, 1992, BEHAV NEUROSCI, V106, P447, DOI 10.1037/0735-7044.106.3.447; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Spear N.E., 1994, MEMORY PHENOMENA PRI; Spear NE, 1978, PROCESSING MEMORIES; Strack S, 1997, J NEUROCHEM, V68, P2119; Sweatt JD, 2001, CURR BIOL, V11, pR391, DOI 10.1016/S0960-9822(01)00216-0; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776	30	343	360	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2002	418	6901					970	975		10.1038/nature00928	http://dx.doi.org/10.1038/nature00928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	588AP	12198546				2022-12-28	WOS:000177677500043
J	Kruger, GM; Morrison, SJ				Kruger, GM; Morrison, SJ			Brain repair by endogenous progenitors	CELL			English	Review							MYELIN-ASSOCIATED GLYCOPROTEIN; NOGO RECEPTOR; ADULT; NEUROGENESIS; REGENERATION; HIPPOCAMPAL; INDUCTION; NEOCORTEX; NEURONS	Stem cells within the adult brain can be stimulated by injury and growth factor treatment to replace damaged neurons, even neurons that are not normally generated in adults. Coupled with recent insights into the mechanism by which Nogo inhibits axonal regeneration, this discovery may inspire new treatments for central nervous system injuries and neurodegenerative diseases.	Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Howard Hughes Med Inst, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Crane, Genevieve M/AAK-9224-2020; Morrison, Sean/ABD-5326-2021	Crane, Genevieve M/0000-0001-9274-0214; Morrison, Sean/0000-0003-1587-8329				Brittis PA, 2001, NEURON, V30, P11, DOI 10.1016/S0896-6273(01)00258-6; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Lim DA, 1997, P NATL ACAD SCI USA, V94, P14832, DOI 10.1073/pnas.94.26.14832; LIU BP, 2002, SCIENCE         0627; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998	20	60	69	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					399	402		10.1016/S0092-8674(02)00899-1	http://dx.doi.org/10.1016/S0092-8674(02)00899-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202029	Bronze			2022-12-28	WOS:000177653200001
J	Mehlmann, LM; Jones, TLZ; Jaffe, LA				Mehlmann, LM; Jones, TLZ; Jaffe, LA			Meiotic arrest in the mouse follicle maintained by a G(s) protein in the oocyte	SCIENCE			English	Article							BETA-GAMMA-SUBUNITS; PLATELET MEMBRANES; ADENYLYL-CYCLASE; MOLECULAR-BASIS; XENOPUS-LAEVIS; RELEASE; MATURATION; INHIBITION; INVITRO; FLUID	The mammalian ovarian follicle consists of a multilayered complex of somatic cells that surround the oocyte. A signal from the follicle cells keeps the oocyte cell cycle arrested at prophase of meiosis I until luteinizing hormone from the pituitary acts on the follicle cells to release the arrest, causing meiosis to continue. Here we show that meiotic arrest can be released in mice by microinjecting the oocyte within the follicle with an antibody that inhibits the stimulatory heterotrimeric GTP-binding protein G(s). This indicates that G(s) activity in the oocyte is required to maintain meiotic arrest within the ovarian follicle and suggests that the follicle may keep the cell cycle arrested by activating G(s).	Univ Connecticut, Ctr Hlth, Dept Physiol, Farmington, CT 06032 USA; NIDDKD, Metab Dis Branch, NIH, Bethesda, MD 20892 USA	University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Mehlmann, LM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Physiol, Farmington, CT 06032 USA.		Holt, Janet E/B-2415-2013		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK043013] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; ANDERSON E, 1976, J CELL BIOL, V71, P680, DOI 10.1083/jcb.71.2.680; ANTONELLI M, 1994, FEBS LETT, V340, P249, DOI 10.1016/0014-5793(94)80148-7; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; CHIDIAC P, 1994, MOL PHARMACOL, V45, P490; de Ligt RAF, 2000, BRIT J PHARMACOL, V130, P1, DOI 10.1038/sj.bjp.0703311; DOWNS SM, 1992, J EXP ZOOL, V262, P391, DOI 10.1002/jez.1402620405; Eppig J. J., 1993, OVARY, P185; EPPIG JJ, 1991, BIOL REPROD, V45, P824, DOI 10.1095/biolreprod45.6.824; EPPIG JJ, 1985, BIOL REPROD, V33, P1041, DOI 10.1095/biolreprod33.5.1041; GALLO CJ, 1995, J CELL BIOL, V130, P275, DOI 10.1083/jcb.130.2.275; GILULA NB, 1978, J CELL BIOL, V78, P58, DOI 10.1083/jcb.78.1.58; HAND AR, UNPUB; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; KIEHART DP, 1982, METHOD CELL BIOL, V25, P13, DOI 10.1016/S0091-679X(08)61418-1; Lutz LB, 2000, J BIOL CHEM, V275, P41512, DOI 10.1074/jbc.M006757200; MEHLMANN LM, 1994, BIOL REPROD, V51, P1088, DOI 10.1095/biolreprod51.6.1088; Mehlmann LM, 1998, DEV BIOL, V203, P221, DOI 10.1006/dbio.1998.9051; RACOWSKY C, 1989, DEV BIOL, V134, P297, DOI 10.1016/0012-1606(89)90102-4; ROBISHAW JD, 1986, J BIOL CHEM, V261, P9587; Sheng YL, 2001, CURR BIOL, V11, P405, DOI 10.1016/S0960-9822(01)00123-3; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; SIMONDS WF, 1989, FEBS LETT, V249, P189, DOI 10.1016/0014-5793(89)80622-2; TSAFRIRI A, 1975, ENDOCRINOLOGY, V96, P922, DOI 10.1210/endo-96-4-922; WILEY HS, 1981, J BIOL CHEM, V256, P8626; [No title captured]	28	171	178	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1343	1345		10.1126/science.1073978	http://dx.doi.org/10.1126/science.1073978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193786				2022-12-28	WOS:000177573900046
J	Schroder, ARW; Shinn, P; Chen, HM; Berry, C; Ecker, JR; Bushman, F				Schroder, ARW; Shinn, P; Chen, HM; Berry, C; Ecker, JR; Bushman, F			HIV-1 integration in the human genome favors active genes and local hotspots	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; I-HYPERSENSITIVE SITES; RETROVIRUS INTEGRATION; DNA INTEGRATION; DIRECTS INTEGRATION; PREFERRED TARGETS; SEQUENCE; VITRO; VIVO; INFECTION	A defining feature of HIV replication is integration of the proviral cDNA into human DNA. The selection of chromosomal targets for integration is crucial for efficient viral replication, but the mechanism is poorly understood. Here we describe mapping of 524 sites of HIV cDNA integration on the human genome sequence. Genes were found to be strongly favored as integration acceptor sites. Global analysis of cellular transcription indicated that active genes were preferential integration targets, particularly genes that were activated in cells after infection by HIV-1. Regional hotspots for integration were also found, including a 2.4 kb region containing I % of sites. These data document unexpectedly strong biases in integration site selection and suggest how selective targeting promotes aggressive HIV replication.	Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Sch Med, Dept Family Prevent Med, La Jolla, CA 92093 USA	Salk Institute; Salk Institute; University of California System; University of California San Diego	Bushman, F (corresponding author), Salk Inst Biol Studies, Infect Dis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bushman@salk.edu	Wilson, Matthew H/K-3193-2013; Ecker, Joseph R/B-9144-2008	Ecker, Joseph R/0000-0001-5799-5895; Chen, Huaming/0000-0001-5289-7882	NIAID NIH HHS [AI34786, AI52845, R01 AI052845] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052845, R01AI034786] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arendt CW, 2001, GENOME BIOL, V2; Boeke JD, 1998, CELL, V93, P1087, DOI 10.1016/S0092-8674(00)81450-6; BROWN PO, 1987, CELL, V49, P347, DOI 10.1016/0092-8674(87)90287-X; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; BURKE WD, 1993, MOL BIOL EVOL, V10, P163; BUSHMAN FD, 1994, P NATL ACAD SCI USA, V91, P9233, DOI 10.1073/pnas.91.20.9233; BUSHMAN FD, 1992, P NATL ACAD SCI USA, V89, P3458, DOI 10.1073/pnas.89.8.3458; Bushman FD, 2001, LATERAL DNA TRANSFER; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Carteau S, 1998, J VIROL, V72, P4005, DOI 10.1128/JVI.72.5.4005-4014.1998; Coffin J, 1997, RETROVIRUSES; Corbeil A, 2001, GENOME RES, V11, P1198, DOI 10.1101/gr.GR-1802R; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; ELLISON V, 1990, J VIROL, V64, P2711, DOI 10.1128/JVI.64.6.2711-2715.1990; Farnet C, 1997, CELL, V88, P1; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Gaiano N, 1996, NATURE, V383, P829, DOI 10.1038/383829a0; GALLAY P, 1995, CELL, V83, P569, DOI 10.1016/0092-8674(95)90097-7; Geiss GK, 2000, VIROLOGY, V266, P8, DOI 10.1006/viro.1999.0044; Hansen MST, 1999, NAT BIOTECHNOL, V17, P578, DOI 10.1038/9886; HARTUNG S, 1986, NATURE, V320, P365, DOI 10.1038/320365a0; JI H, 1993, CELL, V73, P1007, DOI 10.1016/0092-8674(93)90278-X; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kafri T, 1999, J VIROL, V73, P576, DOI 10.1128/JVI.73.1.576-584.1999; Katz RA, 1998, J BIOL CHEM, V273, P24190, DOI 10.1074/jbc.273.37.24190; Katz RA, 2001, J BIOL CHEM, V276, P34213, DOI 10.1074/jbc.M104632200; KIRCHNER J, 1995, SCIENCE, V267, P1488, DOI 10.1126/science.7878467; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leclercq I, 2000, J VIROL, V74, P2305, DOI 10.1128/JVI.74.5.2305-2312.2000; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; MOOSLEHNER K, 1990, J VIROL, V64, P3056, DOI 10.1128/JVI.64.6.3056-3058.1990; PANET A, 1977, CELL, V11, P933, DOI 10.1016/0092-8674(77)90304-X; Popik W, 2000, VIROLOGY, V276, P1, DOI 10.1006/viro.2000.0581; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, P NATL ACAD SCI USA, V89, P9237, DOI 10.1073/pnas.89.19.9237; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; ROHDEWOHLD H, 1987, J VIROL, V61, P336, DOI 10.1128/JVI.61.2.336-343.1987; SCHERDIN U, 1990, J VIROL, V64, P907, DOI 10.1128/JVI.64.2.907-912.1990; Scottoline BP, 1997, GENE DEV, V11, P371, DOI 10.1101/gad.11.3.371; SHIH CC, 1988, CELL, V53, P531, DOI 10.1016/0092-8674(88)90569-7; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Stevens SW, 1996, J VIROL, V70, P6459, DOI 10.1128/JVI.70.9.6459-6462.1996; STEVENS SW, 1994, P NATL ACAD SCI USA, V91, P5557, DOI 10.1073/pnas.91.12.5557; Swingler S, 1997, J VIROL, V71, P4372, DOI 10.1128/JVI.71.6.4372-4377.1997; TEMIN HM, 1980, COLD SPRING HARB SYM, V44, P773, DOI 10.1101/SQB.1980.044.01.083; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VIJAYA S, 1986, J VIROL, V60, P683, DOI 10.1128/JVI.60.2.683-692.1986; Weidhaas JB, 2000, J VIROL, V74, P8382, DOI 10.1128/JVI.74.18.8382-8389.2000; WITHERSWARD ES, 1994, GENE DEV, V8, P1473, DOI 10.1101/gad.8.12.1473; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	54	1305	1373	1	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					521	529		10.1016/S0092-8674(02)00864-4	http://dx.doi.org/10.1016/S0092-8674(02)00864-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202041	Bronze			2022-12-28	WOS:000177653200013
J	Zhang, CL; McKinsey, TA; Chang, SR; Antos, CL; Hill, JA; Olson, EN				Zhang, CL; McKinsey, TA; Chang, SR; Antos, CL; Hill, JA; Olson, EN			Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy	CELL			English	Article							MEF2 TRANSCRIPTION FACTOR; DEPENDENT PROTEIN-KINASE; IN-VIVO; CALCINEURIN; MITR; ASSOCIATION; MYOGENESIS; ACTIVATION; BINDING; P300	The heart responds to stress signals by growth, which is accompanied by activation of MEF2 transcription factor and reprogramming of diac gene expression. We show here that class 11 tone deacetylases (HDACs), which repress MEF2 activity, are substrates for a stress-responsive specific for conserved serines that regulate HDAC interactions. Signal-resistant HDAC lacking these phosphorylation sites are refractory hypertrophic signaling and inhibit cardiomyocyte pertrophy. Conversely, mutant mice lacking the class HDAC, HDAC9, are sensitized to hypertrophic and exhibit stress-dependent cardiomegaly. class 11 HDACs act as signal-responsive of the transcriptional program governing cardiac pertrophy and heart failure.	Univ Texas, SW Med Ctr, Dept Biol Mol, Dallas, TX 75390 USA; Vet Affairs Med Ctr, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Div Cardiovasc, Iowa City, IA 52242 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Biol Mol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.		Antos, Christopher L/E-8171-2010		NHLBI NIH HHS [R01 HL053351, R37 HL053351] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL053351, R01HL053351] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Frey N, 2000, NAT MED, V6, P1221, DOI 10.1038/81321; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson CA, 1999, SEMIN CELL DEV BIOL, V10, P179, DOI 10.1006/scdb.1999.0299; Kato T, 2000, CIRC RES, V87, P937, DOI 10.1161/01.RES.87.10.937; Kirchhefer U, 1999, CARDIOVASC RES, V42, P254, DOI 10.1016/S0008-6363(98)00296-X; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhang CL, 2001, P NATL ACAD SCI USA, V98, P7354, DOI 10.1073/pnas.131198498; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	29	767	802	1	45	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 23	2002	110	4					479	488		10.1016/S0092-8674(02)00861-9	http://dx.doi.org/10.1016/S0092-8674(02)00861-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202037	Green Accepted, Bronze			2022-12-28	WOS:000177653200009
J	Watson, A; Al Ozairi, O; Fraser, A; Loudon, M; O'Kelly, T				Watson, A; Al Ozairi, O; Fraser, A; Loudon, M; O'Kelly, T			Nicorandil associated anal ulceration	LANCET			English	Article							MAJOR APHTHOUS ULCERS	Nicorandil is a vasodilator used to control angina. It has been associated with oral ulceration and stomatitis that resolves upon withdrawal of the drug. We report a series of five patients with non-specific anal ulceration, all of whom received nicorandil for symptomatic control of ischaemic heart disease. Histological appearances were similar and the ulcers healed on withdrawal of the drug. Our results suggest that nicorandil might be a cause of anal ulceration.	Aberdeen Royal Infirm, Dept Gastroenterol, Aberdeen AB25 2ZD, Scotland; Aberdeen Royal Infirm, Dept Surg, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Watson, A (corresponding author), Aberdeen Royal Infirm, Dept Gastroenterol, Aberdeen AB25 2ZD, Scotland.							Agbo-Godeau S, 1998, LANCET, V352, P1598, DOI 10.1016/S0140-6736(05)61045-8; Gupta A, 2000, AGE AGEING, V29, P372, DOI 10.1093/ageing/29.4.372; Reichert S, 1997, EUR J DERMATOL, V7, P132	3	69	71	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					546	547		10.1016/S0140-6736(02)09710-6	http://dx.doi.org/10.1016/S0140-6736(02)09710-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241662				2022-12-28	WOS:000177512800016
J	Morahan, G; Huang, DX; Wu, M; Holt, BJ; White, GP; Kendall, GE; Sly, PD; Holt, PG				Morahan, G; Huang, DX; Wu, M; Holt, BJ; White, GP; Kendall, GE; Sly, PD; Holt, PG			Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children	LANCET			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INDUCED AIRWAY HYPERRESPONSIVENESS; BLOOD MONONUCLEAR-CELLS; INTERFERON-GAMMA; EARLY-LIFE; INTERLEUKIN-12; INFECTIONS; IL-12; RISK; GENE	Background Severe asthma is a frequent cause of hospital admission, especially among children. The main environmental triggers of airway inflammation in asthma are viruses and aeroallergens. These agents elicit reciprocal immune responses, characterised by production of T helper 1 and T helper 2 cytokines, respectively. There is no genetic explanation for how hyper-responsiveness to these disparate environmental stimuli develops among individuals with asthma. Our aim was to assess relation between an IL12B promoter polymorphism and asthma. Methods We did a cohort study in which we initially genotyped 411 6-year olds for the IL12B promoter polymorphism. We then assessed the relation between this polymorphism and asthma severity: A further 85 asthmatic children in an additional sample of 433 children from the same cohort were then assessed to confirm these findings. We also examined in-vitro interleukin-12 responses in a subgroup of individuals. Findings Heterozygosity for the IL12B promoter polymorphism was observed in 76% (16) of atopic and non-atopic individuals with severe asthma in the initial sample. By comparison, heterozygotes comprised only 31% (17) of the moderate asthma group, and 48% (20) of individuals with mild asthma were heterozygous, as were unaffected controls. These findings were confirmed in the second sample (overall p < 0.0001). Our data suggest that IL12B promoter heterozygosity contributes to asthma severity rather than susceptibility per se. The severity-predisposing genotype was associated with reduced interleukin 12 p40 gene transcription and decreased interleukin 12 p70 secretion. Interpretation Interleukin 12 plays a key part in antagonism of T helper 2 differentiation, and in induction of antiviral host defense. Genetically determined attenuation of interleukin-12 response capacity would, therefore, provide a plausible common immunological pathway to disease severity for the two major forms of asthma.	Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6872, Australia; Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6872, Australia; PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Holt, PG (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, POB 855, Perth, WA 6872, Australia.	patrick@ichr.uwa.edu.au	Holt, Patrick G/H-1548-2011; Sly, Peter D/F-1486-2010; Study, Raine/K-4517-2013; Morahan, Grant/T-7501-2019; White, Gregory P/C-8932-2012	Holt, Patrick G/0000-0003-1193-0935; Sly, Peter D/0000-0001-6305-2201; White, Gregory P/0000-0001-9532-0856				Aberle JH, 1999, AM J RESP CRIT CARE, V160, P1263, DOI 10.1164/ajrccm.160.4.9812025; Anderson GG, 1999, MOL MED TODAY, V5, P264, DOI 10.1016/S1357-4310(99)01479-3; BURKE CM, 1995, ALLERGY IMMUNOL LIFE, V14, P75; Busse William W., 2000, Journal of Allergy and Clinical Immunology, V106, P1033; Davoodi-Semiromi A, 2002, DIABETES, V51, P2334, DOI 10.2337/diabetes.51.7.2334; Ehlenfield DR, 2000, PEDIATRICS, V105, P79, DOI 10.1542/peds.105.1.79; Forastiere F, 1997, EPIDEMIOLOGY, V8, P566, DOI 10.1097/00001648-199709000-00015; Gaga M, 2000, CLIN EXP ALLERGY, V30, P663; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Gonzalez J, 1999, CHASQUI, V28, P175, DOI 10.2307/29741560; Haby MM, 2001, THORAX, V56, P589, DOI 10.1136/thorax.56.8.589; HENRY RL, 1993, J PAEDIATR CHILD H, V29, P101; Hofstra CL, 1998, J IMMUNOL, V161, P5054; Holgate ST, 1998, CLIN EXP ALLERGY, V28, P97; HOTL PG, 2002, EUROP RESP J, V19, P1; Huang D, 2000, GENES IMMUN, V1, P515, DOI 10.1038/sj.gene.6363720; Humbert M, 1999, IMMUNOL TODAY, V20, P528, DOI 10.1016/S0167-5699(99)01535-2; ISLES AF, 1993, MED J AUSTRALIA, V158, P761, DOI 10.5694/j.1326-5377.1993.tb121958.x; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Joyner JL, 2000, J INFECT DIS, V182, P974, DOI 10.1086/315796; Keane-Myers A, 1998, J IMMUNOL, V161, P919; Lee SM, 1996, BLOOD, V88, P945; Leech SC, 2000, ALLERGY, V55, P74, DOI 10.1034/j.1398-9995.2000.00222.x; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Noguchi E, 2001, GENES IMMUN, V2, P401, DOI 10.1038/sj.gene.6363790; Oddy WH, 1999, BMJ-BRIT MED J, V319, P815, DOI 10.1136/bmj.319.7213.815; Renzi PM, 1999, AM J RESP CRIT CARE, V159, P1417, DOI 10.1164/ajrccm.159.5.9805080; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Rowe J, 2001, J INFECT DIS, V184, P80, DOI 10.1086/320996; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; TRINCHIERI G, 1994, IMMUNOL TODAY, V15, P460, DOI 10.1016/0167-5699(94)90189-9; von Mutius E, 1999, EUR RESPIR J, V14, P4, DOI 10.1034/j.1399-3003.1999.14a03.x; von Mutius E, 2001, THORAX, V56, P153, DOI 10.1136/thorax.56.2.153; Weir TD, 1998, AM J RESP CRIT CARE, V158, P787, DOI 10.1164/ajrccm.158.3.9801035; WELLIVER RC, 1981, NEW ENGL J MED, V305, P841, DOI 10.1056/NEJM198110083051501; Wills-Karp M, 2001, J ALLERGY CLIN IMMUN, V107, P9, DOI 10.1067/mai.2001.112265; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628; Yokouchi Y, 2000, GENOMICS, V66, P152, DOI 10.1006/geno.2000.6201	39	162	164	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					455	459		10.1016/S0140-6736(02)09676-9	http://dx.doi.org/10.1016/S0140-6736(02)09676-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241719				2022-12-28	WOS:000177342900013
J	Montes, L; Pfister, R; Wilborn, W; Elizalde, F				Montes, L; Pfister, R; Wilborn, W; Elizalde, F			Clinical picture - Vitiligo	LANCET			English	Editorial Material									Vitiligo Unit, RA-1121 Buenos Aires, DF, Argentina		Montes, L (corresponding author), Vitiligo Unit, Paraguay 2302, RA-1121 Buenos Aires, DF, Argentina.								0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					405	405		10.1016/S0140-6736(02)09612-5	http://dx.doi.org/10.1016/S0140-6736(02)09612-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241795				2022-12-28	WOS:000177255600028
J	Gist, R; Devilly, GJ				Gist, R; Devilly, GJ			Post-trauma debriefing: the road too frequently travelled	LANCET			English	Editorial Material							POSTTRAUMATIC-STRESS; WORK		Missouri Fire Dept, Kansas City, MO 64106 USA; Univ Missouri, Kansas City, MO 64106 USA; Univ Melbourne, Dept Criminol, Melbourne, Vic, Australia; Univ Melbourne, Dept Psychol, Melbourne, Vic, Australia	University of Missouri System; University of Missouri Kansas City; University of Melbourne; University of Melbourne	Gist, R (corresponding author), Missouri Fire Dept, Kansas City, MO 64106 USA.			Devilly, Grant/0000-0001-6740-186X				BISSON JI, 1994, BRIT J PSYCHIAT, V165, P717, DOI 10.1192/bjp.165.6.717; Bisson JI, 2000, EFFECTIVE TREATMENTS FOR PTSD, P39; BISSON JI, IN PRESS PSYCHIAT B; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; Carlier IVE, 1998, STRESS MEDICINE, V14, P143, DOI 10.1002/(SICI)1099-1700(199807)14:3<143::AID-SMI770>3.0.CO;2-S; Deahl MP, 1995, J ACCID EMERG MED, V12, P255; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; GALEA S, 2001, IN PRESS MENTAL HLTH; Gist R, 1998, J PERS INTERPERS LOS, V3, P25, DOI 10.1080/10811449808414429; Gist R., 2001, AM PSYCHOL SOC OBSER, V14, P16; Gist R., 1997, J EMERGENCY MED SERV, V22, P27; Gist R., 1999, RESPONSE DISASTER PS; HERBERT JD, 2001, MONITOR PSYCHOL, V32, P4; Kadet A., 2002, SMART MONEY, V11, P108; Kenardy J, 2000, BRIT MED J, V321, P1032, DOI 10.1136/bmj.321.7268.1032; Litz BT, 2002, CLIN PSYCHOL-SCI PR, V9, P112, DOI 10.1093/clipsy/9.2.112; MACNAB AJ, 1998, PREHOSPITAL DISASTER, V14, P8; PARRY G, 2001, EVIDENCE BASED CLIN; RAPHAEL B, 1995, BRIT MED J, V310, P1479, DOI 10.1136/bmj.310.6993.1479; RAPHAEL B, 1999, MENTAL HLTH DISASTER; RITCHIE EC, 2001, MASS VIOL EARL INT W; ROSE S, 2001, COCHRANE LIB; Summerfield D, 2001, BRIT MED J, V322, P95, DOI 10.1136/bmj.322.7278.95; WESSELY S, NATO RUSS ADV WORKSH	24	42	43	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 7	2002	360	9335					741	742		10.1016/S0140-6736(02)09947-6	http://dx.doi.org/10.1016/S0140-6736(02)09947-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592HX	12241829				2022-12-28	WOS:000177933000012
J	Manheimer, E; Anderson, D				Manheimer, E; Anderson, D			Survey of public information about ongoing clinical trials funded by industry: evaluation of completeness and accessibility	BRITISH MEDICAL JOURNAL			English	Article							ACCESS	Objective To evaluate the completeness and accessibility of public information about US clinical trials of drugs in development. Design Review of online registers of clinical trials. Data sources Drugs in phase Ell trials were identified using three drug industry sources: PhRMA Survey, What's in the Pipeline, and the NDA Pipeline. Drug trials were then searched for on the following publicly accessible registers of clinical trials: CancerNet.gov, CenterWatch.com, ClinicalTrials.gov, and registers associated with the 37 "Comprehensive Cancer Centers" designated by the National Cancer Institute. Main outcome measure Extent of availability of public information on phase III trials of drugs in development for treating either prostate or colon cancer. Results Search of industry sources identified 12 drugs for prostate cancer and 20 for colon cancer undergoing phase III trials. The most comprehensive publicly available register, ClinicalTrials.gov, contained trial listings for only seven of the prostate cancer drugs and 10 of the colon cancer drugs. Trials of three prostate cancer and three colon cancer drugs were listed on only one register each. A substantial proportion of trials of prostate cancer drugs (3/12) and colon cancer drugs (8/20) were not associated with trial listings in any registers. Conclusions Existing trials registers are unlikely to be meeting user needs since many ongoing drug trials are not listed. There is a clear need for a comprehensive clinical trials register encompassing all ongoing trials, including industry sponsored trials.	Brown Univ, Ctr Clin Trials & Evidence Based Healthcare, Providence, RI 02912 USA	Brown University	Manheimer, E (corresponding author), Brown Univ, Ctr Clin Trials & Evidence Based Healthcare, 169 Angell St, Providence, RI 02912 USA.							*AM SOC CLIN ONC, ASCO SURV PHARM IND; Anderson D., 2001, CONTROL CLIN TRIALS, V22, p40S; Chalmers I., 2001, SYSTEMATIC REV HLTH, P429, DOI DOI 10.1002/9780470693926.CH24; *DEP HLTH RES DEV, RES GOV FRAM; Dickersin K, 1998, CLIN OBSTET GYNECOL, V41, P315, DOI 10.1097/00003081-199806000-00012; Dickersin K, 2002, EVAL HEALTH PROF, V25, P38, DOI 10.1177/0163278702025001004; Egger M., 2008, SYSTEMATIC REV HLTH; HETHERINGTON J, 1989, PEDIATRICS, V84, P374; Horton R, 1999, BRIT MED J, V319, P865, DOI 10.1136/bmj.319.7214.865; McCray AT, 2000, ANN INTERN MED, V133, P609, DOI 10.7326/0003-4819-133-8-200010170-00013; METZ JM, 2001, P AN M AM SOC CLIN, V20, pA395; *PHRMA, PHRMA 1999 SURV NEW; Rennie D, 1999, JAMA-J AM MED ASSOC, V282, P1766, DOI 10.1001/jama.282.18.1766; SCHERER RW, 1994, JAMA-J AM MED ASSOC, V272, P158, DOI 10.1001/jama.272.2.158; Shepperd S, 1999, BMJ-BRIT MED J, V319, P764, DOI 10.1136/bmj.319.7212.764; Sykes R, 1998, BRIT MED J, V317, P1172, DOI 10.1136/bmj.317.7167.1172; *US NAT LIB MED, UN MED LANG SYST UML; VALE CL, 2001, P 9 ANN COCHR C, P78; 2000, R DIRECTIONS, P6; 1999, R DIRECTIONS, P5	20	35	35	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2002	325	7363					528	531		10.1136/bmj.325.7363.528	http://dx.doi.org/10.1136/bmj.325.7363.528			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593NJ	12217994	Bronze, Green Published			2022-12-28	WOS:000177997800020
J	Masuda, S; Bauer, CE				Masuda, S; Bauer, CE			AppA is a blue light photoreceptor that antirepresses photosynthesis gene expression in Rhodobacter sphaeroides	CELL			English	Article							DISULFIDE BOND FORMATION; PHOTOSYSTEM FORMATION; REDOX; BACTERIOCHLOROPHYLL; FLAVOPROTEIN; REPRESSOR; PPSR; CRTJ; CRYPTOCHROME; THIOREDOXIN	Photosynthetic bacteria regulate photosystem synthesis in response to alterations in oxygen tension and light intensity. In this study we show that the PpsR repressor from Rhodobacter sphaeroides binds to DNA in a redox-dependent manner through the formation/breakage of an intramolecular disulfide bond. We also demonstrate that PpsR is antagonized by the flavin-containing antirepressor, AppA, that is capable of breaking the disulfide bond in oxidized PpsR as well as forming a stable AppA-PpsR(2) antirepressor-repressor complex. Blue light excitation of AppA induces a photocycle that is characterized by a long-lived red-shifted absorbance of the flavin. Light-excited AppA was found to be incapable of forming the AppA-PpsR(2) antirepressor complex. These results establish AppA as a transcription factor that controls both redox and blue light repression of photosystem gene expression by mediating DNA binding activity of PpsR.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Bauer, CE (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	cbauer@bio.indiana.edu	Masuda, Shinji/A-2703-2014	Masuda, Shinji/0000-0002-5349-4927	NIGMS NIH HHS [R01 GM040941, R37 GM040941, GM53940] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040941, R37GM040941, R01GM053940] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Aslund F, 1999, J BACTERIOL, V181, P1375; BARDWELL JCA, 1994, MOL MICROBIOL, V14, P199, DOI 10.1111/j.1365-2958.1994.tb01281.x; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Bauer CE, 2001, ADV PHOTOSYNTH, V11, P67; Braatsch S, 2002, MOL MICROBIOL, V45, P827, DOI 10.1046/j.1365-2958.2002.03058.x; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Debarbieux L, 1999, CELL, V99, P117, DOI 10.1016/S0092-8674(00)81642-6; Elsen S, 1998, J BIOL CHEM, V273, P30762, DOI 10.1074/jbc.273.46.30762; GOMELSKY M, 1995, J BACTERIOL, V177, P4609, DOI 10.1128/jb.177.16.4609-4618.1995; Gomelsky M, 1998, J BIOL CHEM, V273, P35319, DOI 10.1074/jbc.273.52.35319; GOMELSKY M, 1995, J BACTERIOL, V177, P1634, DOI 10.1128/jb.177.6.1634-1637.1995; Gomelsky M, 1997, J BACTERIOL, V179, P128, DOI 10.1128/jb.179.1.128-134.1997; Gregor J, 1999, FEMS MICROBIOL LETT, V179, P1; Hitomi K, 2000, NUCLEIC ACIDS RES, V28, P2353, DOI 10.1093/nar/28.12.2353; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Jiang ZY, 1997, J BACTERIOL, V179, P5720, DOI 10.1128/jb.179.18.5720-5727.1997; KOZIOL J., 1971, Methods in Enzymology, V18B, P253, DOI 10.1016/S0076-6879(71)18089-5; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Link G, 2001, ADV PHOTOSYNTH, V11, P85; Malakhov M, 2001, ADV PHOTOSYNTH, V11, P51; Masuda S, 2002, P NATL ACAD SCI USA, V99, P7078, DOI 10.1073/pnas.102013099; Pellett JD, 2001, BIOCHEMISTRY-US, V40, P7720, DOI 10.1021/bi010206s; PENFOLD RJ, 1994, J BACTERIOL, V176, P2869, DOI 10.1128/JB.176.10.2869-2876.1994; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; PONNAMPALAM SN, 1995, J BACTERIOL, V177, P2990, DOI 10.1128/jb.177.11.2990-2997.1995; Ponnampalam SN, 1997, J BIOL CHEM, V272, P18391, DOI 10.1074/jbc.272.29.18391; Ponnampalam SN, 1998, J BIOL CHEM, V273, P30757, DOI 10.1074/jbc.273.46.30757; SHIMADA H, 1992, PLANT CELL PHYSIOL, V33, P471; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Swem DL, 2002, J BACTERIOL, V184, P2815, DOI 10.1128/JB.184.10.2815-2820.2002; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WEAVER KE, 1983, J BACTERIOL, V156, P507, DOI 10.1128/JB.156.2.507-515.1983; Zeilstra-Ryalls J, 1998, J BACTERIOL, V180, P2801, DOI 10.1128/JB.180.11.2801-2809.1998	37	334	345	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2002	110	5					613	623		10.1016/S0092-8674(02)00876-0	http://dx.doi.org/10.1016/S0092-8674(02)00876-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230978	Bronze			2022-12-28	WOS:000177943700008
J	Yellen, G				Yellen, G			The voltage-gated potassium channels and their relatives	NATURE			English	Review							SHAKER K+ CHANNEL; 2 INACTIVATION MECHANISMS; BETA-SUBUNIT; MOLECULAR-BASIS; SODIUM-CHANNEL; TRANSMEMBRANE REGION; SELECTIVITY FILTER; ACTIVATION GATE; ION CHANNELS; DOMAIN	The voltage-gated potassium channels are the prototypical members of a family of membrane signalling proteins. These protein-based machines have pores that pass millions of ions per second across the membrane with astonishing selectivity, and their gates snap open and shut in milliseconds as they sense changes in voltage or ligand concentration. The architectural modules and functional components of these sophisticated signalling molecules are becoming clear, but some important links remain to be elucidated.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yellen, G (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	gary_yellen@hms.harvard.edu		Yellen, Gary/0000-0003-4228-7866	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS029693] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1974, Q REV BIOPHYS, V7, P179, DOI 10.1017/S0033583500001402; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chapman ML, 1997, BIOPHYS J, V72, P708, DOI 10.1016/S0006-3495(97)78707-1; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Durell SR, 1998, J STRUCT BIOL, V121, P263, DOI 10.1006/jsbi.1998.3962; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Elinder F, 2001, J GEN PHYSIOL, V118, P1, DOI 10.1085/jgp.118.1.1; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; KNAUS HG, 1994, J BIOL CHEM, V269, P23336; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Roeper J, 1998, NATURE, V391, P390, DOI 10.1038/34916; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tapper AR, 2001, J BIOL CHEM, V276, P38249; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	81	492	506	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					35	42		10.1038/nature00978	http://dx.doi.org/10.1038/nature00978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214225				2022-12-28	WOS:000177788600030
J	Brotherton, SE; Simon, FA; Etzel, SI				Brotherton, SE; Simon, FA; Etzel, SI			US graduate medical education, 2001-2002 changing dynamics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								The National Graduate Medical Education (GME) Census, jointly administered by the American Medical Association and the Association of American Medical Colleges, completed its second year as an online survey of all GME programs accredited by the Accreditation Council for Graduate Medical Education as well as combined specialty programs approved by their corresponding medical specialty boards. Continuing trends include the growing number of subspecialty programs, which increased by 65 since last year to 3822, and a smaller number of specialty programs, which decreased by 25 to 4203. There were corresponding shifts in the number of residents training in them. The number of graduates from osteopathic medical schools in allopathic GME has increased from 3288 in 1996-1997 to 4658 in 2001-2002, an increase of 42%. Overall, the total number of residents in GME has declined slightly, to an estimated 96410 this year. The number of residents in graduate year 1 (GY1) positions (entry positions in GME, for which prior training is not required) has also decreased, although the proportion of residents in GY1 positions who have not had prior GME has increased. The number of international medical graduates (IMGs) in GY1 positions has decreased from a high of 6727 in 1999-2000 to 5898 in 2001-2002, a decrease of 12.3%. However, the number who have entered GME immediately on graduation has grown from 310 in 1996-1997 to 936 in 2001-2002. Most of these IMGs were citizens or permanent residents of the United States and attended medical schools in the Caribbean. New race and ethnicity questions, which parallel those of the US Census, continue to reveal disparities in the racial/ethnic distribution of the training physician population relative to the US population. Despite continued interest in resident work hours, there was no decrease in reported hours worked between 2000-2001 and 2001-2002. Physicians training in surgical specialties are reported to work the most hours per week, while internal medicine and pediatrics allow for the most consecutive time on duty, at 30 hours or more. Specialties and subspecialties with limited on-call schedules, such as forensic psychiatry and pediatric pathology, have, on average, the lowest number of duty hours.	Amer Med Assoc, Div Undergrad & Grad Med Educ Policy & Stand, Chicago, IL 60610 USA	American Medical Association	Brotherton, SE (corresponding author), Amer Med Assoc, Div Undergrad & Grad Med Educ Policy & Stand, 515 N State St, Chicago, IL 60610 USA.							*AAMC, 2002, AAMC DAT BOOK STAT I; Accreditation Council for Graduate Medical Education, 2002, ACGME COMM PROGR REQ; *AM MED ASS, 2002, 9 AM MED ASS; *ASS AM MED COLL, 2002, AAMC POL GUID GRAD M; BAER LD, 2001, 71 N CAR RUR HLTH RE; BOODMAN SG, 2001, LA TIMES        0416, pS1; BOOTH W, 2002, WASHINGTON POST 0704, pA2; Brotherton SE, 2001, JAMA-J AM MED ASSOC, V286, P1056, DOI 10.1001/jama.286.9.1056; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; Donini-Lenhoff FG, 2000, JAMA-J AM MED ASSOC, V284, P1284, DOI 10.1001/jama.284.10.1284; Greico EM, 2001, OVERVIEW RACE HISPAN; Mullan F, 2000, NEW ENGL J MED, V343, P213, DOI 10.1056/NEJM200007203430312; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; ROMNEY L, 2002, LOS ANGELES TIM 0707; Snyderman R, 2002, HEALTH AFFAIR, V21, P167, DOI 10.1377/hlthaff.21.1.167; *US DEP HHS, 1999, COGME PHYS WORKF POL; Weiner JP, 2002, HEALTH AFFAIR, V21, P160, DOI 10.1377/hlthaff.21.1.160	17	37	39	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1073	1078		10.1001/jama.288.9.1073	http://dx.doi.org/10.1001/jama.288.9.1073			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NA	12204074				2022-12-28	WOS:000177764600008
J	Gutfreund, Y; Zheng, WM; Knudsen, EI				Gutfreund, Y; Zheng, WM; Knudsen, EI			Gated visual input to the central auditory system	SCIENCE			English	Article							OPTIC TECTUM; SPACE MAP; BARN OWL; INFERIOR COLLICULUS; REPRESENTATION; CALIBRATION; EXPERIENCE; PLASTICITY; ADJUSTMENT; MIDBRAIN	The central auditory system translates sound localization cues into a map of space guided, in part, by visual experience. In barn owls, this process takes place in the external nucleus of the inferior colliculus (ICX). However, to date, no trace of visual activity has been observed in this auditory nucleus. Here we show that strong visual responses, which are appropriate to guide auditory plasticity, appear in the ICX when inhibition is blocked in the optic tectum. Thus, visual spatial information is gated into the auditory system by an inhibitory mechanism that operates at a higher level in the brain.	Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA	Stanford University	Gutfreund, Y (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.				NIDCD NIH HHS [DC 00155-2] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRAINARD MS, 1993, J NEUROSCI, V13, P4589; Feldman DE, 1997, J NEUROSCI, V17, P6820; FELIX D, 1994, NEUROSCI LETT, V169, P212, DOI 10.1016/0304-3940(94)90394-8; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hyde PS, 2000, J COMP NEUROL, V421, P146, DOI 10.1002/(SICI)1096-9861(20000529)421:2<146::AID-CNE2>3.0.CO;2-5; Hyde PS, 2002, NATURE, V415, P73, DOI 10.1038/415073a; Hyde PS, 2001, J NEUROSCI, V21, P8586, DOI 10.1523/JNEUROSCI.21-21-08586.2001; Kim JJ, 1998, SCIENCE, V279, P570, DOI 10.1126/science.279.5350.570; KING AJ, 1993, EXP BRAIN RES, V94, P444; King AJ, 1999, BIOESSAYS, V21, P900, DOI 10.1002/(SICI)1521-1878(199911)21:11<900::AID-BIES2>3.0.CO;2-6; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1991, SCIENCE, V253, P85, DOI 10.1126/science.2063209; Luksch H, 2000, J NEUROSCI, V20; OLSEN JF, 1989, J NEUROSCI, V9, P2591; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; VEENMAN CL, 1994, J COMP NEUROL, V344, P161, DOI 10.1002/cne.903440202; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Zheng WM, 2001, J NEUROSCI, V21, P4356, DOI 10.1523/JNEUROSCI.21-12-04356.2001	19	73	75	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1556	1559		10.1126/science.1073712	http://dx.doi.org/10.1126/science.1073712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202831				2022-12-28	WOS:000177697300058
J	Kodama, R; Shiraga, H; Shigemori, K; Toyama, Y; Fujioka, S; Azechi, H; Fujita, H; Habara, H; Hall, T; Izawa, Y; Jitsuno, T; Kitagawa, Y; Krushelnick, KM; Lancaster, KL; Mima, K; Nagai, K; Nakai, M; Nishimura, H; Norimatsu, T; Norreys, PA; Sakabe, S; Tanaka, KA; Youssef, A; Zepf, M				Kodama, R; Shiraga, H; Shigemori, K; Toyama, Y; Fujioka, S; Azechi, H; Fujita, H; Habara, H; Hall, T; Izawa, Y; Jitsuno, T; Kitagawa, Y; Krushelnick, KM; Lancaster, KL; Mima, K; Nagai, K; Nakai, M; Nishimura, H; Norimatsu, T; Norreys, PA; Sakabe, S; Tanaka, KA; Youssef, A; Zepf, M		Fast Ignitor Consortium	Nuclear fusion - Fast heating scalable to laser fusion ignition	NATURE			English	Article									Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan	Osaka University	Kodama, R (corresponding author), Osaka Univ, Inst Laser Engn, 2-6 Yamada Oka, Suita, Osaka 5650871, Japan.	ryo@ile.osaka-u.ac.jp	Zepf, Matt/M-1232-2014; Norimatsu, Takayoshi/I-5710-2015; Nishimura, Hiroaki/I-4908-2015; Toyama, Yusuke/H-8023-2012; Nakai, Mitsuo/I-6758-2015; Nagai, Keiji/E-5155-2014; Krushelnick, Karl/AAZ-3028-2020; Kodama, Ryosuke/G-2627-2016; Jitsuno, Takahisa/M-6056-2015; Shigemori, Keisuke/B-3262-2013; Mima, Kunioki/H-9014-2016; Shiraga, Hiroyuki/I-9565-2015; Habara, Hideaki/AAC-8553-2019; Tanaka, Kazuo A/AAL-2115-2020; Azechi, Hiroshi/H-5876-2015; Fujioka, Shinsuke/J-5530-2015; Shigemori, Keisuke/GPK-4304-2022	Toyama, Yusuke/0000-0003-3230-1062; Nakai, Mitsuo/0000-0001-6076-756X; Nagai, Keiji/0000-0002-7641-562X; Shigemori, Keisuke/0000-0002-3978-8427; Fujioka, Shinsuke/0000-0001-8406-1772; Habara, Hideaki/0000-0002-7697-6830				Key MH, 2001, NATURE, V412, P775, DOI 10.1038/35090666; Kitagawa Y, 2002, PHYS PLASMAS, V9, P2202, DOI 10.1063/1.1458588; Kodama R, 2001, PHYS PLASMAS, V8, P2268, DOI 10.1063/1.1352598; Kodama R, 2001, NATURE, V412, P798, DOI 10.1038/35090525; Norreys PA, 2000, PHYS PLASMAS, V7, P3721, DOI 10.1063/1.1287419; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; YOSHIDA H, 2002, C LAS EL OPT 2002, V4, P402	7	437	454	6	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2002	418	6901					933	934		10.1038/418933a	http://dx.doi.org/10.1038/418933a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198536				2022-12-28	WOS:000177677500033
J	Huey, RB; Moody, WJ				Huey, RB; Moody, WJ			Snake sodium channels resist TTX arrest	SCIENCE			English	Editorial Material							TETRODOTOXIN; PERFORMANCE; PREY				Huey, RB (corresponding author), Univ Washington, Dept Zool, Seattle, WA 98195 USA.	hueyrb@u.washington.edu	Huey, Raymond/F-1597-2010	Huey, Raymond/0000-0002-4962-8670				ARNOLD SJ, 1982, COPEIA, P247, DOI 10.2307/1444602; BENEDEK C, 1989, TOXICON, V27, P473, DOI 10.1016/0041-0101(89)90210-9; Brodie ED, 1999, EVOLUTION, V53, P626, DOI 10.1111/j.1558-5646.1999.tb03798.x; BRODIE ED, IN PRESS EVOLUTION; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; JAYNE BC, 1990, EVOLUTION, V44, P1204, DOI 10.1111/j.1558-5646.1990.tb05226.x; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; MOSHER HS, 1964, SCIENCE, V144, P1100, DOI 10.1126/science.144.3622.1100; ROMANES GJ, 1884, MENTAL EVOLUTION ANI, P380; Thompson JD., 1994, COEVOLUTIONARY PROCE	12	9	10	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1289	+		10.1126/science.1075987	http://dx.doi.org/10.1126/science.1075987			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193775				2022-12-28	WOS:000177573900030
J	Kim, WJ				Kim, WJ			Benefits and risks of intercountry adoption	LANCET			English	Editorial Material							INTERNATIONAL ADOPTEES; PROBLEM BEHAVIOR; MENTAL-HEALTH; CHILDREN; ADJUSTMENT; PLACEMENT		Med Coll Ohio, Kobacker Ctr, Dept Psychiat, Div Child & Adolescent Psychiat, Toledo, OH 43614 USA		Kim, WJ (corresponding author), Med Coll Ohio, Kobacker Ctr, Dept Psychiat, Div Child & Adolescent Psychiat, Toledo, OH 43614 USA.							Brooks D, 1999, AM J ORTHOPSYCHIAT, V69, P87, DOI 10.1037/h0080384; Cederblad M, 1999, J CHILD PSYCHOL PSYC, V40, P1239, DOI 10.1017/S0021963099004746; Groza V, 2002, PSYCHONEUROENDOCRINO, V27, P181, DOI 10.1016/S0306-4530(01)00044-0; KIM WJ, 1995, CHILD PSYCHIAT HUM D, V25, P141, DOI 10.1007/BF02251299; KIM WJ, 1988, J AM ACAD CHILD PSY, V27, P111, DOI 10.1097/00004583-198801000-00017; Kim WJ, 1999, CHILD PSYCHIAT HUM D, V29, P221, DOI 10.1023/A:1022665024514; KIM WJ, 1997, BASIC HDB CHILD PSYC, V4, P600; Rushton A, 1997, J CHILD PSYCHOL PSYC, V38, P147, DOI 10.1111/j.1469-7610.1997.tb01850.x; Stams GJJM, 2000, J CHILD PSYCHOL PSYC, V41, P1025, DOI 10.1017/S0021963099006344; TIZARD B, 1991, J CHILD PSYCHOL PSYC, V32, P743, DOI 10.1111/j.1469-7610.1991.tb01899.x; VERHULST FC, 1990, J AM ACAD CHILD PSY, V29, P104, DOI 10.1097/00004583-199001000-00016; VERHULST FC, 1995, J AM ACAD CHILD PSY, V34, P151, DOI 10.1097/00004583-199502000-00010; VERHULST FC, 1990, J AM ACAD CHILD PSY, V29, P94, DOI 10.1097/00004583-199001000-00015; WEGAR K, 1995, AM J ORTHOPSYCHIAT, V65, P540, DOI 10.1037/h0079676	14	4	4	2	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					423	424		10.1016/S0140-6736(02)09681-2	http://dx.doi.org/10.1016/S0140-6736(02)09681-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582GZ	12241709				2022-12-28	WOS:000177342900003
J	Raff, JP; Dobson, CE; Tsai, HM				Raff, JP; Dobson, CE; Tsai, HM			Transfusion of polymerised human haemoglobin in a patient with severe sickle-cell anaemia	LANCET			English	Article							BLOOD SUBSTITUTE; ACUTE TRAUMA; HEMOGLOBIN; SURGERY; ANEMIA	Many patients with sickle-cell anaemia have red-cell alloantibodies. We could not obtain compatible blood for a 40-year-old woman with a sickle-cell crisis after a hip operation. We transfused a polymerised human haemoglobin solution, after which the patient's pain was alleviated. This treatment, in combination with erythropoietin, resulted in a rise in our patient's haemoglobin concentration, and her eventual recovery. Increased oxygen delivery to the microcirculation might have contributed to the rapid resolution of pain after the transfusion.	Montefiore Med Ctr, Div Haematol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Tsai, HM (corresponding author), Montefiore Med Ctr, Div Haematol, 111 E 210th St, Bronx, NY 10467 USA.							Gould SA, 1997, J TRAUMA, V43, P325, DOI 10.1097/00005373-199708000-00019; Gould SA, 1998, J AM COLL SURGEONS, V187, P113, DOI 10.1016/S1072-7515(98)00095-7; Mullon J, 2000, NEW ENGL J MED, V342, P1638, DOI 10.1056/NEJM200006013422204; STEINBERG MH, 2001, DISORDERS HEMOGLOBIN, V4; VICHINSKY EP, 1990, NEW ENGL J MED, V322, P1617, DOI 10.1056/NEJM199006073222301	5	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					464	465		10.1016/S0140-6736(02)09640-X	http://dx.doi.org/10.1016/S0140-6736(02)09640-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241723				2022-12-28	WOS:000177342900017
J	Blanke, O; Ortigue, S; Landis, T; Seeck, M				Blanke, O; Ortigue, S; Landis, T; Seeck, M			Neuropsychology: Stimulating illusory own-body perceptions - The part of the brain that can induce out-of-body experiences has been located.	NATURE			English	Article							CORTEX; STROKE		Univ Hosp Geneva, Program Funct Neurol & Neurosurg, Lab Presurg Epilepsy Evaluat, CH-1211 Geneva, Switzerland; Univ Lausanne Hosp, CH-1011 Lausanne, Switzerland; Univ Hosp Geneva, Dept Neurol, Funct Brain Mapping Lab, CH-1211 Geneva, Switzerland	University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva	Blanke, O (corresponding author), Univ Hosp Geneva, Program Funct Neurol & Neurosurg, Lab Presurg Epilepsy Evaluat, CH-1211 Geneva, Switzerland.							Blanke O, 2000, J NEUROL NEUROSUR PS, V69, P553, DOI 10.1136/jnnp.69.4.553; Brugger P, 1997, Cogn Neuropsychiatry, V2, P19, DOI 10.1080/135468097396397; Damasio A., 2000, FEELING WHAT HAPPENS, P213; GRUSSER OJ, 1991, VISUAL AGNOSIAS OTHE, P297; HALLIGAN PW, 1995, CORTEX, V31, P173, DOI 10.1016/S0010-9452(13)80115-3; Hecaen H., 1952, MECONNAISSANCES HALL, P310; Lobel E, 1998, J NEUROPHYSIOL, V80, P2699, DOI 10.1152/jn.1998.80.5.2699; NATHAN SS, 1993, ELECTROEN CLIN NEURO, V86, P183, DOI 10.1016/0013-4694(93)90006-H; PENFIELD W, 1963, BRAIN, V86, P595, DOI 10.1093/brain/86.4.595; Worthington A, 1996, NEUROCASE, V2, P135	10	512	524	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2002	419	6904					269	270		10.1038/419269a	http://dx.doi.org/10.1038/419269a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239558	Green Submitted, Green Published			2022-12-28	WOS:000178056300036
J	Kops, GJPL; Dansen, TB; Polderman, PE; Saarloos, I; Wirtz, KWA; Coffer, PJ; Huang, TT; Bos, JL; Medema, RH; Burgering, BMT				Kops, GJPL; Dansen, TB; Polderman, PE; Saarloos, I; Wirtz, KWA; Coffer, PJ; Huang, TT; Bos, JL; Medema, RH; Burgering, BMT			Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GLUCOSE DEPRIVATION; GENE-EXPRESSION; KINASE; CYTOTOXICITY; ACTIVATION; AKT/PKB; SIGNALS	Reactive oxygen species are required for cell proliferation but can also induce apoptosis(1). In proliferating cells this paradox is solved by the activation of protein kinase B (PKB; also known as c-Akt), which protects cells from apoptosis(2). By contrast, it is unknown how quiescent cells that lack PKB activity are protected against cell death induced by reactive oxygen species. Here we show that the PKB-regulated Forkhead transcription factor FOXO3a (also known as FKHR-L1) protects quiescent cells from oxidative stress by directly increasing their quantities of manganese superoxide dismutase (MnSOD) messenger RNA and protein. This increase in protection from reactive oxygen species antagonizes apoptosis caused by glucose deprivation. In quiescent cells that lack the protective mechanism of PKB-mediated signalling, an alternative mechanism is induced as a consequence of PKB inactivity. This mechanism entails the activation of Forkhead transcription factors, the transcriptional activation of MnSOD and the subsequent reduction of reactive oxygen species. Increased resistance to oxidative stress is associated with longevity. The model of Forkhead involvement in regulating longevity stems from genetic analysis in Caenorhabditis elegans(3-6), and we conclude that this model also extends to mammalian systems.	Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, Dept Biochem Lipids, NL-3584 CH Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Pulm Dis, NL-3584 CX Utrecht, Netherlands; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; Netherlands Cancer Institute	Burgering, BMT (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands.		Coffer, Paul J/A-5769-2009; Medema, Rene H/E-2981-2013; Coffer, Paul/AAF-7970-2020; Medema, Rene H/G-5415-2011	Medema, Rene/0000-0002-6754-0381; Kops, Geert/0000-0003-3555-5295				Aulwurm UR, 2000, EUR J BIOCHEM, V267, P5693, DOI 10.1046/j.1432-1327.2000.01576.x; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Blackburn RV, 1999, FREE RADICAL BIO MED, V26, P419, DOI 10.1016/S0891-5849(98)00217-2; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Huang TT, 1997, ARCH BIOCHEM BIOPHYS, V344, P424, DOI 10.1006/abbi.1997.0237; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pap EHW, 1999, FEBS LETT, V453, P278, DOI 10.1016/S0014-5793(99)00696-1; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712	27	1222	1259	5	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2002	419	6904					316	321		10.1038/nature01036	http://dx.doi.org/10.1038/nature01036			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239572	Green Published			2022-12-28	WOS:000178056300050
J	Liberman, MC; Gao, JG; He, DZZ; Wu, XD; Jia, SP; Zuo, J				Liberman, MC; Gao, JG; He, DZZ; Wu, XD; Jia, SP; Zuo, J			Prestin is required for electromotility of the outer hair cell and for the cochlear amplifier	NATURE			English	Article							BASILAR-MEMBRANE; MOTOR PROTEIN; RESPONSES; ADAPTATION	Hearing sensitivity in mammals is enhanced by more than 40 dB (that is, 100-fold) by mechanical amplification thought to be generated by one class of cochlear sensory cells, the outer hair cells(1-4). In addition to the mechano-electrical transduction required for auditory sensation, mammalian outer hair cells also perform electromechanical transduction, whereby transmembrane voltage drives cellular length changes at audio frequencies in vitro(5-7). This electromotility is thought to arise through voltage-gated conformational changes in a membrane protein 8,9, and prestin has been proposed as this molecular motor(10-12). Here we show that targeted deletion of prestin in mice results in loss of outer hair cell electromotility in vitro and a 40-60 dB loss of cochlear sensitivity in vivo, without disruption of mechano-electrical transduction in outer hair cells. In heterozygotes, electromotility is halved and there is a twofold (about 6 dB) increase in cochlear thresholds. These results suggest that prestin is indeed the motor protein, that there is a simple and direct coupling between electromotility and cochlear amplification, and that there is no need to invoke additional active processes to explain cochlear sensitivity in the mammalian ear.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; Boys Town Natl Res Hosp, Omaha, NE 68131 USA; Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA	St Jude Children's Research Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Boys Town National Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Zuo, J (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jian.zuo@stjude.org		He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004696] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ashmore J. F., 1989, COCHLEAR MECH, P107; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BOHNE BA, 1983, HEARING RES, V11, P41, DOI 10.1016/0378-5955(83)90044-8; BROWN MC, 1983, SCIENCE, V222, P69, DOI 10.1126/science.6623058; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; DALLOS P, 1974, AUDIOLOGY, V13, P277; DALLOS P, 1992, J NEUROSCI, V12, P4575; DALLOS P, 1978, J NEUROPHYSIOL, V41, P365, DOI 10.1152/jn.1978.41.2.365; Ehret G, 1983, AUDITORY PSYCHOBIOLO, P169; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; FORGE A, 1991, CELL TISSUE RES, V265, P473, DOI 10.1007/BF00340870; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; HE DZZ, 1994, HEARING RES, V78, P77, DOI 10.1016/0378-5955(94)90046-9; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; JOHNSTONE BM, 1986, HEARING RES, V22, P147, DOI 10.1016/0378-5955(86)90090-0; KACHAR B, 1986, NATURE, V322, P365, DOI 10.1038/322365a0; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; KIANG NYS, 1974, J ACOUST SOC AM, V55, P620, DOI 10.1121/1.1914572; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Ruggero M A, 1992, Curr Opin Neurobiol, V2, P449, DOI 10.1016/0959-4388(92)90179-O; RUGGERO MA, 1991, HEARING RES, V51, P215, DOI 10.1016/0378-5955(91)90038-B; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	29	632	673	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2002	419	6904					300	304		10.1038/nature01059	http://dx.doi.org/10.1038/nature01059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239568				2022-12-28	WOS:000178056300046
J	Kassirer, JP; Cecil, JS				Kassirer, JP; Cecil, JS			Inconsistency in evidentiary standards for medical testimony - Disorder in the courts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Several recent decisions by the US Supreme Court have strengthened the ability of federal courts to consider medical testimony regarding injuries associated with exposure to toxic substances. Judges are expected to examine the basis of all expert testimony before it is introduced at trial to ensure that it meets the same standards of intellectual rigor that professionals use outside the courtroom. However, courts have been inconsistent in measuring this testimony against the standards of medical practice, especially when courts consider testimony that is not supported by clinical trials or epidemiological studies. A number of courts have required standards for expert testimony that exceed those that physicians use in ordinary clinical decision making. In this article, we illustrate such inconsistencies across federal courts by contrasting different decisions in cases involving similar facts and expert testimony. We argue that there may be good reason to require a standard of admissibility that exceeds the standards of ordinary clinical decision making, but such requirements are not faithful to the mandate of the Supreme Court. Courts with especially demanding standards are misled if they believe that they are fairly representing medical practice. Physicians should respond by correcting courts' misinterpretations of medical practice and assisting in the development of legal standards that encourage thoughtful and informed consideration of medical testimony by judges and juries.	Tufts Univ, Sch Med, Boston, MA 02111 USA; Yale Univ, Sch Med, New Haven, CT USA; Fed Judicial Ctr, Washington, DC USA	Tufts University; Yale University	Kassirer, JP (corresponding author), 21 Squirrel Rd, Wellesley, MA 02481 USA.							ANNAS GJ, 1994, NEW ENGL J MED, V330, P1018, DOI 10.1056/NEJM199404073301420; Berger MA, 1997, COLUMBIA LAW REV, V97, P2117, DOI 10.2307/1123343; Berger Margaret A, 2000, REFERENCE MANUAL SCI; Bryant Arthur H., 2001, American Journal of Epidemiology, V154, pS27, DOI 10.1093/aje/154.12.S27; *CAN TASK FORC, 2001, CAN TASK FORC METH; Cole P., 1997, J MARKETING RES, V27, P10279; Curfman GD, 1997, NEW ENGL J MED, V337, P629, DOI 10.1056/NEJM199708283370909; EGGEN JM, 2001, HOUS L REV, V38, P369; Eisenberg JM, 2001, J HEALTH POLIT POLIC, V26, P369, DOI 10.1215/03616878-26-2-369; Greenland Sander, 2000, JURIMETRICS, V40, P321; HENEFIN MS, 2000, REFERENCE MANUAL SCI; Kassirer J., 1989, TXB INTERNAL MED; KASSIRER JP, 1987, HOSP PRACT, V22, P43; KASSIRER JP, 1989, ANN INTERN MED, V110, P893, DOI 10.7326/0003-4819-110-11-893; KASSIRER JP, 1987, HOSP PRACT, V22, P48; Kassirer JP., 2009, LEARNING CLIN REASON; KASSIRER JP, 1987, HOSP PRACT, V22, P50; Mello MM, 2001, HEALTH AFFAIR, V20, P101, DOI 10.1377/hlthaff.20.5.101; *NEW US PREV SERV, 2002, USPSTF; RELMAN AS, 1989, NEW ENGL J MED, V321, P827, DOI 10.1056/NEJM198909213211211; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sanders Joseph, 2001, LAW CONTEMP PROBL, V64, P107; SLOBODA G, 2001, U SAN FRANCISCO LAW, V35, P301; Weed DL, 1998, AM J EPIDEMIOL, V147, P415; Weed DL, 2001, J EPIDEMIOL COMMUN H, V55, P104, DOI 10.1136/jech.55.2.104; 2000, HARVARD LAW REV, V113, P1467	26	36	36	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2002	288	11					1382	1387		10.1001/jama.288.11.1382	http://dx.doi.org/10.1001/jama.288.11.1382			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	593TB	12234232				2022-12-28	WOS:000178008300020
J	Berg, AO; Allan, JD; Frame, PS; Homer, CJ; Johnson, MS; Klein, JD; Lieu, TA; Mulrow, CD; Orleans, CT; Peipert, JF; Pender, NJ; Siu, AL; Teutsch, SM; Westhoff, C; Woolf, SH				Berg, AO; Allan, JD; Frame, PS; Homer, CJ; Johnson, MS; Klein, JD; Lieu, TA; Mulrow, CD; Orleans, CT; Peipert, JF; Pender, NJ; Siu, AL; Teutsch, SM; Westhoff, C; Woolf, SH		US Preventive Serv Task Force	Screening for osteoporosis in postmenopausal women: Recommendations and rationale	ANNALS OF INTERNAL MEDICINE			English	Article								This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendations on screening for osteoporosis and the supporting scientific evidence and updates the 1996 USPSTF recommendations on this topic. The complete USPSTF recommendation and rationale statement on this topic, which includes a brief review of the supporting evidence, is available through the USPSTF Web site (www.preventiveservices.ahrq.gov), the National Guideline Clearinghouse (www.guideline.gov), and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (telephone, 800-358-9295; e-mail, ahrqpubs@ahrq.gov). The complete information on which this statement is based, including evidence tables and references, is available in the accompanying article in this issue and in the summary of the evidence and the systematic evidence review on the Web sites already mentioned.	Univ Washington, Seattle, WA 98195 USA; Univ Maryland, Baltimore, MD 21201 USA; Univ Rochester, Rochester, NY 14627 USA; Natl Initiat Childrens Healthcare Qual, Boston, MA USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; Univ Rochester, Sch Med, Rochester, NY 14642 USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Univ Texas, Hlth Sci Ctr, Audie L Murphy Mem Vet Hosp, San Antonio, TX 78284 USA; Robert Wood Johnson Fdn, Princeton, NJ 08540 USA; Brown Univ, Women & Infants Hosp, Providence, RI 02905 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Mt Sinai Sch Med, New York, NY USA; Merck & Co Inc, West Point, PA USA; Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; Virginia Commonwealth Univ, Fairfax, VA USA	University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore; University of Rochester; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Rochester; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Robert Wood Johnson Foundation (RWJF); Brown University; Women & Infants Hospital Rhode Island; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai; Merck & Company; Columbia University; Virginia Commonwealth University	Berg, AO (corresponding author), Univ Washington, Seattle, WA 98195 USA.							*AM ASS CLIN END, 2001, MED GUID CLIN PRACT; Cadarette SM, 2000, CAN MED ASSOC J, V162, P1289; Cadarette SM, 2001, JAMA-J AM MED ASSOC, V286, P57, DOI 10.1001/jama.286.1.57; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; National Osteoporosis Foundation, 1999, PHYS GUID PREV TREAT	5	238	242	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					526	528		10.7326/0003-4819-137-6-200209170-00014	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00014			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230355				2022-12-28	WOS:000178069100008
J	Hanratty, B; Hibbert, D; Mair, F; May, C; Ward, C; Capewell, S; Litva, A; Corcoran, G				Hanratty, B; Hibbert, D; Mair, F; May, C; Ward, C; Capewell, S; Litva, A; Corcoran, G			Doctors' perceptions of palliative care for heart failure: focus group study	BRITISH MEDICAL JOURNAL			English	Article							OF-LIFE; DISEASE; END; COMMUNICATION; FAMILY; CANCER	Objectives To identify doctors' perceptions of the need for palliative care for heart failure and barriers to change. Design Qualitative study with focus groups. Setting North west England. Participants General practitioners and consultants in cardiology, geriatrics, palliative care, and general medicine. Results Doctors supported the development of palliative care for patients with heart failure with the general practitioner as a central figure. They were reluctant to endorse expansion of specialist palliative care services. Barriers to developing approaches to palliative care in heart failure related to three main areas: the organisation of health care, the unpredictable course of heart failure, and the doctors' understanding of roles. The health system was thought to work against provision of holistic care, exacerbated by issues of professional rivalry and control. The priorities identified for the future were developing the role of the nurse, better community support for primary care, and enhanced communication between all the health professionals involved in the care of patients with heart failure. Conclusions Greater consideration should be given to the care of patients dying with heart failure, clarifying the roles of doctors and nurses in different specialties, and reshaping the services provided for them. Many of the organisational and professional issues are not peculiar to patients dying with heart failure, and addressing such concerns as the lack of coordination and continuity in medical care would benefit all patients.	Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England; Univ Liverpool, Dept Primary Care, Liverpool L69 3GB, Merseyside, England; Univ Newcastle Upon Tyne, Ctr Hlth Serv Res, Newcastle Upon Tyne NE3 1SX, Tyne & Wear, England; Wythenshawe Hosp, Dept Cardiol, Manchester M23 9LT, Lancs, England; Univ Hosp Aintree, Dept Palliat Care, Liverpool L9 7AL, Merseyside, England	University of Liverpool; University of Liverpool; Newcastle University - UK; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Hanratty, B (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England.		May, Carl/A-8502-2011; Hanratty, Barbara/AAH-1801-2019	May, Carl/0000-0002-0451-2690; Hanratty, Barbara/0000-0002-3122-7190; Mair, Frances/0000-0001-9780-1135				ADDINGTONHALL J, 1995, STROKE, V26, P2242, DOI 10.1161/01.STR.26.12.2242; Anderson H, 2001, PALLIATIVE MED, V15, P279, DOI 10.1191/026921601678320269; Blue L, 2001, BRIT MED J, V323, P715, DOI 10.1136/bmj.323.7315.715; Davis RC, 2000, BRIT MED J, V320, P39, DOI 10.1136/bmj.320.7226.39; *DEP HLTH, 2000, NAT SERV FRAM COR HE; FRASER D, 1999, QSR NVIVO REFERENCE; Gibbs LME, 1998, BRIT MED J, V317, P961, DOI 10.1136/bmj.317.7164.961; Gore JM, 2000, THORAX, V55, P1000, DOI 10.1136/thorax.55.12.1000; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Lloyd-Williams M, 2002, FAM PRACT, V19, P219, DOI 10.1093/fampra/19.3.219; McCarthy M, 1996, J ROY COLL PHYS LOND, V30, P325; *NAT COUNC HOSP SP, 1998, 14 NCHSPC; Rich MW, 1995, NEW ENGL J MED, V333, P1213; Rogers AE, 2000, BMJ-BRIT MED J, V321, P605, DOI 10.1136/bmj.321.7261.605; Silverman D., 1985, QUALITATIVE METHODOL; Skilbeck J, 1998, PALLIATIVE MED, V12, P245, DOI 10.1191/026921698677124622; Sloan RH, 2002, BRIT MED J, V324, P1035, DOI 10.1136/bmj.324.7344.1035; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0; Tobin Terry, 2002, Health Serv J, V112, P22; Ward C, 2002, HEART, V87, P294, DOI 10.1136/heart.87.3.294; 2001, 52001 BRIT HEART FDN	22	126	127	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2002	325	7364					581	585		10.1136/bmj.325.7364.581	http://dx.doi.org/10.1136/bmj.325.7364.581			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595JJ	12228136	Green Published, Bronze			2022-12-28	WOS:000178105200023
J	Farkas, I; Helbing, D; Vicsek, T				Farkas, I; Helbing, D; Vicsek, T			Social behaviour: Mexican waves in an excitable medium - The stimulation of this concerted motion among expectant spectators is explained.	NATURE			English	Article									Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary; Tech Univ Dresden, Inst Econ & Traff, D-01062 Dresden, Germany	Eotvos Lorand University; Technische Universitat Dresden	Farkas, I (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary.	vicsek@angel.elte.hu	Helbing, Dirk/C-6114-2008; Vicsek, Tamas/A-3305-2009; Farkas, Illes/C-1504-2008	Farkas, Illes/0000-0001-5341-5582				Bub G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.058101; GREENBERG JM, 1978, SIAM J APPL MATH, V34, P515, DOI 10.1137/0134040; WIENER N, 1946, Arch Inst Cardiol Mex, V16, P205	3	108	111	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					131	132		10.1038/419131a	http://dx.doi.org/10.1038/419131a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226653	Green Submitted			2022-12-28	WOS:000177931200029
J	Kramer, G; Rauch, T; Rist, W; Vorderwulbecke, S; Patzelt, H; Schulze-Specking, A; Ban, N; Deuerling, E; Bukau, B				Kramer, G; Rauch, T; Rist, W; Vorderwulbecke, S; Patzelt, H; Schulze-Specking, A; Ban, N; Deuerling, E; Bukau, B			L23 protein functions as a chaperone docking site on the ribosome	NATURE			English	Article							COLI TRIGGER FACTOR; BINDING; HSP70	During translation, the first encounter of nascent polypeptides is with the ribosome-associated chaperones that assist the folding process-a principle that seems to be conserved in evolution(1-3).In Escherichia coli, the ribosome-bound Trigger Factor chaperones the folding of cytosolic proteins by interacting with nascent polypeptides(4,5). Here we identify a ribosome-binding motif in the amino-terminal domain of Trigger Factor. We also show the formation of crosslinked products between Trigger Factor and two adjacent ribosomal proteins, L23 and L29, which are located at the exit of the peptide tunnel in the ribosome. L23 is essential for the growth of E. coli and the association of Trigger Factor with the ribosome, whereas L29 is dispensable in both processes. Mutation of an exposed glutamate in L23 prevents Trigger Factor from interacting with ribosomes and nascent chains, and causes protein aggregation and conditional lethality in cells that lack the protein repair function of the DnaK chaperone. Purified L23 also interacts specifically with Trigger Factor in vitro. We conclude that essential L23 provides a chaperone docking site on ribosomes that directly links protein biosynthesis with chaperone-assisted protein folding.	Heidelberg Univ, Zentrum Mol Biol ZMBH, D-69120 Heidelberg, Germany; Univ Freiburg, Inst Mol Biol & Biochem, D-79104 Freiburg, Germany; ETH Honggerberg, Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Ruprecht Karls University Heidelberg; University of Freiburg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bukau, B (corresponding author), Heidelberg Univ, Zentrum Mol Biol ZMBH, INF282, D-69120 Heidelberg, Germany.	E.Deuerling@zmbh.uni-heidelberg.de; bukau@zmbh.uni-heidelberg.de		Bukau, Bernd/0000-0003-0521-7199; Kramer, Gunter/0000-0001-7552-8393; Rist, Wolfgang/0000-0002-0626-3544				AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Schaffitzel E, 2001, BIOL CHEM, V382, P1235, DOI 10.1515/BC.2001.154; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	20	262	267	4	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					171	174		10.1038/nature01047	http://dx.doi.org/10.1038/nature01047			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226666	Green Published			2022-12-28	WOS:000177931200042
J	Schatten, GP				Schatten, GP			Sperm mRNA - what does daddy do?	LANCET			English	Editorial Material							FERTILIZATION; INHERITANCE; INJECTION; OOCYTE		Magee Womens Res Inst, Pittsburgh Dev Ctr, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; Magee Womens Res Inst, Pittsburgh Dev Ctr, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Schatten, GP (corresponding author), Magee Womens Res Inst, Pittsburgh Dev Ctr, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA.	pdcgs@mail.magee.edu	Schatten, Gerald/B-3253-2009	Schatten, Gerald/0000-0001-5206-7782				Hewitson L, 1999, NAT MED, V5, P431, DOI 10.1038/7430; Jouannet P, 2001, APMIS, V109, P333, DOI 10.1034/j.1600-0463.2001.090502.x; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; PRATHER R, 1990, DEV BIOL, V138, P247, DOI 10.1016/0012-1606(90)90195-O; Runft LL, 2002, DEV BIOL, V245, P237, DOI 10.1006/dbio.2002.0600; Saunders CM, 2002, DEVELOPMENT, V129, P3533; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; Schieve L. A., 2002, MMWR-MORBID MORTAL W, V51, P97; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Silber SJ, 2000, FERTIL STERIL, V73, P897, DOI 10.1016/S0015-0282(00)00488-X; Simerly C, 1999, MOL BIOL CELL, V10, P2955, DOI 10.1091/mbc.10.9.2955; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; WHITAKER M, 1993, DEVELOPMENT, V117, P1; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wong WY, 2000, FERTIL STERIL, V73, P435, DOI 10.1016/S0015-0282(99)00551-8	16	3	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2002	360	9335					742	742		10.1016/S0140-6736(02)09948-8	http://dx.doi.org/10.1016/S0140-6736(02)09948-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592HX	12241830				2022-12-28	WOS:000177933000013
J	Vinogradova, O; Velyvis, A; Velyviene, A; Hu, B; Haas, TA; Plow, EF; Qin, J				Vinogradova, O; Velyvis, A; Velyviene, A; Hu, B; Haas, TA; Plow, EF; Qin, J			A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face	CELL			English	Article							MEMBRANE-PROXIMAL REGION; GLYCOPROTEIN IIB-IIIA; LIGAND-BINDING; GPIIB-IIIA; SIGNAL-TRANSDUCTION; TALIN-BINDING; DOMAIN; PROTEIN; NMR; MODULATION	Activation of the ligand binding function of integrin heterodimers requires transmission of an "inside-out" signal from their small intracellular segments to their large extracellular domains. The structure of the cytoplasmic domain of a prototypic integrin alpha(IIb)beta(3) has been solved by NMR and reveals multiple hydrophobic and electrostatic contacts within the membrane-proximal helices of its alpha and the beta cytoplasmic tails. The interface interactions are disrupted by point mutations or the cytoskeletal protein talin that are known to activate the receptor. These results provide a structural mechanism by which a handshake between the alpha and the beta cytoplasmic tails restrains the integrin in a resting state and unclasping of this interaction triggers the inside-out conformational signal that leads to receptor activation.	Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Struct Biol Program, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Plow, EF (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org; qinj@ccf.org	Vinogradova, Olga/ABE-8367-2020; Qin, Jun/D-5559-2009	Vinogradova, Olga/0000-0001-5101-7361; Qin, Jun/0000-0002-2647-9270	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010259] Funding Source: NIH RePORTER; NHLBI NIH HHS [F32 HL010259-01, F32 HL010259] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; Bouvard D, 2001, CIRC RES, V89, P211, DOI 10.1161/hh1501.094874; BRUNNETT B, 1993, SURVEYS MATH IND, V3, P1; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Caen J. P., 1996, AM J MED, V41, P2; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; CAMPBELL AP, 1993, ANNU REV BIOPH BIOM, V22, P99, DOI 10.1146/annurev.bb.22.060193.000531; Chou JJ, 2002, J AM CHEM SOC, V124, P2450, DOI 10.1021/ja017875d; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Eigenthaler R, 1997, J BIOL CHEM, V272, P7693, DOI 10.1074/jbc.272.12.7693; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; FITZGERALD LA, 1985, ANAL BIOCHEM, V151, P169, DOI 10.1016/0003-2697(85)90067-3; FRACHET P, 1992, BIOCHEMISTRY-US, V31, P2408, DOI 10.1021/bi00123a028; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; Haas TA, 1996, J BIOL CHEM, V271, P6017, DOI 10.1074/jbc.271.11.6017; Haas TA, 1997, PROTEIN ENG, V10, P1395, DOI 10.1093/protein/10.12.1395; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Knezevic I, 1996, J BIOL CHEM, V271, P16416, DOI 10.1074/jbc.271.27.16416; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leisner TM, 1999, J BIOL CHEM, V274, P12945, DOI 10.1074/jbc.274.18.12945; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; Peterson JA, 1998, BLOOD, V92, P2053, DOI 10.1182/blood.V92.6.2053.418k14_2053_2063; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Plow EF, 1999, CORONARY ARTERY DIS, V10, P547, DOI 10.1097/00019501-199912000-00002; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shattil SJ, 1997, J CLIN INVEST, V100, pS91; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tsuboi S, 2002, J BIOL CHEM, V277, P1919, DOI 10.1074/jbc.M110643200; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799; Woodside DG, 2001, THROMB HAEMOSTASIS, V86, P316, DOI 10.1055/s-0037-1616229; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	59	422	436	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2002	110	5					587	597		10.1016/S0092-8674(02)00906-6	http://dx.doi.org/10.1016/S0092-8674(02)00906-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230976	Bronze			2022-12-28	WOS:000177943700006
J	Church, C; Junor, B				Church, C; Junor, B			Sclerosing peritonitis during continuous ambulatory peritoneal dialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Western Infirm & Associated Hosp, Glasgow G11, Lanark, Scotland		Church, C (corresponding author), Western Infirm & Associated Hosp, Glasgow G11, Lanark, Scotland.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2002	347	10					737	737		10.1056/NEJMicm010754	http://dx.doi.org/10.1056/NEJMicm010754			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NH	12213945				2022-12-28	WOS:000177765800007
J	Moschovis, PP				Moschovis, PP			When cultures are wrong	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FEMALE GENITAL MUTILATION		Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago	Moschovis, PP (corresponding author), Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA.							ALLEN JR, 1995, JAMA-J AM MED ASSOC, V274, P1714; Almroth L, 2001, INT J GYNECOL OBSTET, V74, P179, DOI 10.1016/S0020-7292(01)00392-7; BARNES VL, 1994, AMAN STORY SOMALI GI, P56; Griaule M, 1965, CONVERSATIONS OGOTEM; HONG F, 1997, FOOTBINDING FEMINISM, P43; Horowitz CR, 1997, J GEN INTERN MED, V12, P491, DOI 10.1046/j.1525-1497.1997.00088.x; Hosken F., 1993, HOSKEN REPORT GENITA; LIGHTFOOTKLEIN H, 1989, PRISONERS RITUAL ODY, P29; LORETTA MK, 1994, 2 OPINION, V20, P55; MacIntyre Alasdair., 1988, WHOSE JUSTICE WHICH; MACKLIN R, 1999, RELATIVISM CULTURAL, P65; MAHOWALD MB, 2001, GLOBALIZING FEMINIST, P165; ROSAMOND R, 2001, THEOR MED BIOETH, V22, P493; Shandall A A, 1967, Sudan Med J, V5, P178; Sheldon S, 1998, BIOETHICS, V12, P263, DOI 10.1111/1467-8519.00117; World Health Organisation, 1998, FEM GEN MULT OV; World Health Organization Fund UNP Fund (UNICEF) UNC, 1997, FEM GEN MULT JOINT W; Young Iris Marion, 1990, JUSTICE POLITICS DIF, DOI DOI 10.1515/9781400839902	18	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1131	1132		10.1001/jama.288.9.1131	http://dx.doi.org/10.1001/jama.288.9.1131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NA	12204085	hybrid			2022-12-28	WOS:000177764600018
J	Spangler, JG; George, G; Foley, KL; Crandall, SJ				Spangler, JG; George, G; Foley, KL; Crandall, SJ			Tobacco intervention training - Current efforts and gaps in US medical schools	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PATIENT-CENTERED APPROACH; SMOKING-CESSATION; CARDIOVASCULAR-DISEASE; DEPENDENCE CURRICULA; OVERCOMING BARRIERS; STUDENTS; PHYSICIAN; ATTITUDES; NICOTINE; SKILLS	Context Research has documented that US medical schools inadequately teach tobacco intervention skills. Objective To examine effective training methods for tobacco intervention in undergraduate medical education. Data Sources Using indexing terms related to tobacco intervention and medical education, we searched MEDLINE (1966-June 2002) and the Cochrane Database of Systematic Reviews (through issue 2, 2002). Reference lists of relevant articles were also read to identify additional articles. Because of their importance to tobacco intervention, we also reviewed Ockene and colleagues' tobacco education research and the tobacco treatment guidelines of the United States Public Health Service and the United States Preventive Services Task Force. Study Selection All study designs that incorporated process or outcome evaluation of tobacco intervention educational methods for medical students were included in this review. Of an initial 1241 articles retrieved, 82 included medical students. Reviewing abstracts and references of these articles identified 13 pertinent studies. Data Extraction Quality criteria for inclusion consisted of explicit evaluation of the educational methods used. Data extraction identified all evaluations and any problems in program implementation. Data Synthesis Enhanced instructional methods (eg, the use of patient-centered counseling, standardized patient instructors, role playing, or a combination of these) are more effective for teaching tobacco intervention than are traditional didactic methods alone and can be effectively inserted into medical school curricula. Conclusions Various educational methods have been used to train medical students in tobacco intervention. Nonetheless, gaps still exist within undergraduate medical education, including a lack of integration of tobacco dependence information throughout all 4 years of medical school curricula, specific training in smokeless tobacco intervention, tobacco intervention training that addresses cultural issues, and long-term studies showing that such training is retained.	Wake Forest Univ, Sch Med, Dept Family & Community Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; Univ Texas, MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA	Wake Forest University; Wake Forest University; University of Texas System; UTMD Anderson Cancer Center	Spangler, JG (corresponding author), Wake Forest Univ, Sch Med, Dept Family & Community Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jspangle@wfubmc.edu	Crandall, Sonia/A-1613-2019		PHS HHS [1 D12 HP 00007-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahluwalia CS, 1998, J GEN INTERN MED, V13, P1, DOI 10.1046/j.1525-1497.1998.00001.x; ALLEN SS, 1990, AM J PREV MED, V6, P28, DOI 10.1016/S0749-3797(18)31041-9; [Anonymous], 1998, MMWR-MORBID MORTAL W, V47, P229; Bland E, 2001, AM J DRUG ALCOHOL AB, V27, P483, DOI 10.1081/ADA-100104513; Boehlecke B, 1996, MED EDUC, V30, P283, DOI 10.1111/j.1365-2923.1996.tb00830.x; Campinha-Bacote J, 1999, J NURS EDUC, V38, P203; CANTOR JC, 1993, JAMA-J AM MED ASSOC, V270, P1035, DOI 10.1001/jama.270.9.1035; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P854; Chin JL, 2000, PUBLIC HEALTH REP, V115, P25, DOI 10.1093/phr/115.1.25; Chung TWH, 1996, MED EDUC, V30, P290, DOI 10.1111/j.1365-2923.1996.tb00831.x; COULTAS DB, 1994, ACAD MED, V69, pS48, DOI 10.1097/00001888-199410000-00039; ERAKER SA, 1985, AM J MED, V78, P817, DOI 10.1016/0002-9343(85)90289-X; Eyler AE, 1997, AM J PREV MED, V13, P153, DOI 10.1016/S0749-3797(18)30187-9; Ferry LH, 1999, JAMA-J AM MED ASSOC, V282, P825, DOI 10.1001/jama.282.9.825; Ferry LH, 1999, PRIMARY CARE, V26, P707, DOI 10.1016/S0095-4543(05)70125-1; FIORE MC, 1994, JAMA-J AM MED ASSOC, V271, P624, DOI 10.1001/jama.271.8.624; FIORE MC, 2000, TREATING TOBACCO USE; Geller AC, 2000, J CANCER EDUC, V15, P196; GILPIN E, 1992, TOBACCO CONTROL, V0001; Hatsukami D K, 1999, Nicotine Tob Res, V1, P21, DOI 10.1080/14622299050011131; HATZIANDREU EJ, 1990, J NATL CANCER I, V82, P1402, DOI 10.1093/jnci/82.17.1402; Iribarren C, 1999, NEW ENGL J MED, V340, P1773, DOI 10.1056/NEJM199906103402301; Johnson KM, 1997, ADDICT BEHAV, V22, P207, DOI 10.1016/S0306-4603(96)00015-9; Kristeller J L, 1996, Indiana Med, V89, P199; Leischow SJ, 1996, AM J HEALTH BEHAV, V20, P304; Levenkron J C, 1990, Am J Prev Med, V6, P29; LEVENKRON JC, 1987, J MED EDUC, V62, P665; LEVENKRON JC, 1987, AM J PREV MED, V3, P152; Lipkus I M, 1999, Nicotine Tob Res, V1, P77, DOI 10.1080/14622299050011181; London RF, 1999, JAMA-J AM MED ASSOC, V282, P875, DOI 10.1001/jama.282.9.875; MACMAHON B, 1988, BIOMED PHARMACOTHER, V42, P93; Munoz RF, 1997, AM J COMMUN PSYCHOL, V25, P325, DOI 10.1023/A:1024676626955; *NCI, 1999, NAT AM OUTR REP AM I; *NCI, 1998, SMOK TOB MON, V9; Nunez AE, 2000, ACAD MED, V75, P1071, DOI 10.1097/00001888-200011000-00011; OCKENE JK, 1987, PREV MED, V16, P723, DOI 10.1016/0091-7435(87)90054-5; OCKENE JK, 1988, ARCH INTERN MED, V148, P1039, DOI 10.1001/archinte.148.5.1039; OCKENE JK, 1987, AM J PUBLIC HEALTH, V77, P782, DOI 10.2105/AJPH.77.7.782; OCKENE JK, 1991, J GEN INTERN MED, V6, P1, DOI 10.1007/BF02599381; OCKENE JK, 1992, PREVENTION CORONARY; Office of Evaluations and Inspections, 1992, DHHS PUBL, V92-00500; ORLEANS CT, 1985, ANNU REV MED, V36, P51; Papadakis MA, 1997, ACAD MED, V72, P725, DOI 10.1097/00001888-199708000-00021; Roche AM, 1996, PREV MED, V25, P251, DOI 10.1006/pmed.1996.0054; ROYCE JM, 1995, J NATL MED ASSOC, V87, P291; Schorling JB, 1997, PREV MED, V26, P92, DOI 10.1006/pmed.1996.9988; SEIM HC, 1995, MED EDUC, V29, P139, DOI 10.1111/j.1365-2923.1995.tb02817.x; SEVERSON H, 1994, ENOUGH SNUFF GUIDE Q, P50; SHERIN K, 1982, POSTGRAD MED, V72, P99, DOI 10.1080/00325481.1982.11716185; Short GJ, 1999, ACAD MED, V74, P1158, DOI 10.1097/00001888-199911000-00007; SILAGY C, 2001, PHYSICIAN ADVICE SMO; Smith SS, 1999, PRIMARY CARE, V26, P433, DOI 10.1016/S0095-4543(05)70112-3; Spangler JG, 2001, ACAD MED, V76, P521, DOI 10.1097/00001888-200105000-00055; STEVENS VJ, 1995, AM J PUBLIC HEALTH, V85, P231, DOI 10.2105/AJPH.85.2.231; STILLMAN PL, 1983, J MED EDUC, V58, P941; U.S. Department of Health and Human Services, 2001, WOM SMOK REP SURG GE; *US DEP HHS, 1992, SMOK TOB HLTH INT PE, P219; US Department of Health and Human Services, 1998, TOB US US RAC ETHN M; *US PREV SERV TASK, 1996, COUNS PREV TOB US; Usatine RP, 1996, ACAD MED, V71, pS96, DOI 10.1097/00001888-199601000-00055; Wadland W, 2000, JAMA-J AM MED ASSOC, V283, P1426, DOI 10.1001/jama.283.11.1426; WELCH M, 2002, CONCEPT PAPERS COMMI; WELLS KB, 1984, MED CARE, V22, P360, DOI 10.1097/00005650-198404000-00007; WELTY TK, 1995, AM J EPIDEMIOL, V142, P269, DOI 10.1093/oxfordjournals.aje.a117633; Winn D M, 1997, Adv Dent Res, V11, P313; 1993, MMWR MORB MORTAL WKL, V42, P645; 1997, MMWR MORB MORTAL WKL, V46, P1217; 1993, MMWR MORB MORTAL WKL, V42, P263	68	98	104	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1102	1109		10.1001/jama.288.9.1102	http://dx.doi.org/10.1001/jama.288.9.1102			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589NA	12204079				2022-12-28	WOS:000177764600013
J	Partridge, L; Gems, D				Partridge, L; Gems, D			Ageing: A lethal side-effect	NATURE			English	Editorial Material									UCL, Dept Biol, London WC1E 6BT, England	University of London; University College London	Partridge, L (corresponding author), UCL, Dept Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.		Partridge, Linda/E-7342-2015; Partridge, Linda/A-5501-2010	Partridge, Linda/0000-0001-9615-0094; Gems, David/0000-0002-6653-4676	Biotechnology and Biological Sciences Research Council [SF19106] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Austad S. N., 1997, WHY WE AGE; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; [No title captured]	3	17	18	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					921	921		10.1038/418921a	http://dx.doi.org/10.1038/418921a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198525				2022-12-28	WOS:000177677500023
J	Soper, AK				Soper, AK			Water and ice	SCIENCE			English	Editorial Material							LIQUID WATER		Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Soper, AK (corresponding author), Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England.			Soper, Alan/0000-0002-7903-8356				KELL GS, 1975, J CHEM ENG DATA, V20, P97, DOI 10.1021/je60064a005; MISHIMA O, 1984, NATURE, V310, P393, DOI 10.1038/310393a0; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; PRIELMEIER FX, 1987, PHYS REV LETT, V59, P1128, DOI 10.1103/PhysRevLett.59.1128; SPEEDY RJ, 1982, J PHYS CHEM-US, V86, P982, DOI 10.1021/j100395a030; Truskett TM, 1999, J CHEM PHYS, V111, P2647, DOI 10.1063/1.479540; Tulk CA, 2002, SCIENCE, V297, P1320, DOI 10.1126/science.1074178	7	63	64	5	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1288	1289		10.1126/science.297.5585.1288	http://dx.doi.org/10.1126/science.297.5585.1288			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193774				2022-12-28	WOS:000177573900029
J	Ribeiro, ALP; dos Reis, AM; Barros, MVL; de Sousa, MR; Rocha, ALL; Perez, AA; Pereira, JB; Machado, FS; Rocha, MOC				Ribeiro, ALP; dos Reis, AM; Barros, MVL; de Sousa, MR; Rocha, ALL; Perez, AA; Pereira, JB; Machado, FS; Rocha, MOC			Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease	LANCET			English	Article							CONGESTIVE-HEART-FAILURE	Left ventricular dysfunction in Chagas' disease is common but can be difficult to detect. We investigated whether measurement of plasma brain natriuretic peptide (BNP) could identify patients with left ventricular dysfunction who need further investigation or treatment. Among patients with an abnormal electrocardiogram or chest radiograph, a BNP concentration of 60.7 pmol/L or higher has a sensitivity and positive predictive value of 80%, and specificity and negative predictive value of 97%. Measurement of plasma BNP concentration could be a useful method to screen patients with Chagas' disease.	Univ Fed Minas Gerais, Sch Med, Postgrad Course Trop Med, Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Hosp Clin, Serv Cardiol, Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; Ecoar Med Diagnost, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Ribeiro, ALP (corresponding author), Univ Fed Minas Gerais, Sch Med, Postgrad Course Trop Med, Belo Horizonte, MG, Brazil.		Rocha, Ana L/B-1645-2014; Reis, Adelina/C-8162-2013; Ribeiro, Ana Cristina/HHN-7466-2022; Rocha, Manoel Otávio C/H-4776-2013; Barros, Marcio/GXF-3499-2022; Ribeiro, Antonio L/C-2707-2009	Rocha, Ana L/0000-0002-4717-9541; Reis, Adelina/0000-0003-0138-9612; Ribeiro, Ana Cristina/0000-0002-0493-8376; Ribeiro, Antonio L/0000-0002-2740-0042				Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6; GUTKOWSKA J, 1987, ENDOCRIN METAB CLIN, V16, P183, DOI 10.1016/S0889-8529(18)30500-0; Hjalmarson A, 1999, LANCET, V353, P2001; MADY C, 1994, CIRCULATION, V90, P3098, DOI 10.1161/01.CIR.90.6.3098; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1	5	57	63	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					461	462		10.1016/S0140-6736(02)09638-1	http://dx.doi.org/10.1016/S0140-6736(02)09638-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241721				2022-12-28	WOS:000177342900015
J	Park, JM; Greten, FR; Li, ZW; Karin, M				Park, JM; Greten, FR; Li, ZW; Karin, M			Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; BACILLUS-ANTHRACIS; KAPPA-B; TOXIN; SUSCEPTIBILITY; TRANSCRIPTION	The bacterium Bacillus anthracis causes the death of macrophages, which may allow it to avoid detection by the innate immune system. We found that B. anthracis lethal factor (LF) selectively induces apoptosis of activated macrophages by cleaving the amino-terminal extension of mitogen-activated protein kinase (MAPK) kinases (MKKs) that activate p38 MAPKs. Because macrophages that are deficient in transcription factor nuclear factor kappaB (NF-kappaB) are also sensitive to activation-induced death and p38 is required for expression of certain NF-kappaB target genes, p38 is probably essential for synergistic induction of those NF-kappaB target genes that prevent apoptosis of activated macrophages. This dismantling of the p38 MAPK module represents a strategy used by B. anthracis to paralyze host innate immunity.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Greten, Florian R/AAF-5196-2020	Greten, Florian R/0000-0002-3928-6080	NIAID NIH HHS [AI43477] Funding Source: Medline; NIEHS NIH HHS [ES04151, ES06376, ES10337] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004151, R01ES006376, P42ES010337, R37ES004151] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen KD, 2000, J CELL BIOCHEM, V76, P585, DOI 10.1002/(SICI)1097-4644(20000315)76:4<585::AID-JCB7>3.0.CO;2-U; Chu WM, 2000, CELL, V103, P909, DOI 10.1016/S0092-8674(00)00194-X; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; Erwin JL, 2001, INFECT IMMUN, V69, P1175, DOI 10.1128/IAI.69.2.1175-1177.2001; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Hanna PC, 1999, TRENDS MICROBIOL, V7, P180, DOI 10.1016/S0966-842X(99)01507-3; Hirayoshi K, 1999, METHOD ENZYMOL, V304, P351; KEPPIE J, 1963, BRIT J EXP PATHOL, V44, P446; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lin CG, 1996, CURR MICROBIOL, V33, P224, DOI 10.1007/s002849900104; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Roberts JE, 1998, MOL MICROBIOL, V29, P581, DOI 10.1046/j.1365-2958.1998.00953.x; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; SINGH Y, 1989, J BIOL CHEM, V264, P11099; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369	30	403	427	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2002	297	5589					2048	2051		10.1126/science.1073163	http://dx.doi.org/10.1126/science.1073163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12202685	Green Submitted			2022-12-28	WOS:000178078500045
J	Iglehart, JK				Iglehart, JK			Changing health insurance trends	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		ABELSON R, 2002, NY TIMES        0809, pA1; *AON, 2001, US WORK STUD; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; BENNETT J, 2002, WALL STREET J   0606, pD3; BROCK F, 2002, NY TIMES        0602, pBU10; *CAL PUBL EMPL RET, 2002, FACT SHEET 2002 2003; CAUSEY M, 2002, WASHINGTON TIME 0521, pA6; Christianson JB, 2002, HEALTH AFFAIR, V21, P49, DOI 10.1377/hlthaff.21.1.49; Epstein AM, 2002, NEW ENGL J MED, V346, P1161, DOI 10.1056/NEJM200204113461512; FREUDENHEIM M, 2002, NY TIMES        1227, pA1; FREUDENHEIM M, 2002, NY TIMES        0609, pC1; FREUDENHEIM M, 2001, NY TIMES        0313, pA1; FRONSTIN P, 2001, EMPLOYMENT BASED HLT; FRONSTIN P, 2001, DEFINED CONTRIBUTION; FRONSTIN P, 2002, CAN CONSUMERISM SLOW; Fuchs VR, 2002, NEW ENGL J MED, V346, P1822, DOI 10.1056/NEJM200206063462314; FUCHS VR, 2001, SAN JOSE MERCUR 0722, pC1; GABEL J, 1991, HEALTH AFFAIR, V10, P48, DOI 10.1377/hlthaff.10.4.48; Gabel J, 2002, HEALTH AFFAIR, V21, P143, DOI 10.1377/hlthaff.21.5.143; Galvin R, 2002, NEW ENGL J MED, V347, P939, DOI 10.1056/NEJMsb012850; *GEN ACC OFF, 2001, GAO01374; *HJ KAIS FAM FDN, 2002, ER PRIV HLTH INS COV; *HLTH POL ALT, 2002, DEF CONTR PLANS AN P; HOLAHAN J, 2002, CHANGES INSURANCE CO; JOHNSON RW, 2002, MEDICARE BUY NEAR EL; Lee D., 2002, LOS ANGELES TIM 0523, pC1; LEE JS, 2002, LOW CAN YOU GO IMPAC; Levit K, 2002, HEALTH AFFAIR, V21, P172, DOI 10.1377/hlthaff.21.1.172; *M STANL, 2002, 2002 LARG EMPL SURV; MARTIN KE, 2002, SHIFTING RESPONSIBIL; MARTINEZ B, 2000, WALL ST J       1114, pB1; MARTINEZ B, 2002, WALL STREET J   0412, pA1; McCormack LA, 2002, HEALTH CARE FINANC R, V23, P17; MILSTEIN A, 2002, IMPROVING VALUE HLTH; Newhouse J., 1994, FREE ALL LESSONS RAN; NICHOLS L, 2002, CAN DEFINED CONTRIBU; Pauly MV, 2000, J HEALTH POLIT POLIC, V25, P9, DOI 10.1215/03616878-25-1-9; ROBINSON JC, 2002, RENEWED EMPHASIS CON; RUBIN AJ, 1999, LOS ANGELES TIM 0716, pA1; SCANDLEN G, 2000, 154 NAT CTR POL AN; SILOWCARROLL S, 2001, STATE EMPLOYMENT BAS; STRUNK BC, 2001, TRACKING HLTH CARE C; TERHUNE C, 2002, WALL STREET J   0730, pD3; TERHUNE C, 2002, WALL STREET J   0409, pA1; TOLLEN L, 2002, TEMPORARY FIX IMPLIC; TONER R, 2002, NY TIMES        0219, pA1; Trude S, 2002, HEALTH AFFAIR, V21, P66, DOI 10.1377/hlthaff.21.1.66; Weber J, 2002, BUS WEEK, P90; White R., 2002, LOS ANGELES TIM 0627, pC1; Wyatt Edward, 2002, NEW YORK TIMES  0420, pA1; 2002, MERCER FOSTER HIGGIN; 2002, CONSUM REP, V67, P48	52	38	38	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					956	962		10.1056/NEJMhpr022143	http://dx.doi.org/10.1056/NEJMhpr022143			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239275				2022-12-28	WOS:000178040700035
J	Straus, SE; Majumdar, SR; McAlister, FA				Straus, SE; Majumdar, SR; McAlister, FA			New evidence for stroke prevention - Scientific review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ISOLATED SYSTOLIC HYPERTENSION; CORONARY-HEART-DISEASE; ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY; CAROTID-ENDARTERECTOMY; SECONDARY PREVENTION; BLOOD-PRESSURE; ANTIHYPERTENSIVE THERAPIES; REDUCTASE INHIBITORS; SERUM-CHOLESTEROL	Context Stroke is a major cause of morbidity and mortality, and the application of evidence for stroke prevention varies considerably. Objective To review the most recent, high-quality evidence for primary and secondary stroke prevention. Data Sources and Study Selection Searches of MEDLINE, The Cochrane Library, and the ACP Journal Club were performed to identify English-language articles published from 1998 to 2001 that focused on primary and secondary stroke prevention. The references of each retrieved article were scanned, and experts in the field were contacted to identify additional relevant articles. Data Extraction Each of the articles was appraised, and its quality was graded with levels of evidence based on specific scientific methods that affect a study's validity. Data Synthesis For primary prevention of stroke, adequate blood pressure reduction, and treatment of hyperlipidemia, use of antithrombotic therapy in patients with atrial fibrillation and of antiplatelet therapy in patients with myocardial infarction are effective and supported by evidence from several randomized trials. Effective strategies for the secondary prevention of stroke include treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, antiplatelet therapy, and carotid endarterectomy in patients with severe carotid artery stenosis. Conclusions Stroke is a major public health concern, and a significant body of evidence supports many primary and secondary prevention strategies.	Univ Toronto, Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada; Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Alberta	Straus, SE (corresponding author), Toronto Gen Hosp, Univ Hlth Network, Dept Med, 200 Elizabeth St,ENG 248, Toronto, ON M5G 2C4, Canada.	sstraus@mtsinai.on.ca	McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341				Albers GW, 2001, CHEST, V119, p194S, DOI 10.1378/chest.119.1_suppl.194S; American Heart Association, 1999, HEART STROK STAT UPD; Ashenden R, 1997, FAM PRACT, V14, P160, DOI 10.1093/fampra/14.2.160; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BAUDOIN C, 1989, DIABETES, V38, P491; BECKER RC, 1995, ARCH INTERN MED, V155, P149, DOI 10.1001/archinte.155.2.149; Benavente O, 1998, BMJ-BRIT MED J, V317, P1477, DOI 10.1136/bmj.317.7171.1477; Benavente O, 1999, STROKE MODULE COCHRA; BENFANTE R, 1994, STROKE, V25, P814, DOI 10.1161/01.STR.25.4.814; Benson RT, 2000, NEUROL CLIN, V18, P309, DOI 10.1016/S0733-8619(05)70194-8; Blackshear JL, 1996, LANCET, V348, P633; BRONNER LL, 1995, NEW ENGL J MED, V333, P1392, DOI 10.1056/NEJM199511233332106; Bucher HC, 1998, ANN INTERN MED, V128, P89, DOI 10.7326/0003-4819-128-2-199801150-00002; Byington RP, 2001, CIRCULATION, V103, P387; Caro JJ, 1999, CAN MED ASSOC J, V161, P493; CINA CA, 2001, CAROTID ENDARTERECTO; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COLLINS R, 1999, STROKE, V30, P1304; COTE R, 1995, ANN INTERN MED, V123, P649, DOI 10.7326/0003-4819-123-9-199511010-00002; Crouse JR, 1997, ARCH INTERN MED, V157, P1305, DOI 10.1001/archinte.157.12.1305; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; De Schryver ELLM, 2000, CEREBROVASC DIS, V10, P147, DOI 10.1159/000016044; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Elkind MS, 1998, SEMIN NEUROL, V18, P429, DOI 10.1055/s-2008-1040896; Ezekowitz MD, 1999, JAMA-J AM MED ASSOC, V281, P1830, DOI 10.1001/jama.281.19.1830; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Fox KM, 1998, EUR HEART J, V19, pJ52; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; GOLDSTEIN LB, 1995, STROKE, V26, P1607, DOI 10.1161/01.STR.26.9.1607; Goldstein LB, 2001, CIRCULATION, V103, P163; Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112; Gueyffier F, 1997, STROKE, V28, P2557, DOI 10.1161/01.STR.28.12.2557; Gueyffier F, 1999, LANCET, V353, P793, DOI 10.1016/S0140-6736(98)08127-6; Hankey GJ, 1999, LANCET, V354, P1457, DOI 10.1016/S0140-6736(99)04407-4; HANKEY GJ, 2001, THIENOPYRIDINE DERIV; Hart RG, 2000, J AM COLL CARDIOL, V35, P183, DOI 10.1016/S0735-1097(99)00489-1; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 2000, ARCH NEUROL-CHICAGO, V57, P326, DOI 10.1001/archneur.57.3.326; HUGHES JR, 2001, ANTIDEPRESSANTS SMOK; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Johnson ES, 1999, ARCH INTERN MED, V159, P1248, DOI 10.1001/archinte.159.11.1248; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; KAWACHI I, 1993, JAMA-J AM MED ASSOC, V269, P232, DOI 10.1001/jama.269.2.232; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; LANCASTER T, 2001, INDIVIDUAL BEHAV COU; LANDEFELD CS, 1989, AM J MED, V87, P144; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; LAW M, 1995, ARCH INTERN MED, V155, P1933, DOI 10.1001/archinte.155.18.1933; Lindley RI, 1995, J ROY COLL PHYS LOND, V29, P479; Loh E, 1997, NEW ENGL J MED, V336, P251, DOI 10.1056/NEJM199701233360403; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; McAlister FA, 2002, INT J EPIDEMIOL, V31, P76, DOI 10.1093/ije/31.1.76; McAlister FA, 2001, CAN J CARDIOL, V17, P543; McAlister FA, 2001, AM J MED, V111, P553, DOI 10.1016/S0002-9343(01)00900-7; MEINERT CL, 1970, DIABETES, V19, P789; Neal B, 2000, LANCET, V356, P1955; Perry HM, 2000, JAMA-J AM MED ASSOC, V284, P465, DOI 10.1001/jama.284.4.465; Pfeffer MA, 2001, AM HEART J, V142, P375, DOI 10.1067/mhj.2001.117603; Plutzky J, 2001, CIRCULATION, V103, P348; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Qizilbash N, 1995, LANCET, V346, P1647; RICE VH, 2001, NURSING INTERVENTION; Rodgers A, 1996, BRIT MED J, V313, P147, DOI 10.1136/bmj.313.7050.147; Rothwell PM, 1997, BMJ-BRIT MED J, V315, P1571, DOI 10.1136/bmj.315.7122.1571; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; SILAGY C, 2001, NICOTINE REPLACEMENT; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; Stearne MR, 1998, BRIT MED J, V317, P713; Strandgaard S, 1996, J HYPERTENS, V14, pS23, DOI 10.1097/00004872-199610003-00005; Svensson P, 2001, HYPERTENSION, V38, pE28, DOI 10.1161/hy1101.099502; SZEKELY P, 1964, BMJ-BRIT MED J, V1, P1209, DOI 10.1136/bmj.1.5392.1209; TANNE D, 1993, STROKE, V24, P1490, DOI 10.1161/01.STR.24.10.1490; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Tu JV, 1998, NEW ENGL J MED, V339, P1441, DOI 10.1056/NEJM199811123392006; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Warshafsky S, 1999, J GEN INTERN MED, V14, P763, DOI 10.1046/j.1525-1497.1999.02109.x; White HD, 2000, NEW ENGL J MED, V343, P317, DOI 10.1056/NEJM200008033430502; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; Wright JM, 1999, CAN MED ASSOC J, V161, P25; Yusuf S, 2000, NEW ENGL J MED, V342, P145; 2002, STROKE PREVENTION AG	85	202	214	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2002	288	11					1388	1395		10.1001/jama.288.11.1388	http://dx.doi.org/10.1001/jama.288.11.1388			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593TB	12234233	Bronze			2022-12-28	WOS:000178008300021
J	Suzuki, Y; Kelly, SD; Kemner, KM; Banfield, JF				Suzuki, Y; Kelly, SD; Kemner, KM; Banfield, JF			Radionuclide contamination - Nanometre-size products of uranium bioreduction	NATURE			English	Article									Argonne Natl Lab, Div Environm Res, Argonne, IL 60439 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison	Suzuki, Y (corresponding author), Japan Marine Sci & Technol Ctr, Yokosuka, Kanagawa 237006, Japan.	jill@seismo.berkeley.edu	Suzuki, Yohey/G-4980-2014	Banfield, Jill/0000-0001-8203-8771				Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; Grenthe I., 1992, CHEM THERMODYNAMICS; Lovely D.R., 1991, NATURE, V350, P413; RAI D, 1990, INORG CHEM, V29, P260, DOI 10.1021/ic00327a022	4	292	309	0	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					134	134		10.1038/419134a	http://dx.doi.org/10.1038/419134a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226656	Bronze			2022-12-28	WOS:000177931200032
J	Boerma, D; Rauws, EAJ; Keulemans, YCA; Janssen, IMC; Bolwerk, CJM; Timmer, R; Boerma, EJ; Obertop, H; Huibregtse, K; Gouma, DJ				Boerma, D; Rauws, EAJ; Keulemans, YCA; Janssen, IMC; Bolwerk, CJM; Timmer, R; Boerma, EJ; Obertop, H; Huibregtse, K; Gouma, DJ			Wait-and-see policy or laparoscopic cholecystectomy after endoscopic sphincterotomy for bile-duct stones: a randomised trial	LANCET			English	Article							GALLBLADDER IN-SITU; HEALTH SURVEY; FOLLOW-UP; CALCULI; MANAGEMENT; INSITU; SURGERY; IMPACT	Background Patients who undergo endoscopic sphincterotomy for common bile-duct stones, who have residual gallbladder stones, are referred for laparoscopic cholecystectomy. However, only 10% of patients who do not have this operation are reported to develop recurrent biliary symptoms. We aimed to assess whether a wait-and-see policy is justified. Methods We did a prospective, randomised, multicentre trial in 120 patients (age 18-80 years) who underwent endoscopic sphincterotomy and stone extraction, with proven gallbladder stones. Patients were randomly allocated to wait and see (n=64) or laparoscopic cholecystectomy (56). Primary outcome was reoccurrence of at least one biliary event during 2-year follow-up, and secondary outcomes were complications of cholecystectomy and quality of life. Analysis was by intention to treat. Findings 12 patients were lost to follow-up immediately. Of 59 patients allocated to wait and see, 27 (47%) had recurrent biliary symptoms compared with one (2%) of 49 patients after laparoscopic cholecystectomy (relative risk 22-42, 95% CI 3.16-159.14, p<0.0001). 22 (81%) of 27 patients underwent cholecystectomy, mainly for biliary pain (n=13) or acute cholecystitis (7). Conversion rate to open surgery was 55% in patients allocated to wait and see who underwent cholecystectomy compared with 23% in those who were allocated laparoscopic cholecystectomy (p=0.0104). Morbidity was 32% versus 14% (p=0.1048), and median hospital stay was 9 versus 7 days. Quality of life returned to normal within 3 months after either treatment policy. Interpretation A wait-and-see policy after endoscopic sphincterotomy in. combined cholecystodocholithiasis cannot be recommended as standard treatment, since 47% of expectantly managed patients developed at least one recurrent biliary event and 37% needed cholecystectomy. No major biliary complications arose, but conversion rate was high.	Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1105 AZ Amsterdam, Netherlands; Rijnstate Hosp, Arnhem, Netherlands; Reinier de Graaf Hosp, Delft, Netherlands; St Antonius Hosp, Nieuwegein, Netherlands; Kennemer Gasthuis, Haarlem, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Rijnstate Hospital; Reinier de Graaf Hospital; St. Antonius Hospital Utrecht; Spaarne Hospital	Gouma, DJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.			janssen, ignace/0000-0001-5666-754X				Cotton PB, 1998, ANN SURG, V227, P201, DOI 10.1097/00000658-199802000-00008; COTTON PB, 1981, BRIT J SURG, V68, P373, DOI 10.1002/bjs.1800680602; Cuschieri A, 1999, SURG ENDOSC-ULTRAS, V13, P952, DOI 10.1007/s004649901145; DAVIDSON BR, 1988, GUT, V29, P114, DOI 10.1136/gut.29.1.114; Eldar S, 1999, AM J SURG, V178, P303, DOI 10.1016/S0002-9610(99)00172-5; ESCOURROU J, 1984, GUT, V25, P598, DOI 10.1136/gut.25.6.598; HAMMARSTROM LE, 1995, BRIT J SURG, V82, P1516, DOI 10.1002/bjs.1800821121; Hammarstrom LE, 1996, SCAND J GASTROENTERO, V31, P294, DOI 10.3109/00365529609004881; HILL J, 1991, BRIT J SURG, V78, P554, DOI 10.1002/bjs.1800780512; HOLBROOK RF, 1991, ARCH SURG-CHICAGO, V126, P738; Keulemans YCA, 1997, GASTROINTEST ENDOSC, V46, P514, DOI 10.1016/S0016-5107(97)70006-3; Lai KH, 1999, GASTROINTEST ENDOSC, V49, P483, DOI 10.1016/S0016-5107(99)70047-7; NEOPTOLEMOS JP, 1984, BRIT J SURG, V71, P69, DOI 10.1002/bjs.1800710123; *SIG ZORG, 1999, LAND MED REG NED ZIE; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; TANAKA M, 1987, AM J SURG, V154, P505, DOI 10.1016/0002-9610(87)90265-0; Targarona EM, 1996, LANCET, V347, P926, DOI 10.1016/S0140-6736(96)91413-0; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WELBOURN CRB, 1995, GUT, V37, P119, DOI 10.1136/gut.37.1.119; WORTHLEY CS, 1988, BRIT J SURG, V75, P796, DOI 10.1002/bjs.1800750825	20	216	225	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 7	2002	360	9335					761	765		10.1016/S0140-6736(02)09896-3	http://dx.doi.org/10.1016/S0140-6736(02)09896-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592HX	12241833				2022-12-28	WOS:000177933000016
J	Einsle, O; Tezcan, FA; Andrade, SLA; Schmid, B; Yoshida, M; Howard, JB; Rees, DC				Einsle, O; Tezcan, FA; Andrade, SLA; Schmid, B; Yoshida, M; Howard, JB; Rees, DC			Nitrogenase MoFe-protein at 1.16 angstrom resolution: A central ligand in the FeMo-cofactor	SCIENCE			English	Article							MOLYBDENUM IRON PROTEIN; CRYSTAL-STRUCTURE; CLUSTERS; MODELS; SYSTEM	A high-resolution crystallographic analysis of the nitrogenase MoFe-protein reveals a previously unrecognized ligand coordinated to six iron atoms in the center of the catalytically essential FeMo-cofactor. The electron density for this ligand is masked in structures with resolutions lower than 1.55 angstroms, owing to Fourier series termination ripples from the surrounding iron and sulfur atoms in the cofactor. The central atom completes an approximate tetrahedral coordination for the six iron atoms, instead of the trigonal coordination proposed on the basis of lower resolution structures. The crystallographic refinement at 1.16 angstrom resolution is consistent with this newly detected component being a light element, most plausibly nitrogen. The presence of a nitrogen atom in the cofactor would have important implications for the mechanism of dinitrogen reduction by nitrogenase.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of Minnesota System; University of Minnesota Twin Cities	Rees, DC (corresponding author), CALTECH, Howard Hughes Med Inst, Mail Code 147-75CH, Pasadena, CA 91125 USA.	dcrees@caltech.edu	Andrade, Susana L. A./D-5119-2012	Andrade, Susana L. A./0000-0003-2267-8499; Einsle, Oliver/0000-0001-8722-2893				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOLIN JT, 1993, ACS SYM SER, V535, P186; Bragg WL, 1930, PHILOS MAG, V10, P823; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; Christiansen J, 2001, ANNU REV PLANT PHYS, V52, P269, DOI 10.1146/annurev.arplant.52.1.269; COCHRAN W, 1966, DETERMINATION CRYSTA; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; DENG HB, 1993, ANGEW CHEM INT EDIT, V32, P1062, DOI 10.1002/anie.199310621; EINSLE O, UNPUB; Ertl G., 1997, HDB HETEROGENEOUS CA, V4; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; JAMES RW, 1948, ACTA CRYSTALLOGR, V1, P132, DOI 10.1107/S0365110X48000351; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM J, 1993, BIOCHEMISTRY-US, V32, P7104, DOI 10.1021/bi00079a006; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; Lee HI, 1998, BIOCHEMISTRY-US, V37, P13370, DOI 10.1021/bi980956a; Logadottir A, 2001, SURF SCI, V489, P135, DOI 10.1016/S0039-6028(01)01171-2; MARTINENGO S, 1979, J AM CHEM SOC, V101, P7095, DOI 10.1021/ja00517a067; Mayer SM, 1999, J MOL BIOL, V292, P871, DOI 10.1006/jmbi.1999.3107; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Rees DC, 2000, CURR OPIN CHEM BIOL, V4, P559, DOI 10.1016/S1367-5931(00)00132-0; Siegbahn PEM, 1998, J PHYS CHEM B, V102, P1615, DOI 10.1021/jp972207t; Smith BE, 1999, ADV INORG CHEM, V47, P159, DOI 10.1016/S0898-8838(08)60078-1; Stavrev KK, 1996, CHEM-EUR J, V2, P83, DOI 10.1002/chem.19960020115; THOMANN H, 1987, J AM CHEM SOC, V109, P7913, DOI 10.1021/ja00259a067; Thorneley R.N.F., 1985, MOLYBDENUM ENZYMES, V1, P221; TRUE AE, 1990, J AM CHEM SOC, V112, P651, DOI 10.1021/ja00158a024; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WOLLE D, 1992, J BIOL CHEM, V267, P3667	34	846	863	12	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587					1696	1700		10.1126/science.1073877	http://dx.doi.org/10.1126/science.1073877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215645				2022-12-28	WOS:000177819100048
J	Gao, GX; Guo, XM; Goff, SP				Gao, GX; Guo, XM; Goff, SP			Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein	SCIENCE			English	Article							HUMAN MXA PROTEIN; AU-RICH ELEMENTS; MESSENGER-RNA; GENE-TRANSFER; TRISTETRAPROLIN; CELLS; DESTABILIZATION; DEADENYLATION; TRANSDUCTION; DEGRADATION	Cells have evolved multiple mechanisms to inhibit viral replication. To identify previously unknown antiviral activities, we screened mammalian complementary DNA (cDNA) libraries for genes that prevent infection by a genetically marked retrovirus. Virus-resistant cells were selected from pools of transduced clones, and an active antiviral cDNA was recovered. The gene encodes a CCCH-type zinc finger protein designated ZAP. Expression of the gene caused a profound and specific loss of viral messenger RNAs (mRNAs) from the cytoplasm without affecting the levels of nuclear mRNAs. The finding suggests the existence of a previously unknown machinery for the inhibition of virus replication, targeting a step in viral gene expression.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Chinese Acad Sci, Inst Microbiol, Beijing 100080, Peoples R China	Columbia University; Howard Hughes Medical Institute; Chinese Academy of Sciences; Institute of Microbiology, CAS	Goff, SP (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.		Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547	NATIONAL CANCER INSTITUTE [R01CA030488, R37CA030488] Funding Source: NIH RePORTER; NCI NIH HHS [CA 30488] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		An DS, 1997, J VIROL, V71, P1397, DOI 10.1128/JVI.71.2.1397-1404.1997; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996; GAO G, UNPUB; Gao GX, 1999, MOL BIOL CELL, V10, P1705, DOI 10.1091/mbc.10.6.1705; Haller O, 1998, REV SCI TECH OIE, V17, P220, DOI 10.20506/rst.17.1.1084; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; LANDOLFO S, 1995, PHARMACOL THERAPEUT, V65, P415, DOI 10.1016/0163-7258(95)98599-L; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; MACDONALD ME, COMMUNICATION; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; PAVLOVIC J, 1995, J VIROL, V69, P4506, DOI 10.1128/JVI.69.7.4506-4510.1995; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	24	341	356	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1703	1706		10.1126/science.1074276	http://dx.doi.org/10.1126/science.1074276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215647				2022-12-28	WOS:000177819100050
J	Shirey, SB; Harris, JW; Richardson, SH; Fouch, MJ; James, DE; Cartigny, P; Deines, P; Viljoen, F				Shirey, SB; Harris, JW; Richardson, SH; Fouch, MJ; James, DE; Cartigny, P; Deines, P; Viljoen, F			Diamond genesis, seismic structure, and evolution of the Kaapvaal-Zimbabwe craton	SCIENCE			English	Article							CARBON ISOTOPIC COMPOSITION; NITROGEN-CONTENT; LITHOSPHERIC MANTLE; KOFFIEFONTEIN KIMBERLITE; PERIDOTITE XENOLITHS; INCLUSION CHEMISTRY; ORIGIN; FINSCH; OS; CONSTRAINTS	The lithospheric mantle beneath the Kaapvaal-Zimbabwe craton of southern Africa shows variations in seismic P-wave velocity at depths within the diamond stability field that correlate with differences in the composition of diamonds and their syngenetic inclusions. Middle Archean mantle depletion events initiated craton keel formation and early harzburgitic diamond formation. Late Archean accretionary events involving an oceanic lithosphere component stabilized the craton and contributed a younger Archean generation of eclogitic diamonds. Subsequent Proterozoic tectonic and magmatic events altered the composition of the continental lithosphere and added new lherzolitic and eclogitic diamonds to the Archean diamond suite.	Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Univ Glasgow, Div Earth Sci, Glasgow G12 8QQ, Lanark, Scotland; Univ Cape Town, Dept Geol Sci, ZA-7701 Rondebosch, South Africa; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Univ Paris 07, Inst Phys Globe Paris, Lab Geochim Isotopes Stables, F-75251 Paris 05, France; Penn State Univ, Dept Mineral Sci, University Pk, PA 16802 USA; De Beers GeoSci Ctr, ZA-2135 Southdale, South Africa	Carnegie Institution for Science; University of Glasgow; University of Cape Town; Arizona State University; Arizona State University-Tempe; UDICE-French Research Universities; Universite Paris Cite; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Shirey, SB (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	shirey@dtm.ciw.edu	Fouch, Matthew/F-6507-2010; Cartigny, Pierre/A-6251-2011					Arndt NT, 1997, EARTH PLANET SC LETT, V146, P289, DOI 10.1016/S0012-821X(96)00219-1; BOYD FR, 1986, SCIENCE, V232, P472, DOI 10.1126/science.232.4749.472; CANIL D, 1992, CONTRIB MINERAL PETR, V109, P421, DOI 10.1007/BF00306546; Carlson R. W., 1996, EOS, V77, P273, DOI DOI 10.1029/96E000194; Carlson R.W., 1999, P 7 INT KIMBERLITE C, P99; Carlson RW, 2000, GSA TODAY, V10, P1; Cartigny P, 2001, EARTH PLANET SC LETT, V185, P85, DOI 10.1016/S0012-821X(00)00357-5; Cartigny P, 1998, SCIENCE, V280, P1421, DOI 10.1126/science.280.5368.1421; CARTIGNY P, 1998, THESIS U PARIS 7; DANCHIN RV, 1979, MANTLE SAMPLE INCLUS, V2, P104; Davis G.L., 1977, CARNEGIE I WASH YR B, V76, P631; DAVIS GL, 1976, CARNEGIE I WASHINGTO, V75, P821; Deines P, 1997, GEOCHIM COSMOCHIM AC, V61, P3993, DOI 10.1016/S0016-7037(97)00199-3; DEINES P, 1991, GEOCHIM COSMOCHIM AC, V55, P2615, DOI 10.1016/0016-7037(91)90377-H; DEINES P, 1987, GEOCHIM COSMOCHIM AC, V51, P1227, DOI 10.1016/0016-7037(87)90215-8; DEINES P, 1989, GEOCHIM COSMOCHIM AC, V53, P1367, DOI 10.1016/0016-7037(89)90069-0; Deines P, 2001, GEOCHIM COSMOCHIM AC, V65, P813, DOI 10.1016/S0016-7037(00)00569-X; DEINES P, 1984, GEOCHIM COSMOCHIM AC, V48, P325, DOI 10.1016/0016-7037(84)90254-0; DEINES P, 1991, GEOCHIM COSMOCHIM AC, V55, P515, DOI 10.1016/0016-7037(91)90009-T; DEINES P, 1995, GEOCHIM COSMOCHIM AC, V59, P3173, DOI 10.1016/0016-7037(95)00205-E; DEINES P, 1993, GEOCHIM COSMOCHIM AC, V57, P2781, DOI 10.1016/0016-7037(93)90390-I; GURNEY JJ, 1989, GEOL SOC AUSTR SPEC, V14, P935; HAGGERTY SE, 1986, NATURE, V320, P34, DOI 10.1038/320034a0; Harris J.W., 1992, PROPERTIES NATURAL S, P345; HARRIS JD, UNPUB; Irvine GJ, 2001, GEOPHYS RES LETT, V28, P2505, DOI 10.1029/2000GL012411; James DE, 2001, GEOPHYS RES LETT, V28, P2485, DOI 10.1029/2000GL012578; JAMES DE, IN PRESS EARLY EARTH; JANNEY PE, 1999, 9 ANN VM GOLDSCHM C; JANSE AJA, 1992, RUSS GEOL GEOPHYS, V33, P9; JONES MQW, 1988, J GEOPHYS RES-SOLID, V93, P3243, DOI 10.1029/JB093iB04p03243; Jordan T. H., 1979, MANTLE SAMPLE INCLUS, P1, DOI DOI 10.1029/SP016P0001; KIRKLEY M.B., 1991, GEMS GEMOL, V27, P2, DOI DOI 10.5741/GEMS.27.1.2; MILLEDGE HJ, 1983, NATURE, V303, P791, DOI 10.1038/303791a0; NAVON O, 1999, P 7 INT KIMB C RED R, P584; Parman SW, 2001, GEOPHYS RES LETT, V28, P2513, DOI 10.1029/2000GL012713; Pearson DG, 1998, EARTH PLANET SC LETT, V160, P311, DOI 10.1016/S0012-821X(98)00092-2; PEARSON DG, 1999, APPL RADIOGENIC ISOT, V12, P143; Richardson Samuel, UNPUB, pXI; RICHARDSON SH, 1986, NATURE, V322, P623, DOI 10.1038/322623a0; RICHARDSON SH, 1990, NATURE, V346, P54, DOI 10.1038/346054a0; Richardson SH, 2001, EARTH PLANET SC LETT, V191, P257, DOI 10.1016/S0012-821X(01)00419-8; RICHARDSON SH, 1984, NATURE, V310, P198, DOI 10.1038/310198a0; RICHARDSON SH, 1993, NATURE, V366, P256, DOI 10.1038/366256a0; RICHARDSON SH, 1999, PH NIXON VOLUME, P734; SCHMITZ MD, 2002, THESIS MIT; SHIREY S, UNPUB; Shirey SB, 2001, GEOPHYS RES LETT, V28, P2509, DOI 10.1029/2000GL012589; Smith C.B., 1985, T GEOL SOC S AFR, V88, P249; SMITH CB, 1991, GEOCHIM COSMOCHIM AC, V55, P2579, DOI 10.1016/0016-7037(91)90374-E; Stachel T, 1998, EARTH PLANET SC LETT, V159, P1, DOI 10.1016/S0012-821X(98)00064-8; Valley JW, 1998, CONTRIB MINERAL PETR, V133, P1, DOI 10.1007/s004100050432; WALKER RJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1583, DOI 10.1016/0016-7037(89)90240-8; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29	54	131	134	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587					1683	1686		10.1126/science.1072384	http://dx.doi.org/10.1126/science.1072384			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215642				2022-12-28	WOS:000177819100044
J	Monnin, T; Ratnieks, FLW; Jones, GR; Beard, R				Monnin, T; Ratnieks, FLW; Jones, GR; Beard, R			Pretender punishment induced by chemical signalling in a queenless ant	NATURE			English	Article							CUTICULAR HYDROCARBONS; SOCIAL INSECTS; FERTILITY; DOMINANCE; WORKERS	Animal societies are stages for both conflict and cooperation. Reproduction is often monopolized by one or a few individuals who behave aggressively to prevent subordinates from reproducing (for example, naked mole-rats(1), wasps(2) and ants(3)). Here we report an unusual mechanism by which the dominant individual maintains reproductive control. In the queenless ant Dinoponera quadriceps, only the alpha female reproduces. If the alpha is challenged by another female she chemically marks the pretender who is then punished(4) by low-ranking females. This cooperation between alpha and low-rankers allows the alpha to inflict punishment indirectly, thereby maintaining her reproductive primacy without having to fight.	Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England; Univ Keele, Sch Chem & Phys, Chem Ecol Grp, Keele ST5 5BG, Staffs, England	University of Sheffield; Keele University	Monnin, T (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England.	Thibaud.Monnin@snv.jussieu.fr	Monnin, Thibaud/J-9409-2012	Monnin, Thibaud/0000-0003-3762-942X				ALLIES AB, 1986, J CHEM ECOL, V12, P1285, DOI 10.1007/BF01012348; [Anonymous], 1971, INSECT SOC; Barron AB, 2001, BEHAV ECOL SOCIOBIOL, V50, P199, DOI 10.1007/s002650100362; Billen Johan, 1998, P3; Clarke FM, 1997, P ROY SOC B-BIOL SCI, V264, P993, DOI 10.1098/rspb.1997.0137; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Cuvillier-Hot V, 2001, J INSECT PHYSIOL, V47, P485, DOI 10.1016/S0022-1910(00)00137-2; Foster KR, 2000, NATURE, V407, P692, DOI 10.1038/35037665; Foster KR, 2001, P ROY SOC B-BIOL SCI, V268, P169, DOI 10.1098/rspb.2000.1346; Gobin B, 1999, ANIM BEHAV, V58, P1117, DOI 10.1006/anbe.1999.1245; HEINZE J, 1994, NATURWISSENSCHAFTEN, V81, P489, DOI 10.1007/s001140050114; Heinze J, 1998, CHEMOECOLOGY, V8, P169, DOI 10.1007/s000490050022; HOLLDOBLER B, 1990, NATS; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Liebig J, 1999, P ROY SOC B-BIOL SCI, V266, P1865, DOI 10.1098/rspb.1999.0858; Liebig J, 2000, P NATL ACAD SCI USA, V97, P4124, DOI 10.1073/pnas.97.8.4124; Monnin T, 2001, BEHAV ECOL SOCIOBIOL, V50, P97, DOI 10.1007/s002650100351; Monnin T, 1999, BEHAV ECOL, V10, P323, DOI 10.1093/beheco/10.3.323; Monnin T, 1997, NATURWISSENSCHAFTEN, V84, P499, DOI 10.1007/s001140050433; Monnin T, 1998, ANIM BEHAV, V55, P299, DOI 10.1006/anbe.1997.0601; Monnin T, 1998, J CHEM ECOL, V24, P473, DOI 10.1023/A:1022360718870; Ortius D, 1999, BEHAV ECOL SOCIOBIOL, V45, P151, DOI 10.1007/s002650050548; Peeters C, 1999, P ROY SOC B-BIOL SCI, V266, P1323, DOI 10.1098/rspb.1999.0782; Peeters Christian, 1993, P234; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; REGNIER FE, 1971, SCIENCE, V172, P267, DOI 10.1126/science.172.3980.267; Roseler P.-F., 1991, P309; Solomon N. G., 1997, COOPERATIVE BREEDING; Stacey P.B., 1990, COOPERATIVE BREEDING	30	108	111	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					61	65		10.1038/nature00932	http://dx.doi.org/10.1038/nature00932			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214231	Green Accepted			2022-12-28	WOS:000177788600036
J	Carpena, P; Bernaola-Galvan, P; Ivanov, PC; Stanley, HE				Carpena, P; Bernaola-Galvan, P; Ivanov, PC; Stanley, HE			RETRACTED: Metal-insulator transition in chains with correlated disorder (Retracted Article. See vol 421, pg 764, 2003)	NATURE			English	Article; Retracted Publication							LONG-RANGE CORRELATIONS; 1D ANDERSON MODEL; ELECTRICAL-CONDUCTION; LOCALIZATION LENGTH; DNA; ABSENCE; EXPONENT; DELOCALIZATION; TRANSPORT; SPECTRUM	According to Bloch's theorem, electronic wavefunctions in perfectly ordered crystals are extended, which implies that the probability of finding an electron is the same over the entire crystal(1). Such extended states can lead to metallic behaviour. But when disorder is introduced in the crystal, electron states can become localized, and the system can undergo a metal-insulator transition (also known as an Anderson transition)(2-4). Here we theoretically investigate the effect on the physical properties of the electron wavefunctions of introducing long-range correlations in the disorder in one-dimensional binary solids, and find a correlation-induced metal-insulator transition. We perform-numerical simulations using a one-dimensional tight-binding model, and find a threshold value for the exponent characterizing the long-range correlations of the system. Above this threshold, and in the thermodynamic limit, the system behaves as a conductor within a broad energy band; below threshold, the system behaves as an insulator. We discuss the possible relevance of this result for electronic transport in DNA, which displays long-range correlations(5,6) and has recently been reported to be a one-dimensional disordered conductor(7-10)	Univ Malaga, ETSI Telecomunicac, Dept Fis Aplicada 2, E-29071 Malaga, Spain; Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; Boston Univ, Dept Phys, Boston, MA 02215 USA	Universidad de Malaga; Boston University; Boston University	Carpena, P (corresponding author), Univ Malaga, ETSI Telecomunicac, Dept Fis Aplicada 2, E-29071 Malaga, Spain.	pcarpena@ctima.uma.cs	Ivanov, Plamen Ch./E-8004-2012; Carpena, Pedro/C-6791-2009	Ivanov, Plamen Ch./0000-0001-7629-762X; Carpena, Pedro/0000-0001-5568-0216; Bernaola Galvan, Pedro Angel/0000-0002-2895-3116				ABOUCHACRA R, 1973, J PHYS C SOLID STATE, V6, P1734, DOI 10.1088/0022-3719/6/10/009; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Ashcroft N.W, 1976, SOLID STATE PHYS; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Dandliker PJ, 1997, SCIENCE, V275, P1465, DOI 10.1126/science.275.5305.1465; DAVIDS PS, 1995, PHYS REV B, V52, P4146, DOI 10.1103/PhysRevB.52.4146; de Moura FABF, 1998, PHYS REV LETT, V81, P3735, DOI 10.1103/PhysRevLett.81.3735; de Pablo PJ, 2000, PHYS REV LETT, V85, P4992, DOI 10.1103/PhysRevLett.85.4992; DUNLAP DH, 1990, PHYS REV LETT, V65, P88, DOI 10.1103/PhysRevLett.65.88; Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855; Henderson PT, 1999, P NATL ACAD SCI USA, V96, P8353, DOI 10.1073/pnas.96.15.8353; Hjort M, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.228101; HOFSTETTER E, 1993, PHYS REV B, V48, P16979, DOI 10.1103/PhysRevB.48.16979; Holste D, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041917; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Janssen M, 1998, PHYS REP, V295, P2; Kantelhardt JW, 2000, PHYS REV LETT, V84, P198, DOI 10.1103/PhysRevLett.84.198; Kasumov AY, 2001, SCIENCE, V291, P280, DOI 10.1126/science.291.5502.280; KRAMER B, 1993, REP PROG PHYS, V56, P1469, DOI 10.1088/0034-4885/56/12/001; Kravchenko SV, 1996, PHYS REV LETT, V77, P4938, DOI 10.1103/PhysRevLett.77.4938; MACKINNON A, 1981, PHYS REV LETT, V47, P1546, DOI 10.1103/PhysRevLett.47.1546; Makse HA, 1996, PHYS REV E, V53, P5445, DOI 10.1103/PhysRevE.53.5445; MATSUDA H, 1970, SUP PROG THEOR PHYS, P56; MOTT NF, 1961, ADV PHYS, V10, P107, DOI 10.1080/00018736100101271; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; PHILLIPS P, 1991, SCIENCE, V252, P1805, DOI 10.1126/science.252.5014.1805; Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029; Schweitzer L, 1997, J PHYS-CONDENS MAT, V9, pL441, DOI 10.1088/0953-8984/9/33/001; Weymer A, 1998, ANN PHYS-BERLIN, V7, P159, DOI 10.1002/andp.19985100303; Yoo KH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198102	30	194	200	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2002	418	6901					955	959		10.1038/nature00948	http://dx.doi.org/10.1038/nature00948			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198542				2022-12-28	WOS:000177677500039
J	Kahn, R; Herwald, H; Muller-Esterl, W; Schmitt, R; Sjogren, AC; Truedsson, L; Karpman, D				Kahn, R; Herwald, H; Muller-Esterl, W; Schmitt, R; Sjogren, AC; Truedsson, L; Karpman, D			Contact-system activation in children with vasculitis	LANCET			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MOLECULAR-WEIGHT KININOGEN; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; SCHONLEIN PURPURA NEPHRITIS; HUMAN-PLASMA; HUMAN-NEUTROPHILS; ACE GENE; BRADYKININ; POLYMORPHISM; KALLIKREIN	Background The contact system triggers the kallikrein-kinin cascade, liberating bradykinin from high-molecular-weight kininogen. Effectors of the contact system have proinflammatory and vasoactive properties. Vasculitis is a condition characterised by inflammation around vessel walls, leading to secondary tissue damage for which the underlying molecular mechanisms are poorly understood. Our aim was to investigate contact-system activation in children with vasculitis. Methods We compared 17 children, aged 4-19 years, with vasculitis, engaging the skin, joints, intestines, or kidneys, with 21 controls, aged 2-18 years. We analysed proteolysis of high-molecular-weight kininogen by immunoblotting. Plasma bradykinin concentrations were quantified by ELISA. Kidney and skin biopsies were stained in situ for kinins. Concentrations of heparin binding protein (HBP) were quantified by ELISA. Findings We noted extensive proteolysis of high-molecular-weight kininogen in the plasma of 13 of 17 patients, but in only one of 21 controls (p<0.0001). Bradykinin concentrations were higher in the patients' plasma (median 320 ng/L, range <1-19 680) than in plasma from controls (11 ng/L, <1-304; p=0.0004). Patients had local release of kinins at sites of inflammation in kidney and skin biopsies. HBP values were raised in patients (17.4 mu g/L, 5.4-237.6) compared with controls (6 mu g/L, 2.5-43.4; p=0.008). Interpretation Activation of the contact system could play a part in the pathogenesis of vasculitis, and explain the inflammation, pain, vasodilatation, and oedema seen in patients.	Lund Univ, Dept Paediat, Lund, Sweden; Lund Univ, Dept Cell & Mol Biol, Lund, Sweden; Lund Univ, Dept Lab Med, Lund, Sweden; Univ Hosp, Inst Biochem 2, Frankfurt, Germany	Lund University; Lund University; Lund University; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Karpman, D (corresponding author), Lund Univ, Dept Paediat, Lund, Sweden.	diana.karpman@pedi.lu.se	Herwald, Heiko/AAN-3708-2021	Herwald, Heiko/0000-0002-8111-2842; Karpman, Diana/0000-0001-7220-7658; Schmitt, Roland/0000-0003-4294-6526; Aradottir, Sigridur Sunna/0000-0002-6898-3256				Bank U, 2001, J LEUKOCYTE BIOL, V69, P197; Bergamaschini L, 1998, ALZ DIS ASSOC DIS, V12, P102, DOI 10.1097/00002093-199806000-00008; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Bjartell A, 1999, HISTOCHEM J, V31, P45, DOI 10.1023/A:1003504115690; BUTTERY JE, 1993, CLIN CHEM, V39, P312; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Dudley J, 2000, PEDIATR NEPHROL, V14, P218, DOI 10.1007/s004670050045; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; GUSTAFSON EJ, 1989, J CLIN INVEST, V84, P28, DOI 10.1172/JCI114151; HASAN AAK, 1995, J BIOL CHEM, V270, P19256, DOI 10.1074/jbc.270.33.19256; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; JENNETTE JC, 1990, AM J KIDNEY DIS, V15, P517, DOI 10.1016/S0272-6386(12)80521-X; KAPLAN AP, 1972, J EXP MED, V135, P81, DOI 10.1084/jem.135.1.81; KAUFMANN J, 1993, J BIOL CHEM, V268, P9079; Mahabeer R, 2000, PHARMACOL THERAPEUT, V88, P77, DOI 10.1016/S0163-7258(00)00080-2; Mattsson E, 2001, INFECT IMMUN, V69, P3877, DOI 10.1128/IAI.69.6.3877-3882.2001; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLERESTERL W, 1988, METHOD ENZYMOL, V163, P240; PEREIRA HA, 1995, J LEUKOCYTE BIOL, V57, P805, DOI 10.1002/jlb.57.6.805; PIXLEY RA, 1997, HDB IMMUNOPHARMACOLO, P173; Pullmann R, 1999, CLIN EXP RHEUMATOL, V17, P593; REDDIGARI S, 1995, INT ARCH ALLERGY IMM, V107, P93, DOI 10.1159/000236941; Regoli D, 1998, EUR J PHARMACOL, V348, P1, DOI 10.1016/S0014-2999(98)00165-4; Savige J, 2000, KIDNEY INT, V57, P846, DOI 10.1046/j.1523-1755.2000.057003846.x; SCHAPIRA M, 1983, NEW ENGL J MED, V308, P1050, DOI 10.1056/NEJM198305053081802; Stadnicki A, 1997, DIGEST DIS SCI, V42, P2356, DOI 10.1023/A:1018891323205; Tapper H, 2002, BLOOD, V99, P1785, DOI 10.1182/blood.V99.5.1785; VANDERGRAAF F, 1982, BLOOD, V59, P1225; VERPY E, 1995, J CLIN INVEST, V95, P350, DOI 10.1172/JCI117663; Volpe AR, 1999, IMMUNOPHARMACOLOGY, V44, P87, DOI 10.1016/S0162-3109(99)00140-X; WACHTFOGEL YT, 1989, BLOOD, V73, P468; WACHTFOGEL YT, 1983, J CLIN INVEST, V72, P1672, DOI 10.1172/JCI111126; YANG HYT, 1970, BIOCHIM BIOPHYS ACTA, V214, P374, DOI 10.1016/0005-2795(70)90017-6; Yoshioka T, 1998, ARCH DIS CHILD, V79, P394, DOI 10.1136/adc.79.5.394; Zhao MH, 1996, CLIN EXP IMMUNOL, V103, P397	36	33	37	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2002	360	9332					535	541		10.1016/S0140-6736(02)09743-X	http://dx.doi.org/10.1016/S0140-6736(02)09743-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241658				2022-12-28	WOS:000177512800012
J	Whittle, H; Jaffar, S; Wansbrough, M; Mendy, M; Dumpis, U; Collinson, A; Hall, A				Whittle, H; Jaffar, S; Wansbrough, M; Mendy, M; Dumpis, U; Collinson, A; Hall, A			Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM EFFICACY; 12-YEAR FOLLOW-UP; VIRUS-INFECTION	Objective To determine the duration of protection from hepatitis B vaccine given in-infancy and early childhood. Design Cross sectional serological study of hepatitis B virus infection in children of various ages 14 years after the start of a trial of vaccination regimens. Setting Two villages in the Gambia. Participants Children and adolescents given hepatitis B vaccine in infancy or early childhood: 232 were aged 1-5 years, 225 aged 5-9 years, 220 aged 10-14 years, and 175 aged 15-19 years. Main outcome measures Vaccine efficacy against infection and against chronic infection in the different age groups. Results Vaccine efficacy against chronic hepatitis B virus carriage was 94% (95% confidence interval 89% to 97%) which did not vary significantly between the age groups. Efficacy against infection was 80% (76% to 84%). This, was significantly lower in the oldest age group (65%, 56 to 73). Of the uninfected participants in this age group, 36% had no detectable hepatitis B virus surface antibody. Time since vaccination and a low peak antibody response were the most powerful risk factors for breakthrough infection (P < 0.001 in each case). Low peak antibody response was also a risk factor for chronic carriage (odds ratio 95, 19 to 466). Conclusions Children vaccinated in infancy are at increased risk of hepatitis B virus infection in the late teens. The risk of chronic carriage after sexual exposure needs further assessment to determine if booster vaccines are necessary.	MRC Labs, Banjul, Gambia; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine	Whittle, H (corresponding author), MRC Labs, POB 273, Banjul, Gambia.	hwhittle@mrc.gm	Mendy, Maimuna/ABD-5038-2021	Dumpis, Uga/0000-0001-6778-9411; Jaffar, Shabbar/0000-0002-9615-1588				[Anonymous], 1987, CANCER RES, V47, P5782; Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6; Chen HL, 1996, JAMA-J AM MED ASSOC, V276, P906, DOI 10.1001/jama.276.11.906; COURSAGET P, 1994, J HEPATOL, V21, P250, DOI 10.1016/S0168-8278(05)80404-0; *GAMB HEP INV STUD, 1996, ANN REP 1996, P12; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578; KANE MA, 1993, DIS CONTROL PRIORITI, P321; Liao SS, 1999, VACCINE, V17, P2661, DOI 10.1016/S0264-410X(99)00031-6; MAYANS MV, 1990, LANCET, V336, P1107, DOI 10.1016/0140-6736(90)92580-B; Ratcliffe AA, 2000, B WORLD HEALTH ORGAN, V78, P570; WHITTLE H, 1990, J INFECT DIS, V161, P1112, DOI 10.1093/infdis/161.6.1112; WHITTLE HC, 1987, ANN TROP PAEDIATR, V7, P6, DOI 10.1080/02724936.1987.11748464; WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4; WHITTLE HC, 1995, LANCET, V345, P1089, DOI 10.1016/S0140-6736(95)90822-6; WHITTLE HC, 1983, LANCET, V1, P1203; *WHO SCI GROUP PRE, 1983, LANCET, V1, P463; Yuen MF, 1999, HEPATOLOGY, V29, P924, DOI 10.1002/hep.510290327	18	103	112	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2002	325	7364					569	572		10.1136/bmj.325.7364.569	http://dx.doi.org/10.1136/bmj.325.7364.569			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595JJ	12228132	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000178105200016
J	Rahmstorf, S				Rahmstorf, S			Ocean circulation and climate during the past 120,000 years	NATURE			English	Review							NORTH-ATLANTIC CLIMATE; COUPLED GLOBAL-MODEL; DEEP-WATER FORMATION; YOUNGER DRYAS EVENT; THERMOHALINE CIRCULATION; INTERMEDIATE COMPLEXITY; ICE-SHEET; DANSGAARD-OESCHGER; ICEBERG DISCHARGES; ATMOSPHERE MODEL	Oceans cover more than two-thirds of our blue planet. The waters move in a global circulation system, driven by subtle density differences and transporting huge amounts of heat. Ocean circulation is thus an active and highly nonlinear player in the global climate game. Increasingly clear evidence implicates ocean circulation in abrupt and dramatic climate shifts, such as sudden temperature changes in Greenland on the order of 5-10degreesC and massive surges of icebergs into the North Atlantic Ocean - events that have occurred repeatedly during the last glacial cycle.	Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung	Rahmstorf, S (corresponding author), Potsdam Inst Climate Impact Res, POB 601203, D-14412 Potsdam, Germany.		Rahmstorf, Stefan/A-8465-2010	Rahmstorf, Stefan/0000-0001-6786-7723				Alley RB, 1999, ANNU REV EARTH PL SC, V27, P149, DOI 10.1146/annurev.earth.27.1.149; Alley RB, 2002, QUATERNARY SCI REV, V21, P431, DOI 10.1016/S0277-3791(01)00072-5; Alley RB, 2001, PALEOCEANOGRAPHY, V16, P190, DOI 10.1029/2000PA000518; Andrews JT, 1998, J QUATERNARY SCI, V13, P3; Bacon S, 1998, NATURE, V394, P871, DOI 10.1038/29736; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Bianchi GG, 1999, NATURE, V397, P515, DOI 10.1038/17362; BIRCHFIELD EG, 1994, J GEOPHYS RES-OCEANS, V99, P12459, DOI 10.1029/94JC00523; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Bond G.C., 1999, MECH GLOBAL CLIMATE, P35; BOND GC, 1995, SCIENCE, V267, P1005, DOI 10.1126/science.267.5200.1005; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; BROECKER WS, 1985, NATURE, V315, P21, DOI 10.1038/315021a0; Bush ABG, 1998, SCIENCE, V279, P1341, DOI 10.1126/science.279.5355.1341; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Cane M, 1999, GEOPH MONOG SERIES, V112, P373; Chappell J, 2002, QUATERNARY SCI REV, V21, P1229, DOI 10.1016/S0277-3791(01)00141-X; Clark PU, 2001, SCIENCE, V293, P283, DOI 10.1126/science.1062517; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Claussen M, 2002, CLIM DYNAM, V18, P579, DOI 10.1007/s00382-001-0200-1; Clement AC, 1999, GEOPH MONOG SERIES, V112, P363; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; DELWORTH T, 1993, J CLIMATE, V6, P1993, DOI 10.1175/1520-0442(1993)006<1993:IVOTTC>2.0.CO;2; DENTON GH, 1994, SCIENCE, V264, P1434, DOI 10.1126/science.264.5164.1434; Dickson B, 2002, NATURE, V416, P832, DOI 10.1038/416832a; Dickson R, 1996, PROG OCEANOGR, V38, P241, DOI 10.1016/S0079-6611(97)00002-5; Elliot M, 2002, QUATERNARY SCI REV, V21, P1153, DOI 10.1016/S0277-3791(01)00137-8; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fanning AF, 1997, PALEOCEANOGRAPHY, V12, P307, DOI 10.1029/96PA03726; Gallimore RG, 1996, NATURE, V381, P503, DOI 10.1038/381503a0; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; Ganopolski A, 2002, PHYS REV LETT, V88, DOI [10.1103/PhysRevLett.88.038501, 10.1103/PhysRevB.88.038501]; Ganopolski A, 2001, CLIM DYNAM, V17, P735, DOI 10.1007/s003820000144; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Ganopolski A, 1998, NATURE, V391, P351, DOI 10.1038/34839; Gildor H, 2001, J GEOPHYS RES-OCEANS, V106, P9117, DOI 10.1029/1999JC000120; Gill AE, 1982, ATMOSPHERE OCEAN DYN; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; HAJDAS I, IN PRESS QUAT RES; Hansen B, 2001, NATURE, V411, P927, DOI 10.1038/35082034; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Hemming SR, 2000, QUATERNARY RES, V54, P372, DOI 10.1006/qres.2000.2181; Hewitt CD, 2001, GEOPHYS RES LETT, V28, P1571, DOI 10.1029/2000GL012575; KEIGWIN LD, 1994, PALEOCEANOGRAPHY, V9, P185, DOI 10.1029/94PA00032; KEIGWIN LD, 1994, NATURE, V371, P323, DOI 10.1038/371323a0; Khodri M, 2001, NATURE, V410, P570, DOI 10.1038/35069044; Kubatzki C, 2000, CLIM DYNAM, V16, P799, DOI 10.1007/s003820000078; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; LENDERINK G, 1994, J PHYS OCEANOGR, V24, P1480, DOI 10.1175/1520-0485(1994)024<1480:VAMEOT>2.0.CO;2; Lynch-Stieglitz J, 1999, NATURE, V402, P644, DOI 10.1038/45204; MACAYEAL DR, 1993, PALEOCEANOGRAPHY, V8, P775, DOI 10.1029/93PA02200; MANABE S, 1995, NATURE, V378, P165, DOI 10.1038/378165a0; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Manabe S, 1997, PALEOCEANOGRAPHY, V12, P321, DOI 10.1029/96PA03932; Marchal O, 1999, CLIM DYNAM, V15, P341, DOI 10.1007/s003820050286; Marshall J, 2001, INT J CLIMATOL, V21, P1863, DOI 10.1002/joc.693; Mix AC, 2001, QUATERNARY SCI REV, V20, P627, DOI 10.1016/S0277-3791(00)00145-1; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Moreno PI, 2001, NATURE, V409, P804, DOI 10.1038/35057252; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; Muscheler R, 2000, NATURE, V408, P567, DOI 10.1038/35046041; OPPO DW, 1993, SCIENCE, V259, P1148, DOI 10.1126/science.259.5098.1148; Paillard D, 2001, REV GEOPHYS, V39, P325, DOI 10.1029/2000RG000091; Paillard D, 1999, PALEOCEANOGRAPHY, V14, P716, DOI 10.1029/1999PA900045; Petoukhov V, 2000, CLIM DYNAM, V16, P1, DOI 10.1007/PL00007919; RAHMSTORF S, 1994, NATURE, V372, P82, DOI 10.1038/372082a0; Rahmstorf S, 1996, CLIM DYNAM, V12, P799, DOI 10.1007/s003820050144; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Rahmstorf S, 1999, CLIMATIC CHANGE, V43, P353, DOI 10.1023/A:1005474526406; Rahmstorf S, 2000, CLIMATIC CHANGE, V46, P247, DOI 10.1023/A:1005648404783; RAHMSTORF S, 2002, EOS, V83, P129; RAHMSTORF S, 2001, ENCY OCEAN SCI, P1; RAHMSTORF S, 1999, EL NINO DECADAL INTE, P309; Renssen H, 2001, GEOPHYS RES LETT, V28, P1567, DOI 10.1029/2000GL012602; Renssen H, 2000, QUATERN INT, V68, P373, DOI 10.1016/S1040-6182(00)00060-4; Sachs JP, 1999, SCIENCE, V286, P756, DOI 10.1126/science.286.5440.756; SARNTHEIN M, 1994, PALEOCEANOGRAPHY, V9, P209, DOI 10.1029/93PA03301; Seidov D, 2001, GEOPH MONOG SERIES, V126, P147; Stocker TF, 1998, SCIENCE, V282, P61, DOI 10.1126/science.282.5386.61; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Stouffer RJ, 1999, J CLIMATE, V12, P2224, DOI 10.1175/1520-0442(1999)012<2224:ROACOA>2.0.CO;2; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; van Geel B, 1999, QUATERNARY SCI REV, V18, P331, DOI 10.1016/S0277-3791(98)00088-2; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Voelker AHL, 2002, QUATERNARY SCI REV, V21, P1185, DOI 10.1016/S0277-3791(01)00139-1; Weaver AJ, 1999, GEOPH MONOG SERIES, V112, P285; Weaver AJ, 1998, NATURE, V394, P847, DOI 10.1038/29695; Webb RS, 1997, NATURE, V385, P695, DOI 10.1038/385695a0; WINTON M, 1993, J PHYS OCEANOGR, V23, P1389, DOI 10.1175/1520-0485(1993)023<1389:TOIBSS>2.0.CO;2; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0; [No title captured]	99	746	790	16	368	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					207	214		10.1038/nature01090	http://dx.doi.org/10.1038/nature01090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226675				2022-12-28	WOS:000177931200050
J	McPhee, SJ; Markowitz, AJ				McPhee, SJ; Markowitz, AJ			Reflections at a palliative care unit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Markowitz, Amy/0000-0001-9314-2814				Oliver M., 1992, NEW SELECTED POEMS; RAYMOND RW, COMMENDATORY PRAYER; von Gunten CF, 2002, JAMA-J AM MED ASSOC, V287, P875, DOI 10.1001/jama.287.7.875; Wilder T., 1927, BRIDGE SAN LUIS REY	4	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1279	1279		10.1001/jama.288.10.1279	http://dx.doi.org/10.1001/jama.288.10.1279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215136				2022-12-28	WOS:000177917700028
J	Finlayson, B; Dixon, J; Meadows, S; Blair, G				Finlayson, B; Dixon, J; Meadows, S; Blair, G			Mind the gap: the extent of the NHS nursing shortage	BRITISH MEDICAL JOURNAL			English	Article									Kings Fund, Healt Care Policy Programme, London W1G 0AN, England		Finlayson, B (corresponding author), Kings Fund, Healt Care Policy Programme, London W1G 0AN, England.							*AUD COMM, 1997, FIND KEEP MAN STAFF; Audit commission, 2001, BRIEF ENC GETT BEST; *DEP HLTH, 2001, 20013 DOH; *DEP HLTH, 2000, NAT SURV NHS PAT COR; *DEP HLTH, 2001, VAC SURV MARCH 2000; Finlayson B, 2002, BRIT MED J, V325, P541, DOI 10.1136/bmj.325.7363.541; FINLAYSON B, 2002, COUNTING SMILES MORA; Gray AM, 1996, HEALTH POLICY, V38, P117, DOI 10.1016/0168-8510(96)00854-8; MEADOWS S, 2000, LAST STRAW EXPLAININ; *NAT AUD OFF, 2001, ED TRAIN FUT HLTH PR; *PRIC, 1998, NURS RET RECR REP FA; *ROYAL COLL NURS, 2000, MAK DIFF REV UK NURS; *ROYAL COLL NURS, 1998, SNAPSH SURV IMP NURS; SECCOMBE I, 1997, TAKING PART REGISTER; SMITH G, 1998, CHANGING TIMES SURVE; *UK CENTR COUNC NU, 2000, ANN STAT, V1	16	68	68	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2002	325	7363					538	541		10.1136/bmj.325.7363.538	http://dx.doi.org/10.1136/bmj.325.7363.538			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593NJ	12217997	Green Published			2022-12-28	WOS:000177997800023
J	Gerard, I; Verhelst, D				Gerard, I; Verhelst, D			Pneumopericardium	LANCET			English	Article									Univ Catholique Louvain, Clin Univ St Luc, Dept Intens Care, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Gerard, I (corresponding author), Univ Catholique Louvain, Clin Univ St Luc, Dept Intens Care, B-1200 Brussels, Belgium.								0	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 7	2002	360	9335					771	771		10.1016/S0140-6736(02)09898-7	http://dx.doi.org/10.1016/S0140-6736(02)09898-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592HX	12241835				2022-12-28	WOS:000177933000018
J	Johansson, J; Mandin, P; Renzoni, A; Chiaruttini, C; Springer, M; Cossart, P				Johansson, J; Mandin, P; Renzoni, A; Chiaruttini, C; Springer, M; Cossart, P			An RNA thermosensor controls expression of virulence genes in Listeria monocytogenes	CELL			English	Article							ESCHERICHIA-COLI; PLEIOTROPIC ACTIVATOR; MAMMALIAN-CELLS; PRFA; PROTEIN; TRANSLATION; INTERNALIN; REGULATOR; PROMOTER; CLONING	In Listeria monocytogenes, virulence genes are maximally expressed at 37degreesC, almost silent at 30degreesC and controlled by PrfA, a transcriptional activator whose expression is thermoregulated. Here, we show that the untranslated mRNA (UTR) preceding prfA, forms a secondary structure, which masks the ribosome binding region. Mutations predicted to destabilize this structure led to virulence gene expression and invasion of mammalian cells at 30degreesC. Chemical probing, native gel electrophoresis, in vitro translation, and "compensatory" and "increased stability" mutations demonstrated that the UTR switches between a structure active at high temperatures, and another inactive at low temperatures. Strikingly, when the DNA corresponding to the UTR was fused to gfp in E. coli, bacteria became fluorescent at 37degreesC, but not at 30degreesC. This mechanism of posttranscriptional thermoregulation may have important applications.	Inst Pasteur, Unite Interact Bacteries Cellules, F-75724 Paris 15, France; Inst Biol Physicochim, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, 28 Rue Dr Roux, F-75724 Paris 15, France.		Taylor, Graham/A-4027-2012	Mandin, Pierre/0000-0002-4870-941X; Renzoni, Adriana/0000-0002-4897-5208				BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BHATTACHARYYA A, 1990, NATURE, V343, P484, DOI 10.1038/343484a0; Bockmann R, 1996, MOL MICROBIOL, V22, P643, DOI 10.1046/j.1365-2958.1996.d01-1722.x; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; FREITAG NE, 1993, INFECT IMMUN, V61, P2537, DOI 10.1128/IAI.61.6.2537-2544.1993; GAILLARD JL, 1994, METHOD ENZYMOL, V236, P551; GEUSKENS V, 1992, EMBO J, V11, P5121, DOI 10.1002/j.1460-2075.1992.tb05619.x; HOE NP, 1993, J BACTERIOL, V175, P7901, DOI 10.1128/JB.175.24.7901-7909.1993; Hurme R, 1997, CELL, V90, P55, DOI 10.1016/S0092-8674(00)80313-X; KLARSFELD AD, 1994, MOL MICROBIOL, V13, P585, DOI 10.1111/j.1365-2958.1994.tb00453.x; LEIMEISTERWACHTER M, 1990, P NATL ACAD SCI USA, V87, P8336, DOI 10.1073/pnas.87.21.8336; LEIMEISTERWACHTER M, 1992, J BACTERIOL, V174, P947, DOI 10.1128/jb.174.3.947-952.1992; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; MENGAUD J, 1991, MOL MICROBIOL, V5, P2273, DOI 10.1111/j.1365-2958.1991.tb02158.x; Morita MT, 1999, GENE DEV, V13, P655, DOI 10.1101/gad.13.6.655; NATO F, 1991, INFECT IMMUN, V59, P4641, DOI 10.1128/IAI.59.12.4641-4646.1991; Nocker A, 2001, NUCLEIC ACIDS RES, V29, P4800, DOI 10.1093/nar/29.23.4800; PHILIPPE C, 1993, P NATL ACAD SCI USA, V90, P4394, DOI 10.1073/pnas.90.10.4394; Renzoni A, 1997, INFECT IMMUN, V65, P1515, DOI 10.1128/IAI.65.4.1515-1518.1997; SHEEHAN B, 1995, J BACTERIOL, V177, P6469, DOI 10.1128/jb.177.22.6469-6476.1995; Sheehan B, 1996, MOL MICROBIOL, V20, P785, DOI 10.1111/j.1365-2958.1996.tb02517.x; VICENTE MF, 1985, FEMS MICROBIOL LETT, V30, P77; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	24	470	494	2	56	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 6	2002	110	5					551	561		10.1016/S0092-8674(02)00905-4	http://dx.doi.org/10.1016/S0092-8674(02)00905-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230973	Bronze			2022-12-28	WOS:000177943700003
J	Lee, DM; Friend, DS; Gurish, MF; Benoist, C; Mathis, D; Brenner, MB				Lee, DM; Friend, DS; Gurish, MF; Benoist, C; Mathis, D; Brenner, MB			Mast cells: A cellular link between autoantibodies and inflammatory arthritis	SCIENCE			English	Article							FC-GAMMA-RIII; C-KIT LIGAND; RHEUMATOID-ARTHRITIS; DIFFERENTIAL EXPRESSION; ARTHUS REACTION; TNF-ALPHA; T-CELL; RECEPTOR; MOUSE; DISEASE	Previous studies have revealed that autoantibodies, complement components, and Fc receptors each participate in the pathogenesis of erosive arthritis in K/BxN mice. However, it is not known which cellular populations are responsive to these inflammatory signals. We find that two strains of mice deficient in mast cells, W/W-v and Sl/Sl(d) were resistant to development of joint inflammation and that susceptibility was restored in the W/W-v strain by mast cell engraftment. Thus, mast cells may function as a cellular link between autoantibodies, soluble mediators, and other effector populations in inflammatory arthritis.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Brenner, MB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.				NIAMS NIH HHS [1R01 AR/AI46580-01] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046580] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALBER G, 1992, J IMMUNOL, V149, P2428; Baumann U, 2000, J IMMUNOL, V164, P1065, DOI 10.4049/jimmunol.164.2.1065; Baumann U, 2001, J IMMUNOL, V167, P1022, DOI 10.4049/jimmunol.167.2.1022; Bendele A, 1999, ARTHRITIS RHEUM, V42, P498, DOI 10.1002/1529-0131(199904)42:3<498::AID-ANR15>3.0.CO;2-A; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; BRODER I, 1972, MED CLIN N AM, V56, P529, DOI 10.1016/S0025-7125(16)32412-9; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; FUREDER W, 1995, J IMMUNOL, V155, P3152; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Huang CF, 1998, J IMMUNOL, V160, P1910; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; JONES VE, 1982, CLIN EXP IMMUNOL, V49, P31; KATZ HR, 1992, J IMMUNOL, V148, P868; Kiener HP, 1998, ARTHRITIS RHEUM-US, V41, P233, DOI 10.1002/1529-0131(199802)41:2<233::AID-ART7>3.0.CO;2-V; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1979, J EXP MED, V150, P482, DOI 10.1084/jem.150.3.482; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; LEE DS, UNPUB; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; SUZUKI K, 1995, BIOCHEM J, V305, P301, DOI 10.1042/bj3050301; Sylvestre DL, 1996, IMMUNITY, V5, P387, DOI 10.1016/S1074-7613(00)80264-2; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	34	613	660	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1689	1692		10.1126/science.1073176	http://dx.doi.org/10.1126/science.1073176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215644				2022-12-28	WOS:000177819100046
J	Subramanian, MA; Manzer, LE				Subramanian, MA; Manzer, LE			A "greener" synthetic route for fluoroaromatics via copper (II) fluoride	SCIENCE			English	Article									DuPont Co Inc, Cent Res & Dev, Expt Stn, Wilmington, DE 19880 USA	DuPont	Subramanian, MA (corresponding author), DuPont Co Inc, Cent Res & Dev, Expt Stn, Wilmington, DE 19880 USA.		Subramanian, Mas A./E-2002-2011					Balz G, 1927, BER DTSCH CHEM GES, V60, P1186, DOI 10.1002/cber.19270600539; Banks R.E., 1994, ORGANOFLUORINE CHEM; Clark J. H., 1996, AROMATIC FLUORINATIO; Hewitt CD, 1988, ALDRICHIM ACTA, V21, P3; KRACKOV M, 1988, Patent No. 330420; MANZER LE, 1993, ADV CATAL, V39, P329, DOI 10.1016/S0360-0564(08)60581-7; MOSS JH, 1975, J FLUORINE CHEM, V6, P393, DOI 10.1016/S0022-1139(00)81681-4; SUBRAMANIAN MA, 2000, Patent No. 6166273	8	55	55	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1665	1665		10.1126/science.1076397	http://dx.doi.org/10.1126/science.1076397			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215637				2022-12-28	WOS:000177819100038
J	Ruokolainen, K; Tuomisto, H				Ruokolainen, K; Tuomisto, H			Beta-diversity in tropical forests	SCIENCE			English	Editorial Material									Univ Turku, Dept Biol, FIN-20014 Turku, Finland	University of Turku	Ruokolainen, K (corresponding author), Univ Turku, Dept Biol, FIN-20014 Turku, Finland.	karuoko@utu.fi	Ruokolainen, Kalle/G-3141-2013; Tuomisto, Hanna/G-6483-2012	Ruokolainen, Kalle/0000-0002-7494-9417; Tuomisto, Hanna/0000-0003-1640-490X				AUSTIN MP, 1972, J ECOL, V60, P305, DOI 10.2307/2258348; BAILLIE IC, 1987, J TROP ECOL, V3, P201, DOI 10.1017/S0266467400002078; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; DUIVENVOORDEN JF, 1995, VEGETATIO, V120, P91, DOI 10.1007/BF00034341; Duivenvoorden JF, 1995, TROPENBOS SERIES, V12, P1; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Hubbell Stephen P., 2001, V32, pi; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; PITMAN NCA, 2000, THESIS DUKE U DURHAM; Ruokolainen K, 1997, J TROP ECOL, V13, P243, DOI 10.1017/S0266467400010439; Ruokolainen K, 1998, ANN U TURKUENSIS A, V114, P253; RUOKOLAINEN K, IN PRESS J TROP ECOL; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63	15	33	34	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202787				2022-12-28	WOS:000177697300001
J	Cummins, S; Macintyre, S				Cummins, S; Macintyre, S			"Food deserts" - evidence and assumption in health policy making	BRITISH MEDICAL JOURNAL			English	Article								Assertions can be reported so often that they are considered true ("factoids"). They may sometimes even be used to determine health policy when empirical information is lacking. Steven Cummins and Sally Macintyre use the claimed existence of "food deserts"-poor urban areas where residents cannot buy affordable, healthy food-to illustrate why policy makers need to look more critically at the facts.	MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT	Cummins, S (corresponding author), MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.		Macintyre, Sally/P-6246-2014; Cummins, Steven/C-1230-2009	Cummins, Steven/0000-0002-3957-4357				Acheson D., 1998, INDEPENDENT INQUIRY; [Anonymous], 2002, OXFORD ENGLISH DICT; Beaumont J., 1995, REPORT POLICY SUBGRO; CLARKE G, IN PRESS URBAN STUDI; Competition Commission, 2000, HLN; Cummins S., 1999, British Food Journal, V101, P545, DOI 10.1108/00070709910279027; CUMMINS S, IN PRESS URBAN STUDI; Diez-Roux AV, 1999, J EPIDEMIOL COMMUN H, V53, P55, DOI 10.1136/jech.53.1.55; KILLEEN D, 1994, POOR PAYING IT PRICE; Lang T., 1998, Health Education Journal, V57, P202, DOI 10.1177/001789699805700303; LAURENCE S, 1998, INDEPENDENT     1015; *LOW INC PROJ TEAM, 1996, LOW INC FOOD NUTR HL; Macintyre S, 2000, J EPIDEMIOL COMMUN H, V54, P802, DOI 10.1136/jech.54.11.802; Macintyre S, 2001, BRIT MED J, V322, P222, DOI 10.1136/bmj.322.7280.222; Mooney C., 1990, Journal of Human Nutrition and Dietetics, V3, P111, DOI 10.1111/j.1365-277X.1990.tb00058.x; Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2; PIACHAUD D, 1996, PRICE FOOD MISSING O; SIMPSON A, 2001, HOUSE COMMONS OFFI 5; Smith GD, 1997, P NUTR SOC, V56, P75, DOI 10.1079/PNS19970011; Smith GD, 2001, BRIT MED J, V322, P184, DOI 10.1136/bmj.322.7280.184; Social Exclusion Unit, 1998, BRING BRIT TOG NAT S; Sooman A, 1993, Health Bull (Edinb), V51, P276; WRIGLEY N, IN PRESS URBAN STUDI	23	291	297	1	102	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2002	325	7361					436	438		10.1136/bmj.325.7361.436	http://dx.doi.org/10.1136/bmj.325.7361.436			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193363	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000177715500027
J	Sandford, A; Pare, P				Sandford, A; Pare, P			Homing in on the asthma gene	LANCET			English	Editorial Material							GAMMA PRODUCTION; INTERLEUKIN-12; ASSOCIATION; BLOOD		St Pauls Hosp, iCAPTURE Ctr, McDonald Res Labs, Vancouver, BC V6Z 1Y6, Canada	St. Paul's Hospital; University of Saskatchewan	Sandford, A (corresponding author), St Pauls Hosp, iCAPTURE Ctr, McDonald Res Labs, Vancouver, BC V6Z 1Y6, Canada.	asandford@mrl.ubc.ca	Pare, Peter D/C-7425-2011					BECKMAN L, 1974, HUM HERED, V24, P496, DOI 10.1159/000152688; Blanco-Quiros A, 1999, PEDIATR PULM, V28, P175, DOI 10.1002/(SICI)1099-0496(199909)28:3<175::AID-PPUL3>3.0.CO;2-U; Bont L, 2000, J INFECT DIS, V181, P1772, DOI 10.1086/315433; Comings DE, 1999, AM J MED GENET, V88, P358, DOI 10.1002/(SICI)1096-8628(19990820)88:4<358::AID-AJMG13>3.0.CO;2-G; Comings DE, 1999, MOL PSYCHIATR, V4, P213, DOI 10.1038/sj.mp.4000500; Comings DE, 1999, MOL GENET METAB, V67, P248, DOI 10.1006/mgme.1999.2870; FROHLANDER N, 1989, HUM HERED, V39, P7, DOI 10.1159/000153824; Gately MK, 1996, ANN NY ACAD SCI, V795, P1, DOI 10.1111/j.1749-6632.1996.tb52650.x; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Piccotti JR, 1998, J IMMUNOL, V160, P1132; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188	12	5	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					422	423		10.1016/S0140-6736(02)09693-9	http://dx.doi.org/10.1016/S0140-6736(02)09693-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241708				2022-12-28	WOS:000177342900002
J	Thurfjell, E				Thurfjell, E			Perspective - Breast density and the risk of breast cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Uppsala, S-75185 Uppsala, Sweden	Uppsala University	Thurfjell, E (corresponding author), Univ Uppsala, S-75185 Uppsala, Sweden.								0	22	22	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					866	866		10.1056/NEJMp020093	http://dx.doi.org/10.1056/NEJMp020093			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239254				2022-12-28	WOS:000178040700001
J	Wang, LT; Eckmann, CR; Kadyk, LC; Wickens, M; Kimble, J				Wang, LT; Eckmann, CR; Kadyk, LC; Wickens, M; Kimble, J			A regulatory cytoplasmic poly(A) polymerase in Caenorhabditis elegans	NATURE			English	Article							MESSENGER-RNAS; IDENTIFICATION; FAMILIES; HOMOLOGY; COMPLEX	Messenger RNA regulation is a critical mode of controlling gene expression. Regulation of mRNA stability and translation is linked to controls of poly(A) tail length(1,2). Poly(A) lengthening can stabilize and translationally activate mRNAs, whereas poly(A) removal can trigger degradation and translational repression. Germline granules (for example, polar granules in flies, P granules in worms) are ribonucleoprotein particles implicated in translational control(3). Here we report that the Caenorhabditis elegans gene gld-2, a regulator of mitosis/meiosis decision and other germline events(4), encodes the catalytic moiety of a cytoplasmic poly(A) polymerase (PAP) that is associated with P granules in early embryos. Importantly, the GLD-2 protein sequence has diverged substantially from that of conventional eukaryotic PAPs, and lacks a recognizable RRM (RNA recognition motif)-like domain. GLD-2 has little PAP activity on its own, but is stimulated in vitro by GLD-3. GLD-3 is also a developmental regulator, and belongs to the Bicaudal-C family of RNA binding proteins(5). We suggest that GLD-2 is the prototype for a class of regulatory cytoplasmic PAPs that are recruited to specific mRNAs by a binding partner, thereby targeting those mRNAs for polyadenylation and increased expression.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Kimble, J (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	jekimble@facstaff.wisc.edu	Kadyk, Lisa/W-5243-2019					Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; CRITTENDEN SL, 1998, CELL LAB MANUAL; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; ECKMANN C, IN PRESS DEV CELL; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Kadyk LC, 1998, DEVELOPMENT, V125, P1803; Kashiwabara S, 2000, DEV BIOL, V228, P106, DOI 10.1006/dbio.2000.9894; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kyriakopoulou CB, 2001, J BIOL CHEM, V276, P33504, DOI 10.1074/jbc.M104599200; LINGNER J, 1991, J BIOL CHEM, V266, P8741; Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Praitis V, 2001, GENETICS, V157, P1217; READ RL, IN PRESS P NATL ACAD; Richter JD, 2000, COLD SPRING HARBOR M, V39, P785; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Topalian SL, 2001, MOL CELL BIOL, V21, P5614, DOI 10.1128/MCB.21.16.5614-5623.2001; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295	31	227	238	3	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					312	316		10.1038/nature01039	http://dx.doi.org/10.1038/nature01039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239571				2022-12-28	WOS:000178056300049
J	Rea, TD; Heckbert, SR; Kaplan, RC; Smith, NL; Lemaitre, RN; Psaty, BM				Rea, TD; Heckbert, SR; Kaplan, RC; Smith, NL; Lemaitre, RN; Psaty, BM			Smoking status and risk for recurrent coronary events after myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM PROGNOSIS; CIGARETTE-SMOKING; THROMBOLYTIC THERAPY; SECONDARY PREVENTION; STOPPING SMOKING; CESSATION; MORTALITY; ARTERY; WOMEN; NICOTINE	Background: Questions remain about the importance of smoking and smoking cessation after incident myocardial infarction. Objective: To assess the association between smoking status and risk for recurrent coronary events. Design: Retrospective, population-based, inception cohort study. Setting: Health maintenance organization from 1986 to 1996. Patients: 2619 persons who survived to hospital discharge after a first myocardial infarction. Measurements: Relative risk (RR), assessed by using Cox proportional hazards regression analysis, for recurrent coronary events in nonsmokers (persons with no history of smoking), former smokers (persons who had stopped smoking before infarction), quitters (persons who stopped smoking after infarction), and active smokers (persons who continued smoking after infarction). Results: At the time of incident infarction, 33.6% of patients were nonsmokers, 35.5% were former smokers, and 30.9% were active smokers. Of the 808 persons who were active smokers at the time of incident infarction, 449 quit smoking during hospitalization or after discharge. With nonsmokers as the reference group, the multivariable RR for recurrent coronary events (n = 433) was 1.17 (95% CI, 0.93 to 1.43) for former smokers and 1.51 (CI, 1.10 to 2.07) for active smokers. Among quitters, the RR decreased as duration of cessation increased: With nonsmokers as the reference group, the RR for quitters was 1.62 (CI, 1.02 to 2.61) if the duration of cessation was 0 to less than 6 months, 1.60 (CI, 0.97 to 2.60) if the duration was 6 to less than 18 months, 1.48 (CI, 0.76 to 2.51) if the duration was 18 to less than 36 months, and 1.02 (CI, 0.54 to 1.86) if the duration was 36 months or more (P = 0.01 for trend). Conclusion: After incident myocardial infarction, smoking was associated with an elevated risk for recurrent coronary events. In persons who quit smoking after infarction, the risk declined to equal that of nonsmokers by 3 years after cessation.	Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle	Rea, TD (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Metropolitan Pk,E Tower,1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	rea123@u.washington.edu	Kaplan, Robert/A-2526-2011		NHLBI NIH HHS [HL40628, HL43201, HL53375] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043201, R01HL040628, R29HL040628, R01HL053375] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABERG A, 1983, BRIT HEART J, V49, P416, DOI 10.1136/hrt.49.5.416; [Anonymous], 1997, Eur Heart J, V18, P1569; BARBASH GI, 1995, J AM COLL CARDIOL, V26, P1222, DOI 10.1016/0735-1097(95)00299-5; BURR ML, 1992, EUR HEART J, V13, P166, DOI 10.1093/oxfordjournals.eurheartj.a060141; deChillou C, 1996, J AM COLL CARDIOL, V27, P1662, DOI 10.1016/0735-1097(96)00091-5; Goldstein MG, 2000, MED CLIN N AM, V84, P63, DOI 10.1016/S0025-7125(05)70207-8; Gottlieb S, 1996, J AM COLL CARDIOL, V28, P1506, DOI 10.1016/S0735-1097(96)00334-8; Greenwood DC, 1995, J EPIDEMIOL COMMUN H, V49, P583, DOI 10.1136/jech.49.6.583; GRINES CL, 1995, CIRCULATION, V91, P298, DOI 10.1161/01.CIR.91.2.298; Hasdai D, 1997, NEW ENGL J MED, V336, P755, DOI 10.1056/NEJM199703133361103; HEDBACK B, 1993, EUR HEART J, V14, P831, DOI 10.1093/eurheartj/14.6.831; HERLITZ J, 1995, CARDIOLOGY, V86, P496, DOI 10.1159/000176929; HERMANSON B, 1988, NEW ENGL J MED, V319, P1365, DOI 10.1056/NEJM198811243192101; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Ishihara M, 1997, AM HEART J, V134, P955, DOI 10.1016/S0002-8703(97)80020-8; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; JAFRI SM, 1990, AM J CARDIOL, V65, P271, DOI 10.1016/0002-9149(90)90286-A; JOHANSSON S, 1985, AM J EPIDEMIOL, V121, P823, DOI 10.1093/oxfordjournals.aje.a114053; Jorgensen S, 1999, J CARDIOVASC RISK, V6, P23; Joseph AM, 1996, NEW ENGL J MED, V335, P1792, DOI 10.1056/NEJM199612123352402; KELLY TL, 1985, AM HEART J, V110, P535; Maggioni A P, 1998, G Ital Cardiol, V28, P970; Mahmarian JJ, 1997, J AM COLL CARDIOL, V30, P125, DOI 10.1016/S0735-1097(97)00128-9; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; MOLSTAD P, 1991, EUR HEART J, V12, P753, DOI 10.1093/eurheartj/12.7.753; MULCAHY R, 1977, AM HEART J, V93, P556, DOI 10.1016/S0002-8703(77)80003-3; Nitenberg A, 1999, J CARDIOVASC PHARM, V34, P694, DOI 10.1097/00005344-199911000-00011; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; PERKINS J, 1985, POSTGRAD MED J, V61, P295, DOI 10.1136/pgmj.61.714.295; Petitti Diana B., 1994, Annals of Epidemiology, V4, P115; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; PSATY BM, 1994, ARCH INTERN MED, V154, P1333, DOI 10.1001/archinte.154.12.1333; Qureshi AI, 2001, ARCH INTERN MED, V161, P1621, DOI 10.1001/archinte.161.13.1621; ROSENBERG L, 1990, NEW ENGL J MED, V322, P213, DOI 10.1056/NEJM199001253220401; ROSENBERG L, 1985, NEW ENGL J MED, V313, P1511, DOI 10.1056/NEJM198512123132404; SALONEN JT, 1980, BRIT HEART J, V43, P463, DOI 10.1136/hrt.43.4.463; SIEGEL D, 1988, ANN INTERN MED, V109, P213, DOI 10.7326/0003-4819-109-3-213; SPARROW D, 1978, J CHRON DIS, V31, P425, DOI 10.1016/0021-9681(78)90006-1; TOFLER GH, 1993, AM J CARDIOL, V71, P1031, DOI 10.1016/0002-9149(93)90568-W; *US DEP HHS, 1988, DHHS PUB; van Domburg RT, 2000, J AM COLL CARDIOL, V36, P878, DOI 10.1016/S0735-1097(00)00810-X; Vogel RA, 1997, CLIN CARDIOL, V20, P426, DOI 10.1002/clc.4960200505; Wilhelmsen L, 1998, J Cardiovasc Risk, V5, P173, DOI 10.1097/00043798-199806000-00006; WILHELMSSON C, 1975, LANCET, V1, P416; Wilson K, 2000, ARCH INTERN MED, V160, P939, DOI 10.1001/archinte.160.7.939; ZHU BQ, 1995, AM HEART J, V130, P1270, DOI 10.1016/0002-8703(95)90154-X	46	131	133	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					494	500		10.7326/0003-4819-137-6-200209170-00009	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230350				2022-12-28	WOS:000178069100003
J	Moynihan, R				Moynihan, R			Alosetron: a case study in regulatory capture, or a victory for patients' rights?	BRITISH MEDICAL JOURNAL			English	Article							IRRITABLE-BOWEL-SYNDROME		Australian Financial Review, Sydney, NSW 2201, Australia		Moynihan, R (corresponding author), 4-1312 21st St NW, Washington, DC 20036 USA.		Moynihan, Ray/ABC-3010-2020					Barbehenn E, 2000, LANCET, V356, P2009, DOI 10.1016/S0140-6736(05)72978-0; Camilleri M, 2000, LANCET, V355, P1035, DOI 10.1016/S0140-6736(00)02033-X; *DEP HLTH HUM SERV, 2002, D000674 PID DEP HLTH; *DEP HLTH HUM SERV, 2002, GASTR DRUGS ADV COMM; *DEP HLTH HUM SERV, 2000, GASTR DRUGS ADV COMM; Horton R, 2001, LANCET, V358, P417, DOI 10.1016/S0140-6736(01)05565-9; Horton R, 2001, LANCET, V357, P1544, DOI 10.1016/S0140-6736(00)04776-0; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2002, BRIT MED J, V325, P561, DOI 10.1136/bmj.325.7364.561; Moynihan R., 2002, BMJ-BRIT MED J, V324, P1342; *PUBL CIT, 2002, PROBL NEW DRUG APPR; Shapiro J P, 2000, US News World Rep, V129, P54; WAGNER J, 2002, NEWS OBSERVER   0723, P1; Willman D., 2002, LOS ANGELES TIM 0530, P1; 2002, FDA NEWS        0607	15	36	36	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2002	325	7364					592	595		10.1136/bmj.325.7364.592	http://dx.doi.org/10.1136/bmj.325.7364.592			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595JJ	12228140	Green Published			2022-12-28	WOS:000178105200027
J	Gavriil, FP; Kaspi, VM; Woods, PM				Gavriil, FP; Kaspi, VM; Woods, PM			Magnetar-like X-ray bursts from an anomalous X-ray pulsar	NATURE			English	Article							SOFT GAMMA-REPEATERS; NEUTRON-STARS; FIELD; EMISSION; MODEL	Anomalous X-ray pulsars (AXPs) are a class of rare X-ray emitting pulsars whose energy source has been perplexing for some 20 years(1-3). Unlike other X-ray emitting pulsars, AXPs cannot be powered by rotational energy or by accretion of matter from a binary companion star, hence the designation `anomalous'. Many of the rotational and radiative properties of the AXPs are strikingly similar to those of another class of exotic objects, the soft-gamma-ray repeaters (SGRs). But the defining property of the SGRs-their low-energy-gamma-ray and X-ray bursts-has not hitherto been observed for AXPs. Soft-gamma-ray repeaters are thought to be 'magnetars', which are young neutron stars whose emission is powered by the decay of an ultra-high magnetic field 4,5; the suggestion that AXPs might also be magnetars has been controversial(6). Here we report two X-ray bursts, with properties similar to those of SGRs, from the direction of the anomalous X-ray pulsar 1E1048.1-5937. These events imply a close relationship (perhaps evolutionary) between AXPs and SGRs, with both being magnetars.	McGill Univ, Dept Phys, Montreal, PQ H3W 2C4, Canada; MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, Space Res Ctr, Cambridge, MA 02139 USA; Natl Space Sci & Technol Ctr, Space Sci Res Ctr, Huntsville, AL 35805 USA	McGill University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kaspi, VM (corresponding author), McGill Univ, Dept Phys, Montreal, PQ H3W 2C4, Canada.							ARNAUD KA, 1996, ASTRONOMICAL DATA AN, V5, P17; Chatterjee P, 2000, ASTROPHYS J, V534, P373, DOI 10.1086/308748; FAHLMAN GG, 1981, NATURE, V293, P202, DOI 10.1038/293202a0; FAVRIIL FP, 2002, ASTROPHYS J, V567, P1067; FISHMAN GJ, 1993, ASTRON ASTROPHYS SUP, V97, P17; Gaensler BM, 2001, ASTROPHYS J, V559, P963, DOI 10.1086/322358; Gogus E, 2001, ASTROPHYS J, V558, P228, DOI 10.1086/322463; Gotthelf EV, 1999, ASTROPHYS J, V522, pL49, DOI 10.1086/312220; HEISE J, IN PRESS MEM SOC AST; HEISE J, 2001, ASTROPH0111246; Ibrahim AI, 2001, ASTROPHYS J, V558, P237, DOI 10.1086/322248; Jahoda K, 1996, P SOC PHOTO-OPT INS, V2808, P59, DOI 10.1117/12.256034; Kaspi VM, 2000, ASTROPHYS J, V537, pL31, DOI 10.1086/312758; Kaspi VM, 2001, ASTROPHYS J, V558, P253, DOI 10.1086/321682; Kaspi VM, 1999, ASTROPHYS J, V525, pL33, DOI 10.1086/312330; Kouveliotou C, 1998, NATURE, V393, P235, DOI 10.1038/30410; Lewin W.H.G., 1995, XRAY BINARIES, P175; Liu QZ, 2001, ASTRON ASTROPHYS, V368, P1021, DOI 10.1051/0004-6361:20010075; MEREGHETTI S, 1995, ASTROPHYS J, V442, pL17, DOI 10.1086/187805; Pivovaroff MJ, 2000, ASTROPHYS J, V535, P379, DOI 10.1086/308848; Stern BE, 2001, ASTROPHYS J, V563, P80, DOI 10.1086/322295; Strohmayer TE, 2000, ASTROPHYS J, V537, pL111, DOI 10.1086/312769; Thompson C, 1996, ASTROPHYS J, V473, P322, DOI 10.1086/178147; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255, DOI 10.1093/mnras/275.2.255; Tiengo A, 2002, ASTRON ASTROPHYS, V383, P182, DOI 10.1051/0004-6361:20011718; VANPARADIJS J, 1995, ASTRON ASTROPHYS, V299, pL41; Woods PM, 2001, ASTROPHYS J, V552, P748, DOI 10.1086/320571	27	197	200	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					142	144		10.1038/nature01011	http://dx.doi.org/10.1038/nature01011			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226658				2022-12-28	WOS:000177931200034
J	Christ, GH; Siegel, K; Christ, AE				Christ, GH; Siegel, K; Christ, AE			Adolescent grief - "It never really hit me ... until it actually happened"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PARENTAL DEATH; CHILDREN; DEPRESSION; INTERVENTION; ADJUSTMENT; CHILDHOOD; BEREAVEMENT; ADULTHOOD; VIOLENCE; RISKS		Columbia Univ, Sch Social Work, New York, NY 10025 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10025 USA; SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA; Kings Cty Hosp, Brooklyn, NY USA	Columbia University; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Christ, GH (corresponding author), Columbia Univ, Sch Social Work, 622 W 113th St, New York, NY 10025 USA.	ghc1@columbia.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH041967] Funding Source: NIH RePORTER; NIMH NIH HHS [MH41967] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1987, PIAGETS THEORY INTEL; Balk D., 2001, HDB BEREAVEMENT RES, P199, DOI DOI 10.1037/10436-008; BIFULCO A, 1992, DEV PSYCHOPATHOL, V4, P433, DOI 10.1017/S0954579400000882; BIOS P, 1962, ADOLESCENCE; Block SD, 2001, JAMA-J AM MED ASSOC, V285, P2898, DOI 10.1001/jama.285.22.2898; Bonanno GA, 2001, AM BEHAV SCI, V44, P798, DOI 10.1177/00027640121956502; Bronfenbrenner U., 1988, PERSONS CONTEXT DEV, P25; CHRIST G, 1984, CHILDHOOD CANCER IMP, P109; Christ GH, 2000, CANCER PRACT, V8, P72, DOI 10.1046/j.1523-5394.2000.82005.x; Christ GH., 2000, J DEATH DYING; COHEN J, COGNITIVE BEHAV THER; COHEN J, 2000, J TRAUMA VIOLENCE AB, V1, P29; Cohen JA, 1998, J AM ACAD CHILD PSY, V37, p4S, DOI 10.1097/00004583-199810001-00002; COHEN JA, IN PRESS TRAUMA VIOL; ELIZUR E, 1983, AM J ORTHOPSYCHIAT, V53, P668, DOI 10.1111/j.1939-0025.1983.tb03410.x; ETH S, 1985, POST TRAUMATIC STRES, P169; FIGLEY CR, 1996, LIVING GRIEF SUDDEN, P91; Geis HK, 1998, CHILD ADOL PSYCH CL, V7, P73, DOI 10.1016/S1056-4993(18)30260-8; GERSTEN JC, 1991, AM J COMMUN PSYCHOL, V19, P481, DOI 10.1007/BF00937988; Gilligan C., 1982, DIFFERENT VOICE PSYC; GOLDMAN L, 1996, BREAKING SILENCE GUI; GRAY R E, 1989, Journal of Psychosocial Oncology, V7, P127, DOI 10.1300/J077v07n03_09; INHELDER B, 1952, GROWTH LOGICAL THINK; Jacobs S., 1999, TRAUMATIC GRIEF; Jordan J. V., 1991, WOMENS GROWTH CONNEC; KAFFMAN M, 1987, ISRAEL J PSYCHIAT, V24, P65; Kagawa-Singer M, 2001, JAMA-J AM MED ASSOC, V286, P2993, DOI 10.1001/jama.286.23.2993; KNIGHTBIRNBAUM N, 1988, CHILDHOOD BEREAVEMEN, P107; Layne CM, 2001, GROUP DYN-THEOR RES, V5, P277, DOI 10.1037//1089-2699.5.4.277; LUTZKE JR, 1997, ISSUES CLIN CHILD PS, P215; Meyer C., 1983, CLIN SOCIAL WORK ECO, P5; Nader K.O., 1997, DEATH TRAUMA TRAUMAT, P17; NAGY M, 1948, J GENET PSYCHOL, V73, P3; Nolen-Hoeksema S., 1999, COPING LOSS; Parkes CM, 1983, RECOVERY BEREAVEMENT; Pfeffer CR, 2002, J AM ACAD CHILD PSY, V41, P505, DOI 10.1097/00004583-200205000-00007; Pfefferbaum B, 1999, J AM ACAD CHILD PSY, V38, P1372, DOI 10.1097/00004583-199911000-00011; Prigerson HG, 2001, JAMA-J AM MED ASSOC, V286, P1369, DOI 10.1001/jama.286.11.1369; Pynoos R. S., 1992, BEREAVEMENT CARE, V11, P2, DOI [10.1080/02682629208657280, DOI 10.1080/02682629208657280]; PYNOOS RS, 1990, PSYCHIAT ANN, V20, P334, DOI 10.3928/0048-5713-19900601-11; Rando T.A., 1996, LIVING GRIEF SUDDEN, P139; RANDO TA, 1986, LOSS ANTICIPATORY GR, P97; Raphael B., 1983, ANATOMY BEREAVEMENT; Raveis VH, 1999, J YOUTH ADOLESCENCE, V28, P165, DOI 10.1023/A:1021697230387; Reinherz HZ, 1999, J ABNORM PSYCHOL, V108, P500, DOI 10.1037/0021-843X.108.3.500; RUTTER M, 1994, STRESS RISK RESILIEN, P354; RUTTER M, 1991, BRIT J PSYCHIAT, V174, P480; SALER L, 1992, AM J ORTHOPSYCHIAT, V62, P504, DOI 10.1037/h0079372; Saltzman WR, 2001, GROUP DYN-THEOR RES, V5, P291, DOI 10.1037/1089-2699.5.4.291; SANDLER I, IN PRESS J CONSULT C; SIEGEL K, 1992, J AM ACAD CHILD PSY, V31, P327, DOI 10.1097/00004583-199203000-00022; Siegel K, 1996, J AM ACAD CHILD PSY, V35, P442, DOI 10.1097/00004583-199604000-00010; SIEGEL K, 1990, AM J ORTHOPSYCHIAT, V60, P168, DOI 10.1037/h0079187; Siegel K, 1996, CANC FAMILY, P109; Silverman P., 1995, CHILDREN MOURNING MO, P131; SILVERMAN PR, 1992, OMEGA-J DEATH DYING, V25, P319, DOI 10.2190/0QMH-FR98-R7XW-18VY; SILVERMAN PR, 1992, AM J ORTHOPSYCHIAT, V62, P93, DOI 10.1037/h0079304; Stroebe M., 2001, HDB BEREAVEMENT RES, P375; Tremblay GC, 1998, CLIN PSYCHOL-SCI PR, V5, P424, DOI 10.1111/j.1468-2850.1998.tb00165.x; Tyson-Rawson K. J., 1996, HDB ADOLESCENT DEATH, P155; US Bureau of the Census, 1990, STAT ABSTR US 1990; VANEERDEWEGH MM, 1982, BRIT J PSYCHIAT, V140, P23, DOI 10.1192/bjp.140.1.23; WELLER RA, 1991, AM J PSYCHIAT, V148, P1536; Worden JW., 1996, CHILDREN GRIEF PAREN	64	65	65	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1269	1278		10.1001/jama.288.10.1269	http://dx.doi.org/10.1001/jama.288.10.1269			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	592BW	12215135				2022-12-28	WOS:000177917700027
J	Lifshitz, Y; Kohler, T; Frauenheim, T; Guzmann, I; Hoffman, A; Zhang, RQ; Zhou, XT; Lee, ST				Lifshitz, Y; Kohler, T; Frauenheim, T; Guzmann, I; Hoffman, A; Zhang, RQ; Zhou, XT; Lee, ST			The mechanism of diamond nucleation from energetic species	SCIENCE			English	Article							BIAS-ENHANCED NUCLEATION; ATOMIC-FORCE MICROSCOPY; SUBPLANTATION MODEL; FILM GROWTH; CARBON; BORON	A model for diamond nucleation by energetic species ( for example, bias-enhanced nucleation) is proposed. It involves spontaneous bulk nucleation of a diamond embryo cluster in a dense, amorphous carbon hydrogenated matrix; stabilization of the cluster by favorable boundary conditions of nucleation sites and hydrogen termination; and ion bombardment induced growth through a preferential displacement mechanism. The model is substantiated by density functional tight-binding molecular dynamics simulations and an experimental study of the structure of bias-enhanced and ion beam nucleated films. The model is also applicable to the nucleation of other materials by energetic species, such as cubic boron nitride.	City Univ Hong Kong, Ctr Super Diamond & Adv Films, Hong Kong, Hong Kong, Peoples R China; City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China; Univ Gesamthsch Paderborn, D-33095 Paderborn, Germany; Technion Israel Inst Technol, Dept Chem, IL-32000 Haifa, Israel	City University of Hong Kong; City University of Hong Kong; University of Paderborn; Technion Israel Institute of Technology	Lifshitz, Y (corresponding author), City Univ Hong Kong, Ctr Super Diamond & Adv Films, Hong Kong, Hong Kong, Peoples R China.	apshay@cityu.edu.hk	Lee, Shuit-Tong/Q-7552-2018; Frauenheim, Thomas/C-5653-2015; Zhang, Rui-Qin/L-8947-2014; Zhang, Rui/GXN-3801-2022; Lifshitz, Yeshayahu/E-6043-2011	Frauenheim, Thomas/0000-0002-3073-0616; Zhang, Rui-Qin/0000-0001-6897-4010; Hoffman, Alon/0000-0002-3100-9548				ANGUS JC, 1988, SCIENCE, V241, P913, DOI 10.1126/science.241.4868.913; BADZIAG P, 1990, NATURE, V343, P244, DOI 10.1038/343244a0; Banhart F, 1999, REP PROG PHYS, V62, P1181, DOI 10.1088/0034-4885/62/8/201; BARYAM Y, 1989, NATURE, V342, P786, DOI 10.1038/342786a0; Bilek MMM, 2000, PHYS REV B, V62, P3071, DOI 10.1103/PhysRevB.62.3071; BINKLEY JS, 1980, J AM CHEM SOC, V102, P939, DOI 10.1021/ja00523a008; BUNDY FP, 1955, NATURE, V176, P51, DOI 10.1038/176051a0; Butler JE, 1998, MRS BULL, V23, P22, DOI 10.1557/S0883769400029316; Garcia MM, 1998, APPL PHYS LETT, V72, P2105, DOI 10.1063/1.121290; Garcia MM, 2000, PHYS REV B, V61, P10383, DOI 10.1103/PhysRevB.61.10383; Gouzman I, 1998, APPL PHYS LETT, V72, P296, DOI 10.1063/1.120747; Gruen DM, 1998, MRS BULL, V23, P16, DOI 10.1557/S0883769400029304; Hoffman A, 2001, J APPL PHYS, V89, P5769, DOI 10.1063/1.1367313; HOFFMANN R, 1988, REV MOD PHYS, V60, P601, DOI 10.1103/RevModPhys.60.601; Hwang NM, 1996, J CRYST GROWTH, V160, P87, DOI 10.1016/0022-0248(95)00548-X; JIANG X, 1993, APPL PHYS LETT, V62, P3438, DOI 10.1063/1.109041; Katai S, 1999, J APPL PHYS, V86, P5549, DOI 10.1063/1.371559; LAMBRECHT WRL, 1993, NATURE, V364, P607, DOI 10.1038/364607a0; Lee ST, 2000, SCIENCE, V287, P104, DOI 10.1126/science.287.5450.104; Lifshitz Y, 1999, DIAM RELAT MATER, V8, P1659, DOI 10.1016/S0925-9635(99)00087-4; LIFSHITZ Y, 1990, PHYS REV B, V41, P10468, DOI 10.1103/PhysRevB.41.10468; LIFSHITZ Y, 1989, PHYS REV LETT, V62, P1290, DOI 10.1103/PhysRevLett.62.1290; Mirkarimi PB, 1997, MAT SCI ENG R, V21, P47, DOI 10.1016/S0927-796X(97)00009-0; PAOLETTI A, 1997, PHYSICS DIAMOND; POREZAG D, 1995, PHYS REV B, V51, P12947, DOI 10.1103/PhysRevB.51.12947; SEIFERT G, 1985, PHYS STATUS SOLIDI B, V127, P573, DOI 10.1002/pssb.2221270218; SEIFERT G, 1986, Z PHYS CHEM-LEIPZIG, V267, P529; SEIFERT G, 1991, Z PHYS D ATOM MOL CL, V20, P77, DOI 10.1007/BF01543942; Widany J, 1996, DIAM RELAT MATER, V5, P1031, DOI 10.1016/0925-9635(95)00492-0; YUGO S, 1991, APPL PHYS LETT, V58, P1036, DOI 10.1063/1.104415; Zhang WJ, 2000, PHYS REV B, V61, P5579, DOI 10.1103/PhysRevB.61.5579	31	181	192	6	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1531	1533		10.1126/science.1074551	http://dx.doi.org/10.1126/science.1074551			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202823				2022-12-28	WOS:000177697300050
J	Keleman, K; Rajagopalan, S; Cleppien, D; Teis, D; Paiha, K; Huber, LA; Technau, GM; Dickson, BJ				Keleman, K; Rajagopalan, S; Cleppien, D; Teis, D; Paiha, K; Huber, LA; Technau, GM; Dickson, BJ			Comm sorts Robo to control axon guidance at the Drosophila midline	CELL			English	Article							GROWTH CONE GUIDANCE; CNS MIDLINE; MEMBRANE-PROTEIN; NERVOUS-SYSTEM; RECEPTORS; PATHWAY; MELANOGASTER; NEUROBLASTS; ROUNDABOUT; SUBFAMILY	Axon growth across the Drosophila midline requires Comm to downregulate Robo, the receptor for the midline repellent Slit. We show here that comm is required in neurons, not in midline cells as previously thought, and that it is expressed specifically and transiently in commissural neurons. Comm acts as a sorting receptor for Robo, diverting it from the synthetic to the late endocytic pathway. A conserved cytoplasmic LPSY motif is required for endosomal sorting of Comm in vitro and for Comm to downregulate Robo and promote midline crossing in vivo. Axon traffic at the CNS midline is thus controlled by the intracellular trafficking of the Robo guidance receptor, which in turn depends on the precisely regulated expression of the Comm sorting receptor.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Mainz, Inst Genet, D-55128 Mainz, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Johannes Gutenberg University of Mainz	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Dickson, Barry/AAE-7632-2019; Huber, Lukas Alfons/AAM-3499-2021	Dickson, Barry/0000-0003-0715-892X; Teis, David/0000-0002-8181-0253; Huber, Lukas Alfons/0000-0003-1116-2120				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bonkowsky JL, 1999, MECH DEVELOP, V82, P181, DOI 10.1016/S0925-4773(99)00007-6; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Dittrich R, 1997, DEVELOPMENT, V124, P2515; Georgiou M, 2002, DEVELOPMENT, V129, P2947; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Higashijima S, 1996, DEVELOPMENT, V122, P527; HOLT RA, 2002, IN PRESS SCIENCE; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; O'Keefe DD, 1998, DEVELOPMENT, V125, P3915; Overly CC, 1996, J NEUROSCI, V16, P6056; Prokop Andreas, 1993, P33; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Wolf B, 1998, DEVELOPMENT, V125, P3853	32	236	242	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 23	2002	110	4					415	427		10.1016/S0092-8674(02)00901-7	http://dx.doi.org/10.1016/S0092-8674(02)00901-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202032	Bronze			2022-12-28	WOS:000177653200004
J	Richards, AM; Nicholls, MG; Lainchbury, JG; Fisher, S; Yandle, TG				Richards, AM; Nicholls, MG; Lainchbury, JG; Fisher, S; Yandle, TG			Plasma urotensin II in heart failure	LANCET			English	Article							ARTERIES	Urotensin II has vasoconstrictive and negative inotropic effects, suggesting a possible role in circulatory regulation and pathophysiology of heart failure. We developed a sensitive specific RIA and measured plasma urotensin II in patients with heart failure and in controls. Plasma urotensin II was higher in heart failure patients (mean 3.9 pmol/L [SD 1.4]; than in controls (1.9 pmol/L [0.9]; p<0.0001). The role of urotensin II in heart failure, however, has yet to be defined.	Christchurch Sch Med & Hlth Sci, Christchurch Cardioendocrine Res Grp, Christchurch, New Zealand	University of Otago	Richards, AM (corresponding author), Christchurch Sch Med & Hlth Sci, Christchurch Cardioendocrine Res Grp, POB 4345, Christchurch, New Zealand.							Affolter J, 2001, LANCET, V358, P774, DOI 10.1016/S0140-6736(01)06005-6; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Hillier C, 2001, CIRCULATION, V103, P1378, DOI 10.1161/01.CIR.103.10.1378; Stirrat A, 2001, AM J PHYSIOL-HEART C, V280, pH925, DOI 10.1152/ajpheart.2001.280.2.H925; Totsune K, 2001, LANCET, V358, P810, DOI 10.1016/S0140-6736(01)06002-0	5	149	156	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					545	546						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241661				2022-12-28	WOS:000177512800015
J	Stein, DJ				Stein, DJ			Obsessive-compulsive disorder	LANCET			English	Review							SEROTONIN REUPTAKE INHIBITORS; ANXIETY DISORDERS; BEHAVIOR-THERAPY; DOUBLE-BLIND; STREPTOCOCCAL INFECTIONS; ORBITOFRONTAL CORTEX; BASAL GANGLIA; BRAIN; EPIDEMIOLOGY; DRUG	Obsessive-compulsive disorder is a frequent, chronic, costly, and disabling disorder that presents in several medical settings, but is under-recognised and undertreated. For many years, obsessive-compulsive neurosis was seen as a disorder that provided an important window on the workings of the unconscious mind. Today, obsessive-compulsive disorder is viewed as a good example of a neuropsychiatric disorder, mediated by pathology in specific neuronal circuits, and responsive to specific pharmacotherapeutic and psychotherapeutic interventions. In the future we can expect more precise delineation of the origins of this disorder, with integration of data from neuroanatomical, neurochemical, neuroethological, neurogenetic, and neuroimmunological research.	Univ Stellenbosch, Dept Psychiat, Cape Town, South Africa; Univ Florida, Gainesville, FL USA	Stellenbosch University; State University System of Florida; University of Florida	Stein, DJ (corresponding author), Univ Stellenbosch, Dept Psychiat, Cape Town, South Africa.	djs2@sun.ac.za	Bloch, Michael/O-7845-2017; Stein, Dan/A-1752-2008; Lozano, Andres M/A-5058-2012; Soomro, Mustafa/K-9915-2019; Veale, David M/F-5670-2010; Mathews, Carol A A/M-8922-2017	Bloch, Michael/0000-0003-0352-4080; Stein, Dan/0000-0001-7218-7810; Veale, David M/0000-0002-1717-4766; Mathews, Carol A A/0000-0003-2208-7058	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH113250] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abramowitz JS, 1997, J CONSULT CLIN PSYCH, V65, P44, DOI 10.1037/0022-006X.65.1.44; Ackerman DL, 1999, J CLIN PSYCHOPHARM, V19, P459, DOI 10.1097/00004714-199910000-00010; Alonso P, 2001, AM J PSYCHIAT, V158, P1143, DOI 10.1176/appi.ajp.158.7.1143; *AM AC CHILD AD PS, 1998, J AM ACAD CHILD PSY, V37, P27; Amerian Psychiatric Association, 1994, DIAGN STAT MANN MENT; AMES D, 1994, J NEUROPSYCH CLIN N, V6, P100; [Anonymous], 1997, Behav Res Ther, V35, P667; Bachofen M, 1999, J CLIN PSYCHIAT, V60, P545, DOI 10.4088/JCP.v60n0807; Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P5; Baumgarten HG, 1998, BRIT J PSYCHIAT, V173, P13, DOI 10.1192/S0007125000297857; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; Bebbington PE, 1998, BRIT J PSYCHIAT, V173, P2, DOI 10.1192/S0007125000297833; Bergqvist PBF, 1999, PSYCHOPHARMACOLOGY, V143, P89, DOI 10.1007/s002130050923; BLUM K, 1995, PHARMACOGENETICS, V5, P121, DOI 10.1097/00008571-199506000-00001; Brody AL, 1998, PSYCHIAT RES-NEUROIM, V84, P1, DOI 10.1016/S0925-4927(98)00041-9; Calvocoressi L, 1999, J NERV MENT DIS, V187, P636, DOI 10.1097/00005053-199910000-00008; Carlsson ML, 2001, PROG NEURO-PSYCHOPH, V25, P5, DOI 10.1016/S0278-5846(00)00146-9; CHEYETTE SR, 1995, J NEUROPSYCH CLIN N, V7, P125; Ciarrocchi J. W., 1995, DOUBTING DIS HELP SC; CJ Murray, 1996, GLOBAL BURDEN DIS CO, VI; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Delgado PL, 1998, J PSYCHOACTIVE DRUGS, V30, P359; DODMAN N, 1997, OBSESSIVE COMPULSIVE; DuPont R L, 1995, Med Interface, V8, P102; Eichstedt JA, 2001, CLIN PSYCHOL REV, V21, P137, DOI 10.1016/S0272-7358(99)00044-6; Eisen JL, 2001, PSYCHIAT RES, V104, P221, DOI 10.1016/S0165-1781(01)00323-7; EISEN JL, 1993, J CLIN PSYCHIAT, V54, P373; ELMANSARI M, 1995, NEUROPSYCHOPHARMACOL, V13, P117, DOI 10.1016/0893-133X(95)00045-F; Fallon BA, 1998, ARCH GEN PSYCHIAT, V55, P918, DOI 10.1001/archpsyc.55.10.918; Fernandez Cordoba E, 1967, Actas Luso Esp Neurol Psiquiatr, V26, P119; Geller PA, 2001, J CLIN PSYCHIAT, V62, P432, DOI 10.4088/JCP.v62n0606; GOODMAN WK, 1990, J CLIN PSYCHIAT, V51, P36; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Grados MA, 2001, J CLIN CHILD PSYCHOL, V30, P67, DOI 10.1207/S15374424JCCP3001_8; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; GREIST JH, 1995, ARCH GEN PSYCHIAT, V52, P53; Harel Z, 2001, INT J EAT DISORDER, V29, P463, DOI 10.1002/eat.1043; HARVEY B, 2001, PROG NEUROPSYCHOPHAR; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Hollander E, 1996, Depress Anxiety, V4, P111, DOI 10.1002/(SICI)1520-6394(1996)4:3<111::AID-DA3>3.0.CO;2-J; Hollander E, 1993, OBSESSIVE COMPULSIVE; Hollander E, 1997, CNS SPECTRUMS, V2, P16, DOI DOI 10.1017/S1092852900011068; Hugo F, 1999, DEPRESS ANXIETY, V10, P129, DOI 10.1002/(SICI)1520-6394(1999)10:3<129::AID-DA7>3.0.CO;2-B; Jenike MA, 1998, BRIT J PSYCHIAT, V173, P79, DOI 10.1192/S0007125000297936; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Kinnear CJ, 2000, INT J NEUROPSYCHOPH, V3, P327, DOI 10.1017/S1461145700002054; Koran LM, 2001, EUR NEUROPSYCHOPHARM, V11, P169, DOI 10.1016/S0924-977X(01)00082-7; Lawrence RM, 2000, BEHAV NEUROL, V12, P149, DOI 10.1155/2000/326706; Leckman JF, 2001, AM J MED GENET, V105, P28, DOI 10.1002/1096-8628(20010108)105:1<28::AID-AJMG1050>3.3.CO;2-#; Leonard HL, 2001, INT J NEUROPSYCHOPH, V4, P191, DOI 10.1017/S1461145701002371; Lochner C, 2001, ARCH WOMEN MENT HLTH, V4, P19, DOI DOI 10.1007/S007370170004; Lougee L, 2000, J AM ACAD CHILD PSY, V39, P1120, DOI 10.1097/00004583-200009000-00011; MACLEAN PD, 1949, PSYCHOSOM MED, V11, P338, DOI 10.1097/00006842-194911000-00003; Maina G, 2001, INT CLIN PSYCHOPHARM, V16, P33, DOI 10.1097/00004850-200101000-00004; Marazziti D, 2000, NEUROPSYCHOBIOLOGY, V41, P171, DOI 10.1159/000026656; Marchal IS, 1997, VET IMMUNOL IMMUNOP, V58, P1; Marks I, 1997, CAN J PSYCHIAT, V42, P1021, DOI 10.1177/070674379704201002; MARTIN LJ, 1991, J NEUROSCI, V11, P3344; McDougle CJ, 2000, ARCH GEN PSYCHIAT, V57, P794, DOI 10.1001/archpsyc.57.8.794; MCDOUGLE CJ, 1994, ARCH GEN PSYCHIAT, V51, P302; McDougle CJ, 1999, PSYCHONEUROENDOCRINO, V24, P1; Miguel E C, 2001, Adv Neurol, V85, P43; Moriarty J, 1997, PSYCHOL MED, V27, P737, DOI 10.1017/S0033291796004072; Mundo E, 2000, AM J PSYCHIAT, V157, P1160, DOI 10.1176/appi.ajp.157.7.1160; Nelson E, 1997, AM J PSYCHIAT, V154, P826; Newth S, 2001, BEHAV RES THER, V39, P457, DOI 10.1016/S0005-7967(00)00006-1; Nicolini H, 1998, Gac Med Mex, V134, P521; Niehaus DJH, 2001, J AFFECT DISORDERS, V65, P61, DOI 10.1016/S0165-0327(00)00246-9; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; O'Connor K, 1999, CAN J PSYCHIAT, V44, P64, DOI 10.1177/070674379904400108; Palumbo D, 1997, ARCH NEUROL-CHICAGO, V54, P475, DOI 10.1001/archneur.1997.00550160101023; Pato M T, 2001, Curr Psychiatry Rep, V3, P163, DOI 10.1007/s11920-001-0015-0; Pauls DL, 1999, CHILD ADOL PSYCH CL, V8, P481; Perez J, 2000, AM J PSYCHIAT, V157, P284, DOI 10.1176/appi.ajp.157.2.284; Phillips KA, 1998, B MENNINGER CLIN, V62, pA33; Purcell R, 1998, ARCH GEN PSYCHIAT, V55, P415, DOI 10.1001/archpsyc.55.5.415; Purcell R, 1998, BIOL PSYCHIAT, V43, P348, DOI 10.1016/S0006-3223(97)00201-1; RAPOPORT JL, 1992, ARCH GEN PSYCHIAT, V49, P517; Rauch S L, 2001, Adv Neurol, V85, P207; Rauch S. L., 1998, OBSESSIVE COMPULSIVE; Rauch SL, 2000, J NEUROSURG, V93, P1019, DOI 10.3171/jns.2000.93.6.1019; RIDLEY RM, 1994, PROG NEUROBIOL, V44, P221, DOI 10.1016/0301-0082(94)90039-6; Rosenberg DR, 2001, INT J NEUROPSYCHOPH, V4, P179, DOI 10.1017/S1461145701002401; Rosenberg DR, 1998, BIOL PSYCHIAT, V43, P623, DOI 10.1016/S0006-3223(97)00443-5; SAINTCYR JA, 1995, BEHAV NEUROLOGY MOVE; Salkovskis PM, 1999, BEHAV RES THER, V37, pS29, DOI 10.1016/S0005-7967(99)00049-2; Simpson HB, 1999, J CLIN PSYCHIAT, V60, P584, DOI 10.4088/JCP.v60n0904; Skoog G, 1999, ARCH GEN PSYCHIAT, V56, P121, DOI 10.1001/archpsyc.56.2.121; Spitzer RL, 1999, AM J PSYCHIAT, V156, P1856; Stein D, 1997, ESSENTIAL PAPERS OBS; Stein D J, 2001, Curr Psychiatry Rep, V3, P281, DOI 10.1007/s11920-001-0020-3; Stein D J, 2000, Curr Psychiatry Rep, V2, P341, DOI 10.1007/s11920-000-0079-2; Stein DJ, 2000, CNS SPECTRUMS, V5, P37; Stein Dan J., 1997, PSYCHIAT B, V21, P95; Stein DJ, 1998, PSYCHIAT ANN, V28, P327, DOI 10.3928/0048-5713-19980601-10; STEIN DJ, 1995, INT CLIN PSYCHOPHARM, V10, P11, DOI 10.1097/00004850-199503000-00002; STEIN DJ, 1993, PSYCHIAT ANN, V23, P389, DOI 10.3928/0048-5713-19930701-10; Stein DJ, 2001, DEPRESS ANXIETY, V13, P105, DOI 10.1002/da.1025; Stein DJ, 2000, BIOL PSYCHIAT, V47, P296, DOI 10.1016/S0006-3223(99)00271-1; Stein DJ, 1999, PROG NEURO-PSYCHOPH, V23, P1079, DOI 10.1016/S0278-5846(99)00051-2; Stein DJ, 1994, CURRENT INSIGHTS OBS; Stein DJ, 2001, OBSESSIVE COMPULSIVE; Stein DJ, 1996, CNS SPECTRUMS, V1, P42, DOI DOI 10.1017/S1092852900000675; STEIN DJ, 2001, OBSESSIVE COMPULSIVE, P37; STEIN DJ, 1993, OBSESSIVE COMPULSIVE; Stern L, 1998, EUR NEUROPSYCHOPHARM, V8, P325, DOI 10.1016/S0924-977X(97)00092-8; SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P518; SWEDO SE, 1989, AM J PSYCHIAT, V146, P246; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; Szeszko PR, 1999, ARCH GEN PSYCHIAT, V56, P913, DOI 10.1001/archpsyc.56.10.913; THOREN P, 1980, ARCH GEN PSYCHIAT, V37, P1289; Tibbo P, 1999, J PSYCHIATR NEUROSCI, V24, P15; VEALE D, 1993, BRIT J PSYCHIAT, V162, P198, DOI 10.1192/bjp.162.2.198; Vythilingum B, 2000, INT CLIN PSYCHOPHARM, V15, pS7, DOI 10.1097/00004850-200008002-00003; WEISSMAN MM, 1994, J CLIN PSYCHIAT, V55, P5; WESSELS CJ, 1998, 9 BIENN M INT SOC CO; Williams KE, 1997, J CLIN PSYCHIAT, V58, P330, DOI 10.4088/JCP.v58n0709; Zald DH, 1996, J NEUROPSYCH CLIN N, V8, P125; Zohar AH, 1999, CHILD ADOL PSYCH CL, V8, P445; Zungu-Dirwayi N, 1999, J NEUROPSYCH CLIN N, V11, P398, DOI 10.1176/jnp.11.3.398	120	257	277	1	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2002	360	9330					397	405		10.1016/S0140-6736(02)09620-4	http://dx.doi.org/10.1016/S0140-6736(02)09620-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	580UY	12241794				2022-12-28	WOS:000177255600027
J	Bi, XP; Corpina, RA; Goldberg, J				Bi, XP; Corpina, RA; Goldberg, J			Structure of the Sec23/24-Sar1 pre-budding complex of the COPII vesicle coat	NATURE			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; ADP-RIBOSYLATION FACTOR; ENDOPLASMIC-RETICULUM; MEMBRANE PHOSPHOLIPIDS; PROTEIN-TRANSPORT; GTP; BINDING; ER; ACTIVATION; DOMAIN	COPII-coated vesicles form on the endoplasmic reticulum by the stepwise recruitment of three cytosolic components: Sar1-GTP to initiate coat formation, Sec23/24 heterodimer to select SNARE and cargo molecules, and Sec13/31 to induce coat polymerization and membrane deformation. Crystallographic analysis of the Saccharomyces cerevisiae Sec23/24-Sar1 complex reveals a bow-tie-shaped structure, 15 nm long, with a membrane-proximal surface that is concave and positively charged to conform to the size and acidic-phospholipid composition of the COPII vesicle. Sec23 and Sar1 form a continuous surface stabilized by a non-hydrolysable GTP analogue, and Sar1 has rearranged from the GDP conformation to expose amino-terminal residues that will probably embed in the bilayer. The GTPase-activating protein (GAP) activity of Sec23 involves an arginine side chain inserted into the Sar1 active site. These observations establish the structural basis for GTP-dependent recruitment of a vesicular coat complex, and for uncoating through coat-controlled GTP hydrolysis.	Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10021 USA.	jonathan@ximpact4.ski.mskcc.org						AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Beraud-Dufour S, 1999, J BIOL CHEM, V274, P37629, DOI 10.1074/jbc.274.53.37629; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *COLL COMP PROJ, 1984, ACTA CRYSTALLOGR D, V50, P760; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; FRANCO M, 1993, J BIOL CHEM, V268, P24531; Franco M, 1996, J BIOL CHEM, V271, P1573, DOI 10.1074/jbc.271.3.1573; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Grabowski R, 1997, FEBS LETT, V411, P169, DOI 10.1016/S0014-5793(97)00720-5; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Huang MD, 2002, ACTA CRYSTALLOGR D, V58, P700, DOI 10.1107/S090744490200238X; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Nagahama M, 1996, J CELL BIOL, V133, P507, DOI 10.1083/jcb.133.3.507; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; Peng RW, 1999, P NATL ACAD SCI USA, V96, P3751, DOI 10.1073/pnas.96.7.3751; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Randazzo PA, 1997, J BIOL CHEM, V272, P7688; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Weissman JT, 2001, TRAFFIC, V2, P465, DOI 10.1034/j.1600-0854.2001.20704.x; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644	50	337	349	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					271	277		10.1038/nature01040	http://dx.doi.org/10.1038/nature01040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239560				2022-12-28	WOS:000178056300038
J	Ahmad, T; Wallace, J; Peterman, J; Desbiens, NA				Ahmad, T; Wallace, J; Peterman, J; Desbiens, NA			Doctors' perceptions of drinking alcohol while on call: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article									Univ Tennessee, Coll Med, Dept Med, Chattanooga Unit, Chattanooga, TN 37403 USA; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27599 USA; Univ South, Dept Philosophy, Sewanee, TN 37383 USA	University of Tennessee System; University of Tennessee Health Science Center; University of North Carolina; University of North Carolina Chapel Hill; Sewanee: University of the South	Desbiens, NA (corresponding author), Univ Tennessee, Coll Med, Dept Med, Chattanooga Unit, 975 E 3rd St,Box 94, Chattanooga, TN 37403 USA.							*AM COLL PHYS, 1993, AM COLL PHYS ETH MAN; *AM MED ASS, 1998, COD MED ETH CURR OP, P151; MCAULIFFE WE, 1991, AM J PUBLIC HEALTH, V81, P177, DOI 10.2105/AJPH.81.2.177; Stewart JAD, 1998, BRIT MED J, V317, P1158	4	8	8	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2002	325	7364					579	580		10.1136/bmj.325.7364.579	http://dx.doi.org/10.1136/bmj.325.7364.579			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	595JJ	12228135	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000178105200019
J	Shields, A				Shields, A			Quantum logic with light, glass, and mirrors	SCIENCE			English	Editorial Material									Toshiba Res Europe Ltd, Cambridge CB4 0WE, England	Toshiba Corporation	Shields, A (corresponding author), Toshiba Res Europe Ltd, 260 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WE, England.	andrew.shields@crl.toshiba.co.uk						BOUMEESTER D, 2000, PHYSICS QUANTUM INFO; Bruss D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.127901; Cerf NJ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.127902; Fitzi M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.217901; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Koashi M, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.030301; Leach J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.257901; Macchiavello C., 2000, QUANTUM COMPUTATION; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Pittman TB, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.257902; Resch KJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.037904; Yuan ZL, 2002, SCIENCE, V295, P102, DOI 10.1126/science.1066790	12	12	15	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1821	1822		10.1126/science.1075871	http://dx.doi.org/10.1126/science.1075871			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228707				2022-12-28	WOS:000177955000030
J	Prezant, DJ; Weiden, M; Banauch, GI; McGuinness, G; Rom, WN; Aldrich, TK; Kelly, KJ				Prezant, DJ; Weiden, M; Banauch, GI; McGuinness, G; Rom, WN; Aldrich, TK; Kelly, KJ			Cough and bronchial responsiveness in firefighters at the World Trade Center site	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-RESOLUTION CT; AIRWAY RESPONSIVENESS; RESPIRATORY SYMPTOMS; CHRYSOTILE ASBESTOS; PERSISTENT ASTHMA; METHACHOLINE; EXPOSURE; HYPERREACTIVITY; ISOCYANATES; CHALLENGE	Background: Workers from the Fire Department of New York City were exposed to a variety of inhaled materials during and after the collapse of the World Trade Center. We evaluated clinical features in a series of 332 firefighters in whom severe cough developed after exposure and the prevalence and severity of bronchial hyperreactivity in firefighters without severe cough classified according to the level of exposure. Methods: ``World Trade Center cough'' was defined as a persistent cough that developed after exposure to the site and was accompanied by respiratory symptoms severe enough to require medical leave for at least four weeks. Evaluation of exposed firefighters included completion of a standard questionnaire, spirometry, airway-responsiveness testing, and chest imaging. Results: In the first six months after September 11, 2001, World Trade Center cough occurred in 128 of 1636 firefighters with a high level of exposure (8 percent), 187 of 6958 with a moderate level of exposure (3 percent), and 17 of 1320 with a low level of exposure (1 percent). In addition, 95 percent had symptoms of dyspnea, 87 percent had gastroesophageal reflux disease, and 54 percent had nasal congestion. Of those tested before treatment of World Trade Center cough, 63 percent of firefighters (149 of 237) had a response to a bronchodilator and 24 percent (9 of 37) had bronchial hyperreactivity. Chest radiographs were unchanged from precollapse findings in 319 of the 332 with World Trade Center cough. Among the cohort without severe cough, bronchial hyperreactivity was present in 77 firefighters with a high level of exposure (23 percent) and 26 with a moderate level of exposure (8 percent). Conclusions: Intense, short-term exposure to materials generated during the collapse of the World Trade Center was associated with bronchial responsiveness and the development of cough. Clinical and physiological severity was related to the intensity of exposure.	Fire Dept New York City, Bur Hlth Serv, New York, NY USA; Albert Einstein Coll Med, Bronx, NY 10467 USA; Montefiore Med Ctr, Dept Med, Div Pulm Med, Bronx, NY 10467 USA; NYU, Sch Med, Dept Med, Div Pulm & Crit Care Med, New York, NY USA; NYU, Sch Med, Dept Environm Med, New York, NY USA; NYU, Sch Med, Dept Radiol, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; New York University; New York University; New York University	Prezant, DJ (corresponding author), Montefiore Med Ctr, Div Pulm, Centennial 423, Bronx, NY 10467 USA.	prezand@fdny.nyc.gov		Rom, William/0000-0002-8793-7028; McGuinness, Georgeann/0000-0002-5326-9180	PHS HHS [M010096] Funding Source: Medline; ODCDC CDC HHS [U1Q/CCU221158-01] Funding Source: Medline; NIOSH CDC HHS [R01-OH07350] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); ODCDC CDC HHS; NIOSH CDC HHS		[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2001, MMWR-MORBID MORTAL W, V51, P453; Arakawa H, 1998, AM J ROENTGENOL, V170, P1349, DOI 10.2214/ajr.170.5.9574614; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; CHIA KS, 1990, BRIT J IND MED, V47, P524; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; EBER CD, 1993, J COMPUT ASSIST TOMO, V17, P853, DOI 10.1097/00004728-199311000-00003; ERNST P, 1989, THORAX, V44, P116, DOI 10.1136/thx.44.2.116; Field SK, 2002, CHEST, V121, P1024, DOI 10.1378/chest.121.4.1024; HARGREAVE FE, 1985, AIRWAY RESPONSIVENES, P94; HARLESS KW, 1978, ENVIRON RES, V16, P360, DOI 10.1016/0013-9351(78)90169-X; HERVE P, 1986, AM REV RESPIR DIS, V134, P986, DOI 10.1164/arrd.1986.134.5.986; HUDGEL DW, 1988, J LAB CLIN MED, V111, P684; Irwin RS, 1997, ARCH INTERN MED, V157, P1981, DOI 10.1001/archinte.157.17.1981; Irwin RS, 2000, NEW ENGL J MED, V343, P1715, DOI 10.1056/NEJM200012073432308; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640, DOI 10.1164/ajrccm/141.3.640; JACK CIA, 1995, THORAX, V50, P201, DOI 10.1136/thx.50.2.201; KINSELLA J, 1991, LANCET, V337, P595, DOI 10.1016/0140-6736(91)91650-J; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; KORN RJ, 1987, AM REV RESPIR DIS, V136, P298, DOI 10.1164/ajrccm/136.2.298; KOUFMAN JA, 1998, OTOLARYNGOLOGY HEAD; Lemiere C, 1996, MED CLIN N AM, V80, P749, DOI 10.1016/S0025-7125(05)70466-1; MAPP CE, 1988, AM REV RESPIR DIS, V137, P1326, DOI 10.1164/ajrccm/137.6.1326; Petran M, 2000, OCCUP MED-OXFORD, V50, P103, DOI 10.1093/occmed/50.2.103; PRATTER MR, 1993, ANN INTERN MED, V119, P977, DOI 10.7326/0003-4819-119-10-199311150-00003; RIJCKEN B, 1987, AM REV RESPIR DIS, V136, P62, DOI 10.1164/ajrccm/136.1.62; RIJCKEN B, 1993, AM REV RESPIR DIS, V147, P1447, DOI 10.1164/ajrccm/147.6_Pt_1.1447; RODRIGUEZROISIN R, 1986, B EUR PHYSIOPATH RES, V22, P225; SAETTA M, 1995, AM J RESP CRIT CARE, V151, P489, DOI 10.1164/ajrccm.151.2.7842211; SHERMAN CB, 1989, AM REV RESPIR DIS, V140, P185, DOI 10.1164/ajrccm/140.1.185; Tarlo SM, 2000, OCCUP MED, V15, P471; Townsend MC, 2000, J OCCUP ENVIRON MED, V42, P228, DOI 10.1097/00043764-200003000-00003; VANGANSE WF, 1972, AM REV RESPIR DIS, V105, P30; Verlato G, 1996, EUR RESPIR J, V9, P506, DOI 10.1183/09031936.96.09030506; Vijayan VK, 1996, EUR RESPIR J, V9, P1977, DOI 10.1183/09031936.96.09101977; WRIGHT RA, 1990, GASTROENTEROLOGY, V99, P71, DOI 10.1016/0016-5085(90)91231-T; Zuskin E, 1998, J OCCUP ENVIRON MED, V40, P814, DOI 10.1097/00043764-199809000-00011	37	322	324	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					806	815		10.1056/NEJMoa021300	http://dx.doi.org/10.1056/NEJMoa021300			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226151	Bronze			2022-12-28	WOS:000177921300005
J	Fox, KAA; Poole-Wilson, PA; Henderson, RA; Clayton, TC; Chamberlain, DA; Shaw, TRD; Wheatley, DJ; Pocock, SJ				Fox, KAA; Poole-Wilson, PA; Henderson, RA; Clayton, TC; Chamberlain, DA; Shaw, TRD; Wheatley, DJ; Pocock, SJ		Randomized Intervention Trial Uns	Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial	LANCET			English	Article							ACUTE CORONARY SYNDROMES; MANAGEMENT; ENOXAPARIN; OUTCOMES	Background Current guidelines suggest that, for patients at moderate risk of death from unstable coronary-artery disease, either an interventional strategy (angiography followed by revascularisation) or a conservative strategy (ischaemia-driven or symptom-driven angiography) is appropriate. We aimed to test the hypothesis that an interventional strategy is better than a conservative strategy in such patients. Methods We did a randomised multicentre trial of 1810 patients with non-ST-elevation acute coronary syndromes (mean age 62 years, 38% women). Patients were assigned an early intervention or conservative strategy. The antithrombin agent in both groups was enoxaparin. The co-primary endpoints were a combined rate of death, non-fatal myocardial infarction, or refractory angina at 4 months; and a combined rate of death or non-fatal myocardial infarction at 1 year. Analysis was by intention to treat. Findings At 4 months, 86 (9.6%) of 895 patients in the intervention group had died or had a myocardial infarction or refractory angina, compared with 133 (14.5%) of 915 patients in the conservative group (risk ratio 0.66, 95% CI 0.51-0.85, p=0.001). This difference was mainly due to a halving of refractory angina in the intervention group. Death or myocardial infarction was similar in both treatment groups at 1 year (68 [7.6%] vs 76 [8.3%], respectively; risk ratio 0.91, 95% CI 0.67-1.25, p=0.58). Symptoms of angina were improved and use of antianginal medications significantly reduced with the interventional strategy (p<0.0001). Interpretation In patients presenting with unstable coronary-artery disease, an interventional strategy is preferable to a conservative strategy, mainly because of the halving of refractory or severe angina, and with no increased risk of death or myocardial infarction.	Royal Infirm, Dept Med & Radiol Sci, Edinburgh EH3 9YW, Midlothian, Scotland; Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Dept Cardiac Med, London SW7 2AZ, England; Nottingham City Hosp NHS Trust, Nottingham, England; London Sch Hyg & Trop Med, Med Stat Unit, London, England; Glasgow Royal Infirm, Dept Cardiac Surg, Glasgow G4 0SF, Lanark, Scotland; Western Gen Hosp, Dept Cardiol, Edinburgh EH4 2XU, Midlothian, Scotland	Royal Infirmary of Edinburgh; Imperial College London; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of London; London School of Hygiene & Tropical Medicine; University of Glasgow; University of Edinburgh	Fox, KAA (corresponding author), Royal Infirm, Dept Med & Radiol Sci, Edinburgh EH3 9YW, Midlothian, Scotland.	k.a.a.fox@ed.ac.uk	Fox, keith A A/I-3742-2013	Fox, Keith/0000-0002-0140-2752; Clayton, Tim/0000-0002-1266-3288				Akkerhuis KM, 2002, CIRCULATION, V105, P554, DOI 10.1161/hc0502.104278; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; [Anonymous], 1994, Circulation, V89, P1545; Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Antman EM, 1999, CIRCULATION, V100, P1602, DOI 10.1161/01.CIR.100.15.1602; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; Brener SJ, 2002, EUR HEART J, V23, P869, DOI 10.1053/euhj.2001.2976; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; de Arenaza DP, 2001, NEW ENGL J MED, V345, P1573; Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Markiewicz W, 2000, LANCET, V355, P572, DOI 10.1016/S0140-6736(05)73219-0; McCullough PA, 1998, J AM COLL CARDIOL, V32, P596, DOI 10.1016/S0735-1097(98)00284-8; Michalis LK, 2000, EUR HEART J, V21, P1954, DOI 10.1053/euhj.2000.2397; Spacek R, 2002, EUR HEART J, V23, P230, DOI 10.1053/euhj.2001.2735; *UK CARD SURG REG, 2002, NAT AD CARD SURG DAT; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2	21	616	672	2	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2002	360	9335					743	751		10.1016/S0140-6736(02)09894-X	http://dx.doi.org/10.1016/S0140-6736(02)09894-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592HX	12241831				2022-12-28	WOS:000177933000014
J	Seifritz, E; Esposito, F; Hennel, F; Mustovic, H; Neuhoff, JG; Bilecen, D; Tedeschi, G; Scheffler, K; Di Salle, F				Seifritz, E; Esposito, F; Hennel, F; Mustovic, H; Neuhoff, JG; Bilecen, D; Tedeschi, G; Scheffler, K; Di Salle, F			Spatiotemporal pattern of neural processing in the human auditory cortex	SCIENCE			English	Article							INDEPENDENT COMPONENT ANALYSIS; BLIND SEPARATION; CORTICAL-NEURONS; FUNCTIONAL MRI; FMRI DATA; SOUNDS; BRAIN; TONES; NOISE	The principles that the auditory cortex uses to decipher a stream of acoustic information have remained elusive. Neural responses in the animal auditory cortex can be broadly classified into transient and sustained activity. We examined the existence of similar principles in the human brain. Sound-evoked, blood oxygen level-dependent signal response was decomposed temporally into independent transient and sustained constituents, which predominated in different portions-core and belt-of the auditory cortex. Converging with unit recordings, our data suggest that this spatiotemporal pattern in the auditory cortex may represent a fundamental principle of analyzing sound information.	Univ Basel, Dept Psychiat, CH-4025 Basel, Switzerland; Univ Naples 2, Div Neurol 2, I-80138 Naples, Italy; Ctr Hosp, Fdn Rech Appl Psychiat, Magnet Resonance Dept, F-68250 Rouffach, France; Coll Wooster, Dept Psychol, Wooster, OH 44691 USA; Univ Basel, Dept Radiol, CH-4031 Basel, Switzerland; Univ Freiburg, Dept Radiol, Sect Med Phys, D-79106 Freiburg, Germany; Univ Naples Federico II, Dept Neurol Sci, Div Neuroradiol, I-80127 Naples, Italy	University of Basel; Universita della Campania Vanvitelli; College of Wooster; University of Basel; University of Freiburg; University of Naples Federico II	Seifritz, E (corresponding author), Univ Basel, Dept Psychiat, CH-4025 Basel, Switzerland.		Neuhoff, John G/A-2955-2016; Esposito, Fabrizio/M-8555-2015	Esposito, Fabrizio/0000-0002-5099-9786; Hennel, Franciszek/0000-0003-0043-9921; Scheffler, Klaus/0000-0001-6316-8773; Di Salle, Francesco/0000-0002-0226-8460				Atzori M, 2001, NAT NEUROSCI, V4, P1230, DOI 10.1038/nn760; Bandettini PA, 1998, MAGNET RESON MED, V39, P410, DOI 10.1002/mrm.1910390311; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Biswal BB, 1999, J COMPUT ASSIST TOMO, V23, P265, DOI 10.1097/00004728-199903000-00016; Brown GD, 2001, TRENDS NEUROSCI, V24, P54, DOI 10.1016/S0166-2236(00)01683-0; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Duann JR, 2002, NEUROIMAGE, V15, P823, DOI 10.1006/nimg.2001.1049; Eggermont JJ, 2002, J NEUROPHYSIOL, V87, P305, DOI 10.1152/jn.00490.2001; EHRET G, 1997, CENTRAL AUDITORY SYS; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; HENNEL F, 1998, MAGMA S, V6, P87; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Nagarajan SS, 2002, J NEUROPHYSIOL, V87, P1723, DOI 10.1152/jn.00632.2001; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, HEARING RES, V150, P104, DOI 10.1016/S0378-5955(00)00194-5; Robson MD, 1998, NEUROIMAGE, V7, P185, DOI 10.1006/nimg.1998.0322; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	31	166	171	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1706	1708		10.1126/science.1074355	http://dx.doi.org/10.1126/science.1074355			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215648				2022-12-28	WOS:000177819100051
J	Steward, O				Steward, O			Translating axon guidance cues	CELL			English	Review							PROTEIN-SYNTHESIS; MESSENGER-RNA; SYMPATHETIC NEURONS; GROWTH CONES; LOCALIZATION; ORGANIZATION; TRANSPORT; ACTIN	Recent studies suggest that local translation of mRNA within axons plays a key role in two aspects of growth cone navigation. One line of evidence implies a local synthesis of proteins that mediate growth cone collapse and turning in response to guidance cues; another indicates that growth cones possess the machinery that would allow the local synthesis of receptors for axon guidance cues.	Univ Calif Irvine, Reeve Irvine Res Ctr, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Steward, O (corresponding author), Univ Calif Irvine, Reeve Irvine Res Ctr, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	osteward@uci.edu		Steward, Oswald/0000-0001-7069-8756				Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Bassell GJ, 1998, J NEUROSCI, V18, P251; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Eng H, 1999, J NEUROSCI, V19, P1; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; KLEIMAN R, 1994, J NEUROSCI, V14, P1130, DOI 10.1523/JNEUROSCI.14-03-01130.1994; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; OlinkCoux M, 1996, J NEUROSCI, V16, P1346; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; TENNYSON VM, 1970, J CELL BIOL, V44, P62, DOI 10.1083/jcb.44.1.62; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	18	26	28	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2002	110	5					537	540		10.1016/S0092-8674(02)00934-0	http://dx.doi.org/10.1016/S0092-8674(02)00934-0			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230970	Bronze			2022-12-28	WOS:000177943700001
J	Doyle, MR; Davis, SJ; Bastow, RM; McWatters, HG; Kozma-Bognar, L; Nagy, F; Millar, AJ; Amasino, RM				Doyle, MR; Davis, SJ; Bastow, RM; McWatters, HG; Kozma-Bognar, L; Nagy, F; Millar, AJ; Amasino, RM			The ELF4 gene controls circadian rhythms and flowering time in Arabidopsis thaliana	NATURE			English	Article							HYPOCOTYL ELONGATION; CLOCK; PROTEIN; ENCODES; PHOTOMORPHOGENESIS; DYSFUNCTION; MUTAGENESIS; EXPRESSION; PHYB; TOC1	Many plants use day length as an environmental cue to ensure proper timing of the switch from vegetative to reproductive growth. Day-length sensing involves an interaction between the relative length of day and night, and endogenous rhythms that are controlled by the plant circadian clock(1). Thus, plants with defects in circadian regulation cannot properly regulate the timing of the floral transition(2). Here we describe the gene EARLY FLOWERING 4 (ELF4), which is involved in photoperiod perception and circadian regulation. ELF4 promotes clock accuracy and is required for sustained rhythms in the absence of daily light/dark cycles. elf4 mutants show attenuated expression of CIRCADIAN CLOCK ASSOCIATED 1 (CCA1), a gene that is thought to function as a central oscillator component(3,4). In addition, elf4 plants transiently show output rhythms with highly variable period lengths before becoming arrhythmic. Mutations in elf4 result in early flowering in non-inductive photoperiods, which is probably caused by elevated amounts of CONSTANS (CO), a gene that promotes floral induction(5).	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Biol Res Ctr, Inst Plant Biol, H-6726 Szeged, Hungary	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Warwick; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Amasino, RM (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	Andrew.Millar@warwick.ac.uk; amasino@biochemwisc.edu	Nagy, Ferenc/D-3532-2015; Millar, Andrew J/G-2423-2012; Kozma-Bognar, Laszlo/L-8384-2018	Nagy, Ferenc/0000-0002-6157-9269; Millar, Andrew J/0000-0003-1756-3654; Kozma-Bognar, Laszlo/0000-0002-8289-193X				Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Bell-Pedersen D, 2001, PHILOS T ROY SOC B, V356, P1697, DOI 10.1098/rstb.2001.0968; Bognar LK, 1999, P NATL ACAD SCI USA, V96, P14652, DOI 10.1073/pnas.96.25.14652; Carre IA, 1995, PLANT CELL, V7, P2039, DOI 10.2307/3870149; Carre IA, 2001, J BIOL RHYTHM, V16, P415, DOI 10.1177/074873001129002006; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Davis SJ, 2001, PLANT PHYSIOL, V126, P656, DOI 10.1104/pp.126.2.656; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Reed JW, 2000, PLANT PHYSIOL, V122, P1149, DOI 10.1104/pp.122.4.1149; Samach A, 2000, BIOESSAYS, V22, P38, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;38::AID-BIES8&gt;3.0.CO;2-L; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Thomas B., 1997, PHOTOPERIODISM PLANT; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x	25	357	383	6	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					74	77		10.1038/nature00954	http://dx.doi.org/10.1038/nature00954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214234				2022-12-28	WOS:000177788600039
J	Mittman, DE; Cawley, JF; Fenn, WH				Mittman, DE; Cawley, JF; Fenn, WH			Physician assistants in the United States	BMJ-BRITISH MEDICAL JOURNAL			English	Article								The United States has since the 1960s developed a cadre of physician assistants to work in primary care. They mainly work semi-autonomously in association with individual doctors, but an increasing number work in hospitals. They seem to be well accepted by both doctors and patients and can reasonably expect to take on any unfilled roles for which their training qualifies them	Clinicians Grp, Clifton, NJ 07012 USA; George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA; Western Michigan Univ, Coll Hlth & Human Serv, Kalamazoo, MI 49008 USA	George Washington University; Western Michigan University	Mittman, DE (corresponding author), Clinicians Grp, 2 Brighton Rd,Suite 300, Clifton, NJ 07012 USA.	dmittman@clingroup.com						*AM AC PHYS ASS, 1999, FUT PHYS ASS LOOK 21; *AM AC PHYS ASS, 2000, 2000 GEN CENS; Balling R., 1999, PHYSICIAN GUIDE CLIN, V1, P295; Cawley JF, 1999, JAMA-J AM MED ASSOC, V281, P509; CAWLEY JF, 1999, FED B, V85, P242; CAWLEY JF, 1998, NY HLTH SCI J, V2, P117; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P788, DOI 10.1001/jama.280.9.788; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P795, DOI 10.1001/jama.280.9.795; Counselman FL, 2000, AM J EMERG MED, V18, P661, DOI 10.1053/ajem.2000.16301; Hooker RS, 1996, AM J EMERG MED, V14, P245, DOI 10.1016/S0735-6757(96)90167-9; Hooker RS, 2001, HEALTH AFFAIR, V20, P231, DOI 10.1377/hlthaff.20.4.231; HOOKER RS, 1999, THESIS PORTLAND STAT; HOOKER RS, 1997, PHYSICIAN ASSISTANTS; Hooker RS., 1997, PERMANENTE J, V1, P38; JONES PE, 1994, JAMA-J AM MED ASSOC, V271, P1266, DOI 10.1001/jama.271.16.1266; Miller W, 1998, J TRAUMA, V44, P372, DOI 10.1097/00005373-199802000-00025; Oliver D R, 1986, Physician Assist, V10, P51; OLIVER DR, 1986, PHYS ASSISTANT, V10, P57; *PEW HLTH PROF COM, 1998, CHART COURS 21 CENT; *ROYAL COLL PHYS, 2001, SKILL MIX HOSP DOCT; Rudy E B, 1998, Am J Crit Care, V7, P267; SCHNELLER ES, 1978, PHYSICIAN INNOVATION, P18; SIMON AF, 2001, 17 ASS PHYS ASS PROG; *STAT OFF, 2000, NHS PLAN PLAN INV PL	24	51	51	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2002	325	7362					485	487		10.1136/bmj.325.7362.485	http://dx.doi.org/10.1136/bmj.325.7362.485			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592EZ	12202333	Green Published			2022-12-28	WOS:000177924900026
J	Allen, AP; Brown, JH; Gillooly, JF				Allen, AP; Brown, JH; Gillooly, JF			Global biodiversity, biochemical kinetics, and the energetic-equivalence rule	SCIENCE			English	Article							SPECIES-DIVERSITY; SCALE PATTERNS; TEMPERATURE; GRADIENTS; RICHNESS; SIZE	The latitudinal gradient of increasing biodiversity from poles to equator is one of the most prominent but least understood features of life on Earth. Here we show that species diversity can be predicted from the biochemical kinetics of metabolism. We first demonstrate that the average energy flux of populations is temperature invariant. We then derive a model that quantitatively predicts how species diversity increases with environmental temperature. Predictions are supported by data for terrestrial, freshwater, and marine taxa along latitudinal and elevational gradients. These results establish a thermodynamic basis for the regulation of species diversity and the organization of ecological communities.	Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Allen, AP (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	drewa@unm.edu	Allen, Andrew/B-8045-2011	Allen, Andrew/0000-0003-0304-7544				Brown J. H., 1998, BIOGEOGRAPHY; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; DUELLMAN WE, 1988, ANN MO BOT GARD, V75, P79, DOI 10.2307/2399467; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; GILLOOLY JF, UNPUB; Hubbell Stephen P., 2001, V32, pi; ISOBE T, 1990, ASTROPHYS J, V364, P104, DOI 10.1086/169390; LEGATES DR, 1990, THEOR APPL CLIMATOL, V41, P11, DOI 10.1007/BF00866198; Lieberman D, 1996, J ECOL, V84, P137, DOI 10.2307/2261350; Oberdorff T, 1995, ECOGRAPHY, V18, P345, DOI 10.1111/j.1600-0587.1995.tb00137.x; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Rohde K, 1998, INT J PARASITOL, V28, P461, DOI 10.1016/S0020-7519(97)00209-9; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	24	604	637	8	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1545	1548		10.1126/science.1072380	http://dx.doi.org/10.1126/science.1072380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202828				2022-12-28	WOS:000177697300055
J	Biederer, T; Sara, Y; Mozhayeva, M; Atasoy, D; Liu, XR; Kavalali, ET; Sudhof, TC				Biederer, T; Sara, Y; Mozhayeva, M; Atasoy, D; Liu, XR; Kavalali, ET; Sudhof, TC			SynCAM, a synaptic adhesion molecule that drives synapse assembly	SCIENCE			English	Article							CELL-ADHESION; FASCICLIN II; EPH RECEPTORS; PDZ PROTEIN; NEUREXINS; BINDING; CALMODULIN; MODULATION; EXOCYTOSIS; SEQUENCES	Synapses, the junctions between nerve cells through which they communicate, are formed by the coordinated assembly and tight attachment of pre- and postsynaptic specializations. We now show that SynCAM is a brain-specific, immunoglobulin domain containing protein that binds to intracellular PDZ-domain proteins and functions as a homophilic cell adhesion molecule at the synapse. Expression of the isolated cytoplasmic tail of SynCAM in neurons inhibited synapse assembly. Conversely, expression of full-length SynCAM in nonneuronal cells induced synapse formation by cocultured hippocampal neurons with normal release properties. Glutamatergic synaptic transmission was reconstituted in these nonneuronal cells by coexpressing glutamate receptors with SynCAM, which suggests that a single type of adhesion molecule and glutamate receptor are sufficient for a functional postsynaptic response.	Univ Texas, Ctr Basic Neurosci, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Dept Mol Genet, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Dept Physiol, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Howard Hughes Med Inst, SW Med Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, Ctr Basic Neurosci, SW Med Ctr, Dallas, TX 75390 USA.	Thomas.Biederer@UTSouthwestern.edu; Thomas.Sudhof@UTSouthwestern.edu	Atasoy, Deniz/B-3414-2018; Biederer, Thomas/AAZ-6133-2021; Atasoy, Deniz/AAR-7917-2020	Biederer, Thomas/0000-0003-0912-1514; Atasoy, Deniz/0000-0002-3325-8820; Sara, Yildirim/0000-0003-1079-0782				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BANKER G, 1998, CULTURING NERVE CELL; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hata Y, 1996, J NEUROSCI, V16, P2488; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PHELAN P, 1997, NEUROCHEMISTRY PRACT, P1; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sudhof TC, 2001, SYNAPSES, P275; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Sugita S, 2000, BIOCHEMISTRY-US, V39, P2940, DOI 10.1021/bi9920984; Sugita S, 2002, NEUROSCIENCE, V112, P51, DOI 10.1016/S0306-4522(02)00063-5; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; THIERY JP, 1977, J BIOL CHEM, V252, P6841; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	47	581	608	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1525	1531		10.1126/science.1072356	http://dx.doi.org/10.1126/science.1072356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202822				2022-12-28	WOS:000177697300049
J	Croxall, JP; Trathan, PN; Murphy, EJ				Croxall, JP; Trathan, PN; Murphy, EJ			Environmental change and Antarctic seabird populations	SCIENCE			English	Review							SEA-ICE EXTENT; EMPEROR PENGUINS; CLIMATE-CHANGE; TOP PREDATOR; VARIABILITY; SURVIVAL	Recent changes in Antarctic seabird populations may reflect direct and indirect responses to regional climate change. The best long-term data for high-latitude Antarctic seabirds (Adelie and Emperor penguins and snow petrels) indicate that winter sea-ice has a profound influence. However, some effects are inconsistent between species and areas, some in opposite directions at different stages of breeding and life cycles, and others remain paradoxical. The combination of recent harvest driven changes and those caused by global warming may produce rapid shifts rather than gradual changes.	British Antarctic Survey, NERC, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Croxall, JP (corresponding author), British Antarctic Survey, NERC, Madingley Rd, Cambridge CB3 0ET, England.	j.croxall@bas.ac.uk	murphy, eugene/GZL-1620-2022					AINLEY DG, 1994, J ANIM ECOL, V63, P347, DOI 10.2307/5553; ANCEL A, 1992, NATURE, V360, P336, DOI 10.1038/360336a0; Barbraud C, 2000, OECOLOGIA, V125, P483, DOI 10.1007/s004420000481; Barbraud C, 2001, J AVIAN BIOL, V32, P297, DOI 10.1111/j.0908-8857.2001.320402.x; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Barlow KE, 2002, MAR BIOL, V140, P205, DOI 10.1007/s00227-001-0691-7; *BRIT ANT SURV, 2002, PUBL DAT; CHASTEL O, 1993, OECOLOGIA, V94, P278, DOI 10.1007/BF00341328; Croxall J.P., 1979, DISTRIBUTION PENGUIN; CROXALL J.P., 1981, BR ANTARCT SURV B, V54, P47; CROXALL JP, 1992, PHILOS T ROY SOC B, V338, P319, DOI 10.1098/rstb.1992.0152; CROXALL JP, UNPUB; Emslie SD, 2002, POLAR BIOL, V25, P222, DOI 10.1007/s00300-001-0334-y; Emslie SD, 1998, ANTARCT SCI, V10, P257, DOI 10.1017/S0954102098000352; Fraser William R., 1997, P445; *INT PAN CLIM CHAN, 2001, CLIM CHANG; Jacobs SS, 1997, J CLIMATE, V10, P697, DOI 10.1175/1520-0442(1997)010<0697:CVITAA>2.0.CO;2; Kirkwood R, 1997, ECOL MONOGR, V67, P155, DOI 10.1890/0012-9615(1997)067[0155:TFEOFE]2.0.CO;2; Kooyman GL, 2000, MAR ECOL PROG SER, V204, P269, DOI 10.3354/meps204269; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; MARTIN S, 1992, GEOPHYS MONOGR SER, V68, P303; Massom RA, 1998, ANN GLACIOL, V27, P420; MURPHY EJ, 1995, DEEP-SEA RES PT I, V42, P1045, DOI 10.1016/0967-0637(95)00057-D; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Stammerjohn SE, 1997, CLIMATIC CHANGE, V37, P617, DOI 10.1023/A:1005331731034; STONEHOUSE B, 1967, POLAR REC, V13, P775; Trathan PN, 1996, POLAR BIOL, V16, P321; TRIVELPIECE W, 2001, 32 COMM CONS ANT MAR; *US GEOL SERV, PUBL DAT; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; White WB, 1996, NATURE, V380, P699, DOI 10.1038/380699a0; Wilson PR, 2001, MAR ECOL PROG SER, V213, P301, DOI 10.3354/meps213301; Woehler E., 2001, STAT ASSESSMENT STAT; [No title captured]	36	321	339	3	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1510	1514		10.1126/science.1071987	http://dx.doi.org/10.1126/science.1071987			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202819				2022-12-28	WOS:000177697300045
J	Mazal, PR; Schaufler, R; Altenhuber-Muller, R; Haitel, A; Watschinger, B; Kratzik, C; Krupitza, G; Regele, H; Meisl, FT; Zechner, O; Kerjaschki, D; Susani, M				Mazal, PR; Schaufler, R; Altenhuber-Muller, R; Haitel, A; Watschinger, B; Kratzik, C; Krupitza, G; Regele, H; Meisl, FT; Zechner, O; Kerjaschki, D; Susani, M			Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CALMETTE-GUERIN TREATMENT; URINARY-TRACT; AQUAPORIN FAMILY; WATER CHANNELS; BLADDER; LESION; ADENOCARCINOMA; HISTOGENESIS; METAPLASIA; UROTHELIUM	Background Nephrogenic adenomas are benign, tumor-like lesions within the urothelial mucosa of the urinary tract that are not uncommon in renal-transplant recipients. We investigated the origin of nephrogenic adenomas in renal-transplant recipients. Methods Tissue sections were analyzed by fluorescence in situ hybridization with the use of probes for the X and Y chromosomes, by immunohistochemical methods with the use of antibodies to renal tubular antigens, and by lectin histochemical methods. Forty-six nephrogenic adenomas from 29 patients were analyzed. Results All nephrogenic adenomas in 14 female recipients of transplants from male donors and 10 male recipients of transplants from female donors showed the same sex-chromosome status as the donor kidney, but not the same sex-chromosome status as the recipient's surrounding bladder tissue. The nephrogenic adenomas from all 6 female recipients of transplants from female donors showed female chromosomes, and those from the 16 male recipients of transplants from male donors showed male chromosomes. The presence of aquaporin 1, PAX2, and lectin-binding capacity for peanut agglutinin, Lotus tetragonolobus agglutinin, and Sophora Japonica agglutinin in nephrogenic adenomas indicated an origin from renal tubular cells. Conclusions Nephrogenic adenomas in renal-transplant recipients are derived from tubular cells of the renal transplants and are riot metaplastic proliferations of the recipient's bladder urothelium.	Univ Vienna, Dept Clin Pathol, Gen Hosp, A-1090 Vienna, Austria; Univ Vienna, Ctr Excellence Clin & Expt Oncol, A-1090 Vienna, Austria; Univ Vienna, Dept Internal Med 3, A-1090 Vienna, Austria; Univ Vienna, Dept Urol, A-1090 Vienna, Austria; Wilhelminen Hosp, Dept Nephrol, Vienna, Austria; Wilhelminen Hosp, Dept Urol, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna; University of Vienna; Wilhelminenspital; Wilhelminenspital	Susani, M (corresponding author), Univ Vienna, Dept Clin Pathol, Gen Hosp, Wahringer Guertel 18-20, A-1090 Vienna, Austria.			Mazal, Peter/0000-0002-9586-6231; Krupitza, Georg/0000-0003-2949-7906				Agre P, 1996, NEPHROLOGIE, V17, P409; Banyai-Falger S, 1998, TRANSPLANTATION, V65, P511, DOI 10.1097/00007890-199802270-00010; BEAUDRY C, 1983, J UROLOGY, V130, P1183, DOI 10.1016/S0022-5347(17)51746-2; BEHESTI M, 1982, UROLOGY, V20, P298, DOI 10.1016/0090-4295(82)90645-8; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; DAVIS T A, 1949, Northwest Med, V48, P182; DEVINE P, 1984, AM J CLIN PATHOL, V81, P728, DOI 10.1093/ajcp/81.6.728; Dorrenhaus A, 2000, ARCH TOXICOL, V74, P618, DOI 10.1007/s002040000173; FORD TF, 1985, BRIT J UROL, V57, P427, DOI 10.1111/j.1464-410X.1985.tb06303.x; Fournier G, 1996, J UROLOGY, V156, P41, DOI 10.1016/S0022-5347(01)65932-9; FRIEDMAN NB, 1950, J UROLOGY, V64, P657, DOI 10.1016/S0022-5347(17)68693-2; Gilcrease MZ, 1998, HUM PATHOL, V29, P1451, DOI 10.1016/S0046-8177(98)90015-6; GONZALEZ JA, 1988, J UROLOGY, V139, P45, DOI 10.1016/S0022-5347(17)42285-3; Gordon H L, 1975, Urology, V5, P275, DOI 10.1016/0090-4295(75)90031-X; Grupp C, 2001, AM J KIDNEY DIS, V37, P84, DOI 10.1053/ajkd.2001.20592; IMAHORI SC, 1980, UROLOGY, V16, P310, DOI 10.1016/0090-4295(80)90055-2; JAKSE G, 1983, EUR UROL, V9, P60; JOHANNES A, 1988, UROLOGE A, V27, P204; KAVER I, 1985, UROLOGY, V26, P506, DOI 10.1016/0090-4295(85)90169-4; Kilciler M, 2000, UROL INT, V64, P229, DOI 10.1159/000030538; KUNZE E, 1993, PATHOL RES PRACT, V189, P217, DOI 10.1016/S0344-0338(11)80097-X; MALPICA A, 1994, HUM PATHOL, V25, P390, DOI 10.1016/0046-8177(94)90148-1; MAREK J, 1985, PATHOL RES PRACT, V180, P569, DOI 10.1016/S0344-0338(85)80028-5; MARTINEZ ER, 1998, ARCH ESP UROL, V51, P284; MCINTIRE TL, 1987, UROLOGY, V29, P237, DOI 10.1016/0090-4295(87)90060-4; MIETTINEN HHA, 1983, LAB INVEST, V49, P317; NIELSEN S, 1995, KIDNEY INT, V48, P1057, DOI 10.1038/ki.1995.389; OLIVA E, 1995, MODERN PATHOL, V8, P722; OSHEA PA, 1981, J UROLOGY, V125, P249, DOI 10.1016/S0022-5347(17)54990-3; Oyama N, 1998, Int J Urol, V5, P185, DOI 10.1111/j.1442-2042.1998.tb00275.x; Peeker R, 1997, BRIT J UROL, V80, P539, DOI 10.1046/j.1464-410X.1997.00418.x; Piper NY, 1999, J UROLOGY, V161, P605, DOI 10.1016/S0022-5347(01)61964-5; Pycha A, 1998, UROLOGY, V52, P756, DOI 10.1016/S0090-4295(98)00371-9; RACUSEN LC, 1991, LAB INVEST, V64, P546; Racusen LC, 1998, CLIN EXP PHARMACOL P, V25, P273, DOI 10.1111/j.1440-1681.1998.t01-3-.x; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; RACUSEN LC, 1995, KIDNEY INT, V48, P536, DOI 10.1038/ki.1995.324; Satoh F, 2000, PATHOL INT, V50, P458, DOI 10.1046/j.1440-1827.2000.01070.x; SCHAAFSMA HE, 1990, AM J PATHOL, V136, P329; SILVA FG, 1993, ARCH PATHOL LAB MED, V117, P1233; STILMANT MM, 1986, J UROLOGY, V135, P359, DOI 10.1016/S0022-5347(17)45639-4; STRAND WR, 1987, J UROLOGY, V137, P491, DOI 10.1016/S0022-5347(17)44083-3; Tse V, 1997, UROLOGY, V50, P690, DOI 10.1016/S0090-4295(97)00334-8; ULRICH W, 1985, HISTOPATHOLOGY, V9, P1037; vanderLinden PJQ, 1996, HUM REPROD, V11, P53, DOI 10.1093/humrep/11.suppl_3.53; VORREUTHER R, 1994, UROL INT, V53, P227, DOI 10.1159/000282678; Weingartner K, 1997, J UROLOGY, V158, P1175, DOI 10.1016/S0022-5347(01)64416-1; WOOD DP, 1988, J UROLOGY, V139, P130, DOI 10.1016/S0022-5347(17)42319-6; YOUNG RH, 1986, AM J SURG PATHOL, V10, P268, DOI 10.1097/00000478-198604000-00005; ZEIDAN BS, 1992, TRANSPLANT P, V24, P752	50	98	107	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2002	347	9					653	659		10.1056/NEJMoa013413	http://dx.doi.org/10.1056/NEJMoa013413			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZT	12200552	Bronze			2022-12-28	WOS:000177675500004
J	Stenseth, NC; Mysterud, A; Ottersen, G; Hurrell, JW; Chan, KS; Lima, M				Stenseth, NC; Mysterud, A; Ottersen, G; Hurrell, JW; Chan, KS; Lima, M			Ecological effects of climate fluctuations	SCIENCE			English	Review							NORTH-ATLANTIC OSCILLATION; WESTERN SOUTH-AMERICA; EL-NINO; POPULATION-DYNAMICS; RED DEER; SOAY SHEEP; LONG-TERM; TERRESTRIAL ECOSYSTEMS; C-HELGOLANDICUS; EXTREME WEATHER	Climate influences a variety of ecological processes. These effects operate through local weather parameters such as temperature, wind, rain, snow, and ocean currents, as well as interactions among these. In the temperate zone, local variations in weather are often coupled over large geographic areas through the transient behavior of atmospheric planetary-scale waves. These variations drive temporally and spatially averaged exchanges of heat, momentum, and water vapor that ultimately determine growth, recruitment, and migration patterns. Recently, there have been several studies of the impact of large-scale climatic forcing on ecological systems. We review how two of the best-known climate phenomena the North Atlantic Oscillation and the El Nino Southern Oscillation affect ecological patterns and processes in both marine and terrestrial systems.	Univ Oslo, Dept Biol, Div Zool, N-0316 Oslo, Norway; Flodevigen Marine Res Stn, Inst Marine Res, Dept Coastal Zone Studies, N-4817 His, Norway; Inst Marine Res, N-5024 Bergen, Norway; Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA; Pontificia Univ Catolica Chile, Ctr Adv Studies Ecol & Biodivers, Santiago 6513677, Chile	University of Oslo; Institute of Marine Research - Norway; Institute of Marine Research - Norway; National Center Atmospheric Research (NCAR) - USA; University of Iowa; Pontificia Universidad Catolica de Chile	Stenseth, NC (corresponding author), Univ Oslo, Dept Biol, Div Zool, POB 1050 Blindern, N-0316 Oslo, Norway.		Ottersen, Geir/F-4393-2014; Lima, Mauricio/F-2722-2013; Ottersen, Geir/M-9676-2019; Stenseth, Nils Chr./G-5212-2016; Mysterud, Atle/AAQ-2864-2020; Ólafsdóttir, Guðbjörg Ásta/M-2722-2015; Ottersen, Geir/B-2069-2008; Ottersen, Geir/AAS-3046-2020	Ottersen, Geir/0000-0002-9453-6679; Lima, Mauricio/0000-0002-3700-2945; Ottersen, Geir/0000-0002-9453-6679; Stenseth, Nils Chr./0000-0002-1591-5399; Mysterud, Atle/0000-0001-8993-7382; Ólafsdóttir, Guðbjörg Ásta/0000-0002-2814-9160; Hurrell, James Wilson/0000-0002-3169-6384				Alheit J, 1997, FISH OCEANOGR, V6, P130, DOI 10.1046/j.1365-2419.1997.00035.x; Alheit Juergen, 2001, P247; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Brockwell P.J., 1986, TIME SERIES THEORY M; CASTILLA JC, 1992, S AFR J MARINE SCI, V12, P703; Catchpole EA, 2000, J R STAT SOC C-APPL, V49, P453, DOI 10.1111/1467-9876.00205; Chan KS, 1998, BIOMETRIKA, V85, P413, DOI 10.1093/biomet/85.2.413; CHAN KS, 2002, UNPUB BIOMETRICS; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Couper-Johnston R., 2000, EL NINO WEATHER PHEN; Crawford RMM, 2000, NEW PHYTOL, V147, P257, DOI 10.1046/j.1469-8137.2000.00705.x; Cushing D.H., 1974, P399; Cushing D.H., 1995, POPULATION PRODUCTIO; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Eubank R. L., 1999, NONPARAMETRIC REGRES; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Forchhammer MC, 1998, P ROY SOC B-BIOL SCI, V265, P341, DOI 10.1098/rspb.1998.0301; Forchhammer MC, 2000, TRENDS ECOL EVOL, V15, P286, DOI 10.1016/S0169-5347(00)01869-3; Fromentin JM, 1996, MAR ECOL PROG SER, V134, P111, DOI 10.3354/meps134111; Greatbatch RJ, 2000, STOCH ENV RES RISK A, V14, P213, DOI 10.1007/s004770000047; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; GRENFELL BT, 1992, NATURE, V355, P823, DOI 10.1038/355823a0; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Haydon DT, 2001, P NATL ACAD SCI USA, V98, P13149, DOI 10.1073/pnas.221275198; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; Holmgren M, 2001, TRENDS ECOL EVOL, V16, P89, DOI 10.1016/S0169-5347(00)02052-8; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Inouye DW, 2000, ECOL LETT, V3, P457, DOI 10.1046/j.1461-0248.2000.00165.x; Jaksic FM, 2001, ECOGRAPHY, V24, P241, DOI 10.1034/j.1600-0587.2001.240301.x; Jaksic FM, 1997, OIKOS, V78, P341, DOI 10.2307/3546302; Kaitala V, 2001, P ROY SOC B-BIOL SCI, V268, P1769, DOI 10.1098/rspb.2001.1718; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Lima M, 2001, J ANIM ECOL, V70, P761, DOI 10.1046/j.0021-8790.2001.00536.x; Lima M, 2002, ECOL LETT, V5, P273, DOI 10.1046/j.1461-0248.2002.00312.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Loison A, 1999, ECOGRAPHY, V22, P20, DOI 10.1111/j.1600-0587.1999.tb00451.x; Mann K. H., 1994, Environmental Reviews, V2, P16; MAY RM, 1981, THEORET ECOL PRINCIP; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; MCILROY SG, 1989, VET REC, V125, P79, DOI 10.1136/vr.125.4.79; Meehl GA, 2000, B AM METEOROL SOC, V81, P413, DOI 10.1175/1520-0477(2000)081<0413:AITTIE>2.3.CO;2; Milner JM, 1999, J ANIM ECOL, V68, P1235, DOI 10.1046/j.1365-2656.1999.00366.x; Mysterud A, 2000, J ANIM ECOL, V69, P959, DOI 10.1046/j.1365-2656.2000.00454.x; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; MYSTERUD A, IN PRESS N ATLANTIC; NAMIAS J, 1981, SCIENCE, V214, P869, DOI 10.1126/science.214.4523.869; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Ottersen G, 2000, ICES J MAR SCI, V57, P339, DOI 10.1006/jmsc.1999.0529; Ottersen G, 2001, LIMNOL OCEANOGR, V46, P1774, DOI 10.4319/lo.2001.46.7.1774; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; PEARSON O P, 1975, Mammalia, V39, P375, DOI 10.1515/mamm.1975.39.3.375; PHILANDER SG, 1990, EL NINO LA NINA SO; Planque B, 1996, MAR ECOL PROG SER, V134, P101, DOI 10.3354/meps134101; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 1997, P ROY SOC B-BIOL SCI, V264, P1317, DOI 10.1098/rspb.1997.0182; Post E, 1999, AM NAT, V154, P194, DOI 10.1086/303224; Ranta E, 1999, P ROY SOC B-BIOL SCI, V266, P1851, DOI 10.1098/rspb.1999.0856; Ranta E, 1997, OIKOS, V78, P136, DOI 10.2307/3545809; ROGERS JC, 1984, MON WEATHER REV, V112, P1999, DOI 10.1175/1520-0493(1984)112<1999:TABTNA>2.0.CO;2; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; SAETRE GP, 1993, EVOLUTION, V47, P939, DOI 10.1111/j.1558-5646.1993.tb01247.x; Saetre GP, 1999, P ROY SOC B-BIOL SCI, V266, P1247, DOI 10.1098/rspb.1999.0770; SEASTEDT TR, 1993, AM NAT, V141, P621, DOI 10.1086/285494; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; Stenseth NC, 1998, P NATL ACAD SCI USA, V95, P15430, DOI 10.1073/pnas.95.26.15430; STENSETH NC, 2002, IN PRESS NATURE; TRENBERTH KE, 2001, ENCY OCEAN SCI, P4; Turchin Peter, 1995, P19, DOI 10.1016/B978-012159270-7/50003-8; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	78	1295	1358	9	579	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1292	1296		10.1126/science.1071281	http://dx.doi.org/10.1126/science.1071281			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193777				2022-12-28	WOS:000177573900032
J	Fischbach, W; Goebeler-Kolve, M; Starostik, P; Greiner, A; Muller-Hermelink, HK				Fischbach, W; Goebeler-Kolve, M; Starostik, P; Greiner, A; Muller-Hermelink, HK			Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori	LANCET			English	Article							B-CELL LYMPHOMA; TISSUE-TYPE	Helicobacter pylori eradication is the initial treatment of choice in localised low-grade gastric MALT (mucosa-associated lymphoid-tissue)-type lymphoma. We describe the natural course of seven patients who refused further oncological treatment for persistent lymphoma after successful eradication of H pylori. Despite persistent clonality, neither lymphoma progression nor high-grade transformation arose during a mean observation period of 34 (range 22-44) months. In view of the favourable course of these patients, a watch-and-wait strategy could be a valid approach to management of this disease.	Klin Aschaffenburg, Dept Internal Med 2, D-63739 Aschaffenburg, Germany; Univ Wurzburg, Med Poliklin, D-8700 Wurzburg, Germany; Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Fischbach, W (corresponding author), Klin Aschaffenburg, Dept Internal Med 2, D-63739 Aschaffenburg, Germany.							Fischbach W, 2000, GASTROENTEROLOGY, V119, P1191, DOI 10.1053/gast.2000.19579; Liu HX, 2001, LANCET, V357, P39, DOI 10.1016/S0140-6736(00)03571-6; QIN YF, 1995, BLOOD, V86, P3528, DOI 10.1182/blood.V86.9.3528.bloodjournal8693528; Starostik P, 2002, BLOOD, V99, P3, DOI 10.1182/blood.V99.1.3; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F	5	58	61	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					547	548		10.1016/S0140-6736(02)09711-8	http://dx.doi.org/10.1016/S0140-6736(02)09711-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241663				2022-12-28	WOS:000177512800017
J	Ratliff, NB; Harris, KM; Smith, SA; Tankh-Johnson, M; Gornick, CC; Maron, BJ				Ratliff, NB; Harris, KM; Smith, SA; Tankh-Johnson, M; Gornick, CC; Maron, BJ			Cardiac arrest in a young marathon runner	LANCET			English	Article							DEATH		Minneapolis Heart Inst Fdn, Dept Gen Cardiovasc Res, Minneapolis, MN 55407 USA	Minneapolis Heart Institute Foundation	Harris, KM (corresponding author), Minneapolis Heart Inst Fdn, Dept Gen Cardiovasc Res, Minneapolis, MN 55407 USA.							Maron BJ, 1996, J AM COLL CARDIOL, V28, P428, DOI 10.1016/0735-1097(96)00137-4; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; POELS PJE, 1993, CLIN NEUROL NEUROSUR, V95, P175, DOI 10.1016/0303-8467(93)90122-W; SCHIFF HB, 1978, Q J MED, V47, P463; SEEDAT YK, 1990, RENAL FAILURE, V11, P209	5	16	18	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					542	542		10.1016/S0140-6736(02)09744-1	http://dx.doi.org/10.1016/S0140-6736(02)09744-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241659				2022-12-28	WOS:000177512800013
J	Depew, MJ; Lufkin, T; Rubenstein, JLR				Depew, MJ; Lufkin, T; Rubenstein, JLR			Specification of jaw subdivisions by Dix genes	SCIENCE			English	Article							HOMEOBOX GENES; NEURAL CREST; DISTAL-LESS; BRANCHIAL ARCH; DLX GENES; HOMEOTIC TRANSFORMATION; MORPHOGENESIS; FOREBRAIN; DIFFERENTIATION; DROSOPHILA	The success of vertebrates was due in part to the acquisition and modi cation of jaws. Jaws are principally derived from the branchial arches, embryonic structures that exhibit proximodistal polarity. To investigate the mechanisms that specify the identity of skeletal elements within the arches, we examined mice lacking expression of Dlx5 and Dlx6, linked homeobox genes expressed distally but not proximally within the arches. Dlx5/6(-/-) mutants exhibit homeotic transformation of lower jaws to upper jaws. We suggest that nested Dlx expression in the arches patterns their proximodistal axes. Evolutionary acquisition and subsequent refinement of jaws may have been dependent on modi cation of Dlx expression.	Univ Calif San Francisco, Ctr Neurobiol & Psychiat, Dept Oral Biol, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Neurobiol & Psychiat, Dept Psychiat, San Francisco, CA 94143 USA; Mt Sinai Sch Med, Brookdale Ctr Dev & Mol Biol, New York, NY 10029 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai	Rubenstein, JLR (corresponding author), Univ Calif San Francisco, Ctr Neurobiol & Psychiat, Dept Oral Biol, Nina Ireland Lab Dev Neurobiol, 401 Parnassus Ave, San Francisco, CA 94143 USA.		Lufkin, Thomas/AAG-7476-2019; Lufkin, Thomas/B-5352-2011	Lufkin, Thomas/0000-0002-7902-4771; Lufkin, Thomas/0000-0002-7902-4771	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001046] Funding Source: NIH RePORTER; NIDCR NIH HHS [T32DE07204] Funding Source: Medline; NIMH NIH HHS [K02MH01046-01] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Acampora D, 1999, DEVELOPMENT, V126, P3795; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Barghusen H.R., 1979, P265; Campbell G, 1998, DEVELOPMENT, V125, P4483; Cecconi F, 1997, DEV DYNAM, V210, P184, DOI 10.1002/(SICI)1097-0177(199710)210:2<184::AID-AJA10>3.0.CO;2-E; Charite J, 2001, GENE DEV, V15, P3039, DOI 10.1101/gad.931701; Cohn MJ, 2002, NATURE, V416, P386, DOI 10.1038/416386a; DEBEER G, 1985, DEV VERTEBRATE SKULL; Depew M.J., 2002, MOUSE DEV PATTERNING, P421; Depew MJ, 1999, DEVELOPMENT, V126, P3831; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; HARDY MH, 1968, J EMBRYOL EXP MORPH, V19, P157; Kimmel CB, 2001, J ANAT, V199, P105, DOI 10.1046/j.1469-7580.2001.19910105.x; Kojima T, 2000, DEVELOPMENT, V127, P769; Lanctot C, 1999, DEVELOPMENT, V126, P1805; LANGILLE RM, 1989, BIOL REV, V64, P73, DOI 10.1111/j.1469-185X.1989.tb00672.x; Lee SH, 2001, NATURE, V414, P909, DOI 10.1038/414909a; Lu MF, 1999, DEVELOPMENT, V126, P495; Mallatt J, 1997, ZOOL-ANAL COMPLEX SY, V100, P128; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Moore W.J., 1981, MAMMALIAN SKULL; Neidert AH, 2001, P NATL ACAD SCI USA, V98, P1665, DOI 10.1073/pnas.98.4.1665; Panganiban G, 2000, DEV DYNAM, V218, P554, DOI 10.1002/1097-0177(200008)218:4<554::AID-DVDY1023>3.0.CO;2-#; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Qu SM, 1999, DEVELOPMENT, V126, P359; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; ROBINSON GW, 1994, MECH DEVELOP, V48, P199, DOI 10.1016/0925-4773(94)90060-4; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; SAKAMOTO MK, 1989, ANAT REC, V223, P299, DOI 10.1002/ar.1092230309; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Selleri L, 2001, DEVELOPMENT, V128, P3543; Shigetani Y, 2002, SCIENCE, V296, P1316, DOI 10.1126/science.1068310; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Stock DW, 1996, P NATL ACAD SCI USA, V93, P10858, DOI 10.1073/pnas.93.20.10858; Sumiyama K, 2002, P NATL ACAD SCI USA, V99, P780, DOI 10.1073/pnas.012584999; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Trumpp A, 1999, GENE DEV, V13, P3136, DOI 10.1101/gad.13.23.3136; Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000	46	353	362	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 11	2002	298	5592					381	385		10.1126/science.1075703	http://dx.doi.org/10.1126/science.1075703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12193642				2022-12-28	WOS:000178510400039
J	Zhang, QM; Li, HF; Poh, M; Xia, F; Cheng, ZY; Xu, HS; Huang, C				Zhang, QM; Li, HF; Poh, M; Xia, F; Cheng, ZY; Xu, HS; Huang, C			An all-organic composite actuator material with a high dielectric constant	NATURE			English	Article							THIN-FILMS; ELECTROSTRICTION; ELASTOMERS; POLYMER; FIELD	Electroactive polymers (EAPs) can behave as actuators, changing their shape in response to electrical stimulation. EAPs that are controlled by external electric fields-referred to here as field-type EAPs-include ferroelectric polymers, electrostrictive polymers, dielectric elastomers and liquid crystal polymers(1-6). Field-type EAPs can exhibit fast response speeds, low hysteresis(1-8) and strain levels far above those of traditional piezoelectric materials(4-6,9,10), with elastic energy densities even higher than those of piezoceramics(4,5,9-11). However, these polymers also require a high field (>70 V mum(-1)) to generate such high elastic energy densities (>0.1 J cm(-3); refs 4, 5, 9, 10). Here we report a new class of all-organic field-type EAP composites, which can exhibit high elastic energy densities induced by an electric field of only 13 V mum(-1). The composites are fabricated from an organic filler material possessing very high dielectric constant dispersed in an electrostrictive polymer matrix. The composites can exhibit high net dielectric constants while retaining the flexibility of the matrix. These all-organic actuators could find applications as artificial muscles, 'smart skins' for drag reduction, and in microfluidic systems for drug delivery(1-3,12).	Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, QM (corresponding author), Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA.	qxz1@psu.edu	Cheng, Zhongyang (Z.-Y.)/A-9841-2008; Li, Hengfeng/B-4767-2010	Cheng, Zhongyang (Z.-Y.)/0000-0001-7209-7380; Li, Hengfeng/0000-0002-3406-9335				ACHAR BN, 1982, J POLYM SCI POL CHEM, V20, P1785, DOI 10.1002/pol.1982.170200711; AIALIAK H, 1998, J APPL PHYS, V64, P6477; Bao ZN, 1997, ADV MATER, V9, P42, DOI 10.1002/adma.19970090108; BARCOHEN Y, 2001, ELECTROACTIVE POLYM; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Cheng ZY, 2001, SENSOR ACTUAT A-PHYS, V90, P138, DOI 10.1016/S0924-4247(01)00496-4; Cross LE, 1996, CERAM T, V68, P15; Damjanovic D, 1997, PHYS REV B, V55, pR649, DOI 10.1103/PhysRevB.55.R649; Dario P, 2000, J MICROMECH MICROENG, V10, P235, DOI 10.1088/0960-1317/10/2/322; Gould RD, 1996, COORDIN CHEM REV, V156, P237, DOI 10.1016/S0010-8545(96)01238-6; Hayashi K, 1997, APPL PHYS LETT, V70, P1384, DOI 10.1063/1.118584; Huber JE, 1997, P ROY SOC A-MATH PHY, V453, P2185, DOI 10.1098/rspa.1997.0117; Lehmann W, 2001, NATURE, V410, P447, DOI 10.1038/35068522; Lifshitz E.M., 1970, ELECTRODYNAMICS CONT; McCrum NG, 1967, ANELASTIC DIELECTRIC; MOULSON A, 1995, ELECTROCERAMICS; Nalwa H S, 1995, FERROELECTRIC POLYM; NALWA HS, 1985, EUR POLYM J, V21, P943, DOI 10.1016/0014-3057(85)90180-6; Newnham RE, 1998, CERAM TRANS, V88, P15; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; PHOUGAT N, 1999, HDB LOW HIGH EIELECT, pCH8; Su J, 1998, REV SCI INSTRUM, V69, P2480, DOI 10.1063/1.1148947; Su J, 1997, APPL PHYS LETT, V71, P386, DOI 10.1063/1.119545; Tominaga T, 1997, APPL PHYS LETT, V70, P762, DOI 10.1063/1.118252; VIJAYAKUMAR PS, 1984, J POLYM SCI POL PHYS, V22, P1439, DOI 10.1002/pol.1984.180220808; Xu HS, 2001, APPL PHYS LETT, V78, P2360, DOI 10.1063/1.1358847; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101; ZHANG QM, 1999, MRS S P, V600; [No title captured]	30	901	949	22	1046	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					284	287		10.1038/nature01021	http://dx.doi.org/10.1038/nature01021			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239563				2022-12-28	WOS:000178056300041
J	Bull, SA; Hu, XH; Hunkeler, EM; Lee, JY; Ming, EE; Markson, LE; Fireman, B				Bull, SA; Hu, XH; Hunkeler, EM; Lee, JY; Ming, EE; Markson, LE; Fireman, B			Discontinuation of use and switching of antidepressants - Influence of patient-physician communication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE; TREATMENT GUIDELINES; DEPRESSION; ADHERENCE; NONCOMPLIANCE; METAANALYSIS; MEDICATION	Context Although current depression treatment guidelines recommend continuing antidepressant therapy for at least 4 to 9 months, many patients discontinue treatment prematurely, within 3 months. Objectives To investigate the relationship between patient-physician communication and the continuation of treatment with antidepressants and to explore the demographics, adverse effects, therapeutic response, and frequency of follow-up visits. Design, Setting, and Patients A total of 401 telephone interviews of depressed patients being treated with selective serotonin reuptake inhibitor (SSRI) therapy between December 15,1999, and May 31, 2000, were conducted and 137 prescribing physicians completed written surveys from Northern California Kaiser Permanente health maintenance organization outpatient clinics. Main Outcome Measures Patient-physician communication about therapy duration and about adverse effects; therapy discontinuation or medication switching within 3 months after start of SSRI therapy. Results Ninety-nine physicians (72%) reported that they usually ask patients to continue using antidepressants for at least 6 months, but 137 patients (34%) reported that their physicians asked them to continue using antidepressants for this duration and 228 (56%) reported receiving no instructions. Patients who said they were told to take their medication for less than 6 months were 3 times more likely to discontinue therapy (odds ratio [OR], 3.12; 95% confidence interval [CI], 1.21-8.07) compared with patients who said they were told to continue therapy longer. Patients who discussed adverse effects with their physicians were less likely to discontinue therapy than patients who did not discuss them (OR, 0.49; 95% CI, 0.25-0.95). Patients who reported discussing adverse effects with their physicians were more likely to switch medications (OR, 5.60; 95% CI, 2.31-13.60). Fewer than 3 follow-up visits for depression, adverse effects, and lack of therapeutic response to medication were also associated with patients' discontinuing therapy. Conclusions Discrepancies exist between instructions that physicians report they communicate to patients and what patients remember being told. Explicit instructions about expected duration of therapy and discussions about medication adverse effects throughout treatment may reduce discontinuation of SSRI use. Our finding that patients with 3 or more follow-up visits were more likely to continue using the initially prescribed antidepressant medication suggests that frequent patient-physician contact may increase the probability that patients will continue therapy.	Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94612 USA; Merck & Co Inc, Outcomes Res & Management Dept, West Point, PA USA	Kaiser Permanente; Merck & Company	Bull, SA (corresponding author), Kaiser Permanente Med Care Program, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	scott.bull@alza.com	Ming, Eileen/L-9349-2019					*AM PSYCH ASS WORK, 2001, PRACT GUID TREATM PA; BECK AT, 2001, BDI FASTSCREEN MED P; BLACKWELL B, 1982, J CLIN PSYCHIAT, V43, P14; BROWN WA, 1995, J CLIN PSYCHIAT, V56, P30; *DEPR GUID PAN, DEPR PRIM CAR, V2; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; FRANK E, 1985, PSYCHOPHARMACOL BULL, V21, P37; Hotopf M, 1997, BRIT J PSYCHIAT, V170, P120, DOI 10.1192/bjp.170.2.120; JOHNSON DAW, 1981, ACTA PSYCHIAT SCAND, V63, P447, DOI 10.1111/j.1600-0447.1981.tb00751.x; KATON W, 1992, MED CARE, V30, P67, DOI 10.1097/00005650-199201000-00007; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; LIN EHB, 1995, MED CARE, V33, P67, DOI 10.1097/00005650-199501000-00006; Linden M, 2000, J CLIN PSYCHOPHARM, V20, P523, DOI 10.1097/00004714-200010000-00005; Melfi CA, 1998, ARCH GEN PSYCHIAT, V55, P1128, DOI 10.1001/archpsyc.55.12.1128; Miller N H, 1997, Am J Med, V102, P43; MYERS ED, 1992, BRIT J PSYCHIAT, V160, P83, DOI 10.1192/bjp.160.1.83; *NAT COMM QUAL ASS, 1999, HEDIS 2000 TECHN SPE, V2, P105; Sarrel PM, 1999, AM J OBSTET GYNECOL, V180, pS337, DOI 10.1016/S0002-9378(99)70732-5; Schulberg HC, 1998, ARCH GEN PSYCHIAT, V55, P1121, DOI 10.1001/archpsyc.55.12.1121; SIMON GE, 1993, GEN HOSP PSYCHIAT, V15, P399, DOI 10.1016/0163-8343(93)90009-D; Svensson S, 2000, INT J CARDIOL, V76, P157, DOI 10.1016/S0167-5273(00)00374-0; URQUHART J, 2001, CLIN RES, V1, P26; Venturini F, 1999, J MANAGE CARE PHARM, V5, P243	24	276	279	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2002	288	11					1403	1409		10.1001/jama.288.11.1403	http://dx.doi.org/10.1001/jama.288.11.1403			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593TB	12234237	Bronze			2022-12-28	WOS:000178008300025
J	Straus, SE; Majumdar, SR; McAlister, FA				Straus, SE; Majumdar, SR; McAlister, FA			New evidence for stroke prevention - Clinical applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY; CARE; MANAGEMENT; DECISIONS; IMPACT; RISK	Stroke is a leading cause of morbidity and mortality in most developed nations. There is a significant body of evidence supporting strategies that target primary and secondary stroke prevention. This evidence cannot be broadly applied to all patients, and each patient's situation and values must be considered with regard to shared evidence-based decision making. Several models can be used to apply evidence to individual patients, including formal clinical decision analysis, decision aids, or simpler tools such as the likelihood of being helped vs harmed. Various programmatic models of providing patient care in stroke prevention may also be useful; these include specialized clinics or disease-management programs, anticoagulation management services, and self-testing and management of anticoagulation by patients.	Univ Toronto, Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada; Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Alberta	Straus, SE (corresponding author), Toronto Gen Hosp, Univ Hlth Network, Dept Med, 200 Elizabeth St,ENG 248, Toronto, ON M5G 2C4, Canada.	sstraus@mtsinai.on.ca	McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341				Ansell JE, 1997, ANN PHARMACOTHER, V31, P604, DOI 10.1177/106002809703100516; Chiquette E, 1998, ARCH INTERN MED, V158, P1641, DOI 10.1001/archinte.158.15.1641; Cromheecke ME, 2000, LANCET, V356, P97, DOI 10.1016/S0140-6736(00)02470-3; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; Man-Son-Hing M, 1999, JAMA-J AM MED ASSOC, V282, P737, DOI 10.1001/jama.282.8.737; Man-Son-Hing M, 1999, ARCH INTERN MED, V159, P677, DOI 10.1001/archinte.159.7.677; Matchar DB, 2000, J THROMB THROMBOLYS, V9, pS7; McAlister FA, 2000, JAMA-J AM MED ASSOC, V283, P2829, DOI 10.1001/jama.283.21.2829; McAlister FA, 2001, BRIT MED J, V323, P957, DOI 10.1136/bmj.323.7319.957; McIntyre K, 2001, CHEST, V119, p337S, DOI 10.1378/chest.119.1_suppl.337S; Monette J, 1997, J AM GERIATR SOC, V45, P1060, DOI 10.1111/j.1532-5415.1997.tb05967.x; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; Protheroe J, 2000, BRIT MED J, V320, P1380, DOI 10.1136/bmj.320.7246.1380; Samsa GP, 2000, ARCH INTERN MED, V160, P967, DOI 10.1001/archinte.160.7.967; Straus SE, 2002, EVAL HEALTH PROF, V25, P210, DOI 10.1177/01678702025002006	15	28	34	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2002	288	11					1396	1398		10.1001/jama.288.11.1396	http://dx.doi.org/10.1001/jama.288.11.1396			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593TB	12234234	Bronze			2022-12-28	WOS:000178008300022
J	Nelson, HD; Helfand, M; Woolf, SH; Allan, JD				Nelson, HD; Helfand, M; Woolf, SH; Allan, JD			Screening for postmenopausal osteoporosis: A review of the evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							BONE-MINERAL DENSITY; X-RAY ABSORPTIOMETRY; BAND ULTRASOUND ATTENUATION; DIFFERENT SKELETAL SITES; QUANTITATIVE COMPUTED-TOMOGRAPHY; PREDICT HIP FRACTURE; RISK-FACTORS; ELDERLY-WOMEN; VERTEBRAL FRACTURES; RANDOMIZED-TRIAL	Background: Although osteoporotic fractures present an enormous health burden, it is not clear whether screening to identify high-risk persons is appropriate. Purpose: To examine evidence on the benefits and harms of screening postmenopausal women for osteoporosis. Data Sources: MEDLINE (1966 to May 2001), HealthSTAR (1975 to May 2001), and Cochrane databases; reference lists; and experts. Study Selection: English-language abstracts that included original data about postmenopausal women and osteoporosis and addressed the effectiveness of risk factor assessment, bone density tests, or treatment were included. Data Extraction: Selected information about patient population, interventions, clinical end points, and study design were extracted, and a set of criteria was applied to evaluate study quality. Data Synthesis: No trials of the effectiveness of screening have been published. Instruments developed to assess clinical risk factors for low bone density or fractures have moderate to high sensitivity and low specificity. Among different bone density tests measured at various sites, bone density measured at the femoral neck by dual-energy x-ray absorptiometry is the best predictor of hip fracture. Women with low bone density have approximately a 40% to 50% reduction in fracture risk when treated with bisphosphonates. Conclusions: Population screening would be based on evidence that the risk for osteoporosis and fractures increases with age, that the short-term risk for fracture can be estimated by bone density tests and risk factors, and that fracture risk can be reduced with treatment. The role of risk factor assessment and different bone density techniques, frequency of screening, and identification of subgroups for which screening is most effective remain unclear.	Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; Virginia Commonwealth Univ, Fairfax, VA USA; Univ Maryland, Baltimore, MD 21201 USA	Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Virginia Commonwealth University; University System of Maryland; University of Maryland Baltimore	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.				PHS HHS [290-97-0018] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADAMI S, 1995, BONE, V17, P383, DOI 10.1016/S8756-3282(95)00262-6; AGREN M, 1991, CALCIFIED TISSUE INT, V48, P240, DOI 10.1007/BF02556374; Ahmed AIH, 1997, OSTEOPOROSIS INT, V7, P432, DOI 10.1007/s001980050029; Alenfeld FE, 1998, OSTEOPOROSIS INT, V8, P393, DOI 10.1007/s001980050081; [Anonymous], 1997, J Intern Med Suppl, V739, P1; Arlot ME, 1997, J BONE MINER RES, V12, P683, DOI 10.1359/jbmr.1997.12.4.683; Ballard PA, 1998, OSTEOPOROSIS INT, V8, P535, DOI 10.1007/s001980050095; Barrett JA, 1999, J CLIN EPIDEMIOL, V52, P243, DOI 10.1016/S0895-4356(98)00167-X; Bauer DC, 1997, ARCH INTERN MED, V157, P629, DOI 10.1001/archinte.157.6.629; BLACK DM, 1992, J BONE MINER RES, V7, P633; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Blake GM, 1998, ENDOCRIN METAB CLIN, V27, P267, DOI 10.1016/S0889-8529(05)70005-0; Blake GM, 1997, BRIT J RADIOL, V70, pS177, DOI 10.1259/bjr.1997.0022; *BLUE CROSS BLUE S, 1999, ULTR HEEL DIAGN OST; Bone HG, 1997, J CLIN ENDOCR METAB, V82, P265, DOI 10.1210/jc.82.1.265; BONNICK S, 1998, BONE, V23, P5476; Burger H, 1999, BONE, V25, P369, DOI 10.1016/S8756-3282(99)00173-8; Cadarette SM, 2000, CAN MED ASSOC J, V162, P1289; Cadarette SM, 2001, JAMA-J AM MED ASSOC, V286, P57, DOI 10.1001/jama.286.1.57; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; Chen Z, 1998, OSTEOPOROSIS INT, V8, P423, DOI 10.1007/s001980050086; CHESTNUT CH, 1995, AM J MED, V99, P144, DOI 10.1016/S0002-9343(99)80134-X; CHRISTIANSEN C, 1991, AM J MED, V90, P107; COOPER C, 1991, OSTEOPOROSIS INT, V2, P48, DOI 10.1007/BF01627079; Cranney A, 2002, ENDOCR REV, V23, P517, DOI 10.1210/er.2001-3002; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Cunningham JL, 1996, BRIT J RADIOL, V69, P25, DOI 10.1259/0007-1285-69-817-25; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Duboeuf F, 1997, J BONE MINER RES, V12, P1895, DOI 10.1359/jbmr.1997.12.11.1895; ELLIOT JR, 1993, AUST NZ J MED, V23, P458, DOI 10.1111/j.1445-5994.1993.tb01830.x; Ettinger B, 1998, AM J MANAG CARE, V4, P1377; FALCH JA, 1992, BONE, V13, P337, DOI 10.1016/8756-3282(92)90080-G; FAULKNER KG, 1994, OSTEOPOROSIS INT, V4, P42, DOI 10.1007/BF02352260; Faulkner KG, 1999, J CLIN DENSITOM, V2, P343, DOI 10.1385/JCD:2:3:343; Formica CA, 1998, OSTEOPOROSIS INT, V8, P460, DOI 10.1007/s001980050092; Fujiwara S, 1997, J BONE MINER RES, V12, P998, DOI 10.1359/jbmr.1997.12.7.998; Garnero P, 1998, OSTEOPOROSIS INT, V8, P563, DOI 10.1007/s001980050100; Genant HK, 1996, J BONE MINER RES, V11, P707; Goemaere S, 1999, CALCIFIED TISSUE INT, V65, P354, DOI 10.1007/s002239900712; Graafmans WC, 1996, BONE, V19, P97, DOI 10.1016/8756-3282(96)00134-2; Grampp S, 1996, AM J ROENTGENOL, V167, P133, DOI 10.2214/ajr.167.1.8659357; Grampp S, 1999, AM J ROENTGENOL, V173, P329, DOI 10.2214/ajr.173.2.10430129; GREEN CJ, 1997, 972T BRIT COL OFF HL; Greenspan SL, 1998, J BONE MINER RES, V13, P1431, DOI 10.1359/jbmr.1998.13.9.1431; Greenspan SL, 1997, J BONE MINER RES, V12, P1303, DOI 10.1359/jbmr.1997.12.8.1303; HAILEY D, 1996, INAHTA PROJECT EFFEC; Hans D, 1996, LANCET, V348, P511, DOI 10.1016/S0140-6736(95)11456-4; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Heaney RP, 1998, ANN INTERN MED, V128, P313, DOI 10.7326/0003-4819-128-4-199802150-00014; *HLTH CAR FIN ADM, 2000, NAT PHYS FEE SCHED P; HOMIK J, 1999, HLTH TECHNOLOGY BRIE, V4; Homik J., 1998, QUANTITATIVE ULTRASO; Honkanen R, 1998, OSTEOPOROSIS INT, V8, P25, DOI 10.1007/s001980050044; Hosking D, 1998, NEW ENGL J MED, V338, P485, DOI 10.1056/NEJM199802193380801; Jergas M, 1997, CALCIFIED TISSUE INT, V61, P351, DOI 10.1007/s002239900347; Johansen HK, 1999, JAMA-J AM MED ASSOC, V282, P1752, DOI 10.1001/jama.282.18.1752; JOHNELL O, 1995, J BONE MINER RES, V10, P1802, DOI 10.1002/jbmr.5650101125; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; KLEEREKOPER M, 1989, BONE MINER, V7, P171, DOI 10.1016/0169-6009(89)90074-3; KREIGER N, 1982, AM J EPIDEMIOL, V116, P141, DOI 10.1093/oxfordjournals.aje.a113388; Kroger H, 1999, CALCIFIED TISSUE INT, V64, P191; Langton CM, 1997, CLIN RHEUMATOL, V16, P117, DOI 10.1007/BF02238781; LASKEY MA, 1992, BRIT J RADIOL, V65, P1124, DOI 10.1259/0007-1285-65-780-1124; LAVALJEANTET AM, 1995, CALCIFIED TISSUE INT, V56, P14, DOI 10.1007/BF00298738; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lunt M, 1997, J BONE MINER RES, V12, P1883, DOI 10.1359/jbmr.1997.12.11.1883; Lydick E, 1998, AM J MANAG CARE, V4, P37; LYLES KW, 1993, AM J MED, V94, P595, DOI 10.1016/0002-9343(93)90210-G; MALLMIN H, 1994, OSTEOPOROSIS INT, V4, P298, DOI 10.1007/BF01622186; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Martin JC, 1996, BRIT J RADIOL, V69, P234, DOI 10.1259/0007-1285-69-819-234; MASSIE A, 1993, OSTEOPOROSIS INT, V3, P107, DOI 10.1007/BF01623382; McClung M, 1998, ANN INTERN MED, V128, P253, DOI 10.7326/0003-4819-128-4-199802150-00001; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; MELTON LJ, 1995, J BONE MINER RES, V10, P175; MELTON LJ, 1993, J BONE MINER RES, V8, P1227; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Melton LJ, 1997, SPINE, V22, p2S, DOI 10.1097/00007632-199712151-00002; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; MEYER HE, 1993, AM J EPIDEMIOL, V137, P1203, DOI 10.1093/oxfordjournals.aje.a116622; Michaelsson K, 1996, OSTEOPOROSIS INT, V6, P120, DOI 10.1007/BF01623934; Naganathan V, 1999, MED J AUSTRALIA, V171, P297, DOI 10.5694/j.1326-5377.1999.tb123659.x; *NAT OST FDN, 1998, OSTEOPOROS INT S4, V8, pS7; National Osteoporosis Foundation, 1999, PHYS GUID PREV TREAT; NELSON H, 2002, OSTEOPOROSIS POSTMEN; Nelson HD, 2002, SCREENING POSTMENOPA; Nelson HD, 2002, HORMONE REPLACEMENT; NEVITT MC, 1994, OSTEOPOROSIS INT, V4, P325, DOI 10.1007/BF01622192; PECK WA, 1993, AM J MED, V94, P646; Petley GW, 1996, BRIT J RADIOL, V69, P655, DOI 10.1259/0007-1285-69-823-655; Pocock NA, 1996, MED J AUSTRALIA, V164, P367, DOI 10.5694/j.1326-5377.1996.tb122057.x; Pols HAP, 1999, OSTEOPOROSIS INT, V9, P461, DOI 10.1007/PL00004171; Ranstam J, 1996, AGE AGEING, V25, P439, DOI 10.1093/ageing/25.6.439; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; RIBOT C, 1992, CLIN ENDOCRINOL, V36, P225, DOI 10.1111/j.1365-2265.1992.tb01436.x; Rimes KA, 1999, PSYCHOL HEALTH, V14, P585, DOI 10.1080/08870449908410752; ROSENTHALL L, 1995, EUR J NUCL MED, V22, P402, DOI 10.1007/BF00839053; ROUX C, 1993, REV RHUM, V60, P897; *ROYAL COLL PHYS L, 1999, OST CLIN GUID PREV T; SALAMONE LM, 1994, CALCIFIED TISSUE INT, V54, P87, DOI 10.1007/BF00296056; Schott AM, 1998, OSTEOPOROSIS INT, V8, P247, DOI 10.1007/s001980050061; SCHOTT AM, 1995, J BONE MINER RES, V10, P243; Siebzehner MI, 2000, ISRAEL MED ASSOC J, V2, P397; SIMMONS A, 1995, BRIT J RADIOL, V68, P903, DOI 10.1259/0007-1285-68-812-903; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; SLEMENDA CW, 1990, ANN INTERN MED, V112, P96, DOI 10.7326/0003-4819-112-2-96; Stock JL, 1998, ANN INTERN MED, V128, P996, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00006; Torgerson DJ, 1996, J BONE MINER RES, V11, P293; Tromp AM, 1998, J BONE MINER RES, V13, P1932, DOI 10.1359/jbmr.1998.13.12.1932; Tromp AM, 1999, OSTEOPOROSIS INT, V9, P230, DOI 10.1007/s001980050142; TUPPURAINEN M, 1995, ACTA OBSTET GYN SCAN, V74, P624, DOI 10.3109/00016349509013475; TURNER CH, 1995, OSTEOPOROSIS INT, V5, P130, DOI 10.1007/BF01623314; *US DEP HHS, 1995, AHRQ PUBL; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; VANHEMERT AM, 1990, AM J EPIDEMIOL, V132, P123, DOI 10.1093/oxfordjournals.aje.a115624; Varney LF, 1999, J CLIN DENSITOM, V2, P275, DOI 10.1385/JCD:2:3:275; Verhaar HJJ, 1998, OSTEOPOROSIS INT, V8, P174, DOI 10.1007/BF02672515; Weinstein L, 2000, AM J OBSTET GYNECOL, V183, P547, DOI 10.1067/mob.2000.106594; Weinstein L, 1999, OBSTET GYNECOL, V93, P757, DOI 10.1016/S0029-7844(98)00549-3; WHITE BL, 1987, J BONE JOINT SURG AM, V69A, P1335; WOLINSKY FD, 1994, J GERONTOL, V49, pS165, DOI 10.1093/geronj/49.4.S165; World Health Organization, 1994, WHO TECHN REP SER, V843; YOUNG H, 1993, OSTEOPOROSIS INT, V3, P160, DOI 10.1007/BF01623278	125	232	242	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					529	541		10.7326/0003-4819-137-6-200209170-00015	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00015			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230356				2022-12-28	WOS:000178069100009
J	Goldman, D; Barr, CS				Goldman, D; Barr, CS			Restoring the addicted brain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									NIAAA, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Goldman, D (corresponding author), NIAAA, Rockville, MD 20852 USA.		Majid, Salma/AAT-2616-2020; Goldman, David/F-9772-2010	Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000304] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ADINOFF B, 1990, ARCH GEN PSYCHIAT, V47, P325; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Selye Hans, 1976, STRESS LIFE; Sillaber I, 2002, SCIENCE, V296, P931, DOI 10.1126/science.1069836	5	12	12	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					843	845		10.1056/NEJMcibr021948	http://dx.doi.org/10.1056/NEJMcibr021948			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226158				2022-12-28	WOS:000177921300012
J	Nieder, A; Freedman, DJ; Miller, EK				Nieder, A; Freedman, DJ; Miller, EK			Representation of the quantity of visual items in the primate prefrontal cortex	SCIENCE			English	Article							NUMERICAL ASSESSMENT; ACTIVATION; THINKING; MONKEYS; NUMBER; MODEL; BRAIN; AREAS	Deriving the quantity of items is an abstract form of categorization. To explore it, monkeys were trained to judge whether successive visual displays contained the same quantity of items. Many neurons in the lateral prefrontal cortex were tuned for quantity irrespective of the exact physical appearance of the displays. Their tuning curves formed overlapping filters, which may explain why behavioral discrimination improves with increasing numerical distance and why discrimination of two quantities with equal numerical distance worsens as their numerical size increases. A mechanism that extracts the quantity of visual field items could contribute to general numerical ability.	MIT, RIKEN, Picower Ctr Learning & Memory, Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT)	Nieder, A (corresponding author), MIT, RIKEN, Picower Ctr Learning & Memory, Neurosci Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958				Boysen S. T., 1993, DEV NUMERICAL COMPET; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; BURBAUD P, 1995, J NEUROPHYSIOL, V74, P2194, DOI 10.1152/jn.1995.74.5.2194; DAVIS H, 1988, BEHAV BRAIN SCI, V11, P561, DOI 10.1017/S0140525X00053437; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S, 2001, PSYCHOL SCI, V12, P244, DOI 10.1111/1467-9280.00343; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; EMMERTON J, 2001, AVIAN VISUAL COGNITI; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hauser MD, 1996, P NATL ACAD SCI USA, V93, P1514, DOI 10.1073/pnas.93.4.1514; LUCCHELLI F, 1993, J NEUROL NEUROSUR PS, V56, P304, DOI 10.1136/jnnp.56.3.304; MANDLER G, 1982, J EXP PSYCHOL GEN, V111, P1, DOI 10.1037/0096-3445.111.1.1; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; ROLAND PE, 1985, J NEUROPHYSIOL, V53, P1219, DOI 10.1152/jn.1985.53.5.1219; Sakurai Y, 1996, J NEUROL SCI, V139, P89, DOI 10.1016/0022-510X(96)00039-1; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275; WASHBURN DA, 1991, PSYCHOL SCI, V2, P190, DOI 10.1111/j.1467-9280.1991.tb00130.x; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706	23	461	474	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1708	1711		10.1126/science.1072493	http://dx.doi.org/10.1126/science.1072493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215649				2022-12-28	WOS:000177819100052
J	Bourne, HR; Weiner, O				Bourne, HR; Weiner, O			A chemical compass	NATURE			English	Editorial Material									Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Bourne, HR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.		Weiner, Orion D/F-2576-2011	Weiner, Orion D/0000-0002-1778-6543				CORNER FI, 2002, CELL, V109, P541; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	4	102	103	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					21	21		10.1038/419021a	http://dx.doi.org/10.1038/419021a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214215				2022-12-28	WOS:000177788600021
J	Du, HS; Rosbash, M				Du, HS; Rosbash, M			The U1 snRNP protein U1C recognizes the 5 ' splice site in the absence of base pairing	NATURE			English	Article							PRE-MESSENGER-RNA; 5' SPLICE-SITE; COMPLEX-FORMATION; SR PROTEINS; YEAST; IDENTIFICATION; SELECTION; CLEAVAGE	Splicing of precursor messenger RNA takes place in the spliceosome, a large RNA/protein macromolecular machine(1). Spliceosome assembly occurs in an ordered pathway in vitro and is conserved between yeast and mammalian systems. The earliest step is commitment complex formation in yeast or E complex formation in mammals, which engages the pre-mRNA in the splicing pathway and involves interactions between U1 small nuclear ribonucleoprotein (snRNP) and the pre-mRNA 5' splice site(2,3). Complex formation depends on highly conserved base pairing between the 5' splice site and the 5' end of U1 snRNA, both in vivo and in vitro(4-7). U1 snRNP proteins also contribute to U1 snRNP activity(8-10). Here we show that U1 snRNP lacking the 5' end of its snRNA retains 5'-splice-site sequence specificity. We also show that recombinant yeast U1C protein, a U1 snRNP protein, selects a 5'-splice-site-like sequence in which the first four nucleotides, GUAU, are identical to the first four nucleotides of the yeast 5'-splice-site consensus sequence. We propose that a U1C 5'-splice-site interaction precedes pre-mRNA/U1 snRNA base pairing and is the earliest step in the splicing pathway.	Brandeis Univ, Dept Biol, Howard Hughes Med Inst, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute	Rosbash, M (corresponding author), Brandeis Univ, Dept Biol, Howard Hughes Med Inst, MS008,415 South St, Waltham, MA 02454 USA.	rosbash@brandeis.edu						Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Burge CB, 1999, RNA WORLD, P525; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; CRISPINO JD, 1995, GENE DEV, V9, P2314, DOI 10.1101/gad.9.18.2314; CRISPINO JD, 1994, SCIENCE, V265, P1866, DOI 10.1126/science.8091213; Crispino JD, 1996, RNA, V2, P664; Du H, 2001, RNA, V7, P133, DOI 10.1017/S1355838201001844; HEINRICHS V, 1990, SCIENCE, V247, P69, DOI 10.1126/science.2136774; HERSCHLAG D, 1991, P NATL ACAD SCI USA, V88, P6921, DOI 10.1073/pnas.88.16.6921; JAMISON SF, 1995, NUCLEIC ACIDS RES, V23, P3260, DOI 10.1093/nar/23.16.3260; Johnson TL, 2001, GENE DEV, V15, P1957, DOI 10.1101/gad.895601; KONFORTI BB, 1995, RNA, V1, P815; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; Lund M, 2002, RNA, V8, P166, DOI 10.1017/S1355838202010786; Maroney PA, 2000, MOL CELL, V6, P317, DOI 10.1016/S1097-2765(00)00032-0; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Puig O, 1999, GENE DEV, V13, P569, DOI 10.1101/gad.13.5.569; Reyes J, 1996, RNA, V2, P213; Rossi F, 1996, J BIOL CHEM, V271, P23985, DOI 10.1074/jbc.271.39.23985; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; SERAPHIN B, 1988, EMBO J, V7, P2533, DOI 10.1002/j.1460-2075.1988.tb03101.x; SILICIANO PG, 1988, GENE DEV, V2, P1258, DOI 10.1101/gad.2.10.1258; Tang J, 1997, EMBO J, V16, P4082, DOI 10.1093/emboj/16.13.4082; TARN WY, 1994, GENE DEV, V8, P2704, DOI 10.1101/gad.8.22.2704; TRAUB P, 1969, J MOL BIOL, V40, P391, DOI 10.1016/0022-2836(69)90161-2; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Zhang D, 1999, GENE DEV, V13, P581, DOI 10.1101/gad.13.5.581; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	29	121	123	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					86	90		10.1038/nature00947	http://dx.doi.org/10.1038/nature00947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214237				2022-12-28	WOS:000177788600042
J	Mecher, E; Gallego-Gomez, F; Tillmann, H; Horhold, HH; Hummelen, JC; Meerholz, K				Mecher, E; Gallego-Gomez, F; Tillmann, H; Horhold, HH; Hummelen, JC; Meerholz, K			Near-infrared sensitivity enhancement of photorefractive polymer composites by pre-illumination	NATURE			English	Article							HOLOGRAPHIC STORAGE; SCATTERING MEDIA; DESIGN	Among the various applications for reversible holographic storage media(1,2), a particularly interesting one is time-gated holographic imaging (TGHI)(3-5). This technique could provide a noninvasive medical diagnosis tool, related to optical coherence tomography(6,7). In this technique, biological samples are illuminated within their transparency window with near-infrared light, and information about subsurface features is obtained by a detection method that distinguishes between reflected photons originating from a certain depth and those scattered from various depths. Such an application requires reversible holographic storage media with very high sensitivity in the near-infrared. Photorefractive materials, in particular certain amorphous organic systems, are in principle promising candidate media, but their sensitivity has so far been too low, mainly owing to their long response times in the near-infrared. Here we introduce an organic photorefractive material-a composite based on the poly(arylene vinylene) copolymer TPD-PPV8-that exhibits favourable near-infrared characteristics. We show that pre-illumination of this material at a shorter wavelength before holographic recording improves the response time by a factor of 40. This process was found to be reversible. We demonstrate multiple holographic recording with this technique at video rate under practical conditions.	Univ Munich, Dept Chem, D-81377 Munich, Germany; Univ Munich, Ctr Nanosci, D-81377 Munich, Germany; Univ Jena, D-07743 Jena, Germany; Univ Groningen, Stratingh Inst, NL-9747 AG Groningen, Netherlands; Univ Groningen, Ctr Mat Sci, NL-9747 AG Groningen, Netherlands	University of Munich; University of Munich; Friedrich Schiller University of Jena; University of Groningen; University of Groningen	Meerholz, K (corresponding author), Univ Cologne, Dept Phys Chem, Luxemburgerstr 116, D-50939 Cologne, Germany.	klaus.meerholz@uni-koeln.de	Gallego-Gomez, Francisco/B-8185-2013; Hummelen, Jan C/D-7387-2012; Meerholz, Klaus -/A-7819-2017	Gallego-Gomez, Francisco/0000-0001-9888-2889; Meerholz, Klaus -/0000-0001-7450-4672				Ashley J, 2000, IBM J RES DEV, V44, P341, DOI 10.1147/rd.443.0341; Boppart SA, 1998, NAT MED, V4, P861, DOI 10.1038/nm0798-861; Burr GW, 2000, OPT LETT, V25, P499, DOI 10.1364/OL.25.000499; Buse K, 1998, NATURE, V393, P665, DOI 10.1038/31429; Drexler W, 1999, OPT LETT, V24, P1221, DOI 10.1364/OL.24.001221; Grunnet-Jepsen A, 1998, CHEM PHYS LETT, V291, P553, DOI 10.1016/S0009-2614(98)00638-1; GUNTHER H, 1998, APPL OPTICS, V73, P7611; Herlocker JA, 2000, APPL PHYS LETT, V77, P2292, DOI 10.1063/1.1316077; Horhold H. H., 2001, Proceedings of the SPIE - The International Society for Optical Engineering, V4105, P431, DOI 10.1117/12.416925; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; HUMMELEN JC, 1995, J ORG CHEM, V60, P532, DOI 10.1021/jo00108a012; HYDE SCW, 1995, OPT LETT, V20, P1331, DOI 10.1364/OL.20.001331; Jones R, 1996, APPL PHYS LETT, V69, P1837, DOI 10.1063/1.117450; Kippelen B, 1998, SCIENCE, V279, P54, DOI 10.1126/science.279.5347.54; KUKHTAREV NV, 1979, FERROELECTRICS, V22, P949, DOI 10.1080/00150197908239450; Moerner WE, 1997, ANNU REV MATER SCI, V27, P585, DOI 10.1146/annurev.matsci.27.1.585; MOERNER WE, 1994, J OPT SOC AM B, V11, P320, DOI 10.1364/JOSAB.11.000320; SILENCE SM, 1994, OPT LETT, V19, P1822, DOI 10.1364/OL.19.001822; Steele DD, 1998, OPT LETT, V23, P153, DOI 10.1364/OL.23.000153; STEENWINCKEL DV, 2000, J CHEM PHYS, V112, P11030; STEPANOV S, 2001, HDB ADV ELECT PHOTON, V2; Wang LM, 2001, APPL PHYS LETT, V78, P700, DOI 10.1063/1.1347025; Wang LM, 2000, PHYS REV B, V62, P4973, DOI 10.1103/PhysRevB.62.4973; Wolff J, 1999, J OPT SOC AM B, V16, P1080, DOI 10.1364/JOSAB.16.001080; Wortmann R, 1996, J CHEM PHYS, V105, P10637, DOI 10.1063/1.472950; Wurthner F, 2002, CHEMPHYSCHEM, V3, P17, DOI 10.1002/1439-7641(20020118)3:1<17::AID-CPHC17>3.0.CO;2-N; Zilker SJ, 2000, CHEMPHYSCHEM, V1, P72, DOI 10.1002/1439-7641(20000915)1:2<72::AID-CPHC72>3.0.CO;2-2; Zilker SJ, 2000, APPL OPTICS, V39, P2287, DOI 10.1364/AO.39.002287	28	86	90	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2002	418	6901					959	964		10.1038/nature00975	http://dx.doi.org/10.1038/nature00975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198543	Green Published			2022-12-28	WOS:000177677500040
J	Henry, MR; Cho, MK; Weaver, MA; Merz, JF				Henry, MR; Cho, MK; Weaver, MA; Merz, JF			Genetics: DNA patenting and licensing	SCIENCE			English	Editorial Material									Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA	University of Pennsylvania; Pennsylvania Medicine; Stanford University	Merz, JF (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.			Merz, Jon/0000-0002-0612-7104	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002034] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002034-03, R01 HG002034-01A1, R01HG02034, R01 HG002034-02, R01 HG002034, R01 HG002034-01A1S1, R01 HG002034-01A1S2] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Heller MA, 1998, SCIENCE, V281, P517; Mowery DC, 2001, RES POLICY, V30, P99, DOI 10.1016/S0048-7333(99)00100-6; PRESSMAN L, 2000, AUTM LICENSING SURVE; ROUMEL TJ, COMMUNICATION; Schissel A, 1999, NATURE, V402, P118, DOI 10.1038/45907; Thomas SM, 1996, NATURE, V380, P387, DOI 10.1038/380387a0; Thomas SM, 1997, NATURE, V388, P709, DOI 10.1038/41853; WALSH J, 2001, C OP PAT SYST INS NE; 4237224	9	22	22	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1279	1279		10.1126/science.1070899	http://dx.doi.org/10.1126/science.1070899			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193770	Green Accepted			2022-12-28	WOS:000177573900022
J	West, PM; Packer, C				West, PM; Packer, C			Sexual selection, temperature, and the lion's mane	SCIENCE			English	Article							NATURAL-SELECTION; CLIMATE; COOPERATION; POPULATION; INDUCE; COSTS; GOATS; CELLS; COLOR	The mane of the African lion ( Panthera leo) is a highly variable trait that reflects male condition and ambient temperature. We examined the consequences of this variation in a long-term study of lions in the Serengeti National Park, Tanzania. Mane darkness indicates nutrition and testosterone and influences both female choice and male-male competition. Mane length signals fighting success and only appears to influence male-male assessment. Dark-maned males enjoy longer reproductive life-spans and higher offspring survival, but they suffer higher surface temperatures, abnormal sperm, and lower food intake during hot months of the year. Maned males are hotter than females, and males have lighter and/or shorter manes in hotter seasons, years, and habitats. This phenotypic plasticity suggests that the mane will respond to forecasted increases in ambient temperature.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	West, PM (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.	west0302@umn.edu						ACHARYA RM, 1995, SMALL RUMINANT RES, V18, P245, DOI 10.1016/0921-4488(95)00703-6; Andersson Malte, 1994; Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669; COOK RB, 1994, THERIOGENOLOGY, V41, P653, DOI 10.1016/0093-691X(94)90175-I; Darwin C., 1871, P475; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; HEMMER H, 1974, Veroeffentlichungen der Zoologischen Staatssammlung (Muenchen), V17, P167; HILL GE, 1993, BIOL J LINN SOC, V49, P63, DOI 10.1006/bijl.1993.1023; HILSBERG S, 2000, ASPEKTE KLINISCHEN A; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; Kalas JA, 1997, J BIOGEOGR, V24, P213, DOI 10.1046/j.1365-2699.1997.00093.x; MARLER CA, 1988, BEHAV ECOL SOCIOBIOL, V23, P21, DOI 10.1007/BF00303053; Moen RA, 1999, EVOL ECOL RES, V1, P235; Moller AP., 1994, SEXUAL SELECTION BAR; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Packer C, 2000, AM ANTHROPOL, V102, P829, DOI 10.1525/aa.2000.102.4.829; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; PANT KP, 1985, PESQUI AGROPECU BRAS, V20, P717; Pocock RI, 1931, J BOMBAY NAT HIST SO, V34, P638; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Schaller G. B., 1972, SERENGETI LION; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Selous F. C., 1908, AFRICAN NATURE NOTES; Tear TH, 1997, J WILDLIFE MANAGE, V61, P1142, DOI 10.2307/3802112; Thornton MJ, 2001, J ENDOCRINOL, V168, P401, DOI 10.1677/joe.0.1680401; WALSBERG GE, 1990, PHYSIOL ZOOL, V63, P1025, DOI 10.1086/physzool.63.5.30152627; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wiens JJ, 2001, TRENDS ECOL EVOL, V16, P517, DOI 10.1016/S0169-5347(01)02217-0; WILDT DE, 1987, NATURE, V329, P328, DOI 10.1038/329328a0; WILLIAMS CK, 1989, J ANIM ECOL, V58, P495, DOI 10.2307/4844; WILSON MJ, 1983, ENDOCRINOLOGY, V112, P321, DOI 10.1210/endo-112-1-321; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3	38	206	212	6	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1339	1343		10.1126/science.1073257	http://dx.doi.org/10.1126/science.1073257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193785				2022-12-28	WOS:000177573900045
J	Tateishi-Yuyama, E; Matsubara, H; Murohara, T; Ikeda, U; Shintani, S; Masaki, H; Amano, K; Kishimoto, Y; Yoshimoto, K; Akashi, H; Shimada, K; Iwasaka, T; Imaizumi, T				Tateishi-Yuyama, E; Matsubara, H; Murohara, T; Ikeda, U; Shintani, S; Masaki, H; Amano, K; Kishimoto, Y; Yoshimoto, K; Akashi, H; Shimada, K; Iwasaka, T; Imaizumi, T		TACT Study Investigators	Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial	LANCET			English	Article							ENDOTHELIAL PROGENITOR CELLS; COLONY-STIMULATING FACTOR; GROWTH; VASCULOGENESIS; IMPLANTATION; EXPRESSION	Background Preclinical studies have established that implantation of bone marrow-mononuclear cells, including endothelial progenitor cells, into ischaemic limbs increases collateral vessel formation. We investigated efficacy and safety of autologous implantation of bone marrow-mononuclear cells in patients with ischaemic limbs because of peripheral arterial disease. Methods We first did a pilot study, in which 25 patients (group A) with unilateral ischaemia of the leg were injected with bone marrow-mononuclear cells into the gastrocnemius of the ischaemic limb and with saline into the less ischaemic limb. We then recruited 22 patients (group B) with bilateral leg ischaemia, who were randomly injected with bone marrow-mononuclear cells in one leg and peripheral blood-mononuclear cells in the other as a control. Primary outcomes were safety and feasibility of treatment, based on ankle-brachial index (ABI) and rest pain, and analysis was per protocol. Findings Two patients were excluded from group B after randomisation. At 4 weeks in group B patients, ABI was significantly improved in legs injected with bone marrow-mononuclear cells compared with those injected with peripheral blood-mononuclear cells (difference 0.09 [95% Cl 0.06-0.11]; p < 0.0001). Similar improvements were seen for transcutaneous oxygen pressure (13 [9-17]; p < 0.0001), rest pain (-0.85 [-1.6 to -0.12]; p = 0.025), and pain-free walking time (1.2 [0.7-1.7]; p = 0.0001). These improvements were sustained at 24 weeks. Similar improvements were seen in group A patients. Two patients in group A died after myocardial infarction unrelated to treatment. Interpretation Autologous implantation of bone marrow-mononuclear cells could be safe and effective for achievement of therapeutic angiogenesis, because of the natural ability of marrow cells to supply endothelial progenitor cells and to secrete various angiogenic factors or cytokines.	Kansai Med Univ, Dept Med 2, Osaka 5708507, Japan; Kansai Med Univ, Ctr Cardiovasc, Osaka 5708507, Japan; Kansai Med Univ, Dept Med 1, Osaka 5708507, Japan; Kansai Med Univ, Blood Transfus Unit, Osaka 5708507, Japan; Kurume Univ, Sch Med, Inst Cardiovasc Res, Kurume, Fukuoka 830, Japan; Kurume Univ, Sch Med, Dept Med 3, Kurume, Fukuoka 830, Japan; Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 830, Japan; Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan; Jichi Med Sch, Dept Cardiol, Minami Kawachi, Tochigi, Japan	Kansai Medical University; Kansai Medical University; Kansai Medical University; Kansai Medical University; Kurume University; Kurume University; Kurume University; Kurume University; Jichi Medical University	Matsubara, H (corresponding author), Kansai Med Univ, Dept Med 2, Osaka 5708507, Japan.	matsubah@takii.kmu.ac.jp	Murohara, Toyoaki/M-4958-2014; Mordwinkin, Nicholas M/A-4347-2010					Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Fukumoto Y, 1997, BRIT J HAEMATOL, V97, P666, DOI 10.1046/j.1365-2141.1997.842724.x; GIULIAN D, 1988, J NEUROSCI, V8, P2485; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kawachi Y, 1996, BRIT J HAEMATOL, V94, P413, DOI 10.1046/j.1365-2141.1996.d01-1807.x; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Maruyama K, 1999, J MOL CELL CARDIOL, V31, P607, DOI 10.1006/jmcc.1998.0895; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; RALEVIC V, 1991, CIRCULATION, V84, P1, DOI 10.1161/01.CIR.84.1.1; ROSENFELD CS, 1994, BONE MARROW TRANSPL, V13, P131; RUTHERFORD RB, 1986, J VASC SURG, V4, P80; Seiler C, 2001, CIRCULATION, V104, P2012, DOI 10.1161/hc4201.097835; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Shyu KG, 1998, CIRCULATION, V98, P2081, DOI 10.1161/01.CIR.98.19.2081; Simons M, 2000, CIRCULATION, V102, pE73, DOI 10.1161/01.CIR.102.11.e73; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; Tateishi E, 2001, CIRCULATION, V104, P261	26	1315	1567	0	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					427	435		10.1016/S0140-6736(02)09670-8	http://dx.doi.org/10.1016/S0140-6736(02)09670-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241713				2022-12-28	WOS:000177342900007
J	Modugno, G; Roati, G; Riboli, F; Ferlaino, F; Brecha, RJ; Inguscio, M				Modugno, G; Roati, G; Riboli, F; Ferlaino, F; Brecha, RJ; Inguscio, M			Collapse of a degenerate Fermi gas	SCIENCE			English	Article							HE-3	A degenerate gas of identical fermions is brought to collapse by the interaction with a Bose-Einstein condensate. We used an atomic mixture of fermionic potassium-40 and bosonic rubidium-87, in which the strong interspecies attraction leads to an instability above a critical number of particles. The observed phenomenon suggests a direction for manipulating fermion-fermion interactions on the route to superfluidity.	Univ Florence, European Lab Nonlinear Spect, I-50019 Sesto Fiorentino, Italy; Ist Nazl Fis Mat, I-50019 Sesto Fiorentino, Italy	University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR)	Modugno, G (corresponding author), Univ Florence, European Lab Nonlinear Spect, Via Nello Carrara 1, I-50019 Sesto Fiorentino, Italy.	modugno@lens.unifi.it	Modugno, Giovanni/AAT-9718-2021; Ferlaino, Francesca/E-6726-2012; Modugno, Giovanni/C-3179-2009; roati, giacomo/C-5459-2009	Modugno, Giovanni/0000-0002-4394-8593; Ferlaino, Francesca/0000-0002-3020-6291; Modugno, Giovanni/0000-0002-4394-8593; Riboli, Francesco/0000-0002-5553-9762; Inguscio, Massimo/0000-0001-8152-8103				Amoruso M, 1998, EUR PHYS J D, V4, P261, DOI 10.1007/s100530050207; ANDERSON AC, 1966, PHYS REV LETT, V17, P367, DOI 10.1103/PhysRevLett.17.367; Anglin JR, 2002, NATURE, V416, P211, DOI 10.1038/416211a; Bijlsma NJ, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.053601; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Donley EA, 2001, NATURE, V412, P295, DOI 10.1038/35085500; EDWARDS DO, 1965, PHYS REV LETT, V15, P773, DOI 10.1103/PhysRevLett.15.773; Ferrari G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.053202; Hadzibabic Z, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.160401; Heiselberg H, 2000, PHYS REV LETT, V85, P2418, DOI 10.1103/PhysRevLett.85.2418; Holland M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.120406; Modugno G, 2001, SCIENCE, V294, P1320, DOI 10.1126/science.1066687; Molmer K, 1998, PHYS REV LETT, V80, P1804, DOI 10.1103/PhysRevLett.80.1804; ROATI G, IN PRESS PHYS REV LE; Roth R, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.021603; Roth R, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.013614; Sackett CA, 1999, PHYS REV LETT, V82, P876, DOI 10.1103/PhysRevLett.82.876; Schreck F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.080403; Truscott AG, 2001, SCIENCE, V291, P2570, DOI 10.1126/science.1059318; Viverit L, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.023605	20	302	316	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2002	297	5590					2240	2243		10.1126/science.1077386	http://dx.doi.org/10.1126/science.1077386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597LA	12202686				2022-12-28	WOS:000178222000040
J	Murray, J; Segall, P				Murray, J; Segall, P			Testing time-predictable earthquake recurrence by direct measurement of strain accumulation and release	NATURE			English	Article							SAN-ANDREAS FAULT; PARKFIELD; CALIFORNIA; SEGMENT; MODELS	Probabilistic estimates of earthquake hazard use various models for the temporal distribution of earthquakes, including the 'time-predictable' recurrence model formulated by Shimazaki and Nakata(1) (which incorporates the concept of elastic rebound described as early as 1910 by H. F. Reid(2)). This model states that an earthquake occurs when the fault recovers the stress relieved in the most recent earthquake. Unlike time-independent models (for example, Poisson probability), the time-predictable model is thought to encompass some of the physics behind the earthquake cycle, in that earthquake probability increases with time. The time-predictable model is therefore often preferred when adequate data are available, and it is incorporated in hazard predictions for many earthquake-prone regions, including northern California(3), southern California(4,5), New Zealand(6) and Japan(7). Here we show that the model fails in what should be an ideal locale for its application - Parkfield, California. We estimate rigorous bounds on the predicted recurrence time of the magnitude similar to6 1966 Parkfield earthquake through inversion of geodetic measurements and we show that, according to the time-predictable model, another earthquake should have occurred by 1987. The model's poor performance in a relatively simple tectonic setting does not bode well for its successful application to the many areas of the world characterized by complex fault interactions.	Stanford Univ, Dept Geophys, Stanford, CA 94305 USA	Stanford University	Murray, J (corresponding author), Stanford Univ, Dept Geophys, Stanford, CA 94305 USA.							ANNAKA T, 1998, RISK ANAL; BAKUN WH, 1984, J GEOPHYS RES, V89, P3051, DOI 10.1029/JB089iB05p03051; BEN-ZION Y, 1993, J GEOPHYS RES-SOL EA, V98, P2135, DOI 10.1029/92JB02154; Cole A.T., 1995, SEISMOL RES LETT, V66, P28; Cramer CH, 2000, B SEISMOL SOC AM, V90, P1, DOI 10.1785/0119980087; DIETERICH J, 1994, J GEOPHYS RES-SOL EA, V99, P2601, DOI 10.1029/93JB02581; Dieterich JH, 1996, P NATL ACAD SCI USA, V93, P3787, DOI 10.1073/pnas.93.9.3787; Efron B, 1993, INTRO BOOTSTRAP, DOI DOI 10.1111/1467-9639.00050; ELLSWORTH W, 2000, 17 COURS INT SCH GEO; Gao SS, 2000, J GEOPHYS RES-SOL EA, V105, P2955, DOI 10.1029/1999JB900383; Grace W., 1990, SPLINE MODELS OBSERV; HARRIS RA, 1987, J GEOPHYS RES-SOLID, V92, P7945, DOI 10.1029/JB092iB08p07945; JACKSON DD, 1995, B SEISMOL SOC AM, V85, P379; JOHNSON HO, 1994, B SEISMOL SOC AM, V84, P660; KING NE, 1987, J GEOPHYS RES-SOLID, V92, P2747, DOI 10.1029/JB092iB03p02747; Murray JR, 2001, GEOPHYS RES LETT, V28, P359, DOI 10.1029/2000GL011933; Reid H. F., 1910, REPORT STATE EARTHQU, V2; RICE JR, 1983, J APPL MECH-T ASME, V50, P343, DOI 10.1115/1.3167042; ROELOFFS E, 1994, REV GEOPHYS, V32, P315, DOI 10.1029/94RG01114; SAVAGE JC, 1990, J GEOPHYS RES-SOLID, V95, P4873, DOI 10.1029/JB095iB04p04873; SEGALL P, 1993, J GEOPHYS RES-SOL EA, V98, P4527, DOI 10.1029/92JB02408; SEGALL P, 1987, J GEOPHYS RES-SOLID, V92, P10511, DOI 10.1029/JB092iB10p10511; SHIMAZAKI K, 1980, GEOPHYS RES LETT, V7, P279, DOI 10.1029/GL007i004p00279; SIMPSON RW, 1988, PURE APPL GEOPHYS, V126, P665, DOI 10.1007/BF00879014; SMITH SW, 1968, B SEISMOL SOC AM, V58, P1955; Snay R. A., 1989, Manuscripta Geodaetica, V14, P391; Stirling M. W., 2000, P 12 WORLD C EARTHQ; TODA S, 2002, J GEOPHYS RES, V107; TSAI YB, 1969, B SEISMOL SOC AM, V59, P275; Working Group on California Earthquake Probabilities, 1999, 99517 USGS WORK GROU	30	78	78	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2002	419	6904					287	291		10.1038/nature00984	http://dx.doi.org/10.1038/nature00984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239564				2022-12-28	WOS:000178056300042
J	Shapiro, SD; Owen, CA				Shapiro, SD; Owen, CA			ADAM-33 surfaces as an asthma gene	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Shapiro, SD (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.		Owen, Caroline/H-5925-2013		NHLBI NIH HHS [T32 HL007633, R01 HL063137] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007633, R01HL063137] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Yoshinaka T, 2002, GENE, V282, P227, DOI 10.1016/S0378-1119(01)00818-6	5	75	78	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					936	938		10.1056/NEJMcibr022144	http://dx.doi.org/10.1056/NEJMcibr022144			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239266				2022-12-28	WOS:000178040700013
J	Nilius, N; Wallis, TM; Ho, W				Nilius, N; Wallis, TM; Ho, W			Development of one-dimensional band structure in artificial gold chains	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPE; SURFACE-STATES; SPECTROSCOPY; CLUSTERS; METALS; SPIN	The ability of a scanning tunneling microscope to manipulate single atoms is used to build well- defined gold chains on NiAl(110). The electronic properties of the one-dimensional chains are dominated by an unoccupied electron band, gradually developing from a single atomic orbital present in a gold atom. Spatially resolved conductance measurements along a 20-atom chain provide the dispersion relation, effective mass, and density of states of the free electron like band. These experiments demonstrate a strategy for probing the interrelation between geometric structure, elemental composition, and electronic properties in metallic nanostructures.	Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ho, W (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	wilsonho@uci.edu						Altmann KN, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.035406; Bartels L, 1997, PHYS REV LETT, V79, P697, DOI 10.1103/PhysRevLett.79.697; BERTEL E, 1995, SURF SCI, V331, P1136, DOI 10.1016/0039-6028(95)00074-7; Binns C, 2001, SURF SCI REP, V44, P1, DOI 10.1016/S0167-5729(01)00015-2; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; Bogicevic A, 2000, PHYS REV LETT, V85, P1910, DOI 10.1103/PhysRevLett.85.1910; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; Ertl G., 1997, HDB HETEROGENEOUS CA; Haberland H, 1993, CLUSTERS ATOMS MOL; KEVAN SD, 1987, PHYS REV B, V36, P5809, DOI 10.1103/PhysRevB.36.5809; Kittel C., 2018, INTRO SOLID STATE PH; Kliewer J, 2000, SCIENCE, V288, P1399, DOI 10.1126/science.288.5470.1399; Kreibig U., 1995, OPTICAL PROPERTIES M, V25; LaShell S, 1996, PHYS REV LETT, V77, P3419, DOI 10.1103/PhysRevLett.77.3419; LUI SC, 1989, PHYS REV B, V39, P13149, DOI 10.1103/PhysRevB.39.13149; Mugarza A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.107601; Nilius N, 2000, PHYS REV LETT, V84, P3994, DOI 10.1103/PhysRevLett.84.3994; Repp J, 2000, PHYS REV LETT, V85, P2981, DOI 10.1103/PhysRevLett.85.2981; Stipe BC, 1999, REV SCI INSTRUM, V70, P137, DOI 10.1063/1.1149555; Swamy K, 2001, SURF SCI, V482, P402, DOI 10.1016/S0039-6028(00)01033-5; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; Widdra W, 1998, PHYS REV LETT, V80, P4269, DOI 10.1103/PhysRevLett.80.4269	23	391	395	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1853	1856		10.1126/science.1075242	http://dx.doi.org/10.1126/science.1075242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12193641				2022-12-28	WOS:000177955000038
J	Hung, LCT; Lee, YT; Yu, SCH; Leung, WK; Sung, JJY				Hung, LCT; Lee, YT; Yu, SCH; Leung, WK; Sung, JJY			A middle-aged woman with recurrent haemetemesis	LANCET			English	Article							PORTAL-HYPERTENSION; FISTULA		Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Diagnost & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Hung, LCT (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.		Leung, Wai Keung/B-8140-2011; Sung, Joseph J. Y./R-3203-2018; Yu, Simon Chun Ho/D-1046-2011	Leung, Wai Keung/0000-0002-5993-1059; Sung, Joseph J. Y./0000-0003-3125-5199; Yu, Simon Chun Ho/0000-0002-8715-5026				MISSAVAGE AE, 1984, J TRAUMA, V24, P355, DOI 10.1097/00005373-198404000-00014; PREGER L, 1967, AMER J ROENTGENOL RA, V101, P619, DOI 10.2214/ajr.101.3.619; Sachs R, 1892, DEUT MED WOCHENSCHR, V18, P443, DOI 10.1055/s-0029-1199146; STRODEL WE, 1987, ARCH SURG-CHICAGO, V122, P563; VANWAES L, 1979, DIGEST DIS SCI, V24, P565, DOI 10.1007/BF01489327	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 7	2002	360	9335					778	778		10.1016/S0140-6736(02)09900-2	http://dx.doi.org/10.1016/S0140-6736(02)09900-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592HX	12241837				2022-12-28	WOS:000177933000020
J	Czarnecki, CA; O'Coclain, DF				Czarnecki, CA; O'Coclain, DF			Severe abdominal pain in a girl	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Mayo Clinic	Czarnecki, CA (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW, Rochester, MN 55905 USA.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2002	347	10					E3	E3		10.1056/ENEJMicm020114	http://dx.doi.org/10.1056/ENEJMicm020114			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NH	12213939				2022-12-28	WOS:000177765800006
J	Levinsky, NG				Levinsky, NG			Nonfinancial conflicts of interest in research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Med Ctr, Boston, MA 02118 USA	Boston University	Levinsky, NG (corresponding author), Boston Univ, Med Ctr, Boston, MA 02118 USA.							CARDON PV, 1976, NEW ENGL J MED, V295, P650, DOI 10.1056/NEJM197609162951205; Marshall E, 2000, SCIENCE, V288, P1558, DOI 10.1126/science.288.5471.1558; *NAT BIOETH ADV CO, 2001, ETH POL ISS RES INV, V1; Pellegrino E D, 1992, Camb Q Healthc Ethics, V1, P361; ROYLE JM, 1986, BRIT J CLIN PHARMACO, V21, P548, DOI 10.1111/j.1365-2125.1986.tb02842.x; SOLOV D, 2001, CLEVELAND PLAIN 1221, pA1; Steinbrook R, 2002, NEW ENGL J MED, V346, P1842, DOI 10.1056/NEJMp020046; Steinbrook R, 2002, NEW ENGL J MED, V346, P1425, DOI 10.1056/NEJM200205023461828; Steinbrook R, 2002, NEW ENGL J MED, V346, P716, DOI 10.1056/NEJM200202283460924; WENTZEL M, 1996, ROCHESTER DEMOC 0404, pA1; ZARAFONETIS CJD, 1978, CLIN PHARMACOL THER, V24, P127	11	112	113	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2002	347	10					759	761		10.1056/NEJMsb020853	http://dx.doi.org/10.1056/NEJMsb020853			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NH	12213950				2022-12-28	WOS:000177765800012
J	Rusconi, CP; Scardino, E; Layzer, J; Pitoc, GA; Ortel, TL; Monroe, D; Sullenger, BA				Rusconi, CP; Scardino, E; Layzer, J; Pitoc, GA; Ortel, TL; Monroe, D; Sullenger, BA			RNA aptamers as reversible antagonists of coagulation factor IXa	NATURE			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; ANTICOAGULANT-THERAPY; BIND; INHIBITION; GENERATION; MOLECULES; SELECTION	Many therapeutic agents are associated with adverse effects in patients. Anticoagulants can engender acute complications such as significant bleeding that increases patient morbidity and mortality(1). Antidote control provides the safest means to regulate drug action. For this reason, despite its known limitations and toxicities, heparin use remains high because it is the only anticoagulant that can be controlled by an antidote, the polypeptide protamine(2-4). To date, no generalizable strategy for developing drug-antidote pairs has been described. We investigated whether drug-antidote pairs could be rationally designed by taking advantage of properties inherent to nucleic acids to make antidote-controlled anticoagulant agents. Here we show that protein-binding oligonucleotides (aptamers) against coagulation factor IXa are potent anticoagulants. We also show that oligonucleotides complementary to these aptamers can act as antidotes capable of efficiently reversing the activity of these new anticoagulants in plasma from healthy volunteers and from patients who cannot tolerate heparin(5). This generalizable strategy for rationally designing a drug-antidote pair thus opens up the way for developing safer regulatable therapeutics.	Duke Univ, Med Ctr, Dept Surg, Program Combinatorial Therapeut, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol & Med, Durham, NC 27710 USA; Univ N Carolina, Sch Med, Ctr Thrombosis & Hemostasis, Chapel Hill, NC 27599 USA	Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Rusconi, CP (corresponding author), Duke Univ, Med Ctr, Dept Surg, Program Combinatorial Therapeut, Durham, NC 27710 USA.	c.rusconi@cgct.duke.edu; b.sullenger@cgct.duke.edu		Monroe, Dougald/0000-0002-0493-2943				BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Campbell K R, 2000, J Invasive Cardiol, V12 Suppl F, p14F; Carr JA, 1999, J CARDIOVASC SURG, V40, P659; Choudhri TF, 1999, J EXP MED, V190, P91, DOI 10.1084/jem.190.1.91; Davis JP, 1996, METHOD ENZYMOL, V267, P302; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Feuerstein GZ, 1999, THROMB HAEMOSTASIS, V82, P1443; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; Greinacher A, 1999, CIRCULATION, V99, P73, DOI 10.1161/01.CIR.99.1.73; Hicke BJ, 2000, J CLIN INVEST, V106, P923, DOI 10.1172/JCI11324; Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Johnson K, 1998, CORONARY ARTERY DIS, V9, P83, DOI 10.1097/00019501-199809020-00004; KA High, 1995, MOL BASIS THROMBOSIS, P215; Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S; Lewis BE, 2001, CIRCULATION, V103, P1838; PIEKEN WA, 1991, SCIENCE, V253, P314, DOI 10.1126/science.1857967; PIFARRE R, 1997, NEW ANTICOAGULANTS C, P1; Rusconi CP, 2000, THROMB HAEMOSTASIS, V84, P841; Silverman SK, 1999, BIOCHEMISTRY-US, V38, P8691, DOI 10.1021/bi9906118; Spanier TB, 1998, J THORAC CARDIOV SUR, V116, P860, DOI 10.1016/S0022-5223(98)00437-1; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Tucker CE, 1999, J CHROMATOGR B, V732, P203, DOI 10.1016/S0378-4347(99)00285-6; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van Dijk MA, 2001, CURR OPIN CHEM BIOL, V5, P368, DOI 10.1016/S1367-5931(00)00216-7; Warkentin TE, 1998, THROMB HAEMOSTASIS, V79, P1; Watson SR, 2000, ANTISENSE NUCLEIC A, V10, P63, DOI 10.1089/oli.1.2000.10.63; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; White RR, 2000, J CLIN INVEST, V106, P929, DOI 10.1172/JCI11325	29	408	457	5	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					90	94		10.1038/nature00963	http://dx.doi.org/10.1038/nature00963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214238				2022-12-28	WOS:000177788600043
J	Bishop, M				Bishop, M			Secondary consult	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1053	1054		10.1001/jama.288.9.1053	http://dx.doi.org/10.1001/jama.288.9.1053			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NA	12204067				2022-12-28	WOS:000177764600001
J	Domine, F; Shepson, PB				Domine, F; Shepson, PB			Air-snow interactions and atmospheric chemistry	SCIENCE			English	Review							TROPOSPHERIC OZONE DEPLETION; ARCTIC BOUNDARY-LAYER; TO-FIRN TRANSFER; PHOTOCHEMICAL PRODUCTION; POLAR SUNRISE; SURFACE-AREA; SOUTH-POLE; SUMMIT; FORMALDEHYDE; ALERT	The presence of snow greatly perturbs the composition of near-surface polar air, and the higher concentrations of hydroxyl radicals (OH) observed result in greater oxidative capacity of the lower atmosphere. Emissions of nitrogen oxides, nitrous acid, light aldehydes, acetone, and molecular halogens have also been detected. Photolysis of nitrate ions contained in the snow appears to play an important role in creating these perturbations. OH formed in the snowpack can oxidize organic matter and halide ions in the snow, producing carbonyl compounds and halogens that are released to the atmosphere or incorporated into snow crystals. These reactions modify the composition of the snow, of the interstitial air, and of the overlying atmosphere. Reconstructing the composition of past atmospheres from ice-core analyses may therefore require complex corrections and modeling for reactive species.	CNRS, Lab Glaciol & Geophys Environm, F-38042 Grenoble, France; Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Domine, F (corresponding author), CNRS, Lab Glaciol & Geophys Environm, BP 96,54 Rue Moliere, F-38042 Grenoble, France.	orent@lgge.obs.ujf-grenoble.fr; pshepson@purdue.edu	Shepson, Paul B/E-9955-2012; Domine, Florent/E-8699-2011					Albert MR, 2002, ATMOS ENVIRON, V36, P2789, DOI 10.1016/S1352-2310(02)00119-X; Albert MR, 2002, ATMOS ENVIRON, V36, P2779, DOI 10.1016/S1352-2310(02)00118-8; Albert MR, 2000, ANN GLACIOL-SER, V31, P353, DOI 10.3189/172756400781820273; BARRIE LA, 1988, NATURE, V334, P138, DOI 10.1038/334138a0; BEINE HJ, IN PRESS J GEOPHYS R; Bottenheim JW, 2002, ATMOS ENVIRON, V36, P2535, DOI 10.1016/S1352-2310(02)00121-8; Cabanes A, 2002, ATMOS ENVIRON, V36, P2767, DOI 10.1016/S1352-2310(02)00111-5; Chen G, 2001, GEOPHYS RES LETT, V28, P3633, DOI 10.1029/2001GL013158; COLBECK SC, 1983, J GEOPHYS RES-OCEANS, V88, P5475, DOI 10.1029/JC088iC09p05475; DASSAU TM, 2002, IN PRESS J GEOPHYS R; Davis D, 2001, GEOPHYS RES LETT, V28, P3625, DOI 10.1029/2000GL012584; Domine F, 1996, GEOPHYS RES LETT, V23, P3627, DOI 10.1029/96GL03290; Domine F, 2002, ATMOS ENVIRON, V36, P2753, DOI 10.1016/S1352-2310(02)00108-5; DOMINE F, IN PRESS GEOPHYS RES; Doppenschmidt A, 2000, LANGMUIR, V16, P6709, DOI 10.1021/la990799w; Dubowski Y, 2001, J PHYS CHEM A, V105, P4928, DOI 10.1021/jp0042009; FAN SM, 1992, NATURE, V359, P522, DOI 10.1038/359522a0; Foster KL, 2001, SCIENCE, V291, P471, DOI 10.1126/science.291.5503.471; Grannas AM, 2002, ATMOS ENVIRON, V36, P2733, DOI 10.1016/S1352-2310(02)00134-6; HOLLAND CK, 2001, IPCC 2001 CLIMATE CH, P99; Honninger G, 2002, ATMOS ENVIRON, V36, P2481, DOI 10.1016/s1352-2310(02)00104-8; Honrath RE, 2000, J GEOPHYS RES-ATMOS, V105, P24183, DOI 10.1029/2000JD900361; Honrath RE, 2002, ATMOS ENVIRON, V36, P2629, DOI 10.1016/S1352-2310(02)00132-2; Hutterli MA, 1999, GEOPHYS RES LETT, V26, P1691, DOI 10.1029/1999GL900327; Jacobi HW, 2002, ATMOS ENVIRON, V36, P2619, DOI 10.1016/S1352-2310(02)00106-1; Jones AE, 2001, GEOPHYS RES LETT, V28, P1499, DOI 10.1029/2000GL011956; Koop T, 2000, J GEOPHYS RES-ATMOS, V105, P26393, DOI 10.1029/2000JD900413; Lalonde JD, 2002, ENVIRON SCI TECHNOL, V36, P174, DOI 10.1021/es010786g; Legrand M, 1997, REV GEOPHYS, V35, P219, DOI 10.1029/96RG03527; Lindberg SE, 2002, ENVIRON SCI TECHNOL, V36, P1245, DOI 10.1021/es0111941; LOGAN JA, 1983, J GEOPHYS RES-OCEANS, V88, P785, DOI 10.1029/JC088iC15p10785; Lu JY, 2001, GEOPHYS RES LETT, V28, P3219, DOI 10.1029/2000GL012603; Mauldin RL, 2001, GEOPHYS RES LETT, V28, P3629, DOI 10.1029/2000GL012711; McConnell JR, 1998, J GEOPHYS RES-ATMOS, V103, P10561, DOI 10.1029/98JD00460; McConnell JR, 2002, GEOPHYS RES LETT, V29, DOI [10.1029/2002GL016016, 10.1029/2002GL016016,2002]; Michalowski BA, 2000, J GEOPHYS RES-ATMOS, V105, P15131, DOI 10.1029/2000JD900004; Perrier S, 2002, ATMOS ENVIRON, V36, P2695, DOI 10.1016/S1352-2310(02)00110-3; Peterson MC, 2001, GEOPHYS RES LETT, V28, P511, DOI 10.1029/2000GL012129; PETRENKO WF, 1999, PHYSICS ICE; Riedel K, 1999, PHYS CHEM CHEM PHYS, V1, P5523, DOI 10.1039/a905368i; ROBINSON DA, 1993, B AM METEOROL SOC, V74, P1689, DOI 10.1175/1520-0477(1993)074<1689:GSCMAU>2.0.CO;2; Simpson WR, 2002, ATMOS ENVIRON, V36, P2663, DOI 10.1016/S1352-2310(02)00124-3; Solberg S, 1996, J ATMOS CHEM, V23, P301, DOI 10.1007/BF00055158; Sturges WT, 2001, J GEOPHYS RES-ATMOS, V106, P1595, DOI 10.1029/2000JD900511; Sumner AL, 1999, NATURE, V398, P230, DOI 10.1038/18423; Sumner AL, 2002, ATMOS ENVIRON, V36, P2553, DOI 10.1016/S1352-2310(02)00105-X; Swanson AL, 2002, ATMOS ENVIRON, V36, P2671, DOI 10.1016/S1352-2310(02)00127-9; Takenaka N, 1998, J ATMOS CHEM, V29, P135, DOI 10.1023/A:1005804007355; Thibert E, 1997, J PHYS CHEM B, V101, P3554, DOI 10.1021/jp962115o; Toom-Sauntry D, 2002, ATMOS ENVIRON, V36, P2683, DOI 10.1016/S1352-2310(02)00115-2; Vogt R, 1996, NATURE, V383, P327, DOI 10.1038/383327a0; WANIA F, 1993, AMBIO, V22, P10; Wei X, 2001, PHYS REV LETT, V86, P1554, DOI 10.1103/PhysRevLett.86.1554; Weller R, 1999, GEOPHYS RES LETT, V26, P2853, DOI 10.1029/1999GL900608; Wessel S, 1998, TELLUS B, V50, P34, DOI 10.1034/j.1600-0889.1998.00003.x; Yang J, 2002, ATMOS ENVIRON, V36, P2523, DOI 10.1016/S1352-2310(02)00128-0; Zhou XL, 2001, GEOPHYS RES LETT, V28, P4087, DOI 10.1029/2001GL013531	57	390	397	5	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1506	1510		10.1126/science.1074610	http://dx.doi.org/10.1126/science.1074610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202818				2022-12-28	WOS:000177697300044
J	Hakimi, MA; Bochar, DA; Schmiesing, JA; Dong, YS; Barak, OG; Speicher, DW; Yokomori, K; Shiekhattar, R				Hakimi, MA; Bochar, DA; Schmiesing, JA; Dong, YS; Barak, OG; Speicher, DW; Yokomori, K; Shiekhattar, R			A chromatin remodelling complex that loads cohesin onto human chromosomes	NATURE			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; RAD21; TRANSCRIPTION; METHYLATION; NUCLEOSOME; ANAPHASE; PROTEIN; FAMILY; GENE	Nucleosomal DNA is arranged in a higher-order structure that presents a barrier to most cellular processes involving protein DNA interactions(1). The cellular machinery involved in sister chromatid cohesion, the cohesin complex, also requires access to the nucleosomal DNA to perform its function in chromosome segregation(2-10). The machineries that provide this accessibility are termed chromatin remodelling factors(11). Here, we report the isolation of a human ISWI (SNF2h)-containing chromatin remodelling complex that encompasses components of the cohesin and NuRD complexes. We show that the hRAD21 subunit of the cohesin complex directly interacts with the ATPase subunit SNF2h. Mapping of hRAD21, SNF2h and Mi2 binding sites by chromatin immunoprecipitation experiments reveals the specific association of these three proteins with human DNA elements containing Alu sequences. We find a correlation between modification of histone tails and association of the SNF2h/cohesin complex with chromatin. Moreover, we show that the association of the cohesin complex with chromatin can be regulated by the state of DNA methylation. Finally, we present evidence pointing to a role for the ATPase activity of SNF2h in the loading of hRAD21 on chromatin.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	The Wistar Institute; University of California System; University of California Irvine	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.		Bochar, Daniel A/A-9224-2009; HAKIMI, Mohamed-ali/Q-6475-2019; HAKIMI, Mohamed-Ali/F-9806-2014; HAKIMI, Mohamed-ali/GYJ-0879-2022	HAKIMI, Mohamed-ali/0000-0002-2547-8233; HAKIMI, Mohamed-Ali/0000-0002-2547-8233; 				BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; BIRKENBIHL RP, 1995, J BIOL CHEM, V270, P7703, DOI 10.1074/jbc.270.13.7703; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Broday L, 1999, MOL CELL BIOL, V19, P3198; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; HELLMANNBLUMBERG U, 1993, MOL CELL BIOL, V13, P4523, DOI 10.1128/MCB.13.8.4523; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; LARIONOV VL, 1985, CURR GENET, V10, P15, DOI 10.1007/BF00418488; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mighell AJ, 1997, FEBS LETT, V417, P1, DOI 10.1016/S0014-5793(97)01259-3; Schmid CW, 1998, NUCLEIC ACIDS RES, V26, P4541, DOI 10.1093/nar/26.20.4541; Schmiesing JA, 1998, P NATL ACAD SCI USA, V95, P12906, DOI 10.1073/pnas.95.22.12906; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; Tatebayashi K, 1998, GENETICS, V148, P49; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	27	218	222	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					994	998		10.1038/nature01024	http://dx.doi.org/10.1038/nature01024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198550				2022-12-28	WOS:000177677500048
J	Vogelbein, WK; Lovko, VJ; Shields, JD; Reece, KS; Mason, PL; Haas, LW; Walker, CC				Vogelbein, WK; Lovko, VJ; Shields, JD; Reece, KS; Mason, PL; Haas, LW; Walker, CC			Pfiesteria shumwayae kills fish by micropredation not exotoxin secretion	NATURE			English	Article							TOXIC PFIESTERIA; ESTUARINE FISH; HUMAN HEALTH; LIFE-CYCLE; DINOFLAGELLATE; PISCICIDA; DINOPHYCEAE; MENHADEN; BEHAVIOR; RECEPTOR	Pfiesteria piscicida and P. shumwayae reportedly secrete potent exotoxins thought to cause fish lesion events, acute fish kills and human disease in mid-Atlantic USA estuaries(1-7). However, Pfiesteria toxins have never been isolated or characterized(8). We investigated mechanisms by which P. shumwayae kills fish using three different approaches. Here we show that larval fish bioassays conducted in tissue culture plates fitted with polycarbonate membrane inserts exhibited mortality (100%) only in treatments where fish and dinospores were in physical contact. No mortalities occurred in treatments where the membrane prevented contact between dinospores and fish. Using differential centrifugation and filtration of water from a fish-killing culture, we produced 'dinoflagellate', 'bacteria' and 'cell-free' fractions. Larval fish bioassays of these fractions resulted in mortalities (60-100% in less than 24 h) only in fractions containing live dinospores ('whole water', 'dinoflagellate'), with no mortalities in 'cell-free' or 'bacteria'-enriched fractions. Videomicrography and electron microscopy show dinospores swarming toward and attaching to skin, actively feeding, and rapidly denuding fish of epidermis. We show here that our cultures of actively fish-killing P. shumwayae do not secrete potent exotoxins; rather, fish mortality results from micropredatory feeding.	Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; US EPA, Natl Hlth & Environm Effects Res Lab, Gulf Ecol Div, Gulf Breeze, FL 32561 USA	William & Mary; Virginia Institute of Marine Science; United States Environmental Protection Agency	Vogelbein, WK (corresponding author), Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA.							BERRY JP, IN PRESS P NATL ACAD; Blazer VS, 1999, J AQUAT ANIM HEALTH, V11, P340, DOI 10.1577/1548-8667(1999)011&lt;0340:AAACOU&gt;2.0.CO;2; Blazer VS, 2002, J AQUAT ANIM HEALTH, V14, P1, DOI 10.1577/1548-8667(2002)014&lt;0001:AIIAMA&gt;2.0.CO;2; Burkholder JM, 2001, PHYCOLOGIA, V40, P186, DOI 10.2216/i0031-8884-40-3-186.1; Burkholder JM, 2001, ENVIRON HEALTH PERSP, V109, P745, DOI 10.2307/3454922; BURKHOLDER JM, 1995, MAR ECOL PROG SER, V124, P43, DOI 10.3354/meps124043; BURKHOLDER JM, 1992, NATURE, V358, P407, DOI 10.1038/358407a0; Burkholder JM, 1997, LIMNOL OCEANOGR, V42, P1052, DOI 10.4319/lo.1997.42.5_part_2.1052; CALLINAN RB, 1994, P ODA REG SEM EP ULC, P248; DYKSTRA MJ, 1989, J FISH DIS, V12, P175, DOI 10.1111/j.1365-2761.1989.tb00289.x; El-Nabawi A, 2000, TOXICOL APPL PHARM, V169, P84, DOI 10.1006/taap.2000.9042; ELNABAWI A, 2000, J EXP MAR BIOL ECOL, V255, P65; Glasgow HB, 2001, PHYCOLOGIA, V40, P234, DOI 10.2216/i0031-8884-40-3-234.1; Glasgow HB, 2001, ENVIRON HEALTH PERSP, V109, P715, DOI 10.2307/3454919; GLASGOW HB, 1995, J TOXICOL ENV HEALTH, V46, P501, DOI 10.1080/15287399509532051; Grattan LM, 1998, LANCET, V352, P532, DOI 10.1016/S0140-6736(98)02132-1; Grattan LM, 2001, BIOSCIENCE, V51, P853, DOI 10.1641/0006-3568(2001)051[0853:HHROET]2.0.CO;2; Kiryu Y, 2002, J AQUAT ANIM HEALTH, V14, P11, DOI 10.1577/1548-8667(2002)014&lt;0011:IOSUIA&gt;2.0.CO;2; Litaker RW, 2002, J PHYCOL, V38, P442, DOI 10.1046/j.1529-8817.2002.t01-1-01242.x; Melo AC, 2001, ENVIRON HEALTH PERSP, V109, P731, DOI 10.2307/3454920; Moeller PDR, 2001, ENVIRON HEALTH PERSP, V109, P739, DOI 10.2307/3454921; NOGA EJ, 1988, DIS AQUAT ORGAN, V4, P189, DOI 10.3354/dao004189; Noga EJ, 1996, MAR POLLUT BULL, V32, P219, DOI 10.1016/0025-326X(95)00114-3; SCHNEPF E, 1984, NATURWISSENSCHAFTEN, V71, P218, DOI 10.1007/BF00490442; SCHNEPF E, 1992, EUR J PROTISTOL, V28, P3, DOI 10.1016/S0932-4739(11)80315-9; SHUMWAY S, 2000, AG S HARMF MAR ALG U, P64; SPERO HJ, 1981, J PHYCOL, V17, P43, DOI 10.1111/j.0022-3646.1981.00043.x; Steidinger KA, 1996, J PHYCOL, V32, P157, DOI 10.1111/j.0022-3646.1996.00157.x; Vogelbein WK, 2001, ENVIRON HEALTH PERSP, V109, P687, DOI 10.2307/3454914; VOGELBEIN WK, 2000, AG S HARMF MAR ALG U, P81	30	64	69	0	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					967	970		10.1038/nature01008	http://dx.doi.org/10.1038/nature01008			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198545				2022-12-28	WOS:000177677500042
J	Ramalho-Santos, M; Yoon, S; Matsuzaki, Y; Mulligan, RC; Melton, DA				Ramalho-Santos, M; Yoon, S; Matsuzaki, Y; Mulligan, RC; Melton, DA			"Stemness": Transcriptional profiling of embryonic and adult stem cells	SCIENCE			English	Article							HUMAN BLASTOCYSTS; IN-VIVO; DIFFERENTIATION; POPULATION; RECEPTOR; PROGRAMS	The transcriptional profiles of mouse embryonic, neural, and hematopoietic stem cells were compared to de ne a genetic program for stem cells. A total of 216 genes are enriched in all three types of stem cells, and several of these genes are clustered in the genome. When compared to differentiated cell types, stem cells express a significantly higher number of genes ( represented by expressed sequence tags) whose functions are unknown. Embryonic and neural stem cells have many similarities at the transcriptional level. These results provide a foundation for a more detailed understanding of stem cell biology.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Melton, DA (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.		Ramalho-Santos, Miguel/L-9092-2018; Young, Richard A/F-6495-2012	Ramalho-Santos, Miguel/0000-0003-0177-5556; Young, Richard A/0000-0001-8855-8647; Matsuzaki, Yumi/0000-0002-3729-2997	NHLBI NIH HHS [P60 HL54785] Funding Source: Medline; NIDDK NIH HHS [R24 DK56947] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK056947] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; BONGSO A, 1994, HUM REPROD, V9, P2110, DOI 10.1093/oxfordjournals.humrep.a138401; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Dunnwald M, 2001, EXP DERMATOL, V10, P45, DOI 10.1034/j.1600-0625.2001.100106.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fortunel N, 2000, STEM CELLS, V18, P102, DOI 10.1634/stemcells.18-2-102; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Good JR, 2000, DEV BIOL, V220, P53, DOI 10.1006/dbio.2000.9611; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; JIANG Y, 2002, NATURE          0620; Kelly DL, 2000, MOL REPROD DEV, V56, P113, DOI 10.1002/(SICI)1098-2795(200006)56:2&lt;113::AID-MRD1&gt;3.0.CO;2-Q; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LI C, 2001, GENOME BIOL, V2; Moutoussamy S, 1998, EUR J BIOCHEM, V255, P1, DOI 10.1046/j.1432-1327.1998.2550001.x; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Raz E., 2000, GENOME BIOL, V1; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; SILVER LM, 1993, TRENDS GENET, V9, P250, DOI 10.1016/0168-9525(93)90090-5; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	35	1313	1396	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 18	2002	298	5593					597	600		10.1126/science.1072530	http://dx.doi.org/10.1126/science.1072530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604RL	12228720				2022-12-28	WOS:000178634800040
J	Horowitz, HW				Horowitz, HW			The three-legged stool	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2002	288	11					1327	1327		10.1001/jama.288.11.1327	http://dx.doi.org/10.1001/jama.288.11.1327			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593TB	12234212				2022-12-28	WOS:000178008300001
J	Fialko, Y; Sandwell, D; Agnew, D; Simons, M; Shearer, P; Minster, B				Fialko, Y; Sandwell, D; Agnew, D; Simons, M; Shearer, P; Minster, B			Deformation on nearby faults induced by the 1999 Hector Mine earthquake	SCIENCE			English	Article							APERTURE RADAR INTERFEROMETRY; VOLCANIC RIFT ZONES; SURFACE DISPLACEMENT; CALIFORNIA; LANDERS; PARKFIELD; WAVES	Interferometric Synthetic Aperture Radar observations of surface deformation due to the 1999 Hector Mine earthquake reveal motion on several nearby faults of the eastern California shear zone. We document both vertical and horizontal displacements of several millimeters to several centimeters across kilometer-wide zones centered on pre-existing faults. Portions of some faults experienced retrograde (that is, opposite to their long-term geologic slip) motion during or shortly after the earthquake. The observed deformation likely represents elastic response of compliant fault zones to the permanent co-seismic stress changes. The induced fault displacements imply decreases in the effective shear modulus within the kilometer-wide fault zones, indicating that the latter are mechanically distinct from the ambient crustal rocks.	Univ Calif San Diego, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; CALTECH, Seismol Lab, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	University of California System; University of California San Diego; California Institute of Technology	Fialko, Y (corresponding author), Univ Calif San Diego, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA.		Fialko, Yuri/B-9567-2012; Simons, Mark/N-4397-2015; Shearer, Peter/K-5247-2012	Fialko, Yuri/0000-0002-6161-8467; Simons, Mark/0000-0003-1412-6395; Shearer, Peter/0000-0002-2992-7630; Sandwell, David/0000-0001-5657-8707				Ben-Zion Y, 1998, J GEOPHYS RES-SOL EA, V103, P12567, DOI 10.1029/98JB00768; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Farr T.G., 2000, EOS T AM GEOPHYS UN, V81, P583, DOI [DOI 10.1029/EO081I048P00583, 10.1029/EO081i048p00583]; Fialko Y, 2001, GEOPHYS RES LETT, V28, P3063, DOI 10.1029/2001GL013174; Fialko YA, 1999, J GEOPHYS RES-SOL EA, V104, P20007, DOI 10.1029/1999JB900143; HARRIS RA, 1995, NATURE, V375, P221, DOI 10.1038/375221a0; LI YG, 1994, SCIENCE, V265, P367, DOI 10.1126/science.265.5170.367; Li YG, 1998, SCIENCE, V279, P217, DOI 10.1126/science.279.5348.217; Li YG, 1997, B SEISMOL SOC AM, V87, P210; Nikolaidis RM, 2001, J GEOPHYS RES-SOL EA, V106, P21897, DOI 10.1029/2001JB000329; POLEY CM, 1987, NATURE, V327, P134, DOI 10.1038/327134a0; Price EJ, 1998, J GEOPHYS RES-SOL EA, V103, P27001, DOI 10.1029/98JB01821; Rosen PA, 2000, P IEEE, V88, P333, DOI 10.1109/5.838084; RUBIN AM, 1992, J GEOPHYS RES-SOL EA, V97, P1839, DOI 10.1029/91JB02170; Sandwell DT, 2000, GEOPHYS RES LETT, V27, P3101, DOI 10.1029/1999GL011209; Scholz C. H., 1990, MECH EARTHQUAKES FAU; SHARP RV, 1986, B SEISMOL SOC AM, V76, P949; Wright T, 2001, GEOPHYS RES LETT, V28, P1079, DOI 10.1029/2000GL011776	19	142	148	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1858	1862		10.1126/science.1074671	http://dx.doi.org/10.1126/science.1074671			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228714				2022-12-28	WOS:000177955000040
J	Martyny, J; Glazer, CS; Newman, LS				Martyny, J; Glazer, CS; Newman, LS			Current concepts: Respiratory protection	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INSPIRATORY RESISTANCE; INDUSTRIAL RESPIRATORS; MEDICAL CLEARANCE; WORK PERFORMANCE; LUNG-DISEASE; EXERCISE; DEVICES; SENSITIVITY; LEVEL; MASK		Natl Jewish Med & Res Ctr, Div Environm & Occupat Hlth Sci, Dept Med, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Newman, LS (corresponding author), Natl Jewish Med & Res Ctr, Div Environm & Occupat Hlth Sci, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.							ALTOSE MD, 1977, J CLIN INVEST, V59, P500, DOI 10.1172/JCI108665; *AM NAT STAND I, 1992, AM NAT STAND RESP PR; [Anonymous], 1994, MMWR-MORBID MORTAL W, V43, P1; Barach P, 1998, ANN EMERG MED, V32, P224, DOI 10.1016/S0196-0644(98)70140-4; Beckett WS, 2000, NEW ENGL J MED, V342, P406, DOI 10.1056/NEJM200002103420607; Boehlecke B.A., 1996, OCCUPATIONAL ENV RES, P963; Bolstad-Johnson DM, 2000, AIHAJ, V61, P636, DOI 10.1202/0002-8894(2000)061<0636:COFEDF>2.0.CO;2; Burgess J.L., 1995, APPL OCCUP ENVIRON H, V10, p37?42; COLTON CE, 1997, OCCUPATIONAL ENV ITS, P974; DUBOIS AB, 1990, AM IND HYG ASSOC J, V51, P550, DOI 10.1202/0002-8894(1990)051<0550:TDORPD>2.0.CO;2; Fennelly KP, 1998, INT J TUBERC LUNG D, V2, pS103; Gross SF., 1990, J OCCUP ENVIRON HYG, V5, P229, DOI 10.1080/1047322X.1990.10389628; HARBER P, 1989, AM J IND MED, V16, P189, DOI 10.1002/ajim.4700160210; HARBER P, 1988, J OCCUP ENVIRON MED, V30, P256; Harber P, 1996, AM J RESP CRIT CARE, V154, P1153, DOI 10.1164/ajrccm.154.4.8887621; HODOUS TK, 1986, AM IND HYG ASSOC J, V47, P176, DOI 10.1202/0002-8894(1986)047<0176:EOIRWD>2.3.CO;2; HODOUS TK, 1983, AM REV RESPIR DIS, V128, P943; HODOUS TK, 1986, J OCCUP ENVIRON MED, V28, P1074, DOI 10.1097/00043764-198610000-00031; JOHNSON AT, 1995, AM IND HYG ASSOC J, V56, P858, DOI 10.1202/0002-8894(1995)056<0858:IOALOW>2.0.CO;2; Johnson AT, 2000, AIHAJ, V61, P678, DOI 10.1080/15298660008984577; Johnson AT, 1999, AM IND HYG ASSOC J, V60, P474, DOI 10.1202/0002-8894(1999)060<0474:EORIRL>2.0.CO;2; JONES JG, 1991, AM IND HYG ASSOC J, V52, P219, DOI 10.1202/0002-8894(1991)052<0219:TPCOWA>2.0.CO;2; KRAUT A, 1988, AM FAM PHYSICIAN, V37, P117; Krishnan U, 1999, AM IND HYG ASSOC J, V60, P228, DOI 10.1080/00028899908984440; LOUHEVAARA VA, 1984, SCAND J WORK ENV HEA, V10, P275, DOI 10.5271/sjweh.2327; Muhm JM, 1999, J OCCUP ENVIRON MED, V41, P989, DOI 10.1097/00043764-199911000-00011; Myers WR, 1995, APPL OCCUP ENV HYG, V10, P934, DOI DOI 10.1080/1047322X.1995.10387716; *NAT I OCC SAF HLT, 1987, DHHS PUBL, P289; *NAT I OCC SAF HLT, 1985, DHHS PUBL; NEWMAN LS, 1995, NEW ENGL J MED, V333, P1128, DOI 10.1056/NEJM199510263331707; NIELSEN R, 1987, AM IND HYG ASSOC J, V48, P639, DOI 10.1202/0002-8894(1987)048<0639:TEOTAH>2.0.CO;2; Pappas GP, 1999, AM J IND MED, V35, P395, DOI 10.1002/(SICI)1097-0274(199904)35:4<395::AID-AJIM11>3.0.CO;2-Q; Pappas GP, 1999, AM J IND MED, V35, P390, DOI 10.1002/(SICI)1097-0274(199904)35:4<390::AID-AJIM10>3.0.CO;2-7; Poirier L, 1999, AM IND HYG ASSOC J, V60, P116; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; RAVEN PB, 1979, AM IND HYG ASSOC J, V40, P517, DOI 10.1080/15298667991429912; RAVEN PB, 1977, J OCCUP ENVIRON MED, V19, P802, DOI 10.1097/00043764-197712000-00005; Salazar MK, 2001, AIHAJ, V62, P236, DOI 10.1080/15298660108984627; Szeinuk J, 2000, AM J IND MED, V37, P142, DOI 10.1002/(SICI)1097-0274(200001)37:1<142::AID-AJIM11>3.0.CO;2-K	39	39	39	2	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					824	830		10.1056/NEJMra012670	http://dx.doi.org/10.1056/NEJMra012670			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226154				2022-12-28	WOS:000177921300008
J	Amaratunga, GAJ				Amaratunga, GAJ			A dawn for carbon etectronics?	SCIENCE			English	Editorial Material							DEVICE APPLICATIONS; DIAMOND; GROWTH		Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England	University of Cambridge	Amaratunga, GAJ (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	ga@eng.cam.ac.uk						ANGUS JC, 1968, J APPL PHYS, V39, P2915, DOI 10.1063/1.1656693; BUNDY FP, 1955, NATURE, V176, P51, DOI 10.1038/176051a0; DERAYAGUIN BV, 1968, J CRYST GROWTH, V2, P380; FOX BA, 1995, DIAM RELAT MATER, V4, P622, DOI 10.1016/0925-9635(94)05245-X; GEIS MW, 1988, J VAC SCI TECHNOL A, V6, P1953, DOI 10.1116/1.575213; GILDENBLAT GS, 1991, P IEEE, V79, P647, DOI 10.1109/5.90130; Isberg J, 2002, SCIENCE, V297, P1670, DOI 10.1126/science.1074374; Kawarada H, 1998, APPL PHYS LETT, V72, P1878, DOI 10.1063/1.121213; MATSUMOTO S, 1982, J MATER SCI, V17, P3106, DOI 10.1007/BF01203472; Okushi H, 2001, DIAM RELAT MATER, V10, P281, DOI 10.1016/S0925-9635(00)00399-X; Ryu SH, 2002, IEEE ELECTR DEVICE L, V23, P321, DOI 10.1109/LED.2002.1004222; Shen L, 2001, IEEE ELECTR DEVICE L, V22, P457, DOI 10.1109/55.954910; SHENAI K, 1989, IEEE T ELECTRON DEV, V36, P1811, DOI 10.1109/16.34247; Taniuchi H, 2001, IEEE ELECTR DEVICE L, V22, P390, DOI 10.1109/55.936353; Vescan A, 1997, IEEE ELECTR DEVICE L, V18, P222, DOI 10.1109/55.568772	15	53	54	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587					1657	1658						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215634				2022-12-28	WOS:000177819100035
J	Saunders, JW				Saunders, JW			Is the progress zone model a victim of progress?	CELL			English	Review							LIMB	The prevailing view has long been that mesenchymal cells at the apex of the vertebrate limb bud proliferate in a progress zone (PZ) under the influence of the apical ectodermal ridge (AER). According to the PZ model, proximodistal cell fates are specified according to the time spent in the PZ. New results, considered along with some earlier findings, fail to support this model.			Saunders, JW (corresponding author), Box 3381, Waquoit, MA 02536 USA.							Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; PIERCE RV, 1998, J EXP ZOOL, V282, P687; RUBIN L, 1972, DEV BIOL, V28, P94, DOI 10.1016/0012-1606(72)90129-7; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; TUTTLE A, 2002, NATURE, V418, P539	9	19	19	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 6	2002	110	5					541	543		10.1016/S0092-8674(02)00936-4	http://dx.doi.org/10.1016/S0092-8674(02)00936-4			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230971	Bronze			2022-12-28	WOS:000177943700002
J	Potter, JE				Potter, JE			Do ask, do tell	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								As a consequence of bias and ignorance within the medical profession, lesbians and gay men frequently receive suboptimal health care. Knowledge of each patient's sexual orientation and behaviors is critical for the development of a productive therapeutic relationship, accurate risk assessment, and the provision of pertinent preventive counseling. However, clinicians often forget to ask about this information, and many lesbians and gay men are reticent to reveal the truth. I present vignettes from my personal experiences as a lesbian patient and doctor to illustrate the importance of creating an environment in which such disclosure can occur and to portray the challenges and rewards of coming out as a gay physician.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Potter, JE (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.	jpotter@caregroup.harvard.edu						Dean L., 2000, J GAY LESBIAN MED AS, V4, P102, DOI DOI 10.1023/A:1009573800168; Diamant A. L., 2000, J GAY LESBIAN MED AS, V4, P41, DOI DOI 10.1023/A:1009513623365; Miller Neil, 1995, OUT PAST GAY LESBIAN	3	10	10	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2002	137	5	1				341	343		10.7326/0003-4819-137-5_Part_1-200209030-00010	http://dx.doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591DZ	12204018				2022-12-28	WOS:000177865600005
J	Benoff, B; Yang, HW; Lawson, CL; Parkinson, G; Liu, JS; Blatter, E; Ebright, YW; Berman, HM; Ebright, RH				Benoff, B; Yang, HW; Lawson, CL; Parkinson, G; Liu, JS; Blatter, E; Ebright, YW; Berman, HM; Ebright, RH			Structural basis of transcription activation: the CAP-alpha CTD-DNA complex	SCIENCE			English	Article							AMP RECEPTOR PROTEIN; COLI RNA-POLYMERASE; C-TERMINAL DOMAIN; LAC OPERON TRANSCRIPTION; PROMOTER OPEN COMPLEX; ESCHERICHIA-COLI; DEPENDENT PROMOTERS; FUNCTIONAL SUBUNIT; MINOR-GROOVE; CLASS-I	The Escherichia coli catabolite activator protein (CAP) activates transcription at P-lac, P-gal, and other promoters through interactions with the RNA polymerase alpha subunit carboxyl-terminal domain (alphaCTD). We determined the crystal structure of the CAP-alphaCTD-DNA complex at a resolution of 3.1 angstroms. CAP makes direct protein-protein interactions with alphaCTD, and alphaCTD makes direct protein-DNA interactions with the DNA segment adjacent to the DNA site for CAP. There are no large-scale conformational changes in CAP and alphaCTD, and the interface between CAP and alphaCTD is small. These findings are consistent with the proposal that activation involves a simple "recruitment" mechanism.	Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA; Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Howard Hughes Medical Institute; Rutgers State University New Brunswick	Berman, HM (corresponding author), Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA.		Ebright, Richard/O-3321-2019	Ebright, Richard/0000-0001-8915-7140; Berman, Helen/0000-0002-3337-0660; Lawson, Catherine/0000-0002-3261-7035	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R01GM021589, P20GM064375] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41376, GM21589, GM64375] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELL A, 1990, NUCLEIC ACIDS RES, V18, P7243, DOI 10.1093/nar/18.24.7243; BERMAN HM, 1999, OXFORD HDB NUCL ACID, P295; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chen H. M., UNPUB; Czarniecki D, 1997, J BACTERIOL, V179, P423, DOI 10.1128/jb.179.2.423-429.1997; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; ESCHENLAUER AC, 1991, J BACTERIOL, V173, P5024, DOI 10.1128/jb.173.16.5024-5029.1991; Flatow U, 1996, J BACTERIOL, V178, P2436, DOI 10.1128/jb.178.8.2436-2439.1996; Gaal T, 1996, GENE DEV, V10, P16, DOI 10.1101/gad.10.1.16; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; KATAHIRA M, 1990, NUCLEIC ACIDS RES, V18, P613, DOI 10.1093/nar/18.3.613; KOLB A, 1993, NUCLEIC ACIDS RES, V21, P319, DOI 10.1093/nar/21.2.319; KOPKA ML, 1983, J MOL BIOL, V163, P129, DOI 10.1016/0022-2836(83)90033-5; Law EC, 1999, BIOCHEM J, V337, P415, DOI 10.1042/0264-6021:3370415; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; MacDonald D, 2001, J MOL BIOL, V306, P1081, DOI 10.1006/jmbi.2001.4447; MALAN TP, 1984, J MOL BIOL, V180, P881, DOI 10.1016/0022-2836(84)90262-6; Murakami K, 1996, EMBO J, V15, P4358, DOI 10.1002/j.1460-2075.1996.tb00809.x; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NIU W, 1994, J MOL BIOL, V243, P595, DOI 10.1016/0022-2836(94)90034-5; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Noel RJ, 1998, J MOL BIOL, V282, P495, DOI 10.1006/jmbi.1998.2040; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Parkinson G, 1996, NAT STRUCT BIOL, V3, P837, DOI 10.1038/nsb1096-837; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; PTASHNE M, 2002, GENES SIGNALS; REN YL, 1988, P NATL ACAD SCI USA, V85, P4138, DOI 10.1073/pnas.85.12.4138; Ross W, 2001, GENE DEV, V15, P491, DOI 10.1101/gad.870001; RYU S, 1994, P NATL ACAD SCI USA, V91, P8582, DOI 10.1073/pnas.91.18.8582; Savery NJ, 1998, EMBO J, V17, P3439, DOI 10.1093/emboj/17.12.3439; Savery NJ, 2002, J BACTERIOL, V184, P2273, DOI 10.1128/JB.184.8.2273-2280.2002; SAVERY NJ, 1995, BIOCHEM J, V309, P77, DOI 10.1042/bj3090077; SCHNEIDER B, 1993, BIOPHYS J, V65, P2291, DOI 10.1016/S0006-3495(93)81306-7; SCHNEIDER BL, UNPUB; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; STRANEY DC, 1989, J MOL BIOL, V206, P41, DOI 10.1016/0022-2836(89)90522-6; TANG H, 1994, GENE DEV, V8, P3058, DOI 10.1101/gad.8.24.3058; Wang SL, 2000, J BIOL CHEM, V275, P33457, DOI 10.1074/jbc.M004877200; YANG ZH, 1991, FASEB J, V5, pA814; Yasuno K, 2001, J MOL BIOL, V306, P213, DOI 10.1006/jmbi.2000.4369; ZHOU YH, 1994, J MOL BIOL, V243, P603, DOI 10.1016/0022-2836(94)90035-3; ZHOU YH, 1994, EMBO J, V13, P4549, DOI 10.1002/j.1460-2075.1994.tb06776.x; ZHOU YH, 1993, P NATL ACAD SCI USA, V90, P6081, DOI 10.1073/pnas.90.13.6081; ZHOU YH, 1993, CELL, V73, P375, DOI 10.1016/0092-8674(93)90236-J; ZOU C, 1992, MOL MICROBIOL, V6, P2599, DOI 10.1111/j.1365-2958.1992.tb01437.x	49	183	192	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1562	1566		10.1126/science.1076376	http://dx.doi.org/10.1126/science.1076376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202833				2022-12-28	WOS:000177697300060
J	Berman, DM; Karhadkar, SS; Hallahan, AR; Pritchard, JI; Eberhart, CG; Watkins, DN; Chen, JK; Cooper, MK; Taipale, J; Olson, JM; Beachy, PA				Berman, DM; Karhadkar, SS; Hallahan, AR; Pritchard, JI; Eberhart, CG; Watkins, DN; Chen, JK; Cooper, MK; Taipale, J; Olson, JM; Beachy, PA			Medulloblastoma growth inhibition by Hedgehog pathway blockade	SCIENCE			English	Article							PRIMITIVE NEUROECTODERMAL TUMORS; CENTRAL-NERVOUS-SYSTEM; BASAL-CELL CARCINOMAS; SONIC HEDGEHOG; CEREBELLUM; MICE; PROLIFERATION; MUTATIONS; EXPRESSION; NETWORK	Constitutive Hedgehog (Hh) pathway activity is associated with initiation of neoplasia, but its role in the continued growth of established tumors is unclear. Here, we investigate the therapeutic efficacy of the Hh pathway antagonist cyclopamine in preclinical models of medulloblastoma, the most common malignant brain tumor in children. Cyclopamine treatment of murine medulloblastoma cells blocked proliferation in vitro and induced changes in gene expression consistent with initiation of neuronal differentiation and loss of neuronal stem cell like character. This compound also caused regression of murine tumor allografts in vivo and induced rapid death of cells from freshly resected human medulloblastomas, but not from other brain tumors, thus establishing a specific role for Hh pathway activity in medulloblastoma growth.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Univ Washington, Childrens Hosp, Div Clin Res, Fred Hutchinson Canc Res Ctr, Seattle, WA 98105 USA; Univ Washington, Childrens Hosp, Div Pediat Oncol, Seattle, WA 98105 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Fred Hutchinson Cancer Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Olson, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.		Chen, James/G-9972-2011; Hallahan, Andrew R/F-1757-2010; Watkins, David N/I-6113-2013; Karhadkar, Sunil/Y-9235-2019; berman, david/HIR-4177-2022	Chen, James/0000-0002-9220-8436; Karhadkar, Sunil/0000-0001-7943-0203; berman, david/0000-0001-5985-3698				Almqvist PM, 2002, J HISTOCHEM CYTOCHEM, V50, P147, DOI 10.1177/002215540205000203; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; Berman D.S., UNPUB; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Burger PC, 1994, TUMORS CENTRAL NERVO; Cogen PH, 1996, J NEURO-ONCOL, V29, P103, DOI 10.1007/BF00165523; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; KEELER RF, 1968, TERATOLOGY, V1, P5, DOI 10.1002/tera.1420010103; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Reifenberger J, 1998, CANCER RES, V58, P1798; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wetmore C, 2000, CANCER RES, V60, P2239; Wetmore C, 2001, CANCER RES, V61, P513; Wolter M, 1997, CANCER RES, V57, P2581; Xie JW, 1997, CANCER RES, V57, P2369; Zurawel RH, 2000, GENE CHROMOSOME CANC, V28, P77, DOI 10.1002/(SICI)1098-2264(200005)28:1<77::AID-GCC9>3.0.CO;2-Y	30	652	728	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1559	1561		10.1126/science.1073733	http://dx.doi.org/10.1126/science.1073733			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202832				2022-12-28	WOS:000177697300059
J	Berger, A; Loutre, MF				Berger, A; Loutre, MF			An exceptionally long interglacial ahead?	SCIENCE			English	Editorial Material							ICE-SHEET; CLIMATE; CYCLE; AGE; CO2		Catholic Univ Louvain, Inst Astron & Geophys G Lemaitre, B-1348 Louvain, Belgium	Universite Catholique Louvain	Berger, A (corresponding author), Catholic Univ Louvain, Inst Astron & Geophys G Lemaitre, 2 Chemin Cyclotron, B-1348 Louvain, Belgium.	berger@astr.ucl.ac.be	Loutre, Marie-France/L-3594-2018	Loutre, Marie-France/0000-0001-6944-4038				Berger A, 1996, CR ACAD SCI II A, V323, P1; BERGER A, 1991, FUTURE CLIMATE CHANG, P148; BERGER A, IN PRESS MARINE ISOT; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; CROWLEY TJ, 1990, J CLIMATE, V3, P1282, DOI 10.1175/1520-0442(1990)003<1282:ATASGA>2.0.CO;2; Crutzen P., 2000, IGBP GLOBAL CHANGE N, P17, DOI DOI 10.1007/3-540-26590-2_3; Droxler AW, 2000, GLOBAL PLANET CHANGE, V24, P1, DOI 10.1016/S0921-8181(99)00065-X; GALLEE H, 1991, J GEOPHYS RES-ATMOS, V96, P13139, DOI 10.1029/91JD00874; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; IMBRIE J, 1980, SCIENCE, V207, P943, DOI 10.1126/science.207.4434.943; Kukla GJ, 1972, QUATERNARY RES, V2, P261, DOI [10.1016/0033-5894(72)90046-4, DOI 10.1016/0033-5894(72)90046-4]; LEDLEY TS, 1995, GEOPHYS RES LETT, V22, P2745, DOI 10.1029/95GL03027; LOUTRE MF, 1995, GEOPHYS RES LETT, V22, P783, DOI 10.1029/95GL00362; Loutre MF, 2000, CLIMATIC CHANGE, V46, P61, DOI 10.1023/A:1005559827189; OERLEMANS J, 1984, ICE SHEETS CLIMATE; PELTIER WR, 2001, 1 INT C GLOB WARM NE, P256; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SALTZMAN B, 1993, GEOPHYS RES LETT, V20, P1051, DOI 10.1029/93GL01015; Winograd IJ, 1997, QUATERNARY RES, V48, P141, DOI 10.1006/qres.1997.1918	19	188	198	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1287	1288		10.1126/science.1076120	http://dx.doi.org/10.1126/science.1076120			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193773				2022-12-28	WOS:000177573900028
J	Nakatomi, H; Kuriu, T; Okabe, S; Yamamoto, S; Hatano, O; Kawahara, N; Tamura, A; Kirino, T; Nakafuku, M				Nakatomi, H; Kuriu, T; Okabe, S; Yamamoto, S; Hatano, O; Kawahara, N; Tamura, A; Kirino, T; Nakafuku, M			Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors	CELL			English	Article							FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; TRANSIENT FOREBRAIN ISCHEMIA; ADULT MAMMALIAN BRAIN; RAT SPINAL-CORD; STEM-CELLS; SUBVENTRICULAR ZONE; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; GERBIL HIPPOCAMPUS	The adult brain is extremely vulnerable to. various insults. The recent discovery of neural progenitors in adult mammals, however, raises the possibility of repairing damaged tissue by recruiting their latent regenerative potential. Here we show that activation of endogenous progenitors leads to massive regeneration of hippocampal pyramidal neurons after ischemic brain injury. Endogenous progenitors proliferate in response to ischemia and subsequently migrate into the hippocampus to regenerate new neurons. Intraventricular infusion of growth factors markedly augments these responses, thereby increasing the number of newborn neurons. Our studies suggest that regenerated neurons are integrated into the existing brain circuitry and contribute to ameliorating neurological deficits. These results expand the possibility of novel neuronal cell regeneration therapies for stroke and other neurological diseases.	Univ Tokyo, Grad Sch Med, Dept Neurobiol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Neurosurg, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Orthoped Surg, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Med & Dent Univ, Dept Anat & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; Japan Sci & Technol Cooperat, CREST, Minato Ku, Tokyo 1050011, Japan; Nara Med Univ, Dept Anat, Nara 6348521, Japan; Teikyo Univ, Sch Med, Dept Neurosurg, Itabashi Ku, Tokyo 1738605, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Nara Medical University; Teikyo University	Nakafuku, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurobiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Nakafuku, Masato/J-3068-2013	Okabe, Shigeo/0000-0003-1216-8890; Nakafuku, Masato/0000-0001-7783-9005				Aberg MAI, 2000, J NEUROSCI, V20, P2896; Bethel A, 1997, STROKE, V28, P609, DOI 10.1161/01.STR.28.3.609; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Colbourne F, 1999, STROKE, V30, P662, DOI 10.1161/01.STR.30.3.662; Colbourne F, 1999, J NEUROSCI, V19, P4200; Craig CG, 1996, J NEUROSCI, V16, P2649; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kiprianova I, 1999, EXP NEUROL, V159, P511, DOI 10.1006/exnr.1999.7109; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P209, DOI 10.1007/BF00691854; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Liu JL, 1998, J NEUROSCI, V18, P7768; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Okabe S, 1998, J NEUROSCI, V18, P4177; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rietze R, 2000, J COMP NEUROL, V424, P397; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319; Suda Y, 2001, DEVELOPMENT, V128, P2433; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Weiss S, 1996, J NEUROSCI, V16, P7599; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yonemori F, 1999, J CEREBR BLOOD F MET, V19, P483, DOI 10.1097/00004647-199905000-00002; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang WD, 2000, HIPPOCAMPUS, V10, P512, DOI 10.1002/1098-1063(2000)10:5<512::AID-HIPO2>3.0.CO;2-M	38	1178	1283	4	110	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 23	2002	110	4					429	441		10.1016/S0092-8674(02)00862-0	http://dx.doi.org/10.1016/S0092-8674(02)00862-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202033	Bronze			2022-12-28	WOS:000177653200005
J	Verghese, A				Verghese, A			The physician as storyteller	ANNALS OF INTERNAL MEDICINE			English	Letter									Texas Tech Hlth Sci Ctr, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University Health Science Center	Verghese, A (corresponding author), Texas Tech Hlth Sci Ctr, El Paso, TX 79905 USA.							BERGER J, 1981, FORTUNATE MAN, P55; BERGER J, 1981, FORTUNATE MAN, P75; BRANDE D, 1981, BECOMING WRITER; Brody H., 1987, STORIES SICKNESS; Brooks P., 1992, READING PLOT DESIGN, P3; BURROWAY J, 1992, WRITING FICTION GUID, P47; BURROWAY J, 1992, WRITING FICTION GUID, P39; CHARON R, 1995, ANN INTERN MED, V122, P599, DOI 10.7326/0003-4819-122-8-199504150-00008; Charon R., 1993, EMPATHY PRACTICE MED, P147; CHEKHOV TH, 1988, BALLANTINE, P332; Forster E. M., 1954, ASPECTS NOVEL; FOWLES J, 1992, PLEASURE READING, P74; FRANK AW, 1995, WOUNDED STORYTELLER, P6; Gardner John, 1984, ART FICTION NOTES CR; Gardner John, 1978, ON MORAL FICTION; Hawkins A.H., 1997, STORIES THEIR LIMITS, P153; JONES AH, 1994, LIT MED, V13, P190; KRISH G, 1989, J CLIN MICROBIOL, V27, P2869, DOI 10.1128/JCM.27.12.2869-2870.1989; Mishler EG, 1984, DISCOURSE MED DIALEC; Montgomery Hunter K, 1991, DOCTORS STORIES NARR; OConnor Flannery, 1971, COMPLETE STORIES, P117; OZICK C, 1989, METAPHOR MEMORY, P265; PERCY W, 1977, LANCELOT, P3; VERGHESE A, 1999, TALK             MAR, P106; Wear D, 1997, Pharos Alpha Omega Alpha Honor Med Soc, V60, P22	25	51	54	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2001	135	11					1012	1017		10.7326/0003-4819-135-11-200112040-00028	http://dx.doi.org/10.7326/0003-4819-135-11-200112040-00028			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498PN	12229928				2022-12-28	WOS:000172520000023
J	Bloom, BJ; Smith, RN; Mark, EJ; Playford, DA; McGillivray, TE; Ang, HTS; Steele, DJR				Bloom, BJ; Smith, RN; Mark, EJ; Playford, DA; McGillivray, TE; Ang, HTS; Steele, DJR			A 17-year-old boy with acute mitral regurgitation and pulmonary edema - The antiphospholipid-antibody syndrome, with vascular thrombosis and infarction of the posterior mitral-valve papillary muscle, causing acute mitral regurgitation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SYSTEMIC LUPUS-ERYTHEMATOSUS; JUVENILE RHEUMATOID-ARTHRITIS; INFECTIVE ENDOCARDITIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; INTRAVASCULAR COAGULATION; REVISED CRITERIA; DISEASE; CHILDHOOD; ONSET; CLASSIFICATION		Hasbro Childrens Hosp, Providence, RI USA; Brown Med Sch, Providence, RI USA	Hasbro Children's Hospital; Brown University	Bloom, BJ (corresponding author), Hasbro Childrens Hosp, Providence, RI USA.							AlarconSegovia D, 1996, J RHEUMATOL, V23, P1319; Bloom BJ, 1998, J RHEUMATOL, V25, P1620; BRAY VJ, 1994, SEMIN ARTHRITIS RHEU, V24, P222; CASSIDY JT, 1995, TXB PEDIAT RHEUMATOL, P178; DAJANI AS, 1993, CIRCULATION, V87, P302; DANIEL WG, 1995, NEW ENGL J MED, V332, P1268, DOI 10.1056/NEJM199505113321906; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; El-Said GM, 1990, SCI PRACTICE PEDIAT, P1485; ERBEL R, 1988, EUR HEART J, V9, P43; Flachskampf FA, 2000, HEART, V84, P3, DOI 10.1136/heart.84.1.3; Han RK, 2000, CAN MED ASSOC J, V162, P807; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; KAHN MA, 1998, RHEUMATOLOGY, V2; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; KIRKLIN JW, 1993, CARDIAC SURG, P415; MATTESON EL, 1998, RHEUMATOLOGY, V1; Netzer ROM, 2000, HEART, V84, P25, DOI 10.1136/heart.84.1.25; OZEN S, 1992, J PEDIATR-US, V120, P206, DOI 10.1016/S0022-3476(05)80428-7; Park CW, 1998, NEPHROL DIAL TRANSPL, V13, P3202, DOI 10.1093/ndt/13.12.3202; Quismorio Francisco P. Jr., 1993, P332; SCOTT JP, 1985, ARTHRITIS RHEUM, V28, P256, DOI 10.1002/art.1780280304; STEPHAN JL, 1993, CLIN EXP RHEUMATOL, V11, P451; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TUCKER LB, 1995, BRIT J RHEUMATOL, V34, P866; VONKEMP K, 1987, J RHEUMATOL, V14, P145; WILLIAMS RC, 1998, RHEUMATOLOGY, V2	26	5	5	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					921	928		10.1056/NEJMcpc020115	http://dx.doi.org/10.1056/NEJMcpc020115			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239262				2022-12-28	WOS:000178040700009
J	Harich, SA; Dai, DX; Wang, CC; Yang, XM; Chao, SD; Skodje, RT				Harich, SA; Dai, DX; Wang, CC; Yang, XM; Chao, SD; Skodje, RT			Forward scattering due to slow-down of the intermediate in the H+HD -> D+H-2 reaction	NATURE			English	Article							DIFFERENTIAL CROSS-SECTIONS; TRANSITION-STATE; SPECTRAL QUANTIZATION; DYNAMICS; RESONANCES	Quantum dynamical processes near the energy barrier that separates reactants from products influence the detailed mechanism by which elementary chemical reactions occur. In fact, these processes can change the product scattering behaviour from that expected from simple collision considerations, as seen in the two classical reactions F + H-2 --> HF + H and H + H-2 --> H-2 + H and their isotopic variants. In the case of the F + HD reaction, the role of a quantized trapped Feshbach resonance state had been directly determined(1), confirming previous conclusions(2) that Feshbach resonances cause state-specific forward scattering of product molecules. Forward scattering has also been observed in the H + D-2 --> HD + D reaction(3,4) and attributed to a time-delayed mechanism(3,5-7). But despite extensive experimental(8-12) and theoretical(13-18) investigations, the details of the mechanism remain unclear. Here we present crossed-beam scattering experiments and quantum calculations on the H + HD --> H-2 + D reaction. We find that the motion of the system along the reaction coordinate slows down as it approaches the top of the reaction barrier, thereby allowing vibrations perpendicular to the reaction coordinate and forward scattering. The reaction thus proceeds, as previously suggested(7), through a well-defined 'quantized bottleneck state' different from the trapped Feshbach resonance states observed before.	Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan; Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Peoples R China; Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; Inst Mol Sci, Okazaki, Aichi 4448585, Japan; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Academia Sinica - Taiwan; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; National Taiwan University; National Tsing Hua University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); University of Colorado System; University of Colorado Boulder	Skodje, RT (corresponding author), Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan.	skodje@spot.colorado.edu	Yang, Xueming/C-8764-2013					Allison TC, 2000, CHEM PHYS LETT, V327, P439, DOI 10.1016/S0009-2614(00)00885-X; Althorpe SC, 2002, NATURE, V416, P67, DOI 10.1038/416067a; AOIZ FJ, 1992, J CHEM PHYS, V97, P7423, DOI 10.1063/1.463514; Boothroyd AI, 1996, J CHEM PHYS, V104, P7139, DOI 10.1063/1.471430; BUNTIN SA, 1987, J CHEM PHYS, V87, P1443, DOI 10.1063/1.453275; Chao SD, 2001, CHEM PHYS LETT, V336, P364, DOI 10.1016/S0009-2614(01)00105-1; Chatfield DC, 2000, J CHEM PHYS, V112, P8387, DOI 10.1063/1.481443; CHATFIELD DC, 1992, J PHYS CHEM-US, V96, P2414, DOI 10.1021/j100185a007; CUCCARO SA, 1989, CHEM PHYS LETT, V157, P440, DOI 10.1016/0009-2614(89)87278-1; DMELLO M, 1991, J CHEM PHYS, V94, P5985, DOI 10.1063/1.460432; Fernandez-Alonso F, 2001, J CHEM PHYS, V115, P4534, DOI 10.1063/1.1390505; Fernandez-Alonso F, 2000, ANGEW CHEM INT EDIT, V39, P2748, DOI 10.1002/1521-3773(20000804)39:15<2748::AID-ANIE2748>3.3.CO;2-#; Goldberger M. L., 1964, COLLISION THEORY; Harich SA, 2002, J CHEM PHYS, V116, P4769, DOI 10.1063/1.1461818; KITSOPOULOS TN, 1993, SCIENCE, V260, P1605, DOI 10.1126/science.260.5114.1605; KLINER DAV, 1991, J CHEM PHYS, V95, P1648, DOI 10.1063/1.461016; KUPPERMANN A, 1976, J CHEM PHYS, V65, P4596, DOI 10.1063/1.432916; Liu XH, 2000, SCIENCE, V289, P1536, DOI 10.1126/science.289.5484.1536; NEUMARK DM, 1984, PHYS REV LETT, V53, P226, DOI 10.1103/PhysRevLett.53.226; SADEGHI R, 1995, J CHEM PHYS, V102, P193, DOI 10.1063/1.469391; Schnieder L, 1997, J CHEM PHYS, V107, P6175, DOI 10.1063/1.474283; SCHNIEDER L, 1995, SCIENCE, V269, P207, DOI 10.1126/science.269.5221.207; SCHNIEDER L, 1990, J CHEM PHYS, V92, P7027, DOI 10.1063/1.458243; SKODJE RT, 1994, J CHEM PHYS, V101, P1725, DOI 10.1063/1.467728; Skodje RT, 2000, PHYS REV LETT, V85, P1206, DOI 10.1103/PhysRevLett.85.1206; Skouteris D, 2000, COMPUT PHYS COMMUN, V133, P128, DOI 10.1016/S0010-4655(00)00167-3; ZHANG JZH, 1989, J CHEM PHYS, V91, P1528, DOI 10.1063/1.457650; ZHAO MS, 1990, J PHYS CHEM-US, V94, P7074, DOI 10.1021/j100381a027; ZHAO MS, 1989, J CHEM PHYS, V91, P5302, DOI 10.1063/1.457577	29	170	174	8	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					281	284		10.1038/nature01068	http://dx.doi.org/10.1038/nature01068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239562				2022-12-28	WOS:000178056300040
J	Pierrehumbert, RT				Pierrehumbert, RT			The hydrologic cycle in deep-time climate problems	NATURE			English	Review							NEOPROTEROZOIC SNOWBALL EARTH; CARBON-DIOXIDE CLOUDS; LAST GLACIAL MAXIMUM; SURFACE-TEMPERATURE; PHANEROZOIC TIME; ATMOSPHERIC CO2; REVISED MODEL; ICE SHEETS; SIMULATION; RADIATION	Hydrology refers to the whole panoply of effects the water molecule has on climate and on the land surface during its journey there and back again between ocean and atmosphere. On its way, it is cycled through vapour, cloud water, snow, sea ice and glacier ice, as well as acting as a catalyst for silicate-carbonate weathering reactions governing atmospheric carbon dioxide. Because carbon dioxide affects the hydrologic cycle through temperature, climate is a pas des deux between carbon dioxide and water, with important guest appearances by surface ice cover.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Pierrehumbert, RT (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.		Zachos, James C/A-7674-2008	Zachos, James C/0000-0001-8439-1886; Pierrehumbert, Raymond/0000-0002-5887-1197				BARRON EJ, 1995, PALEOCEANOGRAPHY, V10, P953, DOI 10.1029/95PA01624; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; BERNER RA, 1994, AM J SCI, V294, P56, DOI 10.2475/ajs.294.1.56; BRIEGLEB BP, 1992, J GEOPHYS RES-ATMOS, V97, P7603, DOI 10.1029/92JD00291; Broccoli AJ, 2000, J CLIMATE, V13, P951, DOI 10.1175/1520-0442(2000)013<0951:TCATLG>2.0.CO;2; Bush ABG, 1997, PALEOCEANOGRAPHY, V12, P495, DOI 10.1029/97PA00721; CALDEIRA K, 1992, NATURE, V359, P226, DOI 10.1038/359226a0; Chandler MA, 2000, J GEOPHYS RES-ATMOS, V105, P20737, DOI 10.1029/2000JD900221; CHRISTIEBLICK N, 1999, SCIENCE, V284, P1087, DOI DOI 10.1126/SCIENCE.284.5417.1087A; DahlJensen D, 1998, SCIENCE, V282, P268, DOI 10.1126/science.282.5387.268; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; Hall NMJ, 1996, CLIM DYNAM, V12, P497, DOI 10.1007/BF02346821; Hay WW, 1997, GEOL RUNDSCH, V86, P471, DOI 10.1007/s005310050155; Held IM, 2000, ANNU REV ENERG ENV, V25, P441, DOI 10.1146/annurev.energy.25.1.441; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HOFFMAN PF, IN PRESS TERRA NOVA; Huber BT, 1998, SCIENCE, V282, P2199, DOI 10.1126/science.282.5397.2199; Huber M, 2001, GEOPHYS RES LETT, V28, P3481, DOI 10.1029/2001GL012943; Huber M, 2000, PALEOCEANOGRAPHY, V15, P443, DOI 10.1029/1999PA000455; Hyde WT, 2000, NATURE, V405, P425, DOI 10.1038/35013005; Jenkins GS, 1999, GEOPHYS RES LETT, V26, P2263, DOI 10.1029/1999GL900538; KASTING JF, 1984, ICARUS, V57, P335, DOI 10.1016/0019-1035(84)90122-2; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; Kiehl JT, 1998, J CLIMATE, V11, P1131, DOI 10.1175/1520-0442(1998)011<1131:TNCFAR>2.0.CO;2; KIRKDAVIDOFF DB, IN PRESS GEOPHYS RES; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Lunine JI, 1998, PLANET SPACE SCI, V46, P1099, DOI 10.1016/S0032-0633(97)00221-3; MANABE S, 1985, J GEOPHYS RES-ATMOS, V90, P2167, DOI 10.1029/JD090iD01p02167; McKay CP, 2000, GEOPHYS RES LETT, V27, P2153, DOI 10.1029/2000GL008525; McMechan ME, 2000, B CAN PETROL GEOL, V48, P246, DOI 10.2113/48.3.246; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Pierrehumbert RT, 1998, J ATMOS SCI, V55, P1897, DOI 10.1175/1520-0469(1998)055<1897:OTSGEO>2.0.CO;2; Pierrehumbert RT, 1999, GEOPHYS MONOGR SER, V112; Poulsen CJ, 2001, GEOPHYS RES LETT, V28, P1575, DOI 10.1029/2000GL012058; Sokolov AP, 1998, CLIM DYNAM, V14, P291, DOI 10.1007/s003820050224; Trenberth KE, 2001, J CLIMATE, V14, P3433, DOI 10.1175/1520-0442(2001)014<3433:EOMAAO>2.0.CO;2; Vogelezang DHP, 1996, BOUND-LAY METEOROL, V81, P245, DOI 10.1007/BF02430331; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WARREN SG, IN PRESS J GEOPHYS R	42	150	160	6	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					191	198		10.1038/nature01088	http://dx.doi.org/10.1038/nature01088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226673				2022-12-28	WOS:000177931200048
J	Hartwig, JF				Hartwig, JF			Raising the bar for the "Perfect reaction"	SCIENCE			English	Editorial Material							INTERNAL OLEFINS; HYDROFORMYLATION; ALDEHYDES; CATALYSTS		Yale Univ, Dept Chem, New Haven, CT 06422 USA	Yale University	Hartwig, JF (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06422 USA.	john.hartwig@yale.edu						BILLIG E, 1987, Patent No. 213639; Breit B, 1997, J CHEM SOC PERK T 1, P2681, DOI 10.1039/a705249i; BURKE PM, 1997, Patent No. 9733854; Chenier P. J., 1992, SURVEY IND CHEM; Devon T. J., 1987, U.S. Patent, Patent No. [4694109, 4,694,109 A]; Eilbracht P, 1999, CHEM REV, V99, P3329, DOI 10.1021/cr970413r; Hayes KS, 2001, APPL CATAL A-GEN, V221, P187, DOI 10.1016/S0926-860X(01)00813-4; Huheey J.E., 1993, INORGANIC CHEM PRINC, P522; Klein H, 2001, ANGEW CHEM INT EDIT, V40, P3408, DOI 10.1002/1521-3773(20010917)40:18<3408::AID-ANIE3408>3.0.CO;2-A; Mullineaux R. D., 1966, US, Patent No. [3239569 A, 3239569]; Seayad A, 2002, SCIENCE, V297, P1676, DOI 10.1126/science.1074801; SLAUGH LH, 1966, Patent No. 3239570; Tararov VI, 2000, CHEM COMMUN, P1867, DOI 10.1039/b005777k; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; van der Veen LA, 1999, ANGEW CHEM INT EDIT, V38, P336, DOI 10.1002/(SICI)1521-3773(19990201)38:3<336::AID-ANIE336>3.0.CO;2-P; Wender PA, 1996, CHEM REV, V96, P1, DOI 10.1021/cr9500803; Zimmermann B, 1999, ANGEW CHEM INT EDIT, V38, P2372, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2372::AID-ANIE2372>3.0.CO;2-H	17	36	36	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587					1653	1654		10.1126/science.1076371	http://dx.doi.org/10.1126/science.1076371			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215631				2022-12-28	WOS:000177819100032
J	Migliari, S; Fender, R; Mendez, M				Migliari, S; Fender, R; Mendez, M			Iron emission lines from extended X-ray jets in SS 433: Reheating of atomic nuclei	SCIENCE			English	Article							RADIO; SS-433; SS433; SYSTEM	Powerful relativistic jets are among the most ubiquitous and energetic observational consequences of accretion around supermassive black holes in active galactic nuclei and neutron stars and stellar-mass black holes in x-ray binary (XRB) systems. But despite more than three decades of study, the structure and composition of these jets remain unknown. Here we present spatially resolved x-ray spectroscopy of arc second-scale x-ray jets from XRB SS 433 analyzed with the Chandra advanced charge-coupled device imaging spectrometer. These observations reveal evidence for a hot continuum and Doppler-shifted iron emission lines from spatially resolved regions. Apparently, in situ reheating of the baryonic component of the jets takes place in a flow that moves with relativistic bulk velocity even more than 100 days after launch from the binary core.	Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; SRON, Natl Inst Space Res, NL-3584 CA Utrecht, Netherlands	University of Amsterdam	Migliari, S (corresponding author), Univ Amsterdam, Astron Inst Anton Pannekoek, Kruislaan 403, NL-1098 SJ Amsterdam, Netherlands.		Mendez, Mariano/C-8011-2012	Mendez, Mariano/0000-0003-2187-2708				ABELL GO, 1979, NATURE, V279, P701, DOI 10.1038/279701a0; BICKNELL GV, 1982, ASTROPHYS J, V262, P511, DOI 10.1086/160444; BRINKMANN W, 1991, ASTRON ASTROPHYS, V241, P112; Brinkmann W, 1996, ASTRON ASTROPHYS, V312, P306; Dolan JF, 1997, ASTRON ASTROPHYS, V327, P648; Dubner GM, 1998, ASTRON J, V116, P1842, DOI 10.1086/300537; Eikenberry SS, 2001, ASTROPHYS J, V561, P1027, DOI 10.1086/323380; Harris DE, 2002, ASTROPHYS J, V565, P244, DOI 10.1086/324544; HJELLMING RM, 1981, NATURE, V290, P100, DOI 10.1038/290100a0; Kotani T, 1996, PUBL ASTRON SOC JPN, V48, P619, DOI 10.1093/pasj/48.4.619; Marshall HL, 2002, ASTROPHYS J, V564, P941, DOI 10.1086/324398; SHAHAM J, 1981, VISTAS ASTRON, V25, P217, DOI 10.1016/0083-6656(81)90063-5; Spada M, 2001, MON NOT R ASTRON SOC, V325, P1559, DOI 10.1046/j.1365-8711.2001.04557.x	13	101	104	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1673	1676		10.1126/science.1073660	http://dx.doi.org/10.1126/science.1073660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215639	Green Submitted			2022-12-28	WOS:000177819100041
J	Otto, A; White, JD; Simoneit, BRT				Otto, A; White, JD; Simoneit, BRT			Natural product terpenoids in Eocene and Miocene conifer fossils	SCIENCE			English	Article							CUPRESSACEAE; GERMANY; BASIN	Numerous saturated and aromatic hydrocarbons, but not polar compounds, originating from plants and microorganisms (biomarkers) have been reported in sediments, coals, and petroleum. Here we describe natural product terpenoids found in two fossil conifers, Taxodium balticum (Eocene) and Glyptostrobus oregonensis (Miocene). A similar terpenoid pattern is also observed in extant Taxodium distichum. The preservation of characteristic terpenoids (unaltered natural products) in the fossil conifers supports their systematic assignment to the Cypress family (Cupressaceae sensu lato). The results also show that fossil conifers can contain polar terpenoids, which are valuable markers for (paleo) chemosystematics and phylogeny.	Oregon State Univ, Environm & Petr Geochem Grp, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Otto, A (corresponding author), Univ Frankfurt, Inst Mineral Umweltanalyt, Georg Voigt Str 14, D-60054 Frankfurt, Germany.		SIMONEIT, BERND R. T./A-2008-2013					Baset ZH, 1980, ADV ORG GEOCHEM, P619; BRUNSFELD SJ, 1994, SYST BOT, V19, P253, DOI 10.2307/2419600; ENZELL CR, 1967, ARK KEMI, V26, P425; ERDTMAN H, 1966, PROGR CHEM ORGANIC N, V24, P207; ERDTMAN H, 1968, RECENT ADV PHYTOCHEM, V1, P1; Gadek PA, 2000, AM J BOT, V87, P1044, DOI 10.2307/2657004; HEGNAUER R., 1986, CHEMOTAXONOMIE PFLAN, V7; HEGNAUER R., 1962, CHEMOTAXONOMIE PFLAN, V1; HIROSE Y, 1983, TETRAHEDRON LETT, V24, P1535, DOI 10.1016/S0040-4039(00)81702-5; KUPCHAN SM, 1969, J ORG CHEM, V34, P3912, DOI 10.1021/jo01264a036; Mai D. H., 1985, ABHANDLUNGEN STAATLI, V38, P1; Otto A, 1997, ORG GEOCHEM, V26, P105, DOI 10.1016/S0146-6380(96)00133-7; Otto A, 2001, GEOCHIM COSMOCHIM AC, V65, P3505, DOI 10.1016/S0016-7037(01)00693-7; Otto A, 2001, BOT REV, V67, P141, DOI 10.1007/BF02858076; OTTO A, UNPUB; Peters K. E., 1993, BIOMARKER GUIDE INTE; SHIBUYA T, 1992, PHYTOCHEMISTRY, V31, P4289, DOI 10.1016/0031-9422(92)80460-V; Simoneit B.R.T., 1998, HDB ENV CHEM, V3, P175; Simoneit B. R. T., 1986, BIOL MARKERS SEDIMEN, P43; Simoneit BRT, 1999, ENVIRON SCI POLLUT R, V6, P159, DOI 10.1007/BF02987621; Smiley C. J., 1985, LATE CENOZOIC HIST P, P95; STREIBL M, 1969, ORGANIC GEOCHEMISTRY, P401; SU WC, 1993, PHYTOCHEMISTRY, V34, P779, DOI 10.1016/0031-9422(93)85358-X; TEGELAAR EW, 1989, GEOCHIM COSMOCHIM AC, V53, P3103, DOI 10.1016/0016-7037(89)90191-9; Tissot B.P., 1984, PETROLEUM FORMATION, DOI 10.1007/978-3-642-96446-6; WANG TG, 1990, FUEL, V69, P12, DOI 10.1016/0016-2361(90)90252-L	26	70	74	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1543	1545		10.1126/science.1074225	http://dx.doi.org/10.1126/science.1074225			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202827				2022-12-28	WOS:000177697300054
J	Stebbins, JF				Stebbins, JF			Dynamics in ceramics	SCIENCE			English	Editorial Material							SITE EXCHANGE; NMR; O-17		Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94025 USA	Stanford University	Stebbins, JF (corresponding author), Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94025 USA.	stebbins@stanford.edu		Stebbins, Jonathan/0000-0002-2384-6637				Gervais C, 2001, J PHYS CHEM B, V105, P1971, DOI 10.1021/jp003519q; Kim N, 2002, SCIENCE, V297, P1317, DOI 10.1126/science.1074130; MASSIOT D, 1995, J PHYS CHEM-US, V99, P16455, DOI 10.1021/j100044a038; Navrotsky A, 1999, SCIENCE, V284, P1788, DOI 10.1126/science.284.5421.1788; STEBBINS JF, 1992, CHEM GEOL, V96, P371, DOI 10.1016/0009-2541(92)90066-E; Stebbins JF, 2001, J NON-CRYST SOLIDS, V293, P67, DOI 10.1016/S0022-3093(01)00653-6; Stebbins JF, 1996, AM MINERAL, V81, P1315; STEBBINS JF, 1989, PHYS CHEM MINER, V16, P763, DOI 10.1007/BF00209699; Wang F, 1998, J AM CHEM SOC, V120, P970, DOI 10.1021/ja972312g; XU Z, 1995, SCIENCE, V270, P1332, DOI 10.1126/science.270.5240.1332	11	8	8	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1285	1287		10.1126/science.1075881	http://dx.doi.org/10.1126/science.1075881			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193772				2022-12-28	WOS:000177573900027
J	Hjern, A; Lindblad, F; Vinnerljung, B				Hjern, A; Lindblad, F; Vinnerljung, B			Suicide, psychiatric illness, and social maladjustment in intercountry adoptees in Sweden: a cohort study	LANCET			English	Article							MENTAL-HEALTH; INTERNATIONAL ADOPTEES; LOWER THRESHOLD; FOLLOW-UP; ADOLESCENTS; CHILDREN; ATTACHMENT; ADJUSTMENT; ADOPTION; PARENTS	Background Many intercountry adoptees are reaching adolescence in western Europe and the USA, and the mental health and social adjustment of these individuals as adolescents and young adults has now become an important issue. We aimed to assess mental health disorders and social maladjustment in adolescence and young adulthood in intercountry adoptees in Sweden. Method Our data was obtained from the Swedish national registers for the cohort born in 1970-79. We used multivariate Cox's regression models of person-years to compare indicators of suicide death (1986-95), court sentences (1986-93), and discharges for psychiatric illness, suicide attempts, and substance abuse (1987-94) in 11320 intercountry adoptees with 2343 Swedish-born siblings, 4006 immigrant children, and a general population of 853 419 Swedish-born residents. Findings After adjustment for major sociodemographic confounders, intercountry adoptees were more likely than other Swedish-born children to die from suicide (odds ratio 3.6, 95% Cl 2.1-5.9); attempt suicide (3.6, 3.1-4.2); be admitted for a psychiatric disorder (3.2, 2.9-3.6), drug abuse (5.2, 2.9-9.3) or alcohol abuse (2.6, 2.0-3.3); or to commit a crime (1.6, 1.5-1.7). Siblings in adoptive homes had lower odds ratios for most outcomes than did adoptees, whereas adoptees and immigrant children had much the same odds ratios. Interpretation Adoptees in Sweden have a high risk for severe mental health problems and social maladjustment in adolescence and young adulthood. We advise professionals to give appropriate consideration to the high risk of suicide in patients who are intercountry adoptees.	Swedish Natl Board Hlth & Welf, Ctr Epidemiol, S-10630 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Clin Sci, Stockholm, Sweden; Karolinska Inst, Dept Publ Hlth Sci, Div Psychosocial Factors & Hlth, Stockholm, Sweden; Natl Board Hlth & Welf, Ctr Evaluat Social Serv, Stockholm, Sweden	National Board of Health & Welfare; Karolinska Institutet; Karolinska Institutet; National Board of Health & Welfare	Hjern, A (corresponding author), Swedish Natl Board Hlth & Welf, Ctr Epidemiol, S-10630 Stockholm, Sweden.	anders.hjern@sos.se		Hjern, Anders/0000-0002-1645-2058				ALLEBECK P, 1991, SCAND J SOC MED, V19, P242, DOI 10.1177/140349489101900405; BAGLEY C, 1990, INTERCOUNTRY ADOPTIO; BERRY M, 1990, CHILD WELFARE, V69, P209; Bieman HJMV, 1995, J CHILD PSYCHOL PSYC, V36, P1411, DOI 10.1111/j.1469-7610.1995.tb01672.x; BOHMAN M, 1979, ACTA PSYCHIAT SCAND, V60, P106, DOI 10.1111/j.1600-0447.1979.tb00269.x; BOTVAR P, 1995, NAR OST MOTER VEST U; Brand AE, 1999, J CHILD PSYCHOL PSYC, V40, P1221, DOI 10.1111/1469-7610.00538; Cederblad M, 1999, J CHILD PSYCHOL PSYC, V40, P1239, DOI 10.1017/S0021963099004746; Cederblad M, 1991, Lakartidningen, V88, P1081; Cederblad M, 1981, Lakartidningen, V78, P816; Chisholm K, 1998, CHILD DEV, V69, P1092, DOI 10.1111/j.1467-8624.1998.tb06162.x; GOLOMBOK S, 1995, CHILD DEV, V66, P285, DOI 10.2307/1131578; HOKSBERGEN R, 1990, INTERCOUNTRY ADOPTIO; Ingersoll BD, 1997, ADOPTION Q, V1, P57, DOI [DOI 10.1300/J145V01N01_, DOI 10.1300/J145V01N01_04]; KIM SP, 1979, CHILD WELFARE, V58, P419; Kim WJ, 1999, CHILD PSYCHIAT HUM D, V29, P221, DOI 10.1023/A:1022665024514; LEWIS G, 1990, BRIT J PSYCHIAT, V157, P410, DOI 10.1192/bjp.157.3.410; Miller BC, 2000, CHILD DEV, V71, P1458, DOI 10.1111/1467-8624.00239; Miller BC, 2000, J AM ACAD CHILD PSY, V39, P1504, DOI 10.1097/00004583-200012000-00011; O'Connor TG, 2000, J AM ACAD CHILD PSY, V39, P703, DOI 10.1097/00004583-200006000-00008; PROOS LA, 1992, UPSALA J MED SCI, V97, P79, DOI 10.3109/03009739209179285; RORBECK M, 1990, INTERCOUNTRY ADOPTIO; ROSENTHAL JA, 1988, CHILD YOUTH SERV REV, V10, P101, DOI 10.1016/0190-7409(88)90031-X; RUSHTON A, 1986, ADOPTION FOSTERING, V10, P54; SCARR S, 1982, SIBLING RELATIONSHIP; Sharma AR, 1998, CHILD DEV, V69, P791, DOI 10.1111/j.1467-8624.1998.00791.x; *STAT S, 1982, SOC CLASS SEI; Stattin H, 1996, DEV PSYCHOPATHOL, V8, P617, DOI 10.1017/S0954579400007331; THOMAS CS, 1993, BRIT J PSYCHIAT, V163, P91, DOI 10.1192/bjp.163.1.91; VERHULST FC, 1992, J AM ACAD CHILD PSY, V31, P518, DOI 10.1097/00004583-199205000-00020; WARREN SB, 1992, J AM ACAD CHILD PSY, V31, P512, DOI 10.1097/00004583-199205000-00019	31	208	210	0	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					443	448		10.1016/S0140-6736(02)09674-5	http://dx.doi.org/10.1016/S0140-6736(02)09674-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582GZ	12241716				2022-12-28	WOS:000177342900010
J	Ensing, G				Ensing, G			Cardiac complications with vertically transmitted HIV infection	LANCET			English	Editorial Material							PROSPECTIVE (PCHIV)-C-2-H-2 MULTICENTER; CHILDREN		Univ Michigan, Congenital Heart Ctr Ann Arbor, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ensing, G (corresponding author), Univ Michigan, Congenital Heart Ctr Ann Arbor, Ann Arbor, MI 48109 USA.							Hornberger LK, 2000, AM HEART J, V140, P575, DOI 10.1067/mhj.2000.109645; Lipshultz SE, 2000, CIRCULATION, V102, P1542, DOI 10.1161/01.CIR.102.13.1542; Lipshultz SE, 2001, CIRCULATION, V104, P310, DOI 10.1161/01.CIR.104.3.310; Saidi AS, 2000, PEDIATR CARDIOL, V21, P189, DOI 10.1007/s002460010038; Starc TJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.2.e14	5	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					350	351		10.1016/S0140-6736(02)09600-9	http://dx.doi.org/10.1016/S0140-6736(02)09600-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241769				2022-12-28	WOS:000177255600002
J	Bach, JF				Bach, JF			Mechanisms of disease: The effect of infections on susceptibility to autoimmune and allergic diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DEPENDENT DIABETES-MELLITUS; T-CELL RESPONSES; CALMETTE-GUERIN VACCINATION; INFLAMMATORY-BOWEL-DISEASE; MULTIPLE-SCLEROSIS; ATOPIC-DERMATITIS; HAY-FEVER; NOD MICE; AIRWAY HYPERRESPONSIVENESS; ENVIRONMENTAL INFLUENCE		Hop Necker Enfants Malad, INSERM, U25, Inst Rech Necker Enfants Malad, F-75743 Paris 15, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bach, JF (corresponding author), Hop Necker Enfants Malad, INSERM, U25, Inst Rech Necker Enfants Malad, 161 Rue Sevres, F-75743 Paris 15, France.	bach@necker.fr						ABERG N, 1995, CLIN EXP ALLERGY, V25, P815, DOI 10.1111/j.1365-2222.1995.tb00023.x; Adlerberth I, 1998, EPIDEMIOL INFECT, V121, P587, DOI 10.1017/S0950268898001484; ADLERBERTH I, 1991, ACTA PAEDIATR SCAND, V80, P602, DOI 10.1111/j.1651-2227.1991.tb11917.x; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Allen HF, 1999, DIABETES CARE, V22, P1703, DOI 10.2337/diacare.22.10.1703; ALSABBAGH A, 1994, EUR J IMMUNOL, V24, P2104, DOI 10.1002/eji.1830240926; Anderson HR, 1997, CIBA F SYMP, V206, P190; [Anonymous], 2000, J Pediatr, V137, P470; [Anonymous], 1988, Diabetes, V37, P1113; Arkwright PD, 2001, J ALLERGY CLIN IMMUN, V107, P531, DOI 10.1067/mai.2001.113081; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; BACH JF, 1994, CLIN IMMUNOL IMMUNOP, V72, P156, DOI 10.1006/clin.1994.1122; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Baris D, 2000, CURR OPIN ONCOL, V12, P383, DOI 10.1097/00001622-200009000-00002; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Blanchard JF, 2001, AM J EPIDEMIOL, V154, P328, DOI 10.1093/aje/154.4.328; BLUMBERG RW, 1947, AM J DIS CHILD, V73, P151; BODANSKY HJ, 1992, BRIT MED J, V304, P1020, DOI 10.1136/bmj.304.6833.1020; BONER AL, 1985, ANN ALLERGY, V55, P605; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; BREBAN MA, 1993, CLIN EXP RHEUMATOL, V11, P61; BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; Calcinaro F, 1997, IMMUNOL CELL BIOL, V75, P467, DOI 10.1038/icb.1997.72; CHARPIN D, 1988, REV MAL RESPIR, V5, P109; Cooke A, 1999, PARASITE IMMUNOL, V21, P169, DOI 10.1046/j.1365-3024.1999.00213.x; Cookson WOC, 2002, CHEST, V121, p7S, DOI 10.1378/chest.121.3_suppl.7S-a; Dahlquist G, 1999, DIABETOLOGIA, V42, P51, DOI 10.1007/s001250051112; Daniels G, 1999, BLOOD REV, V13, P14, DOI 10.1016/S0268-960X(99)90020-6; Droste JHJ, 2000, CLIN EXP ALLERGY, V30, P1547; Dubois P, 1998, THORAX, V53, P101, DOI 10.1136/thx.53.2.101; Elliott JF, 1998, DIABETES CARE, V21, P1691, DOI 10.2337/diacare.21.10.1691; Gale EAM, 2002, DIABETOLOGIA, V45, P588, DOI 10.1007/s00125-002-0801-1; Green A, 2000, LANCET, V355, P873; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; GREENWOOD BM, 1970, NATURE, V226, P266, DOI 10.1038/226266a0; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; GUILLET JG, 1987, SCIENCE, V235, P865, DOI 10.1126/science.2433769; Hammond SR, 2000, BRAIN, V123, P968, DOI 10.1093/brain/123.5.968; Hayes CE, 1997, P SOC EXP BIOL MED, V216, P21, DOI 10.3181/00379727-216-44153A; HEMPEL K, 1985, INT ARCH ALLER A IMM, V76, P193, DOI 10.1159/000233691; Hernan MA, 1999, NEUROLOGY, V53, P1711, DOI 10.1212/WNL.53.8.1711; Hobbs K, 1998, AM J RESP CRIT CARE, V158, P1958, DOI 10.1164/ajrccm.158.6.9804011; Hopfenspirger MT, 2001, INT IMMUNOPHARMACOL, V1, P1743, DOI 10.1016/S1567-5769(01)00084-4; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Imai S, 2001, BIOCHEM BIOPH RES CO, V286, P1051, DOI 10.1006/bbrc.2001.5471; Irvine EJ, 2001, SCAND J GASTROENTERO, V36, P2, DOI 10.1080/00365520150218002; Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x; Joussemet M, 1999, GASTROEN CLIN BIOL, V23, P447; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kero J, 2001, J ALLERGY CLIN IMMUN, V108, P781, DOI 10.1067/mai.2001.119557; KIM C, 1991, J EXP MED, V174, P1431, DOI 10.1084/jem.174.6.1431; KONDO N, 1993, CLIN EXP ALLERGY, V23, P44, DOI 10.1111/j.1365-2222.1993.tb02483.x; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Kurtzke JF, 2000, J NEUROVIROL, V6, pS134; LEHMANN D, 1992, J AUTOIMMUN, V5, P675, DOI 10.1016/0896-8411(92)90185-S; LEIBOWITZ U, 1973, ARCH NEUROL-CHICAGO, V29, P107, DOI 10.1001/archneur.1973.00490260051010; LEIBOWITZ U, 1966, J NEUROL NEUROSUR PS, V29, P60, DOI 10.1136/jnnp.29.1.60; LIACOPOULOS P, 1975, PROG ALLERGY, V18, P97; LIKE AA, 1991, DIABETES, V40, P259, DOI 10.2337/diabetes.40.2.259; Lim S, 1998, LANCET, V352, P113, DOI 10.1016/S0140-6736(98)85018-6; LYNCH NR, 1993, J ALLERGY CLIN IMMUN, V92, P404, DOI 10.1016/0091-6749(93)90119-Z; Marie JC, 2001, IMMUNITY, V14, P69, DOI 10.1016/S1074-7613(01)00090-5; Martins TC, 1999, CLIN EXP IMMUNOL, V115, P248, DOI 10.1046/j.1365-2249.1999.00781.x; Mathieu C, 2002, TRENDS MOL MED, V8, P174, DOI 10.1016/S1471-4914(02)02294-3; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; MAZINGUE C, 1986, INT ARCH ALLER A IMM, V80, P347, DOI 10.1159/000234080; McKinney PA, 2000, DIABETIC MED, V17, P236, DOI 10.1046/j.1464-5491.2000.00220.x; MCLEOD JG, 1994, MED J AUSTRALIA, V160, P117, DOI 10.5694/j.1326-5377.1994.tb126553.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moudgil KD, 2001, J IMMUNOL, V166, P6992; Moudgil KD, 2001, J IMMUNOL, V166, P4237, DOI 10.4049/jimmunol.166.6.4237; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Muntoni S, 1997, LANCET, V349, P160, DOI 10.1016/S0140-6736(96)04241-9; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nowak D, 1996, EUR RESPIR J, V9, P2541, DOI 10.1183/09031936.96.09122541; Oksenberg JR, 2001, J NEUROIMMUNOL, V113, P171, DOI 10.1016/S0165-5728(00)00444-6; OLDSTONE MB, 1972, SCIENCE, V175, P784, DOI 10.1126/science.175.4023.784; OLDSTONE MBA, 1990, J EXP MED, V171, P2091, DOI 10.1084/jem.171.6.2091; Olson JK, 2001, VIRAL IMMUNOL, V14, P227, DOI 10.1089/088282401753266756; Ouaissi A, 1995, IMMUNOL LETT, V48, P221, DOI 10.1016/0165-2478(95)02463-8; Oyama N, 2001, J ALLERGY CLIN IMMUN, V107, P153, DOI 10.1067/mai.2001.111142; Papageorgiou N, 1997, RESP MED, V91, P83, DOI 10.1016/S0954-6111(97)90072-X; Patterson CC, 1996, DIABETOLOGIA, V39, P1063, DOI 10.1007/BF00400655; Pessi T, 2000, CLIN EXP ALLERGY, V30, P1804, DOI 10.1046/j.1365-2222.2000.00948.x; POSER S, 1989, NEUROEPIDEMIOLOGY, V8, P207, DOI 10.1159/000110184; Pross H F, 1974, Adv Immunol, V18, P133, DOI 10.1016/S0065-2776(08)60309-0; Pugliatti M, 2001, ACTA NEUROL SCAND, V103, P20, DOI 10.1034/j.1600-0404.2001.00207.x; QIN HY, 1993, J IMMUNOL, V150, P2072; Quintana FJ, 2000, J IMMUNOL, V165, P6148, DOI 10.4049/jimmunol.165.11.6148; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Ristori G, 1999, NEUROLOGY, V53, P1588, DOI 10.1212/WNL.53.7.1588; Robinson DS, 1996, AM J RESP CELL MOL, V14, P113, DOI 10.1165/ajrcmb.14.2.8630259; ROSATI G, 1988, NEUROLOGY, V38, P384, DOI 10.1212/WNL.38.3.384; Rosenbauer J, 2000, LANCET, V356, P1690; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Sai P, 1996, DIABETES METAB, V22, P341; Scorza T, 1999, PARASITE IMMUNOL, V21, P545, DOI 10.1046/j.1365-3024.1999.00254.x; Serreze DV, 2001, J IMMUNOL, V166, P1352, DOI 10.4049/jimmunol.166.2.1352; SHEHADEH NN, 1993, J AUTOIMMUN, V6, P291, DOI 10.1006/jaut.1993.1025; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; SIELING PA, 1993, J IMMUNOL, V150, P5501; Simpson CR, 2002, CLIN EXP ALLERGY, V32, P37, DOI 10.1046/j.0022-0477.2001.01250.x; Skadhauge LR, 1999, EUR RESPIR J, V13, P8, DOI 10.1183/09031936.99.13100899; SONNENBERG A, 1991, GASTROENTEROLOGY, V100, P143, DOI 10.1016/0016-5085(91)90594-B; SOOS JM, 1993, J NEUROIMMUNOL, V43, P39, DOI 10.1016/0165-5728(93)90073-8; Staines A, 1997, ARCH DIS CHILD, V76, P121, DOI 10.1136/adc.76.2.121; Staines A, 1997, INT J EPIDEMIOL, V26, P1307, DOI 10.1093/ije/26.6.1307; Stewart AW, 2001, INT J EPIDEMIOL, V30, P173, DOI 10.1093/ije/30.1.173; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; SWARBRICK ET, 2001, SCAND J GASTROENTERO, V36, pA560; SYMMONS DPM, 1995, LUPUS, V4, P176, DOI 10.1177/096120339500400303; Takanashi S, 1999, EUR RESPIR J, V14, P309, DOI 10.1034/j.1399-3003.1999.14b12.x; TAKANASKI S, 1994, J EXP MED, V180, P711, DOI 10.1084/jem.180.2.711; TAKEI I, 1992, J AUTOIMMUN, V5, P665, DOI 10.1016/0896-8411(92)90184-R; TAMASHIRO VG, 1987, PEDIATR INFECT DIS J, V6, P451, DOI 10.1097/00006454-198705000-00007; Todd JA, 1997, PATHOL BIOL, V45, P219; TOYOTA T, 1986, DIABETES, V35, P496, DOI 10.2337/diab.35.4.496; Tuomilehto J, 1999, DIABETOLOGIA, V42, P655, DOI 10.1007/s001250051212; Upton MN, 2000, BMJ-BRIT MED J, V321, P88, DOI 10.1136/bmj.321.7253.88; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; VERMUND SH, 1988, AM J DIS CHILD, V142, P566, DOI 10.1001/archpedi.1988.02150050104044; Vineis P, 2000, J EPIDEMIOL COMMUN H, V54, P907, DOI 10.1136/jech.54.12.907; von Pirquet C, 1908, DEUT MED WOCHENSCHR, V34, P1297; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; Weinberg EG, 2000, J ALLERGY CLIN IMMUN, V105, P224, DOI 10.1016/S0091-6749(00)90069-1; WEINER HL, 1994, ANNU REV IMMUNOL, V12, P809, DOI 10.1146/annurev.immunol.12.1.809; Wickens K, 1999, CLIN EXP ALLERGY, V29, P766; WILBERZ S, 1991, DIABETOLOGIA, V34, P2, DOI 10.1007/BF00404016; WILLIAMS HC, 1992, CLIN EXP DERMATOL, V17, P385, DOI 10.1111/j.1365-2230.1992.tb00244.x; Woolcock AJ, 1997, CIBA F SYMP, V206, P122; Zinkernagel RM, 2001, NEW ENGL J MED, V345, P1331, DOI 10.1056/NEJMra012493; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	137	1831	1921	9	260	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					911	920		10.1056/NEJMra020100	http://dx.doi.org/10.1056/NEJMra020100			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239261				2022-12-28	WOS:000178040700008
J	Bekoff, M				Bekoff, M			Awareness: Animal reflections	NATURE			English	Article									Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Bekoff, M (corresponding author), Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA.							Bekoff Marc, 2002, MINDING ANIMALS AWAR; Gallup G.G., 2002, THE COGNITIVE ANIMAL, P335; Mitchell RW, 2003, HANDBOOK OF SELF AND IDENTITY, P567; Reiss D, 2002, NATURE, V418, P369, DOI 10.1038/418369a; Rilling J, 2000, AM J PHYS ANTHROPOL, P263; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2001, BIOL PSYCHIAT, V49, P146, DOI 10.1016/S0006-3223(00)00977-X	7	20	20	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					255	255		10.1038/419255a	http://dx.doi.org/10.1038/419255a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239547	Bronze			2022-12-28	WOS:000178056300026
J	Braun-Fahrlander, C; Riedler, J; Herz, U; Eder, W; Waser, M; Grize, L; Maisch, S; Carr, D; Gerlach, F; Bufe, A; Lauener, RP; Schierl, R; Renz, H; Nowak, D; von Mutius, E				Braun-Fahrlander, C; Riedler, J; Herz, U; Eder, W; Waser, M; Grize, L; Maisch, S; Carr, D; Gerlach, F; Bufe, A; Lauener, RP; Schierl, R; Renz, H; Nowak, D; von Mutius, E		Allergy Endotoxin Study Team	Environmental exposure to endotoxin and its relation to asthma in school-age children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOUSE-DUST ENDOTOXIN; AIRBORNE ENDOTOXIN; IMMUNE-RESPONSE; CHILDHOOD; LIFE; RISK; SENSITIZATION; ALLERGY	Background: In early life, the innate immune system can recognize both viable and nonviable parts of microorganisms. Immune activation may direct the immune response, thus conferring tolerance to allergens such as animal dander or tree and grass pollen. Methods: Parents of children who were 6 to 13 years of age and were living in rural areas of Germany, Austria, or Switzerland where there were both farming and nonfarming households completed a standardized questionnaire on asthma and hay fever. Blood samples were obtained from the children and tested for atopic sensitization; peripheral-blood leukocytes were also harvested from the samples for testing. The levels of endotoxin in the bedding used by these children were examined in relation to clinical findings and to the cytokine-production profiles of peripheral-blood leukocytes that had been stimulated with lipopolysaccharide and staphylococcal enterotoxin B. Complete data were available for 812 children. Results: Endotoxin levels in samples of dust from the child's mattress were inversely related to the occurrence of hay fever, atopic asthma, and atopic sensitization. Nonatopic wheeze was not significantly associated with the endotoxin level. Cytokine production by leukocytes (production of tumor necrosis factor (alpha), interferon-(gamma), interleukin-10, and interleukin-12) was inversely related to the endotoxin level in the bedding, indicating a marked down-regulation of immune responses in exposed children. Conclusions: A subject's environmental exposure to endotoxin may have a crucial role in the development of tolerance to ubiquitous allergens found in natural environments.	Univ Basel, Inst Social & Prevent Med, CH-4051 Basel, Switzerland; Childrens Hosp Salzburg, Salzburg, Austria; Hosp Univ Marburg, Dept Clin Chem & Mol Diagnost, Marburg, Germany; Dr von Hauner Childrens Hosp, Munich, Germany; Ruhr Univ Bochum, Dept Expt Pneumol, D-4630 Bochum, Germany; Univ Zurich, Childrens Hosp, Zurich, Switzerland; Univ Munich, Inst Occupat & Environm Med, Munich, Germany	University of Basel; University of Munich; Ruhr University Bochum; University Children's Hospital Zurich; University of Zurich; University of Munich	Braun-Fahrlander, C (corresponding author), Univ Basel, Inst Social & Prevent Med, Steinengraben 49, CH-4051 Basel, Switzerland.		Fahimifar, Sepideh/M-5303-2019; Lauener, Roger P/O-8612-2016; riedler, josef/AAQ-4666-2020	Lauener, Roger P/0000-0002-8412-606X; von Mutius, Erika/0000-0002-8893-4515; Bufe, Albrecht/0000-0001-7335-9362				AbouZeid C, 1997, INFECT IMMUN, V65, P1856, DOI 10.1128/IAI.65.5.1856-1862.1997; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Cleveland MG, 1996, INFECT IMMUN, V64, P1906, DOI 10.1128/IAI.64.6.1906-1912.1996; D'Amato G, 2000, J INVEST ALLERG CLIN, V10, P123; Delves PJ, 2000, NEW ENGL J MED, V343, P37, DOI 10.1056/NEJM200007063430107; Douwes J, 2000, AM J RESP CRIT CARE, V162, P1348, DOI 10.1164/ajrccm.162.4.9909118; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gold DR, 2000, ENVIRON HEALTH PERSP, V108, P643, DOI 10.2307/3454400; HOLLANDER A, 1993, AM IND HYG ASSOC J, V54, P647, DOI 10.1202/0002-8894(1993)054<0647:IAEITA>2.0.CO;2; ISAAC Steering Committee, 1998, PHAS 2 MOD INT STUD; Kabesch M, 1999, EUR RESPIR J, V13, P577, DOI 10.1183/09031936.99.13357799; Lauener RP, 2002, LANCET, V360, P465, DOI 10.1016/S0140-6736(02)09641-1; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; *MATHS, 2000, S PLUS; Park JH, 2001, AM J RESP CRIT CARE, V163, P322, DOI 10.1164/ajrccm.163.2.2002088; Park JH, 2000, ENVIRON HEALTH PERSP, V108, P1023, DOI 10.2307/3434953; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; RYLANDER R, 1989, AM REV RESPIR DIS, V140, P981, DOI 10.1164/ajrccm/140.4.981; *SAS I, 2001, SAS REL 8 02; Schade FU, 1996, J ENDOTOXIN RES, V3, P455, DOI 10.1177/096805199600300603; Silverman M, 1997, THORAX, V52, P936, DOI 10.1136/thx.52.11.936; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Strachan DP, 1996, BRIT MED J, V312, P1195; Tulic MK, 2000, AM J RESP CELL MOL, V22, P604; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009	27	1338	1369	3	167	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					869	877		10.1056/NEJMoa020057	http://dx.doi.org/10.1056/NEJMoa020057			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239255				2022-12-28	WOS:000178040700002
J	Crawford, LM				Crawford, LM			Drug for colorectal cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1225	1225		10.1001/jama.288.10.1225	http://dx.doi.org/10.1001/jama.288.10.1225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215114				2022-12-28	WOS:000177917700005
J	Ball, P				Ball, P			Let's catch some rays	NATURE			English	News Item							ENERGY											BIRD DJ, 1995, ASTROPHYS J, V441, P144, DOI 10.1086/175344; Enomoto R, 2002, NATURE, V416, P823, DOI 10.1038/416823a; Feng JL, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.021303; GREISEN K, 1966, PHYS REV LETT, V16, P748, DOI 10.1103/PhysRevLett.16.748; KOYAMA K, 1995, NATURE, V378, P255, DOI 10.1038/378255a0; LINSLEY J, 1963, PHYS REV LETT, V10, P146, DOI 10.1103/PhysRevLett.10.146; ZATSEPIN GT, 1966, JETP LETT-USSR, V4, P78	7	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					12	14		10.1038/419012a	http://dx.doi.org/10.1038/419012a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214207				2022-12-28	WOS:000177788600014
J	Lassen, MR; Borris, LC; Nakov, RL				Lassen, MR; Borris, LC; Nakov, RL			Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOTAL HIP-REPLACEMENT; VENOUS THROMBOSIS; PROLONGED THROMBOPROPHYLAXIS; PLASTER-CAST; DOUBLE-BLIND; THROMBOEMBOLISM; PROPHYLAXIS; OUTPATIENTS; SURGERY; METAANALYSIS	Background: Deep-vein thrombosis is a well-recognized complication after trauma to the legs and subsequent immobilization, but there are no generally accepted approaches to preventing this complication. Methods: We performed a prospective, double-blind, placebo-controlled trial to evaluate the efficacy and safety of subcutaneous reviparin (1750 anti-Xa units given once daily) in 440 patients who required immobilization in a plaster cast or brace for at least five weeks after a leg fracture or rupture of the Achilles tendon. The study drug was given throughout the period of immobilization. Venography of the injured leg was performed within one week after removal of the plaster cast or brace, or earlier if there were symptoms suggesting deep-vein thrombosis. Results: Data on efficacy and end points were available for 371 patients. Deep-vein thrombosis was diagnosed in 17 of the 183 patients randomly assigned to receive reviparin (9 percent) and in 35 of the 188 patients randomly assigned to receive placebo (19 percent) (odds ratio, 0.45; 95 percent confidence interval, 0.24 to 0.82). Most of the thromboses were distal (14 in the reviparin group and 25 in the placebo group). There were two cases of pulmonary embolism, both in patients in the placebo group who also had proximal deep-vein thrombosis. There were no differences between the two groups with respect to bleeding or other adverse events. Conclusions: Deep-vein thrombosis is common in persons with leg injury requiring prolonged immobilization. Reviparin given once daily appears to be effective and safe in reducing the risk of this complication.	Cent Hosp Hillerod, Dept Orthoped, DK-3400 Hillerod, Denmark; Arhus Univ Hosp, Dept Orthoped, Sect Traumatol, Aarhus, Denmark; Knoll AG, D-6700 Ludwigshafen, Germany	Aarhus University; Abbott Laboratories; Knoll Pharmaceuticals	Lassen, MR (corresponding author), Cent Hosp Hillerod, Dept Orthoped, Helsevej 2, DK-3400 Hillerod, Denmark.			Borris, Lars/0000-0002-0527-1518				BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bergqvist D, 1996, NEW ENGL J MED, V335, P696, DOI 10.1056/NEJM199609053351002; Borris L C, 1990, Eur J Vasc Surg, V4, P473, DOI 10.1016/S0950-821X(05)80786-8; BORRIS LC, 1989, THROMB HAEMOSTASIS, V61, P363; CASAGRANDE JT, 1978, BIOMETRICS, V34, P483, DOI 10.2307/2530613; Dahl OE, 1997, THROMB HAEMOSTASIS, V77, P26; Eikelboom JW, 2001, LANCET, V358, P9, DOI 10.1016/S0140-6736(00)05249-1; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Harenberg J, 1998, ZBL CHIR, V123, P1284; Hirsh J, 2001, CHEST, V119, p1S, DOI 10.1378/chest.119.1_suppl.1S; Kleinschmidt K, 2001, EMERG MED CLIN N AM, V19, P1025, DOI 10.1016/S0733-8627(05)70233-9; KOCK HJ, 1995, LANCET, V346, P459, DOI 10.1016/S0140-6736(95)91320-3; KUJATH P, 1993, HAEMOSTASIS, V23, P20; Lassen MR, 1998, THROMB RES, V89, P281, DOI 10.1016/S0049-3848(98)00018-8; Leppilahti J, 1998, SPORTS MED, V25, P79, DOI 10.2165/00007256-199825020-00002; PHILBRICK JT, 1988, ARCH INTERN MED, V148, P2131, DOI 10.1001/archinte.148.10.2131; Planes A, 1996, LANCET, V348, P224, DOI 10.1016/S0140-6736(96)01453-5; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; SPANNAGEL U, 1993, SEMIN THROMB HEMOST, V19, P131; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; WELLS PS, 1995, ANN INTERN MED, V122, P47, DOI 10.7326/0003-4819-122-1-199501010-00008; ZACHRISSON BE, 1973, ACTA RADIOL DIAGN, V14, P82, DOI 10.1177/028418517301400111	23	151	158	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2002	347	10					726	730		10.1056/NEJMoa011327	http://dx.doi.org/10.1056/NEJMoa011327			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NH	12213943				2022-12-28	WOS:000177765800004
J	Troiano, RP				Troiano, RP			Perspective: Physical inactivity among young people	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Troiano, RP (corresponding author), NCI, Bethesda, MD 20892 USA.		Troiano, Richard/AAK-3540-2021	Troiano, Richard/0000-0002-6807-989X					0	17	17	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2002	347	10					706	707		10.1056/NEJMp020085	http://dx.doi.org/10.1056/NEJMp020085			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NH	12213940				2022-12-28	WOS:000177765800001
J	Green, DG; Irvine, B				Green, DG; Irvine, B			For and against - Social insurance-the right way forward for health care in the United Kingdom?	BRITISH MEDICAL JOURNAL			English	Article								The NHS in the United Kingdom is struggling to meet the needs of patients as costs continue to rise. Does the current system of funding need to change? David G Green and Benedict Irvine argue for a system based on social insurance, while Martin McKee and colleagues suggest that a tax based system is more equitable.	Civitas Inst Study Civil Soc, Civitas Hlth Unit, London SE1 7NQ, England		Green, DG (corresponding author), Civitas Inst Study Civil Soc, Civitas Hlth Unit, Elizabeth House, London SE1 7NQ, England.		McKee, Martin/E-6673-2018	McKee, Martin/0000-0002-0121-9683				MOSSIALOS E, 1998, CITIZENS HLTH SYSTEM; MOSSIALOS E, 1999, HLTH CARE COST CONTA; NORMAND C, 2002, FUNDING HLTH CARE OP; OR Z, 2002, SUMMARY RESULTS BREA; *ORG EC COOP DEV, 2001, HLTH DAT 2001 COMP A; Wagstaff A, 1993, EQUITY FINANCE DELIV; Wanless, 2002, SECURING OUR FUTURE; World Health Organization, 2000, WORLD HLTH REP 2000	8	5	5	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2002	325	7362					488	489						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592EZ	12202334				2022-12-28	WOS:000177924900027
J	Baker, DN				Baker, DN			How to cope with space weather	SCIENCE			English	Editorial Material									Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Baker, DN (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA.							Baker DN, 1998, ADV SPACE RES, V22, P7, DOI 10.1016/S0273-1177(97)01095-8; BAKER DN, 1998, EOS T AGU, V79, P477, DOI [10.1029/98EO00359, DOI 10.1029/98E000359]; BROOKS J, 1959, NEW YORKER MAGA 0207, P39; Carlowicz M.J., 2002, STORMS SUN; Kappenman J. G., 2001, NATO ASI BOOK SPACE, V38, P335; Lanzerotti LJ, 2001, GEOPHYS MONOGR SER, V125, P11; *NOAA, 1995, NAT SPAC WEATH PROGR; Robinson RM, 2001, GEOPH MONOG SERIES, V125, P1; Singer HJ, 2001, GEOPH MONOG SERIES, V125, P23; Turner R, 2000, IEEE T PLASMA SCI, V28, P2103, DOI 10.1109/27.902237; Withbroe GL, 2001, GEOPH MONOG SERIES, V125, P45	11	150	160	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1486	1487		10.1126/science.1074956	http://dx.doi.org/10.1126/science.1074956			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202809				2022-12-28	WOS:000177697300035
J	Boyen, HG; Kastle, G; Weigl, F; Koslowski, B; Dietrich, C; Ziemann, P; Spatz, JP; Riethmuller, S; Hartmann, C; Moller, M; Schmid, G; Garnier, MG; Oelhafen, P				Boyen, HG; Kastle, G; Weigl, F; Koslowski, B; Dietrich, C; Ziemann, P; Spatz, JP; Riethmuller, S; Hartmann, C; Moller, M; Schmid, G; Garnier, MG; Oelhafen, P			Oxidation-resistant gold-55 clusters	SCIENCE			English	Article							OXYGEN; OXIDE	Gold nanoparticles ranging in diameter from 1 to 8 nanometers were prepared on top of silicon wafers in order to study the size dependence of their oxidation behavior when exposed to atomic oxygen. X-ray photoelectron spectroscopy showed a maximum oxidation resistance for magic-number clusters containing 55 gold atoms. This inertness is not related to electron confinement leading to a size-induced metal-to-insulator transition, but rather seems to be linked to the closed-shell structure of such magic clusters. The result additionally suggests that gold-55 clusters may act as especially effective oxidation catalysts, such as for oxidizing carbon monoxide.	Univ Ulm, Abt Festkorperphys, D-89069 Ulm, Germany; Univ Ulm, Abt Organ Chem 3, D-89069 Ulm, Germany; Heidelberg Univ, Inst Phys Chem, D-69120 Heidelberg, Germany; Univ Essen Gesamthsch, Inst Anorgan Chem, D-45117 Essen, Germany; Univ Basel, Inst Phys, CH-4056 Basel, Switzerland	Ulm University; Ulm University; Ruprecht Karls University Heidelberg; University of Duisburg Essen; University of Basel	Boyen, HG (corresponding author), Univ Ulm, Abt Festkorperphys, D-89069 Ulm, Germany.	hans-gerd.boyen@physik.uni-ulm.de	Möller, Martin/F-7860-2015; Boyen, Hans-Gerd/N-2214-2014; Spatz, Joachim P/A-1107-2017	Möller, Martin/0000-0002-5955-4185; Boyen, Hans-Gerd/0000-0003-0711-7597; Spatz, Joachim P/0000-0003-3419-9807				Boyen HG, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.276401; DONIACH S, 1970, J PHYS C SOLID STATE, V3, P385; ELEY DD, 1978, SURF SCI, V76, pL599, DOI 10.1016/0039-6028(78)90119-X; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; Heiz U, 2000, J PHYS D APPL PHYS, V33, pR85, DOI 10.1088/0022-3727/33/11/201; HENKE BL, 1972, PHYS REV A, V6, P94, DOI 10.1103/PhysRevA.6.94; Henry CR, 1998, SURF SCI REP, V31, P235; Koslowski B, 2001, SURF SCI, V475, P1, DOI 10.1016/S0039-6028(00)00986-9; LEUCHTNER RE, 1989, J CHEM PHYS, V91, P2753, DOI 10.1063/1.456988; PARKER DH, 1990, J VAC SCI TECHNOL A, V8, P2585, DOI 10.1116/1.576675; PEUCKERT M, 1984, SURF SCI, V141, P515, DOI 10.1016/0039-6028(84)90146-8; PIREAUX JJ, 1984, SURF SCI, V141, P221, DOI 10.1016/0039-6028(84)90207-3; RADU G, 2001, P SPRING M GERM PHYS, V36, P393; RON H, 1994, LANGMUIR, V10, P4566, DOI 10.1021/la00024a030; Schmid G, 1990, INORG SYNTHESES, V7, P214; Seah M. P., 1979, Surface and Interface Analysis, V1, P2, DOI 10.1002/sia.740010103; Spatz JP, 1998, J LUMIN, V76-7, P168, DOI 10.1016/S0022-2313(97)00144-0; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; WERTHEIM GK, 1985, J ELECTRON SPECTROSC, V37, P57, DOI 10.1016/0368-2048(85)80082-7	19	445	453	5	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1533	1536		10.1126/science.1076248	http://dx.doi.org/10.1126/science.1076248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202824				2022-12-28	WOS:000177697300051
J	Takahashi, N; Kishimoto, T; Nemoto, T; Kadowaki, T; Kasai, H				Takahashi, N; Kishimoto, T; Nemoto, T; Kadowaki, T; Kasai, H			Fusion pore dynamics and insulin granule exocytosis in the pancreatic islet	SCIENCE			English	Article							MOTOR-NERVE TERMINALS; MEMBRANE-FUSION; SECRETORY GRANULE; BETA-CELLS; FLUORESCENCE MICROSCOPY; MAST-CELLS; VESICLE; RELEASE; PROTEIN	Insulin secretion from intact mouse pancreatic islets was investigated with two-photon excitation imaging. Insulin granule exocytosis occurred mainly toward the interstitial space, away from blood vessels. The fusion pore was unusually stable with a lifetime of 1.8 seconds. Opening of the 1.4-nanometer-diameter pore was preceded by unrestricted lateral diffusion of lipids along the inner wall of the pore, supporting the idea that this structure is composed of membrane lipids. When the pore dilated to 12 nanometers, the granules rapidly flattened and discharged their contents. Thus, our methodology reveals fusion pore dynamics in intact tissues at nanometer resolution.	Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan; Univ Tokyo, Grad Sch Med, Dept Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; University of Tokyo	Kasai, H (corresponding author), Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan.		Nemoto, Tomomi/B-4412-2012	Nemoto, Tomomi/0000-0001-6102-1495; Kasai, Haruo/0000-0003-2327-9027				Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9; Bennett M V, 1992, Semin Cell Biol, V3, P29; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BONNERWEIR S, 1988, DIABETES, V37, P616, DOI 10.2337/diabetes.37.5.616; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; CHANDLER DE, 1980, J CELL BIOL, V86, P666, DOI 10.1083/jcb.86.2.666; Chanturiya A, 1997, P NATL ACAD SCI USA, V94, P14423, DOI 10.1073/pnas.94.26.14423; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; HUTTON JC, 1989, DIABETOLOGIA, V32, P271, DOI 10.1007/BF00265542; INTVELD PA, 1984, DIABETES, V33, P101, DOI 10.2337/diabetes.33.1.101; Ioan CE, 2000, MACROMOLECULES, V33, P5730, DOI 10.1021/ma000282n; Kahn CR, 1994, JOSLINS DIABETES MEL; Kanaseki T, 1997, J CELL BIOL, V137, P1041, DOI 10.1083/jcb.137.5.1041; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; ORCI L, 1987, NATURE, V326, P77, DOI 10.1038/326077a0; ORCI L, 1973, SCIENCE, V179, P82, DOI 10.1126/science.179.4068.82; PIPELEERS DG, 1992, DIABETES, V41, P777, DOI 10.2337/diabetes.41.7.777; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Qian WJ, 2000, ANAL CHEM, V72, P711, DOI 10.1021/ac991085t; Takahashi N, 1999, P NATL ACAD SCI USA, V96, P760, DOI 10.1073/pnas.96.2.760; Takahashi N, 1997, J CELL BIOL, V138, P55, DOI 10.1083/jcb.138.1.55; Takahashi N, 2002, DIABETES, V51, pS25, DOI 10.2337/diabetes.51.2007.S25; TSE FW, 1993, J CELL BIOL, V121, P543, DOI 10.1083/jcb.121.3.543; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; Zimmerberg J, 2001, TRENDS CELL BIOL, V11, P233, DOI 10.1016/S0962-8924(01)02003-7; ZIMMERBERG J, 1987, P NATL ACAD SCI USA, V84, P1585, DOI 10.1073/pnas.84.6.1585	34	220	226	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1349	1352		10.1126/science.1073806	http://dx.doi.org/10.1126/science.1073806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193788				2022-12-28	WOS:000177573900048
J	Bignall, J				Bignall, J			"Chimps plead hands off our genome"	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Bignall, J (corresponding author), The Lancet, London NW1 7BY, England.							BASKIN GB, 2002, PATHOLOGY NONHUMAN P; Bignall J, 1999, LANCET, V353, P610, DOI 10.1016/S0140-6736(99)00058-6; BRAY RS, 1963, J PARASITOL, V49, P888, DOI 10.2307/3275713	3	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2002	360	9332					504	504		10.1016/S0140-6736(02)09761-1	http://dx.doi.org/10.1016/S0140-6736(02)09761-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241652				2022-12-28	WOS:000177512800006
J	Strunk, T; Neppert, B; Bucsky, P; Hof, M; Schultz, C				Strunk, T; Neppert, B; Bucsky, P; Hof, M; Schultz, C			Anaemia and short stature	LANCET			English	Editorial Material									Univ Lubeck, Sch Med, Dept Paediat, D-23538 Lubeck, Germany; Univ Lubeck, Sch Med, Dept Ophthalmol, D-23538 Lubeck, Germany	University of Lubeck; University of Lubeck	Strunk, T (corresponding author), Univ Lubeck, Sch Med, Dept Paediat, D-23538 Lubeck, Germany.	tobiasstrunk@yahoo.de	Strunk, Tobias/AIE-3407-2022	Strunk, Tobias/0000-0001-7079-2339				Attard M, 1999, HUM MOL GENET, V8, P2507, DOI 10.1093/hmg/8.13.2507; Gahl W, 2001, METABOLIC MOL BASES, P5085; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; McDowell GA, 1998, J MOL MED-JMM, V76, P295, DOI 10.1007/s001090050220	4	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					460	460		10.1016/S0140-6736(02)09677-0	http://dx.doi.org/10.1016/S0140-6736(02)09677-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241720				2022-12-28	WOS:000177342900014
J	Bryan, CS; Stinson, MS				Bryan, CS; Stinson, MS			The choice: Lewellys F. Barker and the full-time plan	ANNALS OF INTERNAL MEDICINE			English	Article							UNIVERSITY; MEDICINE	In 1914, Lewellys F. Barker, William Osler's successor as Professor of Medicine and physician-in-chief at Johns Hopkins University School of Medicine, resigned to enter private practice rather than accept the terms of a full-time plan, whereby professors in clinical departments would be salaried like other professors in the university. Barker had been an early proponent of the full-time plan. His decision reflected not only a personal desire for a larger income but also contradictions inherent in the Flexnerian ideal of clinical medicine as a research-oriented university discipline devoid of financial incentives to see patients. In private practice, Barker maintained a high profile as a teacher, writer, supporter of the Johns Hopkins medical institutions, and public figure. The issues raised by his difficult decision remain relevant and have not been satisfactorily resolved.	Univ S Carolina, Sch Med, Columbia, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Bryan, CS (corresponding author), 2 Med Pk,Suite 502, Columbia, SC 29203 USA.	cbryan@richmed.medpark.sc.edu						*ASS AM MED COLL, 2000, ASS AM MED COLL REP, P50; BAKER LF, 1928, INT CLIN 38, V2, P3; BARKER LF, 1905, COMMUNICATION   0314; BARKER LF, 1921, NEW YORK STATE J MED, V21, P189; BARKER LF, 1936, LIVE LONG BE HAPPY P; BARKER LF, 1942, TIME PHYSICIAN AUTOB, P47; BARKER LF, 1914, COMMUNICATION   0119; BARKER LF, 1902, AM MED, V4, P143; BARKER LF, 1942, TIME PHYSICIAN AUTOB, P308; BARKER LF, 1909, COMMUNICATION   0605; Bonner TN, 1999, ACAD MED, V74, P1067, DOI 10.1097/00001888-199910000-00006; BONNER TN, 1963, AM DOCTORS GERMAN U, P86; BONNER TN, 1995, BECOMING PHYSICIAN M, P251; Bryan CS, 1997, ANN INTERN MED, V127, P148, DOI 10.7326/0003-4819-127-2-199707150-00010; CHESNEY AM, 1963, J HOPKINS HOSP J HOP, V3, P145; CHESNEY AM, 1963, J HOPKINS HOSP J HOP, V3, P254; CHESNEY AM, 1958, J HOPKINS HOSP J HOP, V2, P322; FLEXNER A, 1912, CARNEGIE FDN ADV TEA, V6, P148; FLEXNER S, 1993, WH WELCH HEROIC AGE, P312; FYE WB, 1991, JAMA-J AM MED ASSOC, V265, P1555, DOI 10.1001/jama.265.12.1555; FYE WB, 1989, NEW ENGL J MED, V320, P1425, DOI 10.1056/NEJM198905253202123; GATES FT, 1916, COMMUNICATION   1225; GILMAN DC, 1899, COMMUNICATION   0220; Harrell G T, 1973, Bull Hist Med, V47, P545; HARVEY AM, 1975, JOHNS HOPKINS MED J, V136, P168; HARVEY AM, 1990, OSLERS LEGACY DEP ME, P19; Howell WH, 1909, SCIENCE, V30, P129, DOI 10.1126/science.30.761.129; LEVINSON DJ, 1978, SEASONS MANS LIFE, P144; LUDMERER KM, 1985, LEARNING HEAL DEV AM, P207; LUDMERER KM, 1999, TIME HEAL AM MED ED, P162; MALL FP, 1905, COMMUNICATION   0302; MALL FP, 1901, COMMUNICATION   0512; MALL FP, 1905, COMMUNICATION   0202; MALL FP, 1900, COMMUNICATION   1211; MALL FP, 1905, COMMUNICATION    MAR; Osler W, 1911, LANCET, V1, P211; OSLER W, 1905, COMMUNICATION   0304; OSLER W, 1914, COMMUNICATION   0102; OSLER W, 1914, COMMUNICATION   0130; ROSENBERG CE, 1997, NO OTHER GODS SCI AM, P123; Rosenberg Charles, 1987, CARE STRANGERS RISE, P184; SCARBOROUGH K, 1929, BALTIMORE SUN   0219, P20; Starr Paul, 1982, SOCIAL TRANSFORMATIO, P123; Welch WH, 1908, J AMER MED ASSOC, V50, P1; WELCH WH, 1902, COMMUNICATION   0819	45	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					521	525		10.7326/0003-4819-137-6-200209170-00013	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00013			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230354				2022-12-28	WOS:000178069100007
J	Ingelfinger, JR				Ingelfinger, JR			Perspective - Ambulatory blood-pressure monitoring as a predictive tool	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	7	8	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					778	779		10.1056/NEJMp020090	http://dx.doi.org/10.1056/NEJMp020090			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226147				2022-12-28	WOS:000177921300001
J	Amowitz, LL; Reis, C; Iacopino, V				Amowitz, LL; Reis, C; Iacopino, V			Maternal mortality in Herat Province, Afghanistan, in 2002 - An indicator of women's human rights	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SISTERHOOD METHOD; COUNTRIES; HEALTH; BIRTH	Context Maternal mortality rates in Afghanistan are estimated to be high. Objective To assess maternal mortality and human rights issues in Herat, Afghanistan Design and Setting Cross-sectional survey of 4886 Afghan women living in 7 districts in Afghanistan's Herat Province, which included 34 urban and rural villages/ towns. Using structured interviews/questionnaires, these women also provided maternal mortality information on 14085 sisters in March 2002. A survey of health facilities in the 7 districts was also conducted. Participants Mean (SE) age of the respondents was 31 (0.23) years (range, 15-49 years). The majority had received 0.35 (0.11) years of formal education and 4233 (88%) were married (mean [SE] age at marriage, 15 [0.3] years; range, 5-39 years). The mean (SE) number of pregnancies was 5.0 (0.08) and live births was 4.6 (0.2). Results There were 276 maternal deaths among 14085 sisters of the survey response dents (593 maternal deaths/100000 live births per year; 95% confidence interval [Cl], 557-630). Of the 276 deaths, 254 (92%) were reported from rural areas. The respondents reported the following primary problems: lack of food (41%), shelter (18%), and clean water (14%). Of 4721 respondents, 4008 (85%) wanted to get married at the time of their wedding, but 957 (20%) felt family pressure. Of 4703 women, 4117 (87%) had to obtain permission from their husband or male relative to seek health care; only 1 % (54/3946) reported not being permitted to obtain prenatal care. Of 4881 women, 597 (12%) used birth control, but 23% (1013/4294) wanted to use birth control. Of 4306 women, 3189 (74%) reported that decisions about the number and spacing of children were made by husband and wife equally. Of 4637 respondents, 519 (11 %) reported receiving prenatal care. Of 4624 women, 40 (0.9%) reported a trained health care worker was present at birth; 97% (4475/4612) had untrained traditional birth attendants. Only 17 of 27 listed health facilities were functional and only 5 provided essential obstetric care. Only 35 physicians served a population of 793214. Conclusions Women in most of Herat Province, Afghanistan, have a high risk of maternal mortality. Human rights factors may contribute to preventable maternal deaths in the region.	Phys Human Rights, Boston, MA 02116 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Amowitz, LL (corresponding author), Phys Human Rights, 100 Boylston St,Suite 702, Boston, MA 02116 USA.	phrusa@phrusa.org	Lawry, Lynn/ABE-8391-2021	Lawry, Lynn/0000-0001-8229-8768; Reis, Chen/0000-0003-4647-7149				Amowitz L, 2000, LANCET, V356, pS65, DOI 10.1016/S0140-6736(00)92052-X; AMOWITZ LL, 2001, WOMENS HLTH HUMAN RI; [Anonymous], 1997, HUM DEV REP 1997; Bartlett LA, 2002, LANCET, V359, P643, DOI 10.1016/S0140-6736(02)07808-X; Benatar SR, 1998, AM J PUBLIC HEALTH, V88, P295, DOI 10.2105/AJPH.88.2.295; CHOWDHURY MK, 1996, 961 CAR POP CTR; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; FORTNEY J A, 1990, World Health Statistics Quarterly, V43, P246; GRAHAM W, 1989, STUD FAMILY PLANN, V20, P125, DOI 10.2307/1966567; GROSSMAN M, 1975, NBER STUDIES INCOME, V40; Hanley JA, 1996, STUD FAMILY PLANN, V27, P220, DOI 10.2307/2137955; IACOPINO V, 1995, MED HLTH CARE 21 CEN, P376; Institute of Medicine, 1990, NUTR PREGN; Lalonde AB, 1998, CAN MED ASSOC J, V158, P889; Mann Jonathan M, 1994, Health Hum Rights, V1, P6; ONDIMU KN, DETERMINANTS ADOLESC; Patton M., 2015, QUALITATIVE RES EVAL, V4th; Rasekh Z, 1998, JAMA-J AM MED ASSOC, V280, P449, DOI 10.1001/jama.280.5.449; RELDMAN J, 1989, AM J EPIDEMIOL, V129, P919; Robinson JJA, 2001, J ADV NURS, V34, P445, DOI 10.1046/j.1365-2648.2001.01773.x; Ronsmans C, 1997, LANCET, V350, P1810, DOI 10.1016/S0140-6736(97)08012-4; ROSSO P, 1990, NUTR METABOLISM PREG; Shen C, 1999, SOC SCI MED, V49, P197, DOI 10.1016/S0277-9536(99)00112-4; *STATA CORP, 1997, STATA 5 0 INT WIND; *UN CHILDR FUND, 1997, STAT WORLDS CHILDR R; *UN COMM HUM RIGHT, 2000, REP SECR GEN SIT WOM; *UN DEP HUM AFF, 1997, REP DHA MISS AFGH; United Nations Children's Fund, 1997, GUID MON AV US OBST; Walraven G, 1999, TROP MED INT HEALTH, V4, P527, DOI 10.1046/j.1365-3156.1999.00441.x; *WHO, 1996, HOP; *WHO, SIST METH EST MAT MO; *WHO, ADV SAF MOTH HUM RIG; *WHO, 2000, DROUGHT CENTR AS 200; World Health Organisation, 1999, RED MAT MORT JOINT W; *WORLD MED ASS, 2000, DECL HELS ETH PRINC; Yamin AE, 1999, HUM RIGHTS QUART, V21, P563	36	35	35	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1284	1291		10.1001/jama.288.10.1284	http://dx.doi.org/10.1001/jama.288.10.1284			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	592BW	12215139				2022-12-28	WOS:000177917700031
J	Weil, E; Wachterman, M; McCarthy, EP; Davis, RB; O'Day, B; Iezzoni, LI; Wee, CC				Weil, E; Wachterman, M; McCarthy, EP; Davis, RB; O'Day, B; Iezzoni, LI; Wee, CC			Obesity among adults with disabling conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; DISABILITY; OVERWEIGHT; WEIGHT; PEOPLE; WOMEN; RISK; LIFE	Context Obesity, a leading cause of preventable death and chronic disease, is associated with disability. Little is known about obesity among adults with specific disabilities. Objectives To determine the prevalence of obesity in adults with physical and sensory limitations and serious mental illness. Design, Setting, and Participants The 1994-1995 National Health Interview Survey of 145007 US community-dwelling respondents, 25626 of whom had 1 or more disabilities. Main Outcome Measures Likelihood of being obese, attempting weight loss, and receiving exercise counseling among adults with and without disabilities. Results Among adults with disabilities, 24.9% were obese vs 15.1 % of those without disabilities. After adjusting for sociodemographic factors, adults with a disability were more likely to be obese, with an adjusted odds ratio (AOR) of 1.9 (95% confidence interval [01, 1.8-2.0). The highest risk occurred among adults with some (AOR, 2.4; 95% Cl, 2.3-2.5) or severe (AOR, 2.5; 95% Cl, 2.3-2.7) lower extremity mobility difficulties. After further adjustment for comorbid conditions, adults with disabilities were as likely to attempt weight loss as those without disabilities, except for adults with severe lower extremity mobility difficulties, who were less likely (AOR, 0.7; 95% Cl, 0.5-0.9]), and adults with mental illness, who were more likely (AOR, 1.4; 95% Cl, 1.2-1.8). Physician exercise counseling was reported less often among adults with severe lower extremity (AOR, 0.5; 95% Cl, 0.4-0.7) and upper extremity (AOR, 0.7; 95% Cl, 0.5-1.0) mobility difficulties. Conclusion Obesity appears to be more prevalent in adults with sensory, physical, and mental health conditions. Health care practitioners should address weight control and exercise among adults with disabilities.	Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, Boston, MA 02215 USA; Cherry Engn Support Serv Inc, Mclean, VA USA	Harvard University; Beth Israel Deaconess Medical Center	Wee, CC (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, 330 Brookline Ave, Boston, MA 02215 USA.	cweekuo@caregroup.harvard.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK002962] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS10223-03] Funding Source: Medline; NIDDK NIH HHS [1K23 DK02962] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; [Anonymous], 1998, CLIN GUID ID EV TREA; [Anonymous], HLTH PEOPL 2010 UND; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Brownson RC, 2001, AM J PUBLIC HEALTH, V91, P1995, DOI 10.2105/AJPH.91.12.1995; CDC, BEH RISK FACT SURV S; Davidson S, 2001, AUST NZ J PSYCHIAT, V35, P196, DOI 10.1046/j.1440-1614.2001.00877.x; Devlin MJ, 2000, AM J PSYCHIAT, V157, P854, DOI 10.1176/appi.ajp.157.6.854; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; Han TS, 1998, AM J PUBLIC HEALTH, V88, P1814, DOI 10.2105/AJPH.88.12.1814; Heath G W, 1997, Exerc Sport Sci Rev, V25, P195; Iezzoni LI, 2001, AM J MED QUAL, V16, P135; KOCH GG, 1975, INT STAT REV, V43, P59, DOI 10.2307/1402660; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; *RES TRIANGL I, 1992, SUDAAN US MAN REL 5; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P61; Wee CC, 1999, JAMA-J AM MED ASSOC, V282, P1583, DOI 10.1001/jama.282.16.1583	21	182	185	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1265	1268		10.1001/jama.288.10.1265	http://dx.doi.org/10.1001/jama.288.10.1265			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	592BW	12215134	Bronze			2022-12-28	WOS:000177917700026
J	Gianopoulos, I; Stephens, D; Davis, A				Gianopoulos, I; Stephens, D; Davis, A			Follow up of people fitted with hearing aids after adult hearing screening: the need for support after fitting	BRITISH MEDICAL JOURNAL			English	Article							DISABILITY		Univ Wales Hosp, Welsh Hearing Inst, Cardiff CF14 4XW, S Glam, Wales; Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England	Cardiff University; University of Nottingham	Stephens, D (corresponding author), Univ Wales Hosp, Welsh Hearing Inst, Cardiff CF14 4XW, S Glam, Wales.		Davis, Adrian C/E-6022-2015; Gianopoulos, I/F-1211-2013	Davis, Adrian C/0000-0001-7134-7528; 				DAVIES ER, 1992, SIGNAL PROCESS, V26, P1, DOI 10.1016/0165-1684(92)90051-W; DAVIS A, 1997, ADULT AUDIOLOGY; NOBLE WG, 1970, J AUD RES, V10, P229; Rosen J K, 1979, Scand Audiol, V8, P111, DOI 10.3109/01050397909076309; STEPHENS SDG, 1990, BRIT MED J, V300, P508, DOI 10.1136/bmj.300.6723.508	5	31	32	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2002	325	7362					471	471		10.1136/bmj.325.7362.471	http://dx.doi.org/10.1136/bmj.325.7362.471			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592EZ	12202328	Bronze, Green Published			2022-12-28	WOS:000177924900020
J	Slutsky, AS; Drazen, JM				Slutsky, AS; Drazen, JM			Ventilation with small tidal volumes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Michaels Hosp, Toronto, ON M5B 1W8, Canada; Siemens, New York, NY 10022 USA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Siemens AG	Slutsky, AS (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Drazen, Jeffrey M/E-5841-2012; Slutsky, Arthur S/A-6013-2008; Slutsky, Arthur/M-3325-2019	Slutsky, Arthur S/0000-0002-6063-3876; Drazen, Jeffrey/0000-0003-2715-9890					0	67	71	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2002	347	9					630	631		10.1056/NEJMp020082	http://dx.doi.org/10.1056/NEJMp020082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZT	12200549				2022-12-28	WOS:000177675500001
J	Castro, RF; Jackson, KA; Goodell, MA; Robertson, CS; Liu, H; Shine, HD				Castro, RF; Jackson, KA; Goodell, MA; Robertson, CS; Liu, H; Shine, HD			Failure of bone marrow cells to transdifferentiate into neural cells in vivo	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; IN-VIVO; EXPRESSION; BRAIN		Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Shine, HD (corresponding author), Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA.			Goodell, Margaret A./0000-0003-1111-2932				Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	7	346	423	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1299	1299		10.1126/science.297.5585.1299	http://dx.doi.org/10.1126/science.297.5585.1299			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193778				2022-12-28	WOS:000177573900033
J	Lawrence, JG				Lawrence, JG			Shared strategies in gene organization among prokaryotes and eukaryotes	CELL			English	Review							CAENORHABDITIS-ELEGANS; TRANSLATIONAL REGULATION; DROSOPHILA-MELANOGASTER; SELFISH OPERONS; NERVOUS-SYSTEM; MESSENGER-RNA; EXPRESSION; EVOLUTION; PROTEINS; LOCUS	Although genes in prokaryotes and eukaryotes are transcribed and translated by very different mechanisms, they may be organized in their respective chromosomes in surprisingly similar ways. Here, I examine common modes of maintaining nonrandom gene organization in both prokaryotes and eukaryotes, the different ways these organizations have likely arisen, and classes of organization that may be unique to one group or the other.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lawrence, JG (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	jlawrenc@pitt.edu						ALFONSO A, 1994, J MOL BIOL, V241, P627, DOI 10.1006/jmbi.1994.1538; Andrews J, 1996, GENETICS, V143, P1699; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; CLARK SG, 1994, GENETICS, V137, P987; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; DUNBOULE D, 1998, CURR OPIN GENE DEV, V8, P514; Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605; GEBALLE AP, 1994, TRENDS BIOCHEM SCI, V19, P159, DOI 10.1016/0968-0004(94)90277-1; Gerasimova TI, 2001, ANNU REV GENET, V35, P193, DOI 10.1146/annurev.genet.35.102401.090349; Gilson PR, 1996, P NATL ACAD SCI USA, V93, P7737, DOI 10.1073/pnas.93.15.7737; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Hall RM, 1999, ANN NY ACAD SCI, V870, P68, DOI 10.1111/j.1749-6632.1999.tb08866.x; HILL JR, 1993, J BIOL CHEM, V268, P726; Huynen MA, 2001, TRENDS GENET, V17, P304, DOI 10.1016/S0168-9525(01)02302-2; Itoh T, 1999, MOL BIOL EVOL, V16, P332, DOI 10.1093/oxfordjournals.molbev.a026114; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Jagla K, 2001, BIOESSAYS, V23, P125, DOI 10.1002/1521-1878(200102)23:2<125::AID-BIES1019>3.3.CO;2-3; JOHNSTON HM, 1980, P NATL ACAD SCI-BIOL, V77, P508, DOI 10.1073/pnas.77.1.508; KOLTER R, 1982, ANNU REV GENET, V16, P113, DOI 10.1146/annurev.ge.16.120182.000553; Lawrence JG, 1996, GENETICS, V143, P1843; Lawrence JG, 1997, TRENDS MICROBIOL, V5, P355, DOI 10.1016/S0966-842X(97)01110-4; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Levings PP, 2002, EUR J BIOCHEM, V269, P1589, DOI 10.1046/j.1432-1327.2002.02797.x; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; LUO ZG, 1995, MOL CELL BIOL, V15, P5235; NEUFELD TP, 1991, P NATL ACAD SCI USA, V88, P10203, DOI 10.1073/pnas.88.22.10203; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; PIERARD A, 1978, J BACTERIOL, V134, P167; Semple C, 1999, J MOL EVOL, V48, P555, DOI 10.1007/PL00006498; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; Tenson T, 1996, P NATL ACAD SCI USA, V93, P5641, DOI 10.1073/pnas.93.11.5641; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099; YANAI, 2002, GENOME BIOL, V3; Zhang L, 1996, RNA, V2, P682	36	64	66	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					407	413		10.1016/S0092-8674(02)00900-5	http://dx.doi.org/10.1016/S0092-8674(02)00900-5			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202031	Bronze			2022-12-28	WOS:000177653200003
J	Anderson, LJ; Wonke, B; Prescott, E; Holden, S; Walker, JM; Pennell, DJ				Anderson, LJ; Wonke, B; Prescott, E; Holden, S; Walker, JM; Pennell, DJ			Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia	LANCET			English	Article							LONG-TERM TRIAL; MAGNETIC-RESONANCE; CHELATION-THERAPY; DEFEROXAMINE; SURVIVAL; 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE; EFFICACY; L1; OVERLOAD; SAFETY	Background Despite the introduction of the parenteral iron chelator desferrioxamine more than 30 years ago, 50% of patients with thalassaemia major die before the age of 35 years, predominantly from iron-induced heart failure. The only alternative treatment is oral deferiprone, but its long-term efficacy on myocardial iron concentrations is unknown. Methods We compared myocardial iron content and cardiac function in 15 patients receiving long-term deferiprone treatment with 30 matched thalassaemia major controls who were on long-term treatment with desferrioxamine. Myocardial iron concentrations were measured by a new magnetic-resonance T2* technique, which shows values inversely related to tissue iron concentration. Findings The deferiprone group had significantly less myocardial iron (median 34.0 ms vs 11.4 ms, p=0.02) and higher ejection fractions (mean 70% [SD 6.5] vs 63% [6.9], p=0.004) than the desferrioxamine controls. Excess myocardial iron (T2* <20 ms) was less common in the deferiprone group than in the desferrioxamine controls (four [27%] vs 20 [67%], p=0.025), as was severe (T2* <10 ms) iron overload (one [7%] vs 11 [37%], p=0.04). The odds ratio for excess myocardial iron in the desferrioxamine controls versus the deferiprone group was 5.5 (95% Cl 1.2-28.8). Interpretation Conventional chelation treatment with subcutaneous desferrioxamine does not prevent excess cardiac iron deposition in two-thirds of patients with thalassaemia major, placing them at risk of heart failure and its complications. Oral deferiprone is more effective than desferrioxamine in removal of myocardial iron.	Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, London SW3 6NP, England; UCL Hosp, London, England; Whittington Hosp, London N19 5NF, England	Royal Brompton Hospital; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Pennell, DJ (corresponding author), Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, London SW3 6NP, England.	d.pennell@ic.ac.uk		Walker, John Malcolm/0000-0002-8559-7218; Pennell, Dudley/0000-0001-5523-1314				AGARWAL MB, 1992, BRIT J HAEMATOL, V82, P460, DOI 10.1111/j.1365-2141.1992.tb06445.x; ALREFAIE FN, 1992, BLOOD, V80, P593; Anderson L, 2000, BLOOD, V96, p606A; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; ARDEN GB, 1984, BRIT J OPHTHALMOL, V68, P873, DOI 10.1136/bjo.68.12.873; BARRY M, 1974, BMJ-BRIT MED J, V2, P16, DOI 10.1136/bmj.2.5909.16; Bellenger NG, 2000, J CARDIOV MAGN RESON, V2, P271, DOI 10.3109/10976640009148691; Bellenger NG, 2000, J CARDIOV MAGN RESON, V2, P15, DOI 10.3109/10976640009148669; BRILL PW, 1991, AM J ROENTGENOL, V156, P561, DOI 10.2214/ajr.156.3.1899759; BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902; De Franceschi L, 1999, J LAB CLIN MED, V133, P64, DOI 10.1053/lc.1999.v133.a94241; DEVIRGILIIS S, 1988, J PEDIATR-US, V113, P661; Hoffbrand AV, 1998, BLOOD, V91, P295, DOI 10.1182/blood.V91.1.295.295_295_300; Karnon J, 1999, CLIN LAB HAEMATOL, V21, P377, DOI 10.1046/j.1365-2257.1999.00262.x; KONTOGHIORGHES GJ, 1990, BRIT J HAEMATOL, V76, P295, DOI 10.1111/j.1365-2141.1990.tb07887.x; Lorenz CH, 1999, J CARDIOVASC MAGN R, V1, P7, DOI 10.3109/10976649909080829; MODELL B, 1982, BRIT MED J, V284, P1081, DOI 10.1136/bmj.284.6322.1081; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; OLIVIERI NF, 1986, NEW ENGL J MED, V314, P869, DOI 10.1056/NEJM198604033141402; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Olivieri NF, 1998, NEW ENGL J MED, V339, P417, DOI 10.1056/NEJM199808133390701; OLIVIERI NF, 1995, NEW ENGL J MED, V332, P918, DOI 10.1056/NEJM199504063321404; Porter JB, 1997, DRUG SAFETY, V17, P407, DOI 10.2165/00002018-199717060-00006; PORTER JB, 1999, THESIS U CAMBRIDGE; SEPHTONSMITH R, 1962, BRIT MED J, V2, P1577; SHALEV O, 1995, BLOOD, V86, P2008, DOI 10.1182/blood.V86.5.2008.bloodjournal8652008; TONDURY P, 1990, BRIT J HAEMATOL, V76, P550; WEATHERALL DJ, 1983, NEW ENGL J MED, V308, P456, DOI 10.1056/NEJM198302243080813; WOLFE L, 1985, NEW ENGL J MED, V312, P1600, DOI 10.1056/NEJM198506203122503; ZURLO MG, 1989, LANCET, V2, P27, DOI 10.1016/S0140-6736(89)90264-X	30	359	365	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2002	360	9332					516	520		10.1016/S0140-6736(02)09740-4	http://dx.doi.org/10.1016/S0140-6736(02)09740-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241655				2022-12-28	WOS:000177512800009
J	Kouznetsov, AV; Prinz, JC				Kouznetsov, AV; Prinz, JC			Molecular diagnosis of syphilis: the Schaudinn-Hoffmann lymph-node biopsy	LANCET			English	Article							HIV	Although serological tests are usually sufficient for the diagnosis of syphilis, they can be unhelpful in identifying the stage of Treponema pallidum infection in various situations. We used fine-needle aspiration of inguinal lymph nodes followed by PCR and Southern blotting to test for treponemal DNA In three patients with suspected secondary or latent syphilis. All three patients were positive by this technique. This approach could serve as a useful new tool for the diagnosis of syphilis in uncertain cases.	Univ Munich, Dept Dermatol, D-80337 Munich, Germany; IM Sechenov Med Acad, Moscow, Russia	University of Munich; Sechenov First Moscow State Medical University	Prinz, JC (corresponding author), Univ Munich, Dept Dermatol, Frauenlobstr 9-11, D-80337 Munich, Germany.		Prinz, Jörg/AAP-9472-2021					Blocker ME, 2000, SEX TRANSM DIS, V27, P53, DOI 10.1097/00007435-200001000-00011; Schaudinn F, 1905, DEUT MED WOCHENSCHR, V31, P711, DOI 10.1055/s-0029-1188114; Schofer H, 1996, GENITOURIN MED, V72, P176; SELL S, 1983, PATHOGENESIS IMMUNOL, P297; Zoechling N, 1997, BRIT J DERMATOL, V136, P683, DOI 10.1046/j.1365-2133.1997.6561614.x	5	11	15	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					388	389		10.1016/S0140-6736(02)09598-3	http://dx.doi.org/10.1016/S0140-6736(02)09598-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241783				2022-12-28	WOS:000177255600016
J	Lipshultz, SE; Easley, KA; Orav, EJ; Kaplan, S; Starc, TJ; Bricker, JT; Lai, WW; Moodie, DS; Sopko, G; Schluchter, MD; Colan, SD				Lipshultz, SE; Easley, KA; Orav, EJ; Kaplan, S; Starc, TJ; Bricker, JT; Lai, WW; Moodie, DS; Sopko, G; Schluchter, MD; Colan, SD		Pediat Pulm Cardiovasc Complicatio	Cardiovascular status of infants and children of women infected with HIV-1 ((PC2)-C-2 HIV): a cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DOXORUBICIN THERAPY; CARDIAC STRUCTURE; MORTALITY	Background Data from cross-sectional and short-term longitudinal studies have suggested that children infected with HIV-1 might have cardiovascular abnormalities. We aimed to investigate this hypothesis in a long-term cohort study. Methods We measured cardiovascular function every 4-6 months for up to 5 years in a birth cohort of 600 infants born to women infected with HIV-1. We included 93 infants infected with HIV-1 and 463 uninfected infants (internal controls) from the same cohort. We also included a cross-sectionally measured comparison group of 195 healthy children born to mothers who were not infected with HIV-1 (external controls). Findings Children infected with HIV-1 had a significantly higher heart rate at all ages (mean difference 10 bpm, 95% Cl 8-13) than internal controls. At birth, both cohort groups of children had similar low left ventricular (LV) fractional shortening. At 8 months, fractional shortening was similar in internal and external controls, whereas in children infected with HIV-1, fractional shortening remained significantly lower than in controls for the first 20 months of life (mean difference from internal controls at 8 months 3.7%, 2.3-5.1). LV mass was similar at birth in both cohort groups, but became significantly higher in children with HIV-1 from 4-30 months (mean difference 2.4 g at 8 months, 0.9-3.9). Conclusions Vertically-transmitted HIV-1 infection is associated with persistent cardiovascular abnormalities identifiable shortly after birth. Irrespective of their HIV-1 status, infants born to women infected with HIV-1 have significantly worse cardiac function than other infants, suggesting that the uterine environment has an important role in postnatal cardiovascular abnormalities.	Univ Rochester, Med Ctr, Sch Med & Dent, Dept Pediat,Div Pediat Cardiol, Rochester, NY 14642 USA; Strong Childrens Hosp, Div Pediat Cardiol, Rochester, NY USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; Boston Med Ctr, Dept Pediat, Boston, MA USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Pediat, Div Pediat Cardiol, Cleveland, OH 44195 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Univ Calif Los Angeles, Med Ctr, Dept Pediat, Div Pediat Cardiol, Los Angeles, CA 90024 USA; Mt Sinai Sch Med, Dept Pediat, Div Pediat Cardiol, New York, NY USA; Columbia Univ Coll Phys & Surg, Presbyterian Hosp, Div Pediat Cardiol, Dept Pediat, New York, NY 10032 USA; Baylor Coll Med, Dept Pediat, Div Pediat Cardiol, Houston, TX 77030 USA; NHLBI, Bethesda, MD 20892 USA; Sch Med, Los Angeles, CA USA	University of Rochester; University of Rochester; Harvard University; Boston Children's Hospital; Harvard Medical School; Boston Medical Center; Boston University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Icahn School of Medicine at Mount Sinai; Columbia University; NewYork-Presbyterian Hospital; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lipshultz, SE (corresponding author), Univ Rochester, Med Ctr, Sch Med & Dent, Dept Pediat,Div Pediat Cardiol, 601 Elmwood Ave,Box 631, Rochester, NY 14642 USA.	steve_lipshultz@urmc.rochester.edu	Easley, Kirk A/K-6910-2015; Colan, Steven/ABB-4580-2020	Easley, Kirk A/0000-0003-4419-2617; 	NCRR NIH HHS [M01 RR000533, M01 RR000645, M01 RR000865, K01 RR000188, RR-00865, RR-00071, M01 RR000043, RR-00645, RR-00533, M01 RR002172, RR-00043, M01 RR000188, M01 RR000071, RR-00188, RR-00685, RR-02172] Funding Source: Medline; NHLBI NIH HHS [N01 HR096043, N01-HR-96038, N01-HR-96040, N01-HR-96039, N01-HR-96042, N01-HR-96041, N01 HR096037] Funding Source: Medline; DIVISION OF LUNG DISEASES [N01HR096039, N01HR096041, N01HR096037, N01HR096043, N01HR096042, N01HR096038, N01HR096040] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071, M01RR002172, M01RR000043, M01RR000533, M01RR000865, M01RR000188, M01RR000645, K01RR000188] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		[Anonymous], 2001, LANCET, V357, P405; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; BARKER DJP, 2001, FETAL ORIGINS CARDIO; Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Hornberger LK, 2000, AM HEART J, V140, P575, DOI 10.1067/mhj.2000.109645; Kattan M, 1996, J CLIN EPIDEMIOL, V49, P1285; Langston C, 2001, PEDIATRICS, V107, P328, DOI 10.1542/peds.107.2.328; Lipshultz, 2000, Prog Pediatr Cardiol, V12, P1, DOI 10.1016/S1058-9813(00)00076-X; Lipshultz SE, 2000, CIRCULATION, V102, P1542, DOI 10.1161/01.CIR.102.13.1542; Lipshultz SE, 2000, NEW ENGL J MED, V343, P759, DOI 10.1056/NEJM200009143431102; Lipshultz SE, 1998, CIRCULATION, V97, P1246, DOI 10.1161/01.CIR.97.13.1246; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; LIPSHULTZ SE, 1992, NEW ENGL J MED, V327, P1260, DOI 10.1056/NEJM199210293271802; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; LUGINBUHL LM, 1993, JAMA-J AM MED ASSOC, V269, P2869, DOI 10.1001/jama.269.22.2869; Shearer WT, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e9; STARC TJ, 1999, PEDIATRICS, V104; *UNAIDS JOINT UN P, 2000, AIDS EP UPD; *UNAIDS JOINT UN P, 2000, REP GLOB HIV AIDS EP; *US CDCP, 2000, HIV AIDS SURV REP, V7, P1	21	63	64	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2002	360	9330					368	373		10.1016/S0140-6736(02)09607-1	http://dx.doi.org/10.1016/S0140-6736(02)09607-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241776	Green Accepted			2022-12-28	WOS:000177255600009
J	Lu, YJ; Hing, S; Williams, R; Pinkerton, R; Shipley, J; Pritchard-Jones, K				Lu, YJ; Hing, S; Williams, R; Pinkerton, R; Shipley, J; Pritchard-Jones, K		UK Childrens Canc Study Grp	Chromosome 1q expression profiling and relapse in Wilms' tumour	LANCET			English	Article							GENE-EXPRESSION; CLASSIFICATION	Gene-expression patterns have proved useful for tumour classification and prediction of prognosis. We investigated a new gene-expression profiling method that targets individual chromosomes-comparative expressed sequence hybridisation (CESH)-to establish if any expression pattern was associated with relapse, and if this pattern could accurately predict outcome. We studied IS cases of Wilms' tumour with favourable histological findings. Relative overexpression of genes on the long arm of chromosome 1 was shown in all tumours that subsequently relapsed but in none of those from patients in remission (odds ratio 357, 95% Cl 6.4-19 960). This finding shows the value of CESH analysis to rapidly screen for chromosomal regions that carry genes whose differential expression is important in establishment of tumour behaviour.	Inst Canc Res, Paediat Sect, Sutton, Surrey, England; Inst Canc Res, Sect Mol Carcinogenesis, Sutton, Surrey, England; Royal Marsden Hosp NHS Trust, Sutton, Surrey, England	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Pritchard-Jones, K (corresponding author), Inst Canc Res, Paediat Sect, Sutton, Surrey, England.		pinkerton, ross/I-4808-2014; Pritchard-Jones, Kathy/F-4286-2014	Pritchard-Jones, Kathy/0000-0002-2384-9475; Lu, Yong-Jie/0000-0001-6174-6621; Shipley, Janet/0000-0001-6748-8678				Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Grundy P, 1996, MED PEDIATR ONCOL, V27, P429, DOI 10.1002/(SICI)1096-911X(199611)27:5<429::AID-MPO7>3.0.CO;2-O; Hing S, 2001, AM J PATHOL, V158, P393, DOI 10.1016/S0002-9440(10)63982-X; Lu YJ, 2001, P NATL ACAD SCI USA, V98, P9197, DOI 10.1073/pnas.161272798; Pritchard-Jones K, 1997, CRIT REV ONCOGENESIS, V8, P1	5	44	45	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					385	386		10.1016/S0140-6736(02)09596-X	http://dx.doi.org/10.1016/S0140-6736(02)09596-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241781				2022-12-28	WOS:000177255600014
J	Gong, F; Yanofsky, C				Gong, F; Yanofsky, C			Instruction of translating ribosome by nascent peptide	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; TRYPTOPHANASE OPERON EXPRESSION; OPEN READING FRAMES; ERYTHROMYCIN RESISTANCE; ANGSTROM RESOLUTION; SUBUNIT; RNA; RECOGNITION; INDUCTION; CLEAVAGE	Expression of the tryptophanase operon of Escherichia coli is regulated by catabolite repression and tryptophan-induced transcription antitermination. An induction site activated by L-tryptophan is created in the translating ribosome during synthesis of TnaC, the 24-residue leader peptide. Replacing the tnaC stop codon with a tryptophan codon allows tryptophan-charged tryptophan transfer RNA to substitute for tryptophan as inducer. This suggests that the ribosomal A site occupied by the tryptophanyl moiety of the charged transfer RNA is the site of induction. The location of tryptophan-12 of nascent TnaC in the peptide exit tunnel was crucial for induction. These results show that a nascent peptide sequence can influence translation continuation and termination within a translating ribosome.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Yanofsky, C (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							Alderete JP, 2001, J VIROL, V75, P7188, DOI 10.1128/JVI.75.15.7188-7192.2001; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BOTSFORD JL, 1971, J BACTERIOL, V105, P303, DOI 10.1128/JB.105.1.303-312.1971; DEELEY MC, 1981, J BACTERIOL, V147, P787, DOI 10.1128/JB.147.3.787-796.1981; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; GOLLNICK P, 1990, J BACTERIOL, V172, P3100, DOI 10.1128/jb.172.6.3100-3107.1990; Gong F, 2002, J BIOL CHEM, V277, P17095, DOI 10.1074/jbc.M201213200; Gong F, 2001, J BIOL CHEM, V276, P1974, DOI 10.1074/jbc.M008892200; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; KAZARINOFF MN, 1977, J BIOL CHEM, V252, P7598; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; PHILLIPS RS, 1985, J BIOL CHEM, V260, P4665; Raney A, 2002, J BIOL CHEM, V277, P5988, DOI 10.1074/jbc.M108375200; Simonson AB, 2002, NATURE, V416, P281, DOI 10.1038/416281a; STEWART V, 1986, J BACTERIOL, V166, P217, DOI 10.1128/jb.166.1.217-223.1986; STEWART V, 1986, J BACTERIOL, V167, P383, DOI 10.1128/jb.167.1.383-386.1986; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	27	186	191	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1864	1867		10.1126/science.1073997	http://dx.doi.org/10.1126/science.1073997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228716				2022-12-28	WOS:000177955000042
J	Milligan, AJ; Morel, FMM				Milligan, AJ; Morel, FMM			A proton buffering role for silica in diatoms	SCIENCE			English	Article							CARBONIC-ANHYDRASE ACTIVITY; MARINE DIATOMS; GROWTH; CYCLE; MECHANISMS; LIMITATION; TRANSPORT; FAMILY; ENZYME; ALGAE	For 40 million years, diatoms have dominated the reverse weathering of silica on Earth. These photosynthetic protists take up dissolved silicic acid from the water and precipitate opaline silica to form their cell wall. We show that the biosilica of diatoms is an effective pH buffer, enabling the enzymatic conversion of bicarbonate to CO2, an important step in inorganic carbon acquisition by these organisms. Because diatoms are responsible for one-quarter of global primary production and for a large fraction of the carbon exported to the deep sea, the global cycles of Si and C may be linked mechanistically.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University	Morel, FMM (corresponding author), Princeton Univ, Dept Geosci, Guyot Hall, Princeton, NJ 08544 USA.		Morel, Francois M M/A-8107-2008					AIZAWA K, 1986, FEMS MICROBIOL LETT, V39, P215, DOI 10.1016/0378-1097(86)90447-7; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; CARLISLE EM, 1986, CIBA F SYMP, V121, P123; Cox EH, 2000, BIOCHEMISTRY-US, V39, P12128, DOI 10.1021/bi001416s; DAVIDSON AT, 1994, MAR BIOL, V119, P507, DOI 10.1007/BF00354312; Dixit S, 2002, GEOCHIM COSMOCHIM AC, V66, P2559, DOI 10.1016/S0016-7037(02)00854-2; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; KROGER N, 1994, EMBO J, V13, P4676, DOI 10.1002/j.1460-2075.1994.tb06791.x; MALVIA RG, 1989, PALAIOS, V4, P519; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; Nimer NA, 1999, J PHYCOL, V35, P1200, DOI 10.1046/j.1529-8817.1999.3561200.x; PAASCHE E, 1980, LIMNOL OCEANOGR, V25, P474, DOI 10.4319/lo.1980.25.3.0474; PALMQVIST K, 1994, PHYSIOL PLANTARUM, V90, P537; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Pocker Y, 2000, CELL MOL LIFE SCI, V57, P1008, DOI 10.1007/PL00000741; PRICE N M, 1988, Biological Oceanography, V6, P443; Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7; RAVEN JA, 1983, BIOL REV, V58, P179, DOI 10.1111/j.1469-185X.1983.tb00385.x; RIEBESELL U, 1993, NATURE, V361, P249, DOI 10.1038/361249a0; Roberts SB, 1997, J PHYCOL, V33, P845, DOI 10.1111/j.0022-3646.1997.00845.x; Schindler P., 1968, HELV CHIM ACTA, V51, P1781, DOI DOI 10.1002/HLCA.19680510738; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Sultemeyer D, 1998, CAN J BOT, V76, P962; Tripp BC, 2000, BIOCHEMISTRY-US, V39, P9232, DOI 10.1021/bi0001877; Tu C, 2001, J AM CHEM SOC, V123, P5861, DOI 10.1021/ja010301o; VILLAREAL TA, 1988, DEEP-SEA RES, V35, P1037, DOI 10.1016/0198-0149(88)90075-1	32	135	142	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1848	1850		10.1126/science.1074958	http://dx.doi.org/10.1126/science.1074958			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228711				2022-12-28	WOS:000177955000036
J	Munn, DH; Sharma, MD; Lee, JR; Jhaver, KG; Johnson, TS; Keskin, DB; Marshall, B; Chandler, P; Antonia, SJ; Burgess, R; Slingluff, CL; Mellor, AL				Munn, DH; Sharma, MD; Lee, JR; Jhaver, KG; Johnson, TS; Keskin, DB; Marshall, B; Chandler, P; Antonia, SJ; Burgess, R; Slingluff, CL; Mellor, AL			Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; TRYPTOPHAN CATABOLISM; HUMAN MACROPHAGES; PERIPHERAL-BLOOD; FETAL REJECTION; LYMPH-NODES; IFN-GAMMA; INTERFERON; ANTIGEN; PROLIFERATION	Antigen-presenting cells (APCs) can induce tolerance or immunity. We describe a subset of human APCs that express indoleamine 2,3-dioxygenase (IDO) and inhibit T cell proliferation in vitro. IDO-positive APCs constituted a discrete subset identified by coexpression of the cell-surface markers CD123 and CCR6. In the dendritic cell (DC) lineage, IDO-mediated suppressor activity was present in fully mature as well as immature CD123(+) DCs. IDO+ DCs could also be readily detected in vivo, which suggests that these cells may represent a regulatory subset of APCs in humans.	Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; Vet Affairs Med Ctr, Augusta, GA 30912 USA; Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA; H Lee Moffitt Canc Ctr & Res Inst, Interdisciplinary Oncol Program, Tampa, FL 33612 USA; Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; Univ Virginia, Dept Surg, Charlottesville, VA 22908 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; H Lee Moffitt Cancer Center & Research Institute; University System of Georgia; Augusta University; University of Virginia	Munn, DH (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.	dmunn@mail.mcg.edu		Munn, David/0000-0002-7711-2858	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044759, R01AI044219] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60137] Funding Source: Medline; NIAID NIH HHS [AI44759, AI44219] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander AM, 2002, DIABETES, V51, P356, DOI 10.2337/diabetes.51.2.356; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chambers CA, 2001, TRENDS IMMUNOL, V22, P217, DOI 10.1016/S1471-4906(01)01868-3; Chen BG, 1998, BLOOD, V91, P4652, DOI 10.1182/blood.V91.12.4652.412a03_4652_4661; Cochran AJ, 2001, MODERN PATHOL, V14, P604, DOI 10.1038/modpathol.3880358; Curelli S, 2001, J INTERF CYTOK RES, V21, P431, DOI 10.1089/107999001750277916; DAI W, 1990, BIOCHEM BIOPH RES CO, V168, P1, DOI 10.1016/0006-291X(90)91666-G; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Grant RS, 2000, J VIROL, V74, P4110, DOI 10.1128/JVI.74.9.4110-4115.2000; Grohmann U, 2001, J IMMUNOL, V167, P708, DOI 10.4049/jimmunol.167.2.708; Grohmann U, 2001, J IMMUNOL, V166, P277, DOI 10.4049/jimmunol.166.1.277; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; KAMIMURA S, 1991, ACTA MED OKAYAMA, V45, P135; Konieczny BT, 1998, J IMMUNOL, V160, P2059; Kudo Y, 2000, BBA-MOL BASIS DIS, V1500, P119, DOI 10.1016/S0925-4439(99)00096-4; Mellor AL, 2002, J IMMUNOL, V168, P3771, DOI 10.4049/jimmunol.168.8.3771; MELLROY D, 2001, BLOOD, V97, P3470; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Munn DH, 1996, J IMMUNOL, V156, P523; MUNN DH, UNPUB; Orenstein JM, 1999, ULTRASTRUCT PATHOL, V23, P79, DOI 10.1080/019131299281734; Reddy A, 1997, BLOOD, V90, P3640, DOI 10.1182/blood.V90.9.3640; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shortman K, 2001, NAT IMMUNOL, V2, P988, DOI 10.1038/ni1101-988; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Summers KL, 2001, AM J PATHOL, V159, P285, DOI 10.1016/S0002-9440(10)61694-X; THOMAS SR, 1994, J BIOL CHEM, V269, P14457; Thomas SR, 2001, J IMMUNOL, V166, P6332, DOI 10.4049/jimmunol.166.10.6332; Yang D, 1999, J IMMUNOL, V163, P1737	34	823	898	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1867	1870		10.1126/science.1073514	http://dx.doi.org/10.1126/science.1073514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228717				2022-12-28	WOS:000177955000043
J	Pell, JP; Sirel, JM; Marsden, AK; Ford, I; Walker, NL; Cobbe, SM				Pell, JP; Sirel, JM; Marsden, AK; Ford, I; Walker, NL; Cobbe, SM			Potential impact of public access defibrillators on survival after out of hospital cardiopulmonary arrest: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							AMERICAN-HEART-ASSOCIATION; CARDIAC-ARREST; AIRLINE	Objective To estimate the potential impact of public access defibrillators on overall survival after out of hospital cardiac arrest. Design Retrospective cohort study using data from an electronic register. A statistical model was used to estimate the effect on survival of placing public access defibrillators at suitable or possibly suitable sites. Setting Scottish Ambulance Service. Subjects Records of all out of hospital cardiac arrests due to heart disease in Scotland in 1991-8. Main outcome measures Observed and predicted survival to discharge from hospital. Results Of 15 189 arrests, 12 004 (79.0%) occurred in sites not suitable for the location of public access defibrillators, 453 (3.0%) in sites where they may be suitable, and 2732 (18.0%) in suitable sites. Defibrillation was given in 67.9% of arrests that occurred in possibly suitable sites for locating defibrillators and in 72.9% of arrests that occurred in suitable sites. Compared with an actual overall survival of 744 (5.0%), the predicted survival with public access defibrillators ranged from 942 (6.3%) to 959 (6.5%), depending on the assumptions made regarding defibrillator coverage. Conclusions The predicted increase in survival from targeted provision of public access defibrillators is less than the increase achievable through expansion of first responder defibrillation to non-ambulance personnel, such as police or firefighters, or of bystander cardiopulmonary resuscitation. Additional resources for wide scale coverage of public access defibrillators are probably not justified by the marginal improvement in survival.	Univ Glasgow, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland; Scottish Ambulance Serv Headquarters, Edinburgh EH10 5UU, Midlothian, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Cobbe, SM (corresponding author), Univ Glasgow, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland.		Ford, Ian/ABE-6145-2020	Pell, Jill/0000-0002-8898-7035				CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Nichol G, 1998, CIRCULATION, V97, P1309, DOI 10.1161/01.CIR.97.13.1309; Nichol G, 1998, CIRCULATION, V97, P1315, DOI 10.1161/01.CIR.97.13.1315; ORourke MF, 1997, CIRCULATION, V96, P2849, DOI 10.1161/01.CIR.96.9.2849; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Pell JP, 2001, BRIT MED J, V322, P1385, DOI 10.1136/bmj.322.7299.1385; *SECR STAT HLTH, 1999, SAV LIV OUR HLTH NAT; SEDGWICK ML, 1994, RESUSCITATION, V27, P55, DOI 10.1016/0300-9572(94)90022-1; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; WEAVER WD, 1988, NEW ENGL J MED, V319, P661, DOI 10.1056/NEJM198809153191101; WILCOXGOK VL, 1991, MED CARE, V29, P104, DOI 10.1097/00005650-199102000-00003	11	58	61	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2002	325	7363					515	517		10.1136/bmj.325.7363.515	http://dx.doi.org/10.1136/bmj.325.7363.515			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593NJ	12217989	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000177997800015
J	Dehaene, S				Dehaene, S			Single-neuron arithmetic	SCIENCE			English	Editorial Material							MONKEYS		Serv Hosp Frederic Joliot, INSERM, U562, CEA,DRM,DSV, F-91401 Orsay, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Dehaene, S (corresponding author), Serv Hosp Frederic Joliot, INSERM, U562, CEA,DRM,DSV, F-91401 Orsay, France.							Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S., 1997, NUMBER SENSE; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; GALLISTEL CR, 1992, COGNITION, V44, P43, DOI 10.1016/0010-0277(92)90050-R; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; THOMPSON RF, 1970, SCIENCE, V168, P271, DOI 10.1126/science.168.3928.271; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	11	26	28	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1652	1653		10.1126/science.1076392	http://dx.doi.org/10.1126/science.1076392			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215630				2022-12-28	WOS:000177819100031
J	Hatten, ME				Hatten, ME			Neuroscience - New directions in neuronal migration	SCIENCE			English	Review							CAENORHABDITIS-ELEGANS DEVELOPMENT; CEREBELLAR GRANULE NEURONS; DEVELOPING CEREBRAL-CORTEX; SUBVENTRICULAR ZONE; CELL-MIGRATION; C-ELEGANS; CORTICAL DEVELOPMENT; RHOMBIC LIP; SYSTEM; BRAIN	Over the past decade, genetic analyses have yielded a more molecular view of neuronal migration and its role in central nervous system development. We now realize that many of the molecular mechanisms that guide migrations in invertebrates are recapitulated in the vertebrate nervous system. These mechanisms guide dorsoventral and anterior-posterior migrations and merge with radial migratory pathways that are prominent in the development of the mammalian cortex. This review discusses the choreography of these different migratory mechanisms within the context of genetic approaches that have defined their molecular mechanisms.	Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA	Rockefeller University	Hatten, ME (corresponding author), Rockefeller Univ, Dev Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.							Adams NC, 2002, DEVELOPMENT, V129, P965; Alcantara S, 2000, DEVELOPMENT, V127, P1359; Alvarez C, 1997, REV MEX AST ASTR, V7, P207; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Anton ES, 1997, DEVELOPMENT, V124, P3501; Blelloch R, 1999, CURR OPIN CELL BIOL, V11, P608, DOI 10.1016/S0955-0674(99)00028-9; Burgess HA, 1999, J NEUROSCI RES, V58, P567, DOI 10.1002/(SICI)1097-4547(19991115)58:4<567::AID-JNR9>3.3.CO;2-K; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; de Diego I, 2002, DEVELOPMENT, V129, P297; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; Forrester WC, 1998, GENETICS, V148, P151; GASSER UE, 1990, J NEUROSCI, V10, P1276; GASSER UE, 1990, P NATL ACAD SCI USA, V87, P4543, DOI 10.1073/pnas.87.12.4543; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Kwon YT, 1998, J COMP NEUROL, V395, P510, DOI 10.1002/(SICI)1096-9861(19980615)395:4<510::AID-CNE7>3.0.CO;2-4; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; Lim DA, 1997, P NATL ACAD SCI USA, V94, P14832, DOI 10.1073/pnas.94.26.14832; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Montell DJ, 1999, DEVELOPMENT, V126, P3035; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Sym M, 1999, CELL, V98, P25, DOI 10.1016/S0092-8674(00)80603-0; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Tomoda T, 1999, NEURON, V24, P833, DOI 10.1016/S0896-6273(00)81031-4; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Wolf FW, 1998, NEURON, V20, P655, DOI 10.1016/S0896-6273(00)81006-5; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	54	248	249	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1660	1663		10.1126/science.1074572	http://dx.doi.org/10.1126/science.1074572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215636				2022-12-28	WOS:000177819100037
J	Di Noia, J; Neuberger, MS				Di Noia, J; Neuberger, MS			Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase	NATURE			English	Article							SOMATIC HYPERMUTATION; DEAMINATED CYTOSINE; ESCHERICHIA-COLI; GENE CONVERSION; N-GLYCOSIDASE; HUMAN-CELLS; EXCISION; BACTERIOPHAGE-PBS2; INSTABILITY; EXPRESSION	A functional immune system depends on the production of a wide range of immunoglobulin molecules. Immunoglobulin variable region (IgV) genes are diversified after gene rearrangement by hypermutation. In the DNA deamination model, we have proposed that deamination of dC residues to dU by activation-induced deaminase (AID) triggers this diversification. In hypermutating chicken DT40 B cells, most IgV mutations are dC --> dG/dA or dG --> dC/dT transversions, which are proposed to result from replication over sites of base loss produced by the excision activity of uracil-DNA glycosylase. Blocking the activity of uracil-DNA glycosylase should instead lead to replication over the dU lesion, resulting in dC --> dT (and dG --> dA) transitions. Here we show that expression in DT40 cells of a bacteriophage-encoded protein that inhibits uracil-DNA glycosylase shifts the pattern of IgV gene mutations from transversion dominance to transition dominance. This is good evidence that antibody diversification involves dC --> dU deamination within the immunoglobulin locus itself.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Neuberger, MS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.		Di Noia, Javier Marcelo/D-2285-2012	Di Noia, Javier Marcelo/0000-0003-2896-0321				BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; FRIEDBERG EC, 1975, J VIROL, V16, P315, DOI 10.1128/JVI.16.2.315-321.1975; Handa P, 2001, J BIOL CHEM, V276, P17324, DOI 10.1074/jbc.M011166200; Harris RS, 2001, J VIROL, V75, P10488, DOI 10.1128/JVI.75.21.10488-10492.2001; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; KARRAN P, 1981, BIOCHEMISTRY-US, V20, P6092, DOI 10.1021/bi00524a027; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 2001, EMBO J, V20, P4278, DOI 10.1093/emboj/20.15.4278; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Radany EH, 2000, MUTAT RES-DNA REPAIR, V461, P41, DOI 10.1016/S0921-8777(00)00040-9; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; WANG ZG, 1988, J BACTERIOL, V170, P1082, DOI 10.1128/jb.170.3.1082-1091.1988	21	429	439	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					43	48		10.1038/nature00981	http://dx.doi.org/10.1038/nature00981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214226				2022-12-28	WOS:000177788600031
J	Whelan, GP; Gary, NE; Kostis, J; Boulet, JR; Hallock, JA				Whelan, GP; Gary, NE; Kostis, J; Boulet, JR; Hallock, JA			The changing pool of international medical graduates seeking certification training in US graduate medical education programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL SKILLS ASSESSMENT; COMMISSION	International medical graduates (IMGs) consistently represent approximately one fourth of both the physician workforce and the graduate medical education (GME) population of the United States. To enter into accredited US GME programs, IMGs must be certified by the Educational Commission for Foreign Medical Graduates (ECFMG). Changes in the number and characteristics of those seeking certification directly affect the GME population and the future physician workforce in the United States. In July 1998, in response to concerns that IMGs might be lacking in basic clinical skills (eg, history taking, physical examinations, communicating with patients in spoken English), the ECFMG initiated a requirement that IMGs pass a clinical skills assessment (CSA) to achieve ECFMG certification. In this study we examined the pool of IMGs seeking certification, using databases reporting on all individuals beginning the certification process from 1995 through 2001. For this period, we found that the number of IMG candidates taking the Step 1 examination decreased by 45.5% (36983 vs 16828), and the number of IMGs registered to take Step 2 decreased by 38.1 % (31751 vs 12 122). The number of ECFMG certificates issued annually decreased, from a range of 9000 to 12000 (1995-1998) to fewer than 6000 (1999-2001). Although the number of IMGs annually seeking and receiving certification has decreased, the quality of the applicants appears to have improved and the number of IMGs certified annually continues to adequately fill GME positions not taken by US medical graduates.	Educ Commiss Foreign Med Grad, Philadelphia, PA 19104 USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Whelan, GP (corresponding author), Educ Commiss Foreign Med Grad, 3624 Market St, Philadelphia, PA 19104 USA.			Boulet, John/0000-0003-3703-5613				Ayers WR, 2001, TEACH LEARN MED, V13, P214, DOI 10.1207/S15328015TLM1304_01; Boulet JR, 1998, ACAD MED, V73, pS94, DOI 10.1097/00001888-199810000-00057; Boulet JR, 2001, MED EDUC, V35, P767, DOI 10.1046/j.1365-2923.2001.00998.x; BOULET JR, IN PRESS ADV HLTH SC; *ED COMM FOR MED G, 1996, ECFMG CERT APPL STEP; *US MED LIC EX SEC, 2002, USMLE CLIN SKILLS EX; Whelan GP, 2001, MED EDUC, V35, P757, DOI 10.1046/j.1365-2923.2001.00977.x; Whelan GP, 1999, MED TEACH, V21, P156, DOI 10.1080/01421599979789; World Health Organization, 2000, WORLD DIR MED SCH	9	50	50	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1079	1084		10.1001/jama.288.9.1079	http://dx.doi.org/10.1001/jama.288.9.1079			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NA	12204075				2022-12-28	WOS:000177764600009
J	Berger, A				Berger, A			How does it work? Bone mineral density scans	BRITISH MEDICAL JOURNAL			English	Review																		KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093	2	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2002	325	7362					484	484		10.1136/bmj.325.7362.484	http://dx.doi.org/10.1136/bmj.325.7362.484			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592EZ	12202332	Green Published			2022-12-28	WOS:000177924900025
J	Ravasz, E; Somera, AL; Mongru, DA; Oltvai, ZN; Barabasi, AL				Ravasz, E; Somera, AL; Mongru, DA; Oltvai, ZN; Barabasi, AL			Hierarchical organization of modularity in metabolic networks	SCIENCE			English	Article							SCALE-FREE NETWORKS; REGULATORY NETWORKS; SMALL-WORLD; BIOLOGY; PATHWAYS; DEFINITION; MOTIFS	Spatially or chemically isolated functional modules composed of several cellular components and carrying discrete functions are considered fundamental building blocks of cellular organization, but their presence in highly integrated biochemical networks lacks quantitative support. Here, we show that the metabolic networks of 43 distinct organisms are organized into many small, highly connected topologic modules that combine in a hierarchical manner into larger, less cohesive units, with their number and degree of clustering following a power law. Within Escherichia coli, the uncovered hierarchical modularity closely overlaps with known metabolic functions. The identified network architecture may be generic to system-level cellular organization.	Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	Northwestern University; University of Notre Dame	Oltvai, ZN (corresponding author), Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA.	zno008@northwestern.edu; alb@nd.edu	Barabasi, Albert-Laszlo/S-6474-2017; Regan, Erzsébet Ravasz/AAG-8989-2019	Regan, Erzsébet Ravasz/0000-0002-8663-3153; Barabasi, Albert/0000-0002-4028-3522				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2001, PHYSICA A, V299, P559, DOI 10.1016/S0378-4371(01)00369-7; Bollobas B., 1985, RANDOM GRAPHS; Dorogovtsev SN, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066122; DOROGOVTSEV SN, 2001, CONDMAT0112143; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; Flake GW, 2002, COMPUTER, V35, P66, DOI 10.1109/2.989932; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GIRVAN M, 2001, CONDMAT0112110; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Holter NS, 2001, P NATL ACAD SCI USA, V98, P1693, DOI 10.1073/pnas.98.4.1693; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; Rao CV, 2001, ANNU REV BIOMED ENG, V3, P391, DOI 10.1146/annurev.bioeng.3.1.391; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; SOKAL J, 1973, NUMERICAL TAXONOMY; Vazquez A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066130; VAZQUEZ AM, IN PRESS; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wolf YI, 2002, BIOESSAYS, V24, P105, DOI 10.1002/bies.10059; Wuchty S, 2001, MOL BIOL EVOL, V18, P1694, DOI 10.1093/oxfordjournals.molbev.a003957	32	2819	2959	6	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1551	1555		10.1126/science.1073374	http://dx.doi.org/10.1126/science.1073374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202830	Green Submitted			2022-12-28	WOS:000177697300057
J	Tapon, N; Harvey, KF; Bell, DW; Wahrer, DCR; Schiripo, TA; Haber, DA; Hariharan, IK				Tapon, N; Harvey, KF; Bell, DW; Wahrer, DCR; Schiripo, TA; Haber, DA; Hariharan, IK			salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines	CELL			English	Article							DEPENDENT KINASE INHIBITOR; REAPER; HID; DEGRADATION; PROTEINS; SURVIVAL; GROWTH; DIAP1; GRIM; HOMOLOGS	The number of cells in an organism is determined by regulating both cell proliferation and cell death. Relatively few mechanisms have been identified that can modulate both of these processes. In a screen for Drosophila mutations that result in tissue overgrowth, we identified salvador (sav), a gene that promotes both cell cycle exit and cell death. Elevated Cyclin E and DIAP1 levels are found in mutant cells, resulting in delayed cell cycle exit and impaired apoptosis. Salvador contains two WW domains and binds to the Warts (or LATS) protein kinase. The human ortholog of salvador(hWW45) is mutated in three cancer cell lines. Thus, salvador restricts cell numbers in vivo by functioning as a dual regulator of cell proliferation and apoptosis.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hariharan, IK (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.	hariharan@helix.mgh.harvard.edu	Harvey, Kieran/AAD-5268-2022	Tapon, Nicolas/0000-0001-5267-6510; Harvey, Kieran/0000-0001-7845-369X	NATIONAL CANCER INSTITUTE [R21CA087691] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061672] Funding Source: NIH RePORTER; NCI NIH HHS [CA87691] Funding Source: Medline; NEI NIH HHS [EY11632] Funding Source: Medline; NIGMS NIH HHS [GM61672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; BRYANT PJ, 1993, DEVELOPMENT, P239; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hays R, 2002, NAT CELL BIOL, V4, P425, DOI 10.1038/ncb794; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Jones L, 2000, DEVELOPMENT, V127, P4619; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kato Y, 2002, J BIOL CHEM, V277, P10173, DOI 10.1074/jbc.M110490200; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lisi S, 2000, GENETICS, V154, P669; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Valverde P, 2000, BIOCHEM BIOPH RES CO, V276, P990, DOI 10.1006/bbrc.2000.3582; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Wolff Tanya, 1993, P1277; XU TA, 1995, DEVELOPMENT, V121, P1053; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	29	653	686	2	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					467	478		10.1016/S0092-8674(02)00824-3	http://dx.doi.org/10.1016/S0092-8674(02)00824-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202036	Bronze			2022-12-28	WOS:000177653200008
J	Rubinstein, JT				Rubinstein, JT			Paediatric cochlear implantation: prosthetic hearing and language development	LANCET			English	Review							DEAF-CHILDREN; SPEECH-PERCEPTION; AGE; THRESHOLDS	Context Cochlear implantation offers hearing and vocational benefits to children and adults who lose their hearing after acquiring speech and language. But such implantations in prelingually deaf children are controversial, with concerns about diagnosis in very young children, safety, and durability. Implantation of children under age 2 years is potentially associated with higher surgical and anaesthesia risks, and with more challenging preoperative and postoperative management. Starting point Although only a small number of children implanted before age 2 have sufficient maturity and implant experience to undergo adult-type speech recognition tests, surgical series show that these children may be implanted safely and that their subsequent speech perceptions is at least as good as children implanted at an older age. The Nottingham, UK, group recently reported on a consecutive sample of 12 children aged under 2 years at implantation (Arch Otolaryngol Head Neck Surg 2002; 128: 11-14). S S Hehar and colleagues show satisfactory perioperative and postoperative surgical outcomes, 2 years after the implantation, mean scores on the Listening Progress Profile had increased from 1 to 42 Median scores of Categories of Auditory Performance increased from 0 to 5. There were no significant differences compared with a historical control group of deaf children implanted at ages 3-5. Where next? Early results from parental observation of auditory behaviours show that children who receive a cochlear implant at an early age perform at least as well as those implanted later. These data, combined with more rigorous speech recognition results in older children, merit a gradual reduction in the age of implantation, although the uncertainties inherent in audiometric assessment and measurement of hearing-aid benefit in infants must be borne in mind. Cochlear implants in prelingually deafened children permit improved development of speech reception, language acquisition, and reading comprehension.	Univ Iowa, Dept Otolaryngol, Iowa City, IA 52242 USA; Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Rubinstein, JT (corresponding author), Univ Iowa, Dept Otolaryngol, Iowa City, IA 52242 USA.	jay-rubinstein@uiowa.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC000242, P50DC000242] Funding Source: NIH RePORTER; NCRR NIH HHS [RR59] Funding Source: Medline; NIDCD NIH HHS [DC00242] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BROOKHOUSER PE, 1990, LARYNGOSCOPE, V100, P803; Chamberlain C, 2000, LANGUAGE ACQUISITION BY EYE, P221; CHARROW VR, 1974, DEV PSYCHOL, V10, P463, DOI 10.1037/h0036711; Cheng AK, 2000, JAMA-J AM MED ASSOC, V284, P850, DOI 10.1001/jama.284.7.850; Connor CM, 2000, J SPEECH LANG HEAR R, V43, P1185, DOI 10.1044/jslhr.4305.1185; Crouch RA, 1997, HASTINGS CENT REP, V27, P14, DOI 10.2307/3528774; FryaufBertschy H, 1997, J SPEECH LANG HEAR R, V40, P183, DOI 10.1044/jslhr.4001.183; Gravel JS, 2000, J SPEECH LANG HEAR R, V43, P631, DOI 10.1044/jslhr.4303.631; Hehar SS, 2002, ARCH OTOLARYNGOL, V128, P11, DOI 10.1001/archotol.128.1.11; Hughes ML, 2000, EAR HEARING, V21, P164, DOI 10.1097/00003446-200004000-00010; Lane H., 1999, MASK BENEVOLENCE DIS; Miyamoto RT, 1999, ACTA OTO-LARYNGOL, V119, P219; Nikolopoulos TP, 1999, LARYNGOSCOPE, V109, P595, DOI 10.1097/00005537-199904000-00014; O'Donoghue GM, 2000, LANCET, V356, P466, DOI 10.1016/S0140-6736(00)02555-1; Osberger MJ, 1997, OTOLARYNG HEAD NECK, V117, P145, DOI 10.1016/S0194-5998(97)70166-9; Ruben RJ, 1997, ACTA OTO-LARYNGOL, V117, P202, DOI 10.3109/00016489709117769; Ruben RJ, 2000, LARYNGOSCOPE, V110, P241, DOI 10.1097/00005537-200002010-00010; Rubinstein JT, 1999, AM J OTOL, V20, P445; Spencer L, 1997, VOLTA REV, V99, P193; Summerfield AQ, 1999, INT J PEDIATR OTORHI, V47, P141, DOI 10.1016/S0165-5876(98)00133-5; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Tomblin JB, 1999, J SPEECH LANG HEAR R, V42, P497, DOI 10.1044/jslhr.4202.497; TYEMURRAY N, 1988, J SPEECH HEAR DISORD, V53, P226, DOI 10.1044/jshd.5303.226; Tyler R S, 2000, Cochlear Implants Int, V1, P39, DOI 10.1179/cim.2000.1.1.39; Tyler RS, 2000, ANN OTO RHINOL LARYN, V109, P82, DOI 10.1177/0003489400109S1235; Waltzman SB, 1998, AM J OTOL, V19, P158; Wilbur R B, 2000, J Deaf Stud Deaf Educ, V5, P81, DOI 10.1093/deafed/5.1.81; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161	28	27	30	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					483	485		10.1016/S0140-6736(02)09679-4	http://dx.doi.org/10.1016/S0140-6736(02)09679-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582GZ	12241737				2022-12-28	WOS:000177342900030
J	Kinchen, KS; Sadler, J; Fink, N; Brookmeyer, R; Klag, MJ; Levey, AS; Powe, NR				Kinchen, KS; Sadler, J; Fink, N; Brookmeyer, R; Klag, MJ; Levey, AS; Powe, NR			The timing of specialist evaluation in chronic kidney disease and mortality	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC-RENAL-FAILURE; MAINTENANCE DIALYSIS; COMORBIDITY ASSESSMENT; COEXISTENT DISEASES; REPLACEMENT THERAPY; SERUM CREATININE; OUTCOMES; CARE; HEMODIALYSIS; INITIATION	Background: Care for chronic renal failure involves management of complications and preparation for possible dialysis. Patients often are not evaluated by nephrologists in a timely manner. Objective: To identify factors associated with late evaluation by a nephrologist and to assess whether late evaluation is associated with worse survival once patients develop end-stage renal disease (ESRD). Design: National prospective cohort study. Setting: 81 dialysis facilities throughout the United States. Patients: 828 patients with new-onset ESRD. Measurements: Time from first evaluation by a nephrologist to initiation of dialysis, classified as late (<4 months), intermediate (4 to 12 months), or early (>12 months); rate of death, from initiation of dialysis to an average of 2.2 years of follow-up; and demographic, clinical, and laboratory characteristics. Results: After adjustment for potential confounders, late evaluation was more common among black men than white men (44.8% vs. 24.5%; P < 0.05), uninsured patients than insured patients (56.7% vs. 29.0%; P < 0.05) and patients with severe comorbid disease than those with mild comorbid disease (35.0% vs. 23.0%; P < 0.05). Compared with patients who had early evaluation, the risk for death was greater among patients evaluated late and was graded (hazard ratio, 1.3 [95% CI, 0.87 to 2.06] for patients with intermediate evaluation and 1.8 [CI, 1.21 to 2.61] for those with late evaluation) after adjustment for dialysis method, demographic characteristics, and socioeconomic status in Cox proportional hazards regression analysis. After additional adjustment for such factors as the presence and severity of comorbid conditions, the association remained graded (hazard ratio, 1.2 [CI, 0.73 to 1.82] for patients evaluated at an intermediate point and 1.6 [CI, 1.04 to 2.39] for those evaluated late). Conclusions: Late evaluation of patients with chronic renal failure by a nephrologist is associated with greater burden and severity of comorbid disease, black ethnicity, lack of health insurance, and shorter duration of survival.	Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Sch Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Robert Wood Johnson Clin Scholars Program, Sch Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Independent Dialysis Fdn, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Tufts Univ New England Med Ctr, Boston, MA 02111 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tufts Medical Center	Powe, NR (corresponding author), Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Sch Med, 2024 E Monument Sr,Suite 2-600, Baltimore, MD 21205 USA.	npowe@jhmi.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059616, K24DK002643, K24DK002856] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS-08365] Funding Source: Medline; NIDDK NIH HHS [K24DK02856, K24DK02643, R01 DK59616] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1997, Am J Kidney Dis, V30, pS67; Arora P, 1999, J AM SOC NEPHROL, V10, P1281; Athienites NV, 2000, SEMIN DIALYSIS, V13, P320, DOI 10.1046/j.1525-139x.2000.00095.x; Campbell JD, 1989, DIALYSIS TRANSPLANT, V18, P660; Eknoyan G, 2000, AM J KIDNEY DIS, V35, pS69, DOI 10.1016/S0272-6386(00)70232-0; GREENFIELD S, 1993, MED CARE, V31, P141, DOI 10.1097/00005650-199302000-00005; HAKIM RM, 1995, J AM SOC NEPHROL, V6, P1319; HOOD SA, 1995, ASAIO J, V41, pM422, DOI 10.1097/00002480-199507000-00044; Hood SA, 1998, SEMIN DIALYSIS, V11, P175, DOI 10.1111/j.1525-139X.1998.tb00329.x; INNES A, 1992, NEPHROL DIAL TRANSPL, V7, P467; Ismail N, 1998, NEPHROL DIAL TRANSPL, V13, P246, DOI 10.1093/ndt/13.2.246; Jones CA, 1998, AM J KIDNEY DIS, V32, P992, DOI 10.1016/S0272-6386(98)70074-5; JUNGERS P, 1993, NEPHROL DIAL TRANSPL, V8, P1089; Jungers P, 2001, NEPHROL DIAL TRANSPL, V16, P2357, DOI 10.1093/ndt/16.12.2357; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; KHAN IH, 1994, Q J MED, V87, P559; Klein JP., 2003, SURVIVAL ANAL TECHNI; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Ma JZ, 1999, J AM SOC NEPHROL, V10, P610; Miskulin DC, 2001, KIDNEY INT, V60, P1498, DOI 10.1046/j.1523-1755.2001.00954.x; Miskulin DC, 2002, AM J KIDNEY DIS, V39, P324, DOI 10.1053/ajkd.2002.30552; *NAT KIDN FDN, 2002, AM J KIDNEY DIS S, V39, pS65; Nicolucci A, 1992, ASAIO J, V38, pM291, DOI 10.1097/00002480-199207000-00040; *NIH, PROSP COH STUD CHRON; Obrador GT, 1999, J AM SOC NEPHROL, V10, P1793; Obrador GT, 1998, AM J KIDNEY DIS, V31, P398, DOI 10.1053/ajkd.1998.v31.pm9506677; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Powe NR, 1999, KIDNEY INT, V55, P1081, DOI 10.1046/j.1523-1755.1999.0550031081.x; Powe NR, 1996, SEMIN DIALYSIS, V9, P9, DOI 10.1111/j.1525-139X.1996.tb00890.x; RATCLIFFE PJ, 1984, BRIT MED J, V288, P441, DOI 10.1136/bmj.288.6415.441; Ritz E, 1999, DIABETES CARE, V22, pB80; Roubicek C, 2000, AM J KIDNEY DIS, V36, P35, DOI 10.1053/ajkd.2000.8241; Schmidt RJ, 1998, AM J KIDNEY DIS, V32, P278, DOI 10.1053/ajkd.1998.v32.pm9708613; Sesso R, 1996, NEPHROL DIAL TRANSPL, V11, P2417, DOI 10.1093/oxfordjournals.ndt.a027207; *US REN DAT SYST, 2000, USRDS 2000 ANN DAT R; US Renal Data System, 1999, USRDS 1999 ANN DAT R; US Renal Data System, 1998, USRDS 1998 ANN DAT R; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; 2000, CAN FAM PHYSICIAN, V46, P661	40	370	377	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					479	486		10.7326/0003-4819-137-6-200209170-00007	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230348				2022-12-28	WOS:000178069100001
J	Frimmel, HE				Frimmel, HE			Genesis of the world's largest gold deposits	SCIENCE			English	Editorial Material							DETRITAL HEAVY MINERALS; 3250-2750 MA SANDSTONES; ARCHEAN ATMOSPHERE; PILBARA CRATON; REDOX STATE; AUSTRALIA; ORIGIN; REEF		Univ Cape Town, Dept Geol Sci, ZA-7701 Rondebosch, South Africa	University of Cape Town	Frimmel, HE (corresponding author), Univ Cape Town, Dept Geol Sci, ZA-7701 Rondebosch, South Africa.		Frimmel, Hartwig/R-3324-2019	Frimmel, Hartwig/0000-0003-3041-8208				Barnicoat AC, 1997, NATURE, V386, P820, DOI 10.1038/386820a0; Barton ES, 1996, CHEM GEOL, V133, P173, DOI 10.1016/S0009-2541(96)00075-7; England GL, 2001, TERRA NOVA, V13, P360, DOI 10.1046/j.1365-3121.2001.00363.x; FRIMMEL HE, 2002, INTEGRATED METHODS D, V9, P17; Goldfarb RJ, 2001, ORE GEOL REV, V18, P1, DOI 10.1016/S0169-1368(01)00016-6; Kirk J, 2002, SCIENCE, V297, P1856, DOI 10.1126/science.1075270; MINTER WEL, 1993, ECON GEOL BULL SOC, V88, P237, DOI 10.2113/gsecongeo.88.2.237; Minter WEL, 1999, ECON GEOL BULL SOC, V94, P665, DOI 10.2113/gsecongeo.94.5.665; Ohmoto H, 1999, GEOLOGY, V27, P1151, DOI 10.1130/0091-7613(1999)027<1151:RSOTAA>2.3.CO;2; Rasmussen B, 1999, GEOLOGY, V27, P115, DOI 10.1130/0091-7613(1999)027<0115:RSOTAA>2.3.CO;2; RUNDLE CC, 1977, PHILOS T R SOC A, V286, P567, DOI 10.1098/rsta.1977.0132; 1999, MINERAL PETROL, V66	12	6	9	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1815	1817		10.1126/science.1076515	http://dx.doi.org/10.1126/science.1076515			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228704				2022-12-28	WOS:000177955000026
J	Volpe, TA; Kidner, C; Hall, IM; Teng, G; Grewal, SIS; Martienssen, RA				Volpe, TA; Kidner, C; Hall, IM; Teng, G; Grewal, SIS; Martienssen, RA			Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi	SCIENCE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; DISRUPT CHROMOSOME SEGREGATION; FISSION YEAST; DNA METHYLATION; DROSOPHILA-MELANOGASTER; TRANSPOSABLE ELEMENTS; NEUROSPORA-CRASSA; MESSENGER-RNA; C-ELEGANS; GENE	Eukaryotic heterochromatin is characterized by a high density of repeats and transposons, as well as by modified histones, and influences both gene expression and chromosome segregation. In the fission yeast Schizosaccharomyces pombe, we deleted the argonaute, dicer, and RNA-dependent RNA polymerase gene homologs, which encode part of the machinery responsible for RNA interference (RNAi). Deletion results in the aberrant accumulation of complementary transcripts from centromeric heterochromatic repeats. This is accompanied by transcriptional de-repression of transgenes integrated at the centromere, loss of histone H3 lysine-9 methylation, and impairment of centromere function. We propose that double-stranded RNA arising from centromeric repeats targets formation and maintenance of heterochromatin through RNAi.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Kidner, Catherine/0000-0001-6426-3000	NIGMS NIH HHS [GM59772] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059772] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; ALLSHIRE R, COMMUNICATION; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Ayoub N, 2000, GENETICS, V156, P983; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baum M, 2000, MOL CELL BIOL, V20, P2852, DOI 10.1128/MCB.20.8.2852-2864.2000; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Ekwall K, 1999, GENETICS, V153, P1153; Ekwall K, 1996, J CELL SCI, V109, P2637; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; FISHEL B, 1988, MOL CELL BIOL, V8, P754, DOI 10.1128/MCB.8.2.754; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 1997, GENETICS, V146, P1221; HALL IH, UNPUB; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Henikoff S, 1992, CURR OPIN GENET DEV, V2, P907, DOI 10.1016/S0959-437X(05)80114-5; HOCHSTENBACH F, 1999, FISSION YEAST HDB; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; JORGENSEN R, 1990, TRENDS BIOTECHNOL, V8, P340, DOI 10.1016/0167-7799(90)90220-R; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KIDNER C, UNPUB; KLAR AJS, 1993, COLD SPRING HARB SYM, V58, P457, DOI 10.1101/SQB.1993.058.01.052; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lynn K, 1999, DEVELOPMENT, V126, P469; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Partridge JF, 2000, GENE DEV, V14, P783; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; REINHART B, 1831, SCIENCE, V297, DOI DOI 10.1126/SCIENCE.1077183; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schmidt A, 1999, GENETICS, V151, P749; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; STEINER NC, 1993, MOL CELL BIOL, V13, P4578, DOI 10.1128/MCB.13.8.4578; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; TAKAHASHI K, 1991, J MOL BIOL, V218, P13, DOI 10.1016/0022-2836(91)90867-6; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; VOLPE T, UNPUB; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	72	1564	1752	6	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1833	1837		10.1126/science.1074973	http://dx.doi.org/10.1126/science.1074973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12193640				2022-12-28	WOS:000177955000034
J	Gottfried, K				Gottfried, K			Quantum electrodynamics: Matter all in the mind	NATURE			English	Editorial Material									Cornell Univ, Nucl Studies Lab, Ithaca, NY 14853 USA	Cornell University	Gottfried, K (corresponding author), Cornell Univ, Nucl Studies Lab, Ithaca, NY 14853 USA.							Kragh H., 1990, DIRAC SCI BIOGRAPHY; Miller A., 1994, EARLY QUANTUM ELECTR; Schweber S.S., 1994, QED MEN WHO MADE IT	3	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					117	117		10.1038/419117a	http://dx.doi.org/10.1038/419117a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226643	Bronze			2022-12-28	WOS:000177931200020
J	Hoadley, DJ; Mark, EJ; Bencardino, JT; Gandhi, R				Hoadley, DJ; Mark, EJ; Bencardino, JT; Gandhi, R			A 35-year-old long-term traveler to the Caribbean with a rapidly progressive soft-tissue infection - Toxic shock syndrome due to group A streptococcus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NECROTIZING FASCIITIS; MYIASIS		Baystate Med Ctr, Div Infect Dis, Springfield, MA 01199 USA; Baystate Travel Med Program, Springfield, MA USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Baystate Medical Center; Tufts University	Hoadley, DJ (corresponding author), Baystate Med Ctr, Div Infect Dis, Springfield, MA 01199 USA.							AUERBACH PS, 1991, NEW ENGL J MED, V325, P486, DOI 10.1056/NEJM199108153250707; BISNO AL, 1995, MANDELL DOUGLAS BENN, V2, P1786; BONNER JR, 1983, ANN INTERN MED, V99, P464, DOI 10.7326/0003-4819-99-4-464; BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390, DOI 10.1001/jama.1993.03500030088038; Chan WL, 1999, T ROY SOC TROP MED H, V93, P174, DOI 10.1016/S0035-9203(99)90298-5; HOADLEY DJ, 1988, CLIN RES, V36, pA20; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; Kain KC, 1999, MED CLIN N AM, V83, P1077; Kaul R, 1997, AM J MED, V103, P18, DOI 10.1016/S0002-9343(97)00160-5; KEYSTONE JS, 2001, TRAVEL MED ADVISOR; Kitching J, 1997, J ACCID EMERG MED, V14, P178; Lemons-Estes FM, 1999, DERMATOL CLIN, V17, P151, DOI 10.1016/S0733-8635(05)70076-0; Lille ST, 1996, J AM COLL SURGEONS, V182, P7; Majeski J, 1997, SOUTHERN MED J, V90, P1065, DOI 10.1097/00007611-199711000-00001; Mallon PWG, 1999, LANCET, V354, P1260, DOI 10.1016/S0140-6736(99)06246-7; Millikan LE, 1999, CLIN DERMATOL, V17, P191, DOI 10.1016/S0738-081X(99)00011-5; Minnaganti VR, 2000, HEART LUNG, V29, P306, DOI 10.1067/mhl.2000.106723; Orihel TC, 1997, AM J TROP MED HYG, V56, P452, DOI 10.4269/ajtmh.1997.56.452; Regev A, 1998, EUR J CLIN MICROBIOL, V17, P101, DOI 10.1007/BF01682164; SCHLIEVERT PM, 1998, TOXIC SHOCK SYNDROME, P1689; Schmid MR, 1998, AM J ROENTGENOL, V170, P615, DOI 10.2214/ajr.170.3.9490940; Stevens DL, 2000, J INFECT DIS, V182, P1117, DOI 10.1086/315850; Tsekouras AA, 1998, J INFECTION, V37, P188, DOI 10.1016/S0163-4453(98)80177-1; Walshaw CF, 1996, CLIN RADIOL, V51, P429, DOI 10.1016/S0009-9260(96)80164-4; Wilson ME, 1998, INFECT DIS CLIN N AM, V12, P471, DOI 10.1016/S0891-5520(05)70014-3; YUEN KY, 1993, SCAND J INFECT DIS, V25, P659, DOI 10.3109/00365549309008557	26	7	7	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					831	837		10.1056/NEJMcpc020112	http://dx.doi.org/10.1056/NEJMcpc020112			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226155				2022-12-28	WOS:000177921300009
J	Main, CJ; Williams, ACD				Main, CJ; Williams, ACD			ABC of psychological medicine - Musculoskeletal pain	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Hope Hosp, Dept Behav Med, Salford M6 8HD, Lancs, England; Univ London, Guys Kings & St Thomass Sch Med, London WC1E 7HU, England	University of London; King's College London	Main, CJ (corresponding author), Hope Hosp, Dept Behav Med, Salford M6 8HD, Lancs, England.		de C Williams, Amanda C/C-7816-2009	Williams, Amanda/0000-0003-3761-8704				Accident Compensation Corporation Ministry of Health Health Quality & Safety Commission New Zealand New Zealand Government, 2022, LIV STRONG LONG PREV; *CLIN STAND ADV GR, 1994, CLIN STAND ADV GROUP; ROLAND M, 2002, BACK BOOK; *ROYAL COLL GEN PR, 1996, CLIN GUID MAN AC LOW; Waddell G, 2000, OCCUPATIONAL HLTH GU	5	73	75	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2002	325	7363					534	537		10.1136/bmj.325.7363.534	http://dx.doi.org/10.1136/bmj.325.7363.534			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	593NJ	12217996	Green Published			2022-12-28	WOS:000177997800022
J	Wallentin, L				Wallentin, L			Non-ST-elevation acute coronary syndrome: fuel for the invasive strategy	LANCET			English	Editorial Material							RANDOMIZED TRIAL; ARTERY DISEASE		Univ Uppsala Hosp, Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden	Uppsala University; Uppsala University Hospital	Wallentin, L (corresponding author), Univ Uppsala Hosp, Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden.							Bertrand ME, 2000, EUR HEART J, V21, P1406, DOI 10.1053/euhj.2000.2301; BRAUNWALD E, 2002, ACC AHA 2002 GUIDELI; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Diderholm E, 2002, AM HEART J, V143, P760, DOI 10.1067/mhj.2002.121733; Lagerqvist B, 2001, J AM COLL CARDIOL, V38, P41, DOI 10.1016/S0735-1097(01)01308-0; LAGERQVIST B, IN PRESS J AM COLL C; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; Stenestrand U, 2002, LANCET, V359, P1805, DOI 10.1016/S0140-6736(02)08710-X; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2	10	17	18	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 7	2002	360	9335					738	739		10.1016/S0140-6736(02)09945-2	http://dx.doi.org/10.1016/S0140-6736(02)09945-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592HX	12241827				2022-12-28	WOS:000177933000010
J	Takagi, J; Petre, BM; Walz, T; Springer, TA				Takagi, J; Petre, BM; Walz, T; Springer, TA			Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling	CELL			English	Article							GLYCOPROTEIN-IIB-IIIA; ELECTRON-MICROSCOPY; ACTIVATION; AFFINITY; ANTAGONISTS; MECHANISM; SUBUNIT; LIGANDS; BINDING; ANTIBODIES	How ligand binding alters integrin conformation in outside-in signaling, and how inside-out signals alter integrin affinity for ligand, have been mysterious. We address this with electron microscopy, physicochemical measurements, mutational introduction of disulfides, and ligand binding to alphaVbeta3 and alphaIIbbeta3 integrins. We show that a highly bent integrin conformation is physiological and has low affinity for biological ligands. Addition of a high affinity ligand mimetic peptide or Mn2+ results in a switch blade-like opening to an extended structure. An outward swing of the hybrid domain at its junction with the I-like domain shows conformational change within the headpiece that is linked to ligand binding. Breakage of a C-terminal clasp between the alpha and beta subunits enhances Mn2+ induced unbending and ligand binding.	Harvard Univ, Sch Med, Ctr Blood Res, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Dept Pathol, Boston, MA 02115 USA.	springeroffice@cbr.med.harvard.edu		Walz, Thomas/0000-0003-2606-2835	NHLBI NIH HHS [HL48675] Funding Source: Medline; NIGMS NIH HHS [GM62580] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Bazzoni G, 1998, J BIOL CHEM, V273, P6670, DOI 10.1074/jbc.273.12.6670; Bednar B, 1997, CYTOMETRY, V28, P58, DOI 10.1002/(SICI)1097-0320(19970501)28:1<58::AID-CYTO7>3.0.CO;2-D; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Billheimer JT, 2002, BLOOD, V99, P3540, DOI 10.1182/blood.V99.10.3540; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Coller BS, 2001, THROMB HAEMOSTASIS, V86, P427; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; DU XP, 1993, J BIOL CHEM, V268, P23087; Egbertson MS, 1999, J MED CHEM, V42, P2409, DOI 10.1021/jm980722p; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giblin PA, 2001, ANNU REP MED CHEM, V36, P181, DOI 10.1016/S0065-7743(01)36058-X; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; HUBER W, 1995, EUR J BIOCHEM, V227, P647, DOI 10.1111/j.1432-1033.1995.tb20184.x; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; KOUNS WC, 1992, BLOOD, V80, P2539; Legler DF, 2001, J CELL SCI, V114, P1545; Liu SC, 2000, J CELL SCI, V113, P3563; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; PARISE LV, 1987, J BIOL CHEM, V262, P12597; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Petersen A, 1998, AUST J SOC ISSUES, V33, P92; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Scarborough RM, 2000, J MED CHEM, V43, P3453, DOI 10.1021/jm000022w; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; SMITH JW, 1994, J BIOL CHEM, V269, P960; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tanford C., 1961, PHYS CHEM MACROMOLEC; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yan BX, 2001, BIOCHEMISTRY-US, V40, P8861, DOI 10.1021/bi002902i; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200	45	889	920	4	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2002	110	5					599	611		10.1016/S0092-8674(02)00935-2	http://dx.doi.org/10.1016/S0092-8674(02)00935-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230977	Bronze			2022-12-28	WOS:000177943700007
J	Greiner, M; Mandel, O; Hansch, TW; Bloch, I				Greiner, M; Mandel, O; Hansch, TW; Bloch, I			Collapse and revival of the matter wave field of a Bose-Einstein condensate	NATURE			English	Article							SMALL ATOMIC SAMPLES; QUANTUM; COHERENCE; ENTANGLEMENT; OSCILLATOR; ARRAYS; PHASE	A Bose-Einstein condensate represents the most 'classical' form of a matter wave, just as an optical laser emits the most classical form of an electromagnetic wave. Nevertheless, the matter wave field has a quantized structure owing to the granularity of the discrete underlying atoms. Although such a field is usually assumed to be intrinsically stable (apart from incoherent loss processes), this is no longer true when the condensate is in a coherent superposition of different atom number states(1-6). For example, in a Bose-Einstein condensate confined by a three-dimensional optical lattice, each potential well can be prepared in a coherent superposition of different atom number states, with constant relative phases between neighbouring lattice sites. It is then natural to ask how the individual matter wave fields and their relative phases evolve. Here we use such a set-up to investigate these questions experimentally, observing that the matter wave field of the Bose-Einstein condensate undergoes a periodic series of collapses and revivals; this behaviour is directly demonstrated in the dynamical evolution of the multiple matter wave interference pattern. We attribute the oscillations to the quantized structure of the matter wave field and the collisions between individual atoms.	Univ Munich, Sekt Phys, D-80799 Munich, Germany; Max Planck Inst Quantum Opt, D-85748 Garching, Germany	University of Munich; Max Planck Society	Bloch, I (corresponding author), Univ Munich, Sekt Phys, Schellingstr 4-III, D-80799 Munich, Germany.		Greiner, Markus/E-9512-2017; Bloch, Immanuel/G-3174-2010; Greiner, Markus/A-8502-2010; Bloch, Immanuel/N-9169-2019	Bloch, Immanuel/0000-0002-0679-4759; 				Briegel HJ, 2000, J MOD OPTIC, V47, P415, DOI 10.1080/095003400148303; Castin Y, 1997, PHYS REV A, V55, P4330, DOI 10.1103/PhysRevA.55.4330; Cataliotti FS, 2001, SCIENCE, V293, P843, DOI 10.1126/science.1062612; DANIEL DJ, 1989, PHYS REV A, V39, P4628, DOI 10.1103/PhysRevA.39.4628; Dunningham JA, 1998, PHYS LETT A, V245, P49, DOI 10.1016/S0375-9601(98)00386-7; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Greiner M, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.031401; Greiner M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.160405; Imamoglu A, 1997, PHYS REV LETT, V78, P2511, DOI 10.1103/PhysRevLett.78.2511; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; MILBURN GJ, 1986, PHYS REV LETT, V56, P2237, DOI 10.1103/PhysRevLett.56.2237; Orzel C, 2001, SCIENCE, V291, P2386, DOI 10.1126/science.1058149; ROKHSAR DS, 1991, PHYS REV B, V44, P10328, DOI 10.1103/PhysRevB.44.10328; Walls D. F., 1994, QUANTUM OPT; Wright EM, 1996, PHYS REV LETT, V77, P2158, DOI 10.1103/PhysRevLett.77.2158; Wright EM, 1997, PHYS REV A, V56, P591, DOI 10.1103/PhysRevA.56.591; ZHANG WP, 1995, PHYS REV A, V52, P4696, DOI 10.1103/PhysRevA.52.4696	21	996	1004	3	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					51	54		10.1038/nature00968	http://dx.doi.org/10.1038/nature00968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214228	Green Submitted			2022-12-28	WOS:000177788600033
J	Arroliga, AC; Newman, S; Longworth, DL; Stoller, JK				Arroliga, AC; Newman, S; Longworth, DL; Stoller, JK			Metaphorical medicine: Using metaphors to enhance communication with patients who have pulmonary disease	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER		Cleveland Clin Fdn, Cleveland, OH 44195 USA; Kent State Univ, Kent, OH 44242 USA	Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Stoller, JK (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.	stollej@ccf.org	Arroliga, Alejandro/AAX-3933-2021					ANNAS GJ, 1995, NEW ENGL J MED, V332, P744; Demaitre L, 1998, B HIST MED, V72, P609, DOI 10.1353/bhm.1998.0212; Duffy FD, 1998, ANN INTERN MED, V128, P139, DOI 10.7326/0003-4819-128-2-199801150-00011; FELTOVICH PJ, 1989, COGNITIVE SCI MED, P112; HALL D, 1985, NY TIMES        0714, P2; HODGKIN P, 1985, BRIT MED J, V291, P1820, DOI 10.1136/bmj.291.6511.1820; Honeck R.P., 1996, METAPHOR SYMB ACT, V11, P1, DOI [10.1207/s15327868ms1101_1, DOI 10.1207/S15327868MS1101_1]; JOHNSON M, 1995, METAPHOR SYMB ACT, V10, P157, DOI 10.1207/s15327868ms1003_1; Kangas S, 1998, NURS RES, V47, P190, DOI 10.1097/00006199-199805000-00010; Lakoff G., 1980, METAPHORS WE LIVE; Lakoff G., 1993, METAPHOR THOUGHT, V2nd edition), P202, DOI DOI 10.1017/CBO9781139173865.013; LEMANN N, 2000, NEW YORKER      0731, P49; Mabeck CE, 1997, FAM PRACT, V14, P271, DOI 10.1093/fampra/14.4.271; Morgan G., 1993, IMAGINIZATION NEW MI; Morgan G, 1997, IMAGES ORG; Olweny CLM, 1997, ANN NY ACAD SCI, V809, P179, DOI 10.1111/j.1749-6632.1997.tb48081.x; Ortony A E, 1993, METAPHOR THOUGHT; SHAFER A, 1995, ANESTHESIOLOGY, V83, P1331, DOI 10.1097/00000542-199512000-00024; Sontag Susan, 1983, ILLNESS METAPHOR AID, P59; SPIRO HM, 1990, DRUG THER, V20, pA12; SPIRO RJ, SIMILARITY ANALOGICA, P498; 1984, WEBSTERS 9 NEW COLLE, P746	22	34	36	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2002	137	5	1				376	379		10.7326/0003-4819-137-5_Part_1-200209030-00037	http://dx.doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00037			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591DZ	12204044				2022-12-28	WOS:000177865600028
J	Sharpe, M; Wilks, D				Sharpe, M; Wilks, D			ABC of psychological medicine - Fatigue	BRITISH MEDICAL JOURNAL			English	Review									Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Sharpe, M (corresponding author), Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland.			sharpe, michael/0000-0002-6474-9980; Wilks, David/0000-0001-8284-5610	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Campling F, 2000, CHRONIC FATIGUE SYND; REID S, 2001, CLIN EVIDENCE    NOV; Wessely S, 1998, CHRONIC FATIGUE ITS	3	115	116	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2002	325	7362					480	483		10.1136/bmj.325.7362.480	http://dx.doi.org/10.1136/bmj.325.7362.480			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592EZ	12202331	Green Published			2022-12-28	WOS:000177924900024
J	Truitt, WA; Coolen, LM				Truitt, WA; Coolen, LM			Identification of a potential ejaculation generator in the spinal cord	SCIENCE			English	Article							SEXUAL FUNCTION; RAT; FEMALE; BRAIN; STIMULATION; MEN	We tested the significance of a population of lumbar spinothalamic cells for male sexual behavior in rats. These cells are positioned to relay ejaculation-related signals from reproductive organs to the brain, and they express neurokinin-1 receptors. Ablation of these neurons by the selective toxin SSP-saporin resulted in a complete disruption of ejaculatory behavior. In contrast, other components of sexual behavior remained intact. These results suggest that this population of spinothalamic cells plays a pivotal role in generation of ejaculatory behavior and may be part of a spinal ejaculation generator.	Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Grad Program Neurosci, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Coolen, LM (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, POB 670521, Cincinnati, OH 45267 USA.	Lique.Coolen@uc.edu		Coolen, Lique/0000-0003-2920-1116	NIMH NIH HHS [MH60781] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brackett NL, 1998, J UROLOGY, V159, P1931, DOI 10.1016/S0022-5347(01)63200-2; GILVERNET JM, 1994, BRIT J UROL, V73, P442, DOI 10.1111/j.1464-410X.1994.tb07612.x; HOLMES GM, 1991, PHYSIOL BEHAV, V49, P1235, DOI 10.1016/0031-9384(91)90357-T; JU G, 1987, NEUROSCIENCE, V20, P439, DOI 10.1016/0306-4522(87)90103-5; McKenna K., 1999, ENCY REPROD, P1002; MCKENNA KE, 1991, AM J PHYSIOL, V261, pR1276, DOI 10.1152/ajpregu.1991.261.5.R1276; MCKENNA KE, 1997, AUT NER SYS, V11, P151; Meisel Robert L., 1994, P3; NEWMAN HF, 1982, UROLOGY, V19, P341, DOI 10.1016/0090-4295(82)90186-8; Nicholas AP, 1999, NEUROSCI LETT, V270, P9, DOI 10.1016/S0304-3940(99)00446-2; Ohl DA, 1997, MALE INFERTILITY SEX, P219; PESCATORI ES, 1993, J UROLOGY, V149, P627, DOI 10.1016/S0022-5347(17)36168-2; Pfaus JG, 1997, BRAIN RES BULL, V44, P397, DOI 10.1016/S0361-9230(97)00219-0; TRUITT W, UNPUB; Truitt W. A., 2001, Hormones and Behavior, V39, P352; Veening JG, 1998, BEHAV BRAIN RES, V92, P181, DOI 10.1016/S0166-4328(97)00190-3; Wiley RG, 1999, NEUROSCI LETT, V277, P1, DOI 10.1016/S0304-3940(99)00846-0	17	236	242	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1566	1569		10.1126/science.1073885	http://dx.doi.org/10.1126/science.1073885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202834				2022-12-28	WOS:000177697300061
J	Kwon, HJ; Smith, WC; Scharon, AJ; Hwang, SH; Kurth, MJ; Shen, B				Kwon, HJ; Smith, WC; Scharon, AJ; Hwang, SH; Kurth, MJ; Shen, B			C-O bond formation by polyketide synthases	SCIENCE			English	Article							ACYL CARRIER PROTEIN; MALONYL-COENZYME-A; DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; BIOSYNTHESIS; STREPTOMYCES; PATHWAY; CLONING; STRAIN; ACID	Polyketide synthases (PKSs) assemble the polyketide carbon backbone by sequential decarboxylative condensation of acyl coenzyme A (CoA) precursors, and the C-C bond-forming step in this process is catalyzed by the beta-ketoacyl synthase (KS) domain or subunit. Genetic and biochemical characterization of the nonactin biosynthesis gene cluster from Streptomyces griseus revealed two KSs, NonJ and NonK, that are highly homologous to known KSs but catalyze sequential condensation of the acyl CoA substrates by forming C-O rather than C-C bonds. This chemistry can be used in PKS engineering to increase the scope and diversity of polyketide biosynthesis.	Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA; Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis	Shen, B (corresponding author), Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA.				NIAID NIH HHS [AI51689] Funding Source: Medline; NIGMS NIH HHS [T32 GM08505] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI051689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008505] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652; Fleck WF, 1996, J BASIC MICROB, V36, P235, DOI 10.1002/jobm.3620360405; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; He M, 2000, J BACTERIOL, V182, P2619, DOI 10.1128/JB.182.9.2619-2623.2000; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; KAO CM, 1995, J AM CHEM SOC, V117, P9105, DOI 10.1021/ja00140a043; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Kwon HJ, 2001, J AM CHEM SOC, V123, P3385, DOI 10.1021/ja0100827; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; MARSDEN AFA, 1994, SCIENCE, V263, P378, DOI 10.1126/science.8278811; MCDANIEL R, 1993, SCIENCE, V262, P1546, DOI 10.1126/science.8248802; MCDANIEL R, 1995, NATURE, V375, P549, DOI 10.1038/375549a0; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Nelson ME, 2002, J AM CHEM SOC, V124, P2894, DOI 10.1021/ja016965f; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; PIEPER R, 1995, NATURE, V378, P263, DOI 10.1038/378263a0; Rajgarhia VB, 1997, J BACTERIOL, V179, P2690, DOI 10.1128/jb.179.8.2690-2696.1997; Schroder J., 1999, COMPREHENSIVE NATURA, V1, P749, DOI DOI 10.1016/b978-0-08-091283-7.00029-1; SHEN B, 1993, SCIENCE, V262, P1535, DOI 10.1126/science.8248801; Shen B, 2000, TOP CURR CHEM, V209, P1; Smith WC, 2000, ANTIMICROB AGENTS CH, V44, P1809, DOI 10.1128/AAC.44.7.1809-1817.2000; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; VARA J, 1989, J BACTERIOL, V171, P5872, DOI 10.1128/jb.171.11.5872-5881.1989	31	62	69	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1327	1330		10.1126/science.1073175	http://dx.doi.org/10.1126/science.1073175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193782				2022-12-28	WOS:000177573900041
J	Moore, AW; Jan, LY; Jan, YN				Moore, AW; Jan, LY; Jan, YN			hamlet, a binary genetic switch between single- and multiple-dendrite neuron morphology	SCIENCE			English	Article							ZINC-FINGER PROTEIN; PR-DOMAIN FAMILY; MYELOID-LEUKEMIA; DROSOPHILA; EXPRESSION; OUTGROWTH; GENOME	The dendritic morphology of neurons determines the number and type of inputs they receive. In the Drosophila peripheral nervous system ( PNS), the external sensory (ES) neurons have a single nonbranched dendrite, whereas the lineally related multidendritic ( MD) neurons have extensively branched dendritic arbors. We report that hamlet is a binary genetic switch between these contrasting morphological types. In hamlet mutants, ES neurons are converted to an MD fate, whereas ectopic hamlet expression in MD precursors results in transformation of MD neurons into ES neurons. Moreover, hamlet expression induced in MD neurons undergoing dendrite outgrowth drastically reduces arbor branching.	Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, Box 0444, San Francisco, CA 94143 USA.		Moore, Adrian Walton/AAN-5656-2021; Moore, Adrian W/A-3339-2013	Moore, Adrian Walton/0000-0002-8242-301X; Moore, Adrian W/0000-0002-8242-301X; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040929] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS40929] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; GARRIGA G, 1993, GENE DEV, V7, P2097, DOI 10.1101/gad.7.11.2097; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Huang S, 1998, J BIOL CHEM, V273, P15933, DOI 10.1074/jbc.273.26.15933; HUANG S, 1994, CELL, V78, P9, DOI 10.1016/0092-8674(94)90565-7; Jiang GL, 2000, HISTOL HISTOPATHOL, V15, P109, DOI 10.14670/HH-15.109; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; MISQUITTA L, 2000, PROTOCOLS, P361; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Orgogozo V, 2001, DEVELOPMENT, V128, P631; Soderholm J, 1997, LEUKEMIA, V11, P352, DOI 10.1038/sj.leu.2400584; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VANROESSEL P, 2000, PROTOCOLS, P439	18	100	102	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1355	1358		10.1126/science.1072387	http://dx.doi.org/10.1126/science.1072387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193790				2022-12-28	WOS:000177573900050
J	Yang, T; Espenshade, PJ; Wright, ME; Yabe, D; Gong, Y; Aebersold, R; Goldstein, JL; Brown, MS				Yang, T; Espenshade, PJ; Wright, ME; Yabe, D; Gong, Y; Aebersold, R; Goldstein, JL; Brown, MS			Crucial step in cholesterol homeostasis: Sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER	CELL			English	Article							CLEAVAGE-ACTIVATING PROTEIN; GROWTH-RESPONSE; CELLS; IDENTIFICATION; MUTANTS; GENES; PROTEOLYSIS; EXPRESSION; COMPLEXES; DOMAIN	Using coimmunoprecipitation and tandem mass spectrometry, we identify INSIG-1 as an ER protein that binds the sterol-sensing domain of SREBP cleavage-activating protein (SCAP) and facilitates retention of the SCAP/SREBP complex in the ER. In steroldepleted cells, SCAP escorts SREBPs from ER to Golgi for proteolytic processing, thereby allowing SREBPs to stimulate cholesterol synthesis. Sterols induce binding of SCAP to INSIG-11, as determined by blue native-PAGE, and this is correlated with the inhibition of SCAP exit from the ER. Overexpression of INSIG-1 increases the sensitivity of cells to sterol-mediated inhibition of SREBP processing. Mutant SCAP(Y298C) fails to bind INSIG-11 and is resistant to sterol-mediated inhibition of ER exit. By facilitating sterol -dependent ER retention of SCAP, INSIG-11 plays a central role in cholesterol homeostasis.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Inst Syst Biol, Seattle, WA 98105 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Institute for Systems Biology (ISB)	Goldstein, JL (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu	Yabe, Daisuke/J-6682-2014; Gong, Yi/AAQ-7515-2020	Yabe, Daisuke/0000-0002-5334-7687; Wright, Michael/0000-0002-4243-2931	NATIONAL CANCER INSTITUTE [R33CA084698] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NCI NIH HHS [1R33CA-84698] Funding Source: Medline; NHLBI NIH HHS [HL-20948] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERGMANN JE, 1989, METHOD CELL BIOL, V32, P85; BROWN AJ, 2002, IN PRESS MOL CELL; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; DIAMOND RH, 1993, J BIOL CHEM, V268, P15185; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LUONG A, 2000, THESIS U TEXAS SW ME, P1; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; MOHN KL, 1991, MOL CELL BIOL, V11, P381, DOI 10.1128/MCB.11.1.381; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Peng Y, 1997, GENOMICS, V43, P278, DOI 10.1006/geno.1997.4821; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; TOLLESHAUG H, 1982, CELL, V30, P715, DOI 10.1016/0092-8674(82)90276-8; Yang T, 2000, J BIOL CHEM, V275, P29881, DOI 10.1074/jbc.M005439200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	27	742	780	2	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					489	500		10.1016/S0092-8674(02)00872-3	http://dx.doi.org/10.1016/S0092-8674(02)00872-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202038	Bronze			2022-12-28	WOS:000177653200010
J	Roberts, SE				Roberts, SE			Hazardous occupations in Great Britain	LANCET			English	Article								The aim of this study was to investigate the most hazardous of all occupations in Great Britain. The causes of all deaths in British merchant seafaring and trawler fishing, traditionally the two most dangerous occupations, were established for the period between 1976 and 1995 and compared with official mortality statistics for other occupations. Fishermen were 52-4 times more likely to have a fatal accident at work (95% Cl 42-9-63.8), and seafarers were 26.2 times more likely (19.8-34.7), compared with other British workers. Although the number of work-related deaths has decreased in recent decades, in relative terms the occupations of fishing and seafaring remain as hazardous as before. If mortality rates in these occupations are to decrease, unsafe working practices, especially unnecessary operations in treacherous conditions, should be reduced.	Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England	University of Oxford	Roberts, SE (corresponding author), Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.							*HLTH SAF EX, 1977, HLTH SAF STAT ANN RE; HOME WE, 1934, LANCET, V225, P1081; *OFF POP CENS SURV, 1986, OCC MORT DEC DS6 2 S; *ROYAL COMM LOSS L, 1885, LOSS LIF SEA 1 REP R; SCHILLING RS, 1971, BRIT J IND MED, V28, P27	5	65	65	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					543	544		10.1016/S0140-6736(02)09708-8	http://dx.doi.org/10.1016/S0140-6736(02)09708-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241660				2022-12-28	WOS:000177512800014
J	Sandkuhler, J				Sandkuhler, J			Fear the pain	LANCET			English	Editorial Material							SENSITIZATION; MEMORY		Univ Vienna, Sch Med, Brain Res Inst, A-1090 Vienna, Austria	University of Vienna	Sandkuhler, J (corresponding author), Univ Vienna, Sch Med, Brain Res Inst, Waehringer Guertel 18, A-1090 Vienna, Austria.		Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X				Bridges D, 2001, BRIT J PHARMACOL, V133, P586, DOI 10.1038/sj.bjp.0704110; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Jensen TS, 2001, ACTA ANAESTH SCAND, V45, P1128, DOI 10.1034/j.1399-6576.2001.450913.x; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; RICHMOND CE, 1993, LANCET, V342, P73, DOI 10.1016/0140-6736(93)91284-S; Sandkuhler J, 2000, PAIN, V88, P113, DOI 10.1016/S0304-3959(00)00424-3; Sarkar S, 2000, LANCET, V356, P1154, DOI 10.1016/S0140-6736(00)02758-6; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; Willis WD, 2001, ANN NY ACAD SCI, V933, P142	11	11	12	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					426	426		10.1016/S0140-6736(02)09683-6	http://dx.doi.org/10.1016/S0140-6736(02)09683-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241712				2022-12-28	WOS:000177342900006
J	Simpson, AGB; MacQuarrie, EK; Roger, AJ				Simpson, AGB; MacQuarrie, EK; Roger, AJ			Eukaryotic evolution - Early origin of canonical introns	NATURE			English	Article							SPLICEOSOMAL INTRONS; CARPEDIEMONAS; HISTORY		Dalhousie Univ, Dept Biochem & Mol Biol, Program Evolutionary Biol, Canadian Inst Adv Res, Halifax, NS B3H 4H7, Canada	Canadian Institute for Advanced Research (CIFAR); Dalhousie University	Simpson, AGB (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Program Evolutionary Biol, Canadian Inst Adv Res, Halifax, NS B3H 4H7, Canada.	simpson@hades.biochem.dal.ca		Simpson, Alastair/0000-0002-4133-1709				Archibald JM, 2002, MOL BIOL EVOL, V19, P422, DOI 10.1093/oxfordjournals.molbev.a004097; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; Dacks J, 1999, J MOL EVOL, V48, P779, DOI 10.1007/PL00013156; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; FAST NM, 1999, MOL BIOCHEM PARASIT, V99, P514; Johnson PJ, 2002, P NATL ACAD SCI USA, V99, P3359, DOI 10.1073/pnas.072084199; Logsdon JM, 1998, CURR OPIN GENET DEV, V8, P637, DOI 10.1016/S0959-437X(98)80031-2; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Palmer JD, 1991, CURR OPIN GENET DEV, V1, P470, DOI 10.1016/S0959-437X(05)80194-7; Roger AJ, 1999, AM NAT, V154, pS146, DOI 10.1086/303290; Simpson AGB, 1999, EUR J PROTISTOL, V35, P353, DOI 10.1016/S0932-4739(99)80044-3; Simpson AGB, 2002, MOL BIOL EVOL, V19, P1782, DOI 10.1093/oxfordjournals.molbev.a004000; Sogin ML, 1997, CURR OPIN GENET DEV, V7, P792, DOI 10.1016/S0959-437X(97)80042-1	13	48	52	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					270	270		10.1038/419270a	http://dx.doi.org/10.1038/419270a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239559				2022-12-28	WOS:000178056300037
J	Soteriades, ES; Evans, JC; Larson, MG; Chen, MH; Chen, L; Benjamin, EJ; Levy, D				Soteriades, ES; Evans, JC; Larson, MG; Chen, MH; Chen, L; Benjamin, EJ; Levy, D			Incidence and prognosis of syncope	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM FOLLOW-UP; RECURRENT UNEXPLAINED SYNCOPE; UNKNOWN ORIGIN; UNDETERMINED ORIGIN; DIAGNOSING SYNCOPE; HISTORY; BIAS; RISK	Background: Little is known about the epidemiology and prognosis of syncope in the general population. Methods: We evaluated the incidence, specific causes, and prognosis of syncope among women and men participating in the Framingham Heart Study from 1971 to 1998. Results: Of 7814 study participants followed for an average of 17 years, 822 reported syncope. The incidence of a first report of syncope was 6.2 per 1000 person-years. The most frequently identified causes were vasovagal (21.2 percent), cardiac (9.5 percent), and orthostatic (9.4 percent); for 36.6 percent the cause was unknown. The multivariable-adjusted hazard ratios among participants with syncope from any cause, as compared with those who did not have syncope, were 1.31 (95 percent confidence interval, 1.14 to 1.51) for death from any cause, 1.27 (95 percent confidence interval, 0.99 to 1.64) for myocardial infarction or death from coronary heart disease, and 1.06 (95 percent confidence interval, 0.77 to 1.45) for fatal or nonfatal stroke. The corresponding hazard ratios among participants with cardiac syncope were 2.01 (95 percent confidence interval, 1.48 to 2.73), 2.66 (95 percent confidence interval, 1.69 to 4.19), and 2.01 (95 percent confidence interval, 1.06 to 3.80). Participants with syncope of unknown cause and those with neurologic syncope had increased risks of death from any cause, with multivariable-adjusted hazard ratios of 1.32 (95 percent confidence interval, 1.09 to 1.60) and 1.54 (95 percent confidence interval, 1.12 to 2.12), respectively. There was no increased risk of cardiovascular morbidity or mortality associated with vasovagal (including orthostatic and medication-related) syncope. Conclusions: Persons with cardiac syncope are at increased risk for death from any cause and cardiovascular events, and persons with syncope of unknown cause are at increased risk for death from any cause. Vasovagal syncope appears to have a benign prognosis.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Med Ctr, Dept Cardiol, Boston, MA USA; Boston Med Ctr, Dept Prevent Med, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston Medical Center; Boston Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Beth Israel Deaconess Medical Center	Levy, D (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38038] Funding Source: Medline; NINDS NIH HHS [NS-17950] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barry D, 1996, STAT MED, V15, P2603; BASS EB, 1988, AM J CARDIOL, V62, P1186, DOI 10.1016/0002-9149(88)90257-3; COX DR, 1972, J R STAT SOC B, V34, P187; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; DAY SC, 1982, AM J MED, V73, P15, DOI 10.1016/0002-9343(82)90913-5; DERMKSIAN G, 1958, JAMA-J AM MED ASSOC, V168, P1200, DOI 10.1001/jama.1958.03000090030007; DERMKSIAN G, 1958, JAMA-J AM MED ASSOC, V168, P1623, DOI 10.1001/jama.1958.03000120029005; DOHERTY JU, 1985, AM J CARDIOL, V55, P703, DOI 10.1016/0002-9149(85)90140-7; DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746, DOI 10.1093/oxfordjournals.aje.a115716; EAGLE KA, 1985, AM J MED, V79, P455, DOI 10.1016/0002-9343(85)90032-4; Getchell WS, 1999, J GEN INTERN MED, V14, P677, DOI 10.1046/j.1525-1497.1999.03199.x; GOUELLO JP, 1995, PRESSE MED, V24, P387; HESS DS, 1982, AM J CARDIOL, V50, P1309, DOI 10.1016/0002-9149(82)90468-4; HOUDENT C, 1988, PRESSE MED, V17, P626; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1987, NIH PUBLICATION; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAPOOR WN, 1987, AM J MED, V82, P20, DOI 10.1016/0002-9343(87)90372-X; KAPOOR WN, 1990, MEDICINE, V69, P160, DOI 10.1097/00005792-199005000-00004; Kapoor WN, 1996, AM J MED, V100, P646, DOI 10.1016/S0002-9343(95)00052-6; KAPOOR WN, 1995, MED CLIN N AM, V79, P1153, DOI 10.1016/S0025-7125(16)35877-1; KAPOOR WN, 1983, NEW ENGL J MED, V309, P197, DOI 10.1056/NEJM198307283090401; KROL RB, 1987, J AM COLL CARDIOL, V10, P358, DOI 10.1016/S0735-1097(87)80019-0; KUSHNER JA, 1989, J AM COLL CARDIOL, V14, P391, DOI 10.1016/0735-1097(89)90191-5; Lamb LE, 1960, AEROSPACE MED, V31, P973; LEE RT, 1988, J GEN INTERN MED, V3, P337, DOI 10.1007/BF02595791; Linzer M, 1997, ANN INTERN MED, V127, P76, DOI 10.7326/0003-4819-127-1-199707010-00014; LINZER M, 1990, AM J CARDIOL, V66, P214, DOI 10.1016/0002-9149(90)90591-N; Linzer M, 1997, ANN INTERN MED, V126, P989, DOI 10.7326/0003-4819-126-12-199706150-00012; LIPSITZ LA, 1985, Q J MED, V55, P45; MARTIN GJ, 1984, ANN EMERG MED, V13, P499, DOI 10.1016/S0196-0644(84)80511-9; Martin TP, 1997, ANN EMERG MED, V29, P459, DOI 10.1016/S0196-0644(97)70217-8; MOAZEZ F, 1991, AM HEART J, V121, P81, DOI 10.1016/0002-8703(91)90959-L; MORADY F, 1983, J AM COLL CARDIOL, V2, P1053, DOI 10.1016/S0735-1097(83)80329-5; MURDOCH BD, 1980, S AFR MED J, V57, P771; OLSHANSKY B, 1985, J AM COLL CARDIOL, V5, P216, DOI 10.1016/S0735-1097(85)80040-1; Olshansky B, 1999, AM HEART J, V137, P878, DOI 10.1016/S0002-8703(99)70412-6; *SAS I, 1997, SAS STAT SOFTW CHANG, P413; SAVAGE DD, 1985, STROKE, V16, P626, DOI 10.1161/01.STR.16.4.626; SILVERSTEIN MD, 1982, JAMA-J AM MED ASSOC, V248, P1185, DOI 10.1001/jama.248.10.1185; SRA JS, 1991, ANN INTERN MED, V114, P1013, DOI 10.7326/0003-4819-114-12-1013; TEICHMAN SL, 1985, AM HEART J, V110, P469, DOI 10.1016/0002-8703(85)90171-1; WILLIAMS RL, 1962, AEROSPACE MED, V33, P545	43	801	854	1	19	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					878	885		10.1056/NEJMoa012407	http://dx.doi.org/10.1056/NEJMoa012407			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239256	Bronze			2022-12-28	WOS:000178040700003
J	Fukushima, K; Yamanobe, T; Shinmei, Y; Fukushima, J; Kurkin, S; Peterson, BW				Fukushima, K; Yamanobe, T; Shinmei, Y; Fukushima, J; Kurkin, S; Peterson, BW			Coding of smooth eye movements in three-dimensional space by frontal cortex	NATURE			English	Article							DISPARITY SENSITIVITY; PREMOTOR CORTEX; CORTICAL AREA; PURSUIT; NEURONS; MONKEY; RESPONSES; DIRECTION; MACAQUE; SIGNALS	Through the development of a high-acuity fovea, primates with frontal eyes have acquired the ability to use binocular eye movements to track small objects moving in space(1). The smooth-pursuit system moves both eyes in the same direction to track movement in the frontal plane (frontal pursuit), whereas the vergence system moves left and right eyes in opposite directions to track targets moving towards or away from the observer (vergence tracking). In the cerebral cortex and brainstem, signals related to vergence eye movements-and the retinal disparity and blur signals that elicit them-are coded independently of signals related to frontal pursuit(2-6). Here we show that these types of signal are represented in a completely different way in the smooth-pursuit region of the frontal eye fields(7-11). Neurons of the frontal eye field modulate strongly during both frontal pursuit and vergence tracking, which results in three-dimensional cartesian representations of eye movements. We propose that the brain creates this distinctly different intermediate representation to allow these neurons to function as part of a system that enables primates to track and manipulate objects moving in three-dimensional space.	Hokkaido Univ, Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan; Northwestern Univ, Sch Med, Chicago, IL 60611 USA	Hokkaido University; Northwestern University	Fukushima, K (corresponding author), Hokkaido Univ, Sch Med, Dept Physiol, West 7,North 15, Sapporo, Hokkaido 0608638, Japan.	kikuro@med.hokudai.ac.jp	Kurkin, Sergei/F-3268-2011; /G-2241-2012					COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; CUMMING BG, 1994, VISUAL DETECTION MOT, P333; Eifuku S, 1999, J NEUROPHYSIOL, V82, P2462, DOI 10.1152/jn.1999.82.5.2462; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; FERRERA VP, 2000, SOC NEUR ABSTR, V26, P669; FOGASSI L, 1992, EXP BRAIN RES, V89, P686, DOI 10.1007/BF00229894; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fukushima K, 2000, J NEUROPHYSIOL, V83, P563, DOI 10.1152/jn.2000.83.1.563; Fukushima K, 1999, ANN NY ACAD SCI, V871, P248, DOI 10.1111/j.1749-6632.1999.tb09189.x; Fukushima K, 2002, EXP BRAIN RES, V145, P104, DOI 10.1007/s00221-002-1088-7; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gamlin PDR, 1999, OPHTHAL PHYSL OPT, V19, P81, DOI 10.1046/j.1475-1313.1999.00434.x; GOTTLIEB JP, 1994, J NEUROPHYSIOL, V72, P1634, DOI 10.1152/jn.1994.72.4.1634; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Krauzlis RJ, 1996, EXP BRAIN RES, V109, P289; MacAvoy MG, 1991, CEREB CORTEX, V1, P95, DOI 10.1093/cercor/1.1.95; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; Mays LE, 1995, CURR OPIN NEUROBIOL, V5, P763, DOI 10.1016/0959-4388(95)80104-9; MAYS LE, 1986, J NEUROPHYSIOL, V56, P1007, DOI 10.1152/jn.1986.56.4.1007; Mushiake H, 1997, J NEUROPHYSIOL, V78, P567, DOI 10.1152/jn.1997.78.1.567; ROY JP, 1992, J NEUROSCI, V12, P2478; Semmlow JL, 1998, VISION RES, V38, P1145, DOI 10.1016/S0042-6989(97)00251-4; Shi DX, 1998, J NEUROPHYSIOL, V80, P458, DOI 10.1152/jn.1998.80.1.458; Takemura A, 2001, J NEUROPHYSIOL, V85, P2245, DOI 10.1152/jn.2001.85.5.2245; Tanaka M, 1998, J NEUROPHYSIOL, V80, P28, DOI 10.1152/jn.1998.80.1.28; Tian JR, 1996, J NEUROPHYSIOL, V76, P2740, DOI 10.1152/jn.1996.76.4.2740; Zee DS., 1999, NEUROLOGY EYE MOVEME; Zhou W, 1998, NATURE, V393, P692, DOI 10.1038/31489	30	78	78	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					157	162		10.1038/nature00953	http://dx.doi.org/10.1038/nature00953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226663				2022-12-28	WOS:000177931200039
J	van Emmerik, AAP; Kamphuis, JH; Hulsbosch, AM; Emmelkamp, PMG				van Emmerik, AAP; Kamphuis, JH; Hulsbosch, AM; Emmelkamp, PMG			Single session debriefing after psychological trauma: a meta-analysis	LANCET			English	Article							POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; VICTIMS	Background Despite conflicting research findings and uncertain efficacy, single session debriefing is standard clinical practice after traumatic events. We aimed to assess the efficacy of this intervention in prevention of chronic symptoms of post-traumatic stress disorder and other disorders after trauma. Methods In a meta-analysis, we selected appropriate studies from databases (Medline Advanced, PsychINFO, and PubMed), the Journal of Traumatic Stress, and reference lists of articles and book chapters. Inclusion criteria were that single session debriefing had been done within 1 month after trauma, symptoms were assessed with widely accepted clinical outcome measures, and data from psychological assessments that had been done before (pretest data) and after (post-test data) interventions and were essential for calculation of effect sizes had been reported. We included seven studies in final analyses, in which there were five critical incident stress debriefing (CISD) interventions, three non-CISD interventions, and six no-intervention controls. Findings Non-CISD interventions and no intervention improved symptoms of post-traumatic stress disorder, but CISD did not improve symptoms (weighted mean effect sizes 0.65 [95% CI 0.14-1.16], 0.47 [0.28-0.66], and 0.13 [-0.29 to 0.55], respectively), CISD did not improve natural recovery from other trauma-related disorders (0.12 [-0.22 to 0.47]). Interpretation CISD and non-CISD interventions do not improve natural recovery from psychological trauma.	Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands	University of Amsterdam	van Emmerik, AAP (corresponding author), Univ Amsterdam, Dept Clin Psychol, Roetersstr 15, NL-1018 WB Amsterdam, Netherlands.	kp_emmerik@macmail.psy.uva.nl	, paulemmelkamp/G-3274-2011	, paulemmelkamp/0000-0001-6066-5512				Bisson JI, 1997, BRIT J PSYCHIAT, V171, P78, DOI 10.1192/bjp.171.1.78; Bisson JI, 2000, EFFECTIVE TREATMENTS FOR PTSD, P39; Blake DD., 1990, BEHAV THER, V13, P187; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Bryant RA, 1999, AM J PSYCHIAT, V156, P1780; Campfield KM, 2001, J TRAUMA STRESS, V14, P327, DOI 10.1023/A:1011117018705; Carlier IVE, 2000, BRIT J MED PSYCHOL, V73, P87, DOI 10.1348/000711200160327; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Conlon L, 1999, J PSYCHOSOM RES, V46, P37, DOI 10.1016/S0022-3999(98)00068-3; Dyregrov A, 1989, DISASTER MANAGEMENT, V2, P25; Everly GS, 2000, AGGRESS VIOLENT BEH, V5, P23, DOI 10.1016/S1359-1789(98)00026-3; Everly GS, 1999, STRESS MEDICINE, V15, P229, DOI 10.1002/(SICI)1099-1700(199910)15:4<229::AID-SMI818>3.0.CO;2-M; FOA EB, 1991, J CONSULT CLIN PSYCH, V59, P715, DOI 10.1037/0022-006X.59.5.715; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Horowitz M. J., 1976, STRESS RESPONSE SYND; KRAMER SH, 1998, COMPREHENSIVE CLIN P, P351; Lee C, 1996, BRIT J MED PSYCHOL, V69, P47, DOI 10.1111/j.2044-8341.1996.tb01849.x; MAYOU R, 1987, GEN HOSP PSYCHIAT, V9, P18, DOI 10.1016/0163-8343(87)90096-X; Mayou RA, 2000, BRIT J PSYCHIAT, V176, P589, DOI 10.1192/bjp.176.6.589; Mitchell J T, 1983, JEMS, V8, P36; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Raphael b, 1986, DISASTER STRIKES HDB; Rose S, 1999, PSYCHOL MED, V29, P793, DOI 10.1017/S0033291799008624; Rose S., 2002, COCHRANE LIB; Shalev AY, 1998, MIL MED, V163, P494, DOI 10.1093/milmed/163.7.494; Spielberger C.D., 1970, STATE TRAIT ANXIETY, DOI DOI 10.1037/T06496-000; Van Etten ML, 1998, CLIN PSYCHOL PSYCHOT, V5, P126, DOI 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.3.CO;2-8; Wolpe J., 1966, PRACTICE BEHAV THERA; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	340	349	4	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2002	360	9335					766	771		10.1016/S0140-6736(02)09897-5	http://dx.doi.org/10.1016/S0140-6736(02)09897-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	592HX	12241834				2022-12-28	WOS:000177933000017
J	Gilmour, J				Gilmour, J			The solar system's first clocks	SCIENCE			English	Editorial Material							CHONDRULES; AL-26; METEORITES		Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England	University of Manchester	Gilmour, J (corresponding author), Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England.		Gilmour, Jamie/G-7515-2011	Gilmour, Jamie/0000-0003-1990-8636				Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Gilmour JD, 2001, PHILOS T R SOC A, V359, P2037, DOI 10.1098/rsta.2001.0895; Gounelle M, 2001, ASTROPHYS J, V548, P1051, DOI 10.1086/319019; Hutcheon I. D., 1999, LUNAR PLANET SCI, V30, P1722; Kita NT, 2000, GEOCHIM COSMOCHIM AC, V64, P3913, DOI 10.1016/S0016-7037(00)00488-9; Lugmair GW, 2001, METEORIT PLANET SCI, V36, P1017, DOI 10.1111/j.1945-5100.2001.tb01941.x; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; Marhas KK, 2002, METEORIT PLANET SCI, V37, pA94; McKeegan KD, 2000, SCIENCE, V289, P1334, DOI 10.1126/science.289.5483.1334; Nyquist L, 2001, METEORIT PLANET SCI, V36, P911, DOI 10.1111/j.1945-5100.2001.tb01930.x; Polnau E., 2001, LUNAR PLANET SCI, VXXXII, P1527; Shu FH, 2001, ASTROPHYS J, V548, P1029, DOI 10.1086/319018; Srinivasan G, 1999, SCIENCE, V284, P1348, DOI 10.1126/science.284.5418.1348; Zinner E, 2002, METEORIT PLANET SCI, V37, P1001, DOI 10.1111/j.1945-5100.2002.tb00872.x	14	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1658	1659		10.1126/science.1075519	http://dx.doi.org/10.1126/science.1075519			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215635				2022-12-28	WOS:000177819100036
J	Secord, JA				Secord, JA			Quick and magical shaper of science	SCIENCE			English	Article									Univ Cambridge, Dept Hist & Philosophy Sci, Cambridge CB2 3RH, England	University of Cambridge	Secord, JA (corresponding author), Univ Cambridge, Dept Hist & Philosophy Sci, Cambridge CB2 3RH, England.							1969, ILLUSTRATED LON 0417, P401	1	13	14	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1648	1649		10.1126/science.297.5587.1648	http://dx.doi.org/10.1126/science.297.5587.1648			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215629	Bronze			2022-12-28	WOS:000177819100028
J	O'Keeffe, M				O'Keeffe, M			Materials science - Edge effects	NATURE			English	Editorial Material									Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	O'Keeffe, M (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.							Dorset D.L., 1995, STRUCTURAL ELECT CRY; Erdman N, 2002, NATURE, V419, P55, DOI 10.1038/nature01010; HYDE BG, 1989, INORGANIC CRYSTAL ST; Jiang QD, 1999, SURF SCI, V425, P343, DOI 10.1016/S0039-6028(99)00223-X; Marks LD, 2001, J PHYS-CONDENS MAT, V13, P10677, DOI 10.1088/0953-8984/13/47/310; MARKS LD, 1983, PHYS REV LETT, V51, P1000, DOI 10.1103/PhysRevLett.51.1000; MITCHELL RH, 2002, PEROVSKITES MODERN A; TAKAYANAGI K, 1985, SURF SCI, V164, P367, DOI 10.1016/0039-6028(85)90753-8	8	1	1	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					28	29		10.1038/419028a	http://dx.doi.org/10.1038/419028a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214220				2022-12-28	WOS:000177788600025
J	Cao, YWC; Jin, RC; Mirkin, CA				Cao, YWC; Jin, RC; Mirkin, CA			Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection	SCIENCE			English	Article							SURFACE; RESONANCE	Multiplexed detection of oligonucleotide targets has been performed with gold nanoparticle probes labeled with oligonucleotides and Raman-active dyes. The gold nanoparticles facilitate the formation of a silver coating that acts as a surface-enhanced Raman scattering promoter for the dye-labeled particles that have been captured by target molecules and an underlying chip in microarray format. The strategy provides the high-sensitivity and high-selectivity attributes of grayscale scanometric detection but adds multiplexing and ratioing capabilities because a very large number of probes can be designed based on the concept of using a Raman tag as a narrow-band spectroscopic fingerprint. Six dissimilar DNA targets with six Raman-labeled nanoparticle probes were distinguished, as well as two RNA targets with single nucleotide polymorphisms. The current unoptimized detection limit of this method is 20 femtomolar.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Inst Nanotechnol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.	camirkin@chem.northwestern.edu	Mirkin, Chad A/E-3911-2010	Mirkin, Chad/0000-0002-6634-7627				Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Campion A, 1998, CHEM SOC REV, V27, P241, DOI 10.1039/a827241z; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Demers LM, 2000, ANAL CHEM, V72, P5535, DOI 10.1021/ac0006627; Emory SR, 1998, J PHYS CHEM B, V102, P493, DOI 10.1021/jp9734033; Gearheart LA, 2001, J PHYS CHEM B, V105, P12609, DOI 10.1021/jp0106606; Gibson G., 2002, PRIMER GENOME SCI; Graham D, 2000, ANGEW CHEM INT EDIT, V39, P1061, DOI 10.1002/(SICI)1521-3773(20000317)39:6<1061::AID-ANIE1061>3.0.CO;2-9; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; He L, 2000, J AM CHEM SOC, V122, P9071, DOI 10.1021/ja001215b; Isola NR, 1998, ANAL CHEM, V70, P1352, DOI 10.1021/ac970901z; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; Mattoussi H, 2000, J AM CHEM SOC, V122, P12142, DOI 10.1021/ja002535y; McCreery R.L., 2005, RAMAN SPECTROSCOPY C, VVolume 225; Michaels AM, 1999, J AM CHEM SOC, V121, P9932, DOI 10.1021/ja992128q; MIRKIN CA, 2001, AM ASS CLIN CHEM M S; Musick MD, 1997, CHEM MATER, V9, P1499, DOI 10.1021/cm970087w; Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S; Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003; Pathak S, 2001, J AM CHEM SOC, V123, P4103, DOI 10.1021/ja0058334; Schatz G.C., 2002, HDB VIBRATIONAL SPEC, P759, DOI DOI 10.1002/0470027320.S0601; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Walt DR, 2000, SCIENCE, V287, P451, DOI 10.1126/science.287.5452.451; Willner I, 2001, ANGEW CHEM INT EDIT, V40, P1861	25	2701	2860	19	1323	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1536	1540		10.1126/science.297.5586.1536	http://dx.doi.org/10.1126/science.297.5586.1536			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202825				2022-12-28	WOS:000177697300052
J	Litingtung, Y; Dahn, RD; Li, YN; Fallon, JF; Chiang, C				Litingtung, Y; Dahn, RD; Li, YN; Fallon, JF; Chiang, C			Shh and Gli3 are dispensable for limb skeleton formation but regulate digit number and identity	NATURE			English	Article							CUBITUS-INTERRUPTUS PROTEIN; SONIC HEDGEHOG; POLARIZING ACTIVITY; ACTIVATION; REPRESSOR; MUTATIONS; GENE; MICE; ZPA	Most current models propose Sonic hedgehog (Shh) as the primary determinant of anteroposterior development of amniote limbs(1). Shh protein is said to be required to direct the formation of skeletal elements and to specify digit identity through dose-dependent activation of target gene expression. However, the identity of genes targeted by Shh, and the regulatory mechanisms controlling their expression, remain poorly understood. Gli3 (the gene implicated in human Greig cephalopolysyndactyly syndrome) is proposed to negatively regulate Shh by restricting its expression and influence to the posterior mesoderm(2-4). Here we report genetic analyses in mice showing that Shh and Gli3 are dispensable for formation of limb skeletal elements: Shh(-/-) Gli3(-/-) limbs are distally complete and polydactylous, but completely lack wild-type digit identities. We show that the effects of Shh signalling on skeletal patterning and ridge maintenance are necessarily mediated through Gli3. We propose that the function of Shh and Gli3 in limb skeletal patterning is limited to refining autopodial morphology, imposing pentadactyl constraint on the limb's polydactyl potential, and organizing digit identity specification, by regulating the relative balance of Gli3 transcriptional activator and repressor activities.	Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison	Fallon, JF (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA.	jfallon@facstaff.wisc.edu; chin.chiang@vanderbilt.edu						AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Brewster R, 2000, DEVELOPMENT, V127, P4395; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Caruccio NC, 1999, DEV BIOL, V212, P137, DOI 10.1006/dbio.1999.9321; Castilla EE, 1996, AM J MED GENET, V65, P295, DOI 10.1002/(SICI)1096-8628(19961111)65:4<295::AID-AJMG10>3.0.CO;2-P; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Fraidenraich D, 1998, DEV BIOL, V204, P197, DOI 10.1006/dbio.1998.9053; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Methot N, 2001, DEVELOPMENT, V128, P733; Pearse RV, 1998, J EXP ZOOL, V282, P677, DOI 10.1002/(SICI)1097-010X(19981215)282:6<677::AID-JEZ4>3.0.CO;2-F; Qu SM, 1997, DEVELOPMENT, V124, P3999; Radhakrishna U, 1999, AM J HUM GENET, V65, P645, DOI 10.1086/302557; Sanz-Ezquerro JJ, 2001, DIFFERENTIATION, V69, P91, DOI 10.1046/j.1432-0436.2001.690203.x; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Yang Y, 1997, DEVELOPMENT, V124, P4393; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zuniga A, 1999, DEVELOPMENT, V126, P13; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	30	445	462	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2002	418	6901					979	983		10.1038/nature01033	http://dx.doi.org/10.1038/nature01033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198547				2022-12-28	WOS:000177677500045
J	Paci, E; Duffy, SW; Giorgi, D; Zappa, M; Crocetti, E; Vezzosi, V; Bianchi, S; Cataliotti, L; del Turco, MR				Paci, E; Duffy, SW; Giorgi, D; Zappa, M; Crocetti, E; Vezzosi, V; Bianchi, S; Cataliotti, L; del Turco, MR			Are breast cancer screening programmes increasing rates of mastectomy? Observational study	BRITISH MEDICAL JOURNAL			English	Article									Ctr Study & Prevent Canc CSPO, Epidemiol Unit, I-50135 Florence, Italy; Ctr Study & Prevent Canc CSPO, Screening Unit, I-50135 Florence, Italy; Imperial Canc Res Fund, Dept Math Stat & Epidemiol, London WC2A 3PX, England; Azienda Sanitaria Locale 2, Epidemiol Unit, I-55100 Lucca, Italy; Univ Florence, Dept Pathol, I-50134 Florence, Italy; Univ Florence, Dept Surg, I-50134 Florence, Italy	Cancer Research UK; University of Florence; University of Florence	Paci, E (corresponding author), Ctr Study & Prevent Canc CSPO, Epidemiol Unit, Via S Salvi 12, I-50135 Florence, Italy.		Cataliotti, Luigi/ABD-2131-2021					Day NE, 1984, BIOMETRICS, V43, P1; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; PACI E, 2001, QUANTITATIVE METHODS; Wingo PA, 2000, CANCER CAUSE CONTROL, V11, P497, DOI 10.1023/A:1008944209648	4	40	40	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2002	325	7361					418	418		10.1136/bmj.325.7361.418	http://dx.doi.org/10.1136/bmj.325.7361.418			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193357	Bronze, Green Published			2022-12-28	WOS:000177715500019
J	Coates, TJ				Coates, TJ			Compromise	LANCET			English	Editorial Material									Royal London Hosp, Dept Accid & Emergency, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Coates, TJ (corresponding author), Royal London Hosp, Dept Accid & Emergency, London E1 1BB, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					567	567		10.1016/S0140-6736(02)09714-3	http://dx.doi.org/10.1016/S0140-6736(02)09714-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241676				2022-12-28	WOS:000177512800030
J	Parmar, MKB; Adams, M; Balestrino, M; Bertelsen, K; Bonazzi, C; Calvert, H; Colombo, N; Delaloye, JF; Durando, A; Guthrie, D; Hagen, B; Harper, P; Mangioni, C; Perren, T; Poole, C; Qian, W; Rustin, G; Sandercock, J; Tumolo, S; Torri, V; Vecchione, F				Parmar, MKB; Adams, M; Balestrino, M; Bertelsen, K; Bonazzi, C; Calvert, H; Colombo, N; Delaloye, JF; Durando, A; Guthrie, D; Hagen, B; Harper, P; Mangioni, C; Perren, T; Poole, C; Qian, W; Rustin, G; Sandercock, J; Tumolo, S; Torri, V; Vecchione, F		ICON Grp	Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial	LANCET			English	Article							STAGE-III	Background Previously, we have shown that the combination of cyclophosphamide, doxorubicin, and cisplatin (CAP) and single-agent carboplatin produce similar survival and progression-free survival rates in women with ovarian cancer. Subsequently, paclitaxel combined with platinum has become a widely accepted treatment for the disease. We aimed to compare the safety and efficacy of paclitaxel plus carboplatin with a control of either CAP or carboplatin alone. Methods Between February, 1995, and October, 1998, we enrolled 2074 patients from 130 centres in eight countries. Women were randomly assigned paclitaxel plus carboplatin or control, the control (CAP or single-agent carboplatin) being chosen by the patient and clinician before randomisation. The primary outcome measure was overall survival. Secondary outcomes were progression-free survival and toxicity. Analysis was by intention to treat. Findings With a median follow-up of 51 months, 1265 patients had died, and survival curves showed no evidence of a difference in overall survival between paclitaxel plus carboplatin and control (hazard ratio 0.98, 95% Cl 0.87-1.10, p=0.74). The median overall survival was 36.1 months on paclitaxel plus carboplatin and 35.4 months on control (difference 0.7 months, 95% CI -3.6 to 4.7). 1538 patients had progressive disease or died, and again, Kaplan-Meier curves showed no evidence of a difference between the groups (hazard ratio 0.93, 95% Cl 0.84-1.03, p=0.16). Median progression-free survival was 17.3 months on paclitaxel plus carboplatin and 16.1 months on control (difference 1.2 months, 95% Cl -0.5 to 2.8). Paclitaxel plus carboplatin caused more alopecia, fever, and sensory neuropathy than carboplatin alone, and more sensory neuropathy than CAP. CAP was associated with more fever than paclitaxel plus carboplatin. Interpretation Single-agent carboplatin and CAP are as effective as paclitaxel plus carboplatin as first-line treatment for women requiring chemotherapy for ovarian cancer. The favourable toxicity profile of single-agent carboplatin suggests that this drug is a reasonable option as first-line chemotherapy for ovarian cancer.	ICON Trials, Canc Div, MRC, Clin Trials Unit, London NW1 2DA, England	Medical Research Council Clinical Trials Unit	Parmar, MKB (corresponding author), ICON Trials, Canc Div, MRC, Clin Trials Unit, London NW1 2DA, England.		Perren, Timothy J/D-5387-2013; Rustin, Gordon J. S./J-9763-2019; Torri, Valter/H-7550-2015; Colombo, Nicoletta/AAB-8319-2019	Perren, Timothy J/0000-0001-8472-8856; Torri, Valter/0000-0001-9541-9354; Sandercock, Josie/0000-0001-7337-8635				Aabo K, 1998, BRIT J CANCER, V78, P1479, DOI 10.1038/bjc.1998.710; Adams M, 1998, BRIT J CANCER, V78, P1404, DOI 10.1038/bjc.1998.699; AHERN RP, 1995, J CLIN ONCOL, V13, P726, DOI 10.1200/JCO.1995.13.3.726; BUYSE M, 1991, J CLIN ONCOL, V9, P1668; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748, DOI 10.1200/JCO.1989.7.11.1748; DUBOIS A, 1998, P AN M AM SOC CLIN, V17, P1395; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Muggia FM, 2000, J CLIN ONCOL, V18, P106, DOI 10.1200/JCO.2000.18.1.106; NEIJT JP, 1997, SEMIN ONCOL, V39, pS15; OZOLS RF, 1999, P AN M AM SOC CLIN, V18, P1373; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; PARMAR M, 1995, SURVIVAL ANAL PRACTI; Parmar MKB, 1998, LANCET, V352, P1571; Piccart MJ, 2000, EUR J CANCER, V36, P10, DOI 10.1016/S0959-8049(99)00210-5; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Pisani P, 1999, INT J CANCER, V83, P870; Sandercock J, 1998, BRIT J CANCER, V78, P1471, DOI 10.1038/bjc.1998.709; SANDERCOCK J, IN PRESS BR J CANC; WARWICK J, 1995, BRIT J CANCER, V72, P1513, DOI 10.1038/bjc.1995.539	19	394	400	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2002	360	9332					505	515						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241653				2022-12-28	WOS:000177512800007
J	Belluscio, L; Lodovichi, C; Feinstein, P; Mombaerts, P; Katz, LC				Belluscio, L; Lodovichi, C; Feinstein, P; Mombaerts, P; Katz, LC			Odorant receptors instruct functional circuitry in the mouse olfactory bulb	NATURE			English	Article							INTRABULBAR ASSOCIATIONAL SYSTEM; SENSORY MAP; TOPOGRAPHIC ORGANIZATION; REPRESENTATIONS; MICE; PROJECTIONS; GLOMERULUS; DENDRITES; SYNAPSE	The mammalian olfactory system detects and discriminates thousands of odorants using many different receptors expressed by sensory neurons in the nasal epithelium(1). Axonal projections from these neurons to the main olfactory bulbs form reproducible patterns of glomeruli in two widely separated regions of each bulb, creating two mirror-symmetric maps of odorant receptor projections(2). To investigate whether odorant receptors organize neural circuitry in the olfactory bulb, we have examined a genetically modified mouse line, rI7 --> M71, in which a functionally characterized receptor, rI7(3,4), has been substituted into the M71 receptor locus(5). Here we show that despite their ectopic location the resulting glomeruli are responsive to known ligands of the rI7 receptor, attract postsynaptic innervation by mitral/tufted cell dendrites, and endow these cells with responses that are characteristic of the rI7 receptor. External tufted cells receiving input from rI7 --> M71 glomeruli form precise intrabulbar projections that link medial and lateral rI7 --> M71 glomeruli anatomically, thus providing a substrate for coordinating isofunctional glomeruli. We conclude that odorant receptor identity in epithelial neurons determines not only glomerular convergence and function, but also functional circuitry in the olfactory bulb.	Duke Univ, Med Ctr, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27710 USA; Rockefeller Univ, New York, NY 10021 USA	Duke University; Howard Hughes Medical Institute; Rockefeller University	Belluscio, L (corresponding author), NINDS, NIH, 36 Convent Dr, Bethesda, MD 20892 USA.	belluscl@ninds.nih.gov		Lodovichi, Claudia/0000-0002-0490-4846				Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; BUONVISO N, 1991, J COMP NEUROL, V307, P57, DOI 10.1002/cne.903070106; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GRAZIADEI PPC, 1978, P NATL ACAD SCI USA, V75, P5230, DOI 10.1073/pnas.75.10.5230; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LAMANTIA AS, 1989, NATURE, V341, P646, DOI 10.1038/341646a0; LIU WL, 1994, J COMP NEUROL, V346, P541, DOI 10.1002/cne.903460407; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schaefer ML, 2001, J COMP NEUROL, V436, P351; SCHOENFELD TA, 1985, J COMP NEUROL, V235, P503, DOI 10.1002/cne.902350408; Shipley MT, 1996, J NEUROBIOL, V30, P123; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	29	124	126	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					296	300		10.1038/nature01001	http://dx.doi.org/10.1038/nature01001			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239567				2022-12-28	WOS:000178056300045
J	Boyd, NF; Dite, GS; Stone, J; Gunasekara, A; English, DR; McCredie, MRE; Giles, GG; Tritchler, D; Chiarelli, A; Yaffe, MJ; Hopper, JL				Boyd, NF; Dite, GS; Stone, J; Gunasekara, A; English, DR; McCredie, MRE; Giles, GG; Tritchler, D; Chiarelli, A; Yaffe, MJ; Hopper, JL			Heritability of mammographic density, a risk factor for breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARENCHYMAL PATTERNS; SCREENING-PROGRAM; INCIDENT CANCER; UNITED-STATES; FEATURES; INDICATORS; WOMEN; CLASSIFICATION; QUESTIONNAIRE; ASSOCIATION	Background: Women with extensive dense breast tissue visible on a mammogram have a risk of breast cancer that is 1.8 to 6.0 times that of women of the same age with little or no density. Menopausal status, weight, and parity account for 20 to 30 percent of the age-adjusted variation in the percentage of dense tissue. Methods: We undertook two studies of twins to determine the proportion of the residual variation in the percentage of density measured by mammography that can be explained by unmeasured additive genetic factors (heritability). A total of 353 pairs of monozygotic twins and 246 pairs of dizygotic twins were recruited from the Australian Twin Registry, and 218 pairs of monozygotic twins and 134 pairs of dizygotic twins were recruited in Canada and the United States. Information on putative determinants of breast density was obtained by questionnaire. Mammograms were digitized, randomly ordered, and read by a blinded investigator. Results: After adjustment for age and measured covariates, the correlation coefficient for the percentage of dense tissue was 0.61 for monozygotic pairs in Australia, 0.67 for monozygotic pairs in North America, 0.25 for dizygotic pairs in Australia, and 0.27 for dizygotic pairs in North America. According to the classic twin model, heritability (the proportion of variants attributable to additive genetic factors) accounted for 60 percent of the variation in density (95 percent confidence interval, 54 to 66) in Australian twins, 67 percent (95 percent confidence interval, 59 to 75) in North American twins, and 63 percent (95 percent confidence interval, 59 to 67) in all twins studied. Conclusions: These results show that the population variation in the percentage of dense tissue on mammography at a given age has high heritability. Because mammographic density is associated with an increased risk of breast cancer, finding the genes responsible for this phenotype could be important for understanding the causes of the disease.	Ontario Canc Inst, Div Epidemiol & Stat, Toronto, ON M5G 2M9, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada; Univ Melbourne, Ctr Genet Epidemiol, Melbourne, Vic, Australia; Canc Council Victoria, Ctr Canc Epidemiol, Melbourne, Vic, Australia; Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Melbourne; Cancer Council Victoria; University of Otago	Boyd, NF (corresponding author), Ontario Canc Inst, Div Epidemiol & Stat, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.		English, Dallas/AAH-5005-2019; SALAZAR, ANTONIO/A-5806-2013; Stone, Jennifer/AAS-3805-2020	English, Dallas/0000-0001-7828-8188; SALAZAR, ANTONIO/0000-0003-2639-2340; Dite, Gillian/0000-0002-2448-2548; Stone, Jennifer/0000-0001-5077-0124; Giles, Graham/0000-0003-4946-9099				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; BOYD NF, 1982, BRIT J CANCER, V45, P185, DOI 10.1038/bjc.1982.32; Boyd Norman F., 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P558; BRISSON J, 1984, AM J EPIDEMIOL, V119, P371, DOI 10.1093/oxfordjournals.aje.a113755; BRISSON J, 1989, AM J EPIDEMIOL, V130, P14, DOI 10.1093/oxfordjournals.aje.a115305; BRISSON J, 1982, AM J EPIDEMIOL, V115, P428, DOI 10.1093/oxfordjournals.aje.a113320; Byng JW, 1998, RADIOGRAPHICS, V18, P1587, DOI 10.1148/radiographics.18.6.9821201; Byrne C, 1997, J NATL CANCER I, V89, P531, DOI 10.1093/jnci/89.8.531; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Byrne C, 2000, CANCER RES, V60, P3744; Byrne Celia, 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P153; CIATTO S, 1993, EUR J RADIOL, V17, P122, DOI 10.1016/0720-048X(93)90048-R; Cui JS, 2001, AM J HUM GENET, V68, P420, DOI 10.1086/318187; DESTAVOLA BL, 1990, INT J EPIDEMIOL, V19, P247, DOI 10.1093/ije/19.2.247; EGAN RL, 1977, CANCER, V40, P2087, DOI 10.1002/1097-0142(197711)40:5<2087::AID-CNCR2820400516>3.0.CO;2-3; EGAN RL, 1979, RADIOLOGY, V133, P65, DOI 10.1148/133.1.65; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; GOLDSMITH HH, 1991, BEHAV GENET, V21, P257; GRAVELLE IH, 1982, BRIT J RADIOL, V55, P23, DOI 10.1259/0007-1285-55-649-23; Guo YP, 2001, CANCER EPIDEM BIOMAR, V10, P243; HOPPER JL, 1992, AM J EPIDEMIOL, V136, P1138, DOI 10.1093/oxfordjournals.aje.a116580; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; JOHNS PC, 1987, PHYS MED BIOL, V32, P675, DOI 10.1088/0031-9155/32/6/002; KAPRIO J, 1987, BRIT J RADIOL, V60, P459, DOI 10.1259/0007-1285-60-713-459; KATO I, 1995, CANCER CAUSE CONTROL, V6, P431, DOI 10.1007/BF00052183; KROOK PM, 1978, CANCER, V41, P1093, DOI 10.1002/1097-0142(197803)41:3<1093::AID-CNCR2820410343>3.0.CO;2-H; KROOK PM, 1978, AM J ROENTGENOL, V131, P1031, DOI 10.2214/ajr.131.6.1031; LANGE K, 1987, PROGRAMS PEDIGREE AN; MACDONALD AM, 1993, LANCET, V341, P1419; Maskarinec G, 2000, BREAST CANCER RES TR, V63, P153, DOI 10.1023/A:1006486319848; MOSKOWITZ M, 1980, RADIOLOGY, V134, P293, DOI 10.1148/radiology.134.2.7352202; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; Pankow JS, 1997, J NATL CANCER I, V89, P549, DOI 10.1093/jnci/89.8.549; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; SAFTLAS AF, 1989, AM J EPIDEMIOL, V129, P518, DOI 10.1093/oxfordjournals.aje.a115163; SAFTLAS AF, 1991, CANCER, V67, P2833, DOI 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U; Sala E, 1998, J MED SCREEN, V5, P207, DOI 10.1136/jms.5.4.207; Salminen TM, 2000, ACTA ONCOL, V39, P969; Spitz E, 1996, BEHAV GENET, V26, P55, DOI 10.1007/BF02361159; TABAR L, 1982, JAMA-J AM MED ASSOC, V247, P185, DOI 10.1001/jama.247.2.185; THREATT B, 1980, CANCER, V45, P2550, DOI 10.1002/1097-0142(19800515)45:10<2550::AID-CNCR2820451013>3.0.CO;2-M; Thurfjell E, 1996, EUR J CANCER PREV, V5, P37; TORGERSON DJ, 1994, MATURITAS, V19, P83, DOI 10.1016/0378-5122(94)90057-4; Vachon CM, 2000, CANCER CAUSE CONTROL, V11, P653, DOI 10.1023/A:1008926607428; WITT I, 1984, EUR J RADIOL, V4, P65; Witte JS, 1999, GENET EPIDEMIOL, V16, P290, DOI 10.1002/(SICI)1098-2272(1999)16:3<290::AID-GEPI5>3.0.CO;2-8; WOLFE JN, 1987, AM J ROENTGENOL, V148, P1087, DOI 10.2214/ajr.148.6.1087; WOLFE JN, 1980, CANCER, V46, P2433, DOI 10.1002/1097-0142(19801201)46:11<2433::AID-CNCR2820461123>3.0.CO;2-E; WOLFE JN, 1976, CANCER, V37, P2486, DOI 10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8; WOLFE JN, 1976, AM J ROENTGENOL, V126, P1130, DOI 10.2214/ajr.126.6.1130	53	435	445	1	23	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					886	894		10.1056/NEJMoa013390	http://dx.doi.org/10.1056/NEJMoa013390			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239257				2022-12-28	WOS:000178040700004
J	Fujisawa, T; Austing, DG; Tokura, Y; Hirayama, Y; Tarucha, S				Fujisawa, T; Austing, DG; Tokura, Y; Hirayama, Y; Tarucha, S			Allowed and forbidden transitions in artificial hydrogen and helium atoms	NATURE			English	Article							QUANTUM DOTS; EXCITATION-SPECTRA; ELECTRONIC STATES; TRANSPORT; SYSTEMS	The strength of radiative transitions in atoms is governed by selection rules that depend on the occupation of atomic orbitals with electrons(1). Experiments have shown(2-5) similar electron occupation of the quantized energy levels in semiconductor quantum dots-often described as artificial atoms. But unlike real atoms, the confinement potential of quantum dots is anisotropic, and the electrons can easily couple with phonons of the material(6). Here we report electrical pump-and-probe experiments that probe the allowed and 'forbidden' transitions between energy levels under phonon emission in quantum dots with one or two electrons (artificial hydrogen and helium atoms). The forbidden transitions are in fact allowed by higher-order processes where electrons flip their spin. We find that the relaxation time is about 200 mus for forbidden transitions, 4 to 5 orders of magnitude longer than for allowed transitions. This indicates that the spin degree of freedom is well separated from the orbital degree of freedom, and that the total spin in the quantum dots is an excellent quantum number. This is an encouraging result for potential applications of quantum dots as basic entities for spin-based quantum information storage.	NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; Natl Res Council Canada, Inst Microstruct Sci M23A, Ottawa, ON K1A 0R6, Canada; CREST Interacting Carrier Electron Project, Kawaguchi 3310012, Japan; Univ Tokyo, Bunkyo Ku, Tokyo 1130033, Japan; ERATO, Mesoscop Correlat Project, Atsugi, Kanagawa 2430198, Japan	Nippon Telegraph & Telephone Corporation; National Research Council Canada; Japan Science & Technology Agency (JST); University of Tokyo; Japan Science & Technology Agency (JST)	Fujisawa, T (corresponding author), NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	fujisawa@will.brl.ntt.co.jp	Tokura, Yasuhiro/A-5550-2011; Fujisawa, Toshimasa/M-2428-2013; TARUCHA, SEIGO/I-7030-2012; Hirayama, Yoshiro/AAE-1598-2019	Tokura, Yasuhiro/0000-0001-6656-4237; Fujisawa, Toshimasa/0000-0002-0451-6579; Hirayama, Yoshiro/0000-0003-2638-9133				ASHOORI RC, 1992, PHYS REV LETT, V68, P3088, DOI 10.1103/PhysRevLett.68.3088; AVERIN DV, 1992, NATO ADV SCI I B-PHY, V294, P217; BENISTY H, 1991, PHYS REV B, V44, P10945, DOI 10.1103/PhysRevB.44.10945; BETHE HA, 1957, QUANTUM MECH ONE 2 E; BOCKELMANN U, 1994, PHYS REV B, V50, P17271, DOI 10.1103/PhysRevB.50.17271; Ciorga M, 2001, PHYSICA E, V11, P35, DOI 10.1016/S1386-9477(01)00153-9; De Franceschi S, 2001, PHYS REV LETT, V86, P878, DOI 10.1103/PhysRevLett.86.878; Eto M, 2001, JPN J APPL PHYS 1, V40, P1929, DOI 10.1143/JJAP.40.1929; Fujisawa T, 1998, SCIENCE, V282, P932, DOI 10.1126/science.282.5390.932; Fujisawa T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.236802; Fujisawa T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.081304; Gupta JA, 2001, SCIENCE, V292, P2458, DOI 10.1126/science.1061169; HALPERIN WP, 1986, REV MOD PHYS, V58, P533, DOI 10.1103/RevModPhys.58.533; Kavokin KV, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075305; Khaetskii AV, 2000, PHYS REV B, V61, P12639, DOI 10.1103/PhysRevB.61.12639; Kouwenhoven LP, 1997, SCIENCE, V278, P1788, DOI 10.1126/science.278.5344.1788; Kouwenhoven LP, 1997, NATO ADV SCI I E-APP, V345, P105; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Matagne P, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.085325; Pikus G E, 1984, OPTICAL ORIENTATION, P73; Recher P, 2000, PHYS REV LETT, V85, P1962, DOI 10.1103/PhysRevLett.85.1962; Seck M, 1997, PHYS REV B, V56, P7422, DOI 10.1103/PhysRevB.56.7422; SEEGER K, 1985, SEMICONDUCTOR PHYSIC, P153; Sukhorukov EV, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125315; Tokura Y, 2001, PHYSICA B, V298, P260, DOI 10.1016/S0921-4526(01)00313-1	27	339	342	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2002	419	6904					278	281		10.1038/nature00976	http://dx.doi.org/10.1038/nature00976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239561	Green Submitted			2022-12-28	WOS:000178056300039
J	Marrazzo, J				Marrazzo, J			Vulvovaginal candidiasis	BRITISH MEDICAL JOURNAL			English	Editorial Material									Harborview Med Ctr, Seattle STD HIV Prevent & Training Ctr, Seattle, WA 98104 USA	Harborview Medical Center	Marrazzo, J (corresponding author), Harborview Med Ctr, Seattle STD HIV Prevent & Training Ctr, Box 359931, Seattle, WA 98104 USA.		Nabhan, Ashraf/A-1718-2008	Nabhan, Ashraf/0000-0003-4572-2210; Marrazzo, Jeanne/0000-0002-9277-7364					0	6	6	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2002	325	7364					586	587		10.1136/bmj.325.7364.586	http://dx.doi.org/10.1136/bmj.325.7364.586			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595JJ	12228137	Green Published			2022-12-28	WOS:000178105200024
J	Grimes, DA				Grimes, DA			Switching emergency contraception to over-the-counter status	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADVANCE PROVISION; NICOTINE PATCH; SAFETY; LABEL		Family Hlth Int, Res Triangle Pk, NC 27713 USA		Grimes, DA (corresponding author), Family Hlth Int, Res Triangle Pk, NC 27713 USA.							AUBENY E, 2000, EUR J CONTRACEPT  S1, V5, P41; Davidson M, 1998, ARCH FAM MED, V7, P569, DOI 10.1001/archfami.7.6.569; EC Hughes, 1972, OBSTETRIC GYNECOLOGI, P327; Ellertson C, 1998, J Am Med Womens Assoc (1972), V53, P226; Ellertson C, 2001, OBSTET GYNECOL, V98, P570, DOI 10.1016/S0029-7844(01)01506-X; ELLERTSON C, 1998, J AM MED WOM ASS S2, V53, P232; Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101; Grimes D, 1998, LANCET, V352, P428; Grimes DA, 1997, NEW ENGL J MED, V337, P1078, DOI 10.1056/NEJM199710093371510; Grimes DA, 2001, OBSTET GYNECOL, V98, P151, DOI 10.1016/S0029-7844(01)01412-0; Grimes DA, 2001, WOMEN HEALTH ISS, V11, P397, DOI 10.1016/S1049-3867(01)00126-8; GRIMES DA, 1992, NEW ENGL J MED, V327, P1088, DOI 10.1056/NEJM199210083271509; GRIMES DA, 1992, AM J OBSTET GYNECOL, V166, P1950, DOI 10.1016/0002-9378(92)91394-P; Grimes DA, 2000, LANCET, V356, P1013, DOI 10.1016/S0140-6736(00)02699-4; Hays JT, 1999, AM J PUBLIC HEALTH, V89, P1701, DOI 10.2105/AJPH.89.11.1701; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; *HJ KAIS FAM FDN, 2000, EM CONTR PRESCR COUN, P1; Lovvorn A, 2000, CONTRACEPTION, V61, P287, DOI 10.1016/S0010-7824(00)00107-4; Matheson CI, 1998, FAM PRACT, V15, P38, DOI 10.1093/fampra/15.1.38; Mullen WH, 1997, ANN EMERG MED, V29, P255, DOI 10.1016/S0196-0644(97)70277-4; Piaggio G, 1999, LANCET, V353, P721, DOI 10.1016/S0140-6736(98)05718-3; Raine T, 2000, OBSTET GYNECOL, V96, P1, DOI 10.1016/S0029-7844(00)00830-9; RAMANWILMS L, 1995, OBSTET GYNECOL, V85, P141, DOI 10.1016/0029-7844(94)00341-A; Raymond EG, 2002, OBSTET GYNECOL, V100, P342, DOI 10.1016/S0029-7844(02)02086-0; ROWLANDS S, 1991, BR J FAM PLANN, V17, P23; Soller RW, 1999, DRUG INF J, V33, P799, DOI 10.1177/009286159903300320; Trussell J, 2000, OBSTET GYNECOL, V95, P267, DOI 10.1016/S0029-7844(99)00518-9; U.S. Preventive Services Task Force, 1996, GUID CLIN PREV SERV; Ventura S J, 1999, Natl Vital Stat Rep, V47, P1; von Hertzen H, 2000, CONTRACEPTION, V61, P303, DOI 10.1016/S0010-7824(00)00116-5; Wearn AM, 1999, J CLIN PHARM THER, V24, P313, DOI 10.1046/j.1365-2710.1999.00234.x; WEBB A, 1994, BRIT MED J, V308, P135, DOI 10.1136/bmj.308.6921.135; *WHO, 2000, IMPR ACC QUAL CAR FA; WILLS SE, 2002, NATL REV         MAR; 2002, COUNTER MED WHATS RI; 1987, WHO TECH REP SER, V753, P7; 2002, TAKING EC COUNTER	37	35	35	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					846	849		10.1056/NEJMsb020913	http://dx.doi.org/10.1056/NEJMsb020913			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226159				2022-12-28	WOS:000177921300013
J	Steineck, G; Helgesen, F; Adolfsson, J; Dickman, PW; Johansson, J; Norlen, BJ; Holmberg, L				Steineck, G; Helgesen, F; Adolfsson, J; Dickman, PW; Johansson, J; Norlen, BJ; Holmberg, L		Scandinavian Prostatic Canc Grp St	Quality of life after radical prostatectomy or watchful waiting	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SELF-ADMINISTERED QUESTIONNAIRE; WANING SEXUAL FUNCTION; OF-LIFE; ERECTILE DYSFUNCTION; CANCER OUTCOMES; SILDENAFIL CITRATE; URINARY; MEN; RADIOTHERAPY; MANAGEMENT	Background: We evaluated symptoms and self-assessments of quality of life in men with localized prostate cancer who participated in a randomized comparison between radical prostatectomy and watchful waiting. Methods: Between 1989 and 1999, a group of Swedish urologists randomly assigned men with localized prostate cancer to radical prostatectomy or watchful waiting. In this follow-up study, we obtained information from 326 of 376 eligible men (87 percent) concerning certain symptoms, symptom-induced distress, well-being, and the subjective assessment of quality of life by means of a mailed questionnaire. Results: Erectile dysfunction (80 percent vs. 45 percent) and urinary leakage (49 percent vs. 21 percent) were more common after radical prostatectomy, whereas urinary obstruction (e.g., 28 percent vs. 44 percent for weak urinary stream) was less common. Bowel function, the prevalence of anxiety, the prevalence of depression, well-being, and the subjective quality of life were similar in the two groups. Conclusions: The assignment of patients to watchful waiting or radical prostatectomy entails different risks of erectile dysfunction, urinary leakage, and urinary obstruction, but on average, the choice has little if any influence on well-being or the subjective quality of life after a mean follow-up of four years.	Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden; Univ Hosp, Dept Urol, Orebro, Sweden; Univ Hosp, Ctr Assessment Med Technol, Orebro, Sweden; Karolinska Inst, Surg Sci Ctr, Stockholm, Sweden; Ctr Oncol, Stockholm, Sweden; Univ Hosp, Dept Surg, Reg Oncol Ctr, Uppsala, Sweden; Univ Hosp, Dept Urol, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Orebro University; Orebro University; Karolinska Institutet; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital	Steineck, G (corresponding author), Karolinska Inst, Radiumhemmet, S-17176 Stockholm, Sweden.		Steineck, Gunnar/W-1515-2019; Dickman, Paul W/B-4572-2013	Steineck, Gunnar/0000-0002-0787-3969; Dickman, Paul W/0000-0002-5788-3380; Adolfsson, Jan/0000-0003-2992-1869				ADOLFSSON J, 1993, CANCER-AM CANCER SOC, V72, P310, DOI 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T; Adolfsson J, 1998, EUR UROL, V33, P11, DOI 10.1159/000019528; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; Barry MJ, 2001, CANCER-AM CANCER SOC, V91, P2302, DOI 10.1002/1097-0142(20010615)91:12<2302::AID-CNCR1262>3.0.CO;2-P; Bergmark K, 1999, NEW ENGL J MED, V340, P1383, DOI 10.1056/NEJM199905063401802; Bishoff JT, 1998, J UROLOGY, V160, P454, DOI 10.1016/S0022-5347(01)62924-0; Borjeson S, 1997, CANCER NURS, V20, P260; Feng MI, 2000, J UROLOGY, V164, P1935, DOI 10.1016/S0022-5347(05)66922-4; Fontaine E, 2000, EUR UROL, V37, P223, DOI 10.1159/000020122; Fowler FJ, 2000, JAMA-J AM MED ASSOC, V283, P3217, DOI 10.1001/jama.283.24.3217; FOWLER FJ, 1995, UROLOGY, V45, P1007, DOI 10.1016/S0090-4295(99)80122-8; Harmer M., 1982, TNM CLASSIFICATION M, VThird; Helgason A, 1996, BRIT J CANCER, V73, P1417, DOI 10.1038/bjc.1996.268; Helgason AR, 1996, AGE AGEING, V25, P285, DOI 10.1093/ageing/25.4.285; Helgason AR, 1998, BRIT J UROL, V81, P135; Helgason AR, 1997, J UROLOGY, V158, P155, DOI 10.1097/00005392-199707000-00050; Henningsohn L, 2002, J UROLOGY, V168, P168, DOI 10.1016/S0022-5347(05)64854-9; Hermanek P, 1992, TNM CLASSIFICATION M; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Litwin MS, 1999, UROLOGY, V54, P503, DOI 10.1016/S0090-4295(99)00172-7; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; McMahon CG, 2000, J UROLOGY, V164, P1192, DOI 10.1016/S0022-5347(05)67139-X; Murphy G P, 1994, Scand J Urol Nephrol Suppl, V162, P7; Potosky AL, 2000, JNCI-J NATL CANCER I, V92, P1582, DOI 10.1093/jnci/92.19.1582; Potosky AL, 1999, JNCI-J NATL CANCER I, V91, P1719, DOI 10.1093/jnci/91.20.1719; RADLOFF LS, 1994, APPL PSYCH MEAS, V1, P385; Rothman K., 1998, MODERN EPIDEMIOLOGY; SAS Institute, 1990, SAS PROC GUID VERS 6; SPIELBERGER CD, 1983, MANUAL STATE TRAIT A; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; Steineck G, 2002, ACTA ONCOL, V41, P244, DOI 10.1080/02841860260088782; Thompson IM, 2000, ONCOLOGY-NY, V14, P119; THOMPSON IM, 2000, ONCOLOGY HUNTINGT, V14, P131; WALSH PC, 1983, PROSTATE, V4, P473, DOI 10.1002/pros.2990040506; Walsh PC, 2000, J UROLOGY, V163, P1802, DOI 10.1016/S0022-5347(05)67547-7; Walsh PC, 1998, J UROLOGY, V160, P2418, DOI 10.1016/S0022-5347(01)62202-X	37	506	524	0	26	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					790	796		10.1056/NEJMoa021483	http://dx.doi.org/10.1056/NEJMoa021483			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226149				2022-12-28	WOS:000177921300003
J	Silver, RC; Holman, EA; McIntosh, DN; Poulin, M; Gil-Rivas, V				Silver, RC; Holman, EA; McIntosh, DN; Poulin, M; Gil-Rivas, V			Nationwide longitudinal study of psychological responses to September 11	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article						terrorism	POSTTRAUMATIC-STRESS-DISORDER; GAY MEN; SURVIVORS; SYMPTOMS; TRAUMA; PREDICTORS; DISTRESS; IMPACT; DEPRESSION; COMMUNITY	Context The September 11, 2001, attacks against the United States provide a unique opportunity to examine longitudinally the process of adjustment to a traumatic event on a national scale. Objective To examine the degree to which demographic factors, mental and physical health history, lifetime exposure to stressful events, September 11-related experiences, and coping strategies used shortly after the attacks predict psychological outcomes over time. Design, Setting, and Participants A national probability sample of 3496 adults received a Web-based survey; 2729 individuals (78% participation rate) completed it between 9 and 23 days (75% within 9 to 14 days) after the terrorist attacks. A random sample of 1069 panelists residing outside New York, NY, were drawn from the wave 1 sample (n =2729) and received a second survey; 933 (87% participation rate) completed it approximately 2 months following the attacks. A third survey (n=787) was completed approximately 6 months after the attacks. Main Outcome Measures September 11-related symptoms of acute stress, posttraumatic stress, and global distress. Results Seventeen percent of the US population outside of New York City reported symptoms of September 11-related posttraumatic stress 2 months after the attacks; 5.8% did so at 6 months. High levels of posttraumatic stress symptoms were associated with female sex (odds ratio [OR], 1.64; 95% confidence interval [Cl], 1.17-2.31), marital separation (OR, 2.55; 95% Cl, 1.06-6.14), pre-September 11 physician-diagnosed depression or anxiety disorder (OR, 1.84; 95% Cl, 1.33-2.56) or physical illness (OR, 0.93; 95% Cl, 0.88-0.99), severity of exposure to the attacks (OR, 1.31; 95% Cl, 1.11-1.55), and early disengagement from coping efforts (eg, giving up: OR, 1.68; 95% Cl, 1.27-2.20; denial: OR, 1.33; 95% Cl, 1.07-1.64; and self-distraction: OR, 1.31; 95% Cl, 1.07-1.59). In addition to demographic and pre-September 11 health variables, global distress was associated with severity of loss due to the attacks (beta=.07; P=.008) and early coping strategies (eg, increased with denial: beta=.08; P=.005; and giving up: beta=.05; P=.04; and decreased with active coping: beta=-.08; P=.002). Conclusions The psychological effects of a major national trauma are not limited to those who experience it directly, and the degree of response is not predicted simply by objective measures of exposure to or loss from the trauma. Instead, use of specific coping strategies shortly after an event is associated with symptoms over time. In particular, disengaging from coping efforts can signal the likelihood of psychological difficulties up to 6 months after a trauma.	Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA; Univ Denver, Dept Psychol, Denver, CO 80208 USA	University of California System; University of California Irvine; University of Denver	Silver, RC (corresponding author), Univ Calif Irvine, Dept Psychol & Social Behav, 3340 Social Ecol 2, Irvine, CA 92697 USA.	rsilver@uci.edu		McIntosh, Daniel/0000-0003-2267-9870				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Cardena E, 2000, J TRAUMA STRESS, V13, P719, DOI 10.1023/A:1007822603186; Carnelley KB, 1999, PSYCHOL MED, V29, P1111, DOI 10.1017/S0033291799008971; Carver C.S., 1999, HDB PERSONALITY, V2nd ed., P553; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1993, J PERS SOC PSYCHOL, V65, P375, DOI 10.1037/0022-3514.65.2.375; CARVER CS, IN PRESS OXFORD HDB; CHANG L, 2001, AM ASS PUBL OP RES A; Chemtob CM, 1997, AM J PSYCHIAT, V154, P415; Compas BE, 2001, PSYCHOL BULL, V127, P87, DOI 10.1037//0033-2909.127.1.87; COMPAS BE, 1988, COGNITIVE THER RES, V12, P305, DOI 10.1007/BF01176192; DELEON CFM, 1994, PSYCHOL MED, V24, P613, DOI 10.1017/S0033291700027768; DENNIS JM, 2001, C INT STAT I AUG 29; DENNIS JM, 2001, MARKETING RES    SUM, P34; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Derogatis LR, 2000, HANDBOOK OF PSYCHOLOGICAL ASSESSMENT IN PRIMARY CARE SETTINGS, P297; Derogatis LR, 2001, BSI 18 ADM SCORING P; DOLAN CA, 1988, J RES PERS, V22, P395, DOI 10.1016/0092-6566(88)90037-2; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; HARLOW SD, 1991, ARCH GEN PSYCHIAT, V48, P1065; Holman EA, 2000, ARCH FAM MED, V9, P802, DOI 10.1001/archfami.9.9.802; Holman EA, 1998, J PERS SOC PSYCHOL, V74, P1146, DOI 10.1037/0022-3514.74.5.1146; Ironson G, 1994, Int J Behav Med, V1, P90, DOI 10.1207/s15327558ijbm0101_6; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; KOOPMAN C, 1994, AM J PSYCHIAT, V151, P888; KOOPMAN C, 1997, PROG PSYCH, P21; Krantz J. H., 2000, PSYCHOL EXPT INTERNE, P35, DOI DOI 10.1016/B978-012099980-4/50003-4; Leon A C, 1995, Arch Fam Med, V4, P857, DOI 10.1001/archfami.4.10.857; Mollica RH, 2001, JAMA-J AM MED ASSOC, V286, P546, DOI 10.1001/jama.286.5.546; NORRIS F, 2001, 50 000 DISASTER VICT; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; North CS, 1997, AM J PSYCHIAT, V154, P1696, DOI 10.1176/ajp.154.12.1696; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; North CS, 2002, JAMA-J AM MED ASSOC, V288, P633, DOI 10.1001/jama.288.5.633; NORTH CS, 2001, ANN CLIN PSYCHIAT, V23, P81; Perczek RE, 2002, CANCER-AM CANCER SOC, V94, P2923, DOI 10.1002/cncr.10564; RABEHESKETH S, 2000, HDB STAT ANAL USING; Reed GM, 1999, HEALTH PSYCHOL, V18, P354, DOI 10.1037/0278-6133.18.4.354; REIFMAN A, 2000, J EMOTIONAL ABUSE, V2, P93; Reips U.D., 2000, PSYCHOL EXPT INTERNE, P89, DOI DOI 10.1016/B978-012099980-4/50005-8; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; Shalev AY, 1996, AM J PSYCHIAT, V153, P219; Silver R. L., 1980, HUMAN HELPLESSNESS T, P279; Smith TomW., 2001, AM REBOUNDS NATL STU; Stephenson J, 2001, JAMA-J AM MED ASSOC, V286, P1823, DOI 10.1001/jama.286.15.1823; STONE AA, 1984, J PERS SOC PSYCHOL, V46, P892, DOI 10.1037/0022-3514.46.4.892; TERRY DJ, 1994, J PERS SOC PSYCHOL, V66, P895, DOI 10.1037/0022-3514.66.5.895; *US BUR CENS, 2001, CURR POP SURV; Weiss Daniel S., 1997, P399; Wilson JP., 1997, ASSESSING PSYCHOL TR; Wortman C., 2001, HDB BEREAVEMENT RES, P405, DOI [10.1037/10436-017., DOI 10.1037/10436-017]; WORTMAN CB, 1989, J CONSULT CLIN PSYCH, V57, P349, DOI 10.1037/0022-006X.57.3.349; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941	55	783	792	0	74	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1235	1244		10.1001/jama.288.10.1235	http://dx.doi.org/10.1001/jama.288.10.1235			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215130	Bronze, Green Published			2022-12-28	WOS:000177917700022
J	Herbert, RD; Gabriel, M				Herbert, RD; Gabriel, M			Effects of stretching before and after exercising on muscle soreness and risk of injury: systematic review	BRITISH MEDICAL JOURNAL			English	Review							WARM-UP; CLINICAL-TRIALS; FLEXIBILITY; PREVENTION; METAANALYSIS; PERFORMANCE; BIAS	Objective To determine the effects of stretching before and after exercising on muscle soreness after exercise, risk of injury, and athletic performance. Method Systematic review. Data sources Randomised or quasi-randomised studies identified by searching Medline, Embase, CINAHL, SPORTDiscus, and PEDro, and by recursive checking of bibliographies. Main outcome measures Muscle soreness, incidence of injury, athletic performance. Results Five studies, all of moderate quality, reported sufficient data on the effects of stretching on muscle soreness to be included in the analysis. Outcomes seemed homogeneous. Stretching produced small and statistically non-significant reductions in muscle soreness. The pooled estimate of reduction in muscle soreness 24 hours after exercising was only 0.9 mm on a 100 mm scale (95% confidence interval - 2.6 turn to 4.4 mm). Data from two studies on army recruits in military training show that muscle stretching before exercising does not produce useful reductions in injury risk (pooled hazard ratio 0.95, 0.78 to 1.16). Conclusions Stretching before or after exercising does not confer protection from muscle soreness. Stretching before exercising does not seem to confer a practically useful reduction in the risk of injury, but the generality of this finding needs testing. Insufficient research has been (tone with which to determine the effects of stretching on sporting performance.	Univ Sydney, Sch Physiotherapy, Lidcombe, NSW 1825, Australia	University of Sydney	Herbert, RD (corresponding author), Univ Sydney, Sch Physiotherapy, POB 170, Lidcombe, NSW 1825, Australia.		Herbert, Rob/E-9442-2012	Herbert, Rob/0000-0003-4188-9195				BUROKER KC, 1989, PHYSICIAN SPORTSMED, V17, P65, DOI 10.1080/00913847.1989.11709806; Chalmers I, 1995, SYSTEMATIC REV; Cross KM, 1999, J ATHL TRAINING, V34, P11; DEVRIES HA, 1961, RES QUART, V32, P468, DOI 10.1080/10671188.1961.10613174; DEVRIES HA, 1961, RES QUART, V32, P177, DOI 10.1080/10671188.1961.10613131; DEVRIES HA, 1961, RES QUART, V22, P468; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; DONNER A, 1987, STAT MED, V6, P43, DOI 10.1002/sim.4780060106; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; Gleim G W, 1997, Sports Med, V24, P289; GLEIM GW, 1990, J ORTHOP RES, V8, P814, DOI 10.1002/jor.1100080606; GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B; Gulick Dawn T., 1996, Journal of Athletic Training, V31, P145; Handel M, 1997, EUR J APPL PHYSIOL, V76, P400, DOI 10.1007/s004210050268; Hartig DE, 1999, AM J SPORT MED, V27, P173, DOI 10.1177/03635465990270021001; Herbert RD, 2000, AUST J PHYSIOTHER, V46, P309, DOI 10.1016/S0004-9514(14)60292-0; HIGH DM, 1989, RES Q EXERCISE SPORT, V60, P357, DOI 10.1080/02701367.1989.10607463; Johansson PH, 1999, SCAND J MED SCI SPOR, V9, P219; Laird N M, 1990, Int J Technol Assess Health Care, V6, P5; MCGLYNN GH, 1979, AM J PHYS MED REHAB, V58, P139; Moseley AM, 1999, P 7 COCHR C ROM, P39; *NHS CTR REV DISS, 1996, UND SYST REV RES EFF; Pope Rodney, 1998, Aust J Physiother, V44, P165; Pope RP, 2000, MED SCI SPORT EXER, V32, P271, DOI 10.1097/00005768-200002000-00004; SAFRAN MR, 1989, SPORTS MED, V8, P239, DOI 10.2165/00007256-198908040-00004; Shrier I, 1999, CLIN J SPORT MED, V9, P221, DOI 10.1097/00042752-199910000-00007; SMITH CA, 1994, J ORTHOP SPORT PHYS, V19, P12, DOI 10.2519/jospt.1994.19.1.12; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Wessel J., 1994, CLIN J SPORT MED, V4, P83, DOI DOI 10.1097/00042752-199404000-00003; WILSON GJ, 1992, MED SCI SPORT EXER, V24, P116	31	171	182	2	65	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2002	325	7362					468	470A		10.1136/bmj.325.7362.468	http://dx.doi.org/10.1136/bmj.325.7362.468			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592EZ	12202327	Bronze, Green Published			2022-12-28	WOS:000177924900019
J	Kideys, AE				Kideys, AE			Fall and rise of the Black Sea ecosystem	SCIENCE			English	Editorial Material							CTENOPHORE MNEMIOPSIS; CASPIAN SEA; LARVAE; EGGS		Middle E Tech Univ, Inst Marine Sci, TR-33731 Erdemli, Turkey	Middle East Technical University	Kideys, AE (corresponding author), Middle E Tech Univ, Inst Marine Sci, TR-33731 Erdemli, Turkey.	kideys@ims.metu.edu.tr	KIDEYS, Ahmet E/Q-1824-2015	KIDEYS, AHMET ERKAN/0000-0002-1113-2434				[Anonymous], 2000, BIOL INVASIONS; DUMONT H, 1995, NATURE, V377, P673, DOI 10.1038/377673a0; Dumont HJ, 1998, LIMNOL OCEANOGR, V43, P44, DOI 10.4319/lo.1998.43.1.0044; Eker E, 1999, ICES J MAR SCI, V56, P15, DOI 10.1006/jmsc.1999.0604; Finenko GA, 2001, HYDROBIOLOGIA, V451, P177, DOI 10.1023/A:1011819819448; FINENKO GA, 2001, MNEM ADV GROUP 1 WOR; Humborg C, 1997, NATURE, V386, P385, DOI 10.1038/386385a0; Kideys AE, 2001, MAR BIOL, V139, P535; Kideys AE, 2000, J MARINE SYST, V24, P355, DOI 10.1016/S0924-7963(99)00095-0; KIDEYS AE, 1994, J MARINE SYST, V5, P171, DOI 10.1016/0924-7963(94)90030-2; Kideys AE, 1999, ICES J MAR SCI, V56, P58, DOI 10.1006/jmsc.1999.0605; KIDEYS AE, 2001, STRATEGY COMBATTING; KIDEYS AE, UNPUB; KOPELEVICH OV, IN PRESS J MAR SYS; KOVALEV AV, 1998, NATO TU BLACK SEA PR, P221; Leppakoski E, 1996, AMBIO, V25, P380; MEE LD, 1992, AMBIO, V21, P278; Moncheva S.V., 2001, P 9 INT C HARMF ALG, P177; NIERMANN U, 1994, ICES J MAR SCI, V51, P395, DOI 10.1006/jmsc.1994.1041; Shiganova TA, 2001, OCEANOLOGY+, V41, P517; Shiganova TA, 2000, ICES J MAR SCI, V57, P641, DOI 10.1006/jmsc.2000.0736; Shtereva G, 1999, WATER SCI TECHNOL, V39, P37, DOI 10.1016/S0273-1223(99)00205-X; SHUSHKINA EA, 1990, OCEANOLOGY, V30, P521; SOROKIN YS, 2002, BLACK SEA ECOLOGY OC; TSIKHONLUKASHIN.YA, 1991, OCEANOLOGY, V31, P196; VINOGRADOV ME, 1989, OKEANOLOGIYA+, V29, P293; Vladimirov VL, 1997, NATO ASI 2, V27, P33; Yunev OA, 2002, MAR ECOL PROG SER, V230, P11, DOI 10.3354/meps230011; Zaitsev Yu.P., 1992, Fisheries Oceanography, V1, P180, DOI 10.1111/j.1365-2419.1992.tb00036.x; Zenkevitch L., 1963, BIOL SEAS USSR	30	256	280	0	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1482	1484		10.1126/science.1073002	http://dx.doi.org/10.1126/science.1073002			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202806				2022-12-28	WOS:000177697300032
J	Perozo, E; Cortes, DM; Sompornpisut, P; Kloda, A; Martinac, B				Perozo, E; Cortes, DM; Sompornpisut, P; Kloda, A; Martinac, B			Open channel structure of MscL and the gating mechanism of mechanosensitive channels	NATURE			English	Article							ESCHERICHIA-COLI; ION-CHANNEL; CONFORMATIONAL-CHANGES; PROTEIN STRUCTURES; K+ CHANNEL; ARCHITECTURE; ACTIVATION; PRESSURE; INSIGHTS; MODELS	Mechanosensitive channels act as membrane-embedded mechano-electrical switches, opening a large water-filled pore in response to lipid bilayer deformations. This process is critical to the response of living organisms to direct physical stimulation, such as in touch, hearing and osmoregulation. Here, we have determined the structural rearrangements that underlie these events in the large prokaryotic mechanosensitive channel (MscL) using electron paramagnetic resonance spectroscopy and site-directed spin labelling. MscL was trapped in both the open and in an intermediate closed state by modulating bilayer morphology. Transition to the intermediate state is characterized by small movements in the first transmembrane helix (TM1). Subsequent transitions to the open state are accompanied by massive rearrangements in both TM1 and TM2, as shown by large increases in probe dynamics, solvent accessibility and the elimination of all intersubunit spin-spin interactions. The open state is highly dynamic, supporting a water-filled pore of at least 25 Angstrom, lined mostly by TM1. These structures suggest a plausible molecular mechanism of gating in mechanosensitive channels.	Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22906 USA; Univ Virginia, Ctr Struct Biol, Charlottesville, VA 22906 USA; Univ Western Australia, Queen Elizabeth II Med Ctr, Dept Pharmacol, Crawley, WA 6009, Australia; Chulalongkorn Univ, Fac Sci, Dept Chem, Bangkok 10330, Thailand	University of Virginia; University of Virginia; University of Western Australia; Chulalongkorn University	Perozo, E (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22906 USA.		Martinac, Boris/A-7178-2018	Martinac, Boris/0000-0001-8422-7082				ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; Batiza AF, 1999, STRUCTURE, V7, pR99, DOI 10.1016/S0969-2126(99)80061-6; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Gullingsrud J, 2001, BIOPHYS J, V80, P2074, DOI 10.1016/S0006-3495(01)76181-4; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Martinac B, 2001, CELL PHYSIOL BIOCHEM, V11, P61, DOI 10.1159/000047793; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Perozo E, 2001, J GEN PHYSIOL, V118, P193, DOI 10.1085/jgp.118.2.193; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sompornpisut P, 2001, BIOPHYS J, V81, P2530, DOI 10.1016/S0006-3495(01)75898-5; Sompornpisut Pornthep, 2002, Biophysical Journal, V82, p474a; Spencer RH, 1999, CURR OPIN STRUC BIOL, V9, P650, DOI 10.1016/S0959-440X(99)00022-6; Spencer RH, 1999, CURR OPIN STRUC BIOL, V9, P448, DOI 10.1016/S0959-440X(99)80063-3; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9; [No title captured]	37	465	489	4	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					942	948		10.1038/nature00992	http://dx.doi.org/10.1038/nature00992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198539				2022-12-28	WOS:000177677500036
J	Yin, QZ; Jacobsen, SB; Yamashita, K; Blichert-Toft, J; Telouk, P; Albarede, F				Yin, QZ; Jacobsen, SB; Yamashita, K; Blichert-Toft, J; Telouk, P; Albarede, F			A short timescale for terrestrial planet formation from Hf-W chronometry of meteorites	NATURE			English	Article							EARLY SOLAR-SYSTEM; ISOTOPIC EVIDENCE; CORE FORMATION; ACCRETION; MOON; EARTH; DIFFERENTIATION; CONSTRAINTS; CHONDRITES; GASES	Determining the chronology for the assembly of planetary bodies in the early Solar System is essential for a complete understanding of star- and planet-formation processes. Various radionuclide chronometers (applied to meteorites) have been used to determine that basaltic lava flows on the surface of the asteroid Vesta formed within 3 million years (3 Myr) of the origin of the Solar System(1-3). Such rapid formation is broadly consistent with astronomical observations of young stellar objects, which suggest that formation of planetary systems occurs within a few million years after star formation(4,5). Some hafnium-tungsten isotope data, however, require that Vesta formed later 6 (similar to16 Myr after the formation of the Solar System) and that the formation of the terrestrial planets took a much longer time(7-10) (62(-14)(+4504) Myr). Here we report measurements of tungsten isotope compositions and hafnium-tungsten ratios of several meteorites. Our measurements indicate that, contrary to previous results(7-10), the bulk of metal-silicate separation in the Solar System was completed within <30 Myr. These results are completely consistent with other evidence for rapid planetary formation(1-5), and are also in agreement with dynamic accretion models(11-13) that predict a relatively short time (&SIM;10 Myr) for the main growth stage of terrestrial planet formation.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Ecole Normale Super Lyon, Lab Sci Terr, F-69364 Lyon 7, France	Harvard University; Ecole Normale Superieure de Lyon (ENS de LYON)	Yin, QZ (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.		TELOUK, Philippe/AAY-6708-2021; Blichert-Toft, Janne/C-8280-2012; Jacobsen, Stein/ABA-1063-2021; Yin, Qing-Zhu/B-8198-2009; McDonough, William F/I-7720-2012; Albarede, Francis/A-8871-2011; YAMASHITA, Katsuyuki/B-1887-2011; Jacobsen, Stein/B-1759-2013	Blichert-Toft, Janne/0000-0002-4932-4079; Jacobsen, Stein/0000-0003-2164-0720; Yin, Qing-Zhu/0000-0002-4445-5096; McDonough, William F/0000-0001-9154-3673; Albarede, Francis/0000-0003-1994-1428; 				Bodenheimer P, 2002, ANNU REV EARTH PL SC, V30, P113, DOI 10.1146/annurev.earth.30.091201.140357; Cameron AGW, 2001, METEORIT PLANET SCI, V36, P9, DOI 10.1111/j.1945-5100.2001.tb01806.x; Chambers JE, 2001, ICARUS, V152, P205, DOI 10.1006/icar.2001.6639; Drake MJ, 2002, NATURE, V416, P39, DOI 10.1038/416039a; Halliday A, 1996, EARTH PLANET SC LETT, V142, P75, DOI 10.1016/0012-821X(96)00096-9; HALLIDAY AN, 2000, ORIGIN EARTH MOON, P45; Harper CL, 1996, SCIENCE, V273, P1814, DOI 10.1126/science.273.5283.1814; Harper CL, 1996, GEOCHIM COSMOCHIM AC, V60, P1131, DOI 10.1016/0016-7037(96)00027-0; Horan MF, 1998, GEOCHIM COSMOCHIM AC, V62, P545, DOI 10.1016/S0016-7037(97)00368-2; Humayun M, 2002, EARTH PLANET SC LETT, V198, P225, DOI 10.1016/S0012-821X(02)00500-9; IRELAND TR, 2000, LUNAR PLANET SCI, V31, pA1540; Jacobsen S.B., 1996, EARTH PROCESSES READ, P47; JACOBSEN SB, 1998, LUNAR PLANET SCI, V29, P1852; Kortenkamp SJ, 2001, SCIENCE, V293, P1127, DOI 10.1126/science.1062391; Lee DC, 1997, SCIENCE, V278, P1098, DOI 10.1126/science.278.5340.1098; Lee DC, 2000, SCIENCE, V288, P1629, DOI 10.1126/science.288.5471.1629; LEE DC, 1995, NATURE, V378, P771, DOI 10.1038/378771a0; Lee DC, 2002, EARTH PLANET SC LETT, V198, P267, DOI 10.1016/S0012-821X(02)00533-2; Lee DC, 2000, CHEM GEOL, V169, P35, DOI 10.1016/S0009-2541(99)00193-X; Lee DC, 1996, SCIENCE, V274, P1876, DOI 10.1126/science.274.5294.1876; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; Palme H., 1981, P LUNAR PLANET SCI, V12B, P949; Porcelli D, 2001, EARTH PLANET SC LETT, V193, P237, DOI 10.1016/S0012-821X(01)00493-9; Quitte G, 2000, EARTH PLANET SC LETT, V184, P83, DOI 10.1016/S0012-821X(00)00303-4; RAMMENSEE W, 1977, P LUNAR PLANET SCI C, V8, P399; SRINIVASAN G, 2000, LUNAR PLANET SCI, V31, pA1795; Wetherill G. W, 1986, ORIGIN MOON, P519; YIN QZ, 2002, LUNAR PLANET SCI, V33, pA1700; [No title captured]	30	458	474	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					949	952		10.1038/nature00995	http://dx.doi.org/10.1038/nature00995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198540				2022-12-28	WOS:000177677500037
J	Oliver, A; Healey, A; Le Grand, J				Oliver, A; Healey, A; Le Grand, J			Addressing health inequalities	LANCET			English	Editorial Material									Univ London London Sch Econ & Polit Sci, London Sch Econ Hlth & Social Care, London WC2A 2AE, England	University of London; London School Economics & Political Science	Oliver, A (corresponding author), Univ London London Sch Econ & Polit Sci, London Sch Econ Hlth & Social Care, Houghton St, London WC2A 2AE, England.		Oliver, Adam/CAG-2031-2022	Healey, Andrew/0000-0003-2013-3161				[Anonymous], 1999, DEV FREEDOM; [Anonymous], INEQUALITY RECONSIDE; AUERBACH JA, 2000, IMPROVING HLTH IT DO; DIDERICHSEN F, IN PRESS HLTH CARE P, P46; FITZPATRICK J, 2001, MAPPING HLTH INEQUAL; GILLON R, 2001, ISSUES PANEL EQUITY, P17; HEALEY A, 2001, GUARDIAN        1027; LEGRAND J, 2001, ISSUES PANEL EQUITY, P33; Oliver A, 2001, WHY CARE HLTH INEQUA; Rawls J., 1971, THEORY JUSTICE; Sassi F, 2001, Health Technol Assess, V5, P1; SIHTO M, IN PRESS HLTH CARE P, P43; SMITH GD, 1996, AM J PUBLIC HEALTH, V86, P489; *UK DEP HLTH, 2002, HLTH IN BREAK LINK P; *UK DEP HLTH, 1998, OUR HLTH NAT; *UK DEP HLTH, 1998, IN HLTH REP IND INQ; WILLIAMS A, 1999, HDB HLTH EC, P1863	17	41	41	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					565	567		10.1016/S0140-6736(02)09713-1	http://dx.doi.org/10.1016/S0140-6736(02)09713-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241675				2022-12-28	WOS:000177512800029
J	Chow, KM; Szeto, CC				Chow, KM; Szeto, CC			Calcifications	LANCET			English	Editorial Material									Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Chow, KM (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.		Szeto, Cheuk Chun/N-4954-2015; Ming, Chow Kai/Y-5568-2019	Szeto, Cheuk Chun/0000-0002-8898-8505; Ming, Chow Kai/0000-0001-5310-5197					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					442	442		10.1016/S0140-6736(02)09673-3	http://dx.doi.org/10.1016/S0140-6736(02)09673-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241715				2022-12-28	WOS:000177342900009
J	Alscher, DM				Alscher, DM			Uses of error - Lost in the bedside game of gaps	LANCET			English	Editorial Material									Robert Bosch Krankenhaus, Dept Internal Med, D-70376 Stuttgart, Germany	Bosch; Robert Bosch Krankenhaus	Alscher, DM (corresponding author), Robert Bosch Krankenhaus, Dept Internal Med, D-70376 Stuttgart, Germany.			Alscher, Mark Dominik/0000-0002-9658-1211					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					373	373		10.1016/S0140-6736(02)09608-3	http://dx.doi.org/10.1016/S0140-6736(02)09608-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241777				2022-12-28	WOS:000177255600010
J	Pena, M; Bonatti, LL; Nespor, M; Mehler, J				Pena, M; Bonatti, LL; Nespor, M; Mehler, J			Signal-driven computations in speech processing	SCIENCE			English	Article							LANGUAGE-ACQUISITION; INFANTS; CUES	Learning a language requires both statistical computations to identify words in speech and algebraic-like computations to discover higher level ( grammatical) structure. Here we show that these computations can be influenced by subtle cues in the speech signal. After a short familiarization to a continuous speech stream, adult listeners are able to segment it using powerful statistics, but they fail to extract the structural regularities included in the stream even when the familiarization is greatly extended. With the introduction of subliminal segmentation cues, however, these regularities can be rapidly captured.	Scuola Int Super Studi Avanzati, Trieste, Italy; Univ Paris 08, St Denis, France; Univ Ferrara, I-44100 Ferrara, Italy; CNRS, Lab Sci Cognit & Psycholinguist, Paris, France; EHESS, Paris, France	International School for Advanced Studies (SISSA); Universite Paris-VIII; University of Ferrara; Centre National de la Recherche Scientifique (CNRS)	Mehler, J (corresponding author), Scuola Int Super Studi Avanzati, Trieste, Italy.		Bonatti, Luca Lorenzo/AAA-2410-2019	Bonatti, Luca Lorenzo/0000-0001-8624-9007				Aslin RN, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P117; Chomsky N., 2002, JANUA LINGUARUM; CHRISTOPHE A, 1994, J ACOUST SOC AM, V95, P1570, DOI 10.1121/1.408544; Fiser J, 2002, J EXP PSYCHOL LEARN, V28, P458, DOI 10.1037//0278-7393.28.3.458; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; Gleitman L., 1982, LANG ACQUIS, P3; Hayes J.R., 1970, COGNITION DEV LANGUA, P221; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Marcus G., 2001, ALGEBRAIC MIND INTEG; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; MORGAN JL, 1987, COGNITIVE PSYCHOL, V19, P498, DOI 10.1016/0010-0285(87)90017-X; MORGAN JL, 1989, J MEM LANG, V28, P360, DOI 10.1016/0749-596X(89)90039-9; MORGAN JL, 1981, J VERB LEARN VERB BE, V20, P67, DOI 10.1016/S0022-5371(81)90312-1; MORTON J, 1976, PSYCHOL REV, V83, P405, DOI 10.1037/0033-295X.83.5.405; Newport EL, 2000, PROC ANN BUCLD, P1; PINKER S, 1991, SCIENCE, V253, P530, DOI 10.1126/science.1857983; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Seidenberg MS, 1997, SCIENCE, V275, P1599, DOI 10.1126/science.275.5306.1599	20	270	273	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 18	2002	298	5593					604	607		10.1126/science.1072901	http://dx.doi.org/10.1126/science.1072901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	604RL	12202684				2022-12-28	WOS:000178634800042
J	Chang, J; Klein, MB				Chang, J; Klein, MB			Ulnar-nerve schwannoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Stanford Univ, Med Ctr, Stanford, CA 94305 USA	Stanford University	Chang, J (corresponding author), Stanford Univ, Med Ctr, Stanford, CA 94305 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					903	903		10.1056/NEJMicm010689	http://dx.doi.org/10.1056/NEJMicm010689			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239259				2022-12-28	WOS:000178040700006
J	Dellinger, AM; Staunton, CE				Dellinger, AM; Staunton, CE		CDC	Barriers to children walking and biking to school - United States, 1999 (Reprinted from MMWR, vol 51, pg 701-704, 2002)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint									Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA 30341 USA; CDC, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Dellinger, AM (corresponding author), Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA 30341 USA.							*CDC, 2001, NAT STRAT ADV CHILD; *CDC, 1990, ANN MORT TAP; *CDC, 2001, DAT NAT EL INJ SURV; *CDC NAT HIGHW TRA, 2001, NAT STRAT ADV BIC SA; Department of Health and Human Services, 1999, HUMAN KINETICS; *MAR COUNT BIC COA, 2001, SAF ROUT SCH DEM PRO; Schieber R A, 1996, Inj Prev, V2, P228, DOI 10.1136/ip.2.3.228; *US CENS BUR, 1999, POP EST PROGR IND PO; *US DEP TRANSP, 1997, FHWAPL97028 US DEP T; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; 2002, MMWR, V51, P701	11	32	32	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2002	288	11					1343	1344						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593TB	12240658				2022-12-28	WOS:000178008300004
J	Krantz, MJ; Lewkowiez, L; Hays, H; Woodroffe, MA; Robertson, AD; Mehler, PS				Krantz, MJ; Lewkowiez, L; Hays, H; Woodroffe, MA; Robertson, AD; Mehler, PS			Torsade de Pointes associated with very-high-dose methadone	ANNALS OF INTERNAL MEDICINE			English	Article							LEVOMETHADYL ACETATE	Background: Methadone is an effective treatment for opioid dependency and chronic pain. A methadone derivative, levacetyl-methadol, was withdrawn from the European market after being associated with torsade de pointes. To date, no association between methadone and this arrhythmia has been described. Objective: To evaluate a series of methadone-treated patients experiencing torsade de pointes. Design: Retrospective case series. Setting: Methadone maintenance treatment programs in the United States and a pain management center in Canada. Patients: 17 methadone-treated patients who developed torsade de pointes. Measurements: Chart review for concomitant arrhythmia risk factors and quantification of corrected QT interval (QTc). Results: The mean daily methadone dose was 397 +/- 283 mg, and the mean QTc interval was 615 +/- 77 msec. Fourteen patients had a predisposing risk factor for arrhythmia. A cardiac defibrillator or pacemaker was placed in 14 patients; all 17 patients survived. Conclusions: This series raises concern that very-high-dose methadone may be associated with torsade de pointes. Given the likely expansion of methadone treatment into primary care, further investigation of these findings is warranted.	Denver Hlth Med Ctr, Div Cardiol, Denver, CO 80204 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Univ Alberta, Edmonton, AB, Canada	Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Alberta	Krantz, MJ (corresponding author), Denver Hlth Med Ctr, Div Cardiol, Mail Code 0960,777 Bannock St, Denver, CO 80204 USA.							Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; D'Aunno T, 1999, AM J DRUG ALCOHOL AB, V25, P681, DOI 10.1081/ADA-100101886; Deamer RL, 2001, J ADDICT DIS, V20, P7, DOI 10.1300/J069v20n04_02; Dessertenne F, 1966, Arch Mal Coeur Vaiss, V59, P263; European Agency for the Evaluation of Medical Products, 2001, EMEA877601; HAYS H, 1999, PAIN RES MANAG, V4, P23; Huber A, 2001, DRUG ALCOHOL DEPEN, V63, pS70; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Katchman AN, 2001, PHARMACOLOGIST, V43, P98; KOMTHONG S, 1987, P SOC EXP BIOL MED, V184, P40; KURITA T, 1993, PACE, V16, P33, DOI 10.1111/j.1540-8159.1993.tb01532.x; MAKKAR RR, 1993, JAMA-J AM MED ASSOC, V270, P2590, DOI 10.1001/jama.270.21.2590; McCaffrey BR, 2001, J ADDICT DIS, V20, P93, DOI 10.1300/J069v20n01_09; MONAHAN BP, 1990, JAMA-J AM MED ASSOC, V264, P2788, DOI 10.1001/jama.264.21.2788; RENDIG SV, 1980, J PHARMACOL EXP THER, V215, P259; Vastag B, 2001, JAMA-J AM MED ASSOC, V285, P1435, DOI 10.1001/jama.285.11.1435-b; Vincent G. Michael, 2000, Cardiology Clinics, V18, P309; WESLEY RC, 1992, AM HEART J, V123, P794, DOI 10.1016/0002-8703(92)90525-Z; Wysowski DK, 1996, NEW ENGL J MED, V335, P290, DOI 10.1056/NEJM199607253350416	19	272	280	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					501	504		10.7326/0003-4819-137-6-200209170-00010	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230351				2022-12-28	WOS:000178069100004
J	Bardeesy, N; Sinha, M; Hezel, AF; Signoretti, S; Hathaway, NA; Sharpless, NE; Loda, M; Carrasco, DR; DePinho, RA				Bardeesy, N; Sinha, M; Hezel, AF; Signoretti, S; Hathaway, NA; Sharpless, NE; Loda, M; Carrasco, DR; DePinho, RA			Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation	NATURE			English	Article							PEUTZ-JEGHERS-SYNDROME; SOMATIC MUTATIONS; G(1) CONTROL; INK4A LOCUS; GROWTH; EXPRESSION; MICE; IMMORTALIZATION; ACTIVATION; SENESCENCE	Germline mutations in LKB1 (also known as STK11) are associated with Peutz-Jeghers syndrome (PJS), a disorder with predisposition to gastrointestinal polyposis and cancer(1). PJS polyps are unusual neoplasms characterized by marked epithelial and stromal overgrowth but have limited malignant potential(2). Here we show that Lkb1(+/-) mice develop intestinal polyps identical to those seen in individuals affected with PJS. Consistent with this in vivo tumour suppressor function, Lkb1 deficiency prevents culture-induced senescence without loss of Ink4a/Arf or p53. Despite compromised mortality, Lkb1(-/-) mouse embryonic fibroblasts show resistance to transformation by activated Ha-Ras either alone or with immortalizing oncogenes. This phenotype is in agreement with the paucity of mutations in Ras seen in PJS polyps(3,4) and suggests that loss of Lkb1 function as an early neoplastic event renders cells resistant to subsequent oncogene-induced transformation. In addition, the Lkb1 transcriptome shows modulation of factors linked to angiogenesis, extracellular matrix remodelling, cell adhesion and inhibition of Ras transformation. Together, our data rationalize several features of PJS polyposis-notably its peculiar histopathological presentation and limited malignant potential-and place Lkb1 in a distinct class of tumour suppressors.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.			Sharpless, Norman/0000-0001-7078-9455; DePinho, Ronald/0000-0002-5625-577X				Avizienyte E, 1998, CANCER RES, V58, P2087; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; CARRASCO D, 1994, DEVELOPMENT, V120, P2991; COOPER HS, 1998, PATHOLOGY GASTROINTE, P819; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Entius MM, 2001, J CLIN PATHOL, V54, P126, DOI 10.1136/jcp.54.2.126; Esteller M, 2000, ONCOGENE, V19, P164, DOI 10.1038/sj.onc.1203227; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Gruber SB, 1998, CANCER RES, V58, P5267; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Miyoshi H, 2002, CANCER RES, V62, P2261; Qing J, 1997, ONCOGENE, V15, P2159, DOI 10.1038/sj.onc.1201385; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; REEVE JG, 1995, J BIOL CHEM, V270, P135, DOI 10.1074/jbc.270.1.135; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Vasseur S, 2002, EMBO REP, V3, P165, DOI 10.1093/embo-reports/kvf023; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Yoshioka N, 2000, J VIROL, V74, P1008, DOI 10.1128/JVI.74.2.1008-1013.2000	30	341	352	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					162	167		10.1038/nature01045	http://dx.doi.org/10.1038/nature01045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226664				2022-12-28	WOS:000177931200040
J	Crawford, LM				Crawford, LM			First drug for women with constipation-predominant IBS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fisshers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1225	1225		10.1001/jama.288.10.1225	http://dx.doi.org/10.1001/jama.288.10.1225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215114				2022-12-28	WOS:000177917700007
J	McGaghie, WC				McGaghie, WC			Assessing readiness for medical education evolution of the Medical College Admission Test	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCHOLASTIC APTITUDE-TESTS; COMMITTEE; PROFESSIONS; SELECTION	The attrition rate of 5% to 50% from US medical schools in the 1920s propelled the development of a test that would measure aptitude for medical studies. Since its development in 1928, the Medical College Admission Test (MCAT) has undergone 5 revisions. The first version was divided into 6 to 8 subtests that focused on memory, knowledge of scientific terminology, reading and comprehension, and logic. The second, which appeared in 1946, was reduced to 4 categories: verbal and quantitative skills, science knowledge, and added a category called understanding modern society. The major difference in the third version, launched in 1962, expanded the test's understanding modern society section to a broader test of general information. In 1977, the MCAT underwent its fourth change: its science section, reading and quantitative skill assessment sections were expanded; its general liberal arts knowledge section was eliminated; its scoring report structure and scoring range were altered; and its cultural and social bias was minimized. The current version, beginning in 1991, has undergone another significant change. Although it does not contain independent measures of either liberal arts or numeracy as separate categories, quantitative skills are needed to solve some of the problems in biological and physical sciences. However, its principal innovation is the writing sample section. Through its 74-year history, the various renditions of the MCAT demonstrate that the definition of aptitude for medical education reflects the professional and social mores and values of the time.	Northwestern Univ, Off Med Educ & Fac Dev, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	McGaghie, WC (corresponding author), Northwestern Univ, Off Med Educ & Fac Dev, Feinberg Sch Med, 3-130 Ward Bldg,303 E Chicago Ave, Chicago, IL 60611 USA.	wmcm@northwestern.edu		McGaghie, William/0000-0003-1672-0398				[Anonymous], 2002, REMAKING CONCEPT APT; *ASS AM MED COLL, 1964, MED COLL ADM TEST H; *ASS AM MED COLL, 1941, SCHOL APT TEST MED S; *ASS AM MED COLL, 1973, FIN REP AAMC NAT TAS; *ASS AM MED COLL, 1963, MED COLL ADM TEST HD; *ASS AM MED COLL, 1976, DEV NONC ASS SYST EV; *ASS AM MED COLL, 1998, MCAT INT MAN; Association of American Medical Colleges, 1977, NEW MED COLL ADM TES; Barzansky B, 2001, JAMA-J AM MED ASSOC, V286, P1049, DOI 10.1001/jama.286.9.1049; BOK DC, 1984, PRESIDENTS ANN REPOR; Chesney AM, 1936, J ASSOC AM MED COLL, V11, P15; Cohen JJ, 2002, ACAD MED, V77, P475, DOI 10.1097/00001888-200206000-00002; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Cureton E. F., 1951, ED MEASUREMENT, P621; EDWARDS JC, 1990, ACAD MED, V65, P167, DOI 10.1097/00001888-199003000-00008; ERDMANN JB, 1971, J MED EDUC, V46, P937; FLEXNER A, 1910, MED ED US CANADA, V4; GLASER RJ, 1957, J MED EDUC, V32, P31; HUNT T, 1936, MEASUREMENT PSYCHOL; LADUCA A, 1994, EVAL HEALTH PROF, V17, P178, DOI 10.1177/016327879401700204; LUDMERER KM, 1985, LEARNING HEAL; McGaghie WC, 2002, MED TEACH, V24, P374, DOI 10.1080/01421590220145734; MCGAGHIE WC, 1990, ACAD MED, V65, P145, DOI 10.1097/00001888-199003000-00004; McGaghie WC, 2002, INT HDB RES MED ED, P303; Messick S. L., 1989, ED MEASUREMENT, V3rd, P13, DOI DOI 10.7203/RELIEVE.22.1.8248; Miller G.E., 1961, TEACHING LEARNING ME; MONROE WS, 1976, INTRO THEORY ED MEAS, V31, P228; Moss FA, 1940, J ASSOC AM MED COLL, V15, P249; Moss FA, 1930, J ASSOC AM MED COLL, V5, P90; Moss FA, 1932, J ASSOC AM MED COLL, V7, P129; Moss FA, 1936, J ASSOC AM MED COLL, V11, P273; Moss FA, 1934, J ASSOC AM MED COLL, V9, P65; Moss FA, 1931, J ASSOC AM MED COLL, V6, P1; MOSS FA, 1935, J ASSOC AM MED COLL, V10, P23; Moss FA, 1933, J ASSOC AM MED COLL, V8, P1; Mullin FJ, 1948, J ASSOC AM MED COLL, V23, P163; PRICE PB, 1971, MEASUREMENT PREDICTI; Puschmann Theodor, 1966, HIST MED ED; SANAZARO PJ, 1963, J MED EDUC, V38, P1044; Schwandt Thomas A., 2000, HDB QUALITATIVE RES, DOI DOI 10.1177/1094428109332198; SEDLACEK WE, 1967, MED COLL ADM TEST HD; SHAW DL, 1995, ACAD MED, V70, P532, DOI 10.1097/00001888-199506000-00015; Stalnaker JM, 1950, J ASSOC AM MED COLL, V25, P428; VanSusteren TJ, 1999, TEACH LEARN MED, V11, P66, DOI 10.1207/S15328015TL110202	44	45	48	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1085	1090		10.1001/jama.288.9.1085	http://dx.doi.org/10.1001/jama.288.9.1085			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NA	12204076				2022-12-28	WOS:000177764600010
J	Moritz, RE; Bitz, CM; Steig, EJ				Moritz, RE; Bitz, CM; Steig, EJ			Dynamics of recent climate change in the Arctic	SCIENCE			English	Review							SURFACE AIR-TEMPERATURE; NORTH-ATLANTIC OSCILLATION; TREE-RING CHRONOLOGIES; SEA-ICE; ANNULAR MODES; THERMOHALINE CIRCULATION; EXTRATROPICAL CIRCULATION; ATMOSPHERIC CIRCULATION; GREENHOUSE-GAS; OCEAN	The pattern of recent surface warming observed in the Arctic exhibits both polar amplification and a strong relation with trends in the Arctic Oscillation mode of atmospheric circulation. Paleoclimate analyses indicate that Arctic surface temperatures were higher during the 20th century than during the preceding few centuries and that polar amplification is a common feature of the past. Paleoclimate evidence for Holocene variations in the Arctic Oscillation is mixed. Current understanding of physical mechanisms controlling atmospheric dynamics suggests that anthropogenic influences could have forced the recent trend in the Arctic Oscillation, but simulations with global climate models do not agree. In most simulations, the trend in the Arctic Oscillation is much weaker than observed. In addition, the simulated warming tends to be largest in autumn over the Arctic Ocean, whereas observed warming appears to be largest in winter and spring over the continents.	Univ Washington, Polar Sci Ctr, Seattle, WA 98105 USA; Univ Washington, Quaternary Res Ctr, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Moritz, RE (corresponding author), Univ Washington, Polar Sci Ctr, Seattle, WA 98105 USA.	dickm@apl.washington.edu	Bitz, Cecilia M/S-8423-2016; Steig, Eric J/G-9088-2015	Bitz, Cecilia M/0000-0002-9477-7499; Steig, Eric J/0000-0002-8191-5549				Adkins JF, 1998, SCIENCE, V280, P725, DOI 10.1126/science.280.5364.725; Ambaum MHP, 2001, J CLIMATE, V14, P3495, DOI 10.1175/1520-0442(2001)014<3495:AOONAO>2.0.CO;2; Andrews D. G., 1987, MIDDLE ATMOSPHERE DY; Appenzeller C, 1998, SCIENCE, V282, P446, DOI 10.1126/science.282.5388.446; Baldwin MP, 1999, J GEOPHYS RES-ATMOS, V104, P30937, DOI 10.1029/1999JD900445; BITZ CM, UNPUB; Black RX, 2002, J CLIMATE, V15, P268, DOI 10.1175/1520-0442(2002)015<0268:SFOSCI>2.0.CO;2; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Broecker WS, 1997, SCIENCE, V278, P1582, DOI 10.1126/science.278.5343.1582; CHAPMAN WL, 1993, B AM METEOROL SOC, V74, P33, DOI 10.1175/1520-0477(1993)074<0033:RVOSIA>2.0.CO;2; CHARLES CD, 1992, NATURE, V355, P416, DOI 10.1038/355416a0; CHARNEY JG, 1961, J GEOPHYS RES, V66, P83, DOI 10.1029/JZ066i001p00083; CHEN P, 1992, J ATMOS SCI, V49, P2533, DOI 10.1175/1520-0469(1992)049<2533:POPWBT>2.0.CO;2; Cook ER, 1998, HOLOCENE, V8, P9, DOI 10.1191/095968398677793725; CROWLEY TJ, 1984, QUATERNARY RES, V21, P105, DOI 10.1016/0033-5894(84)90093-0; DELWORTH T, 1993, J CLIMATE, V6, P1993, DOI 10.1175/1520-0442(1993)006<1993:IVOTTC>2.0.CO;2; Delworth TL, 2000, SCIENCE, V287, P2246, DOI 10.1126/science.287.5461.2246; Deser C, 2000, GEOPHYS RES LETT, V27, P779, DOI 10.1029/1999GL010945; DeWeaver E, 2000, J CLIMATE, V13, P2160, DOI 10.1175/1520-0442(2000)013<2160:DSWDTZ>2.0.CO;2; Dickson B, 1999, NATURE, V397, P389, DOI 10.1038/17018; EISCHEID JK, 1995, J APPL METEOROL, V34, P2787, DOI 10.1175/1520-0450(1995)034<2787:TQCOLT>2.0.CO;2; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Feldstein SB, 2002, J CLIMATE, V15, P88, DOI 10.1175/1520-0442(2002)015<0088:TRTAVI>2.0.CO;2; Fyfe JC, 1999, GEOPHYS RES LETT, V26, P1601, DOI 10.1029/1999GL900317; GILLETT NP, 2002, J GEOPHYS RES, V107, P1; GILLETT NP, 2002, GEOPHYS RES LETT, V29, P14444; Graf H.-F., 1995, Contributions to Atmospheric Physics, V68, P233; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hartmann DL, 2000, P NATL ACAD SCI USA, V97, P1412, DOI 10.1073/pnas.97.4.1412; Haywood JM, 1997, GEOPHYS RES LETT, V24, P1335, DOI 10.1029/97GL01163; Held I M, 1983, LARGE SCALE DYNAMICA, P127; Hilmer M, 2000, GEOPHYS RES LETT, V27, P989, DOI 10.1029/1999GL010944; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; HOLLAND M, UNPUB; Holland MM, 2001, J CLIMATE, V14, P656, DOI 10.1175/1520-0442(2001)014<0656:TROIOI>2.0.CO;2; Intergovernmental Panel on Climate Change, 2001, IPCC 3 ASS REP CLIM; JONES PD, 1994, J CLIMATE, V7, P1794, DOI 10.1175/1520-0442(1994)007<1794:HSATVA>2.0.CO;2; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; KAHL JD, 1993, NATURE, V361, P335, DOI 10.1038/361335a0; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Keigwin LD, 2000, P NATL ACAD SCI USA, V97, P1343, DOI 10.1073/pnas.97.4.1343; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Kwok R, 2000, GEOPHYS RES LETT, V27, P775, DOI 10.1029/1999GL002382; Kwok R, 1999, J GEOPHYS RES-OCEANS, V104, P5177, DOI 10.1029/1998JC900103; Limpasuvan V, 2000, J CLIMATE, V13, P4414, DOI 10.1175/1520-0442(2000)013<4414:WMAMOC>2.0.CO;2; Limpasuvan V, 1999, GEOPHYS RES LETT, V26, P3133, DOI 10.1029/1999GL010478; Luterbacher J, 1999, GEOPHYS RES LETT, V26, P2745, DOI 10.1029/1999GL900576; Maloney ED, 2001, J CLIMATE, V14, P2015, DOI 10.1175/1520-0442(2001)014<2015:TSOIVI>2.0.CO;2; Manabe S, 1996, J CLIMATE, V9, P376, DOI 10.1175/1520-0442(1996)009<0376:LFVOSA>2.0.CO;2; MANABE S, 1980, J GEOPHYS RES-OCEANS, V85, P5529, DOI 10.1029/JC085iC10p05529; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mauritzen C, 1997, GEOPHYS RES LETT, V24, P3257, DOI 10.1029/97GL03192; MAYEWSKI PA, 1986, SCIENCE, V232, P975, DOI 10.1126/science.232.4753.975; Meehl GA, 2000, CLIM DYNAM, V16, P257, DOI 10.1007/s003820050326; Meehl GA, 2000, B AM METEOROL SOC, V81, P413, DOI 10.1175/1520-0477(2000)081<0413:AITTIE>2.3.CO;2; Morison J, 2000, ARCTIC, V53, P359; MORISON J, 2001, SEARCH SSC SEARCH ST, P1; OBRIEN SR, 1995, SCIENCE, V270, P1962, DOI 10.1126/science.270.5244.1962; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Parkinson CL, 1999, J GEOPHYS RES-OCEANS, V104, P20837, DOI 10.1029/1999JC900082; PERLWITZ J, 1995, J CLIMATE, V8, P2281, DOI 10.1175/1520-0442(1995)008<2281:TSCBTA>2.0.CO;2; POLYAKOV IV, IN PRESS GEOPHYS RES; Rigor IG, 2002, J CLIMATE, V15, P2648, DOI 10.1175/1520-0442(2002)015<2648:ROSITT>2.0.CO;2; Rigor IG, 2000, J CLIMATE, V13, P896, DOI 10.1175/1520-0442(2000)013<0896:VISATO>2.0.CO;2; RIND D, 1995, J CLIMATE, V8, P449, DOI 10.1175/1520-0442(1995)008<0449:TROSII>2.0.CO;2; Rind D, 1997, GEOPHYS RES LETT, V24, P1491, DOI 10.1029/97GL01433; Robertson AW, 2001, J CLIMATE, V14, P3240, DOI 10.1175/1520-0442(2001)014<3240:IOOAIO>2.0.CO;2; Sachs JP, 1999, SCIENCE, V286, P756, DOI 10.1126/science.286.5440.756; Schmutz C, 2000, GEOPHYS RES LETT, V27, P1135, DOI 10.1029/1999GL011045; SCHNEIDER DP, IN PRESS GEOPHYS RES; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Shindell DT, 1999, NATURE, V399, P452, DOI 10.1038/20905; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; THOMPSON DW, MONOGRAPH N ATLANTIC; Thompson DWJ, 2000, J CLIMATE, V13, P1018, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Tremblay LB, 1997, GEOPHYS RES LETT, V24, P2027, DOI 10.1029/97GL02028; Wallace JM, 2002, PHYS TODAY, V55, P28, DOI 10.1063/1.1461325; Wallace JM, 1996, J CLIMATE, V9, P249, DOI 10.1175/1520-0442(1996)009<0249:IOITIN>2.0.CO;2; Walsh JE, 1996, J CLIMATE, V9, P480, DOI 10.1175/1520-0442(1996)009<0480:RDOSLP>2.0.CO;2; Weatherly JW, 2001, 12 S GLOB CHANG CLIM; Zhang JL, 2000, J CLIMATE, V13, P3099, DOI 10.1175/1520-0442(2000)013<3099:RCIASI>2.0.CO;2	86	281	300	6	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1497	1502		10.1126/science.1076522	http://dx.doi.org/10.1126/science.1076522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202816				2022-12-28	WOS:000177697300042
J	Verissimo, A; Cochrane, MA; Souza, C				Verissimo, A; Cochrane, MA; Souza, C			Ecology - National forests in the Amazon	SCIENCE			English	Editorial Material									Inst Homem & Meio Ambiente Amazonia IMAZON, Belem, Para, Brazil; Michigan State Univ, Ctr Climate & Earth Observat, E Lansing, MI 48823 USA	Michigan State University	Cochrane, MA (corresponding author), Inst Homem & Meio Ambiente Amazonia IMAZON, Belem, Para, Brazil.	cochrane@globalchange.msu.edu	Cochrane, Mark A/A-1735-2018; Souza, CARLOS/AAK-8207-2021	Cochrane, Mark A/0000-0002-4573-568X; Souza, CARLOS/0000-0002-0205-6134				Barreto P, 1998, FOREST ECOL MANAG, V108, P9, DOI 10.1016/S0378-1127(97)00251-X; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; CAPOBIANCO JP, 2001, BIODIVERSIDADE AMAZO, P540; *GOV BRAS MIN MEIO, 2000, PROGR NAC FLOR, P49; *GOV EST ACR, 2002, PROGR DES SUST EST A; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Nepstad D, 2002, SCIENCE, V295, P629, DOI 10.1126/science.1067053; Verissimo A, 2002, CONSERV ECOL, V6; VERISSIMO A, 2000, IDENTIFICACAO AREAS; VERISSIMO A, 2001, IDENTIFICACAO AREAS; VINCENT JR, 1992, SCIENCE, V256, P1651, DOI 10.1126/science.256.5064.1651	11	52	56	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1478	1478						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202804				2022-12-28	WOS:000177697300028
J	Roy, PJ; Stuart, JM; Lund, J; Kim, SK				Roy, PJ; Stuart, JM; Lund, J; Kim, SK			Chromosomal clustering of muscle-expressed genes in Caenorhabditis elegans	NATURE			English	Article							POLYCISTRONIC TRANSCRIPTION; GENOME; DOMAINS; PROTEIN; MAP	Chromosomes are divided into domains of open chromatin, where genes have the potential to be expressed, and domains of closed chromatin, where genes are not expressed(1). Classic examples of open chromatin domains include 'puffs' on polytene chromosomes in Drosophila and extended loops from lampbrush chromosomes(2,3). If multiple genes were typically expressed together from a single open chromatin domain, the position of co-expressed genes along the chromosomes would appear clustered. To investigate whether co-expressed genes are clustered, we examined the chromosomal positions of the genes expressed in muscle of Caenorhabditis elegans at the first larval stage. Here we show that co-expressed genes in C. elegans are clustered in groups of 2-5 along the chromosomes, suggesting that expression from a chromatin domain can extend over several genes. These observations reveal a higher-order organization of the structure of the genome, in which the order of genes along the chromosome is correlated with their expression in specific tissues.	Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; Stanford Med Informat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.		Roy, Peter/G-5357-2014	Roy, Peter/0000-0003-2959-2276; Stuart, Joshua/0000-0002-2171-565X				BEERMANN W, 1964, J EXP ZOOL, V157, P49, DOI 10.1002/jez.1401570110; BLUMENTHAL T, 1995, TRENDS GENET, V11, P132, DOI 10.1016/S0168-9525(00)89026-5; Blumenthal T, 1998, BIOESSAYS, V20, P480, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;480::AID-BIES6&gt;3.0.CO;2-Q; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; FUKAMIKOBAYASHI K, 1993, FEBS LETT, V335, P289, DOI 10.1016/0014-5793(93)80749-K; GALL JG, 1962, P NATL ACAD SCI USA, V48, P562, DOI 10.1073/pnas.48.4.562; Goodenough JB, 2000, INT J INORG MATER, V2, P3, DOI 10.1016/S1466-6049(99)00069-0; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Jones AR, 1996, DEV BIOL, V180, P165, DOI 10.1006/dbio.1996.0293; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; OKKEMA PG, 1993, GENETICS, V135, P385; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; WEINTRAUB H, 1984, HARVEY LECT, V79, P217	20	331	342	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					975	979		10.1038/nature01012	http://dx.doi.org/10.1038/nature01012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12214599				2022-12-28	WOS:000177677500044
J	Bernath, PF; Shayesteh, A; Tereszchuk, K; Colin, R				Bernath, PF; Shayesteh, A; Tereszchuk, K; Colin, R			The vibration-rotation emission spectrum of free BeH2	SCIENCE			English	Article							HYDRIDES	The gaseous BeH2 molecule has been synthesized by means of an electrical discharge inside a high-temperature furnace and identified with infrared emission spectroscopy. The antisymmetric stretching mode nu(3) has been detected near 2179 reciprocal centimeters. The BeH2 molecule has a linear, symmetric structure with an r(o) BeH bond length of 1.333761(2) angstroms.	Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; Free Univ Brussels, Lab Chim Phys Mol, B-1050 Brussels, Belgium	University of Waterloo; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Bernath, PF (corresponding author), Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada.		Shayesteh, Alireza/ABG-6355-2021; Bernath, Peter F/B-6567-2012	Shayesteh, Alireza/0000-0002-6151-7885; Bernath, Peter F/0000-0002-1255-396X				Baer R, 2000, J CHEM PHYS, V112, P1679, DOI 10.1063/1.480733; Bernath P.F., 2000, PHYS CHEM, V96, P177, DOI [10.1039/b001200i, DOI 10.1039/b001200i]; BERNATH PF, 1995, SPECTRA ATOMS MOL, P330; Focsa C, 1998, J CHEM PHYS, V109, P5795, DOI 10.1063/1.477201; GREENWOOD NN, 1984, CHEM ELEMENTS, P125; HERZBERG G, 1966, ELECT SPECTRA POLYAT; Hinze J, 1999, MOL PHYS, V96, P711, DOI 10.1080/00268979909483007; Mahapatra US, 1999, J CHEM PHYS, V110, P6171, DOI 10.1063/1.478523; Martin JML, 1997, CHEM PHYS LETT, V273, P98, DOI 10.1016/S0009-2614(97)00538-1; MARTIN JML, 1992, CHEM PHYS LETT, V200, P502, DOI 10.1016/0009-2614(92)80082-M; Mazziotti DA, 1999, PHYS REV A, V60, P4396, DOI 10.1103/PhysRevA.60.4396; Mori R, 2001, PHYSICA B, V302, P206, DOI 10.1016/S0921-4526(01)00430-6; SHAYESTEH A, UNPUB; SMITH GS, 1988, SOLID STATE COMMUN, V67, P491, DOI 10.1016/0038-1098(84)90168-6; SZALAY PG, 1995, J CHEM PHYS, V103, P3600, DOI 10.1063/1.470243; TAGUE TJ, 1993, J AM CHEM SOC, V115, P12111, DOI 10.1021/ja00078a057	16	54	57	3	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1323	1324		10.1126/science.1074580	http://dx.doi.org/10.1126/science.1074580			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193780				2022-12-28	WOS:000177573900039
J	Rhoades, MW; Reinhart, BJ; Lim, LP; Burge, CB; Bartel, B; Bartel, DP				Rhoades, MW; Reinhart, BJ; Lim, LP; Burge, CB; Bartel, B; Bartel, DP			Prediction of plant microRNA targets	CELL			English	Article							RNA-INTERFERENCE; C-ELEGANS; CAENORHABDITIS-ELEGANS; OVULE DEVELOPMENT; REGULATORY RNA; CELL-DIVISION; DNA-BINDING; GENE; ARABIDOPSIS; LIN-14	We predict regulatory targets for 14 Arabidopsis microRNAs (miRNAs) by identifying mRNAs with near complementarity. Complementary sites within predicted targets are conserved in rice. Of the 49 predicted targets, 34 are members of transcription factor gene families involved in developmental patterning or cell differentiation. The near-perfect complementarity between plant miRNAs and their targets suggests that many plant miRNAs act similarly to small interfering RNAs and direct mRNA cleavage. The targeting of developmental transcription factors suggests that many plant miRNAs function during cellular differentiation to clear key regulatory transcripts from daughter cell lineages.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Rice University	Bartel, B (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	bartel@rice.edu; dbartel@wi.mit.edu	Chan, Edward K. L./B-5671-2009; Bartel, Bonnie/D-3550-2011; Bartel, Bonnie/O-8119-2019; Burge, Christopher B./AAH-2177-2020	Chan, Edward K. L./0000-0003-3938-9503; Bartel, Bonnie/0000-0002-6367-346X; Bartel, Bonnie/0000-0002-6367-346X; 	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG02439] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; BEMSTEIN E, 2001, RNA, V7, P1509; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Bolle C, 2000, GENE DEV, V14, P1269; Cui YH, 1999, PLANT CELL, V11, P2217, DOI 10.1105/tpc.11.11.2217; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Ray A, 1996, DEVELOPMENT, V122, P2631; Ray S, 1996, DEV BIOL, V180, P365, DOI 10.1006/dbio.1996.0309; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinscheid RK, 2000, PEPTIDES, V21, P901, DOI 10.1016/S0196-9781(00)00226-6; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; ROBINSONBEERS K, 1992, PLANT CELL, V4, P1237, DOI 10.1105/tpc.4.10.1237; Rogg LE, 2001, DEV CELL, V1, P595, DOI 10.1016/S1534-5807(01)00077-6; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	49	1648	1950	3	252	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					513	520		10.1016/S0092-8674(02)00863-2	http://dx.doi.org/10.1016/S0092-8674(02)00863-2			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202040	Bronze, Green Published			2022-12-28	WOS:000177653200012
J	Benator, D; Bhattacharya, M; Bozeman, L; Burman, W; Catanzaro, A; Chaisson, R; Gordin, F; Horsburgh, CR; Horton, J; Khan, A; Lahart, C; Metchock, B; Pachucki, C; Stanton, L; Vernon, A; Villarino, ME; Wang, YC; Weiner, M; Weis, S				Benator, D; Bhattacharya, M; Bozeman, L; Burman, W; Catanzaro, A; Chaisson, R; Gordin, F; Horsburgh, CR; Horton, J; Khan, A; Lahart, C; Metchock, B; Pachucki, C; Stanton, L; Vernon, A; Villarino, ME; Wang, YC; Weiner, M; Weis, S		TBTC	Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial	LANCET			English	Article							MYCOBACTERIUM-TUBERCULOSIS; THERAPY; PHARMACOKINETICS; CHEMOTHERAPY; RELEVANT; INVITRO	Background Rifapentine has a long half-life in serum, which suggests a possible treatment once a week for tuberculosis. We aimed to compare rifapentine and isoniazid once a week with rifampicin and isoniazid twice a week. Methods We did a randomised, multicentre, open-label trial in the USA and Canada of HIV-negative people with drug-susceptible pulmonary tuberculosis who had completed 2 months of a 6-month treatment regimen. We randomly allocated patients directly observed treatment with either 600 mg rifapentine plus 900 mg isoniazid once a week or 600 mg rifampicin plus 900 mg isoniazid twice a week. Primary outcome was failure/relapse. Analysis was by intention to treat. Findings 1004 patients were enrolled (502 per treatment group). 928 successfully completed treatment, and 803 completed the 2-year 4-month study. Crude rates of failure/ relapse were 46/502 (9.2%) in those on rifapentine once a week, and 28/502 (5.6%) in those given rifampicin twice a week (relative risk 1.64, 95% Cl 1.04-2.58, p=0.04). By proportional hazards regression, five characteristics were independently associated with increased risk of failure/ relapse: sputum culture positive at 2 months (hazard ratio 2.8, 95% Cl 1.7-4.6); cavitation on chest radiography (3.0, 1.6-5.9); being underweight (3.0, 1.8-4.9); bilateral pulmonary involvement (1.8, 1.0-3.1); and being a non-Hispanic white person (1.8, 1.1-3.0). Adjustment for imbalances in 2-month culture and cavitation diminished the association of treatment group with outcome (1.34; 0.83-2.18; p=0.23). Of participants without cavitation, rates of failure/relapse were 6/210 (2.9%) in the once a week group and 6/241 (2.5%) in the twice a week group (relative risk 1.15; 95% Cl 0.38-3.50; p=0.81). Rates of adverse events and death were similar in the two treatment groups. Interpretation Rifapentine once a week is safe and effective for treatment of pulmonary tuberculosis in HIV-negative people without cavitation on chest radiography. Clinical, radiographic, and microbiological data help to identify patients with tuberculosis who are at increased risk of failure or relapse when treated with either regimen.	Ctr Dis Control & Prevent, TBTC Data & Coordinating Ctr, Res & Evaluat Branch, Div TB Eliminat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Benator, D (corresponding author), Ctr Dis Control & Prevent, TBTC Data & Coordinating Ctr, Res & Evaluat Branch, Div TB Eliminat, Mailstop E-10, Atlanta, GA 30333 USA.			Horsburgh, C./0000-0001-6838-7895	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00827] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABER V R, 1978, Bulletin of the International Union Against Tuberculosis, V53, P260; ACOCELLA G, 1971, CHEMOTHERAPY, V16, P356, DOI 10.1159/000220750; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; Bock NN, 2002, AM J RESP CRIT CARE, V165, P1526, DOI 10.1164/rccm.200201-047OC; BOMAN G, 1974, EUR J CLIN PHARMACOL, V7, P369, DOI 10.1007/BF00558209; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P321, DOI 10.1164/ajrccm.155.1.9001331; CAVE MD, 1994, J CLIN MICROBIOL, V32, P262, DOI 10.1128/JCM.32.1.262-266.1994; *CDCP, 1999, REP TUB US 1998 99; Chaves F, 1996, J CLIN MICROBIOL, V34, P1118, DOI 10.1128/JCM.34.5.1118-1123.1996; COHN DL, 1990, ANN INTERN MED, V112, P407, DOI 10.7326/0003-4819-76-3-112-6-407; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; DICKINSON JM, 1987, TUBERCLE, V68, P113, DOI 10.1016/0041-3879(87)90026-2; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; GIRLING DJ, 1991, AM REV RESPIR DIS, V143, P262; GIRLING DJ, 1977, AM REV RESPIR DIS, V116, P807; HEIFETS LB, 1990, AM REV RESPIR DIS, V141, P626, DOI 10.1164/ajrccm/141.3.626; JI BH, 1993, AM REV RESPIR DIS, V148, P1541, DOI 10.1164/ajrccm/148.6_Pt_1.1541; Kent PT, 1985, GUIDE LEVEL 3 LAB; Keung A, 1999, INT J TUBERC LUNG D, V3, P437; Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P612; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Peloquin CA, 1999, CHEST, V115, P12, DOI 10.1378/chest.115.1.12; Reith K, 1998, DRUG METAB DISPOS, V26, P732; Tam CM, 1998, AM J RESP CRIT CARE, V157, P1726, DOI 10.1164/ajrccm.157.6.9707037; Tam CM, 1997, INT J TUBERC LUNG D, V1, P411; TAYLOR Z, 2000, AM J RESP CRIT CAR S, V161, pA524; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; WEINER M, 2001, AM J RESP CRIT CARE, V163, pA498; WEIS SE, 1994, NEW ENGL J MED, V330, P1179, DOI 10.1056/NEJM199404283301702; ZIERSKI M, 1980, AM REV RESPIR DIS, V122, P879; [No title captured]	32	320	329	1	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					528	534						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241657				2022-12-28	WOS:000177512800011
J	Craddock, C; Hochhauser, D				Craddock, C; Hochhauser, D			Realising the potential of targeted therapies in oncology	LANCET			English	Editorial Material									Univ Hosp, Dept Haematol, Birmingham B15 2TH, W Midlands, England; UCL Royal Free & Univ Coll Med Sch, Dept Oncol, London, England	University of Birmingham; University of London; University College London; UCL Medical School	Craddock, C (corresponding author), Univ Hosp, Dept Haematol, Birmingham B15 2TH, W Midlands, England.	Charles.Craddock@uhb.nhs.uk		Craddock, Charles/0000-0001-5041-6678; Hochhauser, Daniel/0000-0001-5522-9281				Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; O'Brien SG, 2001, LANCET, V358, P1902; Rosenwald A, 2002, SEMIN ONCOL, V29, P258, DOI 10.1053/sonc.2002.32901; Willman CL, 2001, LEUKEMIA, V15, P690, DOI 10.1038/sj.leu.2402087	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					424	425		10.1016/S0140-6736(02)09692-7	http://dx.doi.org/10.1016/S0140-6736(02)09692-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241710				2022-12-28	WOS:000177342900004
J	Wade, DT				Wade, DT			The dis-integration of death	LANCET			English	Editorial Material									Oxford Ctr Enablement, Oxford OX3 7LD, England	University of Oxford	Wade, DT (corresponding author), Oxford Ctr Enablement, Windmill Rd, Oxford OX3 7LD, England.			Wade, Derick/0000-0002-1188-8442				Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Wade DT, 1999, BMJ-BRIT MED J, V319, P841, DOI 10.1136/bmj.319.7213.841	2	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					425	426		10.1016/S0140-6736(02)09682-4	http://dx.doi.org/10.1016/S0140-6736(02)09682-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241711				2022-12-28	WOS:000177342900005
J	Moliterno, DJ; Yakubov, SJ; DiBattiste, PM; Herrmann, HC; Stone, GW; Macaya, C; Neumann, FJ; Ardissino, D; Bassand, JP; Borzi, L; Yeung, AC; Harris, KA; Demopoulos, LA; Topol, EJ				Moliterno, DJ; Yakubov, SJ; DiBattiste, PM; Herrmann, HC; Stone, GW; Macaya, C; Neumann, FJ; Ardissino, D; Bassand, JP; Borzi, L; Yeung, AC; Harris, KA; Demopoulos, LA; Topol, EJ		TARGET Investigators	Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study	LANCET			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITORS; DIABETES-MELLITUS; INTERVENTION; EPTIFIBATIDE; TRIAL; REVASCULARIZATION; CLOPIDOGREL; MORTALITY; RECEPTORS; BLOCKADE	Background Two placebo-controlled trials testing intravenous platelet glycoprotein IIb/IIIa antagonists in the setting of percutaneous coronary revascularisation with intracoronary stents have shown a durable reduction in ischaemic events to 6 months. These trials differed regarding their patient population, IIb/IIIa inhibitor, and reported extent of benefit. Whether a small-molecule agent affecting only the IIb/IIIa receptor would provide a similar outcome for ischaemic events and clinical restenosis at 6 months when directly compared with a monoclonal antibody known to affect several integrin receptors is unknown. Methods In 18 countries at 149 hospitals, 4809 patients undergoing elective or urgent stent implantation were randomly assigned a bolus and infusion of tirofiban or abciximab. Patients were followed for 6 months for the occurrence of death, myocardial infarction, and any target-vessel revascularisation. The results at 30 days have been reported previously. Findings At 6 months the composite endpoint of death, myocardial infarction, and target-vessel revascularisation occurred in 356 (14.8%) patients who received tirofiban and 345 (14.3%) patients who received abciximab (hazard ratio 1.04, 95% Cl 0.90-1.21; p = 0.591). The rates for the individual endpoints were 191 (8.0%) versus 159 (6.6%) for myocardial infarction (hazard ratio 1.21, 95% Cl 0.98-1.50; p = 0.074), 26 (1.1%) versus 25 (1.0%) for death (1.04, 0.60-1.80; p = 0.893), and 194 (8.1%) versus 208 (8.6%) for target-vessel revascularisation (0.93, 0.77-1.14; p = 0.495). Interpretation At 6 months, tirofiban provided a similar level of overall protection to abciximab against the composite of death, myocardial infarction, and any target-vessel revascularisation.	Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Cleveland Clin Cardiovasc Coordinating Ctr, Cleveland, OH 44195 USA; Riverside Methodist Hosp, Columbus, OH 43214 USA; Merck, W Point, PA USA; Univ Penn, Med Ctr, Philadelphia, PA 19104 USA; Lenox Hill Hosp, New York, NY 10021 USA; Hosp Clin San Carlos, Madrid, Spain; Tech Univ Munich, Med Klin, D-8000 Munich, Germany; Osped Maggiore Parma, Parma, Italy; Hop Jean Minjoz, F-25030 Besancon, France; Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Pennsylvania; Northwell Health; Hospital Clinico San Carlos; Technical University of Munich; University of Parma; University Hospital of Parma; Universite de Franche-Comte; CHU Besancon; Stanford University	Moliterno, DJ (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, F-25,9500 Euclid Ave, Cleveland, OH 44195 USA.		Ardissino, Diego/AAC-4041-2022	Topol, Eric/0000-0002-1478-4729; solinas, emilia/0000-0003-3532-1317				Anderson KM, 2001, J AM COLL CARDIOL, V37, P2059, DOI 10.1016/S0735-1097(01)01290-6; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Bhatt DL, 2000, J AM COLL CARDIOL, V35, P922, DOI 10.1016/S0735-1097(99)00650-6; Cadroy Y, 2000, CIRCULATION, V101, P2823, DOI 10.1161/01.CIR.101.24.2823; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; CARROZZA JP, 1993, ANN INTERN MED, V118, P344, DOI 10.7326/0003-4819-118-5-199303010-00004; Chew DP, 2000, J AM COLL CARDIOL, V36, P2028, DOI 10.1016/S0735-1097(00)00979-7; Coller BS, 1999, THROMB HAEMOSTASIS, V82, P326; Gilchrist IC, 2001, CIRCULATION, V104, P406, DOI 10.1161/hc2901.093504; Hanrath P, 1997, CIRCULATION, V96, P1445; Klinkhardt U, 2000, CLIN PHARMACOL THER, V67, P305, DOI 10.1067/mcp.2000.104613; KOMOWSKI R, 1997, CIRCULATION, V95, P1366; Lele M, 2001, CIRCULATION, V104, P582, DOI 10.1161/hc3101.092199; Lincoff AM, 1999, NEW ENGL J MED, V341, P319, DOI 10.1056/NEJM199907293410503; Marciniak SJ, 2001, THROMB HAEMOSTASIS, V85, P539, DOI 10.1055/s-0037-1615618; Marso SP, 1999, CIRCULATION, V100, P2477, DOI 10.1161/01.CIR.100.25.2477; Moliterno DJ, 2000, AM HEART J, V140, P722, DOI 10.1067/mhj.2000.110094; Narins CR, 1999, J AM COLL CARDIOL, V33, P647, DOI 10.1016/S0735-1097(98)00620-2; O'Shea JC, 2001, JAMA-J AM MED ASSOC, V285, P2468, DOI 10.1001/jama.285.19.2468; SIMON D, 2001, CATHETER CARDIOVASC, V52, P433; Simoons ML, 1997, LANCET, V349, P1429; Steinhubl SR, 2001, CIRCULATION, V103, P2572; Steinhubl SR, 2001, CIRCULATION, V103, P1403, DOI 10.1161/01.CIR.103.10.1403; Tcheng JE, 1997, LANCET, V349, P1422; Tcheng JE, 2000, LANCET, V356, P2037; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502	28	58	63	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					355	360		10.1016/S0140-6736(02)09605-8	http://dx.doi.org/10.1016/S0140-6736(02)09605-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241774				2022-12-28	WOS:000177255600007
J	Lockwood, AH; Salvi, RJ; Burkard, RF				Lockwood, AH; Salvi, RJ; Burkard, RF			Current concepts: Tinnitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RETRAINING THERAPY; GINKGO-BILOBA; DOUBLE-BLIND; SEVERITY; TRIAL; REORGANIZATION; DEPRESSION; ALPRAZOLAM; LIDOCAINE; DISORDER		VA Western NY Healthcare Syst, Ctr PET 115P, Buffalo, NY 14215 USA; Univ Buffalo, Ctr Hearing & Deafness, Buffalo, NY USA; Univ Buffalo, Dept Neurol, Buffalo, NY USA; Univ Buffalo, Dept Communicat Disorders & Sci, Buffalo, NY USA; Univ Buffalo, Ctr Positron Emiss Tomog, Mabie Lab, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lockwood, AH (corresponding author), VA Western NY Healthcare Syst, Ctr PET 115P, 3495 Bailey Ave, Buffalo, NY 14215 USA.	alan@petnet.buffalo.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC003600, R01DC003306] Funding Source: NIH RePORTER; NIDCD NIH HHS [P01 DC 3600, R01 DC 3306] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adams P.F., 1999, CURRENT ESTIMATES NA; Andersson G, 2000, ACTA OTO-LARYNGOL, V120, P967, DOI 10.1080/00016480050218717; Baguley DM, 1999, INT J PEDIATR OTORHI, V49, P99, DOI 10.1016/S0165-5876(99)00111-1; Brookes GB, 1996, AM J OTOL, V17, P569; Cazals Y, 2000, PROG NEUROBIOL, V62, P583, DOI 10.1016/S0301-0082(00)00027-7; CHAN SWY, 1994, CLIN OTOLARYNGOL, V19, P370, DOI 10.1111/j.1365-2273.1994.tb01251.x; CHOLE RA, 1992, ARCH OTOLARYNGOL, V118, P817; DENHARTIGH J, 1993, CLIN PHARMACOL THER, V54, P415; DOBIE RA, 1993, AM J OTOL, V14, P18; Dobie RA, 1999, LARYNGOSCOPE, V109, P1202, DOI 10.1097/00005537-199908000-00004; Drew S, 2001, BRIT MED J, V322, P73, DOI 10.1136/bmj.322.7278.73; EGGERMONT JJ, 1990, HEARING RES, V48, P111, DOI 10.1016/0378-5955(90)90202-Z; Ernst E, 1999, CLIN OTOLARYNGOL, V24, P164, DOI 10.1046/j.1365-2273.1999.00243.x; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Folmer RL, 1999, OTOLARYNG HEAD NECK, V121, P48, DOI 10.1016/S0194-5998(99)70123-3; FOX GN, 1991, WESTERN J MED, V154, P98; HELLER MF, 1953, ANN OTO RHINOL LARYN, V62, P73, DOI 10.1177/000348945306200107; Henry J A, 2000, J Am Acad Audiol, V11, P138; Holgers KM, 2000, AUDIOLOGY, V39, P284; HUYNH L, 1995, ANN PHARMACOTHER, V29, P311; Jannetta P J, 1997, Clin Neurosurg, V44, P331; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1993, BRIT J AUDIOL, V27, P7, DOI 10.3109/03005369309077884; JOHNSON RM, 1993, ARCH OTOLARYNGOL, V119, P842; Kay N J, 1981, Br J Audiol, V15, P123, DOI 10.3109/03005368109081425; Kroener-Herwig B, 2000, SCAND AUDIOL, V29, P67, DOI 10.1080/010503900424471; Lechtenberg R, 1984, J LARYNGOL OTOL, V98, P271; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; LEVINE RA, 2001, P 6 INT TINN SEM, P193; Lockwood AH, 2001, NEUROLOGY, V56, P472, DOI 10.1212/WNL.56.4.472; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; MEIKLE MB, 1984, OTOLARYNG HEAD NECK, V92, P689, DOI 10.1177/019459988409200617; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; MURAI K, 1992, AM J OTOL, V13, P454; Park JB, 2000, ARCH OTOLARYNGOL, V126, P489, DOI 10.1001/archotol.126.4.489; PENNER M J, 1992, British Journal of Audiology, V26, P115, DOI 10.3109/03005369209077879; Pinchoff RJ, 1998, AM J OTOL, V19, P785; REYES SA, IN PRESS HEARING RES; RUBINSTEIN B, 1990, Journal of Craniomandibular Disorders, V4, P186; SALVI RJ, 1979, HEARING RES, V1, P237, DOI 10.1016/0378-5955(79)90017-0; SALVI RJ, 1996, P 5 INT TINN SEM POR, P457; STOUFFER JL, 1990, J SPEECH HEAR DISORD, V55, P439, DOI 10.1044/jshd.5503.439; SULLIVAN M, 1993, ARCH INTERN MED, V153, P2251, DOI 10.1001/archinte.153.19.2251; VERNON J, 1990, AM J OTOLARYNG, V11, P44, DOI 10.1016/0196-0709(90)90169-V; Vernon J A, 2000, J Am Acad Audiol, V11, P293; Weissman JL, 2000, RADIOLOGY, V216, P342, DOI 10.1148/radiology.216.2.r00au45342; Wilson PH, 1998, BRIT J AUDIOL, V32, P273, DOI 10.3109/03005364000000078; ZENNER HP, 1993, EUR ARCH OTO-RHINO-L, V249, P447	48	353	373	1	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					904	910		10.1056/NEJMra013395	http://dx.doi.org/10.1056/NEJMra013395			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239260				2022-12-28	WOS:000178040700007
J	Ismail, K; Kent, K; Brugha, T; Hotopf, M; Hull, L; Seed, P; Palmer, I; Reid, S; Unwin, C; David, AS; Wessely, S				Ismail, K; Kent, K; Brugha, T; Hotopf, M; Hull, L; Seed, P; Palmer, I; Reid, S; Unwin, C; David, AS; Wessely, S			The mental health of UK Gulf war veterans: phase 2 of a two phase cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POPULATION-BASED SURVEY; ILLNESSES	Objectives To examine the prevalence of psychiatric disorders in veterans of the Gulf war with or without unexplained physical disability (a proxy measure of ill health) and in similarly disabled veterans who had not been deployed to the Gulf war (non-Gulf veterans). Design Two phase cohort study. Setting Current and ex-service UK military personnel. Participants Phase 1 consisted of three randomly selected samples of Gulf veterans, veterans of the 1992-7 Bosnia peacekeeping mission, and UK military personnel not deployed to the Gulf war (Era veterans) who had completed a postal health questionnaire, Phase 2 consisted of randomly selected subsamples from phase 1 of Gulf veterans who reported physical disability (n=111) or who did not report disability (n=98) and of Bosnia (n=54) and Era (n=79) veterans who reported physical disability. Main outcome measure Psychiatric disorders assessed by the schedule for clinical assessment in neuropsychiatry and classified by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition. Results Only 24% (n=27) of the disabled Gulf veterans had a formal psychiatric disorder (depression, anxiety, or alcohol related disorder). The prevalence of psychiatric disorders in non-disabled Gulf veterans was 12%. Disability and psychiatric disorders were weakly associated in the Gulf group when confounding was adjusted for (adjusted odds ratio 2.4, 99% confidence interval 0.8 to 7.2, P=0.04). The prevalence of psychiatric disorders was similar in disabled non-Gulf veterans and disabled Gulf veterans (19% v 24%; 1.3, 0.5 to 3.4). All groups had rates for post-traumatic stress disorder of between 1% and 3%. Conclusions Most disabled Gulf veterans do not have a formal psychiatric disorder. Post-traumatic stress disorder is not higher in Gulf veterans than in other veterans. Psychiatric disorders do not fully explain self reported ill health in Gulf veterans; alternative explanations for persistent ill health in Gulf veterans are needed.	Guys Kings & St Thomas Sch Med, Gulf War Illnesses Res Unit, London SE5 8AZ, England; Univ Leicester, Leicester Gen Hosp, Dept Psychiat, Sect Social & Epidemiol Psychiat, Leicester LE5 4PW, Leics, England; Royal Def Med Coll, Gosport, Hants, England	University of London; King's College London; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Ismail, K (corresponding author), Guys Kings & St Thomas Sch Med, Gulf War Illnesses Res Unit, London SE5 8AZ, England.	khalida.ismail@iop.kcl.ac.uk	Hotopf, Matthew/E-4971-2010; Seed, Paul T/C-4435-2008; David, Anthony S/C-1315-2011; Brugha, Traolach/T-9326-2019; David, Anthony/O-1750-2019; Wessely, Simon C/A-8713-2008	Seed, Paul T/0000-0001-7904-7933; David, Anthony S/0000-0003-0967-774X; Brugha, Traolach/0000-0002-9786-9591; David, Anthony/0000-0003-0967-774X; Ismail, Khalida/0000-0001-6084-449X; Hotopf, Matthew/0000-0002-3980-4466; Wessely, Simon Charles/0000-0002-6743-9929				Doebbeling BN, 2000, AM J MED, V108, P695, DOI 10.1016/S0002-9343(00)00405-8; DUNN G, 2000, STAT PSYCHIAT; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Ford JD, 2001, PSYCHOSOM MED, V63, P842, DOI 10.1097/00006842-200109000-00019; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Gray GC, 2000, AM J EPIDEMIOL, V151, P63, DOI 10.1093/oxfordjournals.aje.a010123; Gray GC, 1999, AM J TROP MED HYG, V60, P758, DOI 10.4269/ajtmh.1999.60.758; Joseph SC, 1997, MIL MED, V162, P149; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Kroenke K, 1994, Arch Fam Med, V3, P774; Macfarlane GJ, 2000, LANCET, V356, P17, DOI 10.1016/S0140-6736(00)02428-4; Pickles A, 1995, Stat Methods Med Res, V4, P73, DOI 10.1177/096228029500400106; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wolfe J, 1999, PSYCHOSOM MED, V61, P532, DOI 10.1097/00006842-199907000-00018	17	68	71	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2002	325	7364					576	579		10.1136/bmj.325.7364.576	http://dx.doi.org/10.1136/bmj.325.7364.576			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	595JJ	12228134	Bronze, Green Published			2022-12-28	WOS:000178105200018
J	Bayer, R; Colgrove, J				Bayer, R; Colgrove, J			Public health: Enhanced: Public health vs. civil liberties	SCIENCE			English	Editorial Material									Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA	Columbia University	Bayer, R (corresponding author), Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA.							Bor Jonathan, 2001, BALTIMORE SUN   1227, pA1; 2001, CANT C STAT EM HLTH	2	14	14	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1811	1811		10.1126/science.1074274	http://dx.doi.org/10.1126/science.1074274			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	592UJ	12228702				2022-12-28	WOS:000177955000022
J	Kirk, J; Ruiz, J; Chesley, J; Walshe, J; England, G				Kirk, J; Ruiz, J; Chesley, J; Walshe, J; England, G			A major archean, gold- and crust-forming event in the Kaapvaal craton, South Africa	SCIENCE			English	Article							WITWATERSRAND BASIN; U-PB; ORIGIN; MINERALIZATION; MINERALS; REEF	The 2.89- to 2.76-gigayear-old conglomerates of the Central Rand Group of South Africa host an immense concentration of gold. The gold and rounded pyrites from the conglomerates yield a rhenium-osmium isochron age of 3.03 +/- 0.02 gigayears and an initial Os-187/Os-188 ratio of 0.1079 +/- 0.0001. This age is older than that of the conglomerates. Thus, the gold is detrital and was not deposited by later hydrothermal fluids. This Middle Archean gold mineralization event corresponds to a period of rapid crustal growth in which much of the Kaapvaal craton was formed and is evidence for a significant noble metal flux from the mantle.	Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; CSIRO, Div Explorat & Min, Nedlands, WA 6009, Australia; Univ Edinburgh, Dept Geol & Geophys, Edinburgh EH9 3JW, Midlothian, Scotland	University of Arizona; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Edinburgh	Kirk, J (corresponding author), Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA.	jkirk@geo.arizona.edu	Walshe, John/B-7611-2018					[Anonymous], 1988, S AFR J GEOL; Barnicoat AC, 1997, NATURE, V386, P820, DOI 10.1038/386820a0; Coward M.P., 1995, GEOLOGICAL SOC LONDO, V95, P243, DOI [10.1144/gsl.sp.1995.095.01.15, DOI 10.1144/GSL.SP.1995.095.01.15, 10.1144/GSL.SP.1995.095.01.15]; England GL, 2001, TERRA NOVA, V13, P360, DOI 10.1046/j.1365-3121.2001.00363.x; ESSER BK, 1993, GEOCHIM COSMOCHIM AC, V57, P3093, DOI 10.1016/0016-7037(93)90296-9; Frimmel H.E., 2002, SPECIAL PUBLICATION, V9, P17; Frimmel HE, 1997, J GEOL, V105, P601, DOI 10.1086/515962; Graton L. C., 1930, EC GEOL S3, V25, P1; HALLBAUER DK, 1977, MINER DEPOSITA, V12, P293; HART SR, 1989, ECON GEOL, V84, P1651, DOI 10.2113/gsecongeo.84.6.1651; Kirk J, 2001, GEOCHIM COSMOCHIM AC, V65, P2149, DOI 10.1016/S0016-7037(01)00588-9; Kirk J., UNPUB; Lambert DD, 1998, ECON GEOL BULL SOC, V93, P121, DOI 10.2113/gsecongeo.93.2.121; Ludwig K.R., 1991, 91445 US GEOL SURV; MELLOR ET, 1916, T I MIN METALL, V25, P226; MINTER WEL, 1990, ECON GEOL BULL SOC, V85, P943, DOI 10.2113/gsecongeo.85.5.943; Minter WEL, 1999, ECON GEOL BULL SOC, V94, P665, DOI 10.2113/gsecongeo.94.5.665; Minter WEL, 1990, MIN ENG, V42, P195; PEUCKEREHRENBRI.B, 2001, GC000172; PHILLIPS NG, 1994, ORE GEOL REV, V9, P1, DOI 10.1016/0169-1368(94)90017-5; Poujol M, 1996, ECON GEOL BULL SOC, V91, P1455, DOI 10.2113/gsecongeo.91.8.1455; Poujol M, 1999, PRECAMBRIAN RES, V95, P167, DOI 10.1016/S0301-9268(98)00111-9; Robb LJ, 1995, ORE GEOL REV, V10, P67, DOI 10.1016/0169-1368(95)00011-9; RUNDLE CC, 1977, PHILOS T R SOC A, V286, P567, DOI 10.1098/rsta.1977.0132; SAAGER R, 1981, 1161L USGS, P1; Shirey SB, 1998, ANNU REV EARTH PL SC, V26, P423, DOI 10.1146/annurev.earth.26.1.423; Zartman RE, 1999, MINER PETROL, V66, P171, DOI 10.1007/BF01161727	27	96	102	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1856	1858		10.1126/science.1075270	http://dx.doi.org/10.1126/science.1075270			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228713				2022-12-28	WOS:000177955000039
J	Mitsui, T; Rose, MK; Fomin, E; Ogletree, DF; Salmeron, M				Mitsui, T; Rose, MK; Fomin, E; Ogletree, DF; Salmeron, M			Water diffusion and clustering on Pd(111)	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPE; SURFACE-DIFFUSION; ADSORPTION; PT(111); MONOMERS; DIMERS; ICE; H2O; MOLECULES; RU(001)	The adsorption, diffusion, and clustering of water molecules on a Pd(111) surface were studied by scanning tunneling microscopy. At 40 kelvin, low-coverage water adsorbs in the form of isolated molecules, which diffuse by hopping to nearest neighbor sites. Upon collision, they form first dimers, then trimers, tetramers, and so on. The mobility of these species increased by several orders of magnitude when dimers, trimers, and tetramers formed, and decreased again when the cluster contained five or more molecules. Cyclic hexamers were found to be particularly stable. They grow with further exposure to form a commensurate hexagonal honeycomb structure relative to the Pd(111) substrate. These observations illustrate the change in relative strength between intermolecular hydrogen bonds and molecule-substrate bonds as a function of water cluster size, the key property that determines the wetting properties of materials.	Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Salmeron, M (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.	salmeron@stm.lbl.gov	Ogletree, D Frank F/D-9833-2016	Ogletree, D Frank F/0000-0002-8159-0182; Mitsui, Toshiyuki/0000-0002-5465-4742				ANDERSON AB, 1981, SURF SCI, V105, P159, DOI 10.1016/0039-6028(81)90154-0; ANDERSSON S, 1984, CHEM PHYS LETT, V104, P305, DOI 10.1016/0009-2614(84)80069-X; Behler S, 1997, REV SCI INSTRUM, V68, P2479, DOI 10.1063/1.1148172; BROSSEAU R, 1990, J VAC SCI TECHNOL A, V8, P2454, DOI 10.1116/1.576714; Deltour P, 1997, PHYS REV LETT, V78, P4597, DOI 10.1103/PhysRevLett.78.4597; DOERING DL, 1982, SURF SCI, V123, P305, DOI 10.1016/0039-6028(82)90331-4; DYKE TR, 1977, J CHEM PHYS, V66, P498, DOI 10.1063/1.433969; FEIBELMAN PJ, 1987, PHYS REV LETT, V58, P2766, DOI 10.1103/PhysRevLett.58.2766; Glebov AL, 1999, SURF SCI, V427-28, P22, DOI 10.1016/S0039-6028(99)00228-9; He G, 1999, SCIENCE, V284, P1650, DOI 10.1126/science.284.5420.1650; HELD G, 1994, SURF SCI, V316, P92, DOI 10.1016/0039-6028(94)91131-2; Henderson MA, 2002, SURF SCI REP, V46, P1, DOI 10.1016/S0167-5729(01)00020-6; Hirano M, 1997, PHYS REV LETT, V78, P1448, DOI 10.1103/PhysRevLett.78.1448; Jacobi K, 2001, SURF SCI, V472, P9, DOI 10.1016/S0039-6028(00)00932-8; KELLOGG GL, 1991, PHYS REV LETT, V67, P622, DOI 10.1103/PhysRevLett.67.622; Krueger M, 1997, SURF SCI, V385, P146, DOI 10.1016/S0039-6028(97)00222-7; Lauhon LJ, 1999, J CHEM PHYS, V111, P5633, DOI 10.1063/1.479863; Luedtke WD, 1999, PHYS REV LETT, V82, P3835, DOI 10.1103/PhysRevLett.82.3835; Materer N, 1997, SURF SCI, V381, P190, DOI 10.1016/S0039-6028(97)00090-3; Morgenstern K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.066102; Morgenstern K, 2002, J CHEM PHYS, V116, P5746, DOI 10.1063/1.1453965; Morgenstern M, 1996, PHYS REV LETT, V77, P703, DOI 10.1103/PhysRevLett.77.703; Morgenstern M, 1997, Z PHYS CHEM, V198, P43, DOI 10.1524/zpch.1997.198.Part_1_2.043; Mugele F, 1996, REV SCI INSTRUM, V67, P2557, DOI 10.1063/1.1147213; MULLER JE, 1984, PHYS REV LETT, V53, P2493, DOI 10.1103/PhysRevLett.53.2493; Nakamura M, 2000, CHEM PHYS LETT, V325, P293, DOI 10.1016/S0009-2614(00)00663-1; Nakamura M, 1999, CHEM PHYS LETT, V309, P123, DOI 10.1016/S0009-2614(99)00673-9; Nakamura M, 2001, CHEM PHYS LETT, V335, P170, DOI 10.1016/S0009-2614(01)00069-0; OGASAWARA H, 1994, J CHEM PHYS, V111, P188; Pirug G, 1998, SURF SCI, V405, P87, DOI 10.1016/S0039-6028(98)00055-7; Rose MK, 2001, J CHEM PHYS, V115, P10927, DOI 10.1063/1.1420732; SHI H, 1994, SURF SCI, V317, P45, DOI 10.1016/0039-6028(94)90251-8; STOLT K, 1976, J CHEM PHYS, V65, P3206, DOI 10.1063/1.433493; Swartzentruber BS, 1996, PHYS REV LETT, V76, P459, DOI 10.1103/PhysRevLett.76.459; THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X; XANTHEAS SS, 1993, J CHEM PHYS, V99, P8774, DOI 10.1063/1.465599	36	280	282	5	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1850	1852		10.1126/science.1075095	http://dx.doi.org/10.1126/science.1075095			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228712				2022-12-28	WOS:000177955000037
J	Stocker, TF				Stocker, TF			North-south connections	SCIENCE			English	Editorial Material							LAST DEGLACIATION; COLD REVERSAL		Univ Bern, Climate & Environm Phys Div, CH-3012 Bern, Switzerland	University of Bern	Stocker, TF (corresponding author), Inst Pierre Simon Laplace, Lab Climat & Environm, F-91198 Gif Sur Yvette, France.		Stocker, Thomas/B-1273-2013					Blunier T, 1997, GEOPHYS RES LETT, V24, P2683, DOI 10.1029/97GL02658; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Morgan V, 2002, SCIENCE, V297, P1862, DOI 10.1126/science.1074257; Raisbeck GM, 2002, GEOCHIM COSMOCHIM AC, V66, pA623; Rind D, 2001, J GEOPHYS RES-ATMOS, V106, P27335, DOI 10.1029/2000JD000070; SOWERS T, 1995, SCIENCE, V269, P210, DOI 10.1126/science.269.5221.210; Stenni B, 2001, SCIENCE, V293, P2074, DOI 10.1126/science.1059702; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Vimeux F, 1999, NATURE, V398, P410, DOI 10.1038/18860	11	32	35	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1814	1815		10.1126/science.1075870	http://dx.doi.org/10.1126/science.1075870			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228703				2022-12-28	WOS:000177955000025
J	Allen, MR; Stainforth, DA				Allen, MR; Stainforth, DA			Towards objective probabalistic climate forecasting	NATURE			English	Editorial Material							UNCERTAINTY		Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford	Allen, MR (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	d.stainforth1@physics.ox.ac.uk	Allen, Myles R/A-5172-2012					Allen M, 1999, NATURE, V401, P642, DOI 10.1038/44266; CUBASCH U, 2001, CLIMATE CHANGE 2001, P527; Dai A, 2001, B AM METEOROL SOC, V82, P2377, DOI 10.1175/1520-0477(2001)082<2377:ESOTFC>2.3.CO;2; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; Giles J, 2002, NATURE, V418, P476, DOI 10.1038/418476a; Hansen JA, 2001, GLOB WARM INT CTR M, P187; Lea DJ, 2000, TELLUS A, V52, P523, DOI 10.1034/j.1600-0870.2000.01137.x; MITCHELL JFB, 1995, NATURE, V376, P501, DOI 10.1038/376501a0; Palmer TN, 2000, REP PROG PHYS, V63, P71, DOI 10.1088/0034-4885/63/2/201; Palmer TN, 2002, NATURE, V415, P512, DOI 10.1038/415512a; Schneider SH, 2001, NATURE, V411, P17, DOI 10.1038/35075167; Smith LA, 2002, P NATL ACAD SCI USA, V99, P2487, DOI 10.1073/pnas.012580599; Stainforth D, 2002, COMPUT SCI ENG, V4, P82, DOI 10.1109/5992.998644; Stott PA, 2002, NATURE, V416, P723, DOI 10.1038/416723a; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604	15	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					228	228		10.1038/nature01092a	http://dx.doi.org/10.1038/nature01092a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226678				2022-12-28	WOS:000177931200053
J	Fiellin, DA; O'Connor, PG				Fiellin, DA; O'Connor, PG			Office-based treatment of opioid-dependent patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METHADONE-MAINTENANCE; FOLLOW-UP; MEDICAL MAINTENANCE; PRIMARY-CARE; BUPRENORPHINE TREATMENT; HEROIN DEPENDENCE; OPIATE ADDICTS; DETOXIFICATION; OUTCOMES; TRIAL		Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University	Fiellin, DA (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,POB 20825, New Haven, CT 06520 USA.	david.fiellin@yale.edu		Fiellin, David/0000-0002-4006-010X	NATIONAL INSTITUTE ON DRUG ABUSE [K12DA000167] Funding Source: NIH RePORTER; NIDA NIH HHS [K12 DA00167] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		AMASS L, 1994, LIFE SCI, V54, P1215, DOI 10.1016/0024-3205(94)00848-5; American Psychiatric Association, 1994, DSM 4; [Anonymous], 1998, JAMA, V280, P1936; Ball J.C., 2012, EFFECTIVENESS METHAD; Brooner RK, 1997, ARCH GEN PSYCHIAT, V54, P71; Carroll KM, 1997, MED CLIN N AM, V81, P927, DOI 10.1016/S0025-7125(05)70556-3; Chutuape MA, 2001, DRUG ALCOHOL DEPEN, V62, P69, DOI 10.1016/S0376-8716(00)00160-5; CONNELL BJ, 1995, HISTOL HISTOPATHOL, V10, P255; *CTR SUBST AB TREA, 2000, 4365 HR CTR SUBST AB; DAUNNO T, 1992, JAMA-J AM MED ASSOC, V267, P253, DOI 10.1001/jama.267.2.253; *DHHS, 2001, DHHS PUBL; FARREN CK, 1997, NEW TREATMENTS OPIAT, P104; *FDA, 2001, IND SAF REL DRUG LAB; Fiellin DA, 2002, AM J DRUG ALCOHOL AB, V28, P231, DOI 10.1081/ADA-120002972; Fiellin DA, 2001, JAMA-J AM MED ASSOC, V286, P1724, DOI 10.1001/jama.286.14.1724; FIELLIN DA, IN PRESS ANN INTERN; FUDALA PJ, 1990, CLIN PHARMACOL THER, V47, P525, DOI 10.1038/clpt.1990.67; GOSSOP M, 1989, BRIT J PSYCHIAT, V154, P348, DOI 10.1192/bjp.154.3.348; GOWING L, 2000, COCHRANE DB SYST REV, V2; Hubbard RL, 1997, PSYCHOL ADDICT BEHAV, V11, P261, DOI 10.1037/0893-164X.11.4.261; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; JOHNSON RE, 1995, DRUG ALCOHOL DEPEN, V40, P27, DOI 10.1016/0376-8716(95)01189-7; LEPAY D, 2002, COMMUNICATION   0819; MCLELLAN AT, 1993, JAMA-J AM MED ASSOC, V269, P1953, DOI 10.1001/jama.269.15.1953; MEELEE D, 2001, ASAM PPC 2R ASAM PAT, P380; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; *NIH, 1998, NAT CONS DEV PAN EFF; NOVICK DM, 1994, J GEN INTERN MED, V9, P127, DOI 10.1007/BF02600025; O'Connor PG, 1998, AM J MED, V105, P100, DOI 10.1016/S0002-9343(98)00194-6; O'Connor PG, 2000, ANN INTERN MED, V133, P40, DOI 10.7326/0003-4819-133-1-200007040-00008; O'Connor PG, 1998, JAMA-J AM MED ASSOC, V279, P229, DOI 10.1001/jama.279.3.229; OConnor PG, 1997, ANN INTERN MED, V127, P526, DOI 10.7326/0003-4819-127-7-199710010-00004; *OFF NAT DRUG CONT, 1999, POL PAP OP AG TREATM; PAYTE JT, 1993, TREATMENT DURATION P; Rosenheck R, 2001, DRUG ALCOHOL DEPEN, V63, P253, DOI 10.1016/S0376-8716(00)00214-3; Salsitz EA, 2000, MT SINAI J MED, V67, P388; Schwartz RP, 1999, AM J ADDICTION, V8, P293; Sees KL, 2000, JAMA-J AM MED ASSOC, V283, P1303, DOI 10.1001/jama.283.10.1303; SENAY EC, 1977, ARCH GEN PSYCHIAT, V34, P361; Senay Edward C., 1993, Journal of Addictive Diseases, V12, P59, DOI 10.1300/J069v12n04_05; Strain EC, 1999, JAMA-J AM MED ASSOC, V281, P1000, DOI 10.1001/jama.281.11.1000; STRAIN EC, 2002, USE BUPRENORPHINE PH; Strang J, 1996, BMJ-BRIT MED J, V313, P270, DOI 10.1136/bmj.313.7052.270; *SUBST AB MENT HLT, 2002, SUBST AB TREATM FAC; *SUBST AB MENT HLT, 1999, NAT HOUS SURV DRUG A, V2001; *SUBST AB MENT HLT, 2000, TREATM EP DAT SET TE; Vignau J, 1998, EUR ADDICT RES, V4, P24, DOI 10.1159/000052038; WARD J, 1998, METHADONE MAINTENANC, P571; 2002, FED REG, V67, P13114; 2001, FED REG, V66, P4076	50	113	114	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					817	823		10.1056/NEJMcp013579	http://dx.doi.org/10.1056/NEJMcp013579			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226153				2022-12-28	WOS:000177921300007
J	Holmberg, L; Bill-Axelson, A; Helgesen, F; Salo, JO; Folmerz, P; Haggman, M; Andersson, S; Spangberg, A; Busch, C; Nordling, S; Palmgren, J; Adami, HO; Johansson, J; Norlen, BJ				Holmberg, L; Bill-Axelson, A; Helgesen, F; Salo, JO; Folmerz, P; Haggman, M; Andersson, S; Spangberg, A; Busch, C; Nordling, S; Palmgren, J; Adami, HO; Johansson, J; Norlen, BJ		Scandinavian Prostatic Canc Grp St	A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MANAGEMENT; MEN	Background: Radical prostatectomy is widely used in the treatment of early prostate cancer. The possible survival benefit of this treatment, however, is unclear. We conducted a randomized trial to address this question. Methods: From October 1989 through February 1999, 695 men with newly diagnosed prostate cancer in International Union against Cancer clinical stage T1b, T1c, or T2 were randomly assigned to watchful waiting or radical prostatectomy. We achieved complete follow-up through the year 2000 with blinded evaluation of causes of death. The primary end point was death due to prostate cancer, and the secondary end points were overall mortality, metastasis-free survival, and local progression. Results: During a median of 6.2 years of follow-up, 62 men in the watchful-waiting group and 53 in the radical-prostatectomy group died (P=0.31). Death due to prostate cancer occurred in 31 of 348 of those assigned to watchful waiting (8.9 percent) and in 16 of 347 of those assigned to radical prostatectomy (4.6 percent) (relative hazard, 0.50; 95 percent confidence interval, 0.27 to 0.91; P=0.02). Death due to other causes occurred in 31 of 348 men in the watchful-waiting group (8.9 percent) and in 37 of 347 men in the radical-prostatectomy group (10.6 percent). The men assigned to surgery had a lower relative risk of distant metastases than the men assigned to watchful waiting (relative hazard, 0.63; 95 percent confidence interval, 0.41 to 0.96). Conclusions: In this randomized trial, radical prostatectomy significantly reduced disease-specific mortality, but there was no significant difference between surgery and watchful waiting in terms of overall survival.	Univ Hosp, Dept Urol, SE-75185 Uppsala, Sweden; Univ Hosp, Reg Oncol Ctr, Uppsala, Sweden; Orebro Univ Hosp, Ctr Assessment Med Technol, Orebro, Sweden; Orebro Univ Hosp, Dept Urol, Orebro, Sweden; Helsinki Univ Hosp, Dept Urol, Helsinki, Finland; Boras Hosp, Dept Urol, Boras, Sweden; Univ Hosp, Dept Urol, Linkoping, Sweden; Univ Hosp, Dept Pathol, Tromso, Norway; Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland; Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Harvard Ctr Canc Prevent, Boston, MA 02115 USA	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Orebro University; Orebro University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Bill-Axelson, A (corresponding author), Univ Hosp, Dept Urol, SE-75185 Uppsala, Sweden.	anna.bill-axelson@urologi.uas.lul.se	Watanabe, Naoki/L-6185-2014	Watanabe, Naoki/0000-0002-5849-6112; Palmgren, Juni/0000-0002-9031-8615; Adolfsson, Jan/0000-0003-2992-1869				BRENDLER CB, 1980, J UROLOGY, V124, P849, DOI 10.1016/S0022-5347(17)55696-7; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; Fleming C, 1993, JAMA, V269, P2650; Gerber GS, 1996, JAMA-J AM MED ASSOC, V276, P615; Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171; GRAVERSEN PH, 1990, UROLOGY, V36, P493, DOI 10.1016/0090-4295(90)80184-O; HARMER MH, 1978, TNM CLASSIFICATION M; Hermanek P, 1992, TNM CLASSIFICATION M; Iversen P, 1995, Scand J Urol Nephrol Suppl, V172, P65; JOHANSSON JE, 1989, LANCET, V1, P799; MASSARO J, 1998, ENCY BIOSTATISTICS, P824; MIDDLETON RG, 1995, J UROLOGY, V154, P2144, DOI 10.1016/S0022-5347(01)66718-1; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; MOSTOFI FK, 1980, WHO MONOGRAPH SERIES, V22; PAULSON DF, 1982, J UROLOGY, V128, P502, DOI 10.1016/S0022-5347(17)53016-5; Pearson JD, 1996, UROLOGY, V48, P4, DOI 10.1016/S0090-4295(96)00603-6; Poole C, 2001, EPIDEMIOLOGY, V12, P291, DOI 10.1097/00001648-200105000-00005; Schellhammer P, 1997, UROLOGY, V49, P27, DOI 10.1016/S0090-4295(99)80321-5; Siegel T, 2001, J UROLOGY, V165, P430, DOI 10.1097/00005392-200102000-00019; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; WALSH PC, 1987, CANCER, V60, P526, DOI 10.1002/1097-0142(19870801)60:3+<526::AID-CNCR2820601515>3.0.CO;2-9; ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203	23	557	584	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					781	789		10.1056/NEJMoa012794	http://dx.doi.org/10.1056/NEJMoa012794			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226148	Bronze			2022-12-28	WOS:000177921300002
J	Srivastava, R				Srivastava, R			Beyond hope?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1203	1204		10.1001/jama.288.10.1203	http://dx.doi.org/10.1001/jama.288.10.1203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215110				2022-12-28	WOS:000177917700001
J	Finlayson, B; Dixon, J; Meadows, S; Blair, G				Finlayson, B; Dixon, J; Meadows, S; Blair, G			Mind the gap: the policy response to the NHS nursing shortage	BRITISH MEDICAL JOURNAL			English	Article									Kings Fund, Hlth Care Policy Programme, London W1G 0AN, England		Finlayson, B (corresponding author), Kings Fund, Hlth Care Policy Programme, London W1G 0AN, England.							Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; BUCHAN J, 1998, NURSES WORK ANAL UK; COLLIS P, 2001, HM LAND REGISTRY RES; *DEP HLTH, 1999, MAK DIFF STRENGTH NU; *DEP HLTH, 2001, BRIEF PAP; *DEP HLTH, 2001, WORKF DEV CONF GUID; *DEP HLTH, 1999, IMPR WORK LIV NHS; *DEP HLTH, 2000, IMPR WORK LIV STAND; Department of Health, 1998, WORK TOG SEC QUAL WO; Department of Health, 2000, NHS PLAN PLAN INV PL; Duffin Christian, 2001, Nurs Stand, V15, P4, DOI 10.7748/ns.15.29.4.s4; Finlayson B, 2002, BRIT MED J, V325, P538, DOI 10.1136/bmj.325.7363.538; MEADOWS S, 2000, LAST STRAW EXPLAININ; NHS Executive, 2000, RECR RET NURS MIDW H; *ROYAL COLL NURS, 2000, MAK DIFF REV UK NURS; SMITH G, 1998, CHANGING TIMES SURVE	16	28	28	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2002	325	7363					541	544		10.1136/bmj.325.7363.541	http://dx.doi.org/10.1136/bmj.325.7363.541			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593NJ	12217998	Green Published			2022-12-28	WOS:000177997800024
J	Isberg, J; Hammersberg, J; Johansson, E; Wikstrom, T; Twitchen, DJ; Whitehead, AJ; Coe, SE; Scarsbrook, GA				Isberg, J; Hammersberg, J; Johansson, E; Wikstrom, T; Twitchen, DJ; Whitehead, AJ; Coe, SE; Scarsbrook, GA			High carrier mobility in single-crystal plasma-deposited diamond	SCIENCE			English	Article							NATURAL DIAMOND; DRIFT VELOCITY; FILMS; DIODES	Room-temperature drift mobilities of 4500 square centimeters per volt second for electrons and 3800 square centimeters per volt second for holes have been measured in high-purity single-crystal diamond grown using a chemical vapor deposition process. The low-field drift mobility values were determined by using the time-of-flight technique on thick, intrinsic, freestanding diamond plates and were verified by current-voltage measurements on p-i junction diodes. The improvement of the electronic properties of single-crystal diamond and the reproducibility of those properties are encouraging for research on, and development of, high-performance diamond electronics.	ABB Grp Serv Ctr, Corp Res Nanotechnol & Innovat Mat Grp, Vasteras, Sweden; De Beers Ind Diamonds, Ascot, Berks, England		Isberg, J (corresponding author), Univ Uppsala, Div Elect Res, Box 539, S-75121 Uppsala, Sweden.							BARU VG, 1972, SOV PHYS SEMICOND+, V5, P1862; CANALI C, 1975, PHYS REV B, V12, P2265, DOI 10.1103/PhysRevB.12.2265; DENHAM P, 1967, PHYS REV, V161, P762, DOI 10.1103/PhysRev.161.762; DENISENKO AV, 1999, P 25 ANN C IEEE IND, V1, P74; HALLIDAY DP, 1999, P 24 INT C PHYS SEM, V3, pF21; Hammersberg J, 2001, DIAM RELAT MATER, V10, P574, DOI 10.1016/S0925-9635(00)00389-7; JUSKA G, 1994, PHILOS MAG B, V69, P277, DOI 10.1080/01418639408240109; Koizumi S, 2001, SCIENCE, V292, P1899, DOI 10.1126/science.1060258; MANY A, 1962, PHYS REV, V126, P1980, DOI 10.1103/PhysRev.126.1980; MIYATA K, 1993, DIAM RELAT MATER, V2, P1107, DOI 10.1016/0925-9635(93)90281-6; NAVA F, 1979, IEEE T NUCL SCI, V26, P308, DOI 10.1109/TNS.1979.4329650; NAVA F, 1980, SOLID STATE COMMUN, V33, P475, DOI 10.1016/0038-1098(80)90447-0; OTTOAVIANI G, 1975, PHYS REV B, V12, P3318; Pan L. S., 1995, DIAMOND ELECT PROPER; REDFIELD AG, 1954, PHYS REV, V94, P526, DOI 10.1103/PhysRev.94.526; REGGIANI L, 1981, PHYS REV B, V23, P3050, DOI 10.1103/PhysRevB.23.3050; SHIOMI H, 1990, JPN J APPL PHYS 2, V29, pL2163, DOI 10.1143/JJAP.29.L2163; TREW RJ, 1991, P IEEE, V79, P598, DOI 10.1109/5.90128; Weitzel CE, 1996, INST PHYS CONF SER, V142, P765; Yamanaka S, 1999, PHYS STATUS SOLIDI A, V174, P59, DOI 10.1002/(SICI)1521-396X(199907)174:1<59::AID-PSSA59>3.0.CO;2-A	20	901	949	22	300	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1670	1672		10.1126/science.1074374	http://dx.doi.org/10.1126/science.1074374			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215638				2022-12-28	WOS:000177819100040
J	Baker, PJ; Harris, S; Webbon, CC				Baker, PJ; Harris, S; Webbon, CC			Ecology - Effect of British hunting ban on fox numbers	NATURE			English	Article									Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol	Baker, PJ (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	s.harris@bristol.ac.uk						ALEXANDER K, 1996, BAILYS HUNTING DIREC; BURNS L, 2000, REPORT COMMITTEE INQ; HARRIS S, 1993, SYM ZOOL S, P441; Harris S., 1995, REV BRIT MAMMALS POP; Macdonald David W., 1996, P160; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Tapper S., 1999, QUESTION BALANCE GAM; 2000, BAILYS HUNTING DIREC	8	32	32	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					34	34		10.1038/419034a	http://dx.doi.org/10.1038/419034a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214224				2022-12-28	WOS:000177788600029
J	Del Punta, K; Leinders-Zufall, T; Rodriguez, I; Jukam, D; Wysocki, CJ; Ogawa, S; Zufall, F; Mombaerts, P				Del Punta, K; Leinders-Zufall, T; Rodriguez, I; Jukam, D; Wysocki, CJ; Ogawa, S; Zufall, F; Mombaerts, P			Deficient pheromone responses in mice lacking a cluster of vomeronasal receptor genes	NATURE			English	Article							OLFACTORY SYSTEM; ORGAN; MOUSE; NEURONS; ORGANIZATION; AGGRESSION; BEHAVIORS; MAMMALS; ALPHA	The mammalian vomeronasal organ (VNO), a part of the olfactory system, detects pheromones-chemical signals that modulate social and reproductive behaviours(1,2). But the molecular receptors in the VNO that detect these chemosensory stimuli remain undefined. Candidate pheromone receptors are encoded by two distinct and complex superfamilies of genes, V1r and V2r (refs 3 and 4), which code for receptors with seven transmembrane domains. These genes are selectively expressed in sensory neurons of the VNO. However, there is at present no functional evidence for a role of these genes in pheromone responses. Here, using chromosome engineering technology(5), we delete in the germline of mice a similar to600-kilobase genomic region that contains a cluster of 16 intact V1r genes(6). These genes comprise two of the 12 described V1r gene families(7), and represent similar to12% of the V1r repertoire. The mutant mice display deficits in a subset of VNO-dependent behaviours: the expression of male sexual behaviour and maternal aggression is substantially altered. Electrophysiologically, the epithelium of the VNO of such mice does not respond detectably to specific pheromonal ligands. The behavioural impairment and chemosensory deficit support a role of V1r receptors as pheromone receptors.	Rockefeller Univ, New York, NY 10021 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Rockefeller University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Monell Chemical Senses Center	Mombaerts, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Leinders-Zufall, Trese/B-4103-2009; Leinders-Zufall, Trese/S-3664-2019; Zufall, Frank/AAE-5290-2021	Leinders-Zufall, Trese/0000-0002-0678-362X; Leinders-Zufall, Trese/0000-0002-0678-362X; Zufall, Frank/0000-0002-4383-8618; Jukam, David/0000-0003-4167-2754; rodriguez, ivan/0000-0002-6468-0565				AMOORE JE, 1991, CHEM SENSES, V3, P331; BEAN NJ, 1982, PHYSIOL BEHAV, V29, P433, DOI 10.1016/0031-9384(82)90262-1; BEAN NJ, 1982, PHYSIOL BEHAV, V28, P31, DOI 10.1016/0031-9384(82)90097-X; BEAN NJ, 1989, PHYSIOL BEHAV, V45, P875, DOI 10.1016/0031-9384(89)90209-6; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; CLANCY AN, 1984, J NEUROSCI, V4, P2222; Del Punta K, 2000, GENOME RES, V10, P1958, DOI 10.1101/gr.10.12.1958; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Lane RP, 2002, P NATL ACAD SCI USA, V99, P291, DOI 10.1073/pnas.012608399; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Slotnick B, 2002, J NEUROSCI, V22, P4205, DOI 10.1523/JNEUROSCI.22-10-04205.2002; Sorensen PW, 1998, CURR OPIN NEUROBIOL, V8, P458, DOI 10.1016/S0959-4388(98)80032-9; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Takigami S, 1999, NEUROSCI LETT, V272, P115, DOI 10.1016/S0304-3940(99)00582-0; Tirindelli R, 1998, TRENDS NEUROSCI, V21, P482, DOI 10.1016/S0166-2236(98)01274-0; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; WYSOCKI CJ, 1982, PHYSIOL BEHAV, V29, P315, DOI 10.1016/0031-9384(82)90021-X	30	259	281	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					70	74		10.1038/nature00955	http://dx.doi.org/10.1038/nature00955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214233				2022-12-28	WOS:000177788600038
J	Manson, JE; Greenland, P; LaCroix, AZ; Stefanick, ML; Mouton, CP; Oberman, A; Perri, MG; Sheps, DS; Pettinger, MB; Siscovick, DS				Manson, JE; Greenland, P; LaCroix, AZ; Stefanick, ML; Mouton, CP; Oberman, A; Perri, MG; Sheps, DS; Pettinger, MB; Siscovick, DS			Walking compared with vigorous exercise for the prevention of cardiovascular events in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; MYOCARDIAL-INFARCTION; RISK-FACTORS; LIFE-STYLE; FOLLOW-UP; DEATH; MORTALITY; MEN; POPULATION	Background: The role of walking, as compared with vigorous exercise, in the prevention of cardiovascular disease remains controversial. Data for women who are members of minority racial or ethnic groups are particularly sparse. Methods: We prospectively examined the total physical-activity score, walking, vigorous exercise, and hours spent sitting as predictors of the incidence of coronary events and total cardiovascular events among 73,743 postmenopausal women 50 to 79 years of age in the Women's Health Initiative Observational Study. At base line, participants were free of diagnosed cardiovascular disease and cancer, and all participants completed detailed questionnaires about physical activity. We documented 345 newly diagnosed cases of coronary heart disease and 1551 total cardiovascular events. Results: An increasing physical-activity score had a strong, graded, inverse association with the risk of both coronary events and total cardiovascular events. There were similar findings among white women and black women. Women in increasing quintiles of energy expenditure measured in metabolic equivalents (the MET score) had age-adjusted relative risks of coronary events of 1.00, 0.73, 0.69, 0.68, and 0.47, respectively (P for trend, <0.001). In multivariate analyses, the inverse gradient between the total MET score and the risk of cardiovascular events remained strong (adjusted relative risks for increasing quintiles, 1.00, 0.89, 0.81, 0.78, and 0.72, respectively; P for trend <0.001). Walking and vigorous exercise were associated with similar risk reductions, and the results did not vary substantially according to race, age, or body-mass index. A brisker walking pace and fewer hours spent sitting daily also predicted lower risk. Conclusions: These prospective data indicate that both walking and vigorous exercise are associated with substantial reductions in the incidence of cardiovascular events among postmenopausal women, irrespective of race or ethnic group, age, and body-mass index. Prolonged sitting predicts increased cardiovascular risk.	Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Div Prevent Med, Boston, MA USA; Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL USA; Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Stanford Ctr Res Dis Prevent, Stanford, CA USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; Univ Florida, Div Cardiol, Gainesville, FL USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Northwestern University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; University of Texas System; University of Texas Health San Antonio; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Manson, JE (corresponding author), Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu	Greenland, Philip/ABD-5528-2021	Perri, Michael/0000-0003-3651-1542	WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032109] Funding Source: NIH RePORTER; WHI NIH HHS [N01-WH-3-2109] Funding Source: Medline	WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WHI NIH HHS		Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; American College of Sports Medicine, 1986, GUID EX TEST PRESCR; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BRUNNER D, 1974, J CHRON DIS, V27, P217, DOI 10.1016/0021-9681(74)90047-2; CURB D, IN PRESS ANN EPIDEMI; *DHHS, 1996, PHYS ACT HLTH REP SU; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Folsom AR, 1997, MED SCI SPORT EXER, V29, P901, DOI 10.1097/00005768-199707000-00009; FRASER GE, 1992, CIRCULATION, V86, P406, DOI 10.1161/01.CIR.86.2.406; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; LaCroix AZ, 1996, J AM GERIATR SOC, V44, P113, DOI 10.1111/j.1532-5415.1996.tb02425.x; LANGER RD, IN PRESS ANN EPIDEMI; LAPIDUS L, 1986, BRIT HEART J, V55, P295, DOI 10.1136/hrt.55.3.295; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; LEMAITRE RN, 1995, ARCH INTERN MED, V155, P2302, DOI 10.1001/archinte.155.21.2302; MAGNUS K, 1979, AM J EPIDEMIOL, V110, P724, DOI 10.1093/oxfordjournals.aje.a112853; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Manson JE, 1996, NEW ENGL J MED, V334, P1325, DOI 10.1056/NEJM199605163342010; Mayer-Davis EJ, 1998, JAMA-J AM MED ASSOC, V279, P669, DOI 10.1001/jama.279.9.669; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.publhealth.8.1.253; SALONEN JT, 1982, AM J EPIDEMIOL, V115, P526, DOI 10.1093/oxfordjournals.aje.a113334; SAS Institute, 1999, SAS PROC GUID REL 8; SCRAGG R, 1987, AM J EPIDEMIOL, V126, P77, DOI 10.1093/oxfordjournals.aje.a114664; Sesso HD, 1999, AM J EPIDEMIOL, V150, P408; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Ware J.E, 1994, PHYS MENTAL HLTH SUM; Williams PT, 1996, NEW ENGL J MED, V334, P1298, DOI 10.1056/NEJM199605163342004; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	34	868	887	2	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2002	347	10					716	725		10.1056/NEJMoa021067	http://dx.doi.org/10.1056/NEJMoa021067			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NH	12213942	Bronze, Green Published			2022-12-28	WOS:000177765800003
J	Berg, AO; Allan, JD; Frame, PS; Homer, CJ; Johnson, MS; Klein, JD; Lieu, TA; Mulrow, CD; Orleans, CT; Peipert, JF; Pender, NJ; Siu, AL; Teutsch, SM; Westhoff, C; Woolf, SH				Berg, AO; Allan, JD; Frame, PS; Homer, CJ; Johnson, MS; Klein, JD; Lieu, TA; Mulrow, CD; Orleans, CT; Peipert, JF; Pender, NJ; Siu, AL; Teutsch, SM; Westhoff, C; Woolf, SH		US Preventive Serv Task Force	Screening for breast cancer: Recommendations and rationale	ANNALS OF INTERNAL MEDICINE			English	Article							AMERICAN-COLLEGE; GUIDELINES	This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendations on screening for breast cancer and the supporting scientific evidence and updates the 1996 USPSTF recommendations on this topic. The complete USPSTF recommendation and rationale statement on this topic, which includes a brief review of the supporting evidence, is available through the USPSTF Web site (www.preventiveservices.ahrq.gov), the National Guideline Clearinghouse (www.guideline.gov), and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (telephone, 800-358-9295; e-mail, ahrqpubs@ahrq.gov). The complete information on which this statement is based, including evidence tables and references, is available in the accompanying article in this issue and in the summary of the evidence and systematic evidence review on the Web sites already mentioned. To update its recommendations on screening for breast cancer, the USPSTF reviewed the evidence regarding the effectiveness of mammography, clinical breast examination, and breast self-examination in reducing breast cancer mortality. The USPSTF did not review the evidence regarding genetic screening, surveillance of women with prior breast cancer, or formal evaluation of new screening modalities that have not been studied in the general population. A meta-analysis using a Bayesian random-effects model was conducted for the USPSTF to obtain a summary of relative risk estimates of the effectiveness of screening with mammography, either alone or in combination with clinical breast examination, in reducing breast cancer mortality. Clinical studies that evaluated breast self-examination were included in the review. Sources for estimates cited in this Recommendation and Rationale statement are described in the systematic evidence review on this topic, which is available on the USPSTF Web site (www.preventiveservices.ahrq.gov).	Agcy Healthcare Res & Qual, US Prevent Serv Task Force, Rockville, MD USA	Agency for Healthcare Research & Quality	Berg, AO (corresponding author), Univ Washington, Seattle, WA 98195 USA.							*AM AC FAM PHYS, 2002, PER HLTH EX SUMM AAF; *AM COLL OBST GYN, 2000, PRIM PREV CAR PER AS; *AM MED ASS, 1999, 16 COUNC SCI AFF AM; [Anonymous], 1997, NIH Consens Statement, V15, P1; Baxter N, 2001, CAN MED ASSOC J, V164, P1837; *CAN TASK FORC PER, 1994, OTTAWA HLTH CANADA, P788; *CAN TASK FORC PRE, 2002, PREV HLTH CAR 2001 U; Feig SA, 1998, AM J ROENTGENOL, V171, P29, DOI 10.2214/ajr.171.1.9648758; Ferrini R, 1996, AM J PREV MED, V12, P340, DOI 10.1016/S0749-3797(18)30289-7; Leitch AM, 1997, CA-CANCER J CLIN, V47, P150, DOI 10.3322/canjclin.47.3.150	10	326	329	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2002	137	5	1				344	346		10.7326/0003-4819-137-5_Part_1-200209030-00011	http://dx.doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591DZ	12204019				2022-12-28	WOS:000177865600006
J	Raviv, U; Klein, J				Raviv, U; Klein, J			Fluidity of bound hydration layers	SCIENCE			English	Article							WATER; SURFACE; FORCES; MICA; VISCOSITY; LIQUIDS; SYSTEMS; FILMS	We have measured the shear forces between solid surfaces sliding past each other across aqueous salt solutions, at pressures and concentrations typical of naturally occurring systems. In such systems the surface-attached hydration layers keep the compressed surfaces apart as a result of strongly repulsive hydration forces. We find, however, that the bound water molecules retain a shear fluidity characteristic of the bulk liquid, even when compressed down to films 1.0 +/- 0.3 nanometer thick. We attribute this to the ready exchange (as opposed to loss) of water molecules within the hydration layers as they rub past each other under strong compression.	Weizmann Inst Sci, IL-76100 Rehovot, Israel; Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	Weizmann Institute of Science; University of Oxford	Klein, J (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.		Raviv, Uri/C-3600-2019					Barnett RN, 2001, SCIENCE, V294, P567, DOI 10.1126/science.1062864; Cheng L, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.156103; Clifford J., 1975, WATER COMPREHENSIVE, V5, P75; COTTON FA, 1998, ADV INORG CHEM, P1288; Derjaguin BV, 1987, SURFACE FORCES; GAINES GL, 1956, NATURE, V178, P1304, DOI 10.1038/1781304b0; GERSTEIN M, 1998, SCI AM, V100; GOODSELL DS, 1993, MACHINERY LIFE; Harding SE, 2001, BIOPHYS CHEM, V93, P87, DOI 10.1016/S0301-4622(01)00213-7; HOMOLA AM, 1989, J TRIBOL-T ASME, V111, P675, DOI 10.1115/1.3261994; HORN RG, 1989, CHEM PHYS LETT, V162, P404, DOI 10.1016/0009-2614(89)87066-6; Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; ISRAELACHVILI JN, 1986, J COLLOID INTERF SCI, V110, P263, DOI 10.1016/0021-9797(86)90376-0; Klein J, 1998, J CHEM PHYS, V108, P6996, DOI 10.1063/1.476114; LENEVEU DM, 1976, NATURE, V259, P601, DOI 10.1038/259601a0; Marcelja S, 1997, NATURE, V385, P689, DOI 10.1038/385689a0; MCGUIGGAN PM, 1990, J MATER RES, V5, P2232, DOI 10.1557/JMR.1990.2232; MCGUIGGAN PM, 1988, J PHYS CHEM-US, V92, P1235, DOI 10.1021/j100316a045; Miranda PB, 1998, PHYS REV LETT, V81, P5876, DOI 10.1103/PhysRevLett.81.5876; PARSEGIAN VA, 1982, ADV COLLOID INTERFAC, V16, P49; PASHLEY RM, 1981, J COLLOID INTERF SCI, V83, P531, DOI 10.1016/0021-9797(81)90348-9; POPPA H, 1971, SURF SCI, V24, P149, DOI 10.1016/0039-6028(71)90225-1; RAVINA I, 1972, CLAY CLAY MINER, V20, P109, DOI 10.1346/CCMN.1972.0200302; Raviv U, 2002, J CHEM PHYS, V116, P5167, DOI 10.1063/1.1447911; Raviv U, 2001, NATURE, V413, P51, DOI 10.1038/35092523; ROBERTS AD, 1971, PROC R SOC LON SER-A, V325, P323, DOI 10.1098/rspa.1971.0172; SALUJA PPS, 1976, ELECTROCHEMISTRY, V6, P2; Sansom MSP, 2000, TRENDS BIOCHEM SCI, V25, P368, DOI 10.1016/S0968-0004(00)01613-3; TABOR D, 1969, PROC R SOC LON SER-A, V312, P435, DOI 10.1098/rspa.1969.0169; WILHELM M, UNPUB; Zhu YX, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.096104; 1987, P I MECH ENG ENG MEC, V210	33	459	466	11	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1540	1543		10.1126/science.1074481	http://dx.doi.org/10.1126/science.1074481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202826				2022-12-28	WOS:000177697300053
J	Deary, IJ; Whiteman, MC; Pattie, A; Starr, JM; Hayward, C; Wright, AF; Carothers, A; Whalley, LJ				Deary, IJ; Whiteman, MC; Pattie, A; Starr, JM; Hayward, C; Wright, AF; Carothers, A; Whalley, LJ			Ageing - Cognitive change and the APOE&4 allele	NATURE			English	Article							APOLIPOPROTEIN-E; OLD-AGE		Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; Royal Victoria Hosp, Dept Geriatr Med, Edinburgh EH4 2DN, Midlothian, Scotland; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Aberdeen, Royal Cornhill Hosp, Clin Res Ctr, Dept Mental Hlth, Aberdeen AB25 2ZH, Scotland	University of Edinburgh; University of Edinburgh; University of Aberdeen	Deary, IJ (corresponding author), Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.		Starr, John/C-8951-2011; Whiteman, Matthew/C-6079-2009; whalley, lawrence j/E-9019-2011; Deary, Ian J/C-6297-2009; Hayward, Caroline/M-8818-2016	Whiteman, Matthew/0000-0002-6583-6779; Deary, Ian J/0000-0002-1733-263X; Hayward, Caroline/0000-0002-9405-9550				Anstey K, 2000, GERONTOLOGY, V46, P163, DOI 10.1159/000022153; Breitner JCS, 2000, NEUROLOGY, V55, P161; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; ROBERTSON FW, 1985, ARTERIOSCLEROSIS, V5, P283, DOI 10.1161/01.ATV.5.3.283; Rose G., 1992, STRATEGY PREVENTIVE; Scottish Council for Research in Education, 1933, INT SCOTT CHILDR NAT; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; *US NAT RES COUNC, 2000, AG MIND; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K	11	234	242	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					932	932		10.1038/418932a	http://dx.doi.org/10.1038/418932a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	588AP	12198535	Bronze			2022-12-28	WOS:000177677500032
J	Reppert, SM; Weaver, DR				Reppert, SM; Weaver, DR			Coordination of circadian timing in mammals	NATURE			English	Review							RETINAL GANGLION-CELLS; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; PERIPHERAL-TISSUES; DIFFERENTIAL REGULATION; PHOTIC INDUCTION; MESSENGER-RNA; PERIOD GENES; CLOCK; LIGHT	Time in the biological sense is measured by cycles that range from milliseconds to years. Circadian rhythms, which measure time on a scale of 24 h, are generated by one of the most ubiquitous and well-studied timing systems. At the core of this timing mechanism is an intricate molecular mechanism that ticks away in many different tissues throughout the body. However, these independent rhythms are tamed by a master clock in the brain, which coordinates tissue-specific rhythms according to light input it receives from the outside world.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, LRB-728,364 Plantat St, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Weaver, David/0000-0001-7941-6719				Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bartness TJ, 2001, J BIOL RHYTHM, V16, P196, DOI 10.1177/074873001129001908; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Clayton JD, 2001, NATURE, V409, P829, DOI 10.1038/35057006; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Grundschober C, 2001, J BIOL CHEM, V276, P46751, DOI 10.1074/jbc.M107499200; Hamada T, 2001, J NEUROSCI, V21, P7742, DOI 10.1523/JNEUROSCI.21-19-07742.2001; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kita Y, 2002, PHARMACOGENETICS, V12, P55, DOI 10.1097/00008571-200201000-00008; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lavery DJ, 1999, MOL CELL BIOL, V19, P6488; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Oishi K, 2000, BIOCHEM BIOPH RES CO, V268, P164, DOI 10.1006/bbrc.1999.2054; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JA, 2000, GENE DEV, V14, P679; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shearman LP, 1999, NEUROREPORT, V10, P613, DOI 10.1097/00001756-199902250-00031; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Thompson CL, 2001, P NATL ACAD SCI USA, V98, P11708, DOI 10.1073/pnas.201301498; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vielhaber EL, 2001, J BIOL CHEM, V276, P45921, DOI 10.1074/jbc.M107726200; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wright KP, 2002, SCIENCE, V297, P571, DOI 10.1126/science.1071697; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zhang QH, 2002, SCIENCE, V295, P1895; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	83	3113	3215	22	728	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2002	418	6901					935	941		10.1038/nature00965	http://dx.doi.org/10.1038/nature00965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198538				2022-12-28	WOS:000177677500035
J	Rollins, NC; Dedicoat, M; Danaviah, S; Page, T; Bishop, K; Kleinschmidt, I; Coovadia, HM; Cassol, SA				Rollins, NC; Dedicoat, M; Danaviah, S; Page, T; Bishop, K; Kleinschmidt, I; Coovadia, HM; Cassol, SA		Child Hlth Grp	Prevalence, incidence, and mother-to-child transmission of HIV-1 in rural South Africa	LANCET			English	Article								Simple, robust approaches are needed to monitor prevalence, incidence, and mother-to-child transmission of HIV-1 in rural Africa. We have designed a method that uses antibody and viral RNA testing of dried blood spots obtained from mother-infant pairs attending routine immunisation clinics. In our study, prevalence and incidence of HIV-1 was highest in young women in their late teens and early twenties. In children born to infected mothers, prevalence increased from 14% in infants younger than 6 weeks of age to 24% at 3-6 months. The blood-spot approach is an effective method for surveillance of HIV-1 in women and children, and for early identification of incidence of this infection in women of child-bearing age.	Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa; Univ Natal, Dept Paediat & Child Hlth, ZA-4001 Durban, South Africa; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; S African Med Council, Durban, South Africa; Univ Natal, Ctr HIV AIDS Networking, ZA-4001 Durban, South Africa	University of Kwazulu Natal; Liverpool School of Tropical Medicine; University of Liverpool; University of Kwazulu Natal	Cassol, SA (corresponding author), Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa.		Dedicoat, Martin/AFC-7815-2022; Bishop, Karen/G-7073-2015	Bishop, Karen/0000-0003-4935-7708; Green, Taryn Natalie/0000-0001-9527-5960; Dedicoat, Martin/0000-0001-9833-4882				Biggar RJ, 2001, AIDS, V15, P1311, DOI 10.1097/00002030-200107060-00015; Bland RM, 2002, ACTA PAEDIATR, V91, P704, DOI 10.1080/080352502760069151; Gregson S, 2001, INT J STD AIDS, V12, P189, DOI 10.1258/0956462011917009; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; *REP S AFR DEP HLT, 2000, NAT HIV SYPH SER SUR	5	45	46	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					389	390		10.1016/S0140-6736(02)09599-5	http://dx.doi.org/10.1016/S0140-6736(02)09599-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241784				2022-12-28	WOS:000177255600017
J	Kaufman, YJ; Tanre, D; Boucher, O				Kaufman, YJ; Tanre, D; Boucher, O			A satellite view of aerosols in the climate system	NATURE			English	Review							BIOMASS BURNING AEROSOLS; SINGLE-SCATTERING ALBEDO; INDIAN-OCEAN EXPERIMENT; OPTICAL-PROPERTIES; TROPOSPHERIC AEROSOLS; MINERAL DUST; CLOUD MICROPHYSICS; SULFATE AEROSOLS; LIQUID WATER; BLACK CARBON	Anthropogenic aerosols are intricately linked to the climate system and to the hydrologic cycle. The net effect of aerosols is to cool the climate system by reflecting sunlight. Depending on their composition, aerosols can also absorb sunlight in the atmosphere, further cooling the surface but warming the atmosphere in the process. These effects of aerosols on the temperature profile, along with the role of aerosols as cloud condensation nuclei, impact the hydrologic cycle, through changes in cloud cover, cloud properties and precipitation. Unravelling these feedbacks is particularly difficult because aerosols take a multitude of shapes and forms, ranging from desert dust to urban pollution, and because aerosol concentrations vary strongly over time and space. To accurately study aerosol distribution and composition therefore requires continuous observations from satellites, networks of ground-based instruments and dedicated field experiments. Increases in aerosol concentration and changes in their composition, driven by industrialization and an expanding population, may adversely affect the Earth's climate and water supply.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Lille, CNRS, Opt Atmospher Lab, Villeneuve Dascq, France	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Kaufman, YJ (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	kaufman@climate.gsfc.nasa.gov	Keyes, Dennis/AAZ-9285-2021; Boucher, Olivier/J-5810-2012; Boucher, Olivier/K-7483-2012	Boucher, Olivier/0000-0003-2328-5769; Boucher, Olivier/0000-0003-2328-5769				Ackerman AS, 2000, SCIENCE, V288, P1042, DOI 10.1126/science.288.5468.1042; ACKERMAN TP, 1981, APPL OPTICS, V20, P3661, DOI 10.1364/AO.20.003661; ALBRECHT BA, 1989, SCIENCE, V245, P1227, DOI 10.1126/science.245.4923.1227; Alpert P, 1998, NATURE, V395, P367, DOI 10.1038/26456; ANDREAE MO, 1986, SCIENCE, V232, P1620, DOI 10.1126/science.232.4758.1620; Artaxo P, 1998, J GEOPHYS RES-ATMOS, V103, P31837, DOI 10.1029/98JD02346; Bates TS, 1998, J GEOPHYS RES-ATMOS, V103, P16297, DOI 10.1029/97JD03741; Bond TC, 1998, GEOPHYS RES LETT, V25, P337, DOI 10.1029/98GL00039; BOUCHER O, 1995, J CLIMATE, V8, P1403, DOI 10.1175/1520-0442(1995)008<1403:GEOTIA>2.0.CO;2; Boucher O, 2001, CLIM DYNAM, V18, P297, DOI 10.1007/s003820100185; Breon FM, 2002, SCIENCE, V295, P834, DOI 10.1126/science.1066434; CHARLSON RJ, 1992, SCIENCE, V255, P423, DOI 10.1126/science.255.5043.423; Charlson RJ, 2001, SCIENCE, V292, P2025, DOI 10.1126/science.1060096; Chin M, 2002, J ATMOS SCI, V59, P461, DOI 10.1175/1520-0469(2002)059<0461:TAOTFT>2.0.CO;2; CHOU MD, 1992, J ATMOS SCI, V49, P762, DOI 10.1175/1520-0469(1992)049<0762:ASRMFU>2.0.CO;2; Chowdhary J, 2002, J ATMOS SCI, V59, P383, DOI 10.1175/1520-0469(2002)059<0383:CSOARO>2.0.CO;2; Christopher SA, 1996, J GEOPHYS RES-ATMOS, V101, P21265, DOI 10.1029/96JD02161; CHU DA, IN PRESS GEOPHYS RES; Claquin T, 1998, TELLUS B, V50, P491, DOI 10.1034/j.1600-0889.1998.t01-2-00007.x; Clarke AD, 2002, J ATMOS SCI, V59, P363, DOI 10.1175/1520-0469(2002)059<0363:APASPI>2.0.CO;2; CLARKE AD, 1985, SCIENCE, V229, P263, DOI 10.1126/science.229.4710.263; COAKLEY JA, 1987, SCIENCE, V237, P1020, DOI 10.1126/science.237.4818.1020; Collins WD, 2001, J GEOPHYS RES-ATMOS, V106, P7313, DOI 10.1029/2000JD900507; Delene DJ, 2002, J ATMOS SCI, V59, P1135, DOI 10.1175/1520-0469(2002)059<1135:VOAOPA>2.0.CO;2; Deuze JL, 2000, J GEOPHYS RES-ATMOS, V105, P15329, DOI 10.1029/2000JD900148; Diner DJ, 2001, GEOPHYS RES LETT, V28, P3127, DOI 10.1029/2001GL013188; Dubovik O, 2002, J ATMOS SCI, V59, P590, DOI 10.1175/1520-0469(2002)059<0590:VOAAOP>2.0.CO;2; Eck TF, 1998, J GEOPHYS RES-ATMOS, V103, P31865, DOI 10.1029/98JD00399; Eck TF, 2001, J GEOPHYS RES-ATMOS, V106, P3425, DOI 10.1029/2000JD900555; Feingold G, 1999, J ATMOS SCI, V56, P4100, DOI 10.1175/1520-0469(1999)056<4100:TIOGCC>2.0.CO;2; Feingold G, 2002, J ATMOS SCI, V59, P2006, DOI 10.1175/1520-0469(2002)059<2006:AOTIOF>2.0.CO;2; Feingold G, 2001, J GEOPHYS RES-ATMOS, V106, P22907, DOI 10.1029/2001JD000732; Formenti P, 2001, J GEOPHYS RES-ATMOS, V106, P9807, DOI 10.1029/2000JD900609; FOUQUART Y, 1987, J CLIM APPL METEOROL, V26, P28, DOI 10.1175/1520-0450(1987)026<0028:OOSARO>2.0.CO;2; FRASER RS, 1984, ATMOS ENVIRON, V18, P2577, DOI 10.1016/0004-6981(84)90322-6; FRASER RS, 1985, IEEE J GEOSCI REM GE, V23, P525; Gao Y, 2001, GEOPHYS RES LETT, V28, P29, DOI 10.1029/2000GL011926; Gobbi GP, 2000, ATMOS ENVIRON, V34, P5119, DOI 10.1016/S1352-2310(00)00194-1; HAN QY, 1994, J CLIMATE, V7, P465, DOI 10.1175/1520-0442(1994)007<0465:NGSOED>2.0.CO;2; Hansen J, 1997, J GEOPHYS RES-ATMOS, V102, P6831, DOI 10.1029/96JD03436; Haywood J, 2000, REV GEOPHYS, V38, P513, DOI 10.1029/1999RG000078; Hegg DA, 1997, J GEOPHYS RES-ATMOS, V102, P25293, DOI 10.1029/97JD02293; Herman JR, 1997, J GEOPHYS RES-ATMOS, V102, P16911, DOI 10.1029/96JD03680; Herman M, 1997, J GEOPHYS RES-ATMOS, V102, P17039, DOI 10.1029/96JD02109; Heymsfield AJ, 2001, J GEOPHYS RES-ATMOS, V106, P28653, DOI 10.1029/2000JD900776; Holben BN, 2001, J GEOPHYS RES-ATMOS, V106, P12067, DOI 10.1029/2001JD900014; HOPPEL WA, 1990, J GEOPHYS RES-ATMOS, V95, P3659, DOI 10.1029/JD095iD04p03659; Hsu NC, 2000, J GEOPHYS RES-ATMOS, V105, P20649, DOI 10.1029/2000JD900150; Husar RB, 1997, J GEOPHYS RES-ATMOS, V102, P16889, DOI 10.1029/96JD04009; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Kaufman YJ, 1998, J GEOPHYS RES-ATMOS, V103, P31783, DOI 10.1029/98JD02281; Kaufman YJ, 1997, SCIENCE, V277, P1636, DOI 10.1126/science.277.5332.1636; Kaufman YJ, 1997, J GEOPHYS RES-ATMOS, V102, P17051, DOI 10.1029/96JD03988; KAUFMAN YJ, 1993, J APPL METEOROL, V32, P729, DOI [10.1175/1520-0450(1993)032<0729:EOASOC>2.0.CO;2, 10.1175/1520-0450(1993)032&lt;0729:EOASOC&gt;2.0.CO;2]; Kaufman YJ, 2001, GEOPHYS RES LETT, V28, P1479, DOI 10.1029/2000GL012647; KEELING CD, 1960, TELLUS, V12, P200, DOI 10.1111/j.2153-3490.1960.tb01300.x; Khain AP, 2001, GEOPHYS RES LETT, V28, P3887, DOI 10.1029/2000GL012662; KIEHL JT, 1993, SCIENCE, V260, P311, DOI 10.1126/science.260.5106.311; King MD, 1999, B AM METEOROL SOC, V80, P2229, DOI 10.1175/1520-0477(1999)080<2229:RSOTAF>2.0.CO;2; Kreidenweis SM, 2001, J GEOPHYS RES-ATMOS, V106, P4831, DOI 10.1029/2000JD900488; Leon JF, 2001, J GEOPHYS RES-ATMOS, V106, P28427, DOI 10.1029/2001JD900023; Levin Z, 1996, J APPL METEOROL, V35, P1511, DOI 10.1175/1520-0450(1996)035<1511:TEODPC>2.0.CO;2; Li ZQ, 1998, TELLUS B, V50, P543, DOI 10.1034/j.1600-0889.1998.00010.x; Liao H, 1998, J GEOPHYS RES-ATMOS, V103, P3781, DOI 10.1029/97JD03455; Liousse C, 1996, J GEOPHYS RES-ATMOS, V101, P19411, DOI 10.1029/95JD03426; Liu M, 2001, J GEOPHYS RES-ATMOS, V106, P18099, DOI 10.1029/2000JD900711; Lohmann U, 1997, J GEOPHYS RES-ATMOS, V102, P13685, DOI 10.1029/97JD00631; Luo YF, 2001, J GEOPHYS RES-ATMOS, V106, P14501, DOI 10.1029/2001JD900030; Martins JV, 1998, J GEOPHYS RES-ATMOS, V103, P32041, DOI 10.1029/98JD02593; Mishchenko MI, 1997, J GEOPHYS RES-ATMOS, V102, P16989, DOI 10.1029/96JD02425; Moulin C, 1997, NATURE, V387, P691, DOI 10.1038/42679; Nakajima T, 2001, GEOPHYS RES LETT, V28, P1171, DOI 10.1029/2000GL012186; Novakov T, 1997, J GEOPHYS RES-ATMOS, V102, P30023, DOI 10.1029/97JD02793; PENNER JE, 1992, SCIENCE, V256, P1432, DOI 10.1126/science.256.5062.1432; Prospero JM, 1999, J GEOPHYS RES-ATMOS, V104, P15917, DOI 10.1029/1999JD900072; PROSPERO JM, 1986, NATURE, V320, P735, DOI 10.1038/320735a0; PROSPERO JM, IN PRESS GEOPHYS REV; Ramanathan V, 2001, J GEOPHYS RES-ATMOS, V106, P28371, DOI 10.1029/2001JD900133; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Reiner T, 2001, J GEOPHYS RES-ATMOS, V106, P28497, DOI 10.1029/2000JD900695; Remer LA, 1997, J GEOPHYS RES-ATMOS, V102, P16849, DOI 10.1029/96JD01932; REMER LA, IN PRESS GEOPHYS RES; Rosenfeld D, 1999, GEOPHYS RES LETT, V26, P3105, DOI 10.1029/1999GL006066; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; Rosenfeld D, 2000, NATURE, V405, P440, DOI 10.1038/35013030; Ross JL, 1998, J GEOPHYS RES-ATMOS, V103, P31925, DOI 10.1029/97JD03677; Rotstayn LD, 2000, GEOPHYS RES LETT, V27, P3045, DOI 10.1029/2000GL011737; Satheesh SK, 1999, J GEOPHYS RES-ATMOS, V104, P27421, DOI 10.1029/1999JD900478; Satheesh SK, 2000, NATURE, V405, P60, DOI 10.1038/35011039; Smirnov A, 2002, J ATMOS SCI, V59, P501, DOI 10.1175/1520-0469(2002)059<0501:OPOAAI>2.0.CO;2; Sokolik IN, 1996, NATURE, V381, P681, DOI 10.1038/381681a0; Takemura T, 2002, J CLIMATE, V15, P333, DOI 10.1175/1520-0442(2002)015<0333:SSAARF>2.0.CO;2; Tanre D, 1997, J GEOPHYS RES-ATMOS, V102, P16971, DOI 10.1029/96JD03437; Tanre D, 2001, J GEOPHYS RES-ATMOS, V106, P18205, DOI 10.1029/2000JD900663; Torres O, 2002, J ATMOS SCI, V59, P398, DOI 10.1175/1520-0469(2002)059<0398:ALTROA>2.0.CO;2; TWOMEY SA, 1984, TELLUS B, V36, P356, DOI 10.1111/j.1600-0889.1984.tb00254.x; Veefkind JP, 1998, GEOPHYS RES LETT, V25, P3135, DOI 10.1029/98GL02264; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; Winker DM, 1996, P IEEE, V84, P164, DOI 10.1109/5.482227	100	1581	1683	26	519	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					215	223		10.1038/nature01091	http://dx.doi.org/10.1038/nature01091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226676				2022-12-28	WOS:000177931200051
J	Saxena, S; Eliahoo, J; Majeed, A				Saxena, S; Eliahoo, J; Majeed, A			Socioeconomic and ethnic group differences in self reported health status and use of health services by children and young people in England: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOCIAL-CLASS	Objectives To examine whether self reported health status and use of health services varies in children of different social class and ethnic group. Design Cross sectional study from the 1999 health survey for England. Subjects 6648 children and young adults aged 2-20 years. Setting Private households in England. Main outcome measures Proportion of children (or their parents) reporting episodes of acute illness in the preceding fortnight and prevalence of self reported longstanding illness. Proportion reporting specific illnesses. Proportion reporting that they had consulted a general practitioner in the preceding fortnight, attended hospital outpatient departments in the three preceding months, or been admitted to hospital in the preceding year. Results Large socioeconomic differences were observed between ethnic subgroups; a higher proportion of Afro-Caribbean, Indian, Pakistani, and Bangladeshi children belonged to lower social classes than the general population. ne proportion of children and young adults reporting acute illnesses in the preceding two weeks was lower in Bangladeshi and Chinese subgroups (odds ratio 0.41, 95% confidence interval 0.27 to 0.61 and 0.46, 0.28 to 0.77, respectively) than in the general population. Longstanding illnesses was less common in Bangladeshi and Pakistani children (0.52, 0.40 to 0.67 and 0.57, 0.46 to 0.70) than in the general population. Irish and Afro-Caribbean children reported the highest prevalence of asthma (19.5% and 17.70%) and Bangladeshi children the lowest (8.2%). A higher proportion of Afro-Caribbean children reported major injuries than the general population (11.0% v 10.0%), and children from all Asian subgroups reported fewer major and minor injuries than the general population. Indian and Pakistani children were more likely to have consulted their general practitioner in the preceding fortnight than the general population (1.86, 1.35 to 2.57 and 1.51, 1.13 to 2.01, respectively). Indian, Pakistani, Bangladeshi, and Chinese children were less likely to have attended outpatient departments in the preceding three months. No significant differences were found between ethnic groups in the admission of inpatients to hospitals. Acute and chronic illness were the best predictors of children's use of health services. Social classes did not differ in self reported prevalence of treated infections, major injuries, or minor injuries, and no socioeconomic differences were seen in the use of primary and secondary healthcare services. Conclusions Children's use of health services reflected health status rather than ethnic group or socioeconomic status, implying that equity of access has been partly achieved, although reasons why children from ethnic minority groups are able to access primary care but receive less secondary care need to be investigated.	UCL Hosp NHS Trust, Res & Dev Directorate, London NW1 2LT, England; UCL, Sch Publ Policy, London WC1H 9QU, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Saxena, S (corresponding author), UCL Hosp NHS Trust, Res & Dev Directorate, London NW1 2LT, England.	sonia.saxena@pcps.ucl.ac.uk	Saxena, Sonia K/G-4821-2013; Saxena, Sonia/ABD-7737-2021	Saxena, Sonia K/0000-0003-3787-2083; Saxena, Sonia/0000-0003-3787-2083; Majeed, Azeem/0000-0002-2357-9858				ACHESON D, 1998, REPORT INDEPENDENT I; AHMAD WIU, 1991, FAM PRACT, V8, P52, DOI 10.1093/fampra/8.1.52; Bakhshi S S, 1997, Ethn Health, V2, P147; BALARAJAN R, 1989, BRIT MED J, V299, P958, DOI 10.1136/bmj.299.6705.958; Bhopal R, 1998, AM J PUBLIC HEALTH, V88, P1303, DOI 10.2105/AJPH.88.9.1303; BLAXTER M, 1990, HTLH LIFESTYLES; CarrHill RA, 1996, BRIT MED J, V312, P1008; Chandola T, 2001, SOC SCI MED, V52, P1285, DOI 10.1016/S0277-9536(00)00231-8; Cooper H, 1998, BRIT MED J, V317, P1047; HARDING S, 1999, HLTH STAT Q, V8, P30; Irvine L, 1997, THORAX, V52, P766, DOI 10.1136/thx.52.9.766; Kemp A, 1997, J ACCID EMERG MED, V14, P316; *OFF POP CENS SURV, 1992, HLTH SURV ENGL; Roberts I, 1996, BRIT MED J, V313, P784; Saxena S, 1999, BRIT MED J, V318, P642, DOI 10.1136/bmj.318.7184.642; SENIOR PA, 1994, BRIT MED J, V309, P327, DOI 10.1136/bmj.309.6950.327; SMITH GD, 1990, BMJ-BRIT MED J, V301, P373, DOI 10.1136/bmj.301.6748.373; STAPLES B, 1994, ARCH DIS CHILD, V71, P548, DOI 10.1136/adc.71.6.548	18	88	89	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2002	325	7363					520	523		10.1136/bmj.325.7363.520	http://dx.doi.org/10.1136/bmj.325.7363.520			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	593NJ	12217992	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000177997800018
J	Donadio, JV; Grande, JP				Donadio, JV; Grande, JP			IgA nephropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HENOCH-SCHONLEIN PURPURA; TERM FOLLOW-UP; ANGIOTENSIN-CONVERTING ENZYME; IMMUNOGLOBULIN-A NEPHROPATHY; GROWTH-FACTOR-BETA; FISH-OIL; MESANGIAL IGA; CONTROLLED TRIAL; RENAL-DISEASE; NORMOTENSIVE PATIENTS		Mayo Clin & Mayo Fdn, Dept Med, Div Nephrol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Donadio, JV (corresponding author), Mayo Clin & Mayo Fdn, Dept Med, Div Nephrol, 200 1st St SW,Stabile 7-22, Rochester, MN 55905 USA.	donadio.james@mayo.edu	Mubarak, Muhammed/P-6508-2019; Grande, Joseph P./AAG-2128-2020	Mubarak, Muhammed/0000-0001-6120-5884; Grande, Joseph P./0000-0001-5674-1682				ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8; Allen AC, 1997, NEPHROL DIAL TRANSPL, V12, P701, DOI 10.1093/ndt/12.4.701; Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; AMORE A, 1993, KIDNEY INT, V43, pS41; Auwardt R, 1999, CLIN NEPHROL, V52, P1; BAILEY RR, 1989, CLIN NEPHROL, V31, P239; Ballardie FW, 2002, J AM SOC NEPHROL, V13, P142, DOI 10.1681/ASN.V131142; BANNISTER KM, 1995, CONTRIB NEPHROL, V111, P184; BENE MC, 1991, NEPHRON, V58, P240, DOI 10.1159/000186425; BENE MC, 1993, CONTRIB NEPHROL, V104, P153; BENE MC, 1988, AM J KIDNEY DIS, V12, P406, DOI 10.1016/S0272-6386(88)80035-0; BENNETT WM, 1989, CLIN NEPHROL, V31, P128; BERGER J, 1968, J UROL NEPHROL, V74, P694; BERTHOUX F, 1990, PRESSE MED, V19, P1417; BOGENSCHUTZ O, 1990, AM J NEPHROL, V10, P137, DOI 10.1159/000168068; Briganti EM, 2001, NEPHROL DIAL TRANSPL, V16, P1364, DOI 10.1093/ndt/16.7.1364; CATTRAN DC, 1994, AM J KIDNEY DIS, V23, P247, DOI 10.1016/S0272-6386(12)80980-2; Cheng IKP, 1998, NEPHROLOGY, V4, P19, DOI 10.1046/j.1440-1797.1998.d01-12.x; CHENG IKP, 1990, NEPHROL DIAL TRANSPL, V5, P241, DOI 10.1093/ndt/5.4.241; DAMICO G, 1987, SEMIN NEPHROL, V7, P355; DAMICO G, 1987, Q J MED, V64, P709; Dillon JJ, 1997, J AM SOC NEPHROL, V8, P1739; Donadio JV, 1999, J AM SOC NEPHROL, V10, P1772; DONADIO JV, 1994, CLIN NEPHROL, V41, P65; DONADIO JV, 1994, NEW ENGL J MED, V331, P1194, DOI 10.1056/NEJM199411033311804; Donadio JV, 2001, J AM SOC NEPHROL, V12, P791, DOI 10.1681/ASN.V124791; Donadio JV, 1997, J AM SOC NEPHROL, V8, P1324; EMANCIPATOR SN, 1994, AM J KIDNEY DIS, V23, P451, DOI 10.1016/S0272-6386(12)81011-0; Feehally J, 1999, ANN MED INTERNE, V150, P91; Floege J, 2000, J AM SOC NEPHROL, V11, P2395, DOI 10.1681/ASN.V11122395; Fofi C, 2001, J NEPHROL, V14, P280; FRIMAT L, 1994, PRESSE MED, V23, P1879; Frohlich F, 1989, TERRA NOVA, V1, P267, DOI 10.1111/j.1365-3121.1989.tb00368.x; Frohnert PP, 1997, CLIN TRANSPLANT, V11, P127; Galla JH, 2001, NEPHRON, V88, P107, DOI 10.1159/000045969; GALLA JH, 1995, KIDNEY INT, V47, P377, DOI 10.1038/ki.1995.50; Gharavi AG, 2000, NAT GENET, V26, P354, DOI 10.1038/81677; Glassock RJ, 1999, J NEPHROL, V12, P288; Grande JP, 1997, P SOC EXP BIOL MED, V214, P27; Grande JP, 1998, PROG INFLAM RES, P125; Grande JP, 2000, KIDNEY INT, V57, P1027, DOI 10.1046/j.1523-1755.2000.00930.x; HABIB R, 1994, RENAL PATHOLOGY CLIN, P472; HAMAZAKI T, 1984, LANCET, V1, P1017; HARPER SJ, 1994, KIDNEY INT, V45, P836, DOI 10.1038/ki.1994.110; HENE RJ, 1986, ARCH INTERN MED, V146, P745, DOI 10.1001/archinte.146.4.745; Hilgers KF, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341100; HOGG RJ, 1995, AM J KIDNEY DIS, V26, P792, DOI 10.1016/0272-6386(95)90445-X; HOGG RJ, 1994, PEDIATR NEPHROL, V8, P15, DOI 10.1007/BF00868251; HOY WE, 1989, TRANSPLANT P, V21, P3909; Hsu SIH, 2000, KIDNEY INT, V57, P1818, DOI 10.1046/j.1523-1755.2000.00032.x; IBELS LS, 1994, MEDICINE, V73, P79, DOI 10.1097/00005792-199403000-00002; Jafar TH, 2001, KIDNEY INT, V60, P1131, DOI 10.1046/j.1523-1755.2001.0600031131.x; JENNETTE JC, 1985, KIDNEY INT, V28, P944, DOI 10.1038/ki.1985.222; JENNETTE JC, 1991, AM J KIDNEY DIS, V18, P466, DOI 10.1016/S0272-6386(12)80115-6; JOHNSTON PA, 1992, Q J MED, V84, P619; Julian B A, 1999, Adv Nephrol Necker Hosp, V29, P53; JULIAN BA, 1988, AM J MED, V84, P129, DOI 10.1016/0002-9343(88)90019-8; Kashtan CE, 1994, RENAL PATHOLOGY, P1239; KATAFUCHI R, 1994, CLIN NEPHROL, V41, P191; KILGORE LL, 1985, J CLIN INVEST, V76, P225, DOI 10.1172/JCI111951; KITAGAWA T, 1988, PEDIATR NEPHROL, V2, P256, DOI 10.1007/BF00862602; Koselj M, 1997, TRANSPLANT P, V29, P3406, DOI 10.1016/S0041-1345(97)00957-3; LAI KN, 1986, CLIN NEPHROL, V26, P174; LAYWARD L, 1993, NEPHROL DIAL TRANSPL, V8, P25, DOI 10.1093/oxfordjournals.ndt.a092266; LEVY M, 1988, AM J KIDNEY DIS, V12, P340, DOI 10.1016/S0272-6386(88)80021-0; Libetta C, 1997, J AM SOC NEPHROL, V8, P208; Locatelli F, 1999, J NEPHROL, V12, P308; LOMAXSMITH JD, 1983, AM J PATHOL, V113, P359; Maisonneuve P, 2000, AM J KIDNEY DIS, V35, P157, DOI 10.1016/S0272-6386(00)70316-7; MASCHIO G, 1994, NEPHROL DIAL TRANSPL, V9, P265; MEADOW SR, 1985, J PEDIATR-US, V106, P27, DOI 10.1016/S0022-3476(85)80459-5; MESTECKY J, 1986, CLIN IMMUNOL IMMUNOP, V40, P105, DOI 10.1016/0090-1229(86)90073-5; MESTECKY J, 1995, CONTRIB NEPHROL, V111, P66; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; NICHOLLS KM, 1984, Q J MED, V53, P227; NIEMIR ZI, 1995, KIDNEY INT, V48, P1530, DOI 10.1038/ki.1995.443; Nolin L, 1999, KIDNEY INT, V55, pS56, DOI 10.1046/j.1523-1755.1999.07008.x; OCONNELL PJ, 1987, AUST NZ J MED, V17, P27, DOI 10.1111/j.1445-5994.1987.tb05045.x; Olive C, 1997, KIDNEY INT, V52, P1047, DOI 10.1038/ki.1997.427; PETTERSSON EE, 1994, CLIN NEPHROL, V41, P183; Ponticelli C, 2001, KIDNEY INT, V60, P1948, DOI 10.1046/j.1523-1755.2001.00006.x; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Rai A, 1999, J AM SOC NEPHROL, V10, P2637; RAMBAUSEK M, 1987, SEMIN NEPHROL, V7, P370; Rasche FM, 1999, CLIN NEPHROL, V51, P147; REKOLA S, 1989, SCAND J UROL NEPHROL, V23, P37, DOI 10.1080/00365599.1989.11690429; Rena G, 2001, MOL PHARMACOL, V59, P996, DOI 10.1124/mol.59.5.996; ROCCATELLO D, 1993, LAB INVEST, V69, P714; RUEF C, 1990, KIDNEY INT, V38, P249, DOI 10.1038/ki.1990.193; RUSSELL MW, 1986, J CLIN IMMUNOL, V6, P74, DOI 10.1007/BF00915367; Russo D, 2001, AM J KIDNEY DIS, V38, P18, DOI 10.1053/ajkd.2001.25176; Russo D, 1999, AM J KIDNEY DIS, V33, P851, DOI 10.1016/S0272-6386(99)70416-6; Schena FP, 2001, KIDNEY INT, V60, P732, DOI 10.1046/j.1523-1755.2001.060002732.x; SCHENA FP, 1990, AM J MED, V89, P209; SCHMIDT S, 1995, AM J KIDNEY DIS, V26, P727, DOI 10.1016/0272-6386(95)90435-2; SEEDAT YK, 1988, NEPHRON, V50, P137, DOI 10.1159/000185144; Shoji T, 2000, AM J KIDNEY DIS, V35, P194, DOI 10.1016/S0272-6386(00)70326-X; SIMON P, 1994, KIDNEY INT, V46, P1192, DOI 10.1038/ki.1994.384; SMITH SM, 1985, HUM PATHOL, V16, P181, DOI 10.1016/S0046-8177(85)80067-8; Stratta P, 1996, AM J KIDNEY DIS, V27, P631, DOI 10.1016/S0272-6386(96)90096-7; Taniguchi Y, 1999, SCAND J UROL NEPHROL, V33, P243; Taniguchi Y, 1996, NEPHRON, V74, P652, DOI 10.1159/000189470; TIEBOSCH ATMG, 1987, KIDNEY INT, V32, P112, DOI 10.1038/ki.1987.179; TOMANA M, 1988, GASTROENTEROLOGY, V94, P762, DOI 10.1016/0016-5085(88)90252-1; Tomana M, 1997, KIDNEY INT, V52, P509, DOI 10.1038/ki.1997.361; Usui J, 2001, INTERNAL MED, V40, P697, DOI 10.2169/internalmedicine.40.697; VARIS J, 1993, J CLIN PATHOL, V46, P607, DOI 10.1136/jcp.46.7.607; Wyatt RJ, 1998, J AM SOC NEPHROL, V9, P853; YOSHIOKA K, 1993, LAB INVEST, V68, P154	110	611	718	1	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2002	347	10					738	748		10.1056/NEJMra020109	http://dx.doi.org/10.1056/NEJMra020109			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NH	12213946				2022-12-28	WOS:000177765800008
J	Fernandez-Sola, J; Nicolas, JM; Oriola, J; Sacanella, E; Estruch, R; Rubin, E; Urbano-Marquez, A				Fernandez-Sola, J; Nicolas, JM; Oriola, J; Sacanella, E; Estruch, R; Rubin, E; Urbano-Marquez, A			Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy	ANNALS OF INTERNAL MEDICINE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; IDIOPATHIC DILATED CARDIOMYOPATHY; DELETION POLYMORPHISM; ESSENTIAL-HYPERTENSION; MYOCARDIAL-INFARCTION; I/D POLYMORPHISM; BLOOD-PRESSURE; HEART-DISEASE; ACE-GENE; PERFORMANCE	Background: Chronic alcohol abuse has a dose-dependent toxic effect on the myocardium, leading to alcoholic cardiomyopathy. The fact,that only a minority of persons with chronic alcoholism have this condition suggests the possibility of a genetic vulnerability. In this context, polymorphism of the angiotensin-converting enzyme (ACE) gene has been implicated in cardiac dysfunction. Objective: To compare the ACE genotypes of alcoholic persons who have cardiomyopathy with those of comparable alcohol abusers who have normal cardiac function. Design: Case-control study over a 2-year period. Setting: An academic tertiary referral hospital in Barcelona, Spain. Patients: 30 alcoholic men with symptomatic cardiomyopathy and 27 alcoholic men with normal cardiac function. Measurements: Ethanol intake, cardiac status, left ventricular ejection fraction (LVEF), and ACE gene polymorphism. Results: The DD ACE genotype was present in 57% of alcoholic persons with an LVEF less than 0.50 and in 7% of those with normal cardiac function. Compared with persons who had an I allele, the odds ratio for development of left ventricular dysfunction in alcoholic persons with the DD genotype was 16.4. Conclusions: Vulnerability to cardiomyopathy among chronic alcohol abusers is partially genetic and is related to presence of the ACE DD genotype. This finding demonstrates genetic susceptibility to alcohol-induced myocardial damage.	Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Rubin, E (corresponding author), Jefferson Med Coll, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 279, Philadelphia, PA 19107 USA.	emanuel.rubin@mail.tju.edu	SOLA, JOAQUIM FERNANDEZ/K-3991-2019	SOLA, JOAQUIM FERNANDEZ/0000-0002-3218-0582				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Barley J, 1996, J HUM HYPERTENS, V10, P31; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Candy GP, 1999, AM J CARDIOL, V83, P740, DOI 10.1016/S0002-9149(98)00981-3; Cheitlin MD, 1997, CIRCULATION, V95, P1686; Dellgren G, 1999, AM J CARDIOL, V84, P909, DOI 10.1016/S0002-9149(99)00464-6; Dostal DE, 1999, CIRC RES, V85, P643, DOI 10.1161/01.RES.85.7.643; Fernandez-Llama P, 1998, KIDNEY INT, V53, P1743, DOI 10.1046/j.1523-1755.1998.00946.x; FernandezSola J, 1997, ADDICT BIOL, V2, P9, DOI 10.1080/13556219772822; FernandezSola J, 1997, AM J CARDIOL, V80, P481, DOI 10.1016/S0002-9149(97)00399-8; FOY A, 1988, ALCOHOL CLIN EXP RES, V12, P360, DOI 10.1111/j.1530-0277.1988.tb00208.x; Gambaro G, 2000, LANCET, V355, P308, DOI 10.1016/S0140-6736(99)07202-5; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; INNIS MA, 1989, PCR PROTOCOLS GUIDE, P146; Kim HS, 2000, INT J CARDIOL, V72, P151, DOI 10.1016/S0167-5273(99)00184-9; Kohno M, 1999, AM J MED, V106, P544, DOI 10.1016/S0002-9343(99)00067-4; Ledru F, 1998, AM J CARDIOL, V82, P160, DOI 10.1016/S0002-9149(98)00304-X; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; Lopez-Haldon J, 1999, MED CLIN-BARCELONA, V113, P161; Mondorf UF, 1998, AM J HYPERTENS, V11, P174, DOI 10.1016/S0895-7061(97)00402-0; Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374; Morris BJ, 1996, CLIN EXP PHARMACOL P, V23, P1; Nakahara K, 2000, CIRCULATION, V101, P148, DOI 10.1161/01.CIR.101.2.148; NICOLAS JM, 1993, ALCOHOL ALCOHOLISM, V28, P551; Perticone F, 1999, CARDIOVASC RES, V43, P192, DOI 10.1016/S0008-6363(99)00055-3; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; RAYNOLDS MV, 1993, LANCET, V342, P1073, DOI 10.1016/0140-6736(93)92061-W; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; SCHUNKERT H, 1994, NEW ENGL J MED, V330, P1634, DOI 10.1056/NEJM199406093302302; Simko F, 1999, PHYSIOL RES, V48, P1; Staessen J A, 1997, J Cardiovasc Risk, V4, P401, DOI 10.1097/00043798-199710000-00013; URBANOMARQUEZ A, 1995, JAMA-J AM MED ASSOC, V274, P149, DOI 10.1001/jama.274.2.149; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; VRIES JHM, 1999, HLTH ISSUES RELATED, P27; Williams AG, 2000, NATURE, V403, P614, DOI 10.1038/35001141; WOODROW JC, 1994, LANCET, V343, P353, DOI 10.1016/S0140-6736(94)91189-4	36	43	45	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2002	137	5	1				321	326		10.7326/0003-4819-137-5_Part_1-200209030-00007	http://dx.doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591DZ	12204015				2022-12-28	WOS:000177865600003
J	Webster, GF				Webster, GF			Acne vulgaris	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PROPIONIBACTERIUM-ACNES; ERYTHROMYCIN; RESISTANCE		Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol, Philadelphia, PA 19107 USA	Jefferson University	Webster, GF (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol, Philadelphia, PA 19107 USA.	Guy.Webster@mail.tju.edu						CUNLIFFE WJ, 1986, BRIT J DERMATOL, V115, P386, DOI 10.1111/j.1365-2133.1986.tb05757.x; Eady EA, 1998, DERMATOLOGY, V196, P59, DOI 10.1159/000017869; EADY EA, 1994, BRIT J DERMATOL, V131, P331, DOI 10.1111/j.1365-2133.1994.tb08519.x; Jacobs DG, 2001, J AM ACAD DERMATOL, V45, pS168, DOI 10.1067/mjd.2001.118233; JICK SS, 1993, LANCET, V341, P1181, DOI 10.1016/0140-6736(93)91004-6; KLIGMAN AM, 1974, J INVEST DERMATOL, V62, P268, DOI 10.1111/1523-1747.ep12676801; LEVELL MJ, 1989, BRIT J DERMATOL, V120, P649, DOI 10.1111/j.1365-2133.1989.tb01351.x; LEYDEN JJ, 1987, J AM ACAD DERMATOL, V16, P822, DOI 10.1016/S0190-9622(87)70107-8; Leyden JJ, 2001, SEMIN CUTAN MED SURG, V20, P139, DOI 10.1053/sder.2001.28207; LEYDEN JJ, 1983, J AM ACAD DERMATOL, V8, P41, DOI 10.1016/S0190-9622(83)70005-8; McLane J, 2001, J AM ACAD DERMATOL, V45, pS188, DOI 10.1067/mjd.2001.113719; Schlienger RG, 2000, DERMATOLOGY, V200, P223, DOI 10.1159/000018387; Shalita A, 2001, J EUR ACAD DERMATOL, V15, P43, DOI 10.1046/j.0926-9959.2001.00012.x; SYKES NL, 1994, DRUGS, V48, P59, DOI 10.2165/00003495-199448010-00006; Thiboutot D, 2000, ARCH FAM MED, V9, P179, DOI 10.1001/archfami.9.2.179; WEBSTER GF, 1995, J AM ACAD DERMATOL, V33, P247, DOI 10.1016/0190-9622(95)90243-0; Webster GF, 1998, MED CLIN N AM, V82, P1145, DOI 10.1016/S0025-7125(05)70407-7	17	129	155	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2002	325	7362					475	478		10.1136/bmj.325.7362.475	http://dx.doi.org/10.1136/bmj.325.7362.475			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592EZ	12202330	Green Published			2022-12-28	WOS:000177924900022
J	Kumar, S; Vaux, DL				Kumar, S; Vaux, DL			A Cinderella caspase takes center stage	SCIENCE			English	Editorial Material							CELL-DEATH; APOPTOSIS; NEDD2; ENCODES; GENE		Hanson Inst, Adelaide, SA 5000, Australia; Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Hanson Institute; Walter & Eliza Hall Institute	Kumar, S (corresponding author), Hanson Inst, Frome Rd, Adelaide, SA 5000, Australia.	sharad.kumar@imvs.sa.gov.au	Kumar, Sharad/AAX-7787-2020; Vaux, David L/C-7249-2013	Kumar, Sharad/0000-0001-7126-9814; Vaux, David L/0000-0003-2703-1651				Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Finkel E, 2001, SCIENCE, V292, P624, DOI 10.1126/science.292.5517.624; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Harvey NL, 1997, J BIOL CHEM, V272, P13134, DOI 10.1074/jbc.272.20.13134; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; KUMAR S, 1995, FEBS LETT, V368, P69, DOI 10.1016/0014-5793(95)00602-6; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; Paroni G, 2002, J BIOL CHEM, V277, P15147, DOI 10.1074/jbc.M112338200; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Troy CM, 1997, J NEUROSCI, V17, P1911; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593	13	96	108	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1290	1291		10.1126/science.1076118	http://dx.doi.org/10.1126/science.1076118			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193776				2022-12-28	WOS:000177573900031
J	Gavgani, ASM; Hodjati, MH; Mohite, H; Davies, CR				Gavgani, ASM; Hodjati, MH; Mohite, H; Davies, CR			Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial	LANCET			English	Article							CANINE; IMPACT	Background Deltamethrin-impregnated dog collars reduce sandfly bite rates on dogs, and are effective in killing sandflies that attempt to feed. Because domestic dogs are the principal reservoir hosts of zoonotic visceral leishmaniasis, we tested whether community-wide application of dog collars could protect children against infection with Leishmania infantum, the parasite that causes the disease. Methods 18 villages were paired, matched by preintervention child prevalence of L infantum infection. Within pairs, villages were randomly assigned to either control or intervention. All domestic dogs in intervention villages were provided with collars for the transmission season. The main outcome measure was incidence of L infantum infection after 1 year measured by seroconversion. Secondary outcomes were leishmanin skin test (LST) conversion and seroconversion in dogs. Findings The seroconversion rate in children was 1.49% (17/1141) in the intervention villages and 2.41% (26/1078) in control villages (odds ratio 0.57, 95% Cl 0.36-0.90, p = 0.017). LST conversion was also lowered, but not significantly (odds ratio 0.66, 0.41-1.08, p = 0.096). The seroconversion rate in dogs in intervention villages was also significantly reduced (0.46, 0.30-0.70, p = 0.0003). Interpretation Community-wide application of deltamethrin-impregnated dog collars not only protects domestic dogs from L infantum infections, but might also reduce the risk of L infantum infection in children. These dog collars could have a role in control of visceral leishmaniasis and replace controversial dog culling programmes in some countries. However, the effectiveness of dog collars will depend on the importance of wild versus domestic canids as reservoir hosts of L infantum.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Tabriz Univ Med Sci, Tabriz, Iran	University of London; London School of Hygiene & Tropical Medicine; Tabriz University of Medical Science	Davies, CR (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	clive.davies@lshtm.ac.uk						Alimohammadian MH, 1993, MED J ISLAM REPUB IR, V7, P23; Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53; Ashford RW, 1996, CLIN DERMATOL, V14, P523, DOI 10.1016/0738-081X(96)00041-7; COURTENAY O, 1998, THESIS LONDON U; da Silva VO, 2000, VACCINE, V19, P1082, DOI 10.1016/S0264-410X(00)00339-X; Davies CR, 1999, PARASITOLOGY, V119, P247, DOI 10.1017/S0031182099004680; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Dietze R, 1997, CLIN INFECT DIS, V25, P1240, DOI 10.1086/516096; Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125; GAVGANI ASM, 1998, THESIS LONDON U; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; KillickKendrick R, 1997, MED VET ENTOMOL, V11, P105, DOI 10.1111/j.1365-2915.1997.tb00298.x; LACERDA MM, 1994, MEM I OSWALDO CRUZ, V89, P489, DOI 10.1590/S0074-02761994000300036; Maroli M, 2001, MED VET ENTOMOL, V15, P358, DOI 10.1046/j.0269-283x.2001.00321.x; Mohebali M., 1999, Archives of Razi Institute, P87; Nadim A., 1992, Iranian Journal of Public Health, V21, P61; NADIM A, 1978, AM J TROP MED HYG, V27, P25, DOI 10.4269/ajtmh.1978.27.25; Reithinger R, 2001, EMERG INFECT DIS, V7, P872; Slappendel RJ, 1997, VET QUART, V19, P10, DOI 10.1080/01652176.1997.9694729; TESH RB, 1995, AM J TROP MED HYG, V52, P287, DOI 10.4269/ajtmh.1995.52.287; *WHO EXP COMM, 1990, TECHN REP SER WHO EX, V793; XIONG X, 1995, CHIN J PARASITOL PAR, V13, P178; XU ZB, 1989, PARASITOL TODAY, V5, P224	24	140	146	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2002	360	9330					374	379		10.1016/S0140-6736(02)09609-5	http://dx.doi.org/10.1016/S0140-6736(02)09609-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241778				2022-12-28	WOS:000177255600011
J	Jorgensen, CM				Jorgensen, CM			Scientific recommendations and human behaviour: sitting out in the sun	LANCET			English	Editorial Material									Ctr Dis Control & Prevent, Commun & Behav Sci Branch, Div Canc Prevent & Control, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Jorgensen, CM (corresponding author), Ctr Dis Control & Prevent, Commun & Behav Sci Branch, Div Canc Prevent & Control, Atlanta, GA 30333 USA.							AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bandura A, 1995, SELF EFFICACY CHANGI, DOI DOI 10.1017/CBO9780511527692; Geller AC, 2002, PEDIATRICS, V109, P1009, DOI 10.1542/peds.109.6.1009; GLANZ K, 1997, HLTH BEHAV HLTH ED T; HALLI, 2002, PUBLIC HLTH REP, V116, P353; Severi G, 2002, EUR J CANCER, V38, P820, DOI 10.1016/S0959-8049(02)00015-1; Simons-Morton B.G., 1995, INTRO HLTH ED HLTH P	7	6	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					351	352		10.1016/S0140-6736(02)09601-0	http://dx.doi.org/10.1016/S0140-6736(02)09601-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241770				2022-12-28	WOS:000177255600003
J	Hall, IM; Shankaranarayana, GD; Noma, KI; Ayoub, N; Cohen, A; Grewal, SIS				Hall, IM; Shankaranarayana, GD; Noma, KI; Ayoub, N; Cohen, A; Grewal, SIS			Establishment and maintenance of a heterochromatin domain	SCIENCE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME SEGREGATION; HISTONE H3; REPEATS; GENES; RNA; DNA; RECOGNITION; INHERITANCE	The higher-order assembly of chromatin imposes structural organization on the genetic information of eukaryotes and is thought to be largely determined by posttranslational modi cation of histone tails. Here, we study a 20-kilobase silent domain at the mating-type region of fission yeast as a model for heterochromatin formation. We find that, although histone H3 methylated at lysine 9 ( H3 Lys(9)) directly recruits heterochromatin protein Swi6/HP1, the critical determinant for H3 Lys(9) methylation to spread in cis and to be inherited through mitosis and meiosis is Swi6 itself. We demonstrate that a centromere-homologous repeat (cenH) present at the silent mating-type region is sufficient for heterochromatin formation at an ectopic site, and that its repressive capacity is mediated by components of the RNA interference (RNAi) machinery. Moreover, cenH and the RNAi machinery cooperate to nucleate heterochromatin assembly at the endogenous mat locus but are dispensable for its subsequent inheritance. This work defines sequential requirements for the initiation and propagation of regional heterochromatic domains.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91010 Jerusalem, Israel	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Hebrew University of Jerusalem	Grewal, SIS (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059772] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59772] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Ayoub N, 2000, GENETICS, V156, P983; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Birchler JA, 2000, CURR OPIN GENET DEV, V10, P211, DOI 10.1016/S0959-437X(00)00065-4; Cavalli G, 2002, CURR OPIN CELL BIOL, V14, P269, DOI 10.1016/S0955-0674(02)00324-1; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; Cohen DE, 2002, CURR OPIN GENET DEV, V12, P219, DOI 10.1016/S0959-437X(02)00289-7; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; EKWALL K, 1994, GENETICS, V136, P53; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grewal SIS, 1997, GENETICS, V146, P1221; HAHNENBERGER KM, 1991, MOL CELL BIOL, V11, P2206, DOI 10.1128/MCB.11.4.2206; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Henikoff S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P01; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; JACKSON V, 1985, BIOCHEMISTRY-US, V24, P6930, DOI 10.1021/bi00345a027; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; NOMA K, UNPUB; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Reik W, 1998, CURR OPIN GENET DEV, V8, P154, DOI 10.1016/S0959-437X(98)80136-6; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; THON G, 1994, GENETICS, V138, P29; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881	37	649	752	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2002	297	5590					2232	2237		10.1126/science.1076466	http://dx.doi.org/10.1126/science.1076466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597LA	12215653				2022-12-28	WOS:000178222000038
J	Bass, C; Mayou, R				Bass, C; Mayou, R			ABC of psychological medicine - Chest pain	BRITISH MEDICAL JOURNAL			English	Review							CORONARY ANGIOGRAMS; INFARCTION	The improved diagnosis and early treatment of ischaemic heart disease have not been accompanied by similar advances either in the delivery of long term rehabilitation of patients with ischaemic heart disease or in the management of non-cardiac causes of chest pain. Since at least half of those referred to cardiac outpatient clinics and about two thirds of emergency admissions have a non-cardiac cause for their chest pain, there is a pressing need to address this problem.	John Radcliffe Hosp, Dept Psychol Med, Oxford, England; Univ Oxford, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Bass, C (corresponding author), John Radcliffe Hosp, Dept Psychol Med, Oxford, England.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CANNON RO, 1994, NEW ENGL J MED, V330, P1411, DOI 10.1056/NEJM199405193302003; Cooke RA, 1997, HEART, V78, P142, DOI 10.1136/hrt.78.2.142; Creed F, 1999, HEART, V82, P406, DOI 10.1136/hrt.82.4.406; Jain D, 1997, J ROY COLL PHYS LOND, V31, P401; MAYOU R, 1994, BRIT HEART J, V72, P548; MAYOU R, 1997, PSYCHOL MED, V27, P1; Mayou RA, 2000, QJM-INT J MED, V93, P805, DOI 10.1093/qjmed/93.12.805; Thompson DR, 2000, HEART, V84, P101, DOI 10.1136/heart.84.1.101	8	43	44	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2002	325	7364					588	591		10.1136/bmj.325.7364.588	http://dx.doi.org/10.1136/bmj.325.7364.588			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	595JJ	12228139	Green Published			2022-12-28	WOS:000178105200026
J	Scanlon, PD				Scanlon, PD			World Trade Center cough - A lingering legacy and a cautionary tale	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Scanlon, PD (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Harber P, 1996, AM J RESP CRIT CARE, V154, P1153, DOI 10.1164/ajrccm.154.4.8887621; KINSELLA J, 1991, LANCET, V337, P595, DOI 10.1016/0140-6736(91)91650-J; Martyny J, 2002, NEW ENGL J MED, V347, P824, DOI 10.1056/NEJMra012670; *NAT I OCC SAF HLT, 2002, SUGG GUID SUP DIS RE; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; 2001, MMWR MORB MORTAL WKL, V51, P453	7	17	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					840	842		10.1056/NEJMe020100	http://dx.doi.org/10.1056/NEJMe020100			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226157				2022-12-28	WOS:000177921300011
J	Yang, YF; Herbert, L; Ruschen, H; Cooling, RJ				Yang, YF; Herbert, L; Ruschen, H; Cooling, RJ			Lesson of the week - Nitrous oxide anaesthesia in the presence of intraocular gas can cause irreversible blindness	BRITISH MEDICAL JOURNAL			English	Review									Moorfields Eye Hosp, Vitreoretinal Dept, London EC1V 2PD, England; Moorfields Eye Hosp, Dept Anaesthet, London, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Yang, YF (corresponding author), Moorfields Eye Hosp, Vitreoretinal Dept, City Rd, London EC1V 2PD, England.							DIECKERT JP, 1986, OPHTHALMOLOGY, V93, P642; FULLER D, 1975, AM J OPHTHALMOL, V80, P778, DOI 10.1016/0002-9394(75)90415-8; HAIMANN MH, 1982, ARCH OPHTHALMOL-CHIC, V100, P289; HAYREH SS, 1980, BRIT J OPHTHALMOL, V64, P818, DOI 10.1136/bjo.64.11.818; Kilmartin DJ, 2000, BRIT J OPHTHALMOL, V84, P448, DOI 10.1136/bjo.84.5.448; SMITH RB, 1974, AM J OPHTHALMOL, V78, P314, DOI 10.1016/0002-9394(74)90094-4; STINSON TW, 1982, ANESTHESIOLOGY, V56, P385, DOI 10.1097/00000542-198205000-00011; VYGANTAS CM, 1973, ARCH OPHTHALMOL-CHIC, V90, P235; WOLF GL, 1983, ANESTHESIOLOGY, V59, P547, DOI 10.1097/00000542-198312000-00011	9	15	16	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2002	325	7363					532	533		10.1136/bmj.325.7363.532	http://dx.doi.org/10.1136/bmj.325.7363.532			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593NJ	12217995	Green Published			2022-12-28	WOS:000177997800021
J	Yamagata, M; Weiner, JA; Sanes, JR				Yamagata, M; Weiner, JA; Sanes, JR			Sidekicks: Synaptic adhesion molecules that promote lamina-specific connectivity in the retina	CELL			English	Article							GANGLION-CELLS; IMMUNOGLOBULIN SUPERFAMILY; AMACRINE CELLS; EXPRESSION; RECEPTORS; ORGANIZATION; SEGREGATION; PARALLEL; CADHERIN; BINDING	A major determinant of specific connectivity in the central nervous system is that synapses made by distinct afferent populations are restricted to particular laminae in their target area. We identify Sidekick (Sdk)-1 and -2, homologous transmembrane immunoglobulin superfamily molecules that mediate homophilic adhesion in vitro and direct laminar targeting of neurites in vivo. sdk-1 and -2 are expressed by non-overlapping subsets of retinal neurons; each sdk is expressed by presynaptic (amacrine and bipolar) and postsynaptic (ganglion) cells that project to common inner plexiform (synaptic) sublaminae. Sdk proteins are concentrated at synaptic sites, and Sdk-positive synapses are restricted to the 2 (of 10) sublaminae to which sdk-expressing cells project. Ectopic expression of Sdk in Sdk-negative cells redirects their processes to a Sdk-positive sublamina. These results implicate Sdks as determinants of lamina-specific synaptic connectivity.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	sanesj@pcg.wustl.edu	Weiner, Joshua/AAA-6532-2021; Yamagata, Masahito/H-6695-2016	Yamagata, Masahito/0000-0001-8193-2931; Weiner, Joshua/0000-0002-3352-2847				Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Bisti S, 1998, J NEUROSCI, V18, P5019; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; Cajal SR., 1893, CELLULE, V9, P119; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; ELLIS JH, 1991, CELL TISSUE RES, V264, P197, DOI 10.1007/BF00313956; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; FRENCH PW, 1986, J NEUROSCI RES, V16, P479, DOI 10.1002/jnr.490160304; Gunhan-Agar E, 2000, J NEUROSCI, V20, P306, DOI 10.1523/JNEUROSCI.20-01-00306.2000; Holt CE, 1998, CURR OPIN NEUROBIOL, V8, P98, DOI 10.1016/S0959-4388(98)80013-5; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kamiguchi H, 2000, CURR OPIN CELL BIOL, V12, P598, DOI 10.1016/S0955-0674(00)00138-1; Kaprielian Z, 2000, ANAT REC, V261, P176; KARTEN HJ, 1982, CYTOCHEMICAL METHODS, P189; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Layer PG, 1997, CELL TISSUE RES, V288, P407, DOI 10.1007/s004410050827; Lohmann C, 2001, J NEUROBIOL, V48, P150, DOI 10.1002/neu.1048; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MILLAR TJ, 1987, NEUROSCIENCE, V21, P725, DOI 10.1016/0306-4522(87)90033-9; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Nguyen DNT, 1997, DEVELOPMENT, V124, P3303; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCOTT LJC, 1988, J NEUROSCI, V8, P932; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; SHEPPARD AM, 1991, NEUROSCI LETT, V123, P87, DOI 10.1016/0304-3940(91)90164-O; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Williams RR, 2001, VISUAL NEUROSCI, V18, P233, DOI 10.1017/S0952523801182088; Wohrn JCP, 1998, J COMP NEUROL, V396, P20; YAMAGATA M, 1995, DEVELOPMENT, V121, P189; YAMAGATA M, 1995, DEVELOPMENT, V121, P3763; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	40	266	271	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2002	110	5					649	660		10.1016/S0092-8674(02)00910-8	http://dx.doi.org/10.1016/S0092-8674(02)00910-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230981	Bronze			2022-12-28	WOS:000177943700011
J	Pelham, RJ; Chang, F				Pelham, RJ; Chang, F			Actin dynamics in the contractile ring during cytokinesis in fission yeast	NATURE			English	Article							ARP2/3 COMPLEX; SCHIZOSACCHAROMYCES-POMBE; CLEAVAGE FURROW; CELL-DIVISION; BUDDING YEAST; GENE ENCODES; PROTEIN; CYTOSKELETON; PROFILIN; POLYMERIZATION	Cytokinesis in many eukaryotes requires a contractile ring of actin and myosin that cleaves the cell in two. Little is known about how actin filaments and other components assemble into this ring structure and generate force(1,2). Here we show that the contractile ring in the fission yeast Schizosaccharomyces pombe is an active site of actin assembly. This actin polymerization activity requires Arp3, the formin Cdc12, profilin and WASP, but not myosin II or IQGAP proteins. Both newly polymerized actin filaments and pre-existing actin cables can contribute to the initial assembly of the ring. Once formed, the ring remains a dynamic structure in which actin and other ring components continuously assemble and disassemble from the ring every minute. The rate of actin polymerization can influence the rate of cleavage. Thus, actin polymerization driven by the Arp2/3 complex and formins is a central process in cytokinesis. Our studies show that cytokinesis is a more dynamic process than previously thought and provide a perspective on the mechanism of cell division.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Columbia University	Chang, F (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.				NIGMS NIH HHS [R01 GM056836] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arai R, 2002, J CELL SCI, V115, P887; Arai R, 1998, EUR J CELL BIOL, V76, P288, DOI 10.1016/S0171-9335(98)80007-1; Balasubramanian MK, 1997, METHOD ENZYMOL, V283, P494; BALASUBRAMANIAN MK, 1994, J CELL BIOL, V125, P1289, DOI 10.1083/jcb.125.6.1289; Balasubramanian MK, 1998, GENETICS, V149, P1265; CAO LG, 1990, J CELL BIOL, V110, P1089, DOI 10.1083/jcb.110.4.1089; Chang F, 1996, J CELL SCI, V109, P131; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Feierbach B, 2001, CURR OPIN MICROBIOL, V4, P713, DOI 10.1016/S1369-5274(01)00273-9; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Fukui Y, 1999, J CELL SCI, V112, P877; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; LI R, 1995, J CELL BIOL, V128, P599, DOI 10.1083/jcb.128.4.599; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; MCCOLLUM D, 1995, J CELL BIOL, V130, P651, DOI 10.1083/jcb.130.3.651; McCollum D, 1996, EMBO J, V15, P6438, DOI 10.1002/j.1460-2075.1996.tb01035.x; Morrell JL, 1999, MOL BIOL CELL, V10, P4201, DOI 10.1091/mbc.10.12.4201; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Noguchi T, 2001, J CELL SCI, V114, P401; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; RAPPAPORT R, 1996, CYTOKINESIS ANIMAL C, P168; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Sawin KE, 2002, CURR BIOL, V12, pR6, DOI 10.1016/S0960-9822(01)00637-6; Theriot JA, 2000, TRAFFIC, V1, P19, DOI 10.1034/j.1600-0854.2000.010104.x; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288	30	257	258	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					82	86		10.1038/nature00999	http://dx.doi.org/10.1038/nature00999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214236				2022-12-28	WOS:000177788600041
J	Barzansky, B; Etzel, SI				Barzansky, B; Etzel, SI			Educational programs in US medical schools, 2001-2002	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								We used data mainly from the 2001-2002 Liaison Committee on Medical Education Annual Medical School Questionnaire, which had a 100% response rate, to describe the status of US medical education programs. In 2001 2002, the number of full-time medical school faculty members was 104 949, a 2.4% increase from 1999-2000. The 34 859 applicants for the class entering in 2001 represented a 9.5% decrease from the number of applicants in 1999-2000. There were 2 applicants for every acceptance, and the academic qualifications of medical students entering in 2001 were unchanged from 1999. Women comprised 47.8% of entering students in 2001, and 13.1% were members of underrepresented minority groups. Of all first-year students, 67% were in-state residents. Most medical schools had mandatory required night call during at least some required clinical clerkships, but only 17 had formal policies on medical student work hours. In 74 schools (60%), medical students were required to pass Steps 1 and 2 of the United States Medical Licensing Examination to advance or graduate.	Amer Med Assoc, Div Undergrad & Grad Med Educ Policy & Stand, Chicago, IL 60610 USA	American Medical Association	Barzansky, B (corresponding author), Amer Med Assoc, Div Undergrad & Grad Med Educ Policy & Stand, 515 N State St, Chicago, IL 60610 USA.							*AAMC, 2002, AAMC DAT; *AAMC, 2001, AAMC DAT WAR APPL MA; *AAMC, 1995, AAMC DAT; CROWLEY AE, 1982, JAMA-J AM MED ASSOC, V248, P3245; Hall FR, 2001, ACAD MED, V76, P829, DOI 10.1097/00001888-200108000-00017; HOFER H, 1957, ECOLOGY MED STUDENT; JONAS HS, 1992, JAMA-J AM MED ASSOC, V268, P1083, DOI 10.1001/jama.268.9.1083; Jones RF, 2001, ACAD MED, V76, P993, DOI 10.1097/00001888-200110000-00006; LARSON TA, 1976, J MED EDUC, V51, P69; WHITING BE, 1990, ACAD MED, V65, P277, DOI 10.1097/00001888-199004000-00013; 1972, JAMA, V222, P978	11	41	42	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1067	1072		10.1001/jama.288.9.1067	http://dx.doi.org/10.1001/jama.288.9.1067			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NA	12204073				2022-12-28	WOS:000177764600007
J	Falk, SJ; Girling, DJ; White, RJ; Hopwood, P; Harvey, A; Qian, WD; Stephens, RJ				Falk, SJ; Girling, DJ; White, RJ; Hopwood, P; Harvey, A; Qian, WD; Stephens, RJ		Med Res Council Lung Canc Working	Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA	Objective To determine whether patients with locally advanced non-small cell lung cancer unsuitable for resection or radical radiotherapy, and with minimal thoracic symptoms, should be given palliative thoracic radiotherapy immediately or as needed to treat symptoms. Design Multicentre randomised controlled trial. Setting 23 centres in the United Kingdom, Ireland, and South Africa. Participants 230 patients with previously untreated, non-small cell lung cancer that is locally too advanced for resection or radical radiotherapy with curative intent, with minimal thoracic symptoms, and with no indication for immediate thoracic radiotherapy. Interventions All patients were given supportive treatment and were randomised to receive palliative thoracic radiotherapy either immediately or delayed until needed to treat symptoms. The recommended regimens were 17 Gy in two fractions one week apart or 10 Gy as a single dose. Main outcome measures Primary-patients alive and without moderate or severe cough, chest pain, haemoptysis, or dyspnoea six months from randomisation, as recorded by clinicians. Secondary-quality of life, adverse events, survival. Results From December 1992 to May 1999,230 patients were randomised. 104/115 of the patients in the immediate treatment group received thoracic radiotherapy (90 received one of the recommended regimens). In the delayed treatment group, 48/115 (42%) patients received thoracic radiotherapy (29 received one of the recommended regimens); 64 (56%) died without receiving thoracic radiotherapy; the remaining three (3%) were alive at the end of the study without having received the treatment. For patients who received thoracic radiotherapy, the median time to start was 15 days in the immediate treatment group and 125 days in the delayed treatment group. The primary outcome measure was achieved in 28% of the immediate treatment group and 26% of patients from the delayed treatment group (27/97 and 27/103, respectively; absolute difference 1.6%,95% confidence interval -10.7% to 13.9%). No evidence of a difference was observed between the two treatment groups in terms of activity level, anxiety, depression, and psychological distress, as recorded by the patients. Adverse events were more common in the immediate treatment group. Neither group had a survival advantage (hazard ratio 0.95, 0.73 to 1.24; P=0.71). Median survival was 8.3 months and 7.9 months, and the survival rates were 31% and 29% at 12 months, for the immediate and delayed treatment groups, respectively. Conclusion In minimally symptomatic patients with locally advanced non-small cell lung cancer, no persuasive evidence was found to indicate that giving immediate palliative thoracic radiotherapy improves symptom control, quality of life, or survival when compared with delaying until symptoms require treatment.	Bristol Oncol Ctr, Dept Oncol, Bristol BS2 8ED, Avon, England; MRC, Clin Trials Unit, Canc Div, London NW1 2DA, England; Frenchay Hosp, Dept Gen Med, Bristol BS16 1LE, Avon, England; Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England	Bristol Haematology & Oncology Centre; Medical Research Council Clinical Trials Unit; Christie NHS Foundation Trust; Christie Hospital	Stephens, RJ (corresponding author), Bristol Oncol Ctr, Dept Oncol, Bristol BS2 8ED, Avon, England.							ALBERTI W, 1995, BRIT MED J, V311, P899; BLEEHEN NM, 1992, BRIT J CANCER, V65, P934, DOI 10.1038/bjc.1992.196; BLISS JM, 1991, BRIT J CANCER, V63, P412; BRASHEAR RE, 1978, AM REV RESPIR DIS, V117, P411; CARROLL M, 1986, EUR J CANCER CLIN ON, V22, P1353, DOI 10.1016/0277-5379(86)90144-6; COHEN MH, 1983, CANCER TREAT REP, V67, P333; COX JD, 1983, CANCER TREAT REP, V67, P327; Cullen MH, 1999, J CLIN ONCOL, V17, P3188, DOI 10.1200/JCO.1999.17.10.3188; De Haes J, 1996, ROTTERDAM SYMPTOM CH; DEHAES JCJM, 1990, BRIT J CANCER, V62, P1034, DOI 10.1038/bjc.1990.434; DURRANT KR, 1971, LANCET, V1, P715; GIRLING DJ, 1991, BRIT J CANCER, V63, P265; Medical Research Council Lung Cancer Working Party, 1996, CLIN ONCOL, V8, P167; Organization W.H, 1979, WHO HDB REP RES CANC; PHILLIPS TL, 1978, AM REV RESPIR DIS, V117, P405; ROSWIT B, 1968, RADIOLOGY, V90, P688, DOI 10.1148/90.4.688; Saunders M, 1997, LANCET, V350, P161, DOI 10.1016/S0140-6736(97)06305-8; Timothy AR, 2001, CLIN ONCOL-UK, V13, P86, DOI 10.1053/clon.2001.9224; VANZANDWIJK N, 1985, P 4 WORLD C LUNG CAN, V21, pA355; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	20	55	57	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2002	325	7362					465	468		10.1136/bmj.325.7362.465	http://dx.doi.org/10.1136/bmj.325.7362.465			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592EZ	12202326	Green Published			2022-12-28	WOS:000177924900018
J	Johnson, AH; Peacock, JL; Greenough, A; Marlow, N; Limb, ES; Marston, L; Calvert, SA				Johnson, AH; Peacock, JL; Greenough, A; Marlow, N; Limb, ES; Marston, L; Calvert, SA		United Kingdom Oscillation Study G	High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; HYALINE-MEMBRANE DISEASE; PRETERM INFANTS; CONVENTIONAL VENTILATION; TRIAL; PRESSURE; INJURY; VOLUME	Background There remains uncertainty concerning the safety and efficacy of high-frequency oscillatory ventilation as compared with those of conventional ventilation for the respiratory support of very preterm infants. We conducted a multicenter trial to determine whether early intervention with high-frequency oscillatory ventilation reduced mortality and the incidence of chronic lung disease among newborns with a gestational age of 28 weeks or less. Methods We randomly assigned preterm infants with a gestational age of :23 to 28 weeks to either conventional ventilation or high-frequency oscillatory ventilation within one hour after birth. Randomization was stratified according to center and gestational age (23 to 25 weeks or 26 to 28 weeks). Results A total of 400 infants were assigned to high-frequency oscillatory ventilation, and 397 were assigned to conventional ventilation. The composite primary outcome (death or chronic lung disease, diagnosed at 36 weeks of postmenstrual age) occurred in 66 percent of the infants assigned to receive high-frequency oscillatory ventilation and 68 percent of those in the conventional-ventilation group (relative risk in the group assigned to high-frequency oscillatory ventilation, 0.98; 95 percent confidence interval, 0.89 to 1.08). Similar proportions of infants died or had chronic lung disease in each gestational-age group. In both treatment groups treatment failure occurred in 10 percent of infants (relative risk in the group assigned to high-frequency oscillatory ventilation, 0.99; 95 percent confidence interval, 0.66 to 1.50). There were no significant differences between the groups in a range of other secondary outcome measures, including serious brain injury and air leak. Conclusions The results obtained with high-frequency oscillatory ventilation and conventional ventilation do not differ significantly in the early treatment of respiratory disease in Very preterm infants. Assessment of long-term effects will require additional follow-up.	Univ London St Georges Hosp, Dept Child Hlth, Sch Med, London SW17 0QT, England; Univ London St Georges Hosp, Dept Publ Hlth Sci, Sch Med, London SW17 0QT, England; Kings Coll Hosp London, Dept Child Hlth, Sch Med, London, England; Univ Nottingham, Acad Div Child Hlth, Sch Human Dev, Nottingham NG7 2RD, England	St Georges University London; St Georges University London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Nottingham	Calvert, SA (corresponding author), Univ London St Georges Hosp, Dept Child Hlth, Sch Med, 3rd Fl,Lanesborough Wing, London SW17 0QT, England.	scalvert@sghms.ac.uk	Marlow, Neil/D-2918-2009; Marston, Louise/A-8535-2012	Marlow, Neil/0000-0001-5890-2953; Marston, Louise/0000-0002-9973-1131; Greenough, Anne/0000-0002-8672-5349; Peacock, Janet/0000-0002-0310-2518				BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BRYAN AC, 1991, PEDIATRICS, V87, P565; CLARK RH, 1992, PEDIATRICS, V89, P5; Courtney Sherry E., 2001, Pediatric Research, V49, p387A; DELEMOS RA, 1987, PEDIATR RES, V21, P594, DOI 10.1203/00006450-198706000-00018; Gerstmann DR, 1996, PEDIATRICS, V98, P1044; HAMILTON PP, 1983, J APPL PHYSIOL, V55, P131, DOI 10.1152/jappl.1983.55.1.131; Hatcher D, 1998, CRIT CARE MED, V26, P1081, DOI 10.1097/00003246-199806000-00032; HENDERSONSMART DJ, 2001, COCHRANE LIB; HIFI Study Group, 1989, N Engl J Med, V320, P88; Laubscher B, 1996, BR J INTENS CARE, V6, P148; Marlow N, 1998, ARCH DIS CHILD-FETAL, V78, pF1, DOI 10.1136/fn.78.1.F1; MCCULLOCH PR, 1988, AM REV RESPIR DIS, V137, P1185, DOI 10.1164/ajrccm/137.5.1185; MEREDITH KS, 1989, J APPL PHYSIOL, V66, P2150, DOI 10.1152/jappl.1989.66.5.2150; Moriette G, 2001, PEDIATRICS, V107, P363, DOI 10.1542/peds.107.2.363; OGAWA Y, 1993, EARLY HUM DEV, V32, P1, DOI 10.1016/0378-3782(93)90088-C; Plavka R, 1999, INTENS CARE MED, V25, P68, DOI 10.1007/s001340050789; Rettwitz-Volk W, 1998, J PEDIATR-US, V132, P249, DOI 10.1016/S0022-3476(98)70440-8; *STAT, 2001, STAT VERS 7 0; Thome U, 1999, J PEDIATR-US, V135, P39, DOI 10.1016/S0022-3476(99)70325-2; Thome U, 1998, AM J RESP CRIT CARE, V157, P1213, DOI 10.1164/ajrccm.157.4.9706030	21	216	237	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2002	347	9					633	642		10.1056/NEJMoa020432	http://dx.doi.org/10.1056/NEJMoa020432			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZT	12200550				2022-12-28	WOS:000177675500002
J	Moore, R; Mallonee, S; Garwe, T; Sabogal, RI; Zanardi, L; Redd, J; Malone, J				Moore, R; Mallonee, S; Garwe, T; Sabogal, RI; Zanardi, L; Redd, J; Malone, J		CDC	Heat-related deaths - Four states, July-August 2001, and United States, 1979-1999 (Reprinted from MMWR, vol 51, pg 567-570, 2002)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							ILLNESS		Texas Dept Hlth, Bur Vital Stat, Stat Serv Div, Austin, TX 78756 USA; Missouri Dept Hlth & Senior Serv, Jefferson City, MO 65102 USA; Oklahoma Dept Hlth, Oklahoma City, OK 73117 USA; CDC, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA	Texas Department of State Health Services; Centers for Disease Control & Prevention - USA	Moore, R (corresponding author), Texas Dept Hlth, Bur Vital Stat, Stat Serv Div, Austin, TX 78756 USA.							*CDC, 2001, MMWR-MORBID MORTAL W, V50, P623; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P567; Kaiser R, 2001, AM J FOREN MED PATH, V22, P303, DOI 10.1097/00000433-200109000-00022; Kilbourne E. M., 1997, PUBLIC HLTH CONSEQUE, P245; KNOCHEL JP, 1974, ARCH INTERN MED, V133, P841, DOI 10.1001/archinte.133.5.841; McGeehin MA, 2001, ENVIRON HEALTH PERSP, V109, P185, DOI 10.2307/3435008; *NAT CTR HLTH STAT, 2002, COMPR MORT FIL; *NAT OC ATM ASS, 2001, SIZZL JUL TEMP BAK S; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; VASSALLO SU, 1998, GOLDFRANKS TOXICOLOG, P295	10	7	8	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					950	951						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12201273				2022-12-28	WOS:000177656400006
J	Wolfe, RM; Sharp, LK				Wolfe, RM; Sharp, LK			Anti-vaccinationists past and present	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMMUNIZATION; SMALLPOX	The British Vaccination Act of 1840 was the first incursion of the state, in the name of public health, into traditional civil liberties. The activities of today's propagandists against immunisations are directly descended from, indeed little changed from, those of the anti-vaccinationists of the late nineteenth century, say Robert Wolfe and Lisa Sharp.	Northwestern Univ, Feinberg Med Sch, Dept Family Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Wolfe, RM (corresponding author), Northwestern Univ, Feinberg Med Sch, Dept Family Med, Morton Bldg 1-658,303 E Chicago Ave, Chicago, IL 60611 USA.	r-wolfe@northwestern.edu		Wolfe, Robert/0000-0003-1005-7660; Sharp, Lisa/0000-0002-7809-9042				Barquet N, 1997, ANN INTERN MED, V127, P635, DOI 10.7326/0003-4819-127-8_Part_1-199710150-00010; HORTON R, 1995, BRIT MED J, V310, P62, DOI 10.1136/bmj.310.6971.62a; HUMEROTHERY W, 1878, NATL ANTICOMPULSATOR, V3, P1; Kaufman M, 1967, Bull Hist Med, V41, P463; Leask JA, 1998, AUST NZ J PUBL HEAL, V22, P17, DOI 10.1111/j.1467-842X.1998.tb01140.x; NELSON MC, 1992, SOC HIST MED, V5, P369, DOI 10.1093/shm/5.3.369; PORTER D, 1988, MED HIST, V32, P231, DOI 10.1017/S0025727300048225; ROGERS A, 1995, HEALTH CARE ANAL, V3, P99, DOI 10.1007/BF02198210; Scarpelli G, 1992, Nuncius, V7, P109; SWALES JD, 1992, LANCET, V340, P1019, DOI 10.1016/0140-6736(92)93021-E; WILLIAMSON S, 1984, ARCH DIS CHILD, V59, P1195, DOI 10.1136/adc.59.12.1195; WOLFE RM, 2000, PARK RIDGE CTR B JUL, P9	12	224	234	0	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2002	325	7361					430	432		10.1136/bmj.325.7361.430	http://dx.doi.org/10.1136/bmj.325.7361.430			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588RY	12193361	Green Published			2022-12-28	WOS:000177715500023
J	Abrams, JM				Abrams, JM			Competition and compensation: Coupled to death in development and cancer	CELL			English	Review							CELL-PROLIFERATION; DROSOPHILA; APOPTOSIS; GROWTH	Developing systems exhibit robust and tolerant properties in the form of compensation and competition within cell groups. Fundamentally, these behaviors are governed by mechanisms that elicit proliferation and apoptosis. Recent insights from the Drosophila system implicate new determinants that specify "winners" and "losers" in this process.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Abrams, JM (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	john.abrams@utsouthwestern.edu						Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Burke R, 1996, DEVELOPMENT, V122, P2261; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Martin SJ, 2002, CELL, V109, P793, DOI 10.1016/S0092-8674(02)00802-4; Milan M, 2002, DEV CELL, V2, P797, DOI 10.1016/S1534-5807(02)00169-7; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; O'Connor L, 2000, CURR OPIN CELL BIOL, V12, P257, DOI 10.1016/S0955-0674(99)00084-8; Peterson C, 2002, DEVELOPMENT, V129, P1467; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3	19	56	61	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					403	406		10.1016/S0092-8674(02)00904-2	http://dx.doi.org/10.1016/S0092-8674(02)00904-2			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202030	Bronze			2022-12-28	WOS:000177653200002
J	Conway, GA				Conway, GA			Casting their lot upon the water: commercial fishing safety	LANCET			English	Editorial Material									NIOSH, CDC, Anchorage, AK 99508 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Conway, GA (corresponding author), NIOSH, CDC, Anchorage, AK 99508 USA.							Abraham P., 2001, BARENTS NEWSLETT OCC, V4, P24; *BAT MEM I, 1998, OV SCI LIT FAT SLEEP; *FAO, 2000, STAT WORLD FISH FAC; *FAO, 1970, NUMB FISH DOUBL 1970; *INT LAB ORG, 1999, REP SAF HLTH FISH IN; Keatinge W.R., 1969, SURVIVAL COLD WATER; Lincoln JM, 1999, OCCUP ENVIRON MED, V56, P691, DOI 10.1136/oem.56.10.691; *MAR ACC INV BOARD, 2002, SAF DIG, V1, P4; Perkins R, 1995, PUBLIC HEALTH REP, V110, P701; RAFNSSON V, 1994, INT J EPIDEMIOL, V23, P730, DOI 10.1093/ije/23.4.730; Thomas TK, 2001, AM J IND MED, V40, P693, DOI 10.1002/ajim.10010; TURNER J, 2000, P INT FISH IND SAF H; *US NAT RES COUNC, 1991, SAF SURV FISH VESS S; 2001, CHENNAI INDIA   1012	14	10	10	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					503	504		10.1016/S0140-6736(02)09760-X	http://dx.doi.org/10.1016/S0140-6736(02)09760-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241651				2022-12-28	WOS:000177512800005
J	Geddes, DM				Geddes, DM			Respect	LANCET			English	Editorial Material									Royal Brompton Hosp, London SW3 6NP, England	Royal Brompton Hospital	Geddes, DM (corresponding author), Royal Brompton Hosp, London SW3 6NP, England.								0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					448	448		10.1016/S0140-6736(02)09675-7	http://dx.doi.org/10.1016/S0140-6736(02)09675-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241717				2022-12-28	WOS:000177342900011
J	Schmidt, B; Wright, LL; Davis, P; Solimano, A; Roberts, RS				Schmidt, B; Wright, LL; Davis, P; Solimano, A; Roberts, RS		Trial Indomethacin Prophylaxis Pre	Ibuprofen prophylaxis in preterm neonates	LANCET			English	Letter							PERSISTENT PULMONARY-HYPERTENSION; INDOMETHACIN; NEWBORN		McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8N 3Z5, Canada; NICHHD, Neonatl Res Network, Bethesda, MD 20892 USA; Royal Womens Hosp, Melbourne, Vic, Australia; Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada	McMaster University; McMaster University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of British Columbia	Schmidt, B (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.							Alano MA, 2001, PEDIATRICS, V107, P519, DOI 10.1542/peds.107.3.519; Gournay V, 2002, LANCET, V359, P1486, DOI 10.1016/S0140-6736(02)08424-6; Schmidt B, 2001, NEW ENGL J MED, V344, P1966, DOI 10.1056/NEJM200106283442602; TURNER GR, 1984, CLIN PERINATOL, V11, P581, DOI 10.1016/S0095-5108(18)30903-5; Van Overmeire B, 2000, NEW ENGL J MED, V343, P674, DOI 10.1056/NEJM200009073431001	5	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					492	492		10.1016/S0140-6736(02)09658-7	http://dx.doi.org/10.1016/S0140-6736(02)09658-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241754				2022-12-28	WOS:000177342900047
J	Wolfson, C; Talbot, P				Wolfson, C; Talbot, P			Bacterial infection as a cause of multiple sclerosis	LANCET			English	Editorial Material							BORRELIA-BURGDORFERI ANTIBODIES		McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Lady Davis Inst Med Res, Ctr Clin Epidemiol & Community Studies, Montreal, PQ, Canada; Univ Quebec, Inst Armand Frappier, Inst Natl Rech Sci, Laval, PQ, Canada	McGill University; Lady Davis Institute; McGill University; University of Quebec; Institut national de la recherche scientifique (INRS)	Wolfson, C (corresponding author), McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada.							Alvarez-Lafuente R, 2002, ARCH NEUROL-CHICAGO, V59, P929, DOI 10.1001/archneur.59.6.929; Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Brorson O, 2001, INFECTION, V29, P315, DOI 10.1007/s15010-001-9144-y; Chmielewska-Badora J, 2000, ANN AGR ENV MED, V7, P141; COYLE PK, 1989, NEUROLOGY, V39, P760, DOI 10.1212/WNL.39.6.760; Granieri E, 2001, NEUROL SCI, V22, P179, DOI 10.1007/s100720170021; Hernan MA, 2001, EPIDEMIOLOGY, V12, P301, DOI 10.1097/00001648-200105000-00009; Karussis D, 1999, MULT SCLER J, V5, P395, DOI 10.1191/135245899678846429; Marrie Ruth Ann, 2002, Can J Infect Dis, V13, P111; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; SCHMUTZHARD E, 1988, J NEUROL NEUROSUR PS, V51, P1215, DOI 10.1136/jnnp.51.9.1215; Talbot PJ, 2001, CURR TOP MICROBIOL, V253, P247; Wolfson C, 1997, NEUROLOGY, V49, pS5, DOI 10.1212/WNL.49.2_Suppl_2.S5; Wolfson C, 2001, EPIDEMIOLOGY, V12, P298, DOI 10.1097/00001648-200105000-00007	14	19	19	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					352	353		10.1016/S0140-6736(02)09603-4	http://dx.doi.org/10.1016/S0140-6736(02)09603-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241771				2022-12-28	WOS:000177255600004
J	Wagers, AJ; Sherwood, RI; Christensen, JL; Weissman, IL				Wagers, AJ; Sherwood, RI; Christensen, JL; Weissman, IL			Little evidence for developmental plasticity of adult hematopoietic stem cells	SCIENCE			English	Article							BONE-MARROW CELLS; MONOCLONAL-ANTIBODIES; IN-VIVO; MICE; ANTIGENS; MUSCLE; DIFFERENTIATE; REGENERATION; PROGENITORS; HEPATOCYTES	To rigorously test the in vivo cell fate specificity of bone marrow ( BM) hematopoietic stem cells (HSCs), we generated chimeric animals by transplantation of a single green fluorescent protein (GFP)-marked HSC into lethally irradiated nontransgenic recipients. Single HSCs robustly reconstituted peripheral blood leukocytes in these animals, but did not contribute appreciably to nonhematopoietic tissues, including brain, kidney, gut, liver, and muscle. Similarly, in GFP(+):GFP(-) parabiotic mice, we found substantial chimerism of hematopoietic but not nonhematopoietic cells. These data indicate that "transdifferentiation" of circulating HSCs and/or their progeny is an extremely rare event, if it occurs at all.	Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Wagers, AJ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.				NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NCI NIH HHS [CA-86065] Funding Source: Medline; NIAID NIH HHS [5T32AI07290-16] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FLEMING WH, 1993, P NATL ACAD SCI USA, V90, P3760, DOI 10.1073/pnas.90.8.3760; GERLYNG P, 1993, CELL PROLIFERAT, V26, P557, DOI 10.1111/j.1365-2184.1993.tb00033.x; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HAGEMANN RF, 1971, RADIAT RES, V46, P533, DOI 10.2307/3573432; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; JOHNSON P, 1997, WEIRS HDB EXPT IMMUN, V2, P1; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; QUASTLER H, 1956, RADIAT RES, V4, P303, DOI 10.2307/3570211; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Shimizu K, 2001, NAT MED, V7, P738, DOI 10.1038/89121; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; TSUBOUCHI S, 1973, RADIAT RES, V56, P345, DOI 10.2307/3573671; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; VANEWIJK W, 1981, J IMMUNOL, V127, P2594; WAGERS AJ, UNPUB; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	34	1141	1246	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2002	297	5590					2256	2259		10.1126/science.1074807	http://dx.doi.org/10.1126/science.1074807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597LA	12215650				2022-12-28	WOS:000178222000046
J	Buchbinder, R; Ptasznik, R; Gordon, J; Buchanan, J; Prabaharan, V; Forbes, A				Buchbinder, R; Ptasznik, R; Gordon, J; Buchanan, J; Prabaharan, V; Forbes, A			Ultrasound-guided extracorporeal shock wave therapy for plantar fasciitis - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PAINFUL HEEL SYNDROME; NIGHT SPLINTS; INJECTION; BLIND	Context Extracorporeal shock wave therapy (ESWT) is increasingly used for plantar fasciitis, but limited evidence supports its use. Objective To determine whether ultrasound-guided ESWT reduces pain and improves function in patients with plantar fasciitis. Design Double-blind, randomized, placebo-controlled trial conducted between April 1999 and June 2001. Setting Participants were recruited from the community-based referring physicians (primary care physicians, rheumatologists, orthopedic surgeons, and sports physicians) of a radiology group in Melbourne, Australia. Participants We screened 178 patients and enrolled 166; 160 completed the 15-week protocol. Entry criteria included age at least 18 years with plantar fasciitis, defined as heel pain maximal over the plantar aspect of the foot of at least 6 weeks' duration, and an ultrasound-confirmed lesion, defined as thickening of the origin of the plantar fascia of at least 4 mm, hypoechogenicity, and alterations in the normal fibrillary pattern. Interventions Patients were randomly assigned to receive either ultrasound-guided ESWT given weekly for 3 weeks to a total dose of at least 1000 mJ/mm(2) (n = 81), or identical placebo to a total dose of 6.0 mJ/mm(2) (n = 85). Main Outcome Measures Overall, morning, and activity pain, measured on a visual analog scale; Maryland Foot Score; walking ability; Short-Form-36 Health Survey (SF-36) score; and Problem Elicitation Technique score, measured at 6 and 12 weeks after treatment completion. Results At 6 and 12 weeks, there were significant improvements in overall pain in both the active group and placebo group (mean [SD] improvement, 18.1 [30.6] and 19.8 [33.7] at 6 weeks [P=.74 for between-group difference], and 26.3 [34.8] and 25.7 [34.9] at 12 weeks [P=.99], respectively). Similar improvements in both groups were also observed for morning and activity pain, walking ability, Maryland Foot Score, Problem Elicitation Technique, and SF-36. There were no statistically significant differences in the degree of improvement between treatment groups for any measured outcomes. Conclusion We found no evidence to support a beneficial effect on pain, function, and quality of life of ultrasound-guided ESWT over placebo in patients with ultrasound-proven plantar fasciitis 6 and 12 weeks following treatment.	Cabrini Med Ctr, Dept Clin Epidemiol, Malvern, Vic 3144, Australia; Cabrini Hosp, Dept Clin Epidemiol, Malvern, Vic, Australia; Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3168, Australia; La Trobe Univ, Med Ctr, Dept Radiol, Bundoora, Vic, Australia; Epworth Med Fdn, Melbourne, Vic, Australia	Cabrini Health; Cabrini Health; Monash University; La Trobe University; Epworth Medical Foundation	Buchbinder, R (corresponding author), Cabrini Med Ctr, Dept Clin Epidemiol, Suite 41,183 Wattletree Rd, Malvern, Vic 3144, Australia.	rachelle.buchbinder@med.monash.edu.au	Buchbinder, Rachelle/G-2952-2011	Buchbinder, Rachelle/0000-0002-0597-0933; Forbes, Andrew/0000-0003-4269-914X				Alvarez R, 2002, FOOT ANKLE INT, V23, P197, DOI 10.1177/107110070202300302; Atkins D, 1999, RHEUMATOLOGY, V38, P968, DOI 10.1093/rheumatology/38.10.968; BLOCKEY NJ, 1956, BRIT MED J, V1, P1277, DOI 10.1136/bmj.1.4978.1277; BUCHBINDER R, 1995, ARTHRITIS RHEUM, V38, P1568, DOI 10.1002/art.1780381108; Cardinal E, 1996, RADIOLOGY, V201, P257, DOI 10.1148/radiology.201.1.8816554; CHAUSSY C, 1976, UROL RES, V4, P181; CHEN HS, 2001, CLIN ORTHOP RELAT R, V387, P41, DOI DOI 10.1097/00003086-200106000-00006; Cosentino R, 2001, ANN RHEUM DIS, V60, P1064, DOI 10.1136/ard.60.11.1064; Crawford F, 1996, ANN RHEUM DIS, V55, P265, DOI 10.1136/ard.55.4.265; CRAWFORD F, 2002, INTERVENTIONS TREATI; DALY PJ, 1992, FOOT ANKLE, V13, P188, DOI 10.1177/107110079201300404; DAVIS PF, 1994, FOOT ANKLE INT, V15, P531, DOI 10.1177/107110079401501002; *DORN MED TECH INC, 2002, DORN EP ULTR SUMM SA; FUREY JG, 1975, J BONE JOINT SURG AM, V57, P672, DOI 10.2106/00004623-197557050-00016; Gibbon WW, 1999, SKELETAL RADIOL, V28, P21, DOI 10.1007/s002560050467; Gill LH, 1996, FOOT ANKLE INT, V17, P527, DOI 10.1177/107110079601700903; Groshar D, 2000, FOOT, V10, P164; Gudeman SD, 1997, AM J SPORT MED, V25, P312, DOI 10.1177/036354659702500307; Hammer DS, 2002, FOOT ANKLE INT, V23, P309, DOI 10.1177/107110070202300403; Helbig K, 2001, CLIN ORTHOP RELAT R, P68; Heller KD, 1998, Z ORTHOP GRENZGEB, V136, P390, DOI 10.1055/s-2008-1053674; HILL JJ, 1989, FOOT ANKLE, V9, P254, DOI 10.1177/107110078900900509; James KE, 1996, STAT MED, V15, P1421; Kamel M, 2000, J RHEUMATOL, V27, P2139; Kane D, 1998, ANN RHEUM DIS, V57, P383, DOI 10.1136/ard.57.6.383; KIBLER WB, 1991, AM J SPORT MED, V19, P66, DOI 10.1177/036354659101900111; LAPIDUS PAUL W, 1965, CLIN ORTHOP RELAT RES, V39, P178; Loew M, 1995, J Shoulder Elbow Surg, V4, P101, DOI 10.1016/S1058-2746(05)80062-X; Maier M, 2000, J RHEUMATOL, V27, P2455; MYERSON MS, 1986, FOOT ANKLE, V6, P225, DOI 10.1177/107110078600600504; O'Duffy EK, 1998, BRIT J RHEUMATOL, V37, P442; Ogden JA, 2002, FOOT ANKLE INT, V23, P301, DOI 10.1177/107110070202300402; Ogden JA, 2001, CLIN ORTHOP RELAT R, P8; Ogden JA, 2001, CLIN ORTHOP RELAT R, P47, DOI 10.1097/00003086-200106000-00007; Powell M, 1998, FOOT ANKLE INT, V19, P10, DOI 10.1177/107110079801900103; Rompe JD, 1996, J BONE JOINT SURG BR, V78B, P233, DOI 10.1302/0301-620X.78B2.0780233; Rompe JD, 1996, ARCH ORTHOP TRAUM SU, V115, P75, DOI 10.1007/BF00573445; Rompe JD, 2002, J BONE JOINT SURG AM, V84A, P335, DOI 10.2106/00004623-200203000-00001; Rompe JD, 1996, FOOT ANKLE SURG, V2, P215, DOI DOI 10.1016/S1268-7731(96)80004-X; RUBIN G, 1963, Am J Orthop, V5, P38; SCHEPSIS AA, 1991, CLIN ORTHOP RELAT R, P185; Snook G A, 1972, Clin Orthop Relat Res, V82, P163; Tisdel CL, 1996, FOOT ANKLE INT, V17, P41, DOI 10.1177/107110079601700109; Tsai WC, 2000, SCAND J RHEUMATOL, V29, P255; *US FDA, 2000, HLTH TRON OSS TRON S; *US FDA, 2002, FDA APPR SHOCK WAV D; VALCHANOU VD, 1991, INT ORTHOP, V15, P181; Wang CJ, 2002, FOOT ANKLE INT, V23, P204, DOI 10.1177/107110070202300303; WAPNER KL, 1991, FOOT ANKLE, V12, P135, DOI 10.1177/107110079101200301; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WOLGIN M, 1994, FOOT ANKLE INT, V15, P97, DOI 10.1177/107110079401500303	51	188	189	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2002	288	11					1364	1372		10.1001/jama.288.11.1364	http://dx.doi.org/10.1001/jama.288.11.1364			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593TB	12234230	Bronze			2022-12-28	WOS:000178008300018
J	Rosenbaum, PL; Walter, SD; Hanna, SE; Palisano, RJ; Russell, DJ; Raina, P; Wood, E; Bartlett, DJ; Galuppi, BE				Rosenbaum, PL; Walter, SD; Hanna, SE; Palisano, RJ; Russell, DJ; Raina, P; Wood, E; Bartlett, DJ; Galuppi, BE			Prognosis or gross motor function in cerebral palsy - Creation of motor development curves	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Meeting of the European-Academy-for-Childhood-Disability	OCT 13, 2001	GOTHENBURG, SWEDEN	Euro Acad Childhood Disability			SELECTIVE DORSAL RHIZOTOMY; CHILDREN; RELIABILITY; CLASSIFICATION; VALIDITY; SYSTEM; MODEL	Context Lack of a valid classification of severity of cerebral palsy and the absence of longitudinal data on which to base an opinion have made it difficult to consider prognostic issues accurately. Objective To describe patterns of gross motor development of children with cerebral palsy by severity, using longitudinal observations, as a basis for prognostic counseling with parents and for planning clinical management. Design Longitudinal cohort study of children with cerebral palsy, stratified by age and severity of motor function and observed serially for up to 4 years during the period from 1996 to 2001. Setting Nineteen publicly funded regional children's ambulatory rehabilitation programs in Ontario. Participants A total of 657 children aged 1 to 13 years at study onset, representing the full spectrum of clinical severity of motor impairment in children with cerebral palsy. Main Outcome Measures Severity of cerebral palsy, classified with the 5-level Gross Motor Function Classification System; function, formally assessed with the Gross Motor Function Measure (GMFM). Results Based on a total of 2632 GMFM assessments, 5 distinct motor development curves were created; these describe important and significant differences in the rates and limits of gross motor development among children with cerebral palsy by severity. There is substantial within-stratum variation in gross motor development. Conclusions Evidence-based prognostication about gross motor progress in children with cerebral palsy is now possible, providing parents and clinicians with a means to plan interventions and to judge progress over time. Further work is needed to describe motor function of adolescents with cerebral palsy.	McMaster Univ, CanChild Ctr Childhood Disabil Res, IAHS, Hamilton, ON, Canada; McMaster Univ, Dept Pediat, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; MCP Hahnemann Univ, Dept Rehabil Sci, Philadelphia, PA USA; Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; Univ Western Ontario, Sch Phys Therapy, London, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; Drexel University; Dalhousie University; Western University (University of Western Ontario)	Rosenbaum, PL (corresponding author), McMaster Univ, CanChild Ctr Childhood Disabil Res, IAHS, Room 408,1400 Main St W, Hamilton, ON, Canada.	rosenbau@mcmaster.ca	Rosenbaum, Peter/AAW-7913-2021; Walter, Stephen/AAB-5548-2022	Rosenbaum, Peter/0000-0001-6751-5613; Walter, Stephen/0000-0003-4157-8928; Hanna, Steven/0000-0003-3120-9600; Palisano, Robert/0000-0003-0744-0167	NICHD NIH HHS [R01-HD-34947] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034947] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Almeida GL, 1997, PHYS THER, V77, P751, DOI 10.1093/ptj/77.7.751; AVERY L, IN PRESS ARCH PHYS M; Bartlett DJ, 2000, PHYS THER, V80, P598, DOI 10.1093/ptj/80.6.598; BECKUNG E, 2001, DEV MED CHILD NE S89, V43, P27; BLAIR E, 1985, DEV MED CHILD NEUROL, V27, P615; BLECK EE, 1975, DEV MED CHILD NEUROL, V17, P18; BOYCE WF, 1995, PHYS THER, V75, P603, DOI 10.1093/ptj/75.7.603; Butler C, 2000, DEV MED CHILD NEUROL, V42, P634, DOI 10.1017/S0012162200001183; Butler C., 1991, PHYS MED REH CLIN N, V2, P801, DOI [10.1016/S1047-9651(18)30683-1, DOI 10.1016/S1047-9651(18)30683-1]; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Collet JP, 2001, LANCET, V357, P582, DOI 10.1016/S0140-6736(00)04054-X; Crothers B., 1959, NATURAL HIST CEREBRA; Kennes J, 2002, DEV MED CHILD NEUROL, V44, P240, DOI 10.1017/S0012162201002018; Mall V, 2000, J CHILD NEUROL, V15, P214, DOI 10.1177/088307380001500402; McLaughlin J, 2002, DEV MED CHILD NEUROL, V44, P17, DOI 10.1017/S0012162201001608; MOLNAR GE, 1976, ARCH PHYS MED REHAB, V57, P153; MUTCH L, 1992, DEV MED CHILD NEUROL, V34, P547; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974; Pinheiro J, 2001, MIXED EFFECTS MODELS; Russell D, 1998, DEV MED CHILD NEUROL, V40, P693; Russell D, 2002, CLIN DEV MED; RUSSELL DJ, 1994, PHYS THER, V74, P630, DOI 10.1093/ptj/74.7.630; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Russell DJ, 2000, PHYS THER, V80, P873, DOI 10.1093/ptj/80.9.873; Scrutton D, 1997, NEUROPHYSIOLOGY NEUR, P101; Stanley F, 2000, CLIN DEV MED; Steinbok P, 2001, CHILD NERV SYST, V17, P1, DOI 10.1007/PL00013722; WATT JM, 1989, DEV MED CHILD NEUROL, V31, P766; WHO, 2001, WHO INT CLASS FUNCT; Wood E, 2000, DEV MED CHILD NEUROL, V42, P292, DOI 10.1017/S0012162200000529	31	653	688	0	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2002	288	11					1357	1363		10.1001/jama.288.11.1357	http://dx.doi.org/10.1001/jama.288.11.1357			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	593TB	12234229	Bronze			2022-12-28	WOS:000178008300017
J	Morgan, V; Delmotte, M; van Ommen, T; Jouzel, J; Chappellaz, J; Woon, S; Masson-Delmotte, V; Raynaud, D				Morgan, V; Delmotte, M; van Ommen, T; Jouzel, J; Chappellaz, J; Woon, S; Masson-Delmotte, V; Raynaud, D			Relative timing of deglacial climate events in Antarctica and Greenland	SCIENCE			English	Article							LAST GLACIAL PERIOD; VOSTOK ICE CORE; PAST; RECORDS; GASES; DOME	The last deglaciation was marked by large, hemispheric, millennial-scale climate variations: the Bolling-Allerod and Younger Dryas periods in the north, and the Antarctic Cold Reversal in the south. A chronology from the high-accumulation Law Dome East Antarctic ice core constrains the relative timing of these two events and provides strong evidence that the cooling at the start of the Antarctic Cold Reversal did not follow the abrupt warming during the northern Bolling transition around 14,500 years ago. This result suggests that southern changes are not a direct response to abrupt changes in North Atlantic thermohaline circulation, as is assumed in the conventional picture of a hemispheric temperature seesaw.	Antarctic Cooperat Res Ctr, Hobart, Tas, Australia; Australian Antarctic Div, Hobart, Tas, Australia; CNRS, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; CEA Saclay, Inst Pierre Simon Laplacer, Lab Sci Climat & Environm, CEA,CNRS,UMR 1572, F-91191 Gif Sur Yvette, France	Australian Antarctic Division; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	van Ommen, T (corresponding author), Antarctic Cooperat Res Ctr, GPO Box 252-80, Hobart, Tas, Australia.		Masson-Delmotte, Valerie L/G-1995-2011; raynaud, dominique/ABG-4718-2020; Raynaud, Dominique/H-9626-2016; Chappellaz, Jérôme A./A-4872-2011; van Ommen, Tas D/B-5020-2012	Masson-Delmotte, Valerie L/0000-0001-8296-381X; van Ommen, Tas D/0000-0002-2463-1718				Alley RB, 1999, ANNU REV EARTH PL SC, V27, P149, DOI 10.1146/annurev.earth.27.1.149; BARNOLA JM, 1991, TELLUS B, V43, P83, DOI 10.1034/j.1600-0889.1991.t01-1-00002.x; BENDER M, 1994, NATURE, V372, P663, DOI 10.1038/372663a0; Bender ML, 1999, GEOPH MONOG SERIES, V112, P149; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Chappellaz J, 1997, J GEOPHYS RES-ATMOS, V102, P15987, DOI 10.1029/97JD01017; Clark PU, 2002, SCIENCE, V295, P2438; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Dansgaard W., 1969, J GLACIOL, V8, P215, DOI [10.3189/S0022143000031208, DOI 10.3189/S0022143000031208, 10.3189/s0022143000031208]; Etheridge DM, 1996, J GEOPHYS RES-ATMOS, V101, P4115, DOI 10.1029/95JD03410; Ganopolski A, 2002, PHYS REV LETT, V88, DOI [10.1103/PhysRevLett.88.038501, 10.1103/PhysRevB.88.038501]; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; JOHNSEN SJ, 1972, NATURE, V235, P429, DOI 10.1038/235429a0; Jouzel J, 2001, GEOPHYS RES LETT, V28, P3199, DOI 10.1029/2000GL012243; Keeling RF, 2001, PALEOCEANOGRAPHY, V16, P330, DOI 10.1029/2001PA000648; Keeling RF, 2001, PALEOCEANOGRAPHY, V16, P112, DOI 10.1029/2000PA000529; MALAIZE B, 1998, THESIS U PARIS 6; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Morgan VI, 1997, J GLACIOL, V43, P3, DOI 10.3189/S0022143000002768; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Schulz M., 2002, GEOPHYS RES LETT, V29; Schwander J, 1997, J GEOPHYS RES-ATMOS, V102, P19483, DOI 10.1029/97JD01309; Schwander J, 2001, GEOPHYS RES LETT, V28, P4243, DOI 10.1029/2000GL011981; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; SOWERS T, 1995, SCIENCE, V269, P210, DOI 10.1126/science.269.5221.210; Sowers T, 1997, J GEOPHYS RES-OCEANS, V102, P26527, DOI 10.1029/97JC00633; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; STEIG EJ, IN PRESS ANN GLACIOL; Stenni B, 2001, SCIENCE, V293, P2074, DOI 10.1126/science.1059702; Stocker TF, 2000, QUATERNARY SCI REV, V19, P301, DOI 10.1016/S0277-3791(99)00067-0; Stocker TF, 2000, P NATL ACAD SCI USA, V97, P1362, DOI 10.1073/pnas.97.4.1362; vanOmmen TD, 1997, J GEOPHYS RES-ATMOS, V102, P9351, DOI 10.1029/96JD04014	34	73	80	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1862	1864		10.1126/science.1074257	http://dx.doi.org/10.1126/science.1074257			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228715				2022-12-28	WOS:000177955000041
J	Lurbe, E; Redon, J; Kesani, A; Pascual, JM; Tacons, J; Alvarez, V; Batlle, D				Lurbe, E; Redon, J; Kesani, A; Pascual, JM; Tacons, J; Alvarez, V; Batlle, D			Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CULTURED SKIN FIBROBLASTS; ALBUMIN EXCRETION RATE; IDDM PATIENTS; NEPHROPATHY; MELLITUS; HYPERTENSION; DISEASE; PREDISPOSITION; SUSCEPTIBILITY; ADOLESCENTS	Background: Patients with type 1 diabetes mellitus and microalbuminuria often have elevated blood pressure while they are asleep, but it is not known whether the elevation develops concomitantly with microalbuminuria or precedes it. Methods: We monitored 75 adolescents and young adults who had had type 1 diabetes with normal urinary albumin excretion and blood pressure for more than five years. Ambulatory blood-pressure monitoring was used to assess blood pressure at the initial evaluation and about two years later, at which time all subjects had normal urinary albumin excretion. Subsequently, subjects were monitored for the development of microalbuminuria. Results: Microalbuminuria developed in 14 subjects, whereas the other 61 continued to have normal urinary albumin excretion. The mean (+/-SD) systolic pressure during sleep increased significantly in the subjects who ultimately had microalbuminuria (from 109.9+/-11.3 to 114.9+/-11.7 mm Hg, P=0.01) but not in the subjects with normal albumin excretion (from 106.0+/-8.8 to 106.4+/-14.8 mm Hg). The risk of progression to microalbuminuria was examined in relation to the ratio of systolic pressure during sleep to systolic pressure in the daytime. A ratio of 0.9 or lower, used to define a normal fall in nocturnal pressure, had a negative predictive value of 91 percent for the development of microalbuminuria. Moreover, the risk of microalbuminuria was 70 percent lower (95 percent confidence interval, 44 to 110 percent) in subjects with a ratio of 0.9 or less than in those with a ratio higher than 0.9 (P=0.01). Conclusions: In persons with type 1 diabetes, an increase in systolic blood pressure during sleep precedes the development of microalbuminuria. In those whose blood pressure during sleep decreases normally, the progression from normal albumin excretion to microalbuminuria appears to be less likely.	Northwestern Univ, Feinberg Sch Med, Div Nephrol & Hypertens, Chicago, IL 60611 USA; Gen Hosp, Dept Pediat, Pediat Nephrol Unit, Valencia, Spain; Univ Valencia, Valencia, Spain; Hosp Clin, Dept Med, Hypertens Clin, Valencia, Spain; Hosp Sagunto, Dept Med, Sagunto, Spain	Northwestern University; Feinberg School of Medicine; University of Valencia	Batlle, D (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Nephrol & Hypertens, 320 E Super St,10-475 Searle Bldg, Chicago, IL 60611 USA.		REDON, JOSEP/E-1719-2019; Redon, Josep/L-5997-2019	Redon, Josep/0000-0001-8777-6773; Lurbe, Empar/0000-0002-3748-5529				*2 TASK FORC BLOOD, 1987, PEDIATRICS, V79, P1; ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496; Bakris GL, 2000, AM J KIDNEY DIS, V36, P646, DOI 10.1053/ajkd.2000.16225; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399; CLOSE CF, 1995, BMJ-BRIT MED J, V311, P973; EARLE K, 1994, KIDNEY INT, V45, P434, DOI 10.1038/ki.1994.56; Hansen HP, 1996, KIDNEY INT, V50, P579, DOI 10.1038/ki.1996.352; KROLEWSKI AS, 1988, NEW ENGL J MED, V318, P140, DOI 10.1056/NEJM198801213180303; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; Lafferty AR, 2000, DIABETES CARE, V23, P533, DOI 10.2337/diacare.23.4.533; LaPointe MS, 2001, AM J KIDNEY DIS, V38, P646, DOI 10.1053/ajkd.2001.28026; Lurbe A, 1996, KIDNEY INT, V50, P1684, DOI 10.1038/ki.1996.486; LURBE A, 1993, HYPERTENSION, V21, P227, DOI 10.1161/01.HYP.21.2.227; MANCIA G, 1988, AM HEART J, V116, P1134, DOI 10.1016/0002-8703(88)90177-9; MANGILI R, 1988, NEW ENGL J MED, V318, P146, DOI 10.1056/NEJM198801213180304; MOORE WV, 1992, DIABETES, V41, P1035, DOI 10.2337/diabetes.41.9.1035; NORGAARD K, 1990, DIABETOLOGIA, V33, P407, DOI 10.1007/BF00404089; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Pecis M, 2000, DIABETES CARE, V23, P989; PICKERING TG, 1982, JAMA-J AM MED ASSOC, V247, P992, DOI 10.1001/jama.247.7.992; PICKERING TG, 1990, CIRCULATION, V81, P700, DOI 10.1161/01.CIR.81.2.700; Poulsen PL, 1997, DIABETOLOGIA, V40, P718, DOI 10.1007/s001250050739; POULSEN PL, 1994, DIABETES, V43, P1248, DOI 10.2337/diabetes.43.10.1248; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; ROSSKOPF D, 1993, J CLIN INVEST, V92, P2553, DOI 10.1172/JCI116865; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SOKOLOW M, 1966, CIRCULATION, V34, P279; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; *SPSS, 1993, SPSS WIND REL 6 0 AD; Sturrock NDC, 2000, DIABETIC MED, V17, P360, DOI 10.1046/j.1464-5491.2000.00284.x; VERDECCHIA P, 1993, CIRCULATION, V88, P986, DOI 10.1161/01.CIR.88.3.986; VERDECCHIA P, 1990, CIRCULATION, V81, P528, DOI 10.1161/01.CIR.81.2.528; Viberti G, 1999, KIDNEY INT, V55, P2526, DOI 10.1046/j.1523-1755.1999.00507.x; VIBERTI GC, 1982, LANCET, V1, P1430; VIBERTI GC, 1987, BRIT MED J, V295, P515, DOI 10.1136/bmj.295.6597.515; Voros P, 1998, NEPHROL DIAL TRANSPL, V13, P2257, DOI 10.1093/ndt/13.9.2257	37	507	527	0	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					797	805		10.1056/NEJMoa013410	http://dx.doi.org/10.1056/NEJMoa013410			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226150				2022-12-28	WOS:000177921300004
J	Xie, Q; Guo, HS; Dallman, G; Fang, SY; Weissman, AM; Chua, NH				Xie, Q; Guo, HS; Dallman, G; Fang, SY; Weissman, AM; Chua, NH			SINAT5 promotes ubiquitin-related degradation of NAC1 to attenuate auxin signals	NATURE			English	Article							LATERAL ROOT DEVELOPMENT; ARABIDOPSIS-THALIANA; AUX/IAA PROTEINS; LIGASE; SIAH-1; PATHWAY; DOMAIN; P53; ABSENTIA; MUTATION	The plant hormone indole-3 acetic acid (IAA or auxin) controls many aspects of plant development, including the production of lateral roots(1-3). Ubiquitin-mediated proteolysis has a central role in this process. The genes AXR1 and TIR1 aid the assembly of an active SCF (Skp1/Cullin/F-box) complex that probably promotes degradation of the AUX/IAA transcriptional repressors in response to auxin(4-8). The transcription activator NAC1, a member of the NAM/CUC family of transcription factors, functions downstream of TIR1 to transduce the auxin signal for lateral root development(9). Here we show that SINAT5, an Arabidopsis homologue of the RING-finger Drosophila protein SINA, has ubiquitin protein ligase activity and can ubiquitinate NAC1. This activity is abolished by mutations in the RING motif of SINAT5. Overexpressing SINAT5 produces fewer lateral roots, whereas overexpression of a dominant-negative Cys49 --> Ser mutant of SINAT5 develops more lateral roots. These lateral root phenotypes correlate with the expression of NAC1 observed in vivo. Low expression of NAC1 in roots can be increased by treatment with a proteasome inhibitor, which indicates that SINAT5 targets NAC1 for ubiquitin-mediated proteolysis to downregulate auxin signals in plant cells.	Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA; NCI, Ctr Canc Res, Regulat Prot Funct Lab, Bethesda, MD 20892 USA; Natl Univ Singapore, Temasek Life Sci Lab, Mol Cell Biol Lab, Singapore 117604, Singapore	Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National University of Singapore	Chua, NH (corresponding author), Rockefeller Univ, Plant Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.		Fang, Shengyun/H-3802-2011; Dallmann, Geza/E-1630-2012	Fang, Shengyun/0000-0001-7280-5463				Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hu G, 1999, MOL CELL BIOL, V19, P724; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; Tiedt R, 2001, EMBO J, V20, P4143, DOI 10.1093/emboj/20.15.4143; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798	28	362	414	6	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					167	170		10.1038/nature00998	http://dx.doi.org/10.1038/nature00998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226665				2022-12-28	WOS:000177931200041
J	Pierce, JP; Gilpin, EA				Pierce, JP; Gilpin, EA			Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CALIFORNIA TOBACCO SURVEY; NICOTINE PATCH; TRANSDERMAL NICOTINE; DOUBLE-BLIND; TRIAL; POPULATION; TESTS	Context Successful smoking cessation is a major public health goal. In controlled clinical trials, nicotine replacement therapy (NRT) and the antidepressant bupropion have been shown to significantly increase cessation rates only for moderate to heavy smokers ( greater than or equal to15 cigarettes/d). Nicotine replacement therapy is heavily promoted to the general population by both the pharmaceutical industry and tobacco control advocates. Objective To examine trends in smoking cessation, pharmaceutical cessation aid use, and success in cessation in the general California population. Design, Setting, and Participants The large population-based California Tobacco Surveys of 1992, 1996, and 1999, including 5247 (71.3% response rate), 9725 (72.9% response rate), and 6412 (68.4% response rate) respondents, respectively. Main Outcome Measures Rates of cessation attempts ( greater than or equal to1 day) among smokers in the last year, use of pharmaceutical aids (mostly over-the-counter products since 1996), and cessation success. Results Between 1992 and 1999, cessation attempts among California smokers increased 61.4% (from 38.1% to 61.5%),and NRT use among quitters increased 50.5% (from 9.3% to 14.0%). A total of 17.2% of quitters used NRT, an antidepressant, or both as an aid to cessation in 1999. In 1996 and 1999, the median duration of aid use (14 days) was much less than recommended, and only about 20% of users had adjuvant one-on-one or group behavioral counseling. Use of NRT increased short-term cessation success in moderate to heavy smokers in each survey year. However, a long-term cessation advantage was only observed before NRT became widely available over-the-counter (August 1996). In 1999, no advantage for pharmaceutical aid users was observed in either the short or long term for the nearly 60% of California smokers classified as light smokers (<15 cigarettes/d). Conclusion Since becoming available over the counter, NRT appears no longer effective in increasing long-term successful cessation in California smokers.	Univ Calif San Diego, Ctr Canc, Canc Prevent & Control Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pierce, JP (corresponding author), Univ Calif San Diego, Ctr Canc, Canc Prevent & Control Program, 0645, La Jolla, CA 92093 USA.	jppierce@ucsd.edu		Pierce, John/0000-0002-0075-7471				Burton S L, 2000, MMWR Morb Mortal Wkly Rep, V49, P665; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P504; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1217; Curry SJ, 1998, NEW ENGL J MED, V339, P673, DOI 10.1056/NEJM199809033391006; EFRON B, 1982, CMBS REGIONAL C SERI, V38; FIORE MC, 1990, JAMA-J AM MED ASSOC, V263, P2760, DOI 10.1001/jama.263.20.2760; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; FIORE MC, 1994, JAMA-J AM MED ASSOC, V71, P1940; FIORE MC, 2000, TREATING TOBACCO USE; GILPIN E, 1994, CANCER EPIDEM BIOMAR, V3, P613; Gilpin E, 2001, CALIFORNIA TOBACCO C; GIOVINO GA, 1993, TOBACCO CONTROL S, V2, pS3; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HATZIANDREU EJ, 1990, J NATL CANCER I, V82, P1402, DOI 10.1093/jnci/82.17.1402; Hays JT, 1999, AM J PUBLIC HEALTH, V89, P1701, DOI 10.2105/AJPH.89.11.1701; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Leischow SJ, 1999, AM J HEALTH BEHAV, V23, P61, DOI 10.5993/AJHB.23.1.7; ORLEANS CT, 1994, JAMA-J AM MED ASSOC, V271, P601, DOI 10.1001/jama.271.8.601; ORLEANS CT, 1996, TOBACCO CONTROL S, V5, pS3; Ossip-Klein D J, 1986, Health Psychol, V5 Suppl, P3, DOI 10.1037/0278-6133.5.Suppl.3; PIERCE JP, 1995, J NATL CANCER I, V87, P87, DOI 10.1093/jnci/87.2.87; Pierce JP, 1998, JAMA-J AM MED ASSOC, V280, P893, DOI 10.1001/jama.280.10.893; Pierce JP., 1998, TOBACCO CONTROL CALI; PIERCE JP, 1994, TOBACCU USE CALIFORN; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; SAUL H, 1993, NEW SCI, V137, P12; Schauffler H H, 1997, Tob Control, V6 Suppl 1, pS81; SCHNEIDER NG, 1983, ADDICT BEHAV, V8, P253, DOI 10.1016/0306-4603(83)90020-5; Shaw JP, 1998, TOB CONTROL, V7, P161, DOI 10.1136/tc.7.2.161; Shiffman S, 1997, Tob Control, V6, P306; SILAGY C, 2000, COCHRANE DB SYST REV; Solberg LI, 2001, PREV MED, V33, P53, DOI 10.1006/pmed.2001.0853; Sonderskov J, 1997, AM J EPIDEMIOL, V145, P309; Stratton K., 2000, CLEARING SMOKE ASSES; *US DEP HHS, 2000, TREAT TOB US DEP; *US DEP HHS, 1989, DHHS PUBL PHS CDC; *US DEP HHS, 1990, PUBL US DEP HHS; US Department of Health and Human Services, 1980, HLTH CONS SMOK WOM R; Zhu SH, 2000, AM J PREV MED, V18, P305, DOI 10.1016/S0749-3797(00)00124-0	39	198	199	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1260	1264		10.1001/jama.288.10.1260	http://dx.doi.org/10.1001/jama.288.10.1260			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215133	Bronze			2022-12-28	WOS:000177917700025
J	Ostermeier, GC; Dix, DJ; Miller, D; Khatri, P; Krawetz, SA				Ostermeier, GC; Dix, DJ; Miller, D; Khatri, P; Krawetz, SA			Spermatozoal RNA profiles of normal fertile men	LANCET			English	Article							EMBRYONIC GENOME ACTIVATION; GENE-EXPRESSION; INFERTILITY; MECHANISMS; OOCYTE	Background Findings from several studies support the conclusion that spermatozoa contain a complex repertoire of mRNAs. Even though these mRNAs are thought to provide an insight into past events of spermatogenesis, their complexity and function have yet to be established. Our aim was to determine whether we could use spermatozoal mRNAs to generate a genetic fingerprint of normal fertile men. Methods We used a suite of microarrays containing 27 016 unique expressed sequence tags (ESTs) to investigate cDNAs from a pool of 19 testes, cDNAs from a pool of nine individual ejaculate spermatozoal mRNAs, and cDNAs constructed from spermatozoal mRNAs from a single ejaculate. We also used ontological data mining to determine the function of the genes identified in each EST profile. Findings The cDNAs from the testes, pooled ejaculate, and single ejaculate hybridised to 7157, 3281, and 2780 ESTs, respectively. The testicular population contained all of the ESTs identified by the cDNAs from the pooled and individual ejaculate. The pooled ejaculate population contained all but four ESTs identified from the individual ejaculate. A subset of the spermatozoal mRNAs was associated with embryo development. Interpretation The microarray data from testes and spermatozoa (pooled and individual) were concordant, supporting the view that a spermatozoal mRNA fingerprint can be obtained from normal fertile men. Thus, profiling can be used to monitor past events-ie, gene expression of spermatogenesis. Moreover, the data suggest that, in addition to delivering the paternal genome, spermatozoa provide the zygote with a unique suite of paternal mRNAs. Ejaculate spermatozoa can now be used as a non-invasive proxy for investigations of testis-specific infertility.	Wayne State Univ, Dept Obstet & Gynecol, Ctr Mol Med & Genet, Detroit, MI USA; Wayne State Univ, Inst Comp Sci, Detroit, MI USA; Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; US EPA, Off Res & Dev, Washington, DC 20460 USA; Univ Leeds, Reprod Biol Grp, Leeds, W Yorkshire, England	Wayne State University; Wayne State University; Wayne State University; United States Environmental Protection Agency; University of Leeds	Krawetz, SA (corresponding author), 253 CS Mott Ctr 275 E Hancock, Detroit, MI 48201 USA.	steve@compbio.med.wayne.edu	Ostermeier, G. Charles/Y-1172-2019; krawetz, stephen/GQQ-3308-2022	Ostermeier, G. Charles/0000-0002-3951-512X; Khatri, Purvesh/0000-0002-4143-4708	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036512] Funding Source: NIH RePORTER; NICHD NIH HHS [HD36512] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BETLACH CJ, 1976, J EXP ZOOL, V198, P49, DOI 10.1002/jez.1401980107; BHASIN S, 1994, J CLIN ENDOCR METAB, V79, P1525, DOI 10.1210/jc.79.6.1525; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Conover W, 1980, PRACTICAL NONPARAMET, P99; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; JACOBS PA, 1980, NATURE, V286, P714, DOI 10.1038/286714a0; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Kramer JA, 1997, MOL HUM REPROD, V3, P473, DOI 10.1093/molehr/3.6.473; Kramer JA, 2000, MOL REPROD DEV, V56, P254, DOI 10.1002/(SICI)1098-2795(200006)56:2+<254::AID-MRD9>3.0.CO;2-#; Latham KE, 1999, INT REV CYTOL, V193, P71; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; LISSENS W, 1999, MOL BIOL REPROD MED, P479; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Miller D, 1999, GENE, V237, P385, DOI 10.1016/S0378-1119(99)00324-8; MILLER D, 1994, HUM REPROD, V9, P864, DOI 10.1093/oxfordjournals.humrep.a138607; Neilson L, 2000, GENOMICS, V63, P13, DOI 10.1006/geno.1999.6059; Ostermeier GC, 2002, BIOINFORMATICS, V18, P949, DOI 10.1093/bioinformatics/18.7.949; OSTERMEIER GC, 2000, THESIS U WISCONSIN M; Reid KJ, 2001, BIOTECHNIQUES, V30, P20, DOI 10.2144/01301bm01; Richter W, 1999, MOL HUM REPROD, V5, P732, DOI 10.1093/molehr/5.8.732; Sathanathan AH, 1996, HUM REPROD, V11, P345, DOI 10.1093/HUMREP/11.2.345; SIMERLY C, 1995, NAT MED, V1, P47, DOI 10.1038/nm0195-47; Stanton JL, 2001, MOL HUM REPROD, V7, P521, DOI 10.1093/molehr/7.6.521; Swann K, 1999, J EXP ZOOL, V285, P267, DOI 10.1002/(SICI)1097-010X(19991015)285:3&lt;267::AID-JEZ10&gt;3.0.CO;2-P; Taylor E, 2001, BIOTECHNIQUES, V31, P62, DOI 10.2144/01311st01; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546	29	396	426	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2002	360	9335					772	777		10.1016/S0140-6736(02)09899-9	http://dx.doi.org/10.1016/S0140-6736(02)09899-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592HX	12241836				2022-12-28	WOS:000177933000019
J	Walker, Z; Townsend, J; Oakley, L; Donovan, C; Smith, H; Hurst, Z; Bell, J; Marshall, S				Walker, Z; Townsend, J; Oakley, L; Donovan, C; Smith, H; Hurst, Z; Bell, J; Marshall, S			Health promotion for adolescents in primary care: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; LIFE-STYLE; CONSULTATIONS; TEENAGERS; ADVICE	Objectives To evaluate the effectiveness of inviting teenagers to general practice consultations to discuss health behaviour concerns and appropriate follow up care. Design Randomised controlled trial,with participants randomised to a consultation (intervention) or usual care (control). Questionnaires completed at baseline, 3 months, and 12 months. Setting Eight general practices in Hertfordshire, England. Participants 1516 teenagers aged 14-15 years. Intervention Consultations with practice nurses to discuss health concerns and develop plans for healthier lifestyles. Main outcome measures Mental and physical health, "stage of change" for health related behaviour, and use of health services. Results At baseline 970 teenagers completed questionnaires; 23% smoked, 35% had been drunk in the previous three months, 64% considered they ate unhealthily, 39% took little exercise, and 36% had possible depression. 41% (304) of teenagers invited attended for a consultation; over one third (112) were offered follow up care. More intervention group teenagers reported positive movement in stage of change for diet and exercise and in at least one of four behaviours (diet, exercise, smoking, drinking alcohol) at 3 months (41% v 31%, P<0.01), but this did not persist at 12 months. There was marginally more positive change in actual behaviour by intervention teenagers at 3 months (16% v 121%, P=0.06). Recognition of possible depression resulted in improved mental health outcomes at 3 and 12 months. 97% of attenders said they would recommend the intervention to a friend. Conclusions Change in behaviour was slight but encouraging, and the intervention was well received and relatively cheap.	Univ Hertfordshire, Ctr Res Primary & Community Care, Hatfield AL10 9AB, Herts, England; Royal Coll Gen Practitioners, Working Party Adolescent Hlth, London SW7 1PU, England; Maltings Surg, St Albans AL1 3JB, Herts, England; Bennetts End Surg, Hemel Hempstead HP3 9LY, England	University of Hertfordshire	Townsend, J (corresponding author), Univ London London Sch Hyg & Trop Med, Promot Res Unit, Keppel St, London WC1E 7HT, England.			/0000-0002-4697-4316				*AM MED ASS, 1994, AMA GUID AD PREV SER; [Anonymous], 1995, LANCET, V345, P997; Boekeloo BO, 1996, ARCH PEDIAT ADOL MED, V150, P1146, DOI 10.1001/archpedi.1996.02170360036005; Campbell A, 1993, Health Visit, V66, P365; CHURCHILL R, 1999, FACTORS INFLUENCING, P109; COULTER A, 1995, BRIT MED J, V310, P1099; Cowap N, 1996, BRIT MED J, V313, P941; *DEP HLTH, 1998, HLTH SURV ENGL HLTH; *DEP HLTH, 1998, OUR HLTH NAT; DONOVAN CF, 1988, HLTH TRENDS, V20, P64; Gollwitzer P.M., 1993, EUR REV SOC PSYCHOL, V4, DOI [10.1080/14792779343000059, DOI 10.1080/14792779343000059]; JACOBSON LD, 1994, FAM PRACT, V11, P296, DOI 10.1093/fampra/11.3.296; Jacobson LD, 2000, FAM PRACT, V17, P156, DOI 10.1093/fampra/17.2.156; McPherson A, 1996, BRIT J GEN PRACT, V46, P627; *NSPCC CHILDR SOC, 2000, IMPR CHILDR HLTH SUR; Olsson G, 1997, EUR CHILD ADOLES PSY, V6, P81, DOI 10.1007/BF00566670; RICHARDSON G, 2000, BRIDGING GAP TEENAGE; SMITH A, 1996, HLTH VISITOR, V69, P228; TOWNSEND J, 1991, BRIT MED J, V303, P947, DOI 10.1136/bmj.303.6808.947; Walker Z, 1998, J ADOLESCENCE, V21, P621, DOI 10.1006/jado.1998.0183; Walker Z. A. K., 1999, HLTH ED J, V58, P218; Walker ZAK, 2000, METHOD INFORM MED, V39, P260; Walker ZAK, 1999, FAM PRACT, V16, P164, DOI 10.1093/fampra/16.2.164; WOOD DA, 1994, BRIT MED J, V308, P313, DOI 10.1136/bmj.308.6924.313	24	75	76	1	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2002	325	7363					524	527		10.1136/bmj.325.7363.524	http://dx.doi.org/10.1136/bmj.325.7363.524			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593NJ	12217993	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-28	WOS:000177997800019
J	Smith, BE				Smith, BE			Nitrogenase reveals its inner secrets	SCIENCE			English	Editorial Material							CLUSTER; PROTEIN		John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Smith, BE (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	barry.smith@bbsrc.ac.uk						Benton PMC, 2001, BIOCHEMISTRY-US, V40, P13816, DOI 10.1021/bi011571m; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Fumagalli A, 1997, J AM CHEM SOC, V119, P1450, DOI 10.1021/ja961403v; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; Lovell T, 2001, J AM CHEM SOC, V123, P12392, DOI 10.1021/ja011860y; Mayer SM, 1999, J MOL BIOL, V292, P871, DOI 10.1006/jmbi.1999.3107; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Pickett CJ, 1996, J BIOL INORG CHEM, V1, P601, DOI 10.1007/s007750050099; Smith BE, 1999, ADV INORG CHEM, V47, P159, DOI 10.1016/S0898-8838(08)60078-1; Thorneley R.N.F., 1985, MOLYBDENUM ENZYMES, V1, P221	10	127	131	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587					1654	1655		10.1126/science.1076659	http://dx.doi.org/10.1126/science.1076659			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215632				2022-12-28	WOS:000177819100033
J	Erdman, N; Poeppelmeier, KR; Asta, M; Warschkow, O; Ellis, DE; Marks, LD				Erdman, N; Poeppelmeier, KR; Asta, M; Warschkow, O; Ellis, DE; Marks, LD			The structure and chemistry of the TiO2-rich surface of SrTiO3(001)	NATURE			English	Article							TRANSMISSION ELECTRON-DIFFRACTION; AB-INITIO; MICROSCOPY; SET	Oxide surfaces are important for applications in catalysis and thin film growth. An important frontier in solid-state inorganic chemistry is the prediction of the surface structure of an oxide. Comparatively little is known about atomic arrangements at oxide surfaces at present, and there has been considerable discussion concerning the forces that control such arrangements. For instance, one model suggests that the dominant factor is a reduction of Coulomb forces(1); another favours minimization of 'dangling bonds' by charge transfer to states below the Fermi energy(2). The surface structure and properties of SrTiO3-a standard model for oxides with a perovskite structure-have been studied extensively(3-14). Here we report a solution of the 2 x 1 SrTiO3 (001) surface structure obtained through a combination of high-resolution electron microscopy and theoretical direct methods. Our results indicate that surface rearrangement of TiO6-x units into edge-sharing blocks determines the SrO-deficient surface structure of SrTiO3. We suggest that this structural concept can be extended to perovskite surfaces in general.	Northwestern Univ, Inst Environm Catalysis, Dept Mat Sci & Engn, Evanston, IL 60208 USA; Northwestern Univ, Inst Environm Catalysis, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Inst Environm Catalysis, Dept Phys & Astron, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Marks, LD (corresponding author), Northwestern Univ, Inst Environm Catalysis, Dept Mat Sci & Engn, Evanston, IL 60208 USA.		Marks, Laurence/B-7527-2009; Warschkow, Oliver/C-1507-2008					Aruta C, 2001, PHYS STATUS SOLIDI A, V183, P353, DOI 10.1002/1521-396X(200102)183:2<353::AID-PSSA353>3.0.CO;2-V; Bengu E, 1996, PHYS REV LETT, V77, P4226, DOI 10.1103/PhysRevLett.77.4226; Collazo-Davila C, 1998, PHYS REV LETT, V80, P1678, DOI 10.1103/PhysRevLett.80.1678; COLLAZODAVILA C, 1995, J MICROSC SOC AM, V1, P267; CORD B, 1985, SURF SCI, V162, P34, DOI 10.1016/0039-6028(85)90872-6; Droopad R, 2001, MAT SCI ENG B-SOLID, V87, P292, DOI 10.1016/S0921-5107(01)00727-9; JAYARAM G, 1993, PHYS REV LETT, V71, P3489, DOI 10.1103/PhysRevLett.71.3489; Jiang QD, 1996, SURF SCI, V367, pL42, DOI 10.1016/S0039-6028(96)00990-9; Jiang QD, 1999, SURF SCI, V425, P343, DOI 10.1016/S0039-6028(99)00223-X; KAWASAKI M, 1994, SCIENCE, V266, P1540, DOI 10.1126/science.266.5190.1540; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; LIANG Y, 1993, SURF SCI, V285, pL510, DOI 10.1016/0039-6028(93)90422-G; Marks LD, 2001, J PHYS-CONDENS MAT, V13, P10677, DOI 10.1088/0953-8984/13/47/310; Marks LD, 1996, ULTRAMICROSCOPY, V62, P43, DOI 10.1016/0304-3991(95)00085-2; Marks LD, 1998, SURF REV LETT, V5, P1087, DOI 10.1142/S0218625X98001444; Marks LD, 1999, ACTA CRYSTALLOGR A, V55, P601, DOI 10.1107/S0108767398014408; MARKS LD, 1995, PHYS REV LETT, V75, P2172, DOI 10.1103/PhysRevLett.75.2172; MATSUMOTO T, 1992, SURF SCI, V278, P153; NAITO M, 1994, PHYSICA C, V229, P1, DOI 10.1016/0921-4534(94)90805-2; Nishimura T, 1999, SURF SCI, V421, P273, DOI 10.1016/S0039-6028(98)00840-1; Padilla J, 1998, SURF SCI, V418, P64, DOI 10.1016/S0039-6028(98)00670-0; PASHLEY MD, 1989, PHYS REV B, V40, P10481, DOI 10.1103/PhysRevB.40.10481; Perdew J. P., 1991, ELECT STRUCTURE SOLI, P11; Szot K, 1999, PHYS REV B, V60, P5909, DOI 10.1103/PhysRevB.60.5909; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Warschkow O, 1998, J COMPUT PHYS, V143, P70, DOI 10.1006/jcph.1998.5974; WOLF D, 1992, PHYS REV LETT, V68, P3315, DOI 10.1103/PhysRevLett.68.3315; XU P, 1992, ULTRAMICROSCOPY, V45, P155, DOI 10.1016/0304-3991(92)90046-M; XU P, 1994, ULTRAMICROSCOPY, V53, P15, DOI 10.1016/0304-3991(94)90100-7	30	299	299	6	247	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					55	58		10.1038/nature01010	http://dx.doi.org/10.1038/nature01010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214229				2022-12-28	WOS:000177788600034
J	Miller, AB; To, T; Baines, CJ; Wall, C				Miller, AB; To, T; Baines, CJ; Wall, C			The Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up - A randomized screening trial of mammography in women age 40 to 49 years	ANNALS OF INTERNAL MEDICINE			English	Article							PROGRAMS; DEATH	Objective: To compare breast cancer mortality in 40- to 49-year-old women who received either 1) screening with annual mammography, breast physical examination, and instruction on breast self-examination on 4 or 5 occasions or 2) community care after a single breast physical examination and instruction on breast self-examination. Design: Individually randomized, controlled trial. Setting: 15 Canadian centers. Participants: 50 430 volunteers age 40 to 49 years, recruited from January 1980 to March 1985, who were not pregnant, had no previous breast cancer diagnosis, and had not had mammography in the preceding 12 months. Interventions: Breast physical examination and instruction on breast self-examination preceded random assignment of 25 214 women to receive mammography and annual mammography, breast physical examination, and breast self-examination and 25 216 women to receive usual community care with annual follow-up. Measurements: verified breast cancer incidence and cohort mortality through 31 December 1993 and deaths from breast cancer through 30 June 1996. Results: The 105 breast cancer deaths in the mammography group and 108 breast cancer deaths in the usual care group yielded a cumulative rate ratio, adjusted for mammography done outside the study, of 1.06 (95% CI, 0.80 to 1.40). A total of 592 cases of invasive breast cancer and 71 cases of in situ breast cancer were diagnosed by 31 December 1993 in the mammography group compared with 552 and 29 cases, respectively, in the usual care group. The expected proportions of nonpalpable and small invasive tumors were detected on mammography. Conclusion: After 11 to 16 years of follow-up, four or five annual screenings with mammography, breast physical examination, and breast self-examination had not reduced breast cancer mortality compared with usual community care after a single breast physical examination and instruction on breast self-examination. The study data show that true effects of 20% or greater are unlikely.	Univ Toronto, Toronto, ON, Canada	University of Toronto	Miller, AB (corresponding author), Deutsch Krebsforschungszentrum, Div Clin Epidemiol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	a.miller@dkfz-heidelberg.de						Bailar JC, 1997, CAN MED ASSOC J, V156, P193; BAINES CJ, 1988, J CAN ASSOC RADIOL, V39, P273; BAINES CJ, 1984, CONTROL CLIN TRIALS, V5, P129, DOI 10.1016/0197-2456(84)90119-3; BAINES CJ, 1986, J CAN ASSOC RADIOL, V37, P256; BAINES CJ, 1994, ANN INTERN MED, V120, P326, DOI 10.7326/0003-4819-120-4-199402150-00011; BAINES CJ, 1989, CANCER, V63, P1816; Baxter N, 2001, CAN MED ASSOC J, V164, P1837; Berry DA, 1998, JNCI-J NATL CANCER I, V90, P1431, DOI 10.1093/jnci/90.19.1431; Cohen MM, 1996, J CLIN EPIDEMIOL, V49, P1039, DOI 10.1016/0895-4356(96)00117-5; CONNOR RJ, 1994, CONTROL CLIN TRIALS, V15, P81, DOI 10.1016/0197-2456(94)90014-0; Cox D. R., 1984, ANAL SURVIVAL DATA; Duffy SW, 2001, BREAST, V10, P209, DOI 10.1054/brst.2000.0238; EMSTER VL, 1996, JAMA-J AM MED ASSOC, V275, P913; FLETCHER SW, 1993, J NATL CANCER I, V85, P1644, DOI 10.1093/jnci/85.20.1644; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; Harvey BJ, 1997, CAN MED ASSOC J, V157, P1205; Hendrick R E, 1997, J Natl Cancer Inst Monogr, P87; Horton R, 2001, LANCET, V358, P1284, DOI 10.1016/S0140-6736(01)06452-2; Miller A B, 2001, IARC Sci Publ, V154, P171; Miller A B, 1997, J Natl Cancer Inst Monogr, P37; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2000, LANCET, V355, P747, DOI 10.1016/S0140-6736(00)00031-3; MILLER AB, 1981, CLIN INVEST MED, V4, P227; MILLER AB, 1992, CAN MED ASSOC J, V147, P1459; MILLER AB, 1991, CAN J PUBLIC HEALTH, V82, P162; MOSKOWITZ M, 1976, CANCER, V37, P2543, DOI 10.1002/1097-0142(197605)37:5<2543::AID-CNCR2820370547>3.0.CO;2-3; Narod SA, 1997, LANCET, V349, P1846, DOI 10.1016/S0140-6736(05)61736-9; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Paquette D, 2000, CAN MED ASSOC J, V163, P1133; PROROK PC, 1981, J CHRON DIS, V34, P159, DOI 10.1016/0021-9681(81)90026-6; Retsky M, 2001, BREAST CANCER RES TR, V65, P217, DOI 10.1023/A:1010626302152; SHAPIRO S, 1971, J AMER MED ASSOC, V215, P1777; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; Tabar L, 1995, J Med Screen, V2, P94; TARONE RE, 1995, CANCER, V75, P997, DOI 10.1002/1097-0142(19950215)75:4<997::AID-CNCR2820750415>3.0.CO;2-M	35	278	294	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2002	137	5	1				305	312		10.7326/0003-4819-137-5_Part_1-200209030-00005	http://dx.doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591DZ	12204013				2022-12-28	WOS:000177865600001
J	Rajagopalan, H; Bardelli, A; Lengauer, C; Kinzler, KW; Vogelstein, B; Velculescu, VE				Rajagopalan, H; Bardelli, A; Lengauer, C; Kinzler, KW; Vogelstein, B; Velculescu, VE			Tumorigenesis - RAF/RAS oncogenes and mismatch-repair status	NATURE			English	Article							MUTATIONS; GENE		Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21231 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Rajagopalan, H (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	velculescu@jhmi.edu	Velculescu, Victor/ABF-4846-2020; BARDELLI, Alberto/J-9721-2018	Velculescu, Victor/0000-0003-1195-438X; BARDELLI, Alberto/0000-0003-1647-5070				Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Markowitz S, 2000, J CLIN ONCOL, V18, p75S; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sparks AB, 1998, CANCER RES, V58, P1130; STORM SM, 1993, TOXICOL LETT, V67, P201, DOI 10.1016/0378-4274(93)90056-4; Thiagalingam S, 2001, P NATL ACAD SCI USA, V98, P2698, DOI 10.1073/pnas.051625398; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699	9	1000	1055	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2002	418	6901					934	934		10.1038/418934a	http://dx.doi.org/10.1038/418934a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198537	Bronze			2022-12-28	WOS:000177677500034
J	Cowie, MR; Zaphiriou, A				Cowie, MR; Zaphiriou, A			Recent developments - Management of chronic heart failure	BRITISH MEDICAL JOURNAL			English	Review							CORONARY-ARTERY DISEASE; RANDOMIZED TRIAL; TASK-FORCE; RECOMMENDATIONS; SPIRONOLACTONE; DEFIBRILLATOR; DYSFUNCTION; PREVENTION; CARVEDILOL; GUIDELINES		Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London SW3 6LY, England	Imperial College London	Cowie, MR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London SW3 6LY, England.		Cowie, Martin R/AAQ-2818-2020	Cowie, Martin R/0000-0001-7457-2552				Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; ABRAHAM WT, 2001, AM COLL CARD M ORL F; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; COATS AJ, 2000, CURR CONTR TRIALS C, V1, P155; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Cowie MR, 1997, EUR HEART J, V18, P208; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; COWIE MR, 2002, BR J CARDIOL, V9, P171; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Davie AP, 1996, BRIT MED J, V312, P222; Faris R, 2002, INT J CARDIOL, V82, P149, DOI 10.1016/S0167-5273(01)00600-3; Fox KF, 2001, EUR HEART J, V22, P228, DOI 10.1053/euhj.2000.2289; GOLDSTEIN S, 2002, J CARD FAIL S1, V6, P15; Hjalmarson A, 1999, LANCET, V353, P2001; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Kasirajan V, 2000, Semin Thorac Cardiovasc Surg, V12, P229; KUSUMOTO FM, 2001, JAMA-J AM MED ASSOC, V287, P1848; Lechat P, 1999, LANCET, V353, P9; Linde C, 2002, J AM COLL CARDIOL, V40, P111, DOI 10.1016/S0735-1097(02)01932-0; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; McMurray J, 2002, CIRCULATION, V105, P2223, DOI 10.1161/01.CIR.0000014771.38666.22; McMurray J, 2002, CIRCULATION, V105, P2099, DOI 10.1161/01.CIR.0000014763.63528.9D; McMurray J, 2001, EUR J HEART FAIL, V3, P495, DOI 10.1016/S1388-9842(01)00173-8; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Perry G, 1997, NEW ENGL J MED, V336, P525; Petersen S, 2002, CORONARY HEART DIS S; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt M, 2001, PROG CARDIOVASC DIS, V43, P373, DOI 10.1053/pcad.2001.20672; Remme WJ, 2001, EUR HEART J, V22, P1527, DOI 10.1053/euhj.2001.2783; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X	37	39	40	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2002	325	7361					422	+		10.1136/bmj.325.7361.422	http://dx.doi.org/10.1136/bmj.325.7361.422			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193359	Green Published			2022-12-28	WOS:000177715500021
J	Tulk, CA; Benmore, CJ; Urquidi, J; Klug, DD; Neuefeind, J; Tomberli, B; Egelstaff, PA				Tulk, CA; Benmore, CJ; Urquidi, J; Klug, DD; Neuefeind, J; Tomberli, B; Egelstaff, PA			Structural studies of several distinct metastable forms of amorphous ice	SCIENCE			English	Article							HIGH-DENSITY; LIQUID WATER; X-RAY; AMORPHIZATION; TRANSITION; SPECTRUM	Structural changes during annealing of high-density amorphous ice were studied with both neutron and x-ray diffraction. The first diffraction peak was followed from the high- to the low-density amorphous form. Changes were observed to occur through a series of intermediate forms that appear to be metastable at each anneal temperature. Five distinct amorphous forms were studied with neutron scattering, and many more forms may be possible. Radial distribution functions indicate that the structure evolves systematically between 4 and 8 angstroms. The phase transformations in low-temperature liquid water may be much more complex than currently understood.	Argonne Natl Lab, Div Intense Pulsed Neutron Source, Argonne, IL 60439 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Natl Res Council Canada, Ottawa, ON K0A 0R6, Canada; Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; National Research Council Canada; University of Guelph	Tulk, CA (corresponding author), Argonne Natl Lab, Div Intense Pulsed Neutron Source, 9700 S Cass Ave, Argonne, IL 60439 USA.		Neuefeind, Joerg/D-9990-2015; Tulk, Chris A/R-6088-2016	Neuefeind, Joerg/0000-0002-0563-1544; Tulk, Chris A/0000-0003-3400-3878; Benmore, Chris/0000-0001-7007-7749				Bellissent-Funel MC, 1998, EUROPHYS LETT, V42, P161, DOI 10.1209/epl/i1998-00223-5; BELLISSENTFUNEL MC, 1987, J CHEM PHYS, V87, P2231, DOI 10.1063/1.453150; BELLISSENTFUNEL MC, 1992, J CHEM PHYS, V97, P1282, DOI 10.1063/1.463254; BIZID A, 1987, J CHEM PHYS, V87, P2225, DOI 10.1063/1.453149; BOSIO L, 1986, PHYS REV LETT, V56, P460, DOI 10.1103/PhysRevLett.56.460; BURTON EF, 1936, P ROY SOC LOND A MAT, V153, P166; Finney JL, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.225503; FLORIANO MA, 1986, PHYS REV LETT, V57, P3062, DOI 10.1103/PhysRevLett.57.3062; HANDA YP, 1986, J CHEM PHYS, V84, P2766, DOI 10.1063/1.450301; Johari GP, 1996, SCIENCE, V273, P90, DOI 10.1126/science.273.5271.90; KLUG DD, 1987, J CHEM PHYS, V86, P5323, DOI 10.1063/1.452557; Loerting T, 2001, PHYS CHEM CHEM PHYS, V3, P5355, DOI 10.1039/b108676f; MAYER E, 1985, J PHYS CHEM-US, V89, P3474, DOI 10.1021/j100262a011; MAYER E, 1985, J APPL PHYS, V58, P663, DOI 10.1063/1.336179; Mishima O, 1996, NATURE, V384, P546, DOI 10.1038/384546a0; MISHIMA O, 1994, J CHEM PHYS, V100, P5910, DOI 10.1063/1.467103; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; MISHIMA O, 1984, NATURE, V310, P393, DOI 10.1038/310393a0; Rutt U, 2001, NUCL INSTRUM METH A, V467, P1026, DOI 10.1016/S0168-9002(01)00580-0; Schober H, 1997, PHYSICA B, V241, P897, DOI 10.1016/S0921-4526(97)00749-7; Soper AK, 2000, PHYS REV LETT, V84, P2881, DOI 10.1103/PhysRevLett.84.2881; Starr FW, 1999, PHYS REV E, V60, P1084, DOI 10.1103/PhysRevE.60.1084; Tomberli B, 2000, J PHYS-CONDENS MAT, V12, P2597, DOI 10.1088/0953-8984/12/12/303; Tse JS, 1999, NATURE, V400, P647, DOI 10.1038/23216; Tulk CA, 1998, J CHEM PHYS, V109, P8478, DOI 10.1063/1.477512; *US DOE, W31109ENG38 US DOE; *US DOE, DEA0500R22725 US DOE; WHALLEY E, 1986, ANN NY ACAD SCI, V484, P81	28	227	232	4	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1320	1323		10.1126/science.1074178	http://dx.doi.org/10.1126/science.1074178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193779				2022-12-28	WOS:000177573900038
J	Newton, PN; Michelson, G; Ruangveerayuth, R; White, NJ				Newton, PN; Michelson, G; Ruangveerayuth, R; White, NJ			Retinal haemorrhage in P falciparum malaria	LANCET			English	Editorial Material									Mahidol Univ, Fac Trop Med, Bangkok, Thailand; John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England; Mae Sot Hosp, Tak, Thailand; Univ Erlangen Nurnberg, Dept Ophthalmol, D-8520 Erlangen, Germany	Mahidol University; University of Oxford; University of Erlangen Nuremberg	Newton, PN (corresponding author), Mahidol Univ, Fac Trop Med, Bangkok, Thailand.		White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978; Newton, Paul/0000-0002-4608-6431					0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					515	515		10.1016/S0140-6736(02)09739-8	http://dx.doi.org/10.1016/S0140-6736(02)09739-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241654				2022-12-28	WOS:000177512800008
J	Haque, T; Wilkie, GM; Taylor, C; Amlot, PL; Murad, P; Iley, A; Dombagoda, D; Britton, KM; Swerdlow, AJ; Crawford, DH				Haque, T; Wilkie, GM; Taylor, C; Amlot, PL; Murad, P; Iley, A; Dombagoda, D; Britton, KM; Swerdlow, AJ; Crawford, DH			Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells	LANCET			English	Article							ADOPTIVE IMMUNOTHERAPY; IN-VITRO; LYMPHOCYTES; PREVENTION; IMMUNITY; BIOLOGY	Background Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disease (PTLD) is a common, often fatal, complication of bone-marrow and solid-organ transplantation. Since tumour growth results from inadequate T-cell control of latent EBV, new immunotherapeutic approaches to treatment are being pioneered. Methods In a phase 1/2 trial, eight patients with progressive PTLD unresponsive to conventional treatment were given one to six infusions of partly HILA-matched allogeneic EBV-specific cytotoxic T lymphocytes (CTLs) from a frozen bank of CTLs derived from healthy blood donors. Findings Of the five patients who completed treatment, three had complete remission and two had no clinical response. One patient partly responded after two infusions. No graft-versus-host disease or allo-specific antibodies were detected, and graft function improved in three cases. Tumour responses were mainly seen in those with early, localised, polyclonal disease. EBV load in peripheral blood fell to undetectable levels in all patients who responded to treatment, but was more variable in those who did not. Interpretation Treatment of EBV-associated PTLD with partly HLA-matched CTLs grown from unrelated donors is effective. Spontaneous remission is very unlikely to account for tumour regression in our patients; however, a larger, controlled trial is needed to assess this treatment further. The frozen bank of allogeneic CTLs is less prohibitively labour intensive and expensive for wide scale use than treatment with autologous CTLs. Such banks could be established to treat other infectious and neoplastic diseases in many patients.	Univ Edinburgh, Lab Clin & Mol Virol, Edinburgh EH9 1QH, Midlothian, Scotland; UCL Royal Free & Univ Coll Med Sch, Dept Immunol, London, England; Inst Canc Res, Epidemiol Sect, Sutton, Surrey, England	University of Edinburgh; University of London; University College London; UCL Medical School; University of London; Institute of Cancer Research - UK	Haque, T (corresponding author), Univ Edinburgh, Lab Clin & Mol Virol, Edinburgh EH9 1QH, Midlothian, Scotland.	t.haque@ed.ac.uk		Swerdlow, Anthony/0000-0001-5550-4159				Amlot PL, 1996, CLIN EXP IMMUNOL, V105, P176, DOI 10.1046/j.1365-2249.1996.d01-722.x; ARMITAGE JM, 1991, J HEART LUNG TRANSPL, V10, P877; CARMICHAEL A, 1993, J EXP MED, V177, P249, DOI 10.1084/jem.177.2.249; Cook RC, 1999, LANCET, V354, P1698, DOI 10.1016/S0140-6736(99)02058-9; Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783; Faulkner GC, 1999, J VIROL, V73, P1555, DOI 10.1128/JVI.73.2.1555-1564.1999; Haque T, 1998, J IMMUNOL, V160, P6204; Haque T, 1999, BRIT J HAEMATOL, V106, P309, DOI 10.1046/j.1365-2141.1999.01503.x; Haque T, 2001, TRANSPLANTATION, V72, P1399, DOI 10.1097/00007890-200110270-00012; HENLE G, 1966, J BACTERIOL, V91, P1248, DOI 10.1128/JB.91.3.1248-1256.1966; Johannessen I, 1998, J GEN VIROL, V79, P1631, DOI 10.1099/0022-1317-79-7-1631; Khanna R, 1999, P NATL ACAD SCI USA, V96, P10391, DOI 10.1073/pnas.96.18.10391; Khanna R, 2000, ANNU REV MICROBIOL, V54, P19, DOI 10.1146/annurev.micro.54.1.19; Nalesnik MA, 1998, SPRINGER SEMIN IMMUN, V20, P325, DOI 10.1007/BF00838047; O'Reilly RJ, 1998, SPRINGER SEMIN IMMUN, V20, P455, DOI 10.1007/BF00838055; POPE JH, 1968, INT J CANCER, V3, P857, DOI 10.1002/ijc.2910030619; RIDDELL SR, 1992, SCIENCE, V257, P238; Rooney CM, 1998, BLOOD, V92, P1549, DOI 10.1182/blood.V92.5.1549.417k32_1549_1555; ROONEY CM, 1995, LANCET, V345, P9, DOI 10.1016/S0140-6736(95)91150-2; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; STARZL TE, 1984, LANCET, V1, P583; SWINNEN LJ, 1995, BLOOD, V86, P3333, DOI 10.1182/blood.V86.9.3333.bloodjournal8693333	22	266	278	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					436	442		10.1016/S0140-6736(02)09672-1	http://dx.doi.org/10.1016/S0140-6736(02)09672-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241714				2022-12-28	WOS:000177342900008
J	Cox, T; Rochette, J; Camaschella, C; Walker, A; Robson, K				Cox, T; Rochette, J; Camaschella, C; Walker, A; Robson, K			Clinical haemochromatosis in HFE mutation carriers	LANCET			English	Letter									John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England; Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; CHU, Amiens, France; Univ Picardie, Amiens, France; Univ Turin, Dipartimento Sci Clin & Biol, Orbassano, Italy; UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Hepatol, London, England	University of Oxford; University of Cambridge; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); University of Turin; University of London; University College London; UCL Medical School	Robson, K (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England.	kathryn.robson@imm.ox.ac.uk						Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; CREPIN S, 2001, ANN ENDOCRINOL-PARIS, V62, P320; Jackson HA, 2001, BRIT J HAEMATOL, V114, P474, DOI 10.1046/j.1365-2141.2001.02949.x; Merryweather-Clarke AT, 1998, BRIT J HAEMATOL, V101, P369, DOI 10.1046/j.1365-2141.1998.00736.x	4	27	27	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					412	412		10.1016/S0140-6736(02)09582-X	http://dx.doi.org/10.1016/S0140-6736(02)09582-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241804				2022-12-28	WOS:000177255600037
J	Hettich, C; Schmitt, C; Zitzmann, J; Kuhn, S; Gerhardt, I; Sandoghdar, V				Hettich, C; Schmitt, C; Zitzmann, J; Kuhn, S; Gerhardt, I; Sandoghdar, V			Nanometer resolution and coherent optical dipole coupling of two individual molecules	SCIENCE			English	Article							SINGLE; FLUORESCENCE; MICROSCOPY; EXCITATION; TERPHENYL	By performing cryogenic laser spectroscopy under scanning probe electrode that induces local electric field, we have resolved two individual fluorescent molecules separated by 12 nanometers in an organic crystal. The two molecules undergo strong coherent dipole-dipole coupling that produces entangled sub- and superradiant states. Under intense laser illumination, both molecules are excited via two-photon transition, and the fluorescence from this doubly excited system displays photon bunching. Our experimental scheme can be used to optically resolve molecules at the nanometer scale and to manipulate the degree of entanglement among them.	Swiss Fed Inst Technol, Chem Phys Lab, CH-8093 Zurich, Switzerland; Univ Konstanz, Dept Phys, D-78457 Constance, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Konstanz	Sandoghdar, V (corresponding author), Swiss Fed Inst Technol, Chem Phys Lab, CH-8093 Zurich, Switzerland.	vahid.sandoghdar@ethz.ch	Sandoghdar, Vahid/AAT-8856-2020	Sandoghdar, Vahid/0000-0003-2594-4801				Agarwal G., 1974, SPRINGER TRACTS MODE, V70, P1; Akram U, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.013413; Altner SB, 1996, PHYS REV LETT, V76, P1747, DOI 10.1103/PhysRevLett.76.1747; BASCHE T, 1992, PHYS REV LETT, V69, P1516, DOI 10.1103/PhysRevLett.69.1516; Beige A, 1998, PHYS REV A, V58, P4133, DOI 10.1103/PhysRevA.58.4133; BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237; Brown R., 1997, SINGLE MOL OPTICAL D, P109; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; Hu XC, 1997, PHYS TODAY, V50, P28, DOI 10.1063/1.881879; KUMMER S, 1994, CHEM PHYS LETT, V229, P309, DOI 10.1016/0009-2614(94)01043-9; Lacoste TD, 2000, P NATL ACAD SCI USA, V97, P9461, DOI 10.1073/pnas.170286097; Leite JRR, 1980, CHEM PHYS LETT, V73, P71; LLOYD S, 1993, SCIENCE, V261, P1569, DOI 10.1126/science.261.5128.1569; Loudon R., 1983, QUANTUM THEORY LIGHT; Michaelis J, 2000, NATURE, V405, P325, DOI 10.1038/35012545; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; ORRIT M, 1990, PHYS REV LETT, V65, P2716, DOI 10.1103/PhysRevLett.65.2716; RICHTER T, 1982, OPT ACTA, V29, P265, DOI 10.1080/713820845; Sandoghdar V, 2001, SINGLE MOL, V2, P277, DOI 10.1002/1438-5171(200112)2:4<277::AID-SIMO277>3.0.CO;2-Y; van Oijen AM, 1999, J OPT SOC AM A, V16, P909, DOI 10.1364/JOSAA.16.000909; VARADA GV, 1992, PHYS REV A, V45, P6721, DOI 10.1103/PhysRevA.45.6721; VARSANYI F, 1961, PHYS REV LETT, V7, P442, DOI 10.1103/PhysRevLett.7.442; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; ZITZMANN J, UNPUB	26	278	281	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2002	298	5592					385	389		10.1126/science.1075606	http://dx.doi.org/10.1126/science.1075606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12215651				2022-12-28	WOS:000178510400040
J	Mendell, JT; Rhys, CMJP; Dietz, HC				Mendell, JT; Rhys, CMJP; Dietz, HC			Separable roles for rent1/hUpf1 in altered splicing and decay of nonsense transcripts	SCIENCE			English	Article							OPEN READING FRAME; PREMATURE TERMINATION CODON; MESSENGER-RNA; DEPENDENT MANNER; MAMMALIAN-CELLS; MEDIATED DECAY; GENE; TRANSLATION; EXON; SURVEILLANCE	The mechanism by which disruption of reading frame can influence pre-messenger RNA (pre-mRNA) processing is poorly understood. We assessed the role of factors essential for nonsense-mediated mRNA decay (NMD) in nonsense-mediated altered splicing (NAS) with the use of RNA interference (RNAi) in mammalian cells. Inhibition of rent1/hUpf1 expression abrogated both NMD and NAS of nonsense T cell receptor beta transcripts. In contrast, inhibition of rent2/hUpf2 expression did not disrupt NAS despite achieving comparable stabilization of nonsense transcripts. We also demonstrate that NAS and NMD are genetically separable functions of rent1/hUpf1. Additionally, rent1/hUpf1 enters the nucleus where it may directly influence early events in mRNA biogenesis. This provides compelling evidence that NAS relies on a component of the nonsense surveillance machinery but is not an indirect consequence of NMD.	Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, 858 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055239] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55239] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APPLEQUIST SE, 1997, NUCLEIC ACIDS RES, V25, P15; Caputi M, 2002, GENE DEV, V16, P1754, DOI 10.1101/gad.997502; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gersappe A, 1999, MOL CELL BIOL, V19, P1640; Gersappe A, 1999, J BIOL CHEM, V274, P22452, DOI 10.1074/jbc.274.32.22452; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Li BH, 2002, P NATL ACAD SCI USA, V99, P5277, DOI 10.1073/pnas.082095299; Li SL, 1997, J EXP MED, V185, P985, DOI 10.1084/jem.185.6.985; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; MAQUAT LE, 1995, RNA, V1, P453; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Muhlemann O, 2001, MOL CELL, V8, P33, DOI 10.1016/S1097-2765(01)00288-X; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Wang J, 2002, J BIOL CHEM, V277, P18489, DOI 10.1074/jbc.M111781200; Wang J, 2002, SCIENCE, V297, P108, DOI 10.1126/science.1069757; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Weng YM, 1996, MOL CELL BIOL, V16, P5491, DOI 10.1128/mcb.16.10.5491; Wilkinson MF, 2001, BIOESSAYS, V23, P775, DOI 10.1002/bies.1113	25	219	230	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 11	2002	298	5592					419	422		10.1126/science.1074428	http://dx.doi.org/10.1126/science.1074428			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12228722				2022-12-28	WOS:000178510400050
J	Spence, D				Spence, D			Interpreting the evidence	BRITISH MEDICAL JOURNAL			English	Review									Maryhill Hlth Ctr, Glasgow G20 9DR, Lanark, Scotland		Spence, D (corresponding author), Maryhill Hlth Ctr, Glasgow G20 9DR, Lanark, Scotland.							COLLINS R, 1995, LANCET, V345, P669; Evans AT, 2002, LANCET, V359, P1648, DOI 10.1016/S0140-6736(02)08597-5; HILTON E, 1992, ANN INTERN MED, V116, P353, DOI 10.7326/0003-4819-116-5-353; Horton R, 1999, BRIT MED J, V319, P865, DOI 10.1136/bmj.319.7214.865	4	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2002	325	7364					587	587		10.1136/bmj.325.7364.587	http://dx.doi.org/10.1136/bmj.325.7364.587			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595JJ	12228138	Green Published			2022-12-28	WOS:000178105200025
J	Allshire, R				Allshire, R			RNAi and heterochromatin - a hushed-up affair	SCIENCE			English	Editorial Material							DOUBLE-STRANDED-RNA; GENE		Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Allshire, R (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland.			Allshire, Robin/0000-0002-8005-3625				Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Dudley NR, 2002, P NATL ACAD SCI USA, V99, P4191, DOI 10.1073/pnas.062605199; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; RUDERT F, 1995, MAMM GENOME, V6, P76, DOI 10.1007/BF00303248; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574	19	51	166	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1818	1819		10.1126/science.1075874	http://dx.doi.org/10.1126/science.1075874			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12193643				2022-12-28	WOS:000177955000028
J	Gruner, SM				Gruner, SM			Caught in the act	SCIENCE			English	Editorial Material									Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA	Cornell University; Cornell University	Gruner, SM (corresponding author), Cornell Univ, Dept Phys, Ithaca, NY 14853 USA.		Gruner, Sol/G-2924-2010	Gruner, Sol/0000-0002-1171-4426				GRUNER SM, 1989, J PHYS CHEM-US, V93, P7562, DOI 10.1021/j100359a011; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Lentz BR, 2000, CURR OPIN STRUC BIOL, V10, P607, DOI 10.1016/S0959-440X(00)00138-X; Markin VS, 2002, BIOPHYS J, V82, P693, DOI 10.1016/S0006-3495(02)75432-5; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354	6	10	10	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1817	1818		10.1126/science.1076394	http://dx.doi.org/10.1126/science.1076394			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228705				2022-12-28	WOS:000177955000027
J	Falkovich, G; Fouxon, A; Stepanov, MG				Falkovich, G; Fouxon, A; Stepanov, MG			Acceleration of rain initiation by cloud turbulence	NATURE			English	Article							AEROSOL-PARTICLES; HEAVY-PARTICLES; COLLISION; DISPERSION; VELOCITY; DROPS	Vapour condensation in cloud cores produces small droplets that are close to one another in size. Droplets are believed to grow to raindrop size by coalescence due to collision(1,2). Air turbulence is thought to be the main cause for collisions of similar-sized droplets exceeding radii of a few micrometres, and therefore rain prediction requires a quantitative description of droplet collision in turbulence(1-5). Turbulent vortices act as small centrifuges that spin heavy droplets out, creating concentration inhomogeneities (6-14) and jets of droplets, both of which increase the mean collision rate. Here we derive a formula for the collision rate of small heavy particles in a turbulent flow, using a recently developed formalism for tracing random trajectories(15, 16).We describe an enhancement of inertial effects by turbulence intermittency and an interplay between turbulence and gravity that determines the collision rate. We present a new mechanism, the 'sling effect', for collisions due to jets of droplets that become detached from the air flow. We conclude that air turbulence can substantially accelerate the appearance of large droplets that trigger rain.	Weizmann Inst Sci, IL-76100 Rehovot, Israel; Inst Automat & Electrometry, Novosibirsk 630090, Russia	Weizmann Institute of Science; Institute of Automation & Electrometry SB RAS	Falkovich, G (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.	fnfal@wicc.weizmann.ac.il	Stepanov, Mikhail/GZM-6775-2022; FALKOVICH, GREGORY/K-1561-2012	Stepanov, Mikhail/0000-0003-1331-8897; FALKOVICH, GREGORY/0000-0002-0570-7895				Balkovsky E, 2001, PHYS REV LETT, V86, P2790, DOI 10.1103/PhysRevLett.86.2790; Belin F, 1997, PHYS FLUIDS, V9, P3843, DOI 10.1063/1.869484; Brenguier JL, 2001, J ATMOS SCI, V58, P628, DOI 10.1175/1520-0469(2001)058<0628:DSBICC>2.0.CO;2; BRUMFIEL G, 2001, PHYS REV FOCUS, V7; Crowe C, 1993, PARTICULATE 2 PHASE, P626; Davila J, 2001, J FLUID MECH, V440, P117, DOI 10.1017/S0022112001004694; Falkovich G, 2001, REV MOD PHYS, V73, P913, DOI 10.1103/RevModPhys.73.913; GRITS B, 2000, P 13 INT C CLOUDS PR, V1, P138; JOHNSON DB, 1982, J ATMOS SCI, V39, P448, DOI 10.1175/1520-0469(1982)039<0448:TROGAU>2.0.CO;2; Jonas PR, 1996, ATMOS RES, V40, P283, DOI 10.1016/0169-8095(95)00035-6; Kostinski AB, 2001, J FLUID MECH, V434, P389, DOI 10.1017/S0022112001004001; MARBLE FE, 1970, ANNU REV FLUID MECH, V2, P397, DOI 10.1146/annurev.fl.02.010170.002145; MAXEY MR, 1987, J FLUID MECH, V174, P441, DOI 10.1017/S0022112087000193; MAXEY MR, 1983, PHYS FLUIDS, V26, P883, DOI 10.1063/1.864230; Pinsky M, 2001, J ATMOS SCI, V58, P742, DOI 10.1175/1520-0469(2001)058<0742:CEODIA>2.0.CO;2; Pinsky M, 2000, ATMOS RES, V53, P131, DOI 10.1016/S0169-8095(99)00048-4; Pinsky MB, 1997, J AEROSOL SCI, V28, P1177, DOI 10.1016/S0021-8502(97)00005-0; Pruppacher H. R, 1998, MICROPHYSICS CLOUDS; RAJU N, 1995, PHYS FLUIDS, V7, P1241, DOI 10.1063/1.868581; Reade WC, 2000, PHYS FLUIDS, V12, P2530, DOI 10.1063/1.1288515; SAFFMAN PG, 1956, J FLUID MECH, V1, P16, DOI 10.1017/S0022112056000020; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; Shraiman BI, 2000, NATURE, V405, P639, DOI 10.1038/35015000; SQUIRES KD, 1991, J FLUID MECH, V226, P1, DOI 10.1017/S0022112091002276; Sundaram S, 1997, J FLUID MECH, V335, P75, DOI 10.1017/S0022112096004454; Vaillancourt PA, 2000, B AM METEOROL SOC, V81, P285, DOI 10.1175/1520-0477(2000)081<0285:ROPIAC>2.3.CO;2; VEKSHTEIN G, 1992, PHYSICS CONTINUOUS M, P93; WANG LP, 1993, J FLUID MECH, V256, P27, DOI 10.1017/S0022112093002708; Wurzler S, 2000, J GEOPHYS RES-ATMOS, V105, P4501, DOI 10.1029/1999JD900980; Zhou Y, 2001, J FLUID MECH, V433, P77, DOI 10.1017/S0022112000003372	30	445	449	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					151	154		10.1038/nature00983	http://dx.doi.org/10.1038/nature00983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226661				2022-12-28	WOS:000177931200037
J	Miake, J; Marban, E; Nuss, HB				Miake, J; Marban, E; Nuss, HB			Gene therapy - Biological pacemaker created by gene transfer	NATURE			English	Article							CHANNELS; MYOCYTES; NODE		Johns Hopkins Univ, Sch Med, Inst Mol Cardiobiol, Baltimore, MD 21205 USA	Johns Hopkins University	Miake, J (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Cardiol,Cardiol Res Grp, Baltimore, MD 21201 USA.		Marban, Eduardo/GWC-8514-2022; Miake, Junichiro/AAD-3643-2020	Miake, Junichiro/0000-0001-7781-3649				Brooks C., 1972, SINOATRIAL PACEMAKER; BROWN HF, 1984, PROC R SOC SER B-BIO, V222, P329, DOI 10.1098/rspb.1984.0067; CAMPBELL DL, 1988, J PHYSIOL-LONDON, V403, P239, DOI 10.1113/jphysiol.1988.sp017248; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HIRANO Y, 1988, J PHYSIOL-LONDON, V395, P455, DOI 10.1113/jphysiol.1988.sp016929; IMOTO Y, 1987, AM J PHYSIOL, V252, P325; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kusumoto FM, 1996, NEW ENGL J MED, V334, P89, DOI 10.1056/NEJM199601113340206; Rodriguez-Contreras A, 2002, J PHYSIOL-LONDON, V538, P729, DOI 10.1113/jphysiol.2001.013312; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; WOBUS AM, 1995, ANN NY ACAD SCI, V752, P460, DOI 10.1111/j.1749-6632.1995.tb17456.x	13	305	351	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					132	133		10.1038/419132b	http://dx.doi.org/10.1038/419132b			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226654				2022-12-28	WOS:000177931200031
J	Gerritsen, AAM; de Vet, HCW; Scholten, RJPM; Bertelsmann, FW; de Krom, MCTFM; Bouter, LM				Gerritsen, AAM; de Vet, HCW; Scholten, RJPM; Bertelsmann, FW; de Krom, MCTFM; Bouter, LM			Splinting vs surgery in the treatment of carpal tunnel syndrome - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNDERSTANDING CONTROLLED TRIALS; IMMEDIATE SURGERY; CLINICAL-TRIALS	Context Carpal tunnel syndrome (CTS) can be treated with nonsurgical or surgical options. However, there is no consensus on the most effective method of treatment. Objective To compare the short-term and long-term efficacy of splinting and surgery Tor relieving the symptoms of CTS. Design, Setting, and Patients A randomized controlled trial conducted from October 1998 to April 2000 at 13 neurological outpatient clinics in the Netherlands. A total of 176 patients with clinically and electrophysiologically confirmed idiopathic CTS were assigned to wrist splinting during the night for at least 6 weeks (89 patients) or open carpal tunnel release (87 patients); 147 patients (84%) completed the final follow-up assessment 18 months after randomization. Main Outcome Measures General improvement, number of nights waking up due to symptoms, and severity of symptoms. Results In the intention-to-treat analyses, surgery was more effective than splinting on all outcome measures. The success rates (based on general improvement) after 3 months were 80% for the surgery group (62/78 patients) vs 54% for the splinting group (46/86 patients), which is a difference of 26% (95% confidence interval [01, 12%-40%; P<.001). After 18 months, the success rates increased to 90% for the surgery group (61/68 patients) vs 75% for the splinting group (59/79 patients), which is a difference of 15% (95% Cl, 3%-27%; P=.02). However, by that time 41% of patients (32/79) in the splint group had also received the surgery treatment. Conclusion Treatment with open carpal tunnel release surgery resulted in better outcomes than treatment with wrist splinting for patients with CTS.	Free Univ Amsterdam, Med Ctr, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, Dutch Cochrane Ctr, NL-1105 AZ Amsterdam, Netherlands; Amstelveen Hosp, Dept Neurol, Amstelveen, Netherlands; Maastricht Univ Hosp, Dept Neurol, Maastricht, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University Medical Centre (MUMC)	Gerritsen, AAM (corresponding author), Free Univ Amsterdam, Med Ctr, Inst Res Extramural Med, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.			Bouter, Lex/0000-0002-2659-5482; de Vet, Henrica/0000-0002-5454-2804				ALTROCCHI PH, 1993, NEUROLOGY, V43, P2406; BURKE DT, 1994, ARCH PHYS MED REHAB, V75, P1241, DOI 10.1016/0003-9993(94)90012-4; D'Arcy CA, 2000, JAMA-J AM MED ASSOC, V283, P3110, DOI 10.1001/jama.283.23.3110; DEKROM MCTFM, 1992, J CLIN EPIDEMIOL, V45, P373, DOI 10.1016/0895-4356(92)90038-O; GARLAND H, 1964, LANCET, V1, P1129; Gerritsen A A, 2001, BMC Neurol, V1, P8, DOI 10.1186/1471-2377-1-8; Gerritsen AAM, 2002, J NEUROL, V249, P272, DOI 10.1007/s004150200004; Gerritsen AAM, 2001, BRIT J SURG, V88, P1285, DOI 10.1046/j.0007-1323.2001.01858.x; JOHNSON EW, 1995, MUSCLE NERVE, V18, P658, DOI 10.1002/mus.880180613; LEE YJ, 1991, STAT MED, V10, P1595, DOI 10.1002/sim.4780101011; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; Manente G, 2001, MUSCLE NERVE, V24, P1020, DOI 10.1002/mus.1105; Roberts C, 1998, BRIT MED J, V317, P1301, DOI 10.1136/bmj.317.7168.1301; Scholten RJPM, 1997, MUSCLE NERVE, V20, P1334, DOI 10.1002/(SICI)1097-4598(199710)20:10<1334::AID-MUS25>3.0.CO;2-1; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Torgerson DJ, 1999, BRIT MED J, V319, P375, DOI 10.1136/bmj.319.7206.375; van der Windt DAWM, 1998, BRIT MED J, V317, P1292, DOI 10.1136/bmj.317.7168.1292; WILSON JR, 1995, MUSCLE NERVE, V18, P660, DOI 10.1002/mus.880180614	18	225	232	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1245	1251		10.1001/jama.288.10.1245	http://dx.doi.org/10.1001/jama.288.10.1245			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215131	Bronze, Green Published			2022-12-28	WOS:000177917700023
J	Cuschieri, A				Cuschieri, A			Management of patients with gallstones and ductal calculi	LANCET			English	Editorial Material							ENDOSCOPIC SPHINCTEROTOMY; RANDOMIZED TRIAL; IN-SITU; SURGERY; CHOLECYSTECTOMY; EXPLORATION; STONES		Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland	University of Dundee	Cuschieri, A (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland.		Cuschieri, Alfred/O-4092-2019; Cuschieri, Alfred/A-7634-2013	Cuschieri, Alfred/0000-0003-0764-5947; 				Bergman JJGHM, 1996, GASTROINTEST ENDOSC, V44, P643, DOI 10.1016/S0016-5107(96)70045-7; Costamagna G, 2002, ENDOSCOPY, V34, P273, DOI 10.1055/s-2002-23632; Cuschieri A, 1999, SURG ENDOSC-ULTRAS, V13, P952, DOI 10.1007/s004649901145; DAVIDSON BR, 1988, GUT, V29, P114, DOI 10.1136/gut.29.1.114; ESCOURROU J, 1984, GUT, V25, P598, DOI 10.1136/gut.25.6.598; Hammarstrom LE, 1996, SCAND J GASTROENTERO, V31, P294, DOI 10.3109/00365529609004881; HILL J, 1991, BRIT J SURG, V78, P554, DOI 10.1002/bjs.1800780512; Lai KH, 1999, GASTROINTEST ENDOSC, V49, P483, DOI 10.1016/S0016-5107(99)70047-7; Lai KH, 2002, GASTROINTEST ENDOSC, V55, P523, DOI 10.1067/mge.2002.122611; LEZOCHE E, 1995, SURG ENDOSC-ULTRAS, V9, P1070; NEOPTOLEMOS JP, 1987, BRIT MED J, V294, P470, DOI 10.1136/bmj.294.6570.470; PHILLIPS EH, 1994, SURG ENDOSC-ULTRAS, V8, P1389; STIEGMANN GV, 1992, AM J SURG, V163, P227, DOI 10.1016/0002-9610(92)90106-2; Targarona EM, 1996, LANCET, V347, P926, DOI 10.1016/S0140-6736(96)91413-0	14	7	7	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 7	2002	360	9335					739	740		10.1016/S0140-6736(02)09946-4	http://dx.doi.org/10.1016/S0140-6736(02)09946-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592HX	12241828				2022-12-28	WOS:000177933000011
J	Doray, B; Ghosh, P; Griffith, J; Geuze, HJ; Kornfeld, S				Doray, B; Ghosh, P; Griffith, J; Geuze, HJ; Kornfeld, S			Cooperation of GGAs and AP-1 in packaging MPRs at the trans-Golgi network	SCIENCE			English	Article							MANNOSE 6-PHOSPHATE RECEPTORS; CYTOPLASMIC DOMAIN; ADAPTER COMPLEX; GAMMA-ADAPTIN; BINDING-SITES; VHS DOMAINS; PROTEINS; CLATHRIN; FAMILY; INTERACT	The Golgi-localized, gamma-ear-containing, adenosine diphosphate ribosylation factor-binding proteins (GGAs) are multidomain proteins that bind mannose 6-phosphate receptors (MPRs) in the Golgi and have an essential role in lysosomal enzyme sorting. Here the GGAs and the coat protein adaptor protein-1 (AP-1) were shown to colocalize in clathrin-coated buds of the trans-Golgi networks of mouse L cells and human HeLa cells. Binding studies revealed a direct interaction between the hinge domains of the GGAs and the gamma-ear domain of AP-1. Further, AP-1 contained bound casein kinase-2 that phosphorylated GGA1 and GGA3, thereby causing autoinhibition. This could induce the directed transfer of the MPRs from GGAs to AP-1. MPRs that are defective in binding to GGAs are poorly incorporated into AP-1-containing clathrin-coated vesicles. Thus, the GGAs and AP-1 interact to package MPRs into AP-1-containing coated vesicles.	Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Univ Utrecht, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; Univ Utrecht, Univ Med Ctr, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Washington University (WUSTL); Utrecht University; Utrecht University; Utrecht University Medical Center	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, 660 S Euclid Ave, St Louis, MO 63110 USA.			Doray, Balraj/0000-0003-3347-5013	NATIONAL CANCER INSTITUTE [R01CA008759] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA-08759] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Doray B, 2002, P NATL ACAD SCI USA, V99, P8072, DOI 10.1073/pnas.082235699; Doray B, 2001, MOL BIOL CELL, V12, P1925, DOI 10.1091/mbc.12.7.1925; GEUZE HJ, 1981, J CELL BIOL, V89, P653, DOI 10.1083/jcb.89.3.653; Hao WH, 1999, J BIOL CHEM, V274, P22785, DOI 10.1074/jbc.274.32.22785; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Honing S, 1997, J BIOL CHEM, V272, P19884, DOI 10.1074/jbc.272.32.19884; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; MERESSE S, 1990, J BIOL CHEM, V265, P18833; Mishra SK, 2001, J BIOL CHEM, V276, P46230, DOI 10.1074/jbc.M108177200; MISHRA SK, IN PRESS EMBO J; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; RAPOSO G, 1997, WEIRS HDB EXPT IMMUN; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	26	195	199	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1700	1703		10.1126/science.1075327	http://dx.doi.org/10.1126/science.1075327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215646				2022-12-28	WOS:000177819100049
J	Saltmarsh, MJ; Shapira, D				Saltmarsh, MJ; Shapira, D			Questions regarding nuclear emissions in cavitation experiments	SCIENCE			English	Editorial Material									Oak Ridge Natl Lab, Div Phys, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Saltmarsh, MJ (corresponding author), Oak Ridge Natl Lab, Div Phys, Oak Ridge, TN 37831 USA.	shapirad@ornl.gov						Dickens JK., 1988, 6462 ORNL; HARVEY JA, 1979, NUCL INSTRUM METHODS, V162, P507, DOI 10.1016/0029-554X(79)90730-4; *OAK RIDG NAT LAB, DEACO500OR22725 OAK; Taleyarkhan RP, 2002, SCIENCE, V295, P1868, DOI 10.1126/science.1067589	4	3	3	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587												2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215611				2022-12-28	WOS:000177819100001
J	Sahlas, DJ; MacLean, JD; Janevski, J; Detsky, AS				Sahlas, DJ; MacLean, JD; Janevski, J; Detsky, AS			Out of Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRYPANOSOMA-BRUCEI; NERVOUS-SYSTEM; DIAGNOSIS		Sunnybrook & Womens Coll Hosp, Dept Med, Toronto, ON, Canada; McGill Univ, Montreal Gen Hosp, Ctr Trop Dis, Montreal, PQ H3G 1A4, Canada; Mt Sinai Hosp, Univ Hlth Network, Dept Med, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto; University of Toronto; University of Toronto	Sahlas, DJ (corresponding author), Sunnybrook & Womens Coll Hosp, Dept Med, Toronto, ON, Canada.							Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; BENTIVOGLIO M, 1994, TRENDS NEUROSCI, V17, P325, DOI 10.1016/0166-2236(94)90170-8; Buguet A, 1999, CHRONOBIOL INT, V16, P477, DOI 10.3109/07420529908998722; CATTAND P, 1988, B WORLD HEALTH ORGAN, V66, P83; Chimelli L, 1997, BRAIN PATHOL, V7, P599, DOI 10.1111/j.1750-3639.1997.tb01077.x; DUNA GF, 1995, J RHEUMATOL, V22, P662; HOLMES PH, 1987, PARASITOLOGY, V94, P29; Moore AC, 2002, NEW ENGL J MED, V346, P2069, DOI 10.1056/NEJMcpc010056; Penchenier L, 2000, T ROY SOC TROP MED H, V94, P392, DOI 10.1016/S0035-9203(00)90116-0; PEPIN J, 1999, TROPICAL INFECT DIS, P774; ROBINSBROWNE RM, 1975, AM J TROP MED HYG, V24, P226, DOI 10.4269/ajtmh.1975.24.226; SEAH SKK, 1972, CAN MED ASSOC J, V106, P902; Sinha A, 1999, CLIN INFECT DIS, V29, P840, DOI 10.1086/520446; Smith DH, 1998, BRIT MED BULL, V54, P341, DOI 10.1093/oxfordjournals.bmb.a011692; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941	15	17	17	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2002	347	10					749	753		10.1056/NEJMcps021049	http://dx.doi.org/10.1056/NEJMcps021049			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NH	12213947				2022-12-28	WOS:000177765800009
J	Toda, S; Stein, RS; Sagiya, T				Toda, S; Stein, RS; Sagiya, T			Evidence from the AD 2000 Izu islands earthquake swarm that stressing rate governs seismicity	NATURE			English	Article							CRUSTAL DEFORMATION; KILAUEA-VOLCANO; CENTRAL JAPAN; PENINSULA; MAGMA; ICELAND; MODEL	Magma intrusions and eruptions commonly produce abrupt changes in seismicity far from magma conduits(1-4) that cannot be associated with the diffusion of pore fluids or heat(5). Such 'swarm' seismicity also migrates with time, and often exhibits a 'dog-bone'-shaped distribution(3,4,6-9). The largest earthquakes in swarms produce aftershocks that obey an Omori-type (exponential) temporal decay(10-12), but the duration of the aftershock sequences is drastically reduced, relative to normal earthquake activity(7,13). Here we use one of the most energetic swarms ever recorded to study the dependence of these properties on the stress imparted by a magma intrusion(8,11,14,15). A 1,000-fold increase in seismicity rate and a 1,000-fold decrease in aftershock duration occurred during the two-month-long dyke intrusion. We find that the seismicity rate is proportional to the calculated stressing rate, and that the duration of aftershock sequences is inversely proportional to the stressing rate. This behaviour is in accord with a laboratory-based rate/state constitutive law 16, suggesting an explanation for the occurrence of earthquake swarms. Any sustained increase in stressing rate-whether due to an intrusion, extrusion or creep event-should produce such seismological behaviour.	AIST, Act Fault Res Ctr, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; US Geol Survey, Menlo Pk, CA 94025 USA; Geol Survey Inst, Tsukuba, Ibaraki 3050811, Japan	National Institute of Advanced Industrial Science & Technology (AIST); United States Department of the Interior; United States Geological Survey	Toda, S (corresponding author), AIST, Act Fault Res Ctr, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan.		Sagiya, Takeshi/N-8417-2018	Sagiya, Takeshi/0000-0001-7949-8048				Aoki Y, 1999, SCIENCE, V286, P927, DOI 10.1126/science.286.5441.927; BJORNSSON A, 1977, NATURE, V266, P318, DOI 10.1038/266318a0; Chouet BA, 1996, NATURE, V380, P309, DOI 10.1038/380309a0; DELANEY PT, 1982, J GEOPHYS RES, V87, P7739, DOI 10.1029/JB087iB09p07739; Dieterich J, 2000, NATURE, V408, P457, DOI 10.1038/35044054; DIETERICH J, 1994, J GEOPHYS RES-SOL EA, V99, P2601, DOI 10.1029/93JB02581; DVORAK JJ, 1986, TECTONOPHYSICS, V124, P193, DOI 10.1016/0040-1951(86)90200-3; GROSS SJ, 1994, B SEISMOL SOC AM, V84, P1571; HILL DP, 1977, J GEOPHYS RES, V82, P1347, DOI 10.1029/JB082i008p01347; INGEBRITSEN SE, 1998, GROUNDWATER GEOLOGIC, P16; KISSLINGER C, 1991, J GEOPHYS RES-SOLID, V96, P11947, DOI 10.1029/91JB01200; KLEIN FW, 1977, J GEOPHYS RES, V82, P865, DOI 10.1029/JB082i005p00865; Mori J, 1996, FIRE AND MUD, P371; Nishimura T, 2001, GEOPHYS RES LETT, V28, P3745, DOI 10.1029/2001GL013051; OKADA Y, 1991, J PHYS EARTH, V39, P177, DOI 10.4294/jpe1952.39.177; Sagiya T, 2000, PURE APPL GEOPHYS, V157, P2303; Sakai S. I., 2001, J GEOGR, V110, P145; Toda S, 1998, J GEOPHYS RES-SOL EA, V103, P24543, DOI 10.1029/98JB00765; Ukawa M, 1996, TECTONOPHYSICS, V253, P285, DOI 10.1016/0040-1951(95)00077-1; WALTER AW, 1980, J GEOPHYS RES, V85, P2441, DOI 10.1029/JB085iB05p02441; WATANABE K, 1989, B DISASTER PREVENTIO, V39, P1; WEAVER CS, 1981, US GEOL SURV PROF PA, V1250, P109	22	306	307	4	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					58	61		10.1038/nature00997	http://dx.doi.org/10.1038/nature00997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214230				2022-12-28	WOS:000177788600035
J	Graham, R; Roberts, RG; Ostergaard, DJ; Kahn, NB; Pugno, PA; Green, LA				Graham, R; Roberts, RG; Ostergaard, DJ; Kahn, NB; Pugno, PA; Green, LA			Family practice in the United States - A status report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE; HEALTH; PHYSICIANS; CHALLENGE; MEDICINE; QUALITY	Since family practice was first recognized as a specialty in the late 1960s, considerable intellectual and organizational change has occurred in medicine, especially during the 1990s. To reflect on and reconsider the role of family practice in US health care, this article reviews the development of family,practice as a specialty, provides a current assessment of the status of family medicine in the United States, and comments on issues that are of ongoing importance to family practice.	Robert Graham Ctr Policy Studies Family Practice, Washington, DC 20036 USA; Univ Wisconsin, Sch Med, Dept Family Med, Madison, WI USA; Amer Acad Family Phys, Leawood, KS USA	University of Wisconsin System; University of Wisconsin Madison	Graham, R (corresponding author), Robert Graham Ctr Policy Studies Family Practice, 2023 Massachusetts Ave NW, Washington, DC 20036 USA.	rgraham@ahrq.gov						*AD HOC COMM ED FA, 1966, M CHALL FAM PRACT; Adams DP., 1999, AM BOARD FAMILY PRAC; *AM AC FAM PHYS, 2000, 150E AAFP; *AM AC FAM PHYS, 2000, 155Z AM AC FAM PHYS; *AM AC FAM PHYS, 2000, FACTS FAM PRACT 2000, P8; *AM AC FAM PHYS, 2001, 164 AAFP; *AM AC FAM PHYS, 2000, 151 AAFP; *AM BOARD FAM PRAC, 2001, DIPL STAT; *AM MED ASS, 1939, FACT DAT MED EC; BOWMAN MA, 1989, J FAM PRACTICE, V28, P346; Carmichael L P, 1976, J Fam Pract, V3, P562; CHRISTAKIS NA, 1995, JAMA-J AM MED ASSOC, V274, P706, DOI 10.1001/jama.274.9.706; Citizens Commission on Graduate Medical Education, 1966, GRAD ED PHYS; Curry H B, 1974, J Fam Pract, V1, P70; Donaldson M, 1996, PRIMARY CARE AM HLTH; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Ferrante JM, 2000, J AM BOARD FAM PRACT, V13, P408, DOI DOI 10.3122/15572625-13-6-408; Forrest CB, 2001, JAMA-J AM MED ASSOC, V285, P2223, DOI 10.1001/jama.285.17.2223; Fryer GE, 2001, AM FAM PHYSICIAN, V63, P1669; FRYER GE, 2000, AM FAM PHYSICIAN, V62, P477; GEYMAN JP, 1978, NEW ENGL J MED, V298, P593, DOI 10.1056/NEJM197803162981104; Green LA, 2001, NEW ENGL J MED, V344, P2021, DOI 10.1056/NEJM200106283442611; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; HAUG JN, 1970, DISTRIBUTION PHYSICI; Lindenauer PK, 1999, ANN INTERN MED, V130, P343, DOI 10.7326/0003-4819-130-4-199902161-00003; Majumdar SR, 2001, J GEN INTERN MED, V16, P351, DOI 10.1046/j.1525-1497.2001.016006351.x; Mark DH, 1996, J FAM PRACTICE, V43, P33; MCWHINNEY IR, 1975, NEW ENGL J MED, V293, P176, DOI 10.1056/NEJM197507242930405; Mundinger MO, 2000, JAMA-J AM MED ASSOC, V283, P59, DOI 10.1001/jama.283.1.59; *NAT COMM COMM HLT, 1966, HLTH IS COMM AFF, P26; *NAT CTR HLTH STAT, 2002, AMB HLTH CAR DAT NAT; PASKO T, 2001, PHYSICIAN CHARACTERI; PELLEGRINO ED, 1978, JAMA-J AM MED ASSOC, V240, P132, DOI 10.1001/jama.240.2.132; Pugno P, 2000, FAM MED, V32, P534; Pugno PA, 2000, FAM MED, V32, P543; RANSOM DC, 1985, PRINCIPLES FAMILY SY, P5; RHEE S, 1981, MED CARE, V19, P14, DOI 10.1097/00005650-198101000-00003; Roetzheim RG, 2001, J FAM PRACTICE, V50, P1027; ROSENBLATT RA, 1992, JAMA-J AM MED ASSOC, V267, P1665, DOI 10.1001/jama.267.12.1665; ROSENBLATT RA, 1983, NEW ENGL J MED, V309, P892, DOI 10.1056/NEJM198310133091505; Shi LY, 1999, J FAM PRACTICE, V48, P275; Stange KC, 1998, J FAM PRACTICE, V46, P377; Stange KC, 1998, J FAM PRACTICE, V46, P363; STARFIELD B, 1991, JAMA-J AM MED ASSOC, V266, P2268, DOI 10.1001/jama.266.16.2268; Starfield B., 1992, PRIMARY CARE CONCEPT; Stephens G G, 1989, J Am Board Fam Pract, V2, P288; Stephens G. Gayle, 1982, INTELLECTUAL BASIS F; Stevens R., 1998, AM MED PUBLIC INTERE; *US DEP HHS, 2000, AR RES FIL; WHITE KL, 1961, NEW ENGL J MED, V265, P885, DOI 10.1056/NEJM196111022651805; WILLARD WR, 1978, JAMA-J AM MED ASSOC, V240, P454; 1988, JAMA, V260, P1272	52	33	33	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1097	1101		10.1001/jama.288.9.1097	http://dx.doi.org/10.1001/jama.288.9.1097			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NA	12204078				2022-12-28	WOS:000177764600012
J	Humphrey, LL; Helfand, M; Chan, BKS; Woolf, SH				Humphrey, LL; Helfand, M; Chan, BKS; Woolf, SH			Breast cancer screening: A summary of the evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED TRIALS; POSITIVE PREDICTIVE VALUE; SWEDISH 2-COUNTY TRIAL; FAMILY HISTORY; FOLLOW-UP; REPLACEMENT THERAPY; SELF-EXAMINATION; SOJOURN TIME; RISK-FACTORS; DEATH RATES	Purpose: To synthesize new data on breast cancer screening for the U.S. Preventive Services Task Force. Data Sources: MEDLINE; the Cochrane Controlled Trials Registry; and reference lists of reviews, editorials, and original studies. Study Selection: Eight randomized, controlled trials of mammography and 2 trials evaluating breast self-examination were included. One hundred fifty-four publications of the results of these trials, as well as selected articles about the test characteristics and harms associated with screening, were examined. Data Extraction: Predefined criteria were used to assess the quality of each study. Meta-analyses using a Bayesian random-effects model were conducted to provide summary relative risk estimates and credible intervals (CrIs) for the effectiveness of screening with mammography in reducing death from breast cancer. Data Synthesis: For studies of fair quality or better, the summary relative risk was 0.84 (95% CrI, 0.77 to 0.91) and the number needed to screen to prevent one death from breast cancer after approximately 14 years of observation was 1224 (CrI, 665 to 2564). Among women younger than 50 years of age, the summary relative risk associated with mammography was 0.85 (CrI, 0.73 to 0.99) and the number needed to screen to prevent one death from breast cancer after 14 years of observation was 1792 (CrI, 764 to 10 540). For clinical breast examination and breast self-examination, evidence from randomized trials is inconclusive. Conclusions: in the randomized, controlled trials, mammography reduced breast cancer mortality rates among women 40 to 74 years of age. Greater absolute risk reduction was seen among older women. Because these results incorporate several rounds of screening, the actual number of mammograms needed to prevent one death from breast cancer is higher. In addition, each screening has associated risks and costs.	Oregon Hlth & Sci Univ, Portland, OR USA; Portland VA Med Ctr, Portland, OR USA; Virginia Commonwealth Univ, Med Coll Virginia, Fairfax, VA USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Virginia Commonwealth University	Humphrey, LL (corresponding author), Agcy Healthcare Res & Qual, Publicat Clearinghouse, Rockville, MD 20852 USA.		SALAZAR, ANTONIO/A-5806-2013	SALAZAR, ANTONIO/0000-0003-2639-2340	PHS HHS [290-97-0018] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alexander FE, 1999, LANCET, V353, P1903, DOI 10.1016/S0140-6736(98)07413-3; *AM CANC SOC, 2002, CANC FACTS FIG 2001; ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; Andersson I, 1997, J Natl Cancer Inst Monogr, P63; Baines C J, 1992, Womens Health Issues, V2, P206, DOI 10.1016/S1049-3867(05)80174-4; Barton MB, 1999, JAMA-J AM MED ASSOC, V282, P1270, DOI 10.1001/jama.282.13.1270; Berry DA, 1998, JNCI-J NATL CANCER I, V90, P1431, DOI 10.1093/jnci/90.19.1431; Bjurstam N, 1997, J Natl Cancer Inst Monogr, P53; Bjurstam N, 1997, CANCER, V80, P2091, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.0.CO;2-#; Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Burman ML, 1999, ANN INTERN MED, V131, P1, DOI 10.7326/0003-4819-131-1-199907060-00002; COLDITZ GA, 1993, JAMA-J AM MED ASSOC, V270, P338, DOI 10.1001/jama.270.3.338; Cox B, 1997, J Natl Cancer Inst Monogr, P69; Duffy S W, 1997, J Natl Cancer Inst Monogr, P93; Duffy SW, 1996, INT J EPIDEMIOL, V25, P1139, DOI 10.1093/ije/25.6.1139; EDDY DM, 1989, ANN INTERN MED, V111, P389, DOI 10.7326/0003-4819-111-5-389; Ekeberg O, 2001, BREAST, V10, P20, DOI 10.1054/brst.2000.0177; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Elwood JM, 1993, ONLINE J CURR CLIN T; Ernster V L, 1997, J Natl Cancer Inst Monogr, P151; Feig S A, 1997, J Natl Cancer Inst Monogr, P119; FLETCHER SW, 1995, RADIOL CLIN N AM, V33, P1259; FLETCHER SW, 1993, J NATL CANCER I, V85, P1644, DOI 10.1093/jnci/85.20.1644; Frisell J, 1997, BREAST CANCER RES TR, V45, P263, DOI 10.1023/A:1005872617944; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Glasziou P, 1997, J Natl Cancer Inst Monogr, P73; GLASZIOU PP, 1992, J CLIN EPIDEMIOL, V45, P1251, DOI 10.1016/0895-4356(92)90166-K; GLASZIOU PP, 1995, MED J AUSTRALIA, V162, P625, DOI 10.5694/j.1326-5377.1995.tb126047.x; Greendale GA, 1999, ANN INTERN MED, V130, P262, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00003; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; HARRISON TR, 1998, PRINCIPLES INTERNAL, P564; HARSTALL C, 2000, MAMMOGRAPHY SCREENIN; Hendrick R E, 1997, J Natl Cancer Inst Monogr, P87; Humphrey L, 2002, SCREEN BREAST CANC; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; Kerlikowske K, 1997, J Natl Cancer Inst Monogr, P79; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P39, DOI 10.1001/jama.276.1.39; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; KERLIKOWSKE K, 1993, JAMA-J AM MED ASSOC, V270, P2444, DOI 10.1001/jama.270.20.2444; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; KERLIKOWSKE K, 1995, CANCER, V76, P1679, DOI 10.1002/1097-0142(19951101)76:9<1679::AID-CNCR2820760928>3.0.CO;2-Y; Kopans Daniel B., 1997, Journal of the National Cancer Institute Monographs, V0, P1; Lampic C, 2001, EUR J CANCER, V37, P463, DOI 10.1016/S0959-8049(00)00426-3; Larsson L G, 1996, J Med Screen, V3, P129; Larsson L G, 1997, J Natl Cancer Inst Monogr, P57; Laya MB, 1996, J NATL CANCER I, V88, P643, DOI 10.1093/jnci/88.10.643; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; Lidbrink E, 1996, BRIT MED J, V312, P273; Lipkus IM, 2000, CANCER EPIDEM BIOMAR, V9, P973; Marugg RC, 1997, EUR RADIOL, V7, P749, DOI 10.1007/BF02742938; Mattsson A, 2000, BRIT J CANCER, V82, P220; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Meystre-Agustoni G, 2001, J MED SCREEN, V8, P213, DOI 10.1136/jms.8.4.213; Miller A B, 1997, J Natl Cancer Inst Monogr, P37; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2000, LANCET, V355, P747, DOI 10.1016/S0140-6736(00)00031-3; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; MILLER AB, 1992, CAN MED ASSOC J, V147, P1477; MILLER AB, 1992, CAN MED ASSOC J, V147, P1459; Moss SM, 1999, LANCET, V353, P1909, DOI 10.1016/S0140-6736(98)07412-1; *MRC BIOST UN, 1999, WINBUGS VERS 1 2 US; Mushlin AI, 1998, AM J PREV MED, V14, P143, DOI 10.1016/S0749-3797(97)00019-6; Nystrom L, 1996, J Med Screen, V3, P85; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; O'Sullivan I, 2001, J MED SCREEN, V8, P145, DOI 10.1136/jms.8.3.145; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Olsson P, 1999, J MED SCREEN, V6, P89, DOI 10.1136/jms.6.2.89; Pisano ED, 1998, RADIOLOGY, V208, P245, DOI 10.1148/radiology.208.1.9646820; RICHERTBOE KE, 1992, ARCH INTERN MED, V152, P2405, DOI 10.1001/archinte.152.12.2405; Ries L.A.G., 2000, NIH PUB, V00-2789; Rimer B K, 1997, J Natl Cancer Inst Monogr, P131; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; SEIDMAN H, 1982, CA-CANCER J CLIN, V32, P301, DOI 10.3322/canjclin.32.5.301; Semiglazov V. P., 1999, Voprosy Onkologii (St. Petersburg), V45, P265; SEMIGLAZOV VF, 1992, EUR J EPIDEMIOL, V8, P498, DOI 10.1007/BF00146366; SHAPIRO S, 1977, CANCER, V39, P2772, DOI 10.1002/1097-0142(197706)39:6<2772::AID-CNCR2820390665>3.0.CO;2-K; Shapiro S, 1997, J Natl Cancer Inst Monogr, P27; Shapiro S., 1988, SCREEN BREAST CANC, P3; Shen Y, 2001, J CLIN ONCOL, V19, P3490, DOI 10.1200/JCO.2001.19.15.3490; Sirovich BE, 1999, SURG CLIN N AM, V79, P961, DOI 10.1016/S0039-6109(05)70056-6; Sjonell G, 1999, Lakartidningen, V96, P904; SJONELL G, 1999, LAKARTIDNINGEN, V96, P908; SMART CR, 1995, CANCER, V75, P1619, DOI 10.1002/1097-0142(19950401)75:7<1619::AID-CNCR2820750711>3.0.CO;2-T; STRAX P, 1987, BREAST CANCER DIAGNO, P145; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Tabar L, 1996, J NATL CANCER I, V88, P52, DOI 10.1093/jnci/88.1.52-a; TABAR L, 1985, DIAGN IMAG CLIN MED, V54, P158; TABAR L, 1987, BRIT J CANCER, V55, P547, DOI 10.1038/bjc.1987.112; TABAR L, 1989, J EPIDEMIOL COMMUN H, V43, P107, DOI 10.1136/jech.43.2.107; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Tabar L, 1995, J Med Screen, V2, P94; Thomas DB, 1997, JNCI-J NATL CANCER I, V89, P355, DOI 10.1093/jnci/89.5.355; U.S. Preventive Service Task Force, 1989, GUID CLIN PREV SERV; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18	98	840	871	0	40	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2002	137	5	1				347	360		10.7326/0003-4819-137-5_Part_1-200209030-00012	http://dx.doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00012			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591DZ	12204020				2022-12-28	WOS:000177865600007
J	Mann, ME				Mann, ME			The value of multiple proxies	SCIENCE			English	Editorial Material							TREE-RING CHRONOLOGIES; NORTH-ATLANTIC; CLIMATE-CHANGE; TEMPERATURE; RECONSTRUCTION		Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	University of Virginia	Mann, ME (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	mann@virginia.edu	Mann, Michael E/B-8472-2017	Mann, Michael E/0000-0003-3067-296X				BAUER E, IN PRESS KIHZ PROJEC; Briffa KR, 2002, SCIENCE, V295, P2227, DOI 10.1126/science.1069486; Briffa KR, 1998, NATURE, V393, P450, DOI 10.1038/30943; Brovkin V, 1999, GLOBAL ECOL BIOGEOGR, V8, P509, DOI 10.1046/j.1365-2699.1999.00169.x; Cook ER, 2002, J CLIMATE, V15, P1754, DOI 10.1175/1520-0442(2002)015<1754:AWVMRO>2.0.CO;2; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Crowley TJ, 2000, AMBIO, V29, P51, DOI 10.1579/0044-7447-29.1.51; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Evans MN, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000590; Folland CK, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P99; GERBER S, IN PRESS CLIM DYN; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Kirchner I, 1999, J GEOPHYS RES-ATMOS, V104, P19039, DOI 10.1029/1999JD900213; Luterbacher J, 2002, CLIM DYNAM, V18, P545, DOI 10.1007/s00382-001-0196-6; Mann ME, 2002, SCIENCE, V296, P848, DOI 10.1126/science.296.5569.848; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; RUTHERFORD S, IN PRESS J CLIMATE; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363	20	121	127	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1481	1482		10.1126/science.1074318	http://dx.doi.org/10.1126/science.1074318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202805				2022-12-28	WOS:000177697300031
J	Erickson, NI; Ellis, RL				Erickson, NI; Ellis, RL			Neonatal rash due to herpes gestationis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA; Univ Wisconsin Hlth Phys Plus, Fitchburg, WI 53711 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System	Erickson, NI (corresponding author), Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA.								0	4	4	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2002	347	9					660	660		10.1056/NEJMicm010206	http://dx.doi.org/10.1056/NEJMicm010206			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZT	12200553				2022-12-28	WOS:000177675500005
J	Hole, DG; Whittingham, MJ; Bradbury, RB; Anderson, GQA; Lee, PLM; Wilson, JD; Krebs, JR				Hole, DG; Whittingham, MJ; Bradbury, RB; Anderson, GQA; Lee, PLM; Wilson, JD; Krebs, JR			Widespread local house-sparrow extinctions - Agricultural intensification is blamed for the plummeting populations of these birds.	NATURE			English	Article									Univ Oxford, Farmland Bird Grp, Edward Grey Inst Field Ornithol, Oxford OX1 3PS, England; Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; Dunedin House, Edinburgh EH4 3TP, Midlothian, Scotland; Univ Coll Swansea, Sch Biol Sci, Swansea SA2 8PP, W Glam, Wales	University of Oxford; Royal Society for Protection of Birds; Swansea University	Hole, DG (corresponding author), Univ Oxford, Farmland Bird Grp, Edward Grey Inst Field Ornithol, S Parks Rd, Oxford OX1 3PS, England.		Whittingham, Mark/C-4958-2008; Lee, Patricia/N-4157-2013; Hole, David/Q-1692-2019; Wilson, Jeremy/A-6842-2016	Lee, Patricia/0000-0002-8489-9206; Wilson, Jeremy/0000-0001-7485-5878; Bradbury, Richard/0000-0002-1245-2763				Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Cornuet JM, 1996, GENETICS, V144, P2001; Crochet PA, 2000, MOL ECOL, V9, P1463, DOI 10.1046/j.1365-294x.2000.01026.x; GREGORY RD, 2001, STATE UKS BIRDS 2000; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; SUMMERSMITH JD, 1988, SPARROWS; WERNHAM CV, IN PRESS MIGRATION A	9	118	127	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					931	932		10.1038/418931a	http://dx.doi.org/10.1038/418931a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198534				2022-12-28	WOS:000177677500031
J	Lassus, P; Opitz-Araya, X; Lazebnik, Y				Lassus, P; Opitz-Araya, X; Lazebnik, Y			Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization	SCIENCE			English	Article							ONCOGENE-DEPENDENT APOPTOSIS; CELL-DEATH; MAMMALIAN-CELLS; BCL-2; GENE; ACTIVATION; ENCODES; APAF-1; NEDD2; MICE	A current view is that cytotoxic stress, such as DNA damage, induces apoptosis by regulating the permeability of mitochondria. Mitochondria sequester several proteins that, if released, kill by activating caspases, the proteases that disassemble the cell. Cytokines activate caspases in a different way, by assembling receptor complexes that activate caspases directly; in this case, the subsequent mitochondrial permeabilization accelerates cell disassembly by amplifying caspase activity. We found that cytotoxic stress causes activation of caspase-2, and that this caspase is required for the permeabilization of mitochondria. Therefore, we argue that cytokine-induced and stress-induced apoptosis act through conceptually similar pathways in which mitochondria are amplifiers of caspase activity rather than initiators of caspase activation.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Lazebnik, Y (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Lassus, Patrice/0000-0002-2785-7843	NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NCI NIH HHS [CA-13106-31] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bossy Wetzel E, 1998, EMBO J, V17, P37; Duelli DM, 2000, NAT CELL BIOL, V2, P859, DOI 10.1038/35041112; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fearnhead HO, 1998, P NATL ACAD SCI USA, V95, P13664, DOI 10.1073/pnas.95.23.13664; Gerlai R, 2001, BEHAV BRAIN RES, V125, P13, DOI 10.1016/S0166-4328(01)00282-0; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hannon GJ, 1999, SCIENCE, V283, P1129, DOI 10.1126/science.283.5405.1129; Hausmann G, 2000, J CELL BIOL, V149, P623, DOI 10.1083/jcb.149.3.623; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; KUMAR S, 1995, FEBS LETT, V368, P69, DOI 10.1016/0014-5793(95)00602-6; LASSUS P, UNPUB; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Paroni G, 2002, J BIOL CHEM, V277, P15147, DOI 10.1074/jbc.M112338200; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Troy CM, 2000, J NEUROSCI, V20, P1386; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang XD, 2001, GENE DEV, V15, P2922; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343	31	618	641	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1352	1354		10.1126/science.1074721	http://dx.doi.org/10.1126/science.1074721			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193789				2022-12-28	WOS:000177573900049
J	Hohenleutner, U; Landthaler, M				Hohenleutner, U; Landthaler, M			Laser treatment of childhood haemangioma: progress or not?	LANCET			English	Editorial Material							PULSED DYE-LASER; HEMANGIOMAS; MANAGEMENT		Univ Regensburg Klinikum, Dermatol Klin & Poliklin, D-93042 Regensburg, Germany	University of Regensburg	Hohenleutner, U (corresponding author), Univ Regensburg Klinikum, Dermatol Klin & Poliklin, D-93042 Regensburg, Germany.							ASHINOFF R, 1993, PEDIATR DERMATOL, V10, P77, DOI 10.1111/j.1525-1470.1993.tb00021.x; ENJOLRAS O, 1993, PEDIATR DERMATOL, V10, P311, DOI 10.1111/j.1525-1470.1993.tb00393.x; Enjolras Odile, 1997, Journal of Dermatology (Tokyo), V24, P701; Frieden IJ, 1997, PEDIATR DERMATOL, V14, P57; GARDEN JM, 1992, J PEDIATR-US, V120, P555, DOI 10.1016/S0022-3476(05)82481-3; GRANTZOW R, 1995, MONATSSCHR KINDERH, V143, P369; Hohenleutner S, 2001, LASER SURG MED, V28, P273, DOI 10.1002/lsm.1050; MORELLI JG, 1993, MANAGEMENT TREATMENT, P124; Poetke M, 2000, ARCH DERMATOL, V136, P628, DOI 10.1001/archderm.136.5.628; WLOTZKE U, 1996, ZBL HAUT, V168, P21	10	13	13	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					502	503		10.1016/S0140-6736(02)09759-3	http://dx.doi.org/10.1016/S0140-6736(02)09759-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241650				2022-12-28	WOS:000177512800004
J	Tattersall, MHN				Tattersall, MHN			Ovarian cancer chemotherapy: carboplatin as standard	LANCET			English	Editorial Material							STAGE-III; PACLITAXEL; CISPLATIN; CYCLOPHOSPHAMIDE; SURVIVAL		Univ Sydney, Dept Canc Med, Sydney, NSW 2006, Australia	University of Sydney	Tattersall, MHN (corresponding author), Univ Sydney, Dept Canc Med, Sydney, NSW 2006, Australia.							Aabo K, 1998, BRIT J CANCER, V78, P1479, DOI 10.1038/bjc.1998.710; AHERN RP, 1995, J CLIN ONCOL, V13, P726, DOI 10.1200/JCO.1995.13.3.726; BUYSE M, 1991, J CLIN ONCOL, V9, P1668; Christian J, 2001, CANCER TREAT REV, V27, P99, DOI 10.1053/ctrv.2001.0219; Clark TG, 2001, BRIT J CANCER, V85, P944, DOI 10.1054/bjoc.2001.2030; Elit LM, 1996, GYNECOL ONCOL, V62, P329, DOI 10.1006/gyno.1996.0244; Im DD, 2001, OBSTET GYN CLIN N AM, V28, P759, DOI 10.1016/S0889-8545(05)70234-5; Junor EJ, 1999, BRIT J OBSTET GYNAEC, V106, P1130, DOI 10.1111/j.1471-0528.1999.tb08137.x; MCGUIRE WP, 1989, ANN INTERN MED, V111, P273, DOI 10.7326/0003-4819-111-4-273; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Muggia FM, 2000, J CLIN ONCOL, V18, P106, DOI 10.1200/JCO.2000.18.1.106; Parmar MKB, 1998, LANCET, V352, P1571; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; STEWART LA, 1991, BRIT MED J, V303, P884	14	10	12	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					500	501		10.1016/S0140-6736(02)09757-X	http://dx.doi.org/10.1016/S0140-6736(02)09757-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241648				2022-12-28	WOS:000177512800002
J	Mann, H				Mann, H			Research ethics committees and public dissemination of clinical trial results	LANCET			English	Article							RANDOMIZED TRIALS; FAILURE	Biomedical research involving human beings Is subject to codes of ethical conduct that mandate review, approval, and monitoring of clinical trials by research ethics committees (RECs). The role of RECs In public dissemination of results of research is not addressed explicitly In International codes or national regulations governing human research. I contend that RECs should have a prominent role In ensuring that trial results are publicly disseminated. I also propose specific responsibilities and actions that should be assumed and Implemented by RECs to promote this objective.	Univ Hosp, Salt Lake City, UT 84132 USA		Mann, H (corresponding author), Univ Hosp, 50 N Med Dr, Salt Lake City, UT 84132 USA.	Howard.Mann@hsc.utah.edu						*AM MED ASS, 1994, E908 AM MED ASS; Blum J, 1998, BRIT MED J, V316, P312, DOI 10.1136/bmj.316.7127.312; Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; *CENTR OFF RES ETH, 2001, GOV ARR NHS RES ETH; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chalmers I., 2001, SYSTEMATIC REV HLTH, P429, DOI DOI 10.1002/9780470693926.CH24; Clarke MJ., 2001, SYSTEMATIC REV HLTH, P109; Davidoff F, 2001, NEW ENGL J MED, V345, P825, DOI 10.1056/NEJMed20010093; *DEP HLTH, 2001, RES GOV FRAM HLTH SO; EGGER M, 2001, SYSTEMATIC REV HLTH, P46; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Gottlieb S, 2000, BRIT MED J, V321, P1173, DOI 10.1136/bmj.321.7270.1173; Horton R, 1999, BRIT MED J, V319, P865, DOI 10.1136/bmj.319.7214.865; Jenkins V, 2000, BRIT J CANCER, V82, P1783, DOI 10.1054/bjoc.2000.1142; MARLEY C, 2001, CONTROL CLIN TRI S2S, V22, pS33; Reidpath DD, 2001, BIOETHICS, V15, P125, DOI 10.1111/1467-8519.00220; SAVALESU J, 1996, BMJ-BRIT MED J, V313, P1390; Savitz DA, 2000, EPIDEMIOLOGY, V11, P361, DOI 10.1097/00001648-200005000-00028; SCHERER R, 2001, 4 INT C PEER REV BIO; Sim I, 2000, MED DECIS MAKING, V20, P440, DOI 10.1177/0272989X0002000408; Smith R., 2000, WHAT IS RES MISCONDU; SPURGEON D, 1998, BMJ-BRIT MED J, V314, P618; Sugarman Jeremy, 1998, IRB, V20, P1, DOI 10.2307/3564262; Tonks L, 1999, BMJ-BRIT MED J, V319, P1565, DOI 10.1136/bmj.319.7224.1565; Weijer C, 2000, J LAW MED ETHICS, V28, P344, DOI 10.1111/j.1748-720X.2000.tb00686.x; Wise J, 1997, BRIT MED J, V314, P1145; *WORLD MED ASS DEC, 2000, ETH PRINC MED RES IN	27	43	44	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2002	360	9330					406	408		10.1016/S0140-6736(02)09613-7	http://dx.doi.org/10.1016/S0140-6736(02)09613-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241796				2022-12-28	WOS:000177255600029
J	Eldar, A; Dorfman, R; Weiss, D; Ashe, H; Shilo, BZ; Barkai, N				Eldar, A; Dorfman, R; Weiss, D; Ashe, H; Shilo, BZ; Barkai, N			Robustness of the BMP morphogen gradient in Drosophila embryonic patterning	NATURE			English	Article							TWISTED GASTRULATION; DPP ACTIVITY; I RECEPTORS; SPECIFICATION; ACTIVATION; POLARITY; SAX; SOG	Developmental patterning relies on morphogen gradients, which generally involve feedback loops to buffer against perturbations caused by fluctuations in gene dosage and expression(1). Although many gene components involved in such feedback loops have been identified, how they work together to generate a robust pattern remains unclear. Here we study the network of extracellular proteins that patterns the dorsal region of the Drosophila embryo by establishing a graded activation of the bone morphogenic protein (BMP) pathway. We find that the BMP activation gradient itself is robust to changes in gene dosage. Computational search for networks that support robustness shows that transport of the BMP class ligands (Scw and Dpp) into the dorsal midline by the BMP inhibitor Sog is the key event in this patterning process. The mechanism underlying robustness relies on the ability to store an excess of signalling molecules in a restricted spatial domain where Sog is largely absent. It requires extensive diffusion of the BMP-Sog complexes, coupled with restricted diffusion of the free ligands. We show experimentally that Dpp is widely diffusible in the presence of Sog but tightly localized in its absence, thus validating a central prediction of our theoretical study.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	Weizmann Institute of Science; Weizmann Institute of Science; University of Manchester	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il		Dorfman, Ruslan/0000-0002-3421-5582; Shilo, Ben Zion/0000-0003-4903-8889; Eldar, Avigdor/0000-0001-8485-9370				ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Dorfman R, 2001, DEVELOPMENT, V128, P965; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Kosman D, 1997, DEVELOPMENT, V124, P1343; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Mason ED, 1997, MECH DEVELOP, V64, P61, DOI 10.1016/S0925-4773(97)00049-X; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; Nguyen M, 1998, CELL, V95, P495, DOI 10.1016/S0092-8674(00)81617-7; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Srinivasan S, 2002, DEV CELL, V2, P91, DOI 10.1016/S1534-5807(01)00097-1; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; WHARTON KA, 1993, DEVELOPMENT, V117, P807	23	338	366	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					304	308		10.1038/nature01061	http://dx.doi.org/10.1038/nature01061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239569				2022-12-28	WOS:000178056300047
J	Hodnett, ED; Lowe, NK; Hannah, ME; Willan, AR; Stevens, B; Weston, JA; Ohlsson, A; Gafni, A; Muir, HA; Myhr, TL; Stremler, R				Hodnett, ED; Lowe, NK; Hannah, ME; Willan, AR; Stevens, B; Weston, JA; Ohlsson, A; Gafni, A; Muir, HA; Myhr, TL; Stremler, R		Nursing Supportive Care Labor Tria	Effectiveness of nurses as providers of birth labor support in North American hospitals - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDBIRTH OUTCOMES; CARE; INTRAPARTUM; SATISFACTION; WOMEN	Context North American cesarean delivery rates have risen dramatically since the 1960s, without concomitant improvements in perinatal or maternal health. A Cochrane Review concluded that continuous caregiver support during labor has many benefits, including reduced likelihood of cesarean delivery. Objective To evaluate the effectiveness of nurses as providers of labor support in North American hospitals. Design Randomized controlled trial with prognostic stratification by center and parity. Women were enrolled during a 2-year period (May 1999 to May 2001) and followed up until 6 to 8 postpartum weeks. Setting Thirteen US and Canadian hospitals with annual cesarean delivery rates of at least 15%. Participants A total of 6915 women who had a live singleton fetus or twins, were 34 weeks' gestation or more, and were in established labor at randomization. Intervention Patients were randomly assigned to receive usual care (n=3461) or continuous labor support by a specially trained nurse (n=3454) during labor. Main Outcome Measures The primary outcome measure was cesarean delivery rate. Other outcomes included intrapartum events and indicators of maternal and neonatal morbidity, both immediately after birth and in the first 6 to 8 postpartum weeks. Results Data were received for all 6915 women and their infants (n=6949). The rates of cesarean delivery were almost identical in the 2 groups (12.5% in the continuous labor support group and 12.6% in the usual care group; P=.44). There were no significant differences in other maternal or neonatal events during labor, delivery, or the hospital stay. There were no significant differences in women's perceived control during childbirth or in depression, measured at 6 to 8 postpartum weeks. All comparisons of women's likes and dislikes, and their future preference for amount of nursing support, favored the continuous labor support group. Conclusions In hospitals characterized by high rates of routine intrapartum interventions, continuous labor support by nurses does not affect the likelihood of cesarean delivery or other medical or psychosocial outcomes of labor and birth.	Univ Toronto, Fac Nursing, Toronto, ON M5S 3H4, Canada; Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada; Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; Univ Toronto, Ctr Res Womens Hlth, Maternal Child Nursing Res Unit, Toronto, ON, Canada; Univ Toronto, Res Facilitat Off, Toronto, ON, Canada; Univ Toronto, Maternal Infant & Reprod Hlth Res Unit, Toronto, ON, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA; Duke Univ, Dept Anesthesiol, Durham, NC USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University System of Ohio; Ohio State University; Duke University	Hodnett, ED (corresponding author), Univ Toronto, Fac Nursing, 50 St George St, Toronto, ON M5S 3H4, Canada.				NINR NIH HHS [5R01NR04684] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR004684] Funding Source: NIH RePORTER	NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		*ASS WOM HLTH OBST, 2002, PROF NURS SUPP LAB W; Cox J. L., 1994, PERINATAL PSYCHIAT U; DAVIES B, IN PRESS CMAJ; *DEP HLTH HUM SERV, 2000, HLTH PEOPL 2010 UND; *DEP HLTH HUM SERV, 1987, HLTH PEOPL 2000; Flather MD, 1997, CONTROL CLIN TRIALS, V18, P568, DOI 10.1016/S0197-2456(97)00024-X; Gagnon AJ, 1996, BIRTH-ISS PERINAT C, V23, P1, DOI 10.1111/j.1523-536X.1996.tb00453.x; GOULD JB, 1989, NEW ENGL J MED, V321, P233, DOI 10.1056/NEJM198907273210406; HODNET ED, 2002, CAREGIVER SUPPORT WO; Hodnett ED, 1997, BIRTH-ISS PERINAT C, V24, P214, DOI 10.1111/j.1523-536X.1997.tb00593.x; Hodnett ED, 2002, AM J OBSTET GYNECOL, V186, pS160, DOI 10.1067/mob.2002.121141; Hodnett ED, 1996, RES NURS HEALTH, V19, P13, DOI 10.1002/(SICI)1098-240X(199602)19:1<13::AID-NUR2>3.0.CO;2-O; HODNETT ED, 1987, RES NURS HEALTH, V10, P301, DOI 10.1002/nur.4770100503; HODNETT ED, 1989, RES NURS HEALTH, V12, P289, DOI 10.1002/nur.4770120504; HODNETT ED, 2002, HOME LIKE VERSUS CON; Langer A, 1998, BRIT J OBSTET GYNAEC, V105, P1056, DOI 10.1111/j.1471-0528.1998.tb09936.x; LOMAS J, 1993, MILBANK Q, V71, P439, DOI 10.2307/3350410; LUMLEY J, 1985, BIRTH-ISS PERINAT C, V12, P141, DOI 10.1111/j.1523-536X.1985.tb00952.x; MCNIVEN P, 1992, BIRTH-ISS PERINAT C, V19, P3, DOI 10.1111/j.1523-536X.1992.tb00363.x; MIDIRS and the NHS Centre for Reviews and Dissemination, 1999, SUPP LAB INF CHOIC P; NIH, 1981, NIH PUBL, V81-2385; *ONT WOM HLTH COUN, 2002, ATT MAINT BEST PRACT; RADIN TG, 1993, BIRTH-ISS PERINAT C, V20, P14, DOI 10.1111/j.1523-536X.1993.tb00174.x; ROOKS JP, 1989, NEW ENGL J MED, V321, P1804, DOI 10.1056/NEJM198912283212606; ROOKS JP, 1992, J NURSE-MIDWIFERY, V37, P361, DOI 10.1016/0091-2182(92)90122-J; *SOC OBST GYN CAN, 1995, SOGC NEWS, P41	26	94	103	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2002	288	11					1373	1381		10.1001/jama.288.11.1373	http://dx.doi.org/10.1001/jama.288.11.1373			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	593TB	12234231	Bronze			2022-12-28	WOS:000178008300019
J	Kjaer, SK; van den Brule, AJC; Paull, G; Svare, EI; Sherman, ME; Thomsen, BL; Suntum, M; Bock, JE; Poll, PA; Meijer, CJLM				Kjaer, SK; van den Brule, AJC; Paull, G; Svare, EI; Sherman, ME; Thomsen, BL; Suntum, M; Bock, JE; Poll, PA; Meijer, CJLM			Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study	BRITISH MEDICAL JOURNAL			English	Article							NATURAL-HISTORY; RAPID DETECTION; CANCER; INFECTION; DNA	Objectives To investigate the role of human papillomavirus (HPV) in the development of cervical neoplasia in women with no previous cervical cytological abnormalities; whether the presence of virus DNA predicts development of squamous intraepithelial lesion; and whether the risk of incident squamous intraepithelial lesions differs with repeated detection of the same HPV type versus repeated detection of different types. Design Population based prospective cohort study. Setting General population in Copenhagen, Denmark. Participants 10 758 Women aged 20-29 years followed up for development of cervical cytological abnormalities; 370 incident cases were detected (40 with atypical squamous cells of undetermined significance, 165 with low grade squamous intraepithelial lesions, 165 With high grade squamous intraepithelial lesions). Main outcome measures Results of cervical smear tests and cervical swabs at enrolment and at the second examination about two years later. Results Compared with women who were negative for human papillomavirus at enrolment, those with positive results had a significantly increased risk at follow up of having atypical cells (odds ratio 3.2, 95% confidence interval 1.3 to 7.9), low grade lesions (7.5, 4.8 to 11.7), or high grade lesions (25.8, 15.3 to 43.6). Similarly, women who were positive for HPV at the second examination had a strongly increased risk of low (34.3, 17.6 to 67.0) and high grade lesions (60.7, 25.5 to 144.0). For high grade lesions the risk was strongly increased if the same virus type was present at both examinations (813.0, 168.2 to 3229.2). Conclusions Infection with human papillomavirus precedes the development of low and high grade squamous intraepithelial lesions. For high grade lesions the risk is greatest in women positive for the same type of HPV on repeated testing.	Danish Canc Soc, DK-2100 Copenhagen, Denmark; Vrije Univ Amsterdam, Univ Hosp, Dept Pathol, Sect Mol Pathol, Amsterdam, Netherlands; Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; Rigshosp, Dept Gynecol, DK-2100 Copenhagen, Denmark; Nylobing Falster Hosp, Dept Pathol, Falster, Denmark	Danish Cancer Society; Vrije Universiteit Amsterdam; Emory University; Johns Hopkins University; Johns Hopkins Medicine; Rigshospitalet; University of Copenhagen	Kjaer, SK (corresponding author), Danish Canc Soc, DK-2100 Copenhagen, Denmark.			Kjaer, Susanne/0000-0002-8347-1398	NATIONAL CANCER INSTITUTE [R01CA047812] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA047812, R01 CA47812] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Einstein MH, 2001, PAPILLOMAVIRUS REP, V12, P119; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Kjaer SK, 1996, INT J CANCER, V65, P601, DOI 10.1002/(SICI)1097-0215(19960301)65:5<601::AID-IJC8>3.0.CO;2-6; Liaw KL, 1999, J NATL CANCER I, V91, P954, DOI 10.1093/jnci/91.11.954; LUFF RD, 1992, HUM PATHOL, V23, P719, DOI 10.1016/0046-8177(92)90338-4; Meijer CJLM, 2000, CAN MED ASSOC J, V163, P535; Munk C, 1998, ACTA OBSTET GYN SCAN, V77, P917, DOI 10.1034/j.1600-0412.1998.770908.x; Rozendaal L, 1996, INT J CANCER, V68, P766, DOI 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z; VANDENBRULE AJC, 1990, J CLIN MICROBIOL, V28, P2739, DOI 10.1128/JCM.28.12.2739-2743.1990; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; *WHO, 1995, IARC MON EV CARC RIS, P64; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4	13	321	350	0	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2002	325	7364					572	576		10.1136/bmj.325.7364.572	http://dx.doi.org/10.1136/bmj.325.7364.572			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595JJ	12228133	Green Published, Bronze			2022-12-28	WOS:000178105200017
J	Trewick, SC; Henshaw, TF; Hausinger, RP; Lindahl, T; Sedgwick, B				Trewick, SC; Henshaw, TF; Hausinger, RP; Lindahl, T; Sedgwick, B			Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage	NATURE			English	Article							ALPHA-KETOGLUTARATE; ADAPTIVE RESPONSE; ALKYLATING-AGENTS; REPAIR; PROTEIN; GENE; SENSITIVITY; EXPRESSION; HOMOLOG; IRON	Methylating agents generate cytotoxic and mutagenic DNA damage. Cells use 3-methyladenine-DNA glycosylases to excise some methylated bases from DNA, and suicidal O-6-methyl-guanine- DNA methyltransferases to transfer alkyl groups from other lesions onto a cysteine residue(1,2). Here we report that the highly conserved AlkB protein repairs DNA alkylation damage by means of an unprecedented mechanism. AlkB has no detectable nuclease, DNA glycosylase or methyltransferase activity; however, Escherichia coli alkB mutants are defective in processing methylation damage generated in single-stranded DNA(3-5). Theoretical protein fold recognition had suggested that AlkB resembles the Fe(II)- and alpha-ketoglutarate-dependent dioxygenases (6), which use iron-oxo intermediates to oxidize chemically inert compounds(7,8). We show here that purified AlkB repairs the cytotoxic lesions 1-methyladenine and 3-methylcytosine in single- and double-stranded DNA in a reaction that is dependent on oxygen, alpha-ketoglutarate and Fe( II). The AlkB enzyme couples oxidative decarboxylation of alpha-ketoglutarate to the hydroxylation of these methylated bases in DNA, resulting in direct reversion to the unmodified base and the release of formaldehyde.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Cancer Research UK; Michigan State University; Michigan State University	Sedgwick, B (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.			Hausinger, Robert/0000-0002-3643-2054	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045686] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK045686] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; ARAVIND L, 2001, GENOME BIOL, V2; BODELL WJ, 1979, BIOCHEMISTRY-US, V18, P2860, DOI 10.1021/bi00580a029; CHEN BRJ, 1994, J BACTERIOL, V176, P6255, DOI 10.1128/jb.176.20.6255-6261.1994; Colombi D, 1997, J BACTERIOL, V179, P3139, DOI 10.1128/jb.179.10.3139-3145.1997; DEJONG L, 1982, BIOCHIM BIOPHYS ACTA, V704, P326, DOI 10.1016/0167-4838(82)90162-5; Dinglay S, 2000, GENE DEV, V14, P2097; HECK HD, 1982, BIOMED MASS SPECTROM, V9, P347; Hegg EL, 1999, BIOCHEMISTRY-US, V38, P16714, DOI 10.1021/bi991796l; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; KONDO H, 1986, J BIOL CHEM, V261, P5772; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Lizcano JM, 2000, ANAL BIOCHEM, V286, P75, DOI 10.1006/abio.2000.4782; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; Pavel EG, 1998, J AM CHEM SOC, V120, P743, DOI 10.1021/ja972408a; Prescott AG, 2000, NAT PROD REP, V17, P367, DOI 10.1039/a902197c; REBECK GW, 1991, J BACTERIOL, V173, P2068, DOI 10.1128/jb.173.6.2068-2076.1991; Ryle MJ, 2002, CURR OPIN CHEM BIOL, V6, P193, DOI 10.1016/S1367-5931(02)00302-2; Ryle MJ, 1999, BIOCHEMISTRY-US, V38, P15278, DOI 10.1021/bi9912746; SEEBERG E, 1999, BASE EXCISION REPAIR, P151; Singer B., 1983, MOL BIOL MUTAGENS CA, P45; Smith SS, 2000, J MOL BIOL, V302, P1, DOI 10.1006/jmbi.2000.4046; THORNBURG LD, 1993, BIOCHEMISTRY-US, V32, P14023, DOI 10.1021/bi00213a036; VAUGHAN P, 1991, CARCINOGENESIS, V12, P263, DOI 10.1093/carcin/12.2.263; Wei YF, 1996, NUCLEIC ACIDS RES, V24, P931, DOI 10.1093/nar/24.5.931	26	605	633	4	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					174	178		10.1038/nature00908	http://dx.doi.org/10.1038/nature00908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226667				2022-12-28	WOS:000177931200043
J	Casellas, R; Jankovic, M; Meyer, G; Gazumyan, A; Luo, Y; Roeder, RG; Nussenzweig, MC				Casellas, R; Jankovic, M; Meyer, G; Gazumyan, A; Luo, Y; Roeder, RG; Nussenzweig, MC			OcaB is required for normal transcription and V(D)J recombination of a subset of immunoglobulin kappa genes	CELL			English	Article							B-CELL DEVELOPMENT; COACTIVATOR OBF-1; HISTONE ACETYLATION; HEAVY-CHAIN; CHROMATIN STRUCTURE; SEQUENCE ELEMENTS; PROMOTER ACTIVITY; BINDING PROTEINS; MICE LACKING; RECEPTOR	OcaB, a transcriptional coactivator also known as Bob-1 or OBF-1, was isolated on the basis of its ability to enhance transcription of immunoglobulin (Ig) genes in vitro. Paradoxically, OcaB(-/-) mice showed no apparent deficiency in Ig gene transcription, only cellular immune defects including absence of germinal centers (GC) and decreased numbers of immature B cells; the genes targeted by OcaB were not determined. Here we report that OcaB is essential for V(D)J recombination of a subset of IgK genes. We show that OcaB modulates recombination by directly enhancing IgK gene transcription in vivo.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.		Nussenzweig, Michel/AAE-7292-2019					Aranburu A, 2001, BIOCHEM J, V354, P431, DOI 10.1042/0264-6021:3540431; Bemark M, 1998, IMMUNOGENETICS, V47, P183, DOI 10.1007/s002510050347; Bemark M, 1998, J BIOL CHEM, V273, P18881, DOI 10.1074/jbc.273.30.18881; BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0; Chasman D, 1999, GENE DEV, V13, P2650, DOI 10.1101/gad.13.20.2650; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; DREYFUS M, 1987, EMBO J, V6, P1685, DOI 10.1002/j.1460-2075.1987.tb02418.x; ENGLER P, 1993, MOL CELL BIOL, V13, P571, DOI 10.1128/MCB.13.1.571; FRANKE S, 1994, J BIOL CHEM, V269, P20075; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Gonzalgo ML, 1997, NUCLEIC ACIDS RES, V25, P2529, DOI 10.1093/nar/25.12.2529; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Greiner A, 2000, AM J PATHOL, V156, P501, DOI 10.1016/S0002-9440(10)64754-2; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gstaiger M, 1996, EMBO J, V15, P2781, DOI 10.1002/j.1460-2075.1996.tb00638.x; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; LUO Y, 1995, MOL CELL BIOL, V15, P4115; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Nussenzweig MC, 1998, CELL, V95, P875, DOI 10.1016/S0092-8674(00)81711-0; PARRY HD, 1989, TRENDS BIOCHEM SCI, V14, P15, DOI 10.1016/0968-0004(89)90083-2; Pelletier MR, 1997, NUCLEIC ACIDS RES, V25, P3995, DOI 10.1093/nar/25.20.3995; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Qin XF, 1998, EMBO J, V17, P5066, DOI 10.1093/emboj/17.17.5066; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Sauter P, 1998, MOL CELL BIOL, V18, P7397, DOI 10.1128/MCB.18.12.7397; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Schubart DB, 1996, NUCLEIC ACIDS RES, V24, P1913, DOI 10.1093/nar/24.10.1913; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schubart DB, 2000, J IMMUNOL, V164, P18, DOI 10.4049/jimmunol.164.1.18; Schubart K, 2001, NAT IMMUNOL, V2, P69, DOI 10.1038/83190; SCHWARZENBACH H, 1995, J BIOL CHEM, V270, P898, DOI 10.1074/jbc.270.2.898; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; SIGVARDSSON M, 1995, MOL CELL BIOL, V15, P1343; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Tantin D, 2002, MOL CELL BIOL, V22, P1460, DOI 10.1128/MCB.22.5.1460-1473.2002; Thiebe R, 1999, EUR J IMMUNOL, V29, P2072, DOI 10.1002/(SICI)1521-4141(199907)29:07&lt;2072::AID-IMMU2072&gt;3.0.CO;2-E; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; Van Parijs L, 1999, IMMUNITY, V11, P763, DOI 10.1016/S1074-7613(00)80150-8; Whitehurst CE, 2000, IMMUNITY, V13, P703, DOI 10.1016/S1074-7613(00)00069-8; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2	57	58	58	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 6	2002	110	5					575	585		10.1016/S0092-8674(02)00911-X	http://dx.doi.org/10.1016/S0092-8674(02)00911-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230975	Bronze			2022-12-28	WOS:000177943700005
J	Tsuda, L; Nagaraj, R; Zipursky, SL; Banerjee, U				Tsuda, L; Nagaraj, R; Zipursky, SL; Banerjee, U			An EGFR/Ebi/Sno pathway promotes delta expression by inactivating Su(H)/SMRTER repression during inductive Notch signaling	CELL			English	Article							DEVELOPING DROSOPHILA RETINA; EGF RECEPTOR PATHWAY; EYE DEVELOPMENT; C-ELEGANS; TRANSCRIPTIONAL REPRESSION; COREPRESSOR COMPLEX; SMRT COREPRESSOR; TYROSINE KINASES; CELL FATES; ACTIVATION	The Notch and Epidermal Growth Factor Receptor (EGFR) pathways both regulate proliferation and differentiation, and the cellular response to each is often influenced by the other. Here, we describe a mechanism that links them in a sequential fashion, in the developing compound eye of Drosophila. EGFR activation induces photoreceptor (R cell) differentiation and promotes their expression of Delta. This Notch ligand then induces neighboring cells to become nonneuronal cone cells. ebi and strawberry notch (sno) regulate EGFR-dependent Delta transcription by antagonizing a repressor function of Suppressor of Hairless (Su(H)). Sno binds to Su(H), and Ebi, an F-box/WD40 protein, forms a complex with Su(H) and the corepressor SMRTER. EGFR-activated transcriptional derepression requires ebi and sno, is proteasome-dependent, and correlates with the translocation of SMRTER to the cytoplasm.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Human Genet, Los Angeles, CA 90095 USA; RIKEN, Ctr Dev Biol, Morphogenet Signaling Grp, Chuo Ku, Kobe, Hyogo 6500047, Japan	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; RIKEN	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.			Zipursky, Stephen/0000-0001-5630-7181	NEI NIH HHS [EY08152, EY08772] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008772, R01EY008152] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Baker NE, 2001, CELL, V104, P699, DOI 10.1016/S0092-8674(02)06076-2; BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; Boulton SJ, 2000, EMBO J, V19, P5376, DOI 10.1093/emboj/19.20.5376; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Carmena A, 2002, DEV BIOL, V244, P226, DOI 10.1006/dbio.2002.0606; Casci T, 1999, CANCER METAST REV, V18, P181, DOI 10.1023/A:1006313122373; COYLETHOMPSON CA, 1993, DEVELOPMENT, V119, P377; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Frankfort BJ, 2002, DEVELOPMENT, V129, P1295; FREEMAN M, 1994, MECH DEVELOP, V48, P25, DOI 10.1016/0925-4773(94)90003-5; Freeman M, 1997, DEVELOPMENT, V124, P261; Gabay L, 1997, DEVELOPMENT, V124, P3535; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Guenther MG, 2000, GENE DEV, V14, P1048; Hong SH, 1998, MOL ENDOCRINOL, V12, P1161, DOI 10.1210/me.12.8.1161; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2002, J CELL SCI, V115, P689; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; KENYON C, 1995, CELL, V82, P171, DOI 10.1016/0092-8674(95)90302-X; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Lecourtois M, 1997, PERSPECT DEV NEUROBI, V4, P305; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li YX, 2001, CURR BIOL, V11, P330, DOI 10.1016/S0960-9822(01)00093-8; Lim YM, 2000, P NATL ACAD SCI USA, V97, P12233, DOI 10.1073/pnas.210253497; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Majumdar A, 1997, GENE DEV, V11, P1341, DOI 10.1101/gad.11.10.1341; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Morel V, 2000, GENE DEV, V14, P377; Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X; Nagaraj R, 1999, DEVELOPMENT, V126, P975; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Parks AL, 2000, DEVELOPMENT, V127, P1373; PARKS AL, 1995, MECH DEVELOP, V50, P201, DOI 10.1016/0925-4773(94)00336-L; Polakis P, 2001, CELL, V105, P563, DOI 10.1016/S0092-8674(01)00379-8; Privalsky ML, 2001, CURR TOP MICROBIOL, V254, P117; Queenan AM, 1997, DEVELOPMENT, V124, P3871; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; SAVILLE KJ, 1993, P NATL ACAD SCI USA, V90, P8842, DOI 10.1073/pnas.90.19.8842; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SIMSKE JS, 1995, NATURE, V375, P142, DOI 10.1038/375142a0; SINGSON A, 1994, GENE DEV, V8, P2058, DOI 10.1101/gad.8.17.2058; Spencer SA, 1998, DEVELOPMENT, V125, P4777; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Tio M, 1997, DEVELOPMENT, V124, P343; TIO M, 1994, MECH DEVELOP, V48, P13, DOI 10.1016/0925-4773(94)90002-7; Tomlinson A, 2001, MOL CELL, V7, P487, DOI 10.1016/S1097-2765(01)00196-4; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Weber U, 2000, DEVELOPMENT, V127, P3619; WILKINSON HA, 1994, CELL, V79, P1187, DOI 10.1016/0092-8674(94)90010-8; Yung Y, 1997, FEBS LETT, V408, P292, DOI 10.1016/S0014-5793(97)00442-0	68	135	140	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 6	2002	110	5					625	637		10.1016/S0092-8674(02)00875-9	http://dx.doi.org/10.1016/S0092-8674(02)00875-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230979	Bronze			2022-12-28	WOS:000177943700009
J	Holowka, S; Petitto, LA				Holowka, S; Petitto, LA			Left hemisphere cerebral specialization for babies while babbling	SCIENCE			English	Article							LANGUAGE		McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada; Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Dartmouth Coll, Dept Educ, Hanover, NH 03755 USA	McGill University; Dartmouth College; Dartmouth College	Petitto, LA (corresponding author), McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ H3A 1B1, Canada.							BOROD JC, 1988, NEUROPSYCHOLOGIA, V26, P759, DOI 10.1016/0028-3932(88)90013-9; GAZZANIGA MS, 1983, ANN NEUROL, V13, P536, DOI 10.1002/ana.410130511; GRAVES R, 1990, INT J PSYCHOL, V25, P179, DOI 10.1080/00207599008247856; Locke JL, 2000, SCIENCE, V288, P449, DOI 10.1126/science.288.5465.449; MacNeilage PF, 2000, SCIENCE, V288, P527, DOI 10.1126/science.288.5465.527; Petitto LA, 2001, NATURE, V413, P35, DOI 10.1038/35092613; Pinker S, 1992, ADAPTED MIND EVOLUTI, P451	7	93	93	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1515	1515		10.1126/science.1074941	http://dx.doi.org/10.1126/science.1074941			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202820				2022-12-28	WOS:000177697300046
J	Boes, M; Cerny, J; Massol, R; Op den Brouw, M; Kirchhausen, T; Chen, JZ; Ploegh, HL				Boes, M; Cerny, J; Massol, R; Op den Brouw, M; Kirchhausen, T; Chen, JZ; Ploegh, HL			T-cell engagement of dendritic cells rapidly rearranges MHC class II transport	NATURE			English	Article							ANTIGEN PRESENTATION; INVARIANT CHAIN; EXPRESSION; MICE; ACTIVATION; DEGRADATION; MOLECULES; COMPLEXES; GENES	Assembly of major histocompatibility complex (MHC) molecules, which present antigen in the form of short peptides to T lymphocytes, occurs in the endoplasmic reticulum; once assembled, these molecules travel from the endoplasmic reticulum to their final destination. MHC class II molecules follow a route that takes them by means of the endocytic pathway, where they acquire peptide, to the cell surface(1). The transport of MHC class II molecules in 'professional' antigen-presenting cells (APCs) is subject to tight control and responds to inflammatory stimuli such as lipopolysaccharide. To study class II transport in live APCs, we replaced the mouse MHC class II gene with a version that codes for a class II molecule tagged with enhanced green fluorescent protein (EGFP). The resulting mice are immunologically indistinguishable from wild type. In bone-marrow-derived dendritic cells, we observed class II molecules in late endocytic structures with transport patterns similar to those in Langerhans cells observed in situ. We show that tubular endosomes extend intracellularly and polarize towards the interacting T cell, but only when antigen-laden dendritic cells encounter T cells of the appropriate specificity. We propose that such tubulation serves to facilitate the ensuing T-cell response.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Charles Univ, Fac Sci, Prague, Van Cerny, Czech Republic	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Charles University Prague	Ploegh, HL (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.		Cerny, Jan/C-1887-2012	Cerny, Jan/0000-0002-5624-2215; Boes, Marianne/0000-0003-2590-1692				Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HUGO P, 1992, NATURE, V360, P679, DOI 10.1038/360679a0; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; MALISSEN B, 1983, NATURE, V305, P440, DOI 10.1038/305440a0; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; MATHIS DJ, 1983, P NATL ACAD SCI-BIOL, V80, P273, DOI 10.1073/pnas.80.1.273; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; ROWDEN G, 1981, CRC CR REV IMMUNOL, V3, P95; SCHOLL PR, 1994, IMMUNOL TODAY, V15, P418, DOI 10.1016/0167-5699(94)90271-2; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Villadangos JA, 1999, IMMUNOL REV, V172, P109, DOI 10.1111/j.1600-065X.1999.tb01360.x; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611	22	322	348	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					983	988		10.1038/nature01004	http://dx.doi.org/10.1038/nature01004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198548				2022-12-28	WOS:000177677500046
J	Bedu-Addo, G; Bates, I				Bedu-Addo, G; Bates, I			Causes of massive tropical splenomegaly in Ghana	LANCET			English	Article							SPLENIC LYMPHOMA; B-CELL; MALARIA; IGM	Background The causes and diagnosis of massive tropical splenomegaly are not well studied, especially with modern investigative methods.. We aimed to identify features that would help local clinicians differentiate between the underlying conditions. Methods We collected prospective clinical and laboratory data on 221 Ghanaian patients with spleen size of at least 10 cm. We identified conditions associated with massive splenomegaly with molecular and immunological investigations as well as routine tests. Patients were assigned to diagnostic categories on the basis of these test results and predetermined criteria. Findings Hyper-reactive malarial splenomegaly (HMS; 91 patients [41%]) and B-lymphoproliferative disorders (48 [22%]) were the most common disorders associated with massive splenomegaly. Of the remaining patients, 32 (14%) had haematological disorders, and in 50 (23%) we could not identify the cause of splenomegaly. Male sex predominated in all diagnostic groups except HMS and tropical splenic lymphoma. Age less than 40 years and absolute lymphocyte count (less than 10 x 10(9)/L) were the only useful and widely available discriminators for distinguishing patients with HMS from those with lymphoproliferative disorders. Interpretation B-lymphoproliferative disorders are a previously unrecognised cause of massive tropical splenomegaly. This finding has major implications for management of massive splenomegaly. Diagnosis of the less common causes of this disorder is usually straightforward, but differentiating between B-lymphoproliferative disorders and HMS can be difficult. HMS is associated with younger age, a higher proportion of women, and lower absolute lymphocyte counts than lymphoproliferative disorders.	Univ Liverpool, Liverpool Sch Trop Med, Div Trop Med, Liverpool L3 5QA, Merseyside, England; Komfo Anokye Teaching Hosp, Dept Haematol, Kumasi, Ghana	Liverpool School of Tropical Medicine; University of Liverpool; Kwame Nkrumah University Science & Technology	Bates, I (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Div Trop Med, Liverpool L3 5QA, Merseyside, England.	ibates@liv.ac.uk		bates, imelda/0000-0002-0862-8199				[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; BATES I, 1991, LANCET, V337, P505, DOI 10.1016/0140-6736(91)91293-4; Bates I, 1997, LANCET, V349, P1178, DOI 10.1016/S0140-6736(05)63061-9; Bates I, 1997, LEUKEMIA, V11, P2162, DOI 10.1038/sj.leu.2400878; Bedu-Addo G, 2000, POSTGRAD MED J, V76, P107, DOI 10.1136/pmj.76.892.107; BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P2700; BRYCESON A, 1983, T ROY SOC TROP MED H, V77, P879, DOI 10.1016/0035-9203(83)90319-X; Bryceson A D, 1976, Acta Trop, V33, P185; Cook GC, 1980, TROPICAL GASTROENTER, P205; CRANE G, 1986, PAPUA NEW GUINEA MED, V29, P35; CRANE G G, 1986, Parasitology Today, V2, P4, DOI 10.1016/0169-4758(86)90067-0; DECOCK KM, 1986, J TROP MED HYG, V89, P119; FAKUNLE YM, 1981, CLIN HAEMATOL, V10, P963; FAKUNLE YM, 1979, TROP GEOGR MED, V31, P353; FLEMING AF, 1996, MANSONS TROPICAL DIS, P112; GREENWOOD BM, 1987, ANN TROP MED PARASIT, V81, P345, DOI 10.1080/00034983.1987.11812130; HAMILTON PJ, 1966, BRIT MED J, V2, P548, DOI 10.1136/bmj.2.5513.548; HAMILTON PJS, 1966, E AFR MED J, V42, P191; Jimmy EO, 1996, T ROY SOC TROP MED H, V90, P37, DOI 10.1016/S0035-9203(96)90472-1; LOWENTHAL M. N., 1966, Central African Journal of Medicine, V12, P99; LOWENTHAL MN, 1980, T ROY SOC TROP MED H, V74, P91, DOI 10.1016/0035-9203(80)90019-X; PITNEY WR, 1968, T ROY SOC TROP MED H, V62, P717, DOI 10.1016/0035-9203(68)90124-7; PRYOR DS, 1967, Q J MED, V36, P321; RAMASAMY I, 1992, J CLIN PATHOL, V45, P770, DOI 10.1136/jcp.45.9.770; REES PH, 1982, E AFR MED J, V59, P658; SAGOE AS, 1970, BRIT MED J, V3, P378, DOI 10.1136/bmj.3.5719.378; SCHNITZER B, 1976, LANCET, V2, P258; UKAEJIOFO E O, 1987, African Journal of Medicine and Medical Sciences, V16, P113; UKAEJIOFO EO, 1979, J TROP MED HYG, V82, P197; Wallace S, 1998, T ROY SOC TROP MED H, V92, P463, DOI 10.1016/S0035-9203(98)91095-1; YAMADA H, 1992, INTERNAL MED, V31, P1381, DOI 10.2169/internalmedicine.31.1381; Zhu DL, 1999, BRIT J HAEMATOL, V107, P114, DOI 10.1046/j.1365-2141.1999.01679.x	32	30	33	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					449	454		10.1016/S0140-6736(02)09680-0	http://dx.doi.org/10.1016/S0140-6736(02)09680-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241718				2022-12-28	WOS:000177342900012
J	Lauener, RP; Birchler, T; Adamski, J; Braun-Fahrlander, C; Bufe, A; Herz, U; von Mutius, E; Nowak, D; Riedler, J; Waser, M; Sennhauser, FH				Lauener, RP; Birchler, T; Adamski, J; Braun-Fahrlander, C; Bufe, A; Herz, U; von Mutius, E; Nowak, D; Riedler, J; Waser, M; Sennhauser, FH		ALEX Study Grp	Expression of CD14 and Toll-like receptor 2 in farmers' and nonfarmers' children	LANCET			English	Article							ASTHMA	Children of farmers are at decreased risk of developing allergies. Results of epidemiological studies suggest increased exposure to microbial compounds might be responsible for this reduced risk. Alterations in adaptive immune response are thought to be the underlying mechanism. We measured expression of receptors for microbial compounds known to trigger the innate immune response. We showed that blood cells from farmers' children express significantly higher amounts of CD14 (0.96 vs 0.43, p = 0.0013), and Toll-like receptor 2 (0.11 vs 0.04, p < 0.0001) than those from nonfarmers' children. We propose that the innate immune system responds to the microbial burden in the environment and modulates the development of allergic disease.	Univ Zurich, Childrens Hosp, CH-8032 Zurich, Switzerland; Univ Basel, Inst Social & Prevent Med, CH-4003 Basel, Switzerland; Ruhr Univ Bochum, D-4630 Bochum, Germany; Hosp Philipps Univ, Marburg, Germany; Univ Munich, Dr von Hauner Childrens Hosp, D-80539 Munich, Germany; Univ Munich, Inst Occupat & Environm Med, D-80539 Munich, Germany; Childrens Hosp Salzburg, Salzburg, Austria	University Children's Hospital Zurich; University of Zurich; University of Basel; Ruhr University Bochum; Philipps University Marburg; University of Munich; University of Munich	Lauener, RP (corresponding author), Univ Zurich, Childrens Hosp, CH-8032 Zurich, Switzerland.		Lauener, Roger P/O-8612-2016; riedler, josef/AAQ-4666-2020	Lauener, Roger P/0000-0002-8412-606X; von Mutius, Erika/0000-0002-8893-4515; Bufe, Albrecht/0000-0001-7335-9362				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Flo TH, 2001, J LEUKOCYTE BIOL, V69, P474; Martin P, 1999, APPL MICROW WIREL, V11, P12; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3	5	236	243	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					465	466		10.1016/S0140-6736(02)09641-1	http://dx.doi.org/10.1016/S0140-6736(02)09641-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241724				2022-12-28	WOS:000177342900018
J	Sommer, M; Koch, MA; Paulus, W; Weiller, C; Buchel, C				Sommer, M; Koch, MA; Paulus, W; Weiller, C; Buchel, C			Disconnection of speech-relevant brain areas in persistent developmental stuttering	LANCET			English	Article							POSITRON EMISSION TOMOGRAPHY; DIFFUSION TENSOR; FLUENT SPEAKERS; RECOVERY; CORTEX; PET	Background The neuronal basis of persistent developmental stuttering is unknown. The disorder could be related to a reduced left hemisphere dominance, which functional neuroimaging data suggest might lead to right hemispheric motor and premotor overactivation. Alternatively, the core deficit underlying stuttering might be located in the speech-dominant left hemisphere. Furthermore, magnetoencephalography study results show profound timing disturbances between areas involved in language preparation and execution in the left hemisphere, suggesting that persistent developmental stuttering might be related to impaired neuronal communication, possibly caused by a disruption of white matter fibre tracts. We aimed to establish whether disconnection between speech-related cortical areas was the structural basis of persistent developmental stuttering. Methods We analysed the speech of 15 people with persistent developmental stuttering and 15 closely matched controls for the percentage of syllables stuttered. We used diffusion tensor imaging to assess participants' brain tissue structure, and used voxel-based morphometry and two-sample t test to compare diffusion characteristics between groups. Findings Diffusion characteristics of the group with persistent developmental stuttering and controls differed significantly immediately below the laryngeal and tongue representation in the left sensorimotor cortex (mean difference in fractional anisotropy 0.04 [95% Cl 0.03-0.05]). Interpretation Our findings show that persistent developmental stuttering results from disturbed timing of activation in speech-relevant brain areas, and suggest that right hemisphere overactivation merely reflects a compensatory mechanism, analogous to right hemisphere activation in aphasia.	Univ Hamburg, Dept Neurol, Neurolmage Nord, D-20246 Hamburg, Germany; Univ Gottingen, Dept Clin Neurophysiol, D-3400 Gottingen, Germany	University of Hamburg; University of Gottingen	Buchel, C (corresponding author), Univ Hamburg, Dept Neurol, Neurolmage Nord, Martinistr 52, D-20246 Hamburg, Germany.		Paulus, Walter/A-3544-2009; Sommer, Martin/F-1503-2015	Paulus, Walter/0000-0001-5549-8377; 				Ambrose NG, 1997, J SPEECH LANG HEAR R, V40, P567, DOI 10.1044/jslhr.4003.567; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bloodstein O., 1995, HDB STUTTERING; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Foundas AL, 2001, NEUROLOGY, V57, P207, DOI 10.1212/WNL.57.2.207; Fox PT, 2000, BRAIN, V123, P1985, DOI 10.1093/brain/123.10.1985; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Ingham RJ, 2000, BRAIN LANG, V75, P163, DOI 10.1006/brln.2000.2351; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Nakagawa H, 1998, AM J NEURORADIOL, V19, P1129; Nolte UG, 2000, MAGNET RESON MED, V44, P731, DOI 10.1002/1522-2594(200011)44:5<731::AID-MRM11>3.0.CO;2-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onslow M, 1996, J SPEECH HEAR RES, V39, P734, DOI 10.1044/jshr.3904.734; Orton ST, 1928, NEW ENGL J MED, V199, P1046, DOI 10.1056/NEJM192811221992108; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; PERKINS WH, 1991, J SPEECH HEAR RES, V34, P734, DOI 10.1044/jshr.3404.734; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; Salmelin R, 1998, NEUROREPORT, V9, P2225, DOI 10.1097/00001756-199807130-00014; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; TONKONOGY J, 1981, ARCH NEUROL-CHICAGO, V38, P486, DOI 10.1001/archneur.1981.00510080048005; TRAVIS LE, 1978, J SPEECH HEAR DISORD, V43, P278, DOI 10.1044/jshd.4303.278; WEBSTER WG, 1991, J SPEECH HEAR RES, V34, P708, DOI 10.1044/jshr.3404.708; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; Wildgruber D, 1996, NEUROREPORT, V7, P2791, DOI 10.1097/00001756-199611040-00077; Wise RJS, 1999, LANCET, V353, P1057, DOI 10.1016/S0140-6736(98)07491-1; WU JC, 1995, NEUROREPORT, V6, P501, DOI 10.1097/00001756-199502000-00024; Yairi E, 1999, J SPEECH LANG HEAR R, V42, P1097, DOI 10.1044/jslhr.4205.1097	30	260	264	1	32	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					380	383		10.1016/S0140-6736(02)09610-1	http://dx.doi.org/10.1016/S0140-6736(02)09610-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241779				2022-12-28	WOS:000177255600012
J	Thomson, AB; Campbell, AJ; Irvine, DS; Anderson, RA; Kelnar, CJH; Wallace, WHB				Thomson, AB; Campbell, AJ; Irvine, DS; Anderson, RA; Kelnar, CJH; Wallace, WHB			Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study	LANCET			English	Article							INTRACYTOPLASMIC SPERM INJECTION; LONG-TERM SURVIVORS; COMBINATION CHEMOTHERAPY; HODGKINS-DISEASE; GONADAL-FUNCTION; MALE-FERTILITY; INHIBIN B; FERTILIZATION; DAMAGE; CELL	Background Treatment of childhood cancer can result in impaired spermatogenesis. Intracytoplasmic sperm injection (ICSI), however, can enable men to achieve fatherhood, and has focused attention on gamete integrity in men with oligozoospermia. Our aim was to assess testicular function in survivors of childhood cancer. Methods We assessed testicular function in 33 survivors of childhood cancer and 66 age-matched controls. The median age at diagnosis and at the start of the trial was 10.0 years (range 2.2-16.9) and 21.9 years (16.5-35.2), respectively. We assessed pubertal staging, measured plasma sex steroid hormone concentrations, and analysed semen quality, including spermatozoal DNA integrity. Findings Ten (30%) individuals were azoospermic and six (18%) oligozoospermic (sperm concentration <20 x 10(6)/mL). Sperm concentration was significantly lower in the non-azoospermic group than in controls (median 37.1 x 10(6)/mL, IQR 19.7 x 10(6) to 89.9 x 10(6), vs 90.7 x 10(6)/mL, 50-5 x 10(6) to 121.5 x 10(6); p = 0.002). In the non-azoospermic cancer survivor group, inhibin B concentrations were lower than in controls (mean 153.3 ng/L, SEM 17.8, vs 223.7 ng/L, 8.8; p < 0.001), and FSH concentrations were higher (6.6 U/L, 0.9, vs 3.2 U/L, 0.2; p < 0.001). Only 11 (33%) survivors of childhood cancer had normal semen quality. There was no significant difference in sperm DNA integrity between the non-azoospermic and control groups (9%, 5-13, vs 11%, 7-16; p = 0.06). Interpretation Sperm concentration is reduced after treatment for cancer. However, the sperm produced seems to carry as much healthy DNA as those produced by the healthy population, suggesting that assisted conception can be considered as a treatment option for these men.	Univ Edinburgh, Dept Reprod & Dev Sci, Sect Child Life & Hlth, Edinburgh, Midlothian, Scotland; MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh	Wallace, WHB (corresponding author), Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LW, Midlothian, Scotland.	hamish.wallace@luht.scot.nhs.uk		wallace, william, hamish/0000-0001-8080-5674				Aboulghar MA, 1997, FERTIL STERIL, V68, P108, DOI 10.1016/S0015-0282(97)81484-7; Anderson RA, 2000, INT J ANDROL, V23, P136, DOI 10.1046/j.1365-2605.2000.00229.x; Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P4451, DOI 10.1210/jc.83.12.4451; Andreu JAL, 2000, PEDIATR HEMAT ONCOL, V17, P21, DOI 10.1080/088800100276631; Biggers J.D., 1971, CULTURE MOUSE EMBRYO; Bonduelle M, 1999, HUM REPROD, V14, P243, DOI 10.1093/humrep/14.suppl_1.243; CUMMINS JM, 1995, HUM REPROD, V10, P138, DOI 10.1093/humrep/10.suppl_1.138; Groome NP, 1996, J CLIN ENDOCR METAB, V81, P1401, DOI 10.1210/jcem.81.4.8636341; Grundy R, 2001, ARCH DIS CHILD, V84, P355, DOI 10.1136/adc.84.4.355; HAWKINS MM, 1989, INT J CANCER, V43, P975, DOI 10.1002/ijc.2910430604; Humpl T, 1999, ARCH ANDROLOGY, V43, P123, DOI 10.1080/014850199262625; Irvine DS, 2000, J ANDROL, V21, P33; LENDON M, 1978, LANCET, V2, P439; Mackie EJ, 1996, MED PEDIATR ONCOL, V27, P74, DOI 10.1002/(SICI)1096-911X(199608)27:2<74::AID-MPO2>3.0.CO;2-Q; MUSTIELES C, 1995, MED PEDIATR ONCOL, V24, P347, DOI 10.1002/mpo.2950240603; Ramaswamy S, 1999, J ANDROL, V20, P430; RAUTONEN J, 1992, EUR J CANCER, V28A, P1837, DOI 10.1016/0959-8049(92)90016-U; Robbins WA, 1997, NAT GENET, V16, P74, DOI 10.1038/ng0597-74; Schover LR, 1999, MED PEDIATR ONCOL, V33, P53, DOI 10.1002/(SICI)1096-911X(199907)33:1<53::AID-MPO10>3.0.CO;2-K; SHALET SM, 1989, J ENDOCRINOL, V120, P161, DOI 10.1677/joe.0.1200161; SHELBY MD, 1994, ENVIRON MOL MUTAGEN, V23, P30, DOI 10.1002/em.2850230609; Spano M, 2000, FERTIL STERIL, V73, P43, DOI 10.1016/S0015-0282(99)00462-8; SPEISER B, 1973, CANCER, V32, P692, DOI 10.1002/1097-0142(197309)32:3<692::AID-CNCR2820320323>3.0.CO;2-I; Sun JG, 1997, BIOL REPROD, V56, P602, DOI 10.1095/biolreprod56.3.602; Sutcliffe AG, 2001, LANCET, V357, P2080, DOI 10.1016/S0140-6736(00)05180-1; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Thomson AB, 2002, EUR J CANCER, V38, P468, DOI 10.1016/S0959-8049(01)00335-5; TOURNAYE H, 1993, FERTIL STERIL, V60, P197; TRASLER JM, 1985, NATURE, V316, P144, DOI 10.1038/316144a0; Twigg JP, 1998, HUM REPROD, V13, P1864, DOI 10.1093/humrep/13.7.1864; VIVIANI S, 1985, EUR J CANCER CLIN ON, V21, P601, DOI 10.1016/0277-5379(85)90088-4; WALLACE WHB, 1989, MED PEDIATR ONCOL, V17, P409; WALLACE WHB, 1991, INT J ANDROL, V14, P312, DOI 10.1111/j.1365-2605.1991.tb01098.x; WALLACE WHB, 1997, PAEDIAT ONCOLOGY CLI, P706; Waring AB, 2000, HOSP MED, V61, P550, DOI 10.12968/hosp.2000.61.8.1398; WATSON AR, 1985, BRIT MED J, V291, P1457, DOI 10.1136/bmj.291.6507.1457; WHITEHEAD E, 1982, ARCH DIS CHILD, V57, P287, DOI 10.1136/adc.57.4.287; World Health Organization, 1999, WHO LAB MAN EX HUM S; Zenzes MT, 1999, MOL HUM REPROD, V5, P125, DOI 10.1093/molehr/5.2.125	39	130	136	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2002	360	9330					361	367		10.1016/S0140-6736(02)09606-X	http://dx.doi.org/10.1016/S0140-6736(02)09606-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241775				2022-12-28	WOS:000177255600008
J	Phu, NH; Hien, TT; Mai, NTH; Chau, TTH; Chuong, LV; Loc, PP; Winearls, C; Farrar, J; White, N; Day, N				Phu, NH; Hien, TT; Mai, NTH; Chau, TTH; Chuong, LV; Loc, PP; Winearls, C; Farrar, J; White, N; Day, N			Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE FALCIPARUM-MALARIA; ACIDOSIS	Background: In some parts of the world, peritoneal dialysis is widely used for renal replacement in acute renal failure. In resource-rich countries, it has been supplanted in recent years by hemodialysis and, most recently, by hemofiltration and associated techniques. The relative efficacy of peritoneal dialysis and hemofiltration is not known. Methods: We conducted an open, randomized comparison of pumped venovenous hemofiltration and peritoneal dialysis in patients with infection-associated acute renal failure in an infectious-disease referral hospital in Vietnam. Results: Seventy adult patients with severe falciparum malaria (48 patients) or sepsis (22 patients) were enrolled; 34 were assigned to hemofiltration and 36 to peritoneal dialysis. The mortality rate was 47 percent (17 patients) in the group assigned to peritoneal dialysis, as compared with 15 percent (5 patients) in the group assigned to hemofiltration (P=0.005). The rates of resolution of acidosis and of decline in the serum creatinine concentration in the group assigned to hemofiltration were more than twice those in the group assigned to peritoneal dialysis (P<0.005), and renal-replacement therapy was required for a significantly shorter period. In a multivariate analysis, the odds ratio for death was 5.1 (95 percent confidence interval, 1.6 to 16) and that for a need for future dialysis was 4.7 (95 percent confidence interval, 1.3 to 17) in the group assigned to peritoneal dialysis. The cost of hemofiltration per survivor was less than half that of peritoneal dialysis, and the cost per life saved was less than one third. Conclusions: Hemofiltration is superior to peritoneal dialysis in the treatment of infection-associated acute renal failure.	John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England; Cho Quan Hosp, Ctr Trop Dis, Ho Chi Minh City, Vietnam; Cho Quan Hosp, Wellcome Trust Clin Res Unit, Ho Chi Minh City, Vietnam; Churchill Hosp, Renal Unit, Oxford OX3 7LJ, England	University of Oxford; University of Oxford	Day, N (corresponding author), John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England.	nick.day@ndm.ox.ac.uk	White, Nick/AAC-6527-2019; Farrar, Jeremy J./HGA-7610-2022; Thi, Nguyen/AAM-7074-2020; White, Nicholas J/I-4629-2012	White, Nick/0000-0002-1897-1978; Farrar, Jeremy/0000-0002-2700-623X				DAVENPORT A, 1990, NEPHROL DIAL TRANSPL, V5, P342, DOI 10.1093/ndt/5.5.342; Day NPJ, 2000, CRIT CARE MED, V28, P1833, DOI 10.1097/00003246-200006000-00025; Dunham CM, 2001, WORLD J SURG, V25, P669, DOI 10.1007/s002680020029; English M, 1997, QJM-INT J MED, V90, P263, DOI 10.1093/qjmed/90.4.263; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; Hilton PJ, 1998, QJM-MON J ASSOC PHYS, V91, P279, DOI 10.1093/qjmed/91.4.279; HUYGHEBAERT MF, 1985, CRIT CARE MED, V13, P840, DOI 10.1097/00003246-198510000-00013; Karnik AM, 1998, RENAL FAILURE, V20, P103, DOI 10.3109/08860229809045093; Lombardi R, 1998, RENAL FAILURE, V20, P725, DOI 10.3109/08860229809045169; TRANG TTM, 1992, CLIN INFECT DIS, V15, P874, DOI 10.1093/clind/15.5.874; VOERMAN HJ, 1990, CRIT CARE MED, V18, P911, DOI 10.1097/00003246-199009000-00002	11	197	207	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					895	902		10.1056/NEJMoa020074	http://dx.doi.org/10.1056/NEJMoa020074			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239258	Bronze			2022-12-28	WOS:000178040700005
J	Esteller, M; Fraga, MF; Paz, MF; Campo, E; Colomer, D; Novo, FJ; Calasanz, MJ; Galm, O; Guo, MZ; Benitez, J; Herman, JG; Croce, LD; Pelicci, PG				Esteller, M; Fraga, MF; Paz, MF; Campo, E; Colomer, D; Novo, FJ; Calasanz, MJ; Galm, O; Guo, MZ; Benitez, J; Herman, JG; Croce, LD; Pelicci, PG			Cancer epigenetics and methylation	SCIENCE			English	Letter									Spanish Natl Canc Res Ctr, Canc Epigenet Lab, Mol Pathol Program, Madrid 28029, Spain; Hosp Clin Barcelona, Hematopathol Sect, Anat Pathol Lab, Barcelona, Catalonia, Spain; Univ Navarra, Dept Genet, E-31080 Pamplona, Spain; Med Klin 4, Aachen, Germany; Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21205 USA	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Barcelona; Hospital Clinic de Barcelona; University of Navarra; Johns Hopkins University; Johns Hopkins Medicine	Esteller, M (corresponding author), Spanish Natl Canc Res Ctr, Canc Epigenet Lab, Mol Pathol Program, Melchor Fernandez Almagro 3, Madrid 28029, Spain.		Campo, Elias/AAC-5593-2019; Esteller, Manel/L-5956-2014; Pelicci, Pier Giuseppe/AAL-6572-2020; Novo, Francisco/M-7596-2015; Calasanz, MJ/R-5813-2016; COLOMER, DOLORS/ABG-6894-2020; Fraga, Mario F/H-7824-2017	Campo, Elias/0000-0001-9850-9793; Esteller, Manel/0000-0003-4490-6093; Novo, Francisco/0000-0003-4961-3097; Calasanz, MJ/0000-0002-0374-3008; Fraga, Mario F/0000-0001-8450-2603; COLOMER, DOLORS/0000-0001-7486-8484					0	99	107	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1807	1808						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12229925				2022-12-28	WOS:000177955000019
J	Reinhart, BJ; Bartel, DP				Reinhart, BJ; Bartel, DP			Small RNAs correspond to centromere heterochromatic repeats	SCIENCE			English	Article							METHYLATION		MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Reinhart, BJ (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu						Ayoub N, 2000, GENETICS, V156, P983; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; NAKASEKO Y, 1986, EMBO J, V5, P1011, DOI 10.1002/j.1460-2075.1986.tb04316.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	10	390	474	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1831	1831		10.1126/science.1077183	http://dx.doi.org/10.1126/science.1077183			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12193644				2022-12-28	WOS:000177955000033
J	Yang, HJ; Jeffrey, PD; Miller, J; Kinnucan, E; Sun, YT; Thoma, NH; Zheng, N; Chen, PL; Lee, WH; Pavletich, NP				Yang, HJ; Jeffrey, PD; Miller, J; Kinnucan, E; Sun, YT; Thoma, NH; Zheng, N; Chen, PL; Lee, WH; Pavletich, NP			BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure	SCIENCE			English	Article							SINGLE-STRANDED-DNA; REPLICATION PROTEIN-A; HUMAN RAD51 PROTEIN; HOMOLOGY-DIRECTED REPAIR; CRYSTAL-STRUCTURE; CANCER SUSCEPTIBILITY; ESCHERICHIA-COLI; RADIATION HYPERSENSITIVITY; SACCHAROMYCES-CEREVISIAE; COMPLEX-FORMATION	Mutations in the BRCA2 (breast cancer susceptibility gene 2) tumor suppressor lead to chromosomal instability due to defects in the repair of double-strand DNA breaks (DSBs) by homologous recombination, but BRCA2's role in this process has been unclear. Here, we present the 3.1 angstrom crystal structure of a similar to90- kilodalton BRCA2 domain bound to DSS1, which reveals three oligonucleotide-binding ( OB) folds and a helix-turn-helix (HTH) motif. We also (i) demonstrate that this BRCA2 domain binds single-stranded DNA, (ii) present its 3.5 angstrom structure bound to oligo(dT)(9), (iii) provide data that implicate the HTH motif in dsDNA binding, and (iv) show that BRCA2 stimulates RAD51-mediated recombination in vitro. These findings establish that BRCA2 functions directly in homologous recombination and provide a structural and biochemical basis for understanding the loss of recombination-mediated DSB repair in BRCA2-associated cancers.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Cornell Univ, Dept Pharmacol, Sloan Kettering Div, Joan & Sanford I Weill Grad Sch Med Sci, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Univ Texas, Dept Mol Med, Ctr Hlth, San Antonio, TX 78245 USA; Univ Texas, Inst Biotechnol, Ctr Hlth, San Antonio, TX 78245 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas System	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	nikola@xray2.mskcc.org		Sun, Yutong/0000-0002-9368-2957; Miller, Julie/0000-0002-1288-593X; Chen, Phang-Lang/0000-0002-0357-9017; Jeffrey, Philip/0000-0002-4351-5341				Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Baumann P, 1997, EMBO J, V16, P5198, DOI 10.1093/emboj/16.17.5198; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bochkareva E, 1998, J BIOL CHEM, V273, P3932, DOI 10.1074/jbc.273.7.3932; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brill SJ, 1998, MOL CELL BIOL, V18, P7225, DOI 10.1128/MCB.18.12.7225; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen JJ, 1999, CANCER RES, V59, p1752S; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; CHOU CH, 1992, J EXP MED, V175, P1677, DOI 10.1084/jem.175.6.1677; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Crackower MA, 1996, HUM MOL GENET, V5, P571, DOI 10.1093/hmg/5.5.571; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FENG JA, 1994, SCIENCE, V263, P348, DOI 10.1126/science.8278807; FOLMER RHA, 1995, EMBO J, V14, P4132, DOI 10.1002/j.1460-2075.1995.tb00087.x; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanaar R, 1998, NATURE, V391, P335, DOI 10.1038/34790; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Lim DS, 1996, MOL CELL BIOL, V16, P7133; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOLL PJ, 1988, J BIOL CHEM, V263, P18190; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Marston NJ, 1999, MOL CELL BIOL, V19, P4633; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Morimatsu M, 1998, CANCER RES, V58, P3441; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Nayal M, 1999, PROTEIN SCI, V8, P676; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pfuetzner RA, 1997, J BIOL CHEM, V272, P430; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Sheldrick GM, 2001, NATO SCI SER I LIFE, V325, P72; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Suck D, 1997, NAT STRUCT BIOL, V4, P161, DOI 10.1038/nsb0397-161; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; Szabo C, 2000, HUM MUTAT, V16, P123, DOI 10.1002/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; TUCKER PA, 1994, EMBO J, V13, P2994, DOI 10.1002/j.1460-2075.1994.tb06598.x; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Tutt ANJ, 2002, EMBO REP, V3, P255, DOI 10.1093/embo-reports/kvf037; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Warren M, 2002, HUM MOL GENET, V11, P841, DOI 10.1093/hmg/11.7.841; Webster G, 1997, FEBS LETT, V411, P313, DOI 10.1016/S0014-5793(97)00747-3; WEST SC, 1992, ANNU REV BIOCHEM, V61, P603, DOI 10.1146/annurev.bi.61.070192.003131; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yang H., UNPUB; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0; Yu VPCC, 2000, GENE DEV, V14, P1400; Yuan SSF, 1999, CANCER RES, V59, P3547	106	526	542	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1837	1848		10.1126/science.297.5588.1837	http://dx.doi.org/10.1126/science.297.5588.1837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228710				2022-12-28	WOS:000177955000035
J	Mazmanian, PE; Davis, DA				Mazmanian, PE; Davis, DA			Continuing medical education and the physician as a learner - Guide to the evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; CARE; IMPROVEMENT; PERFORMANCE; FEEDBACK; QUALITY		Virginia Commonwealth Univ, Dept Prevent Med & Community Hlth, Richmond, VA 23219 USA; Univ Toronto, Dept Hlth Policy, Toronto, ON, Canada; Univ Toronto, Dept Management & Evaluat, Toronto, ON, Canada; Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada	Virginia Commonwealth University; University of Toronto; University of Toronto; University of Toronto	Mazmanian, PE (corresponding author), Virginia Commonwealth Univ, Dept Prevent Med & Community Hlth, 1223 E Marshall St, Richmond, VA 23219 USA.							*ACGME OUTC PROJ, 2002, PRACT BAS LEARN IMPR; BENNINGER MS, 1995, OTOLARYNG HEAD NECK, V113, P446, DOI 10.1016/S0194-5998(95)70083-8; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; BROWN CR, 1977, QUALITY HLTH CARE RO, P11; Campbell C.M, 1999, J CONTIN EDUC HEALTH, V19, P16; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Davis DA, 1997, CAN MED ASSOC J, V157, P408; DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P1111, DOI 10.1001/jama.268.9.1111; Davis DA, 1994, PHYSICIAN LEARNER LI, P245; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Fox R D, 2000, J Contin Educ Health Prof, V20, P238, DOI 10.1002/chp.1340200407; Fox RD., 1989, CHANGING LEARNING LI, P161; Grol R, 2001, JAMA-J AM MED ASSOC, V286, P2578, DOI 10.1001/jama.286.20.2578; HOULE CO, 1980, CONTINUING LEARNING, P266; Kiefe CI, 2001, JAMA-J AM MED ASSOC, V285, P2871, DOI 10.1001/jama.285.22.2871; MAIMAN LA, 1988, AM J DIS CHILD, V142, P773, DOI 10.1001/archpedi.1988.02150070087033; Norcini JJ, 1999, BRIT MED J, V319, P1183, DOI 10.1136/bmj.319.7218.1183; OBRIEN MAT, 2002, CONT ED M WORKSH EFF; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; POLLACK MM, 1991, CRIT CARE MED, V19, P12, DOI 10.1097/00003246-199101000-00008; RESTUCCIA JD, 1982, MED CARE, V20, P46, DOI 10.1097/00005650-198201000-00004; SCHAAFSMA J, 1994, QUAL LIFE RES, V3, P413, DOI 10.1007/BF00435393; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; *UK U AB, 2001, COCHR EFF PRACT ORG; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; WILSON DM, 1988, JAMA-J AM MED ASSOC, V260, P1570, DOI 10.1001/jama.260.11.1570	27	335	342	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1057	1060		10.1001/jama.288.9.1057	http://dx.doi.org/10.1001/jama.288.9.1057			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589NA	12204068				2022-12-28	WOS:000177764600002
J	Black, C; Kaye, JA; Jick, H				Black, C; Kaye, JA; Jick, H			Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database	BRITISH MEDICAL JOURNAL			English	Article							INFLAMMATORY BOWEL-DISEASE; MEASLES VACCINATION; RISK; USERS	Objectives To assess whether children with autism are more likely to have a history of gastrointestinal disorders than children without autism. Design Nested case-control study. Setting UK General Practice Research Database. Subjects Children born after 1 January 1988 and registered with the General Practice Research Database within 6 months of birth. Outcome measures Chronic inflammation of the gastrointestinal tract, coeliac disease, food intolerance, and recurrent gastrointestinal symptoms recorded by the general practitioner. Results 9 of 96 (9%) children with a diagnosis of autism (cases) and 41 of 449 (9%) children without autism (matched controls) had a history of gastrointestinal disorders before the index date (the date of first recorded diagnosis of autism in the cases and the same date for controls). The estimated odds ratio for a history of gastrointestinal disorders among children with autism compared with children without autism was 1.0 (95% confidence interval 0.5 to 2.2). Conclusions No evidence was found that children with autism were more likely than children without autism to have had defined gastrointestinal disorders at any time before their diagnosis of autism.	Boston Univ, Boston Collaborat Drug Surveillance Program, Boston, MA 02421 USA	Boston University	Black, C (corresponding author), Boston Univ, Boston Collaborat Drug Surveillance Program, Boston, MA 02421 USA.		Black, Corri/A-7924-2012	Jick, Hershel/0000-0003-4270-5992; Kaye, James A./0000-0002-9357-4227				Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; Derby L, 2000, J ALLERGY CLIN IMMUN, V105, P912, DOI 10.1067/mai.2000.106044; Feeney M, 1997, LANCET, V350, P764, DOI 10.1016/S0140-6736(97)03192-9; Fombonne E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e58; Gasse C, 2000, PHARMACOTHERAPY, V20, P629, DOI 10.1592/phco.20.7.629.35174; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1997, LANCET, V349, P525, DOI 10.1016/S0140-6736(97)80084-0; Jick H, 2001, BRIT J CLIN PHARMACO, V52, P451, DOI 10.1046/j.0306-5251.2001.?aid?.x; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; Jick SS, 1997, PHARMACOTHERAPY, V17, P561; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; Myers MW, 2000, BRIT J CLIN PHARMACO, V49, P604, DOI 10.1046/j.1365-2125.2000.00208.x; Perry J, 1978, OXMIS PROBLEM CODES; Taylor B, 2002, BRIT MED J, V324, P393, DOI 10.1136/bmj.324.7334.393; THOMPSON NP, 1995, LANCET, V345, P1071, DOI 10.1016/S0140-6736(95)90816-1; Vasilakis-Scaramozza C, 2001, LANCET, V358, P1427, DOI 10.1016/S0140-6736(01)06522-9; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wing L, 1997, LANCET, V350, P1761, DOI 10.1016/S0140-6736(97)09218-0; Yang CC, 2002, BRIT J CLIN PHARMACO, V53, P101, DOI 10.1046/j.0306-5251.2001.01523.x	19	154	156	0	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2002	325	7361					419	421		10.1136/bmj.325.7361.419	http://dx.doi.org/10.1136/bmj.325.7361.419			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193358	Green Published			2022-12-28	WOS:000177715500020
J	Geffeney, S; Brodie, ED; Ruben, PC; Brodie, ED				Geffeney, S; Brodie, ED; Ruben, PC; Brodie, ED			Mechanisms of adaptation in a predator-prey arms race: TTX-resistant sodium channels	SCIENCE			English	Article							SNAKE SKELETAL-MUSCLE; DANGEROUS PREY; NA+ CHANNEL; EVOLUTIONARY RESPONSE; GARTER SNAKES; TETRODOTOXIN; POPULATIONS; SAXITOXIN; TOXICITY; PERFORMANCE	Populations of the garter snake Thamnophis sirtalis have evolved geographically variable resistance to tetrodotoxin ( TTX) in a coevolutionary arms race with their toxic prey, newts of the genus Taricha. Here, we identify a physiological mechanism, the expression of TTX-resistant sodium channels in skeletal muscle, responsible for adaptive diversification in whole-animal resistance. Both individual and population differences in the ability of skeletal muscle fibers to function in the presence of TTX correlate closely with whole-animal measures of TTX resistance. Demonstration of individual variation in an essential physiological function responsible for the adaptive differences among populations is a step toward linking the selective consequences of coevolutionary interactions to geographic and phylogenetic patterns of diversity.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Utah State Univ, Dept Biol, Logan, UT 84322 USA	Indiana University System; Indiana University Bloomington; Utah System of Higher Education; Utah State University	Brodie, ED (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.		Brodie, Edmund D/B-2335-2013	Geffeney, Shana/0000-0003-0504-2077				ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; BEAM KG, 1985, NATURE, V313, P588, DOI 10.1038/313588a0; Brodie ED, 1999, EVOLUTION, V53, P626, DOI 10.1111/j.1558-5646.1999.tb03798.x; BRODIE ED, 1990, EVOLUTION, V44, P651, DOI 10.1111/j.1558-5646.1990.tb05945.x; BRODIE ED, 1991, EVOLUTION, V45, P221, DOI 10.1111/j.1558-5646.1991.tb05280.x; Brodie ED, 1999, BIOSCIENCE, V49, P557, DOI 10.2307/1313476; BRODIE ED, 1968, COPEIA, P307; BRODIE ED, 1974, COPEIA, P506; BRODIE ED, IN PRESS EVOLUTION; CADE BS, 1999, USER MANUAL BLOSSOM; CALDWELL JH, 1988, J PHYSIOL-LONDON, V401, P145, DOI 10.1113/jphysiol.1988.sp017155; CALDWELL JH, 1986, J GEN PHYSIOL, V87, P907, DOI 10.1085/jgp.87.6.907; GARLAND T, 1990, EXPERIENTIA, V46, P530, DOI 10.1007/BF01954257; GARLAND T, 1994, ANNU REV PHYSIOL, V56, P579, DOI 10.1146/annurev.ph.56.030194.003051; GARLAND T, 1991, ANNU REV ECOL SYST, V22, P193, DOI 10.1146/annurev.es.22.110191.001205; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hanifin CT, 1999, J CHEM ECOL, V25, P2161, DOI 10.1023/A:1021049125805; JANZEN FJ, IN PRESS MOL ECOL; KAO CY, 1967, TOXICON, V5, P24; KIDOKORO Y, 1974, J COMP PHYSIOL, V89, P59, DOI 10.1007/BF00696163; LIPKIND GM, 1994, BIOPHYS J, V66, P1, DOI 10.1016/S0006-3495(94)80746-5; Mielke P. W., 2001, PERMUTATION METHODS; MOSHER HS, 1964, SCIENCE, V144, P1100, DOI 10.1126/science.144.3622.1100; NARAHASH.T, 1967, SCIENCE, V156, P976, DOI 10.1126/science.156.3777.976; Nuismer SL, 1999, P ROY SOC B-BIOL SCI, V266, P605, DOI 10.1098/rspb.1999.0679; Penzotti JL, 1998, BIOPHYS J, V75, P2647, DOI 10.1016/S0006-3495(98)77710-0; Ridenhour BJ, 1999, COPEIA, P531; ROBERTS WM, 1987, J PHYSIOL-LONDON, V388, P213, DOI 10.1113/jphysiol.1987.sp016611; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thompson JN, 1999, AM NAT, V153, pS92, DOI 10.1086/303214; Westfall P.H., 1999, MULTIPLE COMPARISONS; WOOD SJ, 1995, J PHYSIOL-LONDON, V486, P401, DOI 10.1113/jphysiol.1995.sp020821; Yotsu-Yamashita M, 2000, BIOCHEM BIOPH RES CO, V267, P403, DOI 10.1006/bbrc.1999.1974	34	130	135	0	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1336	1339		10.1126/science.1074310	http://dx.doi.org/10.1126/science.1074310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193784				2022-12-28	WOS:000177573900044
J	Pool, MR; Stumm, J; Fulga, TA; Sinning, I; Dobberstein, B				Pool, MR; Stumm, J; Fulga, TA; Sinning, I; Dobberstein, B			Distinct modes of signal recognition particle interaction with the ribosome	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PROTEIN TRANSLOCATION; SEQUENCE RECOGNITION; NASCENT PREPROLACTIN; MICROSOMAL MEMBRANE; ELONGATION ARREST; CHAIN COMPLEXES; 80S RIBOSOME; BINDING; SRP	Signal recognition particle (SRP), together with its receptor (SR), mediates the targeting of ribosome-nascent chain complexes to the endoplasmic reticulum. Using protein cross-linking, we detected distinct modes in the binding of SRP to the ribosome. During signal peptide recognition, SRP54 is positioned at the exit site close to ribosomal proteins L23a and L35. When SRP54 contacts SR, SRP54 is rearranged such that it is no longer close to L23a. This repositioning may allow the translocon to dock with the ribosome, leading to insertion of the signal peptide into the translocation channel.	Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany; European Mol Biol Lab, Struct Biol Programme, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Pool, MR (corresponding author), Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany.	mrp@zmbh.uni-heidelberg.de	Pool, Martin R./AAB-9181-2021; Sinning, Irmgard/A-2982-2010	Pool, Martin R./0000-0003-3071-1535; Fulga, Tudor/0000-0002-1056-0082				Bacher G, 1996, NATURE, V381, P248, DOI 10.1038/381248a0; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; CONNOLLY T, 1989, CELL, V57, P599, DOI 10.1016/0092-8674(89)90129-3; Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Harlow E., 1988, ANTIBODIES LAB MANUA; HAUSER S, 1995, EMBO J, V14, P5485, DOI 10.1002/j.1460-2075.1995.tb00235.x; HIGH S, 1993, J CELL BIOL, V121, P743, DOI 10.1083/jcb.121.4.743; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0; Lu Y, 2001, EMBO J, V20, P6724, DOI 10.1093/emboj/20.23.6724; LUIRINK J, 1992, NATURE, V359, P741, DOI 10.1038/359741a0; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; MARTOGLIO B, 1997, CELL BIOL LAB HDB, P265; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; MILLER JD, 1995, J CELL BIOL, V128, P273, DOI 10.1083/jcb.128.3.273; Neuhof A, 1998, MOL BIOL CELL, V9, P103, DOI 10.1091/mbc.9.1.103; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; ROMISCH K, 1989, NATURE, V340, P478, DOI 10.1038/340478a0; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; WALLECZEK J, 1989, J BIOL CHEM, V264, P4231; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511	36	160	162	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1345	1348		10.1126/science.1072366	http://dx.doi.org/10.1126/science.1072366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193787				2022-12-28	WOS:000177573900047
J	Kjaer, SK				Kjaer, S. K.			Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study (vol 325, pg 572, 2002)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction														Kjaer, Susanne/0000-0002-8347-1398	NATIONAL CANCER INSTITUTE [R01CA047812] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA047812, R01 CA47812] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Kjaer SK, 2016, BMJ-BRIT MED J, V353, DOI [10.1136/bmj.325.7364.572, 10.1136/bmj.i2820]	1	321	350	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2016	353									10.1136/bmj.i2820	http://dx.doi.org/10.1136/bmj.i2820			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GC	12228133	Green Published, Bronze			2022-12-28	WOS:000376447600012
J	Linkenhoker, BA; Knudsen, EI				Linkenhoker, BA; Knudsen, EI			Incremental training increases the plasticity of the auditory space map in adult barn owls	NATURE			English	Article							OPTIC TECTUM; SOUND LOCALIZATION; SENSITIVE PERIODS; EXPERIENCE; MECHANISMS; MIDBRAIN; BIRDSONG; SPEECH	The plasticity in the central nervous system that underlies learning is generally more restricted in adults than in young animals(1-4). In one well-studied example, the auditory localization pathway has been shown to be far more limited in its capacity to adjust to abnormal experience in adult than in juvenile barn owls(5). Plasticity in this pathway has been induced by exposing owls to prismatic spectacles that cause a large, horizontal shift of the visual field. With prisms, juveniles learn new associations between auditory cues, such as interaural time difference (ITD), and locations in visual space, and acquire new neurophysiological maps of ITD in the optic tectum, whereas adults do neither(6). Here we show that when the prismatic shift is experienced in small increments, maps of ITD in adults do change adaptively. Once established through incremental training, new ITD maps can be reacquired with a single large prismatic shift. Our results show that there is a substantially greater capacity for plasticity in adults than was previously recognized and highlight a principled strategy for tapping this capacity that could be applied in other areas of the adult central nervous system.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Knudsen, EI (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.							Brainard MS, 1998, J NEUROSCI, V18, P3929; BRAINARD MS, 1992, J ACOUST SOC AM, V91, P1015, DOI 10.1121/1.402627; Clawson DM, 2001, J EXP PSYCHOL-APPL, V7, P129, DOI 10.1037//1076-898X.7.2.129; Daw NW, 1997, OPTOMETRY VISION SCI, V74, P690, DOI 10.1097/00006324-199709000-00002; DeBello WM, 2001, J NEUROSCI, V21, P3161, DOI 10.1523/JNEUROSCI.21-09-03161.2001; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; FOX K, 1992, J NEUROSCI, V12, P1826; Gold JI, 1999, J NEUROPHYSIOL, V82, P2197, DOI 10.1152/jn.1999.82.5.2197; KING AJ, 1993, EXP PHYSIOL, V78, P559, DOI 10.1113/expphysiol.1993.sp003708; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; KNUDSEN EI, 1985, J NEUROSCI, V5, P3094; Knudsen EI, 1999, J COMP PHYSIOL A, V185, P305, DOI 10.1007/s003590050391; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1989, J NEUROSCI, V9, P3306; KNUDSEN EI, 1993, J NEUROSCI, V13, P2837; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; Mooney R, 1999, CURR OPIN NEUROBIOL, V9, P121, DOI 10.1016/S0959-4388(99)80015-4; MURPHY EH, 1975, EXP NEUROL, V49, P386, DOI 10.1016/0014-4886(75)90096-5; Newport E. L., 2001, LANGUAGE BRAIN COGNI, P481, DOI DOI 10.1067/MHN.2001.115372; Perone M., 1988, HUMAN OPERANT CONDIT, P59; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P693, DOI 10.1111/j.1460-9568.1990.tb00459.x; Zheng WM, 1999, SCIENCE, V284, P962, DOI 10.1126/science.284.5416.962	26	88	93	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2002	419	6904					293	296		10.1038/nature01002	http://dx.doi.org/10.1038/nature01002			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239566				2022-12-28	WOS:000178056300044
J	Rathore, SS; Wang, YF; Radford, MJ; Ordin, DL; Krumholz, HM				Rathore, SS; Wang, YF; Radford, MJ; Ordin, DL; Krumholz, HM			Sex differences in cardiac catheterization after acute myocardial infarction: The role of procedure appropriateness	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ANGIOGRAPHY; GENDER-DIFFERENCES; AMERICAN-COLLEGE; ELDERLY-PATIENTS; MANAGED CARE; WOMEN; MEN; REVASCULARIZATION; OUTCOMES; BIAS	Background: many studies have found that women are less likely than men to have cardiac catheterization after an acute myocardial infarction; however, it is unknown whether sex differences reflect inappropriate treatment. Objective: To ascertain whether cardiac catheterization use after acute myocardial infarction in men and women varied by sex and the appropriateness of the procedure, as determined by clinical guidelines. Design: Retrospective analysis of chart-abstracted data. Setting: U.S. acute-care hospitals. Patients: 143 444 Medicare patients who were hospitalized for acute myocardial infarction between 1994 and 1996. Measurements: Cardiac catheterization use within 60 days of hospitalization for acute myocardial infarction. Results: Women had lower crude rates of cardiac catheterization than men (35.7% for women vs. 46.5% for men [P < 0.001]; difference, 10.8 percentage points). Multivariable adjustment for demographic, clinical, and hospital characteristics reduced most of the sex differences in procedure use (risk-standardized rates, 40.3% for women vs. 41.9% for men [P < 0.001]; difference, 1.6 percentage points), Sex differences in cardiac catheterization use varied by the appropriateness of the procedure. Risk-standardized rates of cardiac catheterization were similar for men and women with strong indications for the procedure (44.1% for women vs. 44.6% for men [P > 0.2]; difference, 0.5 percentage point). Rates of cardiac catheterization use among patients with weak indications did not significantly differ between men and women (16.5% for women vs. 18.0% for men [P = 0.096]; difference, 1.5 percentage points). Sex differences in cardiac catheterization use were largest for patients with equivocal indications (39.4% for women vs. 42.5% for men [P < 0.001]; difference, 3.1 percentage points). Conclusions: Among elderly persons, women have lower rates of cardiac catheterization use after an acute myocardial infarction than men. However, this difference was attenuated after multivariable adjustment, and it occurred primarily in patients with equivocal indications. We found no sex variations in procedure use among patients who had strong indications for cardiac catheterization.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale New Haven Med Ctr, New Haven, CT 06504 USA; Qualidigm, Middletown, CT USA; Ctr Medicare Serv, Boston, MA USA; Ctr Medicaid Serv, Boston, MA USA	Yale University; Yale University; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Room 1E-61 SHM,333 Cedar St,POB 208025, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557				*AM HOSP ASS, 1994, ANN SURV HOSP DAT DO; [Anonymous], CORONARY ANGIOGRAPHY; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; BELL MR, 1995, J AM COLL CARDIOL, V25, P1650, DOI 10.1016/0735-1097(95)00044-5; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; Chen J, 2001, NEW ENGL J MED, V344, P1443, DOI 10.1056/NEJM200105103441906; CHERKIN D, 1977, MED CARE, V15, P767; CHIRIBOGA DE, 1993, AM J CARDIOL, V71, P268, DOI 10.1016/0002-9149(93)90789-F; DHOORE W, 1994, AM J PUBLIC HEALTH, V84, P1013, DOI 10.2105/AJPH.84.6.1013; FUNK M, 1994, AM J CARDIOL, V74, P1170, DOI 10.1016/0002-9149(94)90475-8; GATSONIS CA, 1995, MED CARE, V33, P625, DOI 10.1097/00005650-199506000-00005; GILES WH, 1995, ARCH INTERN MED, V155, P318, DOI 10.1001/archinte.155.3.318; Guadagnoli E, 2000, NEW ENGL J MED, V343, P1460, DOI 10.1056/NEJM200011163432006; HACHAMOVITCH R, 1995, J AM COLL CARDIOL, V26, P1457, DOI 10.1016/0735-1097(95)00356-8; Hippisley-Cox J, 2001, BMJ-BRIT MED J, V322, P832, DOI 10.1136/bmj.322.7290.832; *HLTH CAR FIN ADM, 1997, INT CLASS DIS; Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1; Kilaru PK, 2000, J AM COLL CARDIOL, V35, P974, DOI 10.1016/S0735-1097(99)00641-5; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; KYRIAKIDIS M, 1995, J CLIN EPIDEMIOL, V48, P723, DOI 10.1016/0895-4356(94)00194-U; Laouri M, 1997, INT J QUAL HEALTH C, V9, P15, DOI 10.1093/intqhc/9.1.15; Lauer MS, 1996, AM J CARDIOL, V78, P278, DOI 10.1016/S0002-9149(96)00277-9; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MARK DB, 1994, NEW ENGL J MED, V330, P1101, DOI 10.1056/NEJM199404213301601; MAYNARD C, 1992, ARCH INTERN MED, V152, P972, DOI 10.1001/archinte.152.5.972; Maynard C, 1996, CIRCULATION, V94, P93; Milner KA, 1999, AM J CARDIOL, V84, P396, DOI 10.1016/S0002-9149(99)00322-7; ORENTLICHER D, 1991, JAMA-J AM MED ASSOC, V266, P559; PASHOS CL, 1993, JAMA-J AM MED ASSOC, V270, P1832, DOI 10.1001/jama.270.15.1832; PEARSON ML, 1992, JAMA-J AM MED ASSOC, V268, P1883, DOI 10.1001/jama.268.14.1883; Rathore SS, 2001, JAMA-J AM MED ASSOC, V286, P2849, DOI 10.1001/jama.286.22.2849; Ruiz MT, 1997, J EPIDEMIOL COMMUN H, V51, P106, DOI 10.1136/jech.51.2.106; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Schwartz LM, 1997, ARCH INTERN MED, V157, P1545, DOI 10.1001/archinte.157.14.1545; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; UDVARHELYI IS, 1992, JAMA-J AM MED ASSOC, V268, P2530, DOI 10.1001/jama.268.18.2530; *US BUR CENS, 1991, STAT METR AR DAT BOO; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wong BYY, 1996, CANCER BIOTHER RADIO, V11, P51, DOI 10.1089/cbr.1996.11.51; Wong CC, 1998, AM HEART J, V135, P435, DOI 10.1016/S0002-8703(98)70319-9	42	69	72	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					487	493		10.7326/0003-4819-137-6-200209170-00008	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230349				2022-12-28	WOS:000178069100002
J	Patterson, GH; Lippincott-Schwartz, J				Patterson, GH; Lippincott-Schwartz, J			A photoactivatable GFP for selective photolabeling of proteins and cells	SCIENCE			English	Article							GREEN-FLUORESCENT PROTEIN; LYSOSOMAL MEMBRANE; STRUCTURAL BASIS; LIVING CELLS; MUTATIONS; GLYCOPROTEINS; EXCITATION; DYNAMICS; MUTANTS	We report a photoactivatable variant of the Aequorea victoria green fluorescent protein (GFP) that, after intense irradiation with 413-nanometer light, increases fluorescence 100 times when excited by 488-nanometer light and remains stable for days under aerobic conditions. These characteristics offer a new tool for exploring intracellular protein dynamics by tracking photoactivated molecules that are the only visible GFPs in the cell. Here, we use the photoactivatable GFP both as a free protein to measure protein diffusion across the nuclear envelope and as a chimera with a lysosomal membrane protein to demonstrate rapid interlysosomal membrane exchange.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lippincott-Schwartz, J (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.	jlippin@helix.nih.gov	Patterson, George/ABI-4751-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001609] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DENG YP, 1988, P NATL ACAD SCI USA, V85, P3860, DOI 10.1073/pnas.85.11.3860; EHRIG T, 1995, FEBS LETT, V367, P163, DOI 10.1016/0014-5793(95)00557-P; Elowitz MB, 1997, CURR BIOL, V7, P809, DOI 10.1016/S0960-9822(06)00342-3; FERRIS AL, 1987, J CELL BIOL, V105, P2703, DOI 10.1083/jcb.105.6.2703; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HOWE CL, 1988, P NATL ACAD SCI USA, V85, P7577, DOI 10.1073/pnas.85.20.7577; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Marchant JS, 2001, NAT BIOTECHNOL, V19, P645, DOI 10.1038/90249; Palm GJ, 1997, NAT STRUCT BIOL, V4, P361, DOI 10.1038/nsb0597-361; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Piston DW, 1999, METHOD CELL BIOL, V58, P31; Politz JC, 1999, TRENDS CELL BIOL, V9, P284, DOI 10.1016/S0962-8924(99)01585-8; Prendergast FG, 1999, METHOD CELL BIOL, V58, P1; Sawin KE, 1997, CURR BIOL, V7, pR606, DOI 10.1016/S0960-9822(06)00313-7; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; van Thor JJ, 2002, NAT STRUCT BIOL, V9, P37, DOI 10.1038/nsb739; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Yokoe E, 1996, NAT BIOTECHNOL, V14, P1252, DOI 10.1038/nbt1096-1252	25	1185	1237	13	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1873	1877		10.1126/science.1074952	http://dx.doi.org/10.1126/science.1074952			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228718				2022-12-28	WOS:000177955000045
J	Falnes, PO; Johansen, RF; Seeberg, E				Falnes, PO; Johansen, RF; Seeberg, E			AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli	NATURE			English	Article							ADAPTIVE RESPONSE; ALKYLATING-AGENTS; GLYCOSYLASE; INDUCTION; ADDUCTS; BEARING; REPAIR; CELLS	The bacterial AlkB protein is known to be involved in cellular recovery from alkylation damage; however, the function of this protein remains unknown. AlkB homologues have been identified in several organisms, including humans, and a recent sequence alignment study has suggested that these proteins may belong to a superfamily of 2-oxoglutarate-dependent and iron-dependent oxygenases (2OG-Fe(II)-oxygenases)(1). Here we show that AlkB from Escherichia coli is indeed a 2-oxoglutarate-dependent and iron-dependent DNA repair enzyme that releases replication blocks in alkylated DNA by a mechanism involving oxidative demethylation of 1-methyladenine residues. This mechanism represents a new pathway for DNA repair and the third type of DNA damage reversal mechanism so far discovered.	Univ Oslo, Natl Hosp, Ctr Mol Biol & Neurosci, N-0027 Oslo, Norway; Univ Oslo, Natl Hosp, Inst Med Microbiol, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Falnes, PO (corresponding author), Univ Oslo, Natl Hosp, Ctr Mol Biol & Neurosci, N-0027 Oslo, Norway.		Falnes, Pål Ø./AAA-4581-2020	Falnes, Pal/0000-0001-8114-6025				*AM PHARM BIOT, 1997, GST GEN FUS SYST US; ARAVIND L, 2001, GENOME BIOL, V2; BJELLAND S, 1993, NUCLEIC ACIDS RES, V21, P2045, DOI 10.1093/nar/21.9.2045; CHEN BRJ, 1994, J BACTERIOL, V176, P6255, DOI 10.1128/jb.176.20.6255-6261.1994; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Dinglay S, 2000, GENE DEV, V14, P2097; EVENSEN G, 1982, NATURE, V296, P773, DOI 10.1038/296773a0; Hofer T, 1998, CHEM RES TOXICOL, V11, P882, DOI 10.1021/tx980041x; KARRAN P, 1982, NATURE, V296, P770, DOI 10.1038/296770a0; KARRAN P, 1979, NATURE, V280, P76, DOI 10.1038/280076a0; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; PALEJWALA VA, 1991, BIOCHEMISTRY-US, V30, P8736, DOI 10.1021/bi00100a004; Parkinson A, 1996, TOXICOLOGY BASIC SCI, P113; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; RAPOPORT R, 1994, ANAL BIOCHEM, V218, P309, DOI 10.1006/abio.1994.1183; Singer B., 1983, MOL BIOL MUTAGENS CA; Wang G, 1997, BIOCHEMISTRY-US, V36, P9486, DOI 10.1021/bi970650o; Wei YF, 1996, NUCLEIC ACIDS RES, V24, P931, DOI 10.1093/nar/24.5.931	19	477	495	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					178	182		10.1038/nature01048	http://dx.doi.org/10.1038/nature01048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226668				2022-12-28	WOS:000177931200044
J	Groeneveld, JHM; Puylaert, JBCM				Groeneveld, JHM; Puylaert, JBCM			Septic peripheral embolization from Haemophilus aphrophilus endocarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Westeinde Ziekenhuis, NL-2512 VA The Hague, Netherlands		Groeneveld, JHM (corresponding author), Westeinde Ziekenhuis, NL-2512 VA The Hague, Netherlands.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					816	816		10.1056/NEJMicm010721	http://dx.doi.org/10.1056/NEJMicm010721			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226152				2022-12-28	WOS:000177921300006
J	Malik, I; Berger, A				Malik, I; Berger, A			Science commentary: Coronary angioplasty and stenting	BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE		St Marys Hosp, Waller Dept Cardiol, London W2 1NY, England	Imperial College London	Malik, I (corresponding author), St Marys Hosp, Waller Dept Cardiol, Praed St, London W2 1NY, England.							Alderman EL, 2000, J AM COLL CARDIOL, V35, P1122; Bhatt DL, 2000, J AM COLL CARDIOL, V35, P922, DOI 10.1016/S0735-1097(99)00650-6; George CJ, 1998, AM J CARDIOL, V81, P860, DOI 10.1016/S0002-9149(98)00004-6; LINCOFF AM, 1999, J AM COLL CARDIOL, V133, pA45; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; *SOS INV, 2001, STENT SURG SOS TRIAL	8	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2002	325	7363					519	520		10.1136/bmj.325.7363.519	http://dx.doi.org/10.1136/bmj.325.7363.519			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593NJ	12217991	Bronze, Green Published			2022-12-28	WOS:000177997800017
J	Martinez, J; Patkaniowska, A; Urlaub, H; Luhrmann, R; Tuschl, T				Martinez, J; Patkaniowska, A; Urlaub, H; Luhrmann, R; Tuschl, T			Single-stranded antisense siRNAs guide target RNA cleavage in RNAi	CELL			English	Article							MESSENGER-RNA; C-ELEGANS; CAENORHABDITIS-ELEGANS; CELL-DIFFERENTIATION; GENETIC INTERFERENCE; STEM-CELLS; INITIATION; EXPRESSION; PROTEINS; DEGRADATION	Small interfering RNAs (siRNAs) are the mediators of mRNA degradation in the process of RNA interference (RNAi). Here, we describe a human biochemical system that recapitulates siRNA-mediated target RNA degradation. By using affinity-tagged siRNAs, we demonstrate that a single-stranded siRNA resides in the RNA-induced silencing complex (RISC) together with eIF2C1 and/or eIF2C2 (human GERp95) Argonaute proteins. RISC is rapidly formed in HeLa cell cytoplasmic extract supplemented with 21 nt siRNA duplexes, but also by adding single-stranded antisense RNAs, which range in size between 19 and 29 nucleotides. Single-stranded antisense siRNAs are also effectively silencing genes in HeLa cells, especially when 5'-phosphorylated, and expand the repertoire of RNA reagents suitable for gene targeting.	Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	Max Planck Society	Tuschl, T (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.			Martinez, Javier/0000-0001-9152-7323				Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eckstein F., 1991, OLIGONUCLEOTIDES ANA; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Genschik P, 1997, EMBO J, V16, P2955, DOI 10.1093/emboj/16.10.2955; GUO S, 1995, CELL, V81, P613; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harborth J, 2001, J CELL SCI, V114, P4557; HUTVAGNER G, 2002, IN PRESS SCIENCE; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Koesters R, 1999, GENOMICS, V61, P210, DOI 10.1006/geno.1999.5951; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Scaringe SA, 2001, METHODS, V23, P206, DOI 10.1006/meth.2000.1132; SCHWARZ D, 2002, IN PRESS MOL CELL; Schwarz DS, 2002, GENE DEV, V16, P1025, DOI 10.1101/gad.992502; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Tuschl T, 2002, NAT BIOTECHNOL, V20, P446, DOI 10.1038/nbt0502-446; Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R; TUSCHL T, 2002, MOL INTERV, V2, P42; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Yang SC, 2001, MOL CELL BIOL, V21, P7807, DOI 10.1128/MCB.21.22.7807-7816.2001; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zamore PD, 2001, MOL CELL, V8, P1158, DOI 10.1016/S1097-2765(01)00418-X; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457; Zou C, 1998, GENE, V211, P187, DOI 10.1016/S0378-1119(98)00107-3	55	1070	1393	6	109	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 6	2002	110	5					563	574		10.1016/S0092-8674(02)00908-X	http://dx.doi.org/10.1016/S0092-8674(02)00908-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230974	Green Published, Bronze			2022-12-28	WOS:000177943700004
J	Bochkov, VN; Kadl, A; Huber, J; Gruber, F; Binder, BR; Leitinger, N				Bochkov, VN; Kadl, A; Huber, J; Gruber, F; Binder, BR; Leitinger, N			Protective role of phospholipid oxidation products in endotoxin-induced tissue damage	NATURE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; SOLUBLE CD14; LIPID-A; OXIDIZED PHOSPHOLIPIDS; LPS; CELLS; INFLAMMATION; LIPOPROTEINS; ANTAGONIST; MONOCYTES	Lipopolysaccharide (LPS), an outer-membrane component of Gram-negative bacteria, interacts with LPS-binding protein and CD14, which present LPS to toll-like receptor 4 (refs 1, 2), which activates inflammatory gene expression through nuclear factor kappaB (NFkappaB) and mitogen-activated protein-kinase signalling(3,4). Antibacterial defence involves activation of neutrophils that generate reactive oxygen species capable of killing bacteria(5); therefore host lipid peroxidation occurs, initiated by enzymes such as NADPH oxidase and myeloperoxidase(6). Oxidized phospholipids are pro-inflammatory agonists promoting chronic inflammation in atherosclerosis(7); however, recent data suggest that they can inhibit expression of inflammatory adhesion molecules(8). Here we show that oxidized phospholipids inhibit LPS-induced but not tumour-necrosis factor-alpha-induced or interleukin-1beta-induced NFkappaB-mediated upregulation of inflammatory genes, by blocking the interaction of LPS with LPS-binding protein and CD14. Moreover, in LPS-injected mice, oxidized phospholipids inhibited inflammation and protected mice from lethal endotoxin shock. Thus, in severe Gram-negative bacterial infection, endogenously formed oxidized phospholipids may function as a negative feedback to blunt innate immune responses. Furthermore, identified chemical structures capable of inhibiting the effects of endotoxins such as LPS could be used for the development of new drugs for treatment of sepsis.	Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria; BMT Res, A-1235 Vienna, Austria	University of Vienna	Leitinger, N (corresponding author), Univ Vienna, Dept Vasc Biol & Thrombosis Res, Schwarzspanierstr 17, A-1090 Vienna, Austria.	norbert.leitinger@univie.ac.at	Kadl, Alexandra/AAV-3395-2021	Gruber, Florian/0000-0003-1094-5641				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; CHRIST WJ, 1995, SCIENCE, V268, P80, DOI 10.1126/science.7701344; Cunningham MD, 1996, INFECT IMMUN, V64, P3601, DOI 10.1128/IAI.64.9.3601-3608.1996; Elass-Rochard E, 1998, INFECT IMMUN, V66, P486, DOI 10.1128/IAI.66.2.486-491.1998; EMANCIPATOR K, 1992, INFECT IMMUN, V60, P596, DOI 10.1128/IAI.60.2.596-601.1992; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Kitchens RL, 2001, J CLIN INVEST, V108, P485, DOI 10.1172/JCI200113139; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; RUSTICI A, 1993, SCIENCE, V259, P361, DOI 10.1126/science.8420003; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Su GL, 1995, CRIT REV IMMUNOL, V15, P201, DOI 10.1615/CritRevImmunol.v15.i3-4.10; Sugiyama T, 2001, J IMMUNOL, V166, P826, DOI 10.4049/jimmunol.166.2.826; Tanamoto K, 2000, J IMMUNOL, V164, P3149, DOI 10.4049/jimmunol.164.6.3149; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Wurfel MM, 1997, J IMMUNOL, V158, P3925; Yu B, 1997, J CLIN INVEST, V99, P315, DOI 10.1172/JCI119160; Zhang RL, 2002, BLOOD, V99, P1802, DOI 10.1182/blood.V99.5.1802.h8001802_1802_1810	26	303	323	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					77	81		10.1038/nature01023	http://dx.doi.org/10.1038/nature01023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214235				2022-12-28	WOS:000177788600040
J	Moniaga, NC				Moniaga, NC			A woman's rite to health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FEMALE		Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA	University of Southern California	Moniaga, NC (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA.							Affara FA, 2000, AM J NURS, V100, P52, DOI 10.2307/3522160; AHMED IF, 2001, FEMALE CIRCUMCISION; Beauchamp T. L., 1999, CONT ISSUES BIOETHIC; French H. W., 1997, NY TIMES        0131, pA4; Gibeau A M, 1998, J Obstet Gynecol Neonatal Nurs, V27, P85, DOI 10.1111/j.1552-6909.1998.tb02595.x; Jones H, 1999, STUD FAMILY PLANN, V30, P219, DOI 10.1111/j.1728-4465.1999.00219.x; Morison L, 2001, TROP MED INT HEALTH, V6, P643, DOI 10.1046/j.1365-3156.2001.00749.x; Shell-Duncan B, 2001, SOC SCI MED, V52, P1013, DOI 10.1016/S0277-9536(00)00208-2; Snow RC, 2001, TROP MED INT HEALTH, V6, P89, DOI 10.1046/j.1365-3156.2001.00692.x; Wright J, 1996, J ADV NURS, V24, P251, DOI 10.1046/j.1365-2648.1996.01934.x	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1134	1134		10.1001/jama.288.9.1134	http://dx.doi.org/10.1001/jama.288.9.1134			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589NA	12204087	hybrid			2022-12-28	WOS:000177764600020
J	Davis, BR; Cutler, JA; Furberg, CD; Wright, JT; Farber, MA; Felicetta, JV; Stokes, JD				Davis, BR; Cutler, JA; Furberg, CD; Wright, JT; Farber, MA; Felicetta, JV; Stokes, JD		ALLHAT Collaborative Res Grp	Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: Further analyses from the antihypertensive and lipid-lowering treatment to prevent heart attack trial	ANNALS OF INTERNAL MEDICINE			English	Article							MULTIPLE IMPUTATION	Background: The Anti hypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial reported that treatment initiated with doxazosin compared with chlorthalidone doubled the risk for heart failure in high-risk hypertensive patients (relative risk, 2.04 [95% CI, 1.79 to 2.32]). Patients assigned to doxazosin therapy had a mean in-trial systolic/diastolic blood pressure 3/0 mm Hg higher than that in patients assigned to chlorthalidone. Sixty-eight percent (6167 of 9061) of the former patients and 59% (9081 of 15 256) of the latter patients were given additional medications to achieve a target blood pressure of less than 140/90 mm Hg. Objective: To ascertain the influence of open-label antihypertensive drugs and subsequent blood pressure on relative risk for heart failure. Design: Randomized, double-blind, active-controlled clinical trial. Setting: 623 sites in the United States and Canada. Patients: Hypertensive patients 55 years of age or older with at least one additional risk factor for cardiovascular disease. Intervention: Chlorthalidone (12.5 to 25 mg/d) or doxazosin (2 to 8 mg/d) for a planned follow-up of 4 to 8 years. Measurements: Data on blood pressure, medication, and incident heart failure (treated outside hospital, hospitalized, or fatal) from February 1994 through December 1999. Results: After the treatment groups were categorized as having no exposure to open-label medications (monotherapy) or exposure to open-label therapy, the relative risk for heart failure with doxazosin versus chlorthalidone was 3.10 (CI, 2.51 to 3.82) and 1.42 (CI, 1.20 to 1.69), respectively. After adjustment for follow-up systolic/diastolic blood pressure, the overall relative risk was 2.00 (CI, 1.72 to 2.32). Conclusion: In high-risk patients with hypertension, the higher risk for heart failure while taking doxazosin compared with chlorthalidone is attenuated but not eliminated by adding other anti hypertensive drugs. The small observed difference in systolic blood pressure does not explain this increased risk.	Univ Texas, Sch Publ Hlth, Houston, TX 77030 USA; NHLBI, Bethesda, MD 20892 USA; Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Pitman Internal Med Associates, Pitman, NJ USA; Carl T Hayden Vet Affiars Med Ctr, Phoenix, AZ USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wake Forest University; Case Western Reserve University	Davis, BR (corresponding author), Univ Texas, Sch Publ Hlth, 1200 Herman Pressler St, Houston, TX 77030 USA.	bdavis@sph.uth.tmc.edu			NHLBI NIH HHS [N0-HC-35130] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035130] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; Jennison C, 2000, GROUP SEQUENTIAL MET; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; Klein JP., 2003, SURVIVAL ANAL TECHNI; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; PEDUZZI P, 1993, STAT MED, V12, P1185, DOI 10.1002/sim.4780121102; PILLER LP, 2001, AM J HYPERTENS, V14, pA181; RUBIN DB, 1986, J AM STAT ASSOC, V81, P366, DOI 10.2307/2289225; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676	11	77	77	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2002	137	5	1				313	320		10.7326/0003-4819-137-5_Part_1-200209030-00006	http://dx.doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591DZ	12204014				2022-12-28	WOS:000177865600002
J	Rignot, E; Thomas, RH				Rignot, E; Thomas, RH			Mass balance of polar ice sheets	SCIENCE			English	Review							ELEVATION CHANGE; PINE ISLAND; GREENLAND; CLIMATE; SHELF; GLACIER; RETREAT; STREAMS; FUTURE; ACCELERATION	Recent advances in the determination of the mass balance of polar ice sheets show that the Greenland Ice Sheet is losing mass by near-coastal thinning, and that the West Antarctic Ice Sheet, with thickening in the west and thinning in the north, is probably thinning overall. The mass imbalance of the East Antarctic Ice Sheet is likely to be small, but even its sign cannot yet be determined. Large sectors of ice in southeast Greenland, the Amundsen Sea Embayment of West Antarctica, and the Antarctic Peninsula are changing quite rapidly as a result of processes not yet understood.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; EG&G Serv, Wallops Isl Flight Facil, Wallops Isl, VA 23337 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Rignot, E (corresponding author), CALTECH, Jet Prop Lab, Mail Stop 300-235, Pasadena, CA 91109 USA.	eric@adelie.jpl.nasa.gov; robert_thomas@hotmail.com	Rignot, Eric/A-4560-2014	Rignot, Eric/0000-0002-3366-0481				Abdalati W, 2001, J GEOPHYS RES-ATMOS, V106, P33729, DOI 10.1029/2001JD900192; Allen R.G., 2001, W ANTARCTIC ICE SHEE, P1, DOI 10.1061/40499(2000)125; ALLEY RB, 1991, SCIENCE, V254, P959, DOI 10.1126/science.254.5034.959; Bamber JL, 2000, SCIENCE, V287, P1248, DOI 10.1126/science.287.5456.1248; Bamber JL, 1997, ANN GLACIOL, V25, P439, DOI 10.3189/S0260305500014427; Bentley C R, 1991, INT C ROL POL REG GL, V2, P481; Bentley CR, 1998, J GLACIOL, V44, P207, DOI 10.3189/S0022143000002549; Bindschadler R, 1998, SCIENCE, V282, P428, DOI 10.1126/science.282.5388.428; BRAITHWAITE RJ, 1995, J GLACIOL, V41, P153, DOI 10.3189/S0022143000017846; CHURCH JA, 2002, CHANGES SEA LEVEL IP, pCH11; Davis CH, 2001, J GEOPHYS RES-ATMOS, V106, P33743, DOI 10.1029/2001JD900167; Dickson RR, 2000, J CLIMATE, V13, P2671, DOI 10.1175/1520-0442(2000)013<2671:TAORTT>2.0.CO;2; Doake CSM, 1998, NATURE, V391, P778, DOI 10.1038/35832; Giovinetto MB, 2000, ANN GLACIOL-SER, V31, P171, DOI 10.3189/172756400781820200; *GODD I SPAC STUD, SURF TEMP STAT DATA; Gray AL, 2001, CAN J REMOTE SENS, V27, P193, DOI 10.1080/07038992.2001.10854936; Hindmarsh RCA, 2001, J GLACIOL, V47, P271, DOI 10.3189/172756501781832269; Jacobs SS, 2002, SCIENCE, V297, P386, DOI 10.1126/science.1069574; Jezek KC, 1999, ANN GLACIOL-SER, V29, P286, DOI 10.3189/172756499781820969; Joughin I, 1999, SCIENCE, V286, P283, DOI 10.1126/science.286.5438.283; Joughin I, 2001, J GEOPHYS RES-ATMOS, V106, P34021, DOI 10.1029/2001JD900087; Joughin I, 2002, SCIENCE, V295, P476, DOI 10.1126/science.1066875; Krabill W, 2000, SCIENCE, V289, P428, DOI 10.1126/science.289.5478.428; Lythe MB, 2001, J GEOPHYS RES-SOL EA, V106, P11335, DOI 10.1029/2000JB900449; Mayer C, 1999, J GLACIOL, V45, P384, DOI 10.3189/S002214300000188X; McConnell JR, 2000, NATURE, V406, P877, DOI 10.1038/35022555; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Mosley-Thompson E, 2001, J GEOPHYS RES-ATMOS, V106, P33839, DOI 10.1029/2001JD900067; Paterson WSB, 2001, NATURE, V414, P60, DOI 10.1038/35102044; PFEFFER WT, 1991, J GEOPHYS RES-OCEANS, V96, P22117, DOI 10.1029/91JC02502; Rignot E, 2002, ANN GLACIOL-SER, V34, P217, DOI 10.3189/172756402781817419; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2002, ANN GLACIOL, V34, P189, DOI 10.3189/172756402781817950; Rignot E, 2001, J GEOPHYS RES-ATMOS, V106, P34007, DOI 10.1029/2001JD900071; Rignot E, 2001, J GLACIOL, V47, P213, DOI 10.3189/172756501781832340; Rignot EJ, 1998, SCIENCE, V281, P549, DOI 10.1126/science.281.5376.549; Rott H, 2002, ANN GLACIOL-SER, V34, P277, DOI 10.3189/172756402781817716; Scambos TA, 2000, J GLACIOL, V46, P516, DOI 10.3189/172756500781833043; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; SHABTAIE S, 1987, J GEOPHYS RES-SOLID, V92, P1311, DOI 10.1029/JB092iB02p01311; Shepherd A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014183; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; Swithinbank C., 1988, SATELLITE IMAGE ATLA; Thomas R, 2001, J GEOPHYS RES-ATMOS, V106, P33707, DOI 10.1029/2001JD900033; Thomas RH, 2001, J GEOPHYS RES-ATMOS, V106, P33691, DOI 10.1029/2001JD900042; Thomas RH, 1977, GEOGR PHYS QUATERN, V31, P347; Vaughan DG, 1999, J CLIMATE, V12, P933, DOI 10.1175/1520-0442(1999)012<0933:RONSMB>2.0.CO;2; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; VAUGHAN DG, 1992, CONTRIBUTION ANTARCT, P35; Wahr J, 2000, J GEOPHYS RES-SOL EA, V105, P16279, DOI 10.1029/2000JB900113; Weidick A, 1991, RAPP GRONLANDS GEOL, V152, P73; Wingham DJ, 1998, SCIENCE, V282, P456, DOI 10.1126/science.282.5388.456; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708; ZWALLY J, COMMUNICATION	54	309	329	4	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1502	1506		10.1126/science.1073888	http://dx.doi.org/10.1126/science.1073888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202817	Green Submitted			2022-12-28	WOS:000177697300043
J	Li, HB; Linke, WA; Oberhauser, AF; Carrion-Vazquez, M; Kerkviliet, JG; Lu, H; Marszalek, PE; Fernandez, JM				Li, HB; Linke, WA; Oberhauser, AF; Carrion-Vazquez, M; Kerkviliet, JG; Lu, H; Marszalek, PE; Fernandez, JM			Reverse engineering of the giant muscle protein titin	NATURE			English	Article							ATOMIC-FORCE MICROSCOPY; SINGLE MOLECULES; CONFORMATIONS; ELASTICITY; DNA	Through the study of single molecules it has become possible to explain the function of many of the complex molecular assemblies found in cells(1-5). The protein titin provides muscle with its passive elasticity. Each titin molecule extends over half a sarcomere, and its extensibility has been studied both in situ(6-10) and at the level of single molecules(11-14). These studies suggested that titin is not a simple entropic spring but has a complex structure-dependent elasticity. Here we use protein engineering and single-molecule atomic force microscopy(15) to examine the mechanical components that form the elastic region of human cardiac titin(16,17). We show that when these mechanical elements are combined, they explain the macroscopic behaviour of titin in intact muscle(6). Our studies show the functional reconstitution of a protein from the sum of its parts.	Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Rochester, MN 55905 USA; Heidelberg Univ, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany; Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Mayo Clinic; Ruprecht Karls University Heidelberg; Donald Danforth Plant Science Center	Fernandez, JM (corresponding author), Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Rochester, MN 55905 USA.	jfernandez@columbia.edu	Linke, Wolfgang A/E-8662-2012; Li, Hongbin/G-2949-2012; Carrion-Vazquez, Mariano/Y-3741-2018	Li, Hongbin/0000-0001-7813-1332; Lu, Hui/0000-0001-8347-0830; Carrion-Vazquez, Mariano/0000-0001-7319-406X; Linke, Wolfgang/0000-0003-0801-3773				ALLEN DG, 1985, J MOL CELL CARDIOL, V17, P821, DOI 10.1016/S0022-2828(85)80097-3; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X; BUECHE F, 1962, PHYSICAL PROPERTIES, P37; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; Freiburg A, 2000, CIRC RES, V86, P1114; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; HIGUCHI H, 1993, BIOPHYS J, V65, P1906, DOI 10.1016/S0006-3495(93)81261-X; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; Linke WA, 1999, J CELL BIOL, V146, P631, DOI 10.1083/jcb.146.3.631; Linke WA, 1996, J MOL BIOL, V261, P62, DOI 10.1006/jmbi.1996.0441; Lu H, 1999, PROTEINS, V35, P453, DOI 10.1002/(SICI)1097-0134(19990601)35:4<453::AID-PROT9>3.3.CO;2-D; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Maruyama K, 1997, FASEB J, V11, P341, DOI 10.1096/fasebj.11.5.9141500; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260; SIGWORTH FJ, 1980, NATURE, V287, P447, DOI 10.1038/287447a0; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; TRINKAUS E, 1980, J HUM EVOL, V9, P377, DOI 10.1016/0047-2484(80)90049-4; Trombitas K, 1999, BIOPHYS J, V77, P3189, DOI 10.1016/S0006-3495(99)77149-3; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Tskhovrebova L, 1997, J MOL BIOL, V265, P100, DOI 10.1006/jmbi.1996.0717; Wang K, 1996, ADV BIOPHYS, V33, P123	30	404	411	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2002	418	6901					998	1002		10.1038/nature00938	http://dx.doi.org/10.1038/nature00938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198551				2022-12-28	WOS:000177677500049
J	Hedges, SB; Kumar, S				Hedges, SB; Kumar, S			Vertebrate genomes compared	SCIENCE			English	Editorial Material							DISEASE		Penn State Univ, NASA, Astrobiol Inst, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Arizona State Univ, Dept Biol, Tempe, AZ 85287 USA	National Aeronautics & Space Administration (NASA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Arizona State University; Arizona State University-Tempe	Hedges, SB (corresponding author), Penn State Univ, NASA, Astrobiol Inst, University Pk, PA 16802 USA.		Kumar, Sudhir/F-1411-2011	Kumar, Sudhir/0000-0002-9918-8212				Abrahams BS, 2002, GENOMICS, V80, P45, DOI 10.1006/geno.2002.6795; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Clark MS, 2001, IMMUNOGENETICS, V52, P174, DOI 10.1007/s002510000285; GREEN ED, 2000, METABOLIC MOL BASES, V1, P259; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Thomas JW, 2002, TRENDS GENET, V18, P104, DOI 10.1016/S0168-9525(02)02599-4; Venkatesh B, 2000, FEBS LETT, V476, P3, DOI 10.1016/S0014-5793(00)01659-8; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704	15	83	87	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1283	1285						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193771				2022-12-28	WOS:000177573900026
J	Wang, XQ; McLachlan, J; Zamore, PD; Hall, TMT				Wang, XQ; McLachlan, J; Zamore, PD; Hall, TMT			Modular recognition of RNA by a human pumilio-homology domain	CELL			English	Article							HUNCHBACK MESSENGER-RNA; SPERM-OOCYTE SWITCH; CAENORHABDITIS-ELEGANS; MOLECULAR REPLACEMENT; DROSOPHILA EMBRYOS; BINDING PROTEIN; NANOS; REGULATOR; SEQUENCE; PROGRAM	Puf proteins are developmental regulators that control mRNA stability and translation by binding sequences in the 3' untranslated regions of their target mRNAs. We have determined the structure of the RNA binding domain of the human Puf protein, Pumilio 1 , bound to a high-affinity RNA ligand. The RNA binds the concave surface of the molecule, where each of the protein's eight repeats makes contacts with a different RNA base via three amino acid side chains at conserved positions. We have mutated these three side chains in one repeat, thereby altering the sequence specificity of Pumilio 1. Thus, the high affinity and specificity of the PUM-HD for RNA is achieved using multiple copies of a simple repeated motif.	NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01655 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Massachusetts System; University of Massachusetts Worcester	Hall, TMT (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.		Zamore, Phillip D/A-8941-2013; Hall, Traci/F-5849-2019	Hall, Traci/0000-0001-6166-3009; Zamore, Phillip/0000-0002-4505-9618				AHRINGER J, 1991, NATURE, V349, P346, DOI 10.1038/349346a0; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Forbes A, 1998, DEVELOPMENT, V125, P679; Gamberi C, 2002, DEVELOPMENT, V129, P2699; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEHMANN R, 1987, NATURE, V329, P167, DOI 10.1038/329167a0; Lin HF, 1997, DEVELOPMENT, V124, P2463; MACDONALD PM, 1992, DEVELOPMENT, V114, P221; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Souza GM, 1999, DEVELOPMENT, V126, P3263; Tadauchi T, 2001, EMBO J, V20, P552, DOI 10.1093/emboj/20.3.552; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; White EK, 2001, RNA, V7, P1855; Zamore PD, 1999, BIOCHEMISTRY-US, V38, P596, DOI 10.1021/bi982264s; Zamore PD, 1997, RNA, V3, P1421; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	35	389	413	1	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 23	2002	110	4					501	512		10.1016/S0092-8674(02)00873-5	http://dx.doi.org/10.1016/S0092-8674(02)00873-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202039	Bronze			2022-12-28	WOS:000177653200011
J	Zhu, JJ; Qin, Y; Zhao, MM; Van Aelst, L; Malinow, R				Zhu, JJ; Qin, Y; Zhao, MM; Van Aelst, L; Malinow, R			Ras and Rap control AMPA receptor trafficking during synaptic plasticity	CELL			English	Article							LONG-TERM DEPRESSION; PROTEIN-KINASE CASCADE; GLUTAMATE RECEPTORS; MAP KINASE; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAY; STRUCTURAL BASIS; ACTIVATION; MECHANISMS; TRANSMISSION	Recent studies show that AMPA receptor (-R) trafficking is important in synaptic plasticity. However, the signaling controlling this trafficking is poorly understood. Small GTPases have diverse neuronal functions and their perturbation is responsible for several mental disorders. Here, we examine the small GTPases Ras and Rap in the postsynaptic signaling underlying synaptic plasticity. We show that Ras relays the NMDA-R and CaMKII signaling that drives synaptic delivery of AMPA-Rs during long-term potentiation. In contrast, Rap mediates NMDA-R-dependent removal of synaptic AMPA-Rs that occurs during long-term depression. Ras and Rap exert their effects on AMPA-Rs that contain different subunit composition. Thus, Ras and Rap, whose activity can be controlled by postsynaptic enzymes, serve as independent regulators for potentiating and depressing central synapses.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	Cold Spring Harbor Laboratory; University of Virginia	Malinow, R (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org						Antonarakis SE, 1998, NAT GENET, V19, P106, DOI 10.1038/450; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Comings DE, 1996, PSYCHIAT RES, V63, P25, DOI 10.1016/0165-1781(96)02829-6; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; DUDEK SM, 1993, J NEUROSCI, V13, P2910; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Gutmann DH, 1999, ARCH NEUROL-CHICAGO, V56, P1322, DOI 10.1001/archneur.56.11.1322; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KIM S, 1990, MOL CELL BIOL, V10, P2645, DOI 10.1128/MCB.10.6.2645; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KOHLER M, 1994, J BIOL CHEM, V269, P17367; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; M'Rabet L, 1998, BLOOD, V92, P2133, DOI 10.1182/blood.V92.6.2133.418k19_2133_2140; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MALY FE, 1994, J BIOL CHEM, V269, P18743; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Sawada Y, 2001, J CELL SCI, V114, P1221; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tonini R, 1999, EUR J NEUROSCI, V11, P959, DOI 10.1046/j.1460-9568.1999.00504.x; VAN AL, 1993, P NATL ACAD SCI USA, V90, P6213; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Yoshimura Y, 2000, MOL BRAIN RES, V81, P118, DOI 10.1016/S0169-328X(00)00170-4; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zwartkruis FJT, 1999, EXP CELL RES, V253, P157, DOI 10.1006/excr.1999.4695	70	594	622	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					443	455		10.1016/S0092-8674(02)00897-8	http://dx.doi.org/10.1016/S0092-8674(02)00897-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202034	Bronze			2022-12-28	WOS:000177653200006
J	Crawford, LM				Crawford, LM			Nominations for device panels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1225	1225		10.1001/jama.288.10.1225	http://dx.doi.org/10.1001/jama.288.10.1225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215114				2022-12-28	WOS:000177917700008
J	Crawford, LM				Crawford, LM			Needlestick injury data needed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1225	1225		10.1001/jama.288.10.1225	http://dx.doi.org/10.1001/jama.288.10.1225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215114				2022-12-28	WOS:000177917700006
